##gff-version 3
##sequence-region Q99490 1 1192
Q99490	UniProtKB	Chain	1	1192	.	.	.	ID=PRO_0000074217;Note=Arf-GAP with GTPase%2C ANK repeat and PH domain-containing protein 2	
Q99490	UniProtKB	Domain	676	910	.	.	.	Note=PH	
Q99490	UniProtKB	Domain	931	1051	.	.	.	Note=Arf-GAP	
Q99490	UniProtKB	Repeat	1090	1119	.	.	.	Note=ANK 1	
Q99490	UniProtKB	Repeat	1123	1152	.	.	.	Note=ANK 2	
Q99490	UniProtKB	Nucleotide binding	413	420	.	.	.	Note=GTP;status=Potential	
Q99490	UniProtKB	Nucleotide binding	457	461	.	.	.	Note=GTP;status=Potential	
Q99490	UniProtKB	Nucleotide binding	515	518	.	.	.	Note=GTP;status=Potential	
Q99490	UniProtKB	Zinc finger	946	969	.	.	.	Note=C4-type	
Q99490	UniProtKB	Region	1	23	.	.	.	Note=Interaction with EPB41L1;status=By similarity	
Q99490	UniProtKB	Region	180	225	.	.	.	Note=Interactions with HOMER1 and NF2;status=By similarity	
Q99490	UniProtKB	Region	267	390	.	.	.	Note=Interaction with PLCG1;status=By similarity	
Q99490	UniProtKB	Region	405	572	.	.	.	Note=G domain	
Q99490	UniProtKB	Modified residue	638	638	.	.	.	Note=Phosphoserine	
Q99490	UniProtKB	Alternative sequence	1	336	.	.	.	ID=VSP_018531;Note=In isoform 2.	
Q99490	UniProtKB	Alternative sequence	337	390	.	.	.	ID=VSP_018532;Note=In isoform 2.	
Q99490	UniProtKB	Alternative sequence	853	872	.	.	.	ID=VSP_018533;Note=In isoform 2.	
Q99490	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_036183;Note=In a breast cancer sample%3B somatic mutation.	
Q99490	UniProtKB	Natural variant	455	455	.	.	.	ID=VAR_026438;Note=In a glioblastoma cell line.	
Q99490	UniProtKB	Natural variant	507	507	.	.	.	ID=VAR_022046;Dbxref=dbSNP:rs2301553	
Q99490	UniProtKB	Natural variant	518	518	.	.	.	ID=VAR_026439;Note=In a sarcoma cell line.	
Q99490	UniProtKB	Natural variant	568	568	.	.	.	ID=VAR_026440;Note=In a neuroblastoma cell line.	
Q99490	UniProtKB	Natural variant	651	651	.	.	.	ID=VAR_026441;Note=In a glioblastoma cell line.	
Q99490	UniProtKB	Natural variant	767	767	.	.	.	ID=VAR_026442;Note=In a glioblastoma cell line.	
Q99490	UniProtKB	Natural variant	816	816	.	.	.	ID=VAR_036184;Note=In a breast cancer sample%3B somatic mutation.	
Q99490	UniProtKB	Natural variant	939	939	.	.	.	ID=VAR_026443;Note=In a glioblastoma cell line.	
Q99490	UniProtKB	Natural variant	947	947	.	.	.	ID=VAR_026444;Note=In a sarcoma cell line.	
Q99490	UniProtKB	Natural variant	1022	1022	.	.	.	ID=VAR_026445;Note=In a glioblastoma cell line.	
Q99490	UniProtKB	Natural variant	1124	1124	.	.	.	ID=VAR_055532;Dbxref=dbSNP:rs238521	
Q99490	UniProtKB	Sequence conflict	1137	1137	.	.	.	.	
Q99490	UniProtKB	Sequence conflict	1147	1147	.	.	.	.	
Q99490	UniProtKB	Beta strand	406	412	.	.	.	.	
Q99490	UniProtKB	Helix	415	417	.	.	.	.	
Q99490	UniProtKB	Helix	419	428	.	.	.	.	
Q99490	UniProtKB	Beta strand	438	448	.	.	.	.	
Q99490	UniProtKB	Beta strand	451	459	.	.	.	.	
Q99490	UniProtKB	Beta strand	461	463	.	.	.	.	
Q99490	UniProtKB	Helix	466	471	.	.	.	.	
Q99490	UniProtKB	Beta strand	473	480	.	.	.	.	
Q99490	UniProtKB	Helix	484	501	.	.	.	.	
Q99490	UniProtKB	Beta strand	503	505	.	.	.	.	
Q99490	UniProtKB	Beta strand	509	515	.	.	.	.	
Q99490	UniProtKB	Beta strand	521	523	.	.	.	.	
Q99490	UniProtKB	Helix	529	539	.	.	.	.	
Q99490	UniProtKB	Beta strand	540	548	.	.	.	.	
Q99490	UniProtKB	Turn	549	552	.	.	.	.	
Q99490	UniProtKB	Helix	555	574	.	.	.	.	
Q99490	UniProtKB	Beta strand	677	686	.	.	.	.	
Q99490	UniProtKB	Beta strand	695	703	.	.	.	.	
Q99490	UniProtKB	Turn	704	706	.	.	.	.	
Q99490	UniProtKB	Beta strand	707	713	.	.	.	.	
Q99490	UniProtKB	Helix	714	719	.	.	.	.	
Q99490	UniProtKB	Beta strand	724	730	.	.	.	.	
Q99490	UniProtKB	Beta strand	732	734	.	.	.	.	
Q99490	UniProtKB	Beta strand	878	881	.	.	.	.	
Q99490	UniProtKB	Beta strand	887	894	.	.	.	.	
Q99490	UniProtKB	Helix	895	913	.	.	.	.	
##sequence-region O14862 1 343
O14862	UniProtKB	Chain	1	343	.	.	.	ID=PRO_0000153726;Note=Interferon-inducible protein AIM2	
O14862	UniProtKB	Domain	1	87	.	.	.	Note=DAPIN	
O14862	UniProtKB	Domain	138	337	.	.	.	Note=HIN-200	
O14862	UniProtKB	Compositional bias	206	209	.	.	.	Note=Poly-Ile	
O14862	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_022022;Dbxref=dbSNP:rs2276405	
O14862	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_043379	
O14862	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Fails to activate interleukin-1 beta production.	
O14862	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-K162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	162	162	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	163	163	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	165	165	.	.	.	Note=Impairs DNA binding.	
O14862	UniProtKB	Mutagenesis	198	198	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	251	251	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	309	309	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	311	311	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	335	335	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Mutagenesis	337	337	.	.	.	Note=Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204. Impairs DNA binding%3B when associated with A-160%3B A-162%3B A-163%3B A-198%3B A-204%3B A-244%3B A-251%3B A-309%3B A-311%3B A-355 and A-337.	
O14862	UniProtKB	Sequence conflict	253	253	.	.	.	.	
O14862	UniProtKB	Helix	2	11	.	.	.	.	
O14862	UniProtKB	Helix	14	16	.	.	.	.	
O14862	UniProtKB	Helix	19	27	.	.	.	.	
O14862	UniProtKB	Beta strand	30	32	.	.	.	.	
O14862	UniProtKB	Turn	36	38	.	.	.	.	
O14862	UniProtKB	Helix	39	42	.	.	.	.	
O14862	UniProtKB	Helix	45	56	.	.	.	.	
O14862	UniProtKB	Helix	58	71	.	.	.	.	
O14862	UniProtKB	Helix	75	93	.	.	.	.	
O14862	UniProtKB	Beta strand	148	150	.	.	.	.	
O14862	UniProtKB	Beta strand	154	161	.	.	.	.	
O14862	UniProtKB	Beta strand	165	169	.	.	.	.	
O14862	UniProtKB	Beta strand	172	182	.	.	.	.	
O14862	UniProtKB	Beta strand	187	192	.	.	.	.	
O14862	UniProtKB	Helix	195	199	.	.	.	.	
O14862	UniProtKB	Beta strand	206	214	.	.	.	.	
O14862	UniProtKB	Beta strand	219	221	.	.	.	.	
O14862	UniProtKB	Beta strand	225	229	.	.	.	.	
O14862	UniProtKB	Helix	240	247	.	.	.	.	
O14862	UniProtKB	Helix	252	256	.	.	.	.	
O14862	UniProtKB	Beta strand	263	275	.	.	.	.	
O14862	UniProtKB	Beta strand	277	286	.	.	.	.	
O14862	UniProtKB	Beta strand	289	296	.	.	.	.	
O14862	UniProtKB	Helix	300	302	.	.	.	.	
O14862	UniProtKB	Beta strand	309	319	.	.	.	.	
O14862	UniProtKB	Beta strand	321	327	.	.	.	.	
O14862	UniProtKB	Beta strand	333	337	.	.	.	.	
##sequence-region P25054 1 2843
P25054	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
P25054	UniProtKB	Chain	2	2843	.	.	.	ID=PRO_0000064627;Note=Adenomatous polyposis coli protein	
P25054	UniProtKB	Repeat	453	495	.	.	.	Note=ARM 1	
P25054	UniProtKB	Repeat	505	547	.	.	.	Note=ARM 2	
P25054	UniProtKB	Repeat	548	591	.	.	.	Note=ARM 3	
P25054	UniProtKB	Repeat	592	638	.	.	.	Note=ARM 4	
P25054	UniProtKB	Repeat	639	683	.	.	.	Note=ARM 5	
P25054	UniProtKB	Repeat	684	725	.	.	.	Note=ARM 6	
P25054	UniProtKB	Repeat	726	767	.	.	.	Note=ARM 7	
P25054	UniProtKB	Region	960	1337	.	.	.	Note=Responsible for down-regulation through a process mediated by direct ubiquitination	
P25054	UniProtKB	Region	1866	1893	.	.	.	Note=Highly charged	
P25054	UniProtKB	Coiled coil	1	61	.	.	.	status=Potential	
P25054	UniProtKB	Coiled coil	127	248	.	.	.	status=Potential	
P25054	UniProtKB	Motif	2803	2806	.	.	.	Note=Microtubule tip localization signal	
P25054	UniProtKB	Motif	2841	2843	.	.	.	Note=PDZ-binding	
P25054	UniProtKB	Compositional bias	1	730	.	.	.	Note=Leu-rich	
P25054	UniProtKB	Compositional bias	731	2832	.	.	.	Note=Ser-rich	
P25054	UniProtKB	Compositional bias	1131	1156	.	.	.	Note=Asp/Glu-rich (acidic)	
P25054	UniProtKB	Compositional bias	1558	1577	.	.	.	Note=Asp/Glu-rich (acidic)	
P25054	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
P25054	UniProtKB	Modified residue	744	744	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	780	780	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	1042	1042	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	1360	1360	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	1861	1861	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	1863	1863	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	1864	1864	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2151	2151	.	.	.	Note=Phosphothreonine	
P25054	UniProtKB	Modified residue	2260	2260	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2270	2270	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2283	2283	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2473	2473	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2535	2535	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2671	2671	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2674	2674	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Modified residue	2679	2679	.	.	.	Note=Phosphothreonine	
P25054	UniProtKB	Modified residue	2789	2789	.	.	.	Note=Phosphoserine	
P25054	UniProtKB	Alternative sequence	312	412	.	.	.	ID=VSP_004115;Note=In isoform Short.	
P25054	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_009613;Note=In FAP%3B could be a rare polymorphism.	
P25054	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_005032;Note=In FAP.	
P25054	UniProtKB	Natural variant	414	414	.	.	.	ID=VAR_005033;Dbxref=dbSNP:rs137854567;Note=In FAP.	
P25054	UniProtKB	Natural variant	722	722	.	.	.	ID=VAR_009614;Note=In FAP.	
P25054	UniProtKB	Natural variant	784	784	.	.	.	ID=VAR_005034;Note=In FAP.	
P25054	UniProtKB	Natural variant	817	817	.	.	.	ID=VAR_005035;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	870	870	.	.	.	ID=VAR_053976;Dbxref=dbSNP:rs33974176	
P25054	UniProtKB	Natural variant	880	880	.	.	.	ID=VAR_005036;Note=In colorectal carcinoma and gastric cancer%3B from a patient with MMRCS.	
P25054	UniProtKB	Natural variant	890	890	.	.	.	ID=VAR_012975;Note=In colorectal carcinoma%3B from a patient with MMRCS.	
P25054	UniProtKB	Natural variant	906	906	.	.	.	ID=VAR_005037;Note=In colorectal tumor.	
P25054	UniProtKB	Natural variant	911	911	.	.	.	ID=VAR_005038;Note=In FAP and colorectal tumor.	
P25054	UniProtKB	Natural variant	942	942	.	.	.	ID=VAR_005039;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	1027	1027	.	.	.	ID=VAR_005040;Note=In colorectal tumor.	
P25054	UniProtKB	Natural variant	1057	1057	.	.	.	ID=VAR_009615;Note=In non-FAP%3B unknown pathological significance.	
P25054	UniProtKB	Natural variant	1118	1118	.	.	.	ID=VAR_005041	
P25054	UniProtKB	Natural variant	1120	1120	.	.	.	ID=VAR_005042;Dbxref=dbSNP:rs28933379;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	1171	1171	.	.	.	ID=VAR_008992	
P25054	UniProtKB	Natural variant	1171	1171	.	.	.	ID=VAR_005043;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	1176	1176	.	.	.	ID=VAR_005044;Note=In FAP.	
P25054	UniProtKB	Natural variant	1184	1184	.	.	.	ID=VAR_009616;Note=In FAP.	
P25054	UniProtKB	Natural variant	1197	1197	.	.	.	ID=VAR_005045;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	1254	1254	.	.	.	ID=VAR_035794;Note=In a colorectal cancer sample%3B somatic mutation.	
P25054	UniProtKB	Natural variant	1259	1259	.	.	.	ID=VAR_005046;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	1292	1292	.	.	.	ID=VAR_005047	
P25054	UniProtKB	Natural variant	1296	1296	.	.	.	ID=VAR_017653;Note=In MDB%3B sporadic.	
P25054	UniProtKB	Natural variant	1304	1304	.	.	.	ID=VAR_005048	
P25054	UniProtKB	Natural variant	1307	1307	.	.	.	ID=VAR_005049;Dbxref=dbSNP:rs1801155;Note=In 6%25 of Ashkenazi Jews%3B associated with slightly increased risk of colon and breast cancer.	
P25054	UniProtKB	Natural variant	1312	1312	.	.	.	ID=VAR_005050;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	1313	1313	.	.	.	ID=VAR_005051;Note=In FAP and colorectal tumor.	
P25054	UniProtKB	Natural variant	1317	1317	.	.	.	ID=VAR_009617;Dbxref=dbSNP:rs1801166;Note=May contribute to colorectal tumor development.	
P25054	UniProtKB	Natural variant	1326	1326	.	.	.	ID=VAR_005052;Note=In gastric cancer.	
P25054	UniProtKB	Natural variant	1348	1348	.	.	.	ID=VAR_005053;Note=In FAP.	
P25054	UniProtKB	Natural variant	1395	1395	.	.	.	ID=VAR_065133;Note=In hepatoblastoma.	
P25054	UniProtKB	Natural variant	1422	1422	.	.	.	ID=VAR_005054;Note=In colorectal tumor.	
P25054	UniProtKB	Natural variant	1472	1472	.	.	.	ID=VAR_017654;Note=In MDB%3B sporadic.	
P25054	UniProtKB	Natural variant	1495	1495	.	.	.	ID=VAR_017655;Note=In MDB%3B sporadic.	
P25054	UniProtKB	Natural variant	1496	1496	.	.	.	ID=VAR_020141;Dbxref=dbSNP:rs2229996	
P25054	UniProtKB	Natural variant	1508	1508	.	.	.	ID=VAR_012976;Note=In colorectal carcinoma from a patient with MMRCS.	
P25054	UniProtKB	Natural variant	1822	1822	.	.	.	ID=VAR_008993;Dbxref=dbSNP:rs459552	
P25054	UniProtKB	Natural variant	1882	1882	.	.	.	ID=VAR_053977;Dbxref=dbSNP:rs34157245	
P25054	UniProtKB	Natural variant	1973	1973	.	.	.	ID=VAR_020142;Dbxref=dbSNP:rs4987109	
P25054	UniProtKB	Natural variant	2499	2499	.	.	.	ID=VAR_053978;Dbxref=dbSNP:rs33941929	
P25054	UniProtKB	Natural variant	2502	2502	.	.	.	ID=VAR_005055;Dbxref=dbSNP:rs2229995	
P25054	UniProtKB	Natural variant	2621	2621	.	.	.	ID=VAR_005056;Dbxref=dbSNP:rs72541816;Note=In FAP.	
P25054	UniProtKB	Natural variant	2738	2738	.	.	.	ID=VAR_008994	
P25054	UniProtKB	Natural variant	2839	2839	.	.	.	ID=VAR_005057;Note=In FAP.	
P25054	UniProtKB	Mutagenesis	2841	2841	.	.	.	Note=Loss of interaction with SCRIB.	
P25054	UniProtKB	Mutagenesis	2843	2843	.	.	.	Note=Loss of interaction with SCRIB.	
P25054	UniProtKB	Sequence conflict	184	184	.	.	.	.	
P25054	UniProtKB	Sequence conflict	184	184	.	.	.	.	
P25054	UniProtKB	Sequence conflict	970	970	.	.	.	.	
P25054	UniProtKB	Sequence conflict	970	970	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1309	1309	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1309	1309	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1325	1331	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1325	1331	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1355	1355	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1355	1355	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1591	1591	.	.	.	.	
P25054	UniProtKB	Sequence conflict	1591	1591	.	.	.	.	
P25054	UniProtKB	Sequence conflict	2723	2723	.	.	.	.	
P25054	UniProtKB	Sequence conflict	2723	2723	.	.	.	.	
P25054	UniProtKB	Sequence conflict	2755	2755	.	.	.	.	
P25054	UniProtKB	Sequence conflict	2755	2755	.	.	.	.	
P25054	UniProtKB	Helix	6	53	.	.	.	.	
P25054	UniProtKB	Helix	132	169	.	.	.	.	
P25054	UniProtKB	Helix	180	204	.	.	.	.	
P25054	UniProtKB	Helix	208	238	.	.	.	.	
P25054	UniProtKB	Helix	328	338	.	.	.	.	
P25054	UniProtKB	Helix	343	350	.	.	.	.	
P25054	UniProtKB	Helix	353	360	.	.	.	.	
P25054	UniProtKB	Helix	377	393	.	.	.	.	
P25054	UniProtKB	Helix	407	425	.	.	.	.	
P25054	UniProtKB	Beta strand	429	431	.	.	.	.	
P25054	UniProtKB	Helix	433	435	.	.	.	.	
P25054	UniProtKB	Helix	441	444	.	.	.	.	
P25054	UniProtKB	Helix	446	457	.	.	.	.	
P25054	UniProtKB	Helix	460	468	.	.	.	.	
P25054	UniProtKB	Helix	471	486	.	.	.	.	
P25054	UniProtKB	Helix	492	508	.	.	.	.	
P25054	UniProtKB	Helix	513	521	.	.	.	.	
P25054	UniProtKB	Helix	523	531	.	.	.	.	
P25054	UniProtKB	Helix	532	534	.	.	.	.	
P25054	UniProtKB	Helix	538	552	.	.	.	.	
P25054	UniProtKB	Helix	557	565	.	.	.	.	
P25054	UniProtKB	Helix	568	578	.	.	.	.	
P25054	UniProtKB	Helix	582	596	.	.	.	.	
P25054	UniProtKB	Helix	600	608	.	.	.	.	
P25054	UniProtKB	Helix	612	619	.	.	.	.	
P25054	UniProtKB	Beta strand	625	627	.	.	.	.	
P25054	UniProtKB	Helix	630	646	.	.	.	.	
P25054	UniProtKB	Helix	650	657	.	.	.	.	
P25054	UniProtKB	Turn	658	660	.	.	.	.	
P25054	UniProtKB	Helix	661	668	.	.	.	.	
P25054	UniProtKB	Helix	674	687	.	.	.	.	
P25054	UniProtKB	Helix	692	700	.	.	.	.	
P25054	UniProtKB	Helix	703	708	.	.	.	.	
P25054	UniProtKB	Turn	709	712	.	.	.	.	
P25054	UniProtKB	Helix	716	730	.	.	.	.	
P25054	UniProtKB	Helix	735	737	.	.	.	.	
P25054	UniProtKB	Turn	1027	1030	.	.	.	.	
P25054	UniProtKB	Helix	1470	1479	.	.	.	.	
P25054	UniProtKB	Helix	1520	1524	.	.	.	.	
P25054	UniProtKB	Helix	2036	2045	.	.	.	.	
P25054	UniProtKB	Beta strand	2840	2842	.	.	.	.	
##sequence-region Q61315 1 2845
Q61315	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q61315	UniProtKB	Chain	2	2845	.	.	.	ID=PRO_0000064628;Note=Adenomatous polyposis coli protein	
Q61315	UniProtKB	Repeat	451	493	.	.	.	Note=ARM 1	
Q61315	UniProtKB	Repeat	503	545	.	.	.	Note=ARM 2	
Q61315	UniProtKB	Repeat	546	589	.	.	.	Note=ARM 3	
Q61315	UniProtKB	Repeat	590	636	.	.	.	Note=ARM 4	
Q61315	UniProtKB	Repeat	637	681	.	.	.	Note=ARM 5	
Q61315	UniProtKB	Repeat	682	723	.	.	.	Note=ARM 6	
Q61315	UniProtKB	Repeat	724	765	.	.	.	Note=ARM 7	
Q61315	UniProtKB	Region	1864	1891	.	.	.	Note=Highly charged	
Q61315	UniProtKB	Coiled coil	1	61	.	.	.	status=Potential	
Q61315	UniProtKB	Coiled coil	125	245	.	.	.	status=Potential	
Q61315	UniProtKB	Motif	2805	2808	.	.	.	Note=Microtubule tip localization signal	
Q61315	UniProtKB	Motif	2843	2845	.	.	.	Note=PDZ-binding;status=By similarity	
Q61315	UniProtKB	Compositional bias	1	728	.	.	.	Note=Leu-rich	
Q61315	UniProtKB	Compositional bias	739	2834	.	.	.	Note=Ser-rich	
Q61315	UniProtKB	Compositional bias	1130	1156	.	.	.	Note=Asp/Glu-rich (acidic)	
Q61315	UniProtKB	Compositional bias	1556	1575	.	.	.	Note=Asp/Glu-rich (acidic)	
Q61315	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q61315	UniProtKB	Modified residue	742	742	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	778	778	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	1040	1040	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	1359	1359	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	1859	1859	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	1861	1861	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	1862	1862	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2151	2151	.	.	.	Note=Phosphothreonine;status=By similarity	
Q61315	UniProtKB	Modified residue	2260	2260	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2270	2270	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2283	2283	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2473	2473	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2535	2535	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2671	2671	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2674	2674	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Modified residue	2679	2679	.	.	.	Note=Phosphothreonine;status=By similarity	
Q61315	UniProtKB	Modified residue	2791	2791	.	.	.	Note=Phosphoserine;status=By similarity	
Q61315	UniProtKB	Alternative sequence	243	276	.	.	.	ID=VSP_004116;Note=In isoform 2 and isoform 4.	
Q61315	UniProtKB	Alternative sequence	310	410	.	.	.	ID=VSP_004117;Note=In isoform 3 and isoform 4.	
Q61315	UniProtKB	Natural variant	120	120	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	493	493	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	797	797	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	1330	1330	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	1618	1618	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	2294	2294	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	2496	2496	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	2523	2523	.	.	.	Note=In strain: CAST/Ei.	
Q61315	UniProtKB	Natural variant	2813	2813	.	.	.	Note=In strain: CAST/Ei.	
##sequence-region P70478 1 2842
P70478	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
P70478	UniProtKB	Chain	2	2842	.	.	.	ID=PRO_0000064629;Note=Adenomatous polyposis coli protein	
P70478	UniProtKB	Repeat	451	493	.	.	.	Note=ARM 1	
P70478	UniProtKB	Repeat	503	545	.	.	.	Note=ARM 2	
P70478	UniProtKB	Repeat	546	589	.	.	.	Note=ARM 3	
P70478	UniProtKB	Repeat	590	636	.	.	.	Note=ARM 4	
P70478	UniProtKB	Repeat	637	681	.	.	.	Note=ARM 5	
P70478	UniProtKB	Repeat	682	723	.	.	.	Note=ARM 6	
P70478	UniProtKB	Repeat	724	765	.	.	.	Note=ARM 7	
P70478	UniProtKB	Region	1864	1891	.	.	.	Note=Highly charged	
P70478	UniProtKB	Coiled coil	1	62	.	.	.	status=Potential	
P70478	UniProtKB	Coiled coil	125	260	.	.	.	status=Potential	
P70478	UniProtKB	Motif	2802	2805	.	.	.	Note=Microtubule tip localization signal	
P70478	UniProtKB	Motif	2840	2842	.	.	.	Note=PDZ-binding;status=By similarity	
P70478	UniProtKB	Compositional bias	1	728	.	.	.	Note=Leu-rich	
P70478	UniProtKB	Compositional bias	739	2831	.	.	.	Note=Ser-rich	
P70478	UniProtKB	Compositional bias	1130	1155	.	.	.	Note=Asp/Glu-rich (acidic)	
P70478	UniProtKB	Compositional bias	1556	1575	.	.	.	Note=Asp/Glu-rich (acidic)	
P70478	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
P70478	UniProtKB	Modified residue	742	742	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	778	778	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	1040	1040	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	1357	1357	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	1714	1714	.	.	.	Note=Phosphoserine	
P70478	UniProtKB	Modified residue	1859	1859	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	1861	1861	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	1862	1862	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2151	2151	.	.	.	Note=Phosphothreonine;status=By similarity	
P70478	UniProtKB	Modified residue	2260	2260	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2270	2270	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2283	2283	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2473	2473	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2535	2535	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2671	2671	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2674	2674	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Modified residue	2679	2679	.	.	.	Note=Phosphothreonine;status=By similarity	
P70478	UniProtKB	Modified residue	2788	2788	.	.	.	Note=Phosphoserine;status=By similarity	
P70478	UniProtKB	Mutagenesis	523	523	.	.	.	Note=In an IQ-induced colon tumor.	
##sequence-region Q8IVW6 1 561
Q8IVW6	UniProtKB	Chain	1	561	.	.	.	ID=PRO_0000295162;Note=AT-rich interactive domain-containing protein 3B	
Q8IVW6	UniProtKB	Domain	215	307	.	.	.	Note=ARID	
Q8IVW6	UniProtKB	Domain	419	517	.	.	.	Note=REKLES	
Q8IVW6	UniProtKB	Region	203	365	.	.	.	Note=Interaction with RB1	
Q8IVW6	UniProtKB	Region	490	513	.	.	.	Note=Interaction with ARID3A	
Q8IVW6	UniProtKB	Compositional bias	5	49	.	.	.	Note=Gln-rich	
Q8IVW6	UniProtKB	Compositional bias	341	353	.	.	.	Note=Poly-Ala	
Q8IVW6	UniProtKB	Compositional bias	523	560	.	.	.	Note=Ser-rich	
Q8IVW6	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
Q8IVW6	UniProtKB	Modified residue	89	89	.	.	.	Note=Phosphoserine	
Q8IVW6	UniProtKB	Alternative sequence	390	471	.	.	.	ID=VSP_026773;Note=In isoform 3.	
Q8IVW6	UniProtKB	Alternative sequence	472	561	.	.	.	ID=VSP_026774;Note=In isoform 3.	
Q8IVW6	UniProtKB	Alternative sequence	474	474	.	.	.	ID=VSP_039860;Note=In isoform 4.	
Q8IVW6	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Impairs binding to RB1.	
Q8IVW6	UniProtKB	Mutagenesis	271	271	.	.	.	Note=Impairs binding to RB1.	
Q8IVW6	UniProtKB	Sequence conflict	7	7	.	.	.	.	
##sequence-region Q8HXK9 1 195
Q8HXK9	UniProtKB	Chain	1	195	.	.	.	ID=PRO_0000245585;Note=Apoptosis-associated speck-like protein containing a CARD	
Q8HXK9	UniProtKB	Domain	1	91	.	.	.	Note=DAPIN	
Q8HXK9	UniProtKB	Domain	107	195	.	.	.	Note=CARD	
##sequence-region Q9I9N6 1 203
Q9I9N6	UniProtKB	Chain	1	203	.	.	.	ID=PRO_0000064691;Note=Apoptosis-associated speck-like protein containing a CARD	
Q9I9N6	UniProtKB	Domain	1	91	.	.	.	Note=DAPIN	
Q9I9N6	UniProtKB	Domain	112	203	.	.	.	Note=CARD	
##sequence-region Q9ULZ3 1 195
Q9ULZ3	UniProtKB	Chain	1	195	.	.	.	ID=PRO_0000064692;Note=Apoptosis-associated speck-like protein containing a CARD	
Q9ULZ3	UniProtKB	Domain	1	91	.	.	.	Note=DAPIN	
Q9ULZ3	UniProtKB	Domain	107	195	.	.	.	Note=CARD	
Q9ULZ3	UniProtKB	Alternative sequence	26	85	.	.	.	ID=VSP_004118;Note=In isoform 3.	
Q9ULZ3	UniProtKB	Alternative sequence	93	111	.	.	.	ID=VSP_004119;Note=In isoform 2.	
Q9ULZ3	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	12	12	.	.	.	Note=Abolishes promotion of apoptosis and NF-kappa-B activation.	
Q9ULZ3	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Abolishes interaction with PYDC1.	
Q9ULZ3	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Abolishes interaction with NLRP2.	
Q9ULZ3	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	23	23	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Abolishes interaction with PYDC1.	
Q9ULZ3	UniProtKB	Mutagenesis	40	40	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	45	45	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	48	48	.	.	.	Note=Abolishes interaction with PYDC1.	
Q9ULZ3	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Abolishes homooligomerization.	
Q9ULZ3	UniProtKB	Helix	3	14	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	17	26	.	.	.	.	
Q9ULZ3	UniProtKB	Turn	27	29	.	.	.	.	
Q9ULZ3	UniProtKB	Beta strand	34	36	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	41	46	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	49	58	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	62	75	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	80	90	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	117	126	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	129	135	.	.	.	.	
Q9ULZ3	UniProtKB	Turn	136	140	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	143	150	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	155	164	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	166	168	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	171	184	.	.	.	.	
Q9ULZ3	UniProtKB	Helix	186	193	.	.	.	.	
##sequence-region Q9EPB4 1 193
Q9EPB4	UniProtKB	Chain	1	193	.	.	.	ID=PRO_0000064693;Note=Apoptosis-associated speck-like protein containing a CARD	
Q9EPB4	UniProtKB	Domain	1	91	.	.	.	Note=DAPIN	
Q9EPB4	UniProtKB	Domain	105	193	.	.	.	Note=CARD	
Q9EPB4	UniProtKB	Sequence conflict	159	159	.	.	.	.	
##sequence-region Q13315 1 3056
Q13315	UniProtKB	Chain	1	3056	.	.	.	ID=PRO_0000088840;Note=Serine-protein kinase ATM	
Q13315	UniProtKB	Domain	1960	2566	.	.	.	Note=FAT	
Q13315	UniProtKB	Domain	2712	2962	.	.	.	Note=PI3K/PI4K	
Q13315	UniProtKB	Domain	3024	3056	.	.	.	Note=FATC	
Q13315	UniProtKB	Region	1373	1382	.	.	.	Note=Interaction with ABL1	
Q13315	UniProtKB	Modified residue	367	367	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q13315	UniProtKB	Modified residue	1893	1893	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q13315	UniProtKB	Modified residue	1981	1981	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q13315	UniProtKB	Modified residue	1983	1983	.	.	.	Note=Phosphoserine%3B in variant Ser-1983	
Q13315	UniProtKB	Modified residue	2996	2996	.	.	.	Note=Phosphoserine	
Q13315	UniProtKB	Modified residue	3016	3016	.	.	.	Note=N6-acetyllysine	
Q13315	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_041545;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_056678;Dbxref=dbSNP:rs3218684	
Q13315	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_010798;Dbxref=dbSNP:rs1800054	
Q13315	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_010799;Dbxref=dbSNP:rs2234997	
Q13315	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_041546	
Q13315	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_010800;Dbxref=dbSNP:rs3218707	
Q13315	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_010801;Note=In AT.	
Q13315	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_041547	
Q13315	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_010802;Note=In AT%3B associated with lymphoma.	
Q13315	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_010803;Note=In AT.	
Q13315	UniProtKB	Natural variant	332	332	.	.	.	ID=VAR_010804;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	333	333	.	.	.	ID=VAR_041548;Dbxref=dbSNP:rs28904919	
Q13315	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_041549;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_041550;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	350	350	.	.	.	ID=VAR_010805;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_010806;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	410	410	.	.	.	ID=VAR_041551	
Q13315	UniProtKB	Natural variant	504	504	.	.	.	ID=VAR_041552;Dbxref=dbSNP:rs56365018	
Q13315	UniProtKB	Natural variant	514	514	.	.	.	ID=VAR_010807;Dbxref=dbSNP:rs2235000	
Q13315	UniProtKB	Natural variant	540	540	.	.	.	ID=VAR_041553;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	546	546	.	.	.	ID=VAR_041554;Dbxref=dbSNP:rs2227924	
Q13315	UniProtKB	Natural variant	570	570	.	.	.	ID=VAR_010808;Note=In AT.	
Q13315	UniProtKB	Natural variant	582	582	.	.	.	ID=VAR_041555;Dbxref=dbSNP:rs2235006	
Q13315	UniProtKB	Natural variant	705	707	.	.	.	ID=VAR_010809;Note=In AT%3B might be associated with susceptibility to cancer.	
Q13315	UniProtKB	Natural variant	707	707	.	.	.	ID=VAR_010810;Dbxref=dbSNP:rs4986761	
Q13315	UniProtKB	Natural variant	761	761	.	.	.	ID=VAR_056679;Dbxref=dbSNP:rs2235011	
Q13315	UniProtKB	Natural variant	768	768	.	.	.	ID=VAR_010812;Note=In AT.	
Q13315	UniProtKB	Natural variant	785	785	.	.	.	ID=VAR_010813;Note=In AT.	
Q13315	UniProtKB	Natural variant	788	788	.	.	.	ID=VAR_056680;Dbxref=dbSNP:rs641252	
Q13315	UniProtKB	Natural variant	814	814	.	.	.	ID=VAR_056681;Dbxref=dbSNP:rs3218695	
Q13315	UniProtKB	Natural variant	848	848	.	.	.	ID=VAR_041556;Note=In a lung adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	858	858	.	.	.	ID=VAR_010814;Dbxref=dbSNP:rs1800056;Note=Rare polymorphism.	
Q13315	UniProtKB	Natural variant	872	872	.	.	.	ID=VAR_041557;Dbxref=dbSNP:rs3218673	
Q13315	UniProtKB	Natural variant	924	924	.	.	.	ID=VAR_041558	
Q13315	UniProtKB	Natural variant	935	935	.	.	.	ID=VAR_041559	
Q13315	UniProtKB	Natural variant	935	935	.	.	.	ID=VAR_056682;Dbxref=dbSNP:rs3218708	
Q13315	UniProtKB	Natural variant	942	942	.	.	.	ID=VAR_056683;Dbxref=dbSNP:rs3218688	
Q13315	UniProtKB	Natural variant	950	950	.	.	.	ID=VAR_010815;Note=In AT.	
Q13315	UniProtKB	Natural variant	1001	1001	.	.	.	ID=VAR_010816;Note=In AT%3B associated with T-cell acute lymphoblastic leukemia.	
Q13315	UniProtKB	Natural variant	1040	1040	.	.	.	ID=VAR_010817;Dbxref=dbSNP:rs3092857;Note=In B-cell non-Hodgkin lymphoma.	
Q13315	UniProtKB	Natural variant	1054	1054	.	.	.	ID=VAR_010818;Dbxref=dbSNP:rs1800057	
Q13315	UniProtKB	Natural variant	1082	1082	.	.	.	ID=VAR_010819;Note=In AT.	
Q13315	UniProtKB	Natural variant	1091	1091	.	.	.	ID=VAR_010820;Note=In AT.	
Q13315	UniProtKB	Natural variant	1179	1179	.	.	.	ID=VAR_041560;Note=In a gastric adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	1313	1313	.	.	.	ID=VAR_056684;Dbxref=dbSNP:rs3092841	
Q13315	UniProtKB	Natural variant	1321	1321	.	.	.	ID=VAR_041561	
Q13315	UniProtKB	Natural variant	1380	1380	.	.	.	ID=VAR_041562	
Q13315	UniProtKB	Natural variant	1382	1382	.	.	.	ID=VAR_041563	
Q13315	UniProtKB	Natural variant	1407	1407	.	.	.	ID=VAR_010821;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	1420	1420	.	.	.	ID=VAR_010822;Dbxref=dbSNP:rs1800058;Note=Rare polymorphism.	
Q13315	UniProtKB	Natural variant	1420	1420	.	.	.	ID=VAR_010823;Note=In AT.	
Q13315	UniProtKB	Natural variant	1427	1427	.	.	.	ID=VAR_056685;Dbxref=dbSNP:rs2229021	
Q13315	UniProtKB	Natural variant	1454	1454	.	.	.	ID=VAR_010824	
Q13315	UniProtKB	Natural variant	1463	1463	.	.	.	ID=VAR_010825;Note=In B-cell non-Hodgkin lymphoma.	
Q13315	UniProtKB	Natural variant	1465	1465	.	.	.	ID=VAR_010826;Note=In AT.	
Q13315	UniProtKB	Natural variant	1469	1469	.	.	.	ID=VAR_041564;Note=In a renal papillary cancer sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	1475	1475	.	.	.	ID=VAR_041565	
Q13315	UniProtKB	Natural variant	1541	1541	.	.	.	ID=VAR_056686;Dbxref=dbSNP:rs3092849	
Q13315	UniProtKB	Natural variant	1566	1566	.	.	.	ID=VAR_010827;Note=In AT.	
Q13315	UniProtKB	Natural variant	1570	1570	.	.	.	ID=VAR_010828;Dbxref=dbSNP:rs140856217	
Q13315	UniProtKB	Natural variant	1650	1650	.	.	.	ID=VAR_041566;Dbxref=dbSNP:rs55870064	
Q13315	UniProtKB	Natural variant	1682	1682	.	.	.	ID=VAR_010829;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	1691	1691	.	.	.	ID=VAR_010830;Dbxref=dbSNP:rs1800059;Note=In AT and B-cell chronic lymphocytic leukemia%3B could be a rare polymorphism.	
Q13315	UniProtKB	Natural variant	1729	1729	.	.	.	ID=VAR_056687;Dbxref=dbSNP:rs3092907	
Q13315	UniProtKB	Natural variant	1739	1739	.	.	.	ID=VAR_041567;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	1743	1743	.	.	.	ID=VAR_010831;Note=In AT%3B associated with preleukemic T-cell proliferation.	
Q13315	UniProtKB	Natural variant	1812	1813	.	.	.	ID=VAR_010832;Note=In AT.	
Q13315	UniProtKB	Natural variant	1853	1853	.	.	.	ID=VAR_010833;Dbxref=dbSNP:rs1801516;Note=Common polymorphism.	
Q13315	UniProtKB	Natural variant	1853	1853	.	.	.	ID=VAR_010834;Dbxref=dbSNP:rs1801673;Note=Might contribute to B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	1910	1910	.	.	.	ID=VAR_010835;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	1913	1913	.	.	.	ID=VAR_010836;Note=In AT.	
Q13315	UniProtKB	Natural variant	1916	1916	.	.	.	ID=VAR_041568;Note=In a breast pleomorphic lobular carcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	1945	1945	.	.	.	ID=VAR_041569;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	1953	1953	.	.	.	ID=VAR_010837;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	1961	1961	.	.	.	ID=VAR_041570	
Q13315	UniProtKB	Natural variant	1983	1983	.	.	.	ID=VAR_041571;Dbxref=dbSNP:rs659243	
Q13315	UniProtKB	Natural variant	1991	1991	.	.	.	ID=VAR_041572;Note=In a renal clear cell carcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2016	2016	.	.	.	ID=VAR_010838;Note=In AT.	
Q13315	UniProtKB	Natural variant	2034	2034	.	.	.	ID=VAR_056688;Dbxref=dbSNP:rs3218670	
Q13315	UniProtKB	Natural variant	2063	2063	.	.	.	ID=VAR_010839;Note=In AT.	
Q13315	UniProtKB	Natural variant	2067	2067	.	.	.	ID=VAR_010840;Note=In AT.	
Q13315	UniProtKB	Natural variant	2079	2079	.	.	.	ID=VAR_010841;Dbxref=dbSNP:rs1800060	
Q13315	UniProtKB	Natural variant	2139	2139	.	.	.	ID=VAR_010842;Note=In T-prolymphocytic leukemia%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2164	2164	.	.	.	ID=VAR_010843;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2218	2218	.	.	.	ID=VAR_010844;Note=In AT.	
Q13315	UniProtKB	Natural variant	2224	2227	.	.	.	ID=VAR_010845;Note=In AT.	
Q13315	UniProtKB	Natural variant	2227	2227	.	.	.	ID=VAR_010846;Note=In AT.	
Q13315	UniProtKB	Natural variant	2246	2252	.	.	.	ID=VAR_010847;Note=In AT.	
Q13315	UniProtKB	Natural variant	2274	2274	.	.	.	ID=VAR_010848;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2287	2287	.	.	.	ID=VAR_010849;Dbxref=dbSNP:rs1800061	
Q13315	UniProtKB	Natural variant	2307	2307	.	.	.	ID=VAR_041573	
Q13315	UniProtKB	Natural variant	2332	2332	.	.	.	ID=VAR_041574;Dbxref=dbSNP:rs4988111	
Q13315	UniProtKB	Natural variant	2335	2335	.	.	.	ID=VAR_056689;Dbxref=dbSNP:rs3092831	
Q13315	UniProtKB	Natural variant	2356	2356	.	.	.	ID=VAR_041575;Note=In a renal clear cell carcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2396	2396	.	.	.	ID=VAR_010850;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2408	2408	.	.	.	ID=VAR_041576;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2418	2418	.	.	.	ID=VAR_010851;Note=In mantle cell lymphoma.	
Q13315	UniProtKB	Natural variant	2420	2420	.	.	.	ID=VAR_010852;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2423	2423	.	.	.	ID=VAR_010853;Note=In mantle cell lymphoma.	
Q13315	UniProtKB	Natural variant	2424	2424	.	.	.	ID=VAR_010854;Note=In AT%2C B-cell chronic lymphocytic leukemia and T-prolymphocytic leukemia%3B associated with increased risk for breast cancer.	
Q13315	UniProtKB	Natural variant	2427	2428	.	.	.	ID=VAR_010855;Note=In AT%3B associated with T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2438	2438	.	.	.	ID=VAR_010856;Dbxref=dbSNP:rs147604227	
Q13315	UniProtKB	Natural variant	2442	2442	.	.	.	ID=VAR_010857;Note=In T-prolymphocytic leukemia%3B also in a lung adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2443	2443	.	.	.	ID=VAR_041577;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2464	2464	.	.	.	ID=VAR_041578	
Q13315	UniProtKB	Natural variant	2470	2470	.	.	.	ID=VAR_010858;Note=In AT.	
Q13315	UniProtKB	Natural variant	2486	2486	.	.	.	ID=VAR_010859;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2491	2491	.	.	.	ID=VAR_010860;Note=In AT.	
Q13315	UniProtKB	Natural variant	2492	2492	.	.	.	ID=VAR_041579	
Q13315	UniProtKB	Natural variant	2546	2548	.	.	.	ID=VAR_010861;Note=In AT%2C T-prolymphocytic leukemia and T-cell acute lymphoblastic leukemia.	
Q13315	UniProtKB	Natural variant	2554	2554	.	.	.	ID=VAR_010862;Note=In AT.	
Q13315	UniProtKB	Natural variant	2570	2570	.	.	.	ID=VAR_056690;Dbxref=dbSNP:rs28904920	
Q13315	UniProtKB	Natural variant	2625	2626	.	.	.	ID=VAR_010864;Note=In AT.	
Q13315	UniProtKB	Natural variant	2625	2625	.	.	.	ID=VAR_010863;Note=In AT%3B requires 2 nucleotide substitutions.	
Q13315	UniProtKB	Natural variant	2640	2640	.	.	.	ID=VAR_056691;Dbxref=dbSNP:rs4988125	
Q13315	UniProtKB	Natural variant	2656	2656	.	.	.	ID=VAR_010865;Note=In AT%3B partial functional loss.	
Q13315	UniProtKB	Natural variant	2662	2662	.	.	.	ID=VAR_010866;Note=In AT.	
Q13315	UniProtKB	Natural variant	2663	2663	.	.	.	ID=VAR_010867;Note=In AT.	
Q13315	UniProtKB	Natural variant	2666	2666	.	.	.	ID=VAR_041580;Note=In a lung adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2668	2668	.	.	.	ID=VAR_010868;Note=In AT.	
Q13315	UniProtKB	Natural variant	2695	2695	.	.	.	ID=VAR_010869;Note=In T-prolymphocytic leukemia and B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2702	2702	.	.	.	ID=VAR_010870;Note=In AT.	
Q13315	UniProtKB	Natural variant	2709	2709	.	.	.	ID=VAR_056692;Dbxref=dbSNP:rs3218680	
Q13315	UniProtKB	Natural variant	2719	2719	.	.	.	ID=VAR_041581	
Q13315	UniProtKB	Natural variant	2722	2722	.	.	.	ID=VAR_010871;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2725	2725	.	.	.	ID=VAR_010872;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2725	2725	.	.	.	ID=VAR_010873;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2726	2726	.	.	.	ID=VAR_010874;Note=In AT.	
Q13315	UniProtKB	Natural variant	2732	2732	.	.	.	ID=VAR_010875;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2765	2765	.	.	.	ID=VAR_010876;Note=May contribute to breast cancer.	
Q13315	UniProtKB	Natural variant	2810	2810	.	.	.	ID=VAR_010877;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2824	2824	.	.	.	ID=VAR_010878;Note=In AT.	
Q13315	UniProtKB	Natural variant	2827	2827	.	.	.	ID=VAR_010879;Note=In AT%3B mild.	
Q13315	UniProtKB	Natural variant	2829	2829	.	.	.	ID=VAR_010880;Note=In AT.	
Q13315	UniProtKB	Natural variant	2832	2832	.	.	.	ID=VAR_010881;Note=In AT and B-cell non-Hodgkin lymphoma.	
Q13315	UniProtKB	Natural variant	2842	2842	.	.	.	ID=VAR_041582;Note=In a lung adenocarcinoma sample%3B somatic mutation.	
Q13315	UniProtKB	Natural variant	2849	2849	.	.	.	ID=VAR_010882;Note=In AT.	
Q13315	UniProtKB	Natural variant	2855	2856	.	.	.	ID=VAR_010884;Note=In AT.	
Q13315	UniProtKB	Natural variant	2855	2855	.	.	.	ID=VAR_010883;Note=In AT.	
Q13315	UniProtKB	Natural variant	2860	2860	.	.	.	ID=VAR_010885;Note=In AT.	
Q13315	UniProtKB	Natural variant	2867	2867	.	.	.	ID=VAR_010886;Note=In AT.	
Q13315	UniProtKB	Natural variant	2870	2870	.	.	.	ID=VAR_041583	
Q13315	UniProtKB	Natural variant	2871	2872	.	.	.	ID=VAR_010887;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2890	2890	.	.	.	ID=VAR_010888;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	2904	2904	.	.	.	ID=VAR_010889;Note=In AT.	
Q13315	UniProtKB	Natural variant	2909	2909	.	.	.	ID=VAR_010890;Note=In AT.	
Q13315	UniProtKB	Natural variant	3006	3006	.	.	.	ID=VAR_010892;Note=In T-prolymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	3008	3008	.	.	.	ID=VAR_010893;Note=In AT%2C T-prolymphocytic leukemia and mantle cell lymphoma.	
Q13315	UniProtKB	Natural variant	3008	3008	.	.	.	ID=VAR_010894;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Natural variant	3018	3018	.	.	.	ID=VAR_010895;Note=In B-cell chronic lymphocytic leukemia.	
Q13315	UniProtKB	Mutagenesis	367	367	.	.	.	Note=Loss of IR-induced S-367 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-1893 nor S-1981 autophosphorylation.	
Q13315	UniProtKB	Mutagenesis	1893	1893	.	.	.	Note=Loss of IR-induced S-1893 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1981 autophosphorylation.	
Q13315	UniProtKB	Mutagenesis	1981	1981	.	.	.	Note=Loss of IR-induced S-1981 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1893 autophosphorylation. No dimer disruption.	
Q13315	UniProtKB	Mutagenesis	1981	1981	.	.	.	Note=Disrupts the dimer.	
Q13315	UniProtKB	Mutagenesis	2870	2870	.	.	.	Note=Loss of kinase activity.	
Q13315	UniProtKB	Mutagenesis	2875	2875	.	.	.	Note=Loss of kinase activity.	
Q13315	UniProtKB	Mutagenesis	3016	3016	.	.	.	Note=Loss of DNA damage-inducible acetylation. Retains constitutive kinase activity%2C but blocks DNA damage-induced kinase activation. Disrupts dimer and abolishes S-1981 autophosphorylation.	
Q13315	UniProtKB	Mutagenesis	3018	3018	.	.	.	Note=Retains DNA damage-inducible acetylation and S-1981 autophosphorylation.	
Q13315	UniProtKB	Sequence conflict	46	46	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	56	56	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	313	313	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	488	488	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	554	554	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	750	750	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	754	754	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	887	887	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	1003	1003	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	1049	1049	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	1089	1089	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	3003	3003	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	3003	3003	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	3003	3003	.	.	.	.	
Q13315	UniProtKB	Sequence conflict	3003	3003	.	.	.	.	
##sequence-region Q62388 1 3066
Q62388	UniProtKB	Chain	1	3066	.	.	.	ID=PRO_0000088841;Note=Serine-protein kinase ATM	
Q62388	UniProtKB	Domain	1966	2576	.	.	.	Note=FAT	
Q62388	UniProtKB	Domain	2722	2972	.	.	.	Note=PI3K/PI4K	
Q62388	UniProtKB	Domain	3034	3066	.	.	.	Note=FATC	
Q62388	UniProtKB	Region	1380	1389	.	.	.	Note=Interaction with ABL1;status=By similarity	
Q62388	UniProtKB	Modified residue	367	367	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q62388	UniProtKB	Modified residue	1899	1899	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q62388	UniProtKB	Modified residue	1987	1987	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q62388	UniProtKB	Modified residue	3006	3006	.	.	.	Note=Phosphoserine;status=By similarity	
Q62388	UniProtKB	Modified residue	3026	3026	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q62388	UniProtKB	Mutagenesis	367	367	.	.	.	Note=Retains genomic stability and cell cycle checkpoint correction and kinase activity towards downstream targets%3B when associated with A-1987. Retains genomic stability%2C cell cycle checkpoint correction and kinase activity on downstream targets%3B when associated with A-1899 and A-1987.	
Q62388	UniProtKB	Mutagenesis	1899	1899	.	.	.	Note=Retains genomic stability%2C cell cycle checkpoint correction and kinase activity on downstream targets%3B when associated with A-367 and A-1987.	
Q62388	UniProtKB	Mutagenesis	1987	1987	.	.	.	Note=Retains genomic stability and cell cycle checkpoint correction and kinase activity towards downstream targets%3B when associated with A-367. Retains genomic stability%2C cell cycle checkpoint correction and kinase activity on downstream targets%3B when associated with A-367 and A-1987.	
Q62388	UniProtKB	Sequence conflict	600	600	.	.	.	.	
##sequence-region Q6PQD5 1 3057
Q6PQD5	UniProtKB	Chain	1	3057	.	.	.	ID=PRO_0000088842;Note=Serine-protein kinase ATM	
Q6PQD5	UniProtKB	Domain	1961	2567	.	.	.	Note=FAT	
Q6PQD5	UniProtKB	Domain	2713	3057	.	.	.	Note=PI3K/PI4K	
Q6PQD5	UniProtKB	Domain	3025	3057	.	.	.	Note=FATC	
Q6PQD5	UniProtKB	Region	1374	1383	.	.	.	Note=Interaction with ABL1;status=By similarity	
Q6PQD5	UniProtKB	Modified residue	367	367	.	.	.	Note=Phosphoserine;status=By similarity	
Q6PQD5	UniProtKB	Modified residue	1894	1894	.	.	.	Note=Phosphoserine;status=By similarity	
Q6PQD5	UniProtKB	Modified residue	1982	1982	.	.	.	Note=Phosphoserine%3B by autocatalysis;status=By similarity	
Q6PQD5	UniProtKB	Modified residue	1984	1984	.	.	.	Note=Phosphoserine;status=By similarity	
Q6PQD5	UniProtKB	Modified residue	2997	2997	.	.	.	Note=Phosphoserine;status=By similarity	
Q6PQD5	UniProtKB	Modified residue	3017	3017	.	.	.	Note=N6-acetyllysine;status=By similarity	
##sequence-region O15169 1 862
O15169	UniProtKB	Chain	1	862	.	.	.	ID=PRO_0000220888;Note=Axin-1	
O15169	UniProtKB	Domain	88	211	.	.	.	Note=RGS	
O15169	UniProtKB	Domain	780	862	.	.	.	Note=DIX	
O15169	UniProtKB	Region	209	338	.	.	.	Note=Interaction with TP53;status=By similarity	
O15169	UniProtKB	Region	348	433	.	.	.	Note=Interaction with GSK3B;status=By similarity	
O15169	UniProtKB	Region	434	502	.	.	.	Note=Interaction with CTNNB1;status=By similarity	
O15169	UniProtKB	Region	507	757	.	.	.	Note=Interaction with RNF111	
O15169	UniProtKB	Region	575	789	.	.	.	Note=Interaction with PPP2CA	
O15169	UniProtKB	Region	677	752	.	.	.	Note=Interaction with HIPK2;status=By similarity	
O15169	UniProtKB	Motif	20	29	.	.	.	Note=Tankyrase-binding motif	
O15169	UniProtKB	Modified residue	75	75	.	.	.	Note=Phosphoserine%3B by CK1	
O15169	UniProtKB	Modified residue	77	77	.	.	.	Note=Phosphoserine%3B by CK1	
O15169	UniProtKB	Modified residue	217	217	.	.	.	Note=Phosphoserine%3B by CK1	
O15169	UniProtKB	Modified residue	469	469	.	.	.	Note=Phosphoserine%3B by CK1	
O15169	UniProtKB	Modified residue	481	481	.	.	.	Note=Phosphothreonine%3B by GSK3-beta;status=Probable	
O15169	UniProtKB	Modified residue	486	486	.	.	.	Note=Phosphoserine%3B by GSK3-beta;status=By similarity	
O15169	UniProtKB	Modified residue	493	493	.	.	.	Note=Phosphoserine;status=By similarity	
O15169	UniProtKB	Cross-link	857	857	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
O15169	UniProtKB	Cross-link	860	860	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
O15169	UniProtKB	Alternative sequence	730	765	.	.	.	ID=VSP_019398;Note=In isoform 2.	
O15169	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_015589;Note=In HCC.	
O15169	UniProtKB	Natural variant	345	345	.	.	.	ID=VAR_015590;Note=In HCC.	
O15169	UniProtKB	Natural variant	425	425	.	.	.	ID=VAR_015591;Dbxref=dbSNP:rs116350678;Note=In HCC.	
O15169	UniProtKB	Natural variant	650	650	.	.	.	ID=VAR_015592;Dbxref=dbSNP:rs117208012;Note=In HCC and in hepatoblastoma.	
O15169	UniProtKB	Natural variant	841	841	.	.	.	ID=VAR_015593;Dbxref=dbSNP:rs34015754;Note=In hepatoblastoma.	
O15169	UniProtKB	Sequence conflict	360	360	.	.	.	.	
O15169	UniProtKB	Sequence conflict	451	455	.	.	.	.	
O15169	UniProtKB	Sequence conflict	482	482	.	.	.	.	
O15169	UniProtKB	Helix	81	87	.	.	.	.	
O15169	UniProtKB	Helix	89	92	.	.	.	.	
O15169	UniProtKB	Helix	96	107	.	.	.	.	
O15169	UniProtKB	Turn	108	110	.	.	.	.	
O15169	UniProtKB	Helix	112	126	.	.	.	.	
O15169	UniProtKB	Helix	131	133	.	.	.	.	
O15169	UniProtKB	Helix	134	148	.	.	.	.	
O15169	UniProtKB	Helix	155	159	.	.	.	.	
O15169	UniProtKB	Helix	162	174	.	.	.	.	
O15169	UniProtKB	Turn	179	182	.	.	.	.	
O15169	UniProtKB	Helix	183	195	.	.	.	.	
O15169	UniProtKB	Helix	197	201	.	.	.	.	
O15169	UniProtKB	Helix	205	208	.	.	.	.	
O15169	UniProtKB	Turn	209	212	.	.	.	.	
O15169	UniProtKB	Helix	384	399	.	.	.	.	
##sequence-region O35625 1 863
O35625	UniProtKB	Chain	1	863	.	.	.	ID=PRO_0000220889;Note=Axin-1	
O35625	UniProtKB	Domain	88	211	.	.	.	Note=RGS	
O35625	UniProtKB	Domain	781	863	.	.	.	Note=DIX	
O35625	UniProtKB	Region	209	338	.	.	.	Note=Interaction with TP53	
O35625	UniProtKB	Region	348	432	.	.	.	Note=Interaction with GSK3B;status=By similarity	
O35625	UniProtKB	Region	433	501	.	.	.	Note=Interaction with beta-catenin;status=By similarity	
O35625	UniProtKB	Region	505	758	.	.	.	Note=Interaction with RNF111;status=By similarity	
O35625	UniProtKB	Region	572	790	.	.	.	Note=Interaction with PPP2CA;status=By similarity	
O35625	UniProtKB	Region	678	753	.	.	.	Note=Interaction with HIPK2	
O35625	UniProtKB	Motif	20	29	.	.	.	Note=Tankyrase-binding motif	
O35625	UniProtKB	Modified residue	75	75	.	.	.	Note=Phosphoserine%3B by CK1;status=By similarity	
O35625	UniProtKB	Modified residue	77	77	.	.	.	Note=Phosphoserine%3B by CK1;status=By similarity	
O35625	UniProtKB	Modified residue	217	217	.	.	.	Note=Phosphoserine%3B by CK1;status=By similarity	
O35625	UniProtKB	Modified residue	468	468	.	.	.	Note=Phosphoserine%3B by CK1;status=By similarity	
O35625	UniProtKB	Modified residue	480	480	.	.	.	Note=Phosphothreonine%3B by GSK3-beta;status=Probable	
O35625	UniProtKB	Modified residue	485	485	.	.	.	Note=Phosphoserine%3B by GSK3-beta	
O35625	UniProtKB	Modified residue	492	492	.	.	.	Note=Phosphoserine	
O35625	UniProtKB	Cross-link	858	858	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
O35625	UniProtKB	Cross-link	861	861	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
O35625	UniProtKB	Alternative sequence	731	766	.	.	.	ID=VSP_000452;Note=In isoform 2.	
O35625	UniProtKB	Mutagenesis	480	480	.	.	.	Note=Greatly reduced GSK3B-mediated phosphorylation%3B when associated with A-485 and A-492.	
O35625	UniProtKB	Mutagenesis	485	485	.	.	.	Note=Greatly reduced GSK3B-mediated phosphorylation and large effect on the inhibitory activity in Wnt-signaling%3B when associated with A-480 and A-492.	
O35625	UniProtKB	Mutagenesis	492	492	.	.	.	Note=Greatly reduced GSK3B-mediated phosphorylation%3B when associated with A-480 and A-485.	
O35625	UniProtKB	Mutagenesis	492	492	.	.	.	Note=Little effect on inhibitory activity on Wnt-signaling.	
O35625	UniProtKB	Mutagenesis	495	495	.	.	.	Note=No effect on phosphorylation. Little effect on inhibitory activity on Wnt-signaling.	
O35625	UniProtKB	Mutagenesis	858	863	.	.	.	Note=Abolishes binding of PIAS1 and PIAS2. Dramatically reduces sumoylation and abolishes AXIN1-mediated JNK activation. No effect on homodimerization nor on Wnt-signaling.	
O35625	UniProtKB	Mutagenesis	858	858	.	.	.	Note=Decreased sumoylation followed by increased ubiquitination%3B when associated with A-861.	
O35625	UniProtKB	Mutagenesis	861	861	.	.	.	Note=Decreased sumoylation followed by increased ubiquitination%3B when associated with A-858.	
O35625	UniProtKB	Sequence conflict	589	589	.	.	.	.	
O35625	UniProtKB	Sequence conflict	787	787	.	.	.	.	
O35625	UniProtKB	Sequence conflict	846	846	.	.	.	.	
O35625	UniProtKB	Beta strand	64	66	.	.	.	.	
##sequence-region O88566 1 840
O88566	UniProtKB	Chain	1	840	.	.	.	ID=PRO_0000220896;Note=Axin-2	
O88566	UniProtKB	Domain	81	200	.	.	.	Note=RGS	
O88566	UniProtKB	Domain	758	840	.	.	.	Note=DIX	
O88566	UniProtKB	Region	327	413	.	.	.	Note=Interaction with GSK3B;status=By similarity	
O88566	UniProtKB	Region	413	478	.	.	.	Note=Interaction with beta-catenin;status=By similarity	
O88566	UniProtKB	Motif	21	30	.	.	.	Note=Tankyrase-binding motif	
O88566	UniProtKB	Compositional bias	469	476	.	.	.	Note=Poly-His	
O88566	UniProtKB	Sequence conflict	101	101	.	.	.	.	
O88566	UniProtKB	Sequence conflict	474	474	.	.	.	.	
O88566	UniProtKB	Sequence conflict	484	484	.	.	.	.	
O88566	UniProtKB	Sequence conflict	503	503	.	.	.	.	
O88566	UniProtKB	Sequence conflict	603	603	.	.	.	.	
O88566	UniProtKB	Sequence conflict	648	648	.	.	.	.	
O88566	UniProtKB	Sequence conflict	648	648	.	.	.	.	
##sequence-region Q8N9N5 1 519
Q8N9N5	UniProtKB	Chain	1	519	.	.	.	ID=PRO_0000297910;Note=Protein BANP	
Q8N9N5	UniProtKB	Domain	226	322	.	.	.	Note=BEN	
Q8N9N5	UniProtKB	Region	152	342	.	.	.	Note=Interaction with CUX1 and HDAC1;status=By similarity	
Q8N9N5	UniProtKB	Region	320	349	.	.	.	Note=Necessary and sufficient for TP53 activation;status=By similarity	
Q8N9N5	UniProtKB	Region	342	393	.	.	.	Note=DNA-binding;status=By similarity	
Q8N9N5	UniProtKB	Coiled coil	53	90	.	.	.	status=Potential	
Q8N9N5	UniProtKB	Compositional bias	361	426	.	.	.	Note=Gln-rich	
Q8N9N5	UniProtKB	Alternative sequence	1	24	.	.	.	ID=VSP_027396;Note=In isoform 3.	
Q8N9N5	UniProtKB	Alternative sequence	24	24	.	.	.	ID=VSP_043558;Note=In isoform 5.	
Q8N9N5	UniProtKB	Alternative sequence	25	36	.	.	.	ID=VSP_027398;Note=In isoform 3.	
Q8N9N5	UniProtKB	Alternative sequence	54	54	.	.	.	ID=VSP_027399;Note=In isoform 2%2C isoform 3%2C isoform 4%2C isoform 5%2C isoform 6 and isoform 7.	
Q8N9N5	UniProtKB	Alternative sequence	114	152	.	.	.	ID=VSP_027400;Note=In isoform 2%2C isoform 3%2C isoform 4%2C isoform 5 and isoform 6.	
Q8N9N5	UniProtKB	Alternative sequence	392	392	.	.	.	ID=VSP_027401;Note=In isoform 2%2C isoform 4%2C isoform 5 and isoform 7.	
Q8N9N5	UniProtKB	Alternative sequence	425	446	.	.	.	ID=VSP_027402;Note=In isoform 2%2C isoform 3%2C isoform 6 and isoform 7.	
Q8N9N5	UniProtKB	Sequence conflict	123	123	.	.	.	.	
Q8N9N5	UniProtKB	Sequence conflict	338	338	.	.	.	.	
##sequence-region Q07812 1 192
Q07812	UniProtKB	Chain	1	192	.	.	.	ID=PRO_0000143053;Note=Apoptosis regulator BAX	
Q07812	UniProtKB	Transmembrane	172	192	.	.	.	Note=Helical%3B;status=Potential	
Q07812	UniProtKB	Motif	59	73	.	.	.	Note=BH3	
Q07812	UniProtKB	Motif	98	118	.	.	.	Note=BH1	
Q07812	UniProtKB	Motif	150	165	.	.	.	Note=BH2	
Q07812	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
Q07812	UniProtKB	Alternative sequence	1	78	.	.	.	ID=VSP_031239;Note=In isoform Zeta.	
Q07812	UniProtKB	Alternative sequence	1	19	.	.	.	ID=VSP_031238;Note=In isoform Psi.	
Q07812	UniProtKB	Alternative sequence	12	41	.	.	.	ID=VSP_031234;Note=In isoform Gamma.	
Q07812	UniProtKB	Alternative sequence	30	78	.	.	.	ID=VSP_031235;Note=In isoform Delta.	
Q07812	UniProtKB	Alternative sequence	42	192	.	.	.	ID=VSP_031236;Note=In isoform Gamma.	
Q07812	UniProtKB	Alternative sequence	125	192	.	.	.	ID=VSP_031240;Note=In isoform Epsilon.	
Q07812	UniProtKB	Alternative sequence	159	192	.	.	.	ID=VSP_031237;Note=In isoform Beta.	
Q07812	UniProtKB	Alternative sequence	159	171	.	.	.	ID=VSP_037475;Note=In isoform Sigma.	
Q07812	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_013575;Note=In a plasmacytoma cell line.	
Q07812	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_047053;Dbxref=dbSNP:rs36017265	
Q07812	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_007809;Note=In a T-cell acute lymphoblastic leukemia cell line%3B loss of heterodimerization with Bcl-2 or Bcl-X(L).	
Q07812	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_013576;Note=In a Burkitt lymphoma%3B loss of homodimerization.	
Q07812	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Reduces interaction with BCL2L11%2C homooligomerization and triggering of apoptosis.	
Q07812	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Strongly reduced interaction with MCL1%2C BCL2%2C BCL2L1 and BCL2L2. No effect on cytochrome c release and subsequent apoptosis triggered by etoposide.	
Q07812	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Constitutive cytoplasmic location.	
Q07812	UniProtKB	Mutagenesis	184	184	.	.	.	Note=Constitutive mitochondrial location.	
Q07812	UniProtKB	Turn	2	4	.	.	.	.	
Q07812	UniProtKB	Beta strand	10	14	.	.	.	.	
Q07812	UniProtKB	Helix	16	36	.	.	.	.	
Q07812	UniProtKB	Beta strand	43	45	.	.	.	.	
Q07812	UniProtKB	Helix	54	72	.	.	.	.	
Q07812	UniProtKB	Helix	74	82	.	.	.	.	
Q07812	UniProtKB	Helix	88	99	.	.	.	.	
Q07812	UniProtKB	Turn	100	102	.	.	.	.	
Q07812	UniProtKB	Helix	107	147	.	.	.	.	
Q07812	UniProtKB	Helix	149	154	.	.	.	.	
Q07812	UniProtKB	Turn	155	158	.	.	.	.	
Q07812	UniProtKB	Helix	159	164	.	.	.	.	
Q07812	UniProtKB	Helix	171	188	.	.	.	.	
##sequence-region O95999 1 233
O95999	UniProtKB	Chain	1	233	.	.	.	ID=PRO_0000144074;Note=B-cell lymphoma/leukemia 10	
O95999	UniProtKB	Domain	13	101	.	.	.	Note=CARD	
O95999	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
O95999	UniProtKB	Modified residue	138	138	.	.	.	Note=Phosphoserine	
O95999	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_013208;Dbxref=dbSNP:rs12037217;Note=In MALT lymphoma and mesothelioma.	
O95999	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_013209;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_013210;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_013211;Note=In mesothelioma.	
O95999	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_013212;Note=In mesothelioma.	
O95999	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_013213;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_013214;Note=In germ cell tumor.	
O95999	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_013215;Note=In mesothelioma.	
O95999	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_013216;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_013217;Note=In mesothelioma.	
O95999	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_013218;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_013219;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_013220;Note=In mesothelioma.	
O95999	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_013221;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_013222;Note=In MALT lymphoma.	
O95999	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_013223;Note=In follicular lymphoma.	
O95999	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_013224;Dbxref=dbSNP:rs3768235;Note=In MALT lymphoma and mesothelioma.	
O95999	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_013225;Note=In germ cell tumor%2C mesothelioma and other cancer cell lines.	
O95999	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_013226;Note=In MALT lymphoma.	
O95999	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Abolishes cell death-inducing capability.	
O95999	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Abolishes cell death-inducing capability.	
O95999	UniProtKB	Mutagenesis	41	41	.	.	.	Note=Abolishes NF-kappa-B activation and homo/hetero-dimerization.	
O95999	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Abolishes cell death-inducing capability.	
O95999	UniProtKB	Mutagenesis	47	47	.	.	.	Note=Abolishes cell death-inducing capability.	
O95999	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Abolishes cell death-inducing capability.	
O95999	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Abolishes cell death-inducing capability.	
O95999	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Abolishes NF-kappa-B activation.	
O95999	UniProtKB	Mutagenesis	81	85	.	.	.	Note=Complete loss of IKBKB/IKKB-mediated phosphorylation.	
O95999	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Abolishes MALT1-mediated cleavage.	
O95999	UniProtKB	Mutagenesis	231	231	.	.	.	Note=Promotes NF-kappa-B activation.	
##sequence-region Q9Z0H7 1 233
Q9Z0H7	UniProtKB	Chain	1	233	.	.	.	ID=PRO_0000144075;Note=B-cell lymphoma/leukemia 10	
Q9Z0H7	UniProtKB	Domain	13	101	.	.	.	Note=CARD	
Q9Z0H7	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q9Z0H7	UniProtKB	Modified residue	138	138	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q9QYN5 1 233
Q9QYN5	UniProtKB	Chain	1	233	.	.	.	ID=PRO_0000144076;Note=B-cell lymphoma/leukemia 10	
Q9QYN5	UniProtKB	Domain	13	101	.	.	.	Note=CARD	
Q9QYN5	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q9QYN5	UniProtKB	Modified residue	138	138	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region O00499 1 593
O00499	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
O00499	UniProtKB	Chain	2	593	.	.	.	ID=PRO_0000192951;Note=Myc box-dependent-interacting protein 1	
O00499	UniProtKB	Domain	29	276	.	.	.	Note=BAR	
O00499	UniProtKB	Domain	520	592	.	.	.	Note=SH3	
O00499	UniProtKB	Region	2	122	.	.	.	Note=Interaction with BIN2	
O00499	UniProtKB	Region	378	421	.	.	.	Note=Clathrin-binding	
O00499	UniProtKB	Coiled coil	15	42	.	.	.	status=Potential	
O00499	UniProtKB	Coiled coil	193	267	.	.	.	status=Potential	
O00499	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
O00499	UniProtKB	Modified residue	296	296	.	.	.	Note=Phosphoserine	
O00499	UniProtKB	Modified residue	298	298	.	.	.	Note=Phosphoserine	
O00499	UniProtKB	Modified residue	303	303	.	.	.	Note=Phosphoserine	
O00499	UniProtKB	Modified residue	307	307	.	.	.	Note=Phosphothreonine	
O00499	UniProtKB	Modified residue	323	323	.	.	.	Note=Phosphothreonine	
O00499	UniProtKB	Modified residue	331	331	.	.	.	Note=Phosphoserine	
O00499	UniProtKB	Alternative sequence	174	204	.	.	.	ID=VSP_000246;Note=In isoform IIB%2C isoform IIC2%2C isoform II2%2C isoform II3%2C isoform BIN1%2C isoform BIN1+12A%2C isoform BIN1-10-13 and isoform BIN1-13.	
O00499	UniProtKB	Alternative sequence	285	285	.	.	.	ID=VSP_000247;Note=In isoform BIN1%2C isoform BIN1+12A and isoform BIN1-13.	
O00499	UniProtKB	Alternative sequence	335	487	.	.	.	ID=VSP_000251;Note=In isoform BIN1-10-13 and isoform BIN1-13.	
O00499	UniProtKB	Alternative sequence	335	457	.	.	.	ID=VSP_000250;Note=In isoform II3 and isoform BIN1.	
O00499	UniProtKB	Alternative sequence	335	421	.	.	.	ID=VSP_000249;Note=In isoform IIC1 and isoform IIC2.	
O00499	UniProtKB	Alternative sequence	335	377	.	.	.	ID=VSP_000248;Note=In isoform IID.	
O00499	UniProtKB	Alternative sequence	378	457	.	.	.	ID=VSP_000253;Note=In isoform II2 and isoform BIN1+12A.	
O00499	UniProtKB	Alternative sequence	378	421	.	.	.	ID=VSP_000252;Note=In isoform IIB.	
O00499	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_037425;Note=In CNM2%3B abolishes membrane tubulation.	
O00499	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_037426;Note=In CNM2%3B abolishes membrane tubulation.	
O00499	UniProtKB	Sequence conflict	474	474	.	.	.	.	
O00499	UniProtKB	Sequence conflict	481	481	.	.	.	.	
O00499	UniProtKB	Sequence conflict	481	481	.	.	.	.	
O00499	UniProtKB	Sequence conflict	481	481	.	.	.	.	
O00499	UniProtKB	Sequence conflict	510	510	.	.	.	.	
O00499	UniProtKB	Sequence conflict	510	510	.	.	.	.	
O00499	UniProtKB	Sequence conflict	528	528	.	.	.	.	
O00499	UniProtKB	Sequence conflict	528	528	.	.	.	.	
O00499	UniProtKB	Sequence conflict	576	576	.	.	.	.	
O00499	UniProtKB	Sequence conflict	576	576	.	.	.	.	
O00499	UniProtKB	Helix	8	33	.	.	.	.	
O00499	UniProtKB	Helix	43	89	.	.	.	.	
O00499	UniProtKB	Helix	97	121	.	.	.	.	
O00499	UniProtKB	Helix	123	131	.	.	.	.	
O00499	UniProtKB	Helix	133	161	.	.	.	.	
O00499	UniProtKB	Helix	205	268	.	.	.	.	
O00499	UniProtKB	Beta strand	523	527	.	.	.	.	
O00499	UniProtKB	Beta strand	535	537	.	.	.	.	
O00499	UniProtKB	Beta strand	546	549	.	.	.	.	
O00499	UniProtKB	Helix	555	557	.	.	.	.	
O00499	UniProtKB	Beta strand	562	567	.	.	.	.	
O00499	UniProtKB	Helix	568	572	.	.	.	.	
O00499	UniProtKB	Helix	573	579	.	.	.	.	
O00499	UniProtKB	Beta strand	582	585	.	.	.	.	
O00499	UniProtKB	Helix	586	588	.	.	.	.	
O00499	UniProtKB	Beta strand	589	591	.	.	.	.	
##sequence-region O08539 1 588
O08539	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
O08539	UniProtKB	Chain	2	588	.	.	.	ID=PRO_0000192952;Note=Myc box-dependent-interacting protein 1	
O08539	UniProtKB	Domain	29	276	.	.	.	Note=BAR	
O08539	UniProtKB	Domain	515	588	.	.	.	Note=SH3	
O08539	UniProtKB	Region	2	122	.	.	.	Note=Interaction with BIN2;status=By similarity	
O08539	UniProtKB	Region	379	422	.	.	.	Note=Clathrin-binding;status=By similarity	
O08539	UniProtKB	Coiled coil	15	42	.	.	.	status=Potential	
O08539	UniProtKB	Coiled coil	193	274	.	.	.	status=Potential	
O08539	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
O08539	UniProtKB	Modified residue	296	296	.	.	.	Note=Phosphoserine	
O08539	UniProtKB	Modified residue	298	298	.	.	.	Note=Phosphoserine	
O08539	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphoserine	
O08539	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphothreonine	
O08539	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine	
O08539	UniProtKB	Alternative sequence	174	204	.	.	.	ID=VSP_000254;Note=In isoform 2.	
O08539	UniProtKB	Alternative sequence	335	457	.	.	.	ID=VSP_000255;Note=In isoform 2.	
##sequence-region O08839 1 588
O08839	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
O08839	UniProtKB	Chain	2	588	.	.	.	ID=PRO_0000192953;Note=Myc box-dependent-interacting protein 1	
O08839	UniProtKB	Domain	29	276	.	.	.	Note=BAR	
O08839	UniProtKB	Domain	515	588	.	.	.	Note=SH3	
O08839	UniProtKB	Region	2	122	.	.	.	Note=Interaction with BIN2;status=By similarity	
O08839	UniProtKB	Region	379	422	.	.	.	Note=Clathrin-binding;status=By similarity	
O08839	UniProtKB	Coiled coil	15	42	.	.	.	status=Potential	
O08839	UniProtKB	Coiled coil	193	274	.	.	.	status=Potential	
O08839	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
O08839	UniProtKB	Modified residue	296	296	.	.	.	Note=Phosphoserine;status=By similarity	
O08839	UniProtKB	Modified residue	298	298	.	.	.	Note=Phosphoserine;status=By similarity	
O08839	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphoserine;status=By similarity	
O08839	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphothreonine;status=By similarity	
O08839	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine;status=By similarity	
O08839	UniProtKB	Alternative sequence	173	205	.	.	.	ID=VSP_000256;Note=In isoform AMPH2-4 and isoform AMPH2-6.	
O08839	UniProtKB	Alternative sequence	253	588	.	.	.	ID=VSP_000257;Note=In isoform AMPH2-4.	
O08839	UniProtKB	Alternative sequence	335	588	.	.	.	ID=VSP_000258;Note=In isoform AMPH2-3.	
O08839	UniProtKB	Alternative sequence	335	482	.	.	.	ID=VSP_000259;Note=In isoform AMPH2-5 and isoform AMPH2-6.	
O08839	UniProtKB	Alternative sequence	423	460	.	.	.	ID=VSP_000260;Note=In isoform AMPH2-2.	
O08839	UniProtKB	Beta strand	518	524	.	.	.	.	
O08839	UniProtKB	Beta strand	541	545	.	.	.	.	
O08839	UniProtKB	Helix	550	552	.	.	.	.	
O08839	UniProtKB	Beta strand	557	562	.	.	.	.	
O08839	UniProtKB	Helix	563	567	.	.	.	.	
O08839	UniProtKB	Helix	572	575	.	.	.	.	
O08839	UniProtKB	Beta strand	577	580	.	.	.	.	
O08839	UniProtKB	Helix	581	583	.	.	.	.	
O08839	UniProtKB	Beta strand	584	587	.	.	.	.	
##sequence-region Q864U1 1 1849
Q864U1	UniProtKB	Chain	1	1849	.	.	.	ID=PRO_0000055827;Note=Breast cancer type 1 susceptibility protein homolog	
Q864U1	UniProtKB	Domain	1642	1729	.	.	.	Note=BRCT 1	
Q864U1	UniProtKB	Domain	1749	1848	.	.	.	Note=BRCT 2	
Q864U1	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
Q864U1	UniProtKB	Region	1392	1419	.	.	.	Note=Interaction with PALB2;status=By similarity	
Q864U1	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q864U1	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA;status=By similarity	
Q864U1	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	691	691	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	982	982	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
Q864U1	UniProtKB	Modified residue	1138	1138	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1212	1212	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1274	1274	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1323	1323	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1330	1330	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1382	1382	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1389	1389	.	.	.	Note=Phosphothreonine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1418	1418	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1452	1452	.	.	.	Note=Phosphoserine;status=By similarity	
Q864U1	UniProtKB	Modified residue	1518	1518	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q95153 1 1878
Q95153	UniProtKB	Chain	1	1878	.	.	.	ID=PRO_0000055828;Note=Breast cancer type 1 susceptibility protein homolog	
Q95153	UniProtKB	Domain	1652	1739	.	.	.	Note=BRCT 1	
Q95153	UniProtKB	Domain	1764	1863	.	.	.	Note=BRCT 2	
Q95153	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
Q95153	UniProtKB	Region	1401	1428	.	.	.	Note=Interaction with PALB2;status=By similarity	
Q95153	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q95153	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	305	305	.	.	.	Note=Phosphoserine%3B by AURKA;status=By similarity	
Q95153	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	420	420	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	692	692	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	751	751	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	987	987	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
Q95153	UniProtKB	Modified residue	1144	1144	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1212	1212	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1219	1219	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1281	1281	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1331	1331	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1344	1344	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1391	1391	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1398	1398	.	.	.	Note=Phosphothreonine;status=By similarity	
Q95153	UniProtKB	Modified residue	1427	1427	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1460	1460	.	.	.	Note=Phosphoserine;status=By similarity	
Q95153	UniProtKB	Modified residue	1527	1527	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q6J6I8 1 1863
Q6J6I8	UniProtKB	Chain	1	1863	.	.	.	ID=PRO_0000055829;Note=Breast cancer type 1 susceptibility protein homolog	
Q6J6I8	UniProtKB	Domain	1642	1736	.	.	.	Note=BRCT 1	
Q6J6I8	UniProtKB	Domain	1756	1855	.	.	.	Note=BRCT 2	
Q6J6I8	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
Q6J6I8	UniProtKB	Region	1397	1424	.	.	.	Note=Interaction with PALB2;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	694	694	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	840	840	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	988	988	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1143	1143	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1280	1280	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1328	1328	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1342	1342	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1394	1394	.	.	.	Note=Phosphothreonine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1423	1423	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1457	1457	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Modified residue	1524	1524	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I8	UniProtKB	Sequence conflict	231	231	.	.	.	.	
Q6J6I8	UniProtKB	Sequence conflict	590	590	.	.	.	.	
Q6J6I8	UniProtKB	Sequence conflict	799	799	.	.	.	.	
Q6J6I8	UniProtKB	Sequence conflict	1180	1180	.	.	.	.	
Q6J6I8	UniProtKB	Sequence conflict	1235	1235	.	.	.	.	
##sequence-region P38398 1 1863
P38398	UniProtKB	Chain	1	1863	.	.	.	ID=PRO_0000055830;Note=Breast cancer type 1 susceptibility protein	
P38398	UniProtKB	Domain	1642	1736	.	.	.	Note=BRCT 1	
P38398	UniProtKB	Domain	1756	1855	.	.	.	Note=BRCT 2	
P38398	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
P38398	UniProtKB	Region	1397	1424	.	.	.	Note=Interaction with PALB2	
P38398	UniProtKB	Compositional bias	651	654	.	.	.	Note=Poly-Lys	
P38398	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
P38398	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA	
P38398	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	694	694	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	840	840	.	.	.	Note=Phosphoserine;status=By similarity	
P38398	UniProtKB	Modified residue	988	988	.	.	.	Note=Phosphoserine%3B by CHEK2	
P38398	UniProtKB	Modified residue	1143	1143	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro	
P38398	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	1280	1280	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro	
P38398	UniProtKB	Modified residue	1328	1328	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	1342	1342	.	.	.	Note=Phosphoserine	
P38398	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine%3B by ATM and ATR	
P38398	UniProtKB	Modified residue	1394	1394	.	.	.	Note=Phosphothreonine%3B by ATR%3B in vitro	
P38398	UniProtKB	Modified residue	1423	1423	.	.	.	Note=Phosphoserine%3B by ATM and ATR	
P38398	UniProtKB	Modified residue	1457	1457	.	.	.	Note=Phosphoserine%3B by ATR%3B in vitro	
P38398	UniProtKB	Modified residue	1524	1524	.	.	.	Note=Phosphoserine%3B by ATM	
P38398	UniProtKB	Alternative sequence	1	17	.	.	.	ID=VSP_035396;Note=In isoform 4.	
P38398	UniProtKB	Alternative sequence	64	1863	.	.	.	ID=VSP_047891;Note=In isoform 2.	
P38398	UniProtKB	Alternative sequence	224	1365	.	.	.	ID=VSP_035398;Note=In isoform 5.	
P38398	UniProtKB	Alternative sequence	264	1366	.	.	.	ID=VSP_035399;Note=In isoform 3 and isoform 6.	
P38398	UniProtKB	Alternative sequence	1453	1453	.	.	.	ID=VSP_043797;Note=In isoform 3 and isoform 6.	
P38398	UniProtKB	Alternative sequence	1778	1863	.	.	.	ID=VSP_043798;Note=In isoform 6.	
P38398	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_020679;Note=In BC and BROVCA1.	
P38398	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_007754;Note=Unclassified.	
P38398	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_063899;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_007755;Note=Unclassified.	
P38398	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_007756;Note=In BC.	
P38398	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_020680;Note=In BC and BROVCA1.	
P38398	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_035947;Note=In a breast cancer sample%3B somatic mutation.	
P38398	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_007757;Dbxref=dbSNP:rs28897672;Note=In BC and ovarian cancer%3B no interaction with BAP1.	
P38398	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_007758;Note=In BC%3B no interaction with BAP1.	
P38398	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_007759;Dbxref=dbSNP:rs55851803;Note=Unclassified.	
P38398	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_020681;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_052077;Dbxref=dbSNP:rs28897674	
P38398	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_008759;Note=In ovarian cancer%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_007760	
P38398	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_007761;Dbxref=dbSNP:rs80357244;Note=In BC.	
P38398	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_019944;Dbxref=dbSNP:rs8176153	
P38398	UniProtKB	Natural variant	346	346	.	.	.	ID=VAR_008760;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	356	356	.	.	.	ID=VAR_007762;Dbxref=dbSNP:rs1799950;Note=Common polymorphism.	
P38398	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_007763;Note=In BC.	
P38398	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_007764;Dbxref=dbSNP:rs56128296;Note=Unclassified.	
P38398	UniProtKB	Natural variant	461	461	.	.	.	ID=VAR_007765;Dbxref=dbSNP:rs56046357;Note=In BC.	
P38398	UniProtKB	Natural variant	465	465	.	.	.	ID=VAR_007766;Note=In BC.	
P38398	UniProtKB	Natural variant	507	507	.	.	.	ID=VAR_007767;Note=Unclassified.	
P38398	UniProtKB	Natural variant	552	552	.	.	.	ID=VAR_007768;Note=In BC.	
P38398	UniProtKB	Natural variant	656	656	.	.	.	ID=VAR_020682	
P38398	UniProtKB	Natural variant	693	693	.	.	.	ID=VAR_007769;Dbxref=dbSNP:rs4986850;Note=Rare polymorphism.	
P38398	UniProtKB	Natural variant	723	723	.	.	.	ID=VAR_020110;Dbxref=dbSNP:rs4986845	
P38398	UniProtKB	Natural variant	749	749	.	.	.	ID=VAR_020683;Note=In BC.	
P38398	UniProtKB	Natural variant	758	758	.	.	.	ID=VAR_035948;Note=In a breast cancer sample%3B somatic mutation.	
P38398	UniProtKB	Natural variant	772	772	.	.	.	ID=VAR_007770;Note=Rare polymorphism.	
P38398	UniProtKB	Natural variant	778	778	.	.	.	ID=VAR_035949;Note=In a breast cancer sample%3B somatic mutation.	
P38398	UniProtKB	Natural variant	820	820	.	.	.	ID=VAR_007771;Dbxref=dbSNP:rs56082113;Note=Rare polymorphism.	
P38398	UniProtKB	Natural variant	826	826	.	.	.	ID=VAR_007772;Dbxref=dbSNP:rs28897683;Note=In BC.	
P38398	UniProtKB	Natural variant	835	835	.	.	.	ID=VAR_020684;Note=In BROVCA1%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	841	841	.	.	.	ID=VAR_007773;Dbxref=dbSNP:rs1800709;Note=In BROVCA1%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	856	856	.	.	.	ID=VAR_020685;Dbxref=dbSNP:rs80356892;Note=In a patient with sporadic breast cancer%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	866	866	.	.	.	ID=VAR_020686;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	871	871	.	.	.	ID=VAR_007774;Dbxref=dbSNP:rs799917;Note=Common polymorphism.	
P38398	UniProtKB	Natural variant	888	888	.	.	.	ID=VAR_020687;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	892	892	.	.	.	ID=VAR_007775;Note=In BC.	
P38398	UniProtKB	Natural variant	925	925	.	.	.	ID=VAR_021913;Dbxref=dbSNP:rs4986847	
P38398	UniProtKB	Natural variant	960	960	.	.	.	ID=VAR_007776;Note=In BC.	
P38398	UniProtKB	Natural variant	989	989	.	.	.	ID=VAR_020111;Dbxref=dbSNP:rs4986848	
P38398	UniProtKB	Natural variant	1008	1008	.	.	.	ID=VAR_007777;Dbxref=dbSNP:rs1800704;Note=Common polymorphism.	
P38398	UniProtKB	Natural variant	1025	1025	.	.	.	ID=VAR_007778;Note=In BC.	
P38398	UniProtKB	Natural variant	1038	1038	.	.	.	ID=VAR_007779;Dbxref=dbSNP:rs16941;Note=Common polymorphism.	
P38398	UniProtKB	Natural variant	1040	1040	.	.	.	ID=VAR_007780;Dbxref=dbSNP:rs4986852;Note=Rare polymorphism.	
P38398	UniProtKB	Natural variant	1047	1047	.	.	.	ID=VAR_007781;Note=In BC.	
P38398	UniProtKB	Natural variant	1060	1060	.	.	.	ID=VAR_020688	
P38398	UniProtKB	Natural variant	1139	1139	.	.	.	ID=VAR_020689;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1140	1140	.	.	.	ID=VAR_019945;Dbxref=dbSNP:rs2227945	
P38398	UniProtKB	Natural variant	1150	1150	.	.	.	ID=VAR_007782;Dbxref=dbSNP:rs80357272;Note=In BC.	
P38398	UniProtKB	Natural variant	1183	1183	.	.	.	ID=VAR_007783;Dbxref=dbSNP:rs16942;Note=Common polymorphism.	
P38398	UniProtKB	Natural variant	1187	1187	.	.	.	ID=VAR_020690;Note=In BC and BROVCA1.	
P38398	UniProtKB	Natural variant	1200	1200	.	.	.	ID=VAR_020691;Dbxref=dbSNP:rs56214134;Note=In BC and BROVCA1.	
P38398	UniProtKB	Natural variant	1204	1204	.	.	.	ID=VAR_020692;Note=In BC.	
P38398	UniProtKB	Natural variant	1207	1207	.	.	.	ID=VAR_020693;Note=In BC.	
P38398	UniProtKB	Natural variant	1210	1210	.	.	.	ID=VAR_020694;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1217	1217	.	.	.	ID=VAR_020695;Note=In BC and BROVCA1.	
P38398	UniProtKB	Natural variant	1219	1219	.	.	.	ID=VAR_007784;Note=Unclassified.	
P38398	UniProtKB	Natural variant	1226	1226	.	.	.	ID=VAR_020696;Note=In BROVCA1.	
P38398	UniProtKB	Natural variant	1236	1236	.	.	.	ID=VAR_052078;Dbxref=dbSNP:rs28897687	
P38398	UniProtKB	Natural variant	1243	1243	.	.	.	ID=VAR_020697;Note=In BROVCA1.	
P38398	UniProtKB	Natural variant	1250	1250	.	.	.	ID=VAR_052079;Dbxref=dbSNP:rs28897686	
P38398	UniProtKB	Natural variant	1297	1297	.	.	.	ID=VAR_020698;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1347	1347	.	.	.	ID=VAR_007785;Dbxref=dbSNP:rs28897689	
P38398	UniProtKB	Natural variant	1406	1406	.	.	.	ID=VAR_008761;Dbxref=dbSNP:rs1800707;Note=Polymorphism.	
P38398	UniProtKB	Natural variant	1411	1411	.	.	.	ID=VAR_020699;Note=In ovarian cancer%3B unknown pathological significance%3B decreased interaction with PALB2.	
P38398	UniProtKB	Natural variant	1431	1431	.	.	.	ID=VAR_007786	
P38398	UniProtKB	Natural variant	1443	1443	.	.	.	ID=VAR_007787;Note=Rare polymorphism.	
P38398	UniProtKB	Natural variant	1443	1443	.	.	.	ID=VAR_020112;Dbxref=dbSNP:rs4986849	
P38398	UniProtKB	Natural variant	1495	1495	.	.	.	ID=VAR_063900;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1512	1512	.	.	.	ID=VAR_007788;Dbxref=dbSNP:rs1800744	
P38398	UniProtKB	Natural variant	1561	1561	.	.	.	ID=VAR_007789;Dbxref=dbSNP:rs56158747;Note=Unclassified.	
P38398	UniProtKB	Natural variant	1606	1606	.	.	.	ID=VAR_007790;Note=Unclassified.	
P38398	UniProtKB	Natural variant	1613	1613	.	.	.	ID=VAR_007791;Dbxref=dbSNP:rs1799966;Note=Common polymorphism.	
P38398	UniProtKB	Natural variant	1620	1620	.	.	.	ID=VAR_019946;Dbxref=dbSNP:rs8176219	
P38398	UniProtKB	Natural variant	1623	1623	.	.	.	ID=VAR_063901;Note=Could be associated with cancer susceptibility%3B major splicing aberration identified with this mutant.	
P38398	UniProtKB	Natural variant	1628	1628	.	.	.	ID=VAR_007793;Dbxref=dbSNP:rs4986854;Note=In some patients with sporadic breast cancer%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1628	1628	.	.	.	ID=VAR_007792;Note=Unclassified.	
P38398	UniProtKB	Natural variant	1637	1637	.	.	.	ID=VAR_007794;Note=Rare polymorphism.	
P38398	UniProtKB	Natural variant	1641	1641	.	.	.	ID=VAR_008762;Dbxref=dbSNP:rs1800726;Note=In ovarian cancer%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1652	1652	.	.	.	ID=VAR_007795;Dbxref=dbSNP:rs1799967;Note=Rare polymorphism.	
P38398	UniProtKB	Natural variant	1662	1662	.	.	.	ID=VAR_052080;Dbxref=dbSNP:rs28897695	
P38398	UniProtKB	Natural variant	1665	1665	.	.	.	ID=VAR_020700	
P38398	UniProtKB	Natural variant	1685	1685	.	.	.	ID=VAR_063902;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1685	1685	.	.	.	ID=VAR_063903;Note=Could be associated with cancer susceptibility%3B multifactorial likelihood analysis provides evidence for pathogenicity.	
P38398	UniProtKB	Natural variant	1689	1689	.	.	.	ID=VAR_063904;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1690	1690	.	.	.	ID=VAR_020701;Note=In some patients with sporadic breast cancer%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1692	1692	.	.	.	ID=VAR_008763;Note=In ovarian cancer%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1697	1697	.	.	.	ID=VAR_020702;Note=In ovarian cancer.	
P38398	UniProtKB	Natural variant	1699	1699	.	.	.	ID=VAR_020703;Note=In ovarian cancer.	
P38398	UniProtKB	Natural variant	1706	1706	.	.	.	ID=VAR_063905;Dbxref=dbSNP:rs80356860;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1708	1708	.	.	.	ID=VAR_007796;Dbxref=dbSNP:rs28897696;Note=In BC%3B abolishes ACACA binding.	
P38398	UniProtKB	Natural variant	1713	1713	.	.	.	ID=VAR_007797	
P38398	UniProtKB	Natural variant	1715	1715	.	.	.	ID=VAR_063906;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1738	1738	.	.	.	ID=VAR_063907;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1749	1749	.	.	.	ID=VAR_007798;Note=In ovarian cancer%3B unknown pathological significance%3B abolishes ACACA binding and strongly reduces BRIP1 binding.	
P38398	UniProtKB	Natural variant	1764	1764	.	.	.	ID=VAR_063908;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1766	1766	.	.	.	ID=VAR_063909;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1775	1775	.	.	.	ID=VAR_063212;Note=In BC%3B strongly reduced transcription transactivation%3B abolishes interaction with BRIP1 and RBBP8.	
P38398	UniProtKB	Natural variant	1775	1775	.	.	.	ID=VAR_007799;Note=In BC%3B alters protein stability and abolishes ACACA and BRIP1 binding.	
P38398	UniProtKB	Natural variant	1776	1776	.	.	.	ID=VAR_008764;Dbxref=dbSNP:rs1800757;Note=In ovarian cancer%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1786	1786	.	.	.	ID=VAR_020704;Note=In BROVCA1%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1788	1788	.	.	.	ID=VAR_063910;Note=In BC%3B unknown pathological significance.	
P38398	UniProtKB	Natural variant	1812	1812	.	.	.	ID=VAR_008765;Dbxref=dbSNP:rs1800751;Note=In ovarian cancer%3B unknown pathological significance.	
P38398	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Disrupts the interaction with E2 enzymes%2C thereby abolishing the E3 ubiquitin-protein ligase activity.	
P38398	UniProtKB	Mutagenesis	26	26	.	.	.	Note=No ubiquitination of RBBP8. No restoration RBBP8-mediated focus formation or G2/M checkpoint control upon DNA damage.	
P38398	UniProtKB	Mutagenesis	71	71	.	.	.	Note=No effect on interaction with BAP1.	
P38398	UniProtKB	Mutagenesis	308	308	.	.	.	Note=Abolishes phosphorylation by AURKA and interferes with cell cycle progression from G2 to mitosis.	
P38398	UniProtKB	Mutagenesis	1143	1143	.	.	.	Note=Reduces in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1239	1239	.	.	.	Note=No effect on in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1280	1280	.	.	.	Note=Reduces in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1298	1298	.	.	.	Note=No effect on in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1330	1330	.	.	.	Note=No effect on in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1387	1387	.	.	.	Note=Loss of IR-induced S-phase checkpoint. Reduces in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1394	1394	.	.	.	Note=Reduces in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1423	1423	.	.	.	Note=Inhibition of the infrared-induced G2 arrest. Reduces phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1457	1457	.	.	.	Note=Reduces in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1466	1466	.	.	.	Note=No effect on in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1524	1524	.	.	.	Note=No change in infrared S-phase delay%3B when associated with A-1387. No effect on in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1655	1655	.	.	.	Note=Abolishes interaction with BRIP1.	
P38398	UniProtKB	Mutagenesis	1702	1702	.	.	.	Note=Abolishes interaction with BRIP1.	
P38398	UniProtKB	Mutagenesis	1720	1720	.	.	.	Note=No effect on in vitro phosphorylation by ATR.	
P38398	UniProtKB	Mutagenesis	1738	1738	.	.	.	Note=Abolishes interaction with BRIP1.	
P38398	UniProtKB	Mutagenesis	1755	1755	.	.	.	Note=No effect on in vitro phosphorylation by ATR.	
P38398	UniProtKB	Sequence conflict	89	89	.	.	.	.	
P38398	UniProtKB	Sequence conflict	148	148	.	.	.	.	
P38398	UniProtKB	Sequence conflict	253	253	.	.	.	.	
P38398	UniProtKB	Sequence conflict	1077	1077	.	.	.	.	
P38398	UniProtKB	Sequence conflict	1426	1426	.	.	.	.	
P38398	UniProtKB	Helix	3	5	.	.	.	.	
P38398	UniProtKB	Helix	8	21	.	.	.	.	
P38398	UniProtKB	Beta strand	25	27	.	.	.	.	
P38398	UniProtKB	Helix	46	53	.	.	.	.	
P38398	UniProtKB	Beta strand	54	58	.	.	.	.	
P38398	UniProtKB	Turn	62	64	.	.	.	.	
P38398	UniProtKB	Turn	70	72	.	.	.	.	
P38398	UniProtKB	Beta strand	78	80	.	.	.	.	
P38398	UniProtKB	Helix	81	96	.	.	.	.	
P38398	UniProtKB	Beta strand	1651	1656	.	.	.	.	
P38398	UniProtKB	Helix	1659	1672	.	.	.	.	
P38398	UniProtKB	Beta strand	1675	1679	.	.	.	.	
P38398	UniProtKB	Beta strand	1686	1689	.	.	.	.	
P38398	UniProtKB	Beta strand	1695	1697	.	.	.	.	
P38398	UniProtKB	Helix	1701	1708	.	.	.	.	
P38398	UniProtKB	Beta strand	1712	1715	.	.	.	.	
P38398	UniProtKB	Helix	1717	1724	.	.	.	.	
P38398	UniProtKB	Beta strand	1725	1727	.	.	.	.	
P38398	UniProtKB	Helix	1731	1734	.	.	.	.	
P38398	UniProtKB	Turn	1740	1742	.	.	.	.	
P38398	UniProtKB	Beta strand	1743	1745	.	.	.	.	
P38398	UniProtKB	Helix	1748	1753	.	.	.	.	
P38398	UniProtKB	Turn	1755	1757	.	.	.	.	
P38398	UniProtKB	Turn	1760	1763	.	.	.	.	
P38398	UniProtKB	Beta strand	1765	1768	.	.	.	.	
P38398	UniProtKB	Beta strand	1770	1772	.	.	.	.	
P38398	UniProtKB	Beta strand	1773	1775	.	.	.	.	
P38398	UniProtKB	Helix	1777	1786	.	.	.	.	
P38398	UniProtKB	Beta strand	1789	1791	.	.	.	.	
P38398	UniProtKB	Helix	1795	1797	.	.	.	.	
P38398	UniProtKB	Beta strand	1801	1803	.	.	.	.	
P38398	UniProtKB	Beta strand	1806	1810	.	.	.	.	
P38398	UniProtKB	Helix	1812	1814	.	.	.	.	
P38398	UniProtKB	Helix	1819	1822	.	.	.	.	
P38398	UniProtKB	Turn	1825	1827	.	.	.	.	
P38398	UniProtKB	Beta strand	1828	1830	.	.	.	.	
P38398	UniProtKB	Beta strand	1832	1834	.	.	.	.	
P38398	UniProtKB	Helix	1835	1844	.	.	.	.	
P38398	UniProtKB	Helix	1851	1853	.	.	.	.	
##sequence-region Q6J6I9 1 1863
Q6J6I9	UniProtKB	Chain	1	1863	.	.	.	ID=PRO_0000055831;Note=Breast cancer type 1 susceptibility protein homolog	
Q6J6I9	UniProtKB	Domain	1642	1736	.	.	.	Note=BRCT 1	
Q6J6I9	UniProtKB	Domain	1756	1855	.	.	.	Note=BRCT 2	
Q6J6I9	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
Q6J6I9	UniProtKB	Region	1397	1424	.	.	.	Note=Interaction with PALB2;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	307	307	.	.	.	Note=Phosphoserine%3B by AURKA;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	394	394	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	397	397	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	422	422	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	693	693	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	752	752	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	839	839	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	987	987	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1143	1143	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1280	1280	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1328	1328	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1342	1342	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1394	1394	.	.	.	Note=Phosphothreonine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1423	1423	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1457	1457	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Modified residue	1524	1524	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6I9	UniProtKB	Sequence conflict	366	366	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	569	569	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	717	717	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	750	750	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	773	773	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	913	913	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	1016	1016	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	1063	1063	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	1167	1167	.	.	.	.	
Q6J6I9	UniProtKB	Sequence conflict	1203	1203	.	.	.	.	
##sequence-region P48754 1 1812
P48754	UniProtKB	Chain	1	1812	.	.	.	ID=PRO_0000055832;Note=Breast cancer type 1 susceptibility protein homolog	
P48754	UniProtKB	Domain	1585	1679	.	.	.	Note=BRCT 1	
P48754	UniProtKB	Domain	1698	1797	.	.	.	Note=BRCT 2	
P48754	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
P48754	UniProtKB	Region	1353	1380	.	.	.	Note=Interaction with PALB2;status=By similarity	
P48754	UniProtKB	Compositional bias	1562	1567	.	.	.	Note=Poly-Ala	
P48754	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
P48754	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	305	305	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	686	686	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	831	831	.	.	.	Note=Phosphoserine	
P48754	UniProtKB	Modified residue	971	971	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
P48754	UniProtKB	Modified residue	1174	1174	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	1180	1180	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	1241	1241	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	1297	1297	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	1303	1303	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	1343	1343	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	1350	1350	.	.	.	Note=Phosphothreonine;status=By similarity	
P48754	UniProtKB	Modified residue	1413	1413	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Modified residue	1481	1481	.	.	.	Note=Phosphoserine;status=By similarity	
P48754	UniProtKB	Sequence conflict	93	93	.	.	.	.	
P48754	UniProtKB	Sequence conflict	305	305	.	.	.	.	
P48754	UniProtKB	Sequence conflict	319	319	.	.	.	.	
P48754	UniProtKB	Sequence conflict	377	377	.	.	.	.	
P48754	UniProtKB	Sequence conflict	550	550	.	.	.	.	
P48754	UniProtKB	Sequence conflict	652	652	.	.	.	.	
P48754	UniProtKB	Sequence conflict	765	765	.	.	.	.	
P48754	UniProtKB	Sequence conflict	765	765	.	.	.	.	
P48754	UniProtKB	Sequence conflict	917	917	.	.	.	.	
P48754	UniProtKB	Sequence conflict	933	933	.	.	.	.	
P48754	UniProtKB	Sequence conflict	933	933	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1091	1091	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1122	1122	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1206	1206	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1212	1213	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1255	1255	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1261	1261	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1264	1264	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1269	1269	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1283	1283	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1337	1337	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1349	1349	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1352	1353	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1381	1381	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1390	1390	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1400	1400	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1503	1503	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1549	1549	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1680	1680	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1712	1712	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1721	1721	.	.	.	.	
P48754	UniProtKB	Sequence conflict	1791	1791	.	.	.	.	
##sequence-region Q9GKK8 1 1863
Q9GKK8	UniProtKB	Chain	1	1863	.	.	.	ID=PRO_0000055833;Note=Breast cancer type 1 susceptibility protein homolog	
Q9GKK8	UniProtKB	Domain	1642	1736	.	.	.	Note=BRCT 1	
Q9GKK8	UniProtKB	Domain	1756	1855	.	.	.	Note=BRCT 2	
Q9GKK8	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
Q9GKK8	UniProtKB	Region	1397	1424	.	.	.	Note=Interaction with PALB2;status=By similarity	
Q9GKK8	UniProtKB	Compositional bias	651	654	.	.	.	Note=Poly-Lys	
Q9GKK8	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	694	694	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	840	840	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	988	988	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1143	1143	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1280	1280	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1328	1328	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1342	1342	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1394	1394	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1423	1423	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1457	1457	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Modified residue	1524	1524	.	.	.	Note=Phosphoserine;status=By similarity	
Q9GKK8	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_018712	
Q9GKK8	UniProtKB	Natural variant	590	590	.	.	.	ID=VAR_018713	
Q9GKK8	UniProtKB	Natural variant	731	731	.	.	.	ID=VAR_018714	
Q9GKK8	UniProtKB	Natural variant	1100	1100	.	.	.	ID=VAR_018715	
Q9GKK8	UniProtKB	Sequence conflict	427	427	.	.	.	.	
Q9GKK8	UniProtKB	Sequence conflict	925	925	.	.	.	.	
Q9GKK8	UniProtKB	Sequence conflict	1520	1520	.	.	.	.	
##sequence-region Q6J6J0 1 1863
Q6J6J0	UniProtKB	Chain	1	1863	.	.	.	ID=PRO_0000055834;Note=Breast cancer type 1 susceptibility protein homolog	
Q6J6J0	UniProtKB	Domain	1642	1736	.	.	.	Note=BRCT 1	
Q6J6J0	UniProtKB	Domain	1756	1855	.	.	.	Note=BRCT 2	
Q6J6J0	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
Q6J6J0	UniProtKB	Region	1397	1424	.	.	.	Note=Interaction with PALB2;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	398	398	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	694	694	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	840	840	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	988	988	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1143	1143	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1211	1211	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1280	1280	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1328	1328	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1336	1336	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1342	1342	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1394	1394	.	.	.	Note=Phosphothreonine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1423	1423	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1457	1457	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Modified residue	1524	1524	.	.	.	Note=Phosphoserine;status=By similarity	
Q6J6J0	UniProtKB	Sequence conflict	755	755	.	.	.	.	
##sequence-region O54952 1 1817
O54952	UniProtKB	Chain	1	1817	.	.	.	ID=PRO_0000055835;Note=Breast cancer type 1 susceptibility protein homolog	
O54952	UniProtKB	Domain	1588	1682	.	.	.	Note=BRCT 1	
O54952	UniProtKB	Domain	1701	1800	.	.	.	Note=BRCT 2	
O54952	UniProtKB	Zinc finger	24	65	.	.	.	Note=RING-type	
O54952	UniProtKB	Region	1354	1381	.	.	.	Note=Interaction with PALB2;status=By similarity	
O54952	UniProtKB	Motif	497	503	.	.	.	Note=Nuclear localization signal;status=Potential	
O54952	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
O54952	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	306	306	.	.	.	Note=Phosphoserine%3B by AURKA;status=By similarity	
O54952	UniProtKB	Modified residue	393	393	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	686	686	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	975	975	.	.	.	Note=Phosphoserine%3B by CHEK2;status=By similarity	
O54952	UniProtKB	Modified residue	1181	1181	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	1242	1242	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	1298	1298	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	1304	1304	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	1344	1344	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	1351	1351	.	.	.	Note=Phosphothreonine;status=By similarity	
O54952	UniProtKB	Modified residue	1380	1380	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	1414	1414	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Modified residue	1482	1482	.	.	.	Note=Phosphoserine;status=By similarity	
O54952	UniProtKB	Sequence conflict	38	38	.	.	.	.	
O54952	UniProtKB	Sequence conflict	38	38	.	.	.	.	
O54952	UniProtKB	Sequence conflict	192	192	.	.	.	.	
O54952	UniProtKB	Sequence conflict	192	192	.	.	.	.	
O54952	UniProtKB	Beta strand	1597	1602	.	.	.	.	
O54952	UniProtKB	Helix	1605	1617	.	.	.	.	
O54952	UniProtKB	Beta strand	1632	1635	.	.	.	.	
O54952	UniProtKB	Beta strand	1641	1643	.	.	.	.	
O54952	UniProtKB	Helix	1647	1654	.	.	.	.	
O54952	UniProtKB	Beta strand	1658	1661	.	.	.	.	
O54952	UniProtKB	Helix	1663	1669	.	.	.	.	
O54952	UniProtKB	Turn	1670	1672	.	.	.	.	
O54952	UniProtKB	Helix	1678	1680	.	.	.	.	
O54952	UniProtKB	Turn	1686	1688	.	.	.	.	
O54952	UniProtKB	Beta strand	1690	1692	.	.	.	.	
O54952	UniProtKB	Helix	1694	1701	.	.	.	.	
O54952	UniProtKB	Beta strand	1710	1713	.	.	.	.	
O54952	UniProtKB	Beta strand	1718	1720	.	.	.	.	
O54952	UniProtKB	Helix	1722	1731	.	.	.	.	
O54952	UniProtKB	Beta strand	1735	1737	.	.	.	.	
O54952	UniProtKB	Beta strand	1739	1741	.	.	.	.	
O54952	UniProtKB	Helix	1743	1745	.	.	.	.	
O54952	UniProtKB	Beta strand	1752	1755	.	.	.	.	
O54952	UniProtKB	Beta strand	1777	1779	.	.	.	.	
O54952	UniProtKB	Helix	1781	1788	.	.	.	.	
O54952	UniProtKB	Helix	1795	1798	.	.	.	.	
##sequence-region Q864S8 1 3372
Q864S8	UniProtKB	Chain	1	3372	.	.	.	ID=PRO_0000227014;Note=Breast cancer type 2 susceptibility protein homolog	
Q864S8	UniProtKB	Repeat	994	1028	.	.	.	Note=BRCA2 1	
Q864S8	UniProtKB	Repeat	1208	1242	.	.	.	Note=BRCA2 2	
Q864S8	UniProtKB	Repeat	1417	1451	.	.	.	Note=BRCA2 3	
Q864S8	UniProtKB	Repeat	1518	1552	.	.	.	Note=BRCA2 4	
Q864S8	UniProtKB	Repeat	1663	1697	.	.	.	Note=BRCA2 5	
Q864S8	UniProtKB	Repeat	1925	1959	.	.	.	Note=BRCA2 6	
Q864S8	UniProtKB	Repeat	1995	2029	.	.	.	Note=BRCA2 7	
Q864S8	UniProtKB	Region	1	40	.	.	.	Note=Interaction with PALB2;status=By similarity	
Q864S8	UniProtKB	Region	630	992	.	.	.	Note=Interaction with NPM1;status=By similarity	
Q864S8	UniProtKB	Modified residue	3236	3236	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK2;status=By similarity	
Q864S8	UniProtKB	Modified residue	3331	3331	.	.	.	Note=Phosphothreonine%3B by CHEK1 and CHEK2;status=By similarity	
##sequence-region P51587 1 3418
P51587	UniProtKB	Chain	1	3418	.	.	.	ID=PRO_0000064984;Note=Breast cancer type 2 susceptibility protein	
P51587	UniProtKB	Repeat	1002	1036	.	.	.	Note=BRCA2 1	
P51587	UniProtKB	Repeat	1212	1246	.	.	.	Note=BRCA2 2	
P51587	UniProtKB	Repeat	1421	1455	.	.	.	Note=BRCA2 3	
P51587	UniProtKB	Repeat	1517	1551	.	.	.	Note=BRCA2 4	
P51587	UniProtKB	Repeat	1664	1698	.	.	.	Note=BRCA2 5	
P51587	UniProtKB	Repeat	1837	1871	.	.	.	Note=BRCA2 6	
P51587	UniProtKB	Repeat	1971	2005	.	.	.	Note=BRCA2 7	
P51587	UniProtKB	Repeat	2051	2085	.	.	.	Note=BRCA2 8	
P51587	UniProtKB	Region	1	40	.	.	.	Note=Interaction with PALB2	
P51587	UniProtKB	Region	639	1000	.	.	.	Note=Interaction with NPM1	
P51587	UniProtKB	Region	2350	2545	.	.	.	Note=Interaction with FANCD2	
P51587	UniProtKB	Modified residue	755	755	.	.	.	Note=Phosphoserine	
P51587	UniProtKB	Modified residue	3291	3291	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK2	
P51587	UniProtKB	Modified residue	3387	3387	.	.	.	Note=Phosphothreonine%3B by CHEK1 and CHEK2	
P51587	UniProtKB	Natural variant	25	25	.	.	.	ID=VAR_028167;Note=In BC%3B abolishes interaction with PALB2.	
P51587	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_028168;Note=In BC%3B abolishes interaction with PALB2.	
P51587	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_028169;Note=In BC%3B abolishes interaction with PALB2.	
P51587	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_005085;Note=In BC.	
P51587	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_020705;Dbxref=dbSNP:rs4987046;Note=In BC and ovarian cancer%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_005086;Note=In BC.	
P51587	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_020706;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_032712;Note=In BC.	
P51587	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_005087;Dbxref=dbSNP:rs28897701;Note=In ovarian cancer and renal cancer%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_005088;Note=In BC.	
P51587	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_008766	
P51587	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_032713;Note=In one patient with esophageal carcinoma.	
P51587	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_032714;Note=In one patient with pancreatic cancer.	
P51587	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_005089;Note=In BC.	
P51587	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_005090;Note=In BC.	
P51587	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_005091;Note=In BC.	
P51587	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_032715;Note=In one patient with BC%3B normal RNA expression and splicing.	
P51587	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_005092;Dbxref=dbSNP:rs766173;Note=Common polymorphism%3B was originally thought to be linked to ovarian cancer.	
P51587	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_032716;Dbxref=dbSNP:rs79483201;Note=In one patient with esophageal carcinoma.	
P51587	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_018908;Dbxref=dbSNP:rs11571640	
P51587	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_032717;Dbxref=dbSNP:rs28897706;Note=In BC.	
P51587	UniProtKB	Natural variant	327	327	.	.	.	ID=VAR_008767;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_005093;Note=In lung cancer.	
P51587	UniProtKB	Natural variant	372	372	.	.	.	ID=VAR_005094;Dbxref=dbSNP:rs144848;Note=Common polymorphism%3B associated with an increased risk of breast cancer and with an effect on prenatal viability with increased fitness of males and decreased fitness of females.	
P51587	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_020707;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	431	431	.	.	.	ID=VAR_020708;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	448	448	.	.	.	ID=VAR_020709;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	462	462	.	.	.	ID=VAR_020710;Dbxref=dbSNP:rs56403624;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	505	505	.	.	.	ID=VAR_032718;Dbxref=dbSNP:rs28897708;Note=In BC.	
P51587	UniProtKB	Natural variant	513	513	.	.	.	ID=VAR_056751;Dbxref=dbSNP:rs28897709	
P51587	UniProtKB	Natural variant	554	554	.	.	.	ID=VAR_005095;Note=In BC and pancreas cancer.	
P51587	UniProtKB	Natural variant	582	582	.	.	.	ID=VAR_008768;Dbxref=dbSNP:rs80358457	
P51587	UniProtKB	Natural variant	598	598	.	.	.	ID=VAR_020711;Dbxref=dbSNP:rs28897710	
P51587	UniProtKB	Natural variant	599	599	.	.	.	ID=VAR_035436;Dbxref=dbSNP:rs1046984	
P51587	UniProtKB	Natural variant	613	613	.	.	.	ID=VAR_020712;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	630	630	.	.	.	ID=VAR_005096;Note=In ovarian cancer.	
P51587	UniProtKB	Natural variant	707	707	.	.	.	ID=VAR_008769;Dbxref=dbSNP:rs80358487	
P51587	UniProtKB	Natural variant	728	728	.	.	.	ID=VAR_005097;Note=In BC.	
P51587	UniProtKB	Natural variant	729	729	.	.	.	ID=VAR_032719;Note=In BC.	
P51587	UniProtKB	Natural variant	784	784	.	.	.	ID=VAR_008770;Dbxref=dbSNP:rs11571653	
P51587	UniProtKB	Natural variant	886	886	.	.	.	ID=VAR_008771	
P51587	UniProtKB	Natural variant	929	929	.	.	.	ID=VAR_018909;Dbxref=dbSNP:rs2227943	
P51587	UniProtKB	Natural variant	935	935	.	.	.	ID=VAR_008772;Dbxref=dbSNP:rs28897716;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	976	976	.	.	.	ID=VAR_018910;Dbxref=dbSNP:rs11571656	
P51587	UniProtKB	Natural variant	982	982	.	.	.	ID=VAR_056752;Dbxref=dbSNP:rs28897717	
P51587	UniProtKB	Natural variant	987	987	.	.	.	ID=VAR_018911;Dbxref=dbSNP:rs2227944	
P51587	UniProtKB	Natural variant	991	991	.	.	.	ID=VAR_005098;Dbxref=dbSNP:rs1799944;Note=Common polymorphism.	
P51587	UniProtKB	Natural variant	1036	1036	.	.	.	ID=VAR_020713;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	1106	1106	.	.	.	ID=VAR_020714;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	1147	1147	.	.	.	ID=VAR_005099;Dbxref=dbSNP:rs1799951	
P51587	UniProtKB	Natural variant	1172	1172	.	.	.	ID=VAR_032720;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	1179	1179	.	.	.	ID=VAR_020715;Note=In BC.	
P51587	UniProtKB	Natural variant	1279	1279	.	.	.	ID=VAR_020716	
P51587	UniProtKB	Natural variant	1286	1286	.	.	.	ID=VAR_008773	
P51587	UniProtKB	Natural variant	1290	1290	.	.	.	ID=VAR_008774;Dbxref=dbSNP:rs41293485	
P51587	UniProtKB	Natural variant	1302	1302	.	.	.	ID=VAR_005100;Note=In BC.	
P51587	UniProtKB	Natural variant	1414	1414	.	.	.	ID=VAR_008775;Dbxref=dbSNP:rs70953664	
P51587	UniProtKB	Natural variant	1420	1420	.	.	.	ID=VAR_008776;Dbxref=dbSNP:rs28897727	
P51587	UniProtKB	Natural variant	1445	1445	.	.	.	ID=VAR_020717;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	1513	1513	.	.	.	ID=VAR_008777	
P51587	UniProtKB	Natural variant	1522	1522	.	.	.	ID=VAR_032721;Note=In one patient with BC.	
P51587	UniProtKB	Natural variant	1524	1524	.	.	.	ID=VAR_020718;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	1529	1529	.	.	.	ID=VAR_005101;Dbxref=dbSNP:rs28897728;Note=In bladder cancer.	
P51587	UniProtKB	Natural variant	1542	1542	.	.	.	ID=VAR_056753;Dbxref=dbSNP:rs28897729	
P51587	UniProtKB	Natural variant	1561	1561	.	.	.	ID=VAR_018912;Dbxref=dbSNP:rs2219594	
P51587	UniProtKB	Natural variant	1580	1580	.	.	.	ID=VAR_020719;Note=In BC%3B somatic mutation.	
P51587	UniProtKB	Natural variant	1593	1593	.	.	.	ID=VAR_008778	
P51587	UniProtKB	Natural variant	1643	1643	.	.	.	ID=VAR_056754;Dbxref=dbSNP:rs28897731	
P51587	UniProtKB	Natural variant	1679	1679	.	.	.	ID=VAR_020720;Note=In BC.	
P51587	UniProtKB	Natural variant	1690	1690	.	.	.	ID=VAR_032722;Note=In BC.	
P51587	UniProtKB	Natural variant	1730	1730	.	.	.	ID=VAR_032723;Note=In BC.	
P51587	UniProtKB	Natural variant	1771	1771	.	.	.	ID=VAR_008779;Dbxref=dbSNP:rs80358755;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	1804	1804	.	.	.	ID=VAR_020721;Note=In BC.	
P51587	UniProtKB	Natural variant	1805	1805	.	.	.	ID=VAR_008780;Dbxref=dbSNP:rs80358765	
P51587	UniProtKB	Natural variant	1880	1880	.	.	.	ID=VAR_005102;Dbxref=dbSNP:rs11571657;Note=Polymorphism%3B was originally thought to be linked to breast cancer.	
P51587	UniProtKB	Natural variant	1887	1887	.	.	.	ID=VAR_032724;Note=In BC.	
P51587	UniProtKB	Natural variant	1901	1901	.	.	.	ID=VAR_020722;Note=In BC.	
P51587	UniProtKB	Natural variant	1902	1902	.	.	.	ID=VAR_008781;Dbxref=dbSNP:rs4987048	
P51587	UniProtKB	Natural variant	1915	1915	.	.	.	ID=VAR_005103;Dbxref=dbSNP:rs4987117;Note=May be a rare polymorphism%3B somatic mutation.	
P51587	UniProtKB	Natural variant	1929	1929	.	.	.	ID=VAR_020723;Dbxref=dbSNP:rs79538375;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	1979	1979	.	.	.	ID=VAR_056755;Dbxref=dbSNP:rs28897737	
P51587	UniProtKB	Natural variant	1988	1988	.	.	.	ID=VAR_032725;Note=In one patient with esophageal carcinoma%3B somatic mutation.	
P51587	UniProtKB	Natural variant	2031	2031	.	.	.	ID=VAR_020724;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2034	2034	.	.	.	ID=VAR_005104;Dbxref=dbSNP:rs1799954	
P51587	UniProtKB	Natural variant	2044	2044	.	.	.	ID=VAR_032726;Dbxref=dbSNP:rs56191579;Note=In one patient with BC.	
P51587	UniProtKB	Natural variant	2072	2072	.	.	.	ID=VAR_020725;Note=In BC.	
P51587	UniProtKB	Natural variant	2074	2074	.	.	.	ID=VAR_008782;Dbxref=dbSNP:rs34309943	
P51587	UniProtKB	Natural variant	2089	2089	.	.	.	ID=VAR_008783;Note=In BC.	
P51587	UniProtKB	Natural variant	2094	2094	.	.	.	ID=VAR_020726;Note=In BC.	
P51587	UniProtKB	Natural variant	2096	2096	.	.	.	ID=VAR_020727;Note=In BC.	
P51587	UniProtKB	Natural variant	2108	2108	.	.	.	ID=VAR_032727;Dbxref=dbSNP:rs55794205	
P51587	UniProtKB	Natural variant	2116	2116	.	.	.	ID=VAR_061563;Dbxref=dbSNP:rs55953736	
P51587	UniProtKB	Natural variant	2118	2118	.	.	.	ID=VAR_020728;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2128	2128	.	.	.	ID=VAR_020729;Note=In BC.	
P51587	UniProtKB	Natural variant	2135	2135	.	.	.	ID=VAR_032728;Note=In BC.	
P51587	UniProtKB	Natural variant	2138	2138	.	.	.	ID=VAR_008784;Dbxref=dbSNP:rs11571659	
P51587	UniProtKB	Natural variant	2162	2162	.	.	.	ID=VAR_018913;Dbxref=dbSNP:rs11571660	
P51587	UniProtKB	Natural variant	2222	2222	.	.	.	ID=VAR_032729;Note=In BC.	
P51587	UniProtKB	Natural variant	2238	2238	.	.	.	ID=VAR_056756;Dbxref=dbSNP:rs28897742	
P51587	UniProtKB	Natural variant	2274	2274	.	.	.	ID=VAR_005105;Note=In BC.	
P51587	UniProtKB	Natural variant	2275	2275	.	.	.	ID=VAR_020730;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2293	2293	.	.	.	ID=VAR_020731;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2336	2336	.	.	.	ID=VAR_032730;Dbxref=dbSNP:rs28897743;Note=In FANCD1.	
P51587	UniProtKB	Natural variant	2336	2336	.	.	.	ID=VAR_056757;Dbxref=dbSNP:rs28897743	
P51587	UniProtKB	Natural variant	2353	2353	.	.	.	ID=VAR_020732;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2415	2415	.	.	.	ID=VAR_005106;Note=In BC.	
P51587	UniProtKB	Natural variant	2421	2421	.	.	.	ID=VAR_005107;Note=In BC.	
P51587	UniProtKB	Natural variant	2440	2440	.	.	.	ID=VAR_018914;Dbxref=dbSNP:rs4986860	
P51587	UniProtKB	Natural variant	2447	2447	.	.	.	ID=VAR_056758;Dbxref=dbSNP:rs4986859	
P51587	UniProtKB	Natural variant	2456	2456	.	.	.	ID=VAR_032731;Note=In BC.	
P51587	UniProtKB	Natural variant	2466	2466	.	.	.	ID=VAR_008785;Note=Polymorphism%3B was originally thought to be linked to ovarian cancer.	
P51587	UniProtKB	Natural variant	2480	2480	.	.	.	ID=VAR_008786;Dbxref=dbSNP:rs80358965	
P51587	UniProtKB	Natural variant	2488	2488	.	.	.	ID=VAR_020733;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2490	2490	.	.	.	ID=VAR_008787;Dbxref=dbSNP:rs11571707	
P51587	UniProtKB	Natural variant	2502	2502	.	.	.	ID=VAR_063911;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2502	2502	.	.	.	ID=VAR_008788;Note=In ovarian cancer%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2510	2510	.	.	.	ID=VAR_032732;Note=In FANCD1.	
P51587	UniProtKB	Natural variant	2515	2515	.	.	.	ID=VAR_008789;Dbxref=dbSNP:rs28897744;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2626	2626	.	.	.	ID=VAR_032733;Note=In FANCD1.	
P51587	UniProtKB	Natural variant	2627	2627	.	.	.	ID=VAR_063912;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2653	2653	.	.	.	ID=VAR_063913;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2659	2659	.	.	.	ID=VAR_063914;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2663	2663	.	.	.	ID=VAR_063915;Note=Could be associated with cancer susceptibility%3B major splicing aberration identified with this mutant%3B multifactorial likelihood analysis provides evidence for pathogenicity.	
P51587	UniProtKB	Natural variant	2686	2686	.	.	.	ID=VAR_056759;Dbxref=dbSNP:rs28897746	
P51587	UniProtKB	Natural variant	2706	2706	.	.	.	ID=VAR_020734	
P51587	UniProtKB	Natural variant	2722	2722	.	.	.	ID=VAR_018661;Note=In BC.	
P51587	UniProtKB	Natural variant	2723	2723	.	.	.	ID=VAR_063916;Note=Could be associated with cancer susceptibility%3B has abrogated function consistent with pathogenicity%3B major splicing aberration identified with this mutant.	
P51587	UniProtKB	Natural variant	2723	2723	.	.	.	ID=VAR_020735;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2728	2728	.	.	.	ID=VAR_020736;Dbxref=dbSNP:rs28897749;Note=In BC.	
P51587	UniProtKB	Natural variant	2729	2729	.	.	.	ID=VAR_020737;Dbxref=dbSNP:rs80359065;Note=In BC.	
P51587	UniProtKB	Natural variant	2748	2748	.	.	.	ID=VAR_063917;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2787	2787	.	.	.	ID=VAR_008790;Note=In ovarian cancer%3B somatic mutation.	
P51587	UniProtKB	Natural variant	2792	2792	.	.	.	ID=VAR_056760;Dbxref=dbSNP:rs28897751	
P51587	UniProtKB	Natural variant	2793	2793	.	.	.	ID=VAR_020738;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2835	2835	.	.	.	ID=VAR_018915;Dbxref=dbSNP:rs11571746	
P51587	UniProtKB	Natural variant	2842	2842	.	.	.	ID=VAR_032734;Note=In one patient with esophageal carcinoma%3B somatic mutation.	
P51587	UniProtKB	Natural variant	2856	2856	.	.	.	ID=VAR_018916;Dbxref=dbSNP:rs11571747	
P51587	UniProtKB	Natural variant	2944	2944	.	.	.	ID=VAR_008791;Dbxref=dbSNP:rs4987047	
P51587	UniProtKB	Natural variant	2950	2950	.	.	.	ID=VAR_020739;Dbxref=dbSNP:rs28897754;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	2951	2951	.	.	.	ID=VAR_008792;Dbxref=dbSNP:rs11571769	
P51587	UniProtKB	Natural variant	2969	2969	.	.	.	ID=VAR_008793;Dbxref=dbSNP:rs59004709	
P51587	UniProtKB	Natural variant	3013	3013	.	.	.	ID=VAR_020740;Dbxref=dbSNP:rs28897755;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	3052	3052	.	.	.	ID=VAR_063918;Note=Could be associated with cancer susceptibility%3B has abrogated function consistent with pathogenicity%3B multifactorial likelihood analysis provides evidence for pathogenicity.	
P51587	UniProtKB	Natural variant	3063	3063	.	.	.	ID=VAR_020741;Note=In a patient with ovarian cancer%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	3076	3076	.	.	.	ID=VAR_020742	
P51587	UniProtKB	Natural variant	3095	3095	.	.	.	ID=VAR_005108;Note=In BC%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	3098	3098	.	.	.	ID=VAR_008794;Dbxref=dbSNP:rs41293521;Note=In BC and ovarian cancer%3B unknown pathological significance.	
P51587	UniProtKB	Natural variant	3101	3101	.	.	.	ID=VAR_056761;Dbxref=dbSNP:rs28897758	
P51587	UniProtKB	Natural variant	3103	3103	.	.	.	ID=VAR_005109;Note=In melanoma.	
P51587	UniProtKB	Natural variant	3118	3118	.	.	.	ID=VAR_005110;Note=In BC.	
P51587	UniProtKB	Natural variant	3124	3124	.	.	.	ID=VAR_020743;Note=In BC.	
P51587	UniProtKB	Natural variant	3196	3196	.	.	.	ID=VAR_020744;Dbxref=dbSNP:rs80359228;Note=In BC.	
P51587	UniProtKB	Natural variant	3244	3244	.	.	.	ID=VAR_018917;Dbxref=dbSNP:rs11571831	
P51587	UniProtKB	Natural variant	3257	3257	.	.	.	ID=VAR_008795	
P51587	UniProtKB	Natural variant	3276	3276	.	.	.	ID=VAR_008796	
P51587	UniProtKB	Natural variant	3300	3300	.	.	.	ID=VAR_032735;Note=In one patient with esophageal carcinoma.	
P51587	UniProtKB	Natural variant	3357	3357	.	.	.	ID=VAR_005111;Note=In BC.	
P51587	UniProtKB	Natural variant	3374	3374	.	.	.	ID=VAR_020745;Dbxref=dbSNP:rs56309455	
P51587	UniProtKB	Natural variant	3412	3412	.	.	.	ID=VAR_005112;Dbxref=dbSNP:rs1801426;Note=Polymorphism%3B was originally thought to be associated with breast cancer.	
P51587	UniProtKB	Mutagenesis	3291	3291	.	.	.	Note=Impaired interaction with RAD51.	
P51587	UniProtKB	Mutagenesis	3387	3387	.	.	.	Note=Loss of phosphorylation by CHEK1 and CHEK2 (in vitro).	
P51587	UniProtKB	Sequence conflict	758	758	.	.	.	.	
P51587	UniProtKB	Sequence conflict	1761	1762	.	.	.	.	
P51587	UniProtKB	Sequence conflict	1767	1767	.	.	.	.	
P51587	UniProtKB	Sequence conflict	2536	2536	.	.	.	.	
P51587	UniProtKB	Sequence conflict	3216	3216	.	.	.	.	
P51587	UniProtKB	Helix	31	35	.	.	.	.	
P51587	UniProtKB	Helix	1520	1522	.	.	.	.	
P51587	UniProtKB	Helix	1536	1541	.	.	.	.	
P51587	UniProtKB	Turn	1542	1546	.	.	.	.	
##sequence-region P97929 1 3329
P97929	UniProtKB	Chain	1	3329	.	.	.	ID=PRO_0000064985;Note=Breast cancer type 2 susceptibility protein homolog	
P97929	UniProtKB	Repeat	981	1015	.	.	.	Note=BRCA2 1	
P97929	UniProtKB	Repeat	1192	1226	.	.	.	Note=BRCA2 2	
P97929	UniProtKB	Repeat	1394	1428	.	.	.	Note=BRCA2 3	
P97929	UniProtKB	Repeat	1491	1525	.	.	.	Note=BRCA2 4	
P97929	UniProtKB	Repeat	1623	1657	.	.	.	Note=BRCA2 5	
P97929	UniProtKB	Repeat	1924	1958	.	.	.	Note=BRCA2 6	
P97929	UniProtKB	Repeat	2004	2038	.	.	.	Note=BRCA2 7	
P97929	UniProtKB	Region	1	40	.	.	.	Note=Interaction with PALB2;status=By similarity	
P97929	UniProtKB	Region	628	979	.	.	.	Note=Interaction with NPM1;status=By similarity	
P97929	UniProtKB	Region	2298	2466	.	.	.	Note=Interaction with FANCD2;status=By similarity	
P97929	UniProtKB	Modified residue	735	735	.	.	.	Note=Phosphoserine;status=By similarity	
P97929	UniProtKB	Modified residue	3214	3214	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK2;status=By similarity	
P97929	UniProtKB	Natural variant	44	44	.	.	.	Note=In strain: C57BL/6 and 129/Sv.	
P97929	UniProtKB	Natural variant	340	340	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	377	377	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	407	407	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	661	661	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	739	739	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1198	1199	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1257	1257	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1392	1392	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1520	1521	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1583	1583	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1613	1613	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1686	1686	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1799	1799	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	1881	1881	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	1894	1894	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	2141	2141	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	2392	2392	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	2605	2605	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	2648	2648	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	2717	2717	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	2729	2729	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	2814	2814	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	2827	2827	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	2907	2907	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	2929	2929	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	3058	3058	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	3071	3071	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	3081	3081	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	3089	3089	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	3105	3109	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	3220	3220	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	3238	3238	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Natural variant	3243	3243	.	.	.	Note=In strain: C57BL/6.	
P97929	UniProtKB	Natural variant	3245	3245	.	.	.	Note=In strain: 129/Sv.	
P97929	UniProtKB	Sequence conflict	1038	1038	.	.	.	.	
P97929	UniProtKB	Helix	2404	2420	.	.	.	.	
P97929	UniProtKB	Helix	2430	2435	.	.	.	.	
P97929	UniProtKB	Helix	2446	2448	.	.	.	.	
P97929	UniProtKB	Beta strand	2462	2464	.	.	.	.	
P97929	UniProtKB	Beta strand	2468	2472	.	.	.	.	
P97929	UniProtKB	Turn	2475	2480	.	.	.	.	
P97929	UniProtKB	Helix	2486	2489	.	.	.	.	
P97929	UniProtKB	Turn	2490	2492	.	.	.	.	
P97929	UniProtKB	Beta strand	2495	2497	.	.	.	.	
P97929	UniProtKB	Beta strand	2503	2505	.	.	.	.	
P97929	UniProtKB	Turn	2512	2514	.	.	.	.	
P97929	UniProtKB	Helix	2518	2527	.	.	.	.	
P97929	UniProtKB	Helix	2533	2535	.	.	.	.	
P97929	UniProtKB	Helix	2538	2554	.	.	.	.	
P97929	UniProtKB	Turn	2555	2557	.	.	.	.	
P97929	UniProtKB	Turn	2560	2562	.	.	.	.	
P97929	UniProtKB	Beta strand	2564	2569	.	.	.	.	
P97929	UniProtKB	Helix	2570	2584	.	.	.	.	
P97929	UniProtKB	Helix	2592	2597	.	.	.	.	
P97929	UniProtKB	Beta strand	2606	2608	.	.	.	.	
P97929	UniProtKB	Helix	2627	2643	.	.	.	.	
P97929	UniProtKB	Helix	2655	2662	.	.	.	.	
P97929	UniProtKB	Turn	2672	2674	.	.	.	.	
P97929	UniProtKB	Beta strand	2675	2677	.	.	.	.	
P97929	UniProtKB	Beta strand	2679	2681	.	.	.	.	
P97929	UniProtKB	Turn	2684	2686	.	.	.	.	
P97929	UniProtKB	Beta strand	2691	2694	.	.	.	.	
P97929	UniProtKB	Beta strand	2696	2699	.	.	.	.	
P97929	UniProtKB	Helix	2701	2703	.	.	.	.	
P97929	UniProtKB	Beta strand	2704	2706	.	.	.	.	
P97929	UniProtKB	Beta strand	2713	2715	.	.	.	.	
P97929	UniProtKB	Helix	2726	2728	.	.	.	.	
P97929	UniProtKB	Beta strand	2731	2733	.	.	.	.	
P97929	UniProtKB	Beta strand	2736	2746	.	.	.	.	
P97929	UniProtKB	Beta strand	2752	2754	.	.	.	.	
P97929	UniProtKB	Beta strand	2756	2758	.	.	.	.	
P97929	UniProtKB	Beta strand	2760	2763	.	.	.	.	
P97929	UniProtKB	Helix	2767	2778	.	.	.	.	
P97929	UniProtKB	Helix	2782	2791	.	.	.	.	
P97929	UniProtKB	Helix	2813	2817	.	.	.	.	
P97929	UniProtKB	Helix	2822	2830	.	.	.	.	
P97929	UniProtKB	Beta strand	2833	2835	.	.	.	.	
P97929	UniProtKB	Turn	2836	2840	.	.	.	.	
P97929	UniProtKB	Beta strand	2848	2850	.	.	.	.	
P97929	UniProtKB	Turn	2851	2853	.	.	.	.	
P97929	UniProtKB	Helix	2855	2858	.	.	.	.	
P97929	UniProtKB	Helix	2861	2871	.	.	.	.	
P97929	UniProtKB	Helix	2873	2876	.	.	.	.	
P97929	UniProtKB	Turn	2877	2881	.	.	.	.	
P97929	UniProtKB	Beta strand	2889	2900	.	.	.	.	
P97929	UniProtKB	Beta strand	2904	2910	.	.	.	.	
P97929	UniProtKB	Helix	2913	2918	.	.	.	.	
P97929	UniProtKB	Beta strand	2924	2930	.	.	.	.	
P97929	UniProtKB	Beta strand	2938	2940	.	.	.	.	
P97929	UniProtKB	Beta strand	2945	2957	.	.	.	.	
P97929	UniProtKB	Helix	2961	2964	.	.	.	.	
P97929	UniProtKB	Turn	2965	2967	.	.	.	.	
P97929	UniProtKB	Helix	2977	2980	.	.	.	.	
P97929	UniProtKB	Beta strand	2981	2983	.	.	.	.	
P97929	UniProtKB	Turn	2986	2989	.	.	.	.	
P97929	UniProtKB	Beta strand	2990	3001	.	.	.	.	
P97929	UniProtKB	Beta strand	3004	3006	.	.	.	.	
P97929	UniProtKB	Beta strand	3009	3013	.	.	.	.	
P97929	UniProtKB	Beta strand	3015	3017	.	.	.	.	
P97929	UniProtKB	Beta strand	3019	3026	.	.	.	.	
P97929	UniProtKB	Beta strand	3037	3044	.	.	.	.	
P97929	UniProtKB	Beta strand	3050	3052	.	.	.	.	
P97929	UniProtKB	Beta strand	3056	3058	.	.	.	.	
P97929	UniProtKB	Beta strand	3063	3067	.	.	.	.	
P97929	UniProtKB	Turn	3071	3073	.	.	.	.	
P97929	UniProtKB	Helix	3074	3080	.	.	.	.	
P97929	UniProtKB	Helix	3082	3085	.	.	.	.	
P97929	UniProtKB	Helix	3090	3102	.	.	.	.	
##sequence-region O35923 1 3343
O35923	UniProtKB	Chain	1	3343	.	.	.	ID=PRO_0000064986;Note=Breast cancer type 2 susceptibility protein homolog	
O35923	UniProtKB	Repeat	984	1018	.	.	.	Note=BRCA2 1	
O35923	UniProtKB	Repeat	1197	1231	.	.	.	Note=BRCA2 2	
O35923	UniProtKB	Repeat	1405	1439	.	.	.	Note=BRCA2 3	
O35923	UniProtKB	Repeat	1503	1537	.	.	.	Note=BRCA2 4	
O35923	UniProtKB	Repeat	1645	1669	.	.	.	Note=BRCA2 5	
O35923	UniProtKB	Repeat	1828	1845	.	.	.	Note=BRCA2 6	
O35923	UniProtKB	Repeat	1939	1973	.	.	.	Note=BRCA2 7	
O35923	UniProtKB	Repeat	2019	2053	.	.	.	Note=BRCA2 8	
O35923	UniProtKB	Region	1	40	.	.	.	Note=Interaction with PALB2;status=By similarity	
O35923	UniProtKB	Region	622	982	.	.	.	Note=Interaction with NPM1;status=By similarity	
O35923	UniProtKB	Region	2313	2475	.	.	.	Note=Interaction with FANCD2;status=By similarity	
O35923	UniProtKB	Modified residue	736	736	.	.	.	Note=Phosphoserine;status=By similarity	
O35923	UniProtKB	Modified residue	3222	3222	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK2;status=By similarity	
O35923	UniProtKB	Turn	2407	2409	.	.	.	.	
O35923	UniProtKB	Helix	2410	2428	.	.	.	.	
O35923	UniProtKB	Turn	2441	2443	.	.	.	.	
O35923	UniProtKB	Beta strand	2444	2446	.	.	.	.	
O35923	UniProtKB	Helix	2453	2457	.	.	.	.	
O35923	UniProtKB	Beta strand	2467	2469	.	.	.	.	
O35923	UniProtKB	Helix	2470	2473	.	.	.	.	
O35923	UniProtKB	Helix	2479	2481	.	.	.	.	
O35923	UniProtKB	Turn	2484	2489	.	.	.	.	
O35923	UniProtKB	Helix	2494	2498	.	.	.	.	
O35923	UniProtKB	Turn	2500	2502	.	.	.	.	
O35923	UniProtKB	Beta strand	2503	2505	.	.	.	.	
O35923	UniProtKB	Beta strand	2509	2511	.	.	.	.	
O35923	UniProtKB	Helix	2512	2514	.	.	.	.	
O35923	UniProtKB	Beta strand	2515	2517	.	.	.	.	
O35923	UniProtKB	Helix	2527	2535	.	.	.	.	
O35923	UniProtKB	Helix	2542	2544	.	.	.	.	
O35923	UniProtKB	Helix	2547	2567	.	.	.	.	
O35923	UniProtKB	Turn	2569	2571	.	.	.	.	
O35923	UniProtKB	Turn	2573	2575	.	.	.	.	
O35923	UniProtKB	Beta strand	2576	2578	.	.	.	.	
O35923	UniProtKB	Helix	2579	2593	.	.	.	.	
O35923	UniProtKB	Helix	2601	2606	.	.	.	.	
O35923	UniProtKB	Beta strand	2615	2622	.	.	.	.	
O35923	UniProtKB	Beta strand	2649	2652	.	.	.	.	
O35923	UniProtKB	Beta strand	2657	2660	.	.	.	.	
O35923	UniProtKB	Helix	2664	2671	.	.	.	.	
O35923	UniProtKB	Beta strand	2680	2684	.	.	.	.	
O35923	UniProtKB	Beta strand	2687	2690	.	.	.	.	
O35923	UniProtKB	Helix	2697	2699	.	.	.	.	
O35923	UniProtKB	Beta strand	2705	2707	.	.	.	.	
O35923	UniProtKB	Turn	2710	2712	.	.	.	.	
O35923	UniProtKB	Beta strand	2713	2715	.	.	.	.	
O35923	UniProtKB	Beta strand	2718	2720	.	.	.	.	
O35923	UniProtKB	Beta strand	2722	2724	.	.	.	.	
O35923	UniProtKB	Beta strand	2746	2748	.	.	.	.	
O35923	UniProtKB	Beta strand	2759	2763	.	.	.	.	
O35923	UniProtKB	Beta strand	2765	2772	.	.	.	.	
O35923	UniProtKB	Helix	2774	2782	.	.	.	.	
O35923	UniProtKB	Beta strand	2895	2903	.	.	.	.	
O35923	UniProtKB	Beta strand	2905	2909	.	.	.	.	
O35923	UniProtKB	Beta strand	2913	2919	.	.	.	.	
O35923	UniProtKB	Turn	2922	2927	.	.	.	.	
O35923	UniProtKB	Beta strand	2934	2938	.	.	.	.	
O35923	UniProtKB	Beta strand	2962	2965	.	.	.	.	
O35923	UniProtKB	Helix	2970	2973	.	.	.	.	
O35923	UniProtKB	Turn	2974	2976	.	.	.	.	
O35923	UniProtKB	Helix	2985	2989	.	.	.	.	
O35923	UniProtKB	Helix	2996	2998	.	.	.	.	
O35923	UniProtKB	Beta strand	2999	3005	.	.	.	.	
O35923	UniProtKB	Beta strand	3008	3010	.	.	.	.	
O35923	UniProtKB	Beta strand	3013	3015	.	.	.	.	
O35923	UniProtKB	Beta strand	3018	3022	.	.	.	.	
O35923	UniProtKB	Beta strand	3028	3035	.	.	.	.	
O35923	UniProtKB	Beta strand	3046	3054	.	.	.	.	
O35923	UniProtKB	Beta strand	3064	3076	.	.	.	.	
O35923	UniProtKB	Helix	3080	3097	.	.	.	.	
O35923	UniProtKB	Helix	3101	3110	.	.	.	.	
##sequence-region Q5ZKG2 1 651
Q5ZKG2	UniProtKB	Chain	1	651	.	.	.	ID=PRO_0000227667;Note=Bromodomain-containing protein 7	
Q5ZKG2	UniProtKB	Domain	148	218	.	.	.	Note=Bromo	
Q5ZKG2	UniProtKB	Coiled coil	533	564	.	.	.	status=Potential	
Q5ZKG2	UniProtKB	Motif	65	96	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q5ZKG2	UniProtKB	Compositional bias	3	91	.	.	.	Note=Lys-rich	
##sequence-region Q9NPI1 1 651
Q9NPI1	UniProtKB	Chain	1	651	.	.	.	ID=PRO_0000227664;Note=Bromodomain-containing protein 7	
Q9NPI1	UniProtKB	Domain	148	218	.	.	.	Note=Bromo	
Q9NPI1	UniProtKB	Coiled coil	536	567	.	.	.	status=Potential	
Q9NPI1	UniProtKB	Motif	65	96	.	.	.	Note=Nuclear localization signal	
Q9NPI1	UniProtKB	Compositional bias	3	91	.	.	.	Note=Lys-rich	
Q9NPI1	UniProtKB	Modified residue	279	279	.	.	.	Note=Phosphoserine	
Q9NPI1	UniProtKB	Alternative sequence	500	500	.	.	.	ID=VSP_017564;Note=In isoform 2.	
Q9NPI1	UniProtKB	Sequence conflict	66	66	.	.	.	.	
Q9NPI1	UniProtKB	Sequence conflict	83	83	.	.	.	.	
Q9NPI1	UniProtKB	Sequence conflict	96	96	.	.	.	.	
Q9NPI1	UniProtKB	Sequence conflict	170	170	.	.	.	.	
Q9NPI1	UniProtKB	Sequence conflict	485	485	.	.	.	.	
Q9NPI1	UniProtKB	Helix	133	148	.	.	.	.	
Q9NPI1	UniProtKB	Helix	152	154	.	.	.	.	
Q9NPI1	UniProtKB	Beta strand	156	158	.	.	.	.	
Q9NPI1	UniProtKB	Turn	162	164	.	.	.	.	
Q9NPI1	UniProtKB	Beta strand	165	167	.	.	.	.	
Q9NPI1	UniProtKB	Helix	168	171	.	.	.	.	
Q9NPI1	UniProtKB	Helix	178	185	.	.	.	.	
Q9NPI1	UniProtKB	Turn	186	188	.	.	.	.	
Q9NPI1	UniProtKB	Helix	193	209	.	.	.	.	
Q9NPI1	UniProtKB	Beta strand	213	216	.	.	.	.	
Q9NPI1	UniProtKB	Helix	217	235	.	.	.	.	
##sequence-region O88665 1 651
O88665	UniProtKB	Chain	1	651	.	.	.	ID=PRO_0000227665;Note=Bromodomain-containing protein 7	
O88665	UniProtKB	Domain	148	218	.	.	.	Note=Bromo	
O88665	UniProtKB	Coiled coil	536	567	.	.	.	status=Potential	
O88665	UniProtKB	Motif	65	96	.	.	.	Note=Nuclear localization signal;status=By similarity	
O88665	UniProtKB	Compositional bias	57	91	.	.	.	Note=Lys-rich	
O88665	UniProtKB	Modified residue	279	279	.	.	.	Note=Phosphoserine;status=By similarity	
O88665	UniProtKB	Sequence conflict	102	102	.	.	.	.	
##sequence-region Q5R8B0 1 651
Q5R8B0	UniProtKB	Chain	1	651	.	.	.	ID=PRO_0000227666;Note=Bromodomain-containing protein 7	
Q5R8B0	UniProtKB	Domain	148	218	.	.	.	Note=Bromo	
Q5R8B0	UniProtKB	Coiled coil	536	567	.	.	.	status=Potential	
Q5R8B0	UniProtKB	Motif	65	96	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q5R8B0	UniProtKB	Compositional bias	3	91	.	.	.	Note=Lys-rich	
Q5R8B0	UniProtKB	Modified residue	279	279	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q1LZE0 1 246
Q1LZE0	UniProtKB	Chain	1	246	.	.	.	ID=PRO_0000305306;Note=Breast cancer metastasis-suppressor 1 homolog	
##sequence-region Q9HCU9 1 246
Q9HCU9	UniProtKB	Chain	1	246	.	.	.	ID=PRO_0000064988;Note=Breast cancer metastasis-suppressor 1	
Q9HCU9	UniProtKB	Coiled coil	51	98	.	.	.	.	
Q9HCU9	UniProtKB	Helix	55	93	.	.	.	.	
##sequence-region Q99N20 1 246
Q99N20	UniProtKB	Chain	1	246	.	.	.	ID=PRO_0000064989;Note=Breast cancer metastasis-suppressor 1 homolog	
Q99N20	UniProtKB	Coiled coil	51	98	.	.	.	status=By similarity	
##sequence-region Q5M7T3 1 246
Q5M7T3	UniProtKB	Chain	1	246	.	.	.	ID=PRO_0000305307;Note=Breast cancer metastasis-suppressor 1 homolog	
Q5M7T3	UniProtKB	Coiled coil	51	98	.	.	.	status=By similarity	
##sequence-region O60566 1 1050
O60566	UniProtKB	Chain	1	1050	.	.	.	ID=PRO_0000085673;Note=Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	
O60566	UniProtKB	Domain	62	226	.	.	.	Note=BUB1 N-terminal	
O60566	UniProtKB	Domain	766	1050	.	.	.	Note=Protein kinase	
O60566	UniProtKB	Nucleotide binding	772	780	.	.	.	Note=ATP;status=By similarity	
O60566	UniProtKB	Region	152	185	.	.	.	Note=Necessary for interaction with CASC5	
O60566	UniProtKB	Motif	111	118	.	.	.	Note=Nuclear localization signal;status=Potential	
O60566	UniProtKB	Motif	224	232	.	.	.	Note=D-box	
O60566	UniProtKB	Compositional bias	209	215	.	.	.	Note=Poly-Glu	
O60566	UniProtKB	Active site	882	882	.	.	.	Note=Proton acceptor;status=By similarity	
O60566	UniProtKB	Binding site	795	795	.	.	.	Note=ATP;status=By similarity	
O60566	UniProtKB	Site	579	580	.	.	.	Note=Cleavage%3B by caspase-3	
O60566	UniProtKB	Site	610	611	.	.	.	Note=Cleavage%3B by caspase-3	
O60566	UniProtKB	Modified residue	250	250	.	.	.	Note=N6-acetyllysine%3B by PCAF	
O60566	UniProtKB	Modified residue	435	435	.	.	.	Note=Phosphoserine	
O60566	UniProtKB	Modified residue	543	543	.	.	.	Note=Phosphoserine	
O60566	UniProtKB	Modified residue	670	670	.	.	.	Note=Phosphoserine	
O60566	UniProtKB	Modified residue	676	676	.	.	.	Note=Phosphoserine%3B by PLK1	
O60566	UniProtKB	Modified residue	792	792	.	.	.	Note=Phosphothreonine%3B by PLK1	
O60566	UniProtKB	Modified residue	1008	1008	.	.	.	Note=Phosphothreonine%3B by PLK1	
O60566	UniProtKB	Modified residue	1042	1042	.	.	.	Note=Phosphothreonine	
O60566	UniProtKB	Modified residue	1043	1043	.	.	.	Note=Phosphoserine	
O60566	UniProtKB	Alternative sequence	80	80	.	.	.	ID=VSP_036473;Note=In isoform 3.	
O60566	UniProtKB	Alternative sequence	113	166	.	.	.	ID=VSP_036474;Note=In isoform 2.	
O60566	UniProtKB	Alternative sequence	522	522	.	.	.	ID=VSP_036475;Note=In isoform 2.	
O60566	UniProtKB	Alternative sequence	608	675	.	.	.	ID=VSP_036476;Note=In isoform 2.	
O60566	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_008852;Note=In a colorectal cancer cell line.	
O60566	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_028921;Note=In PCS.	
O60566	UniProtKB	Natural variant	40	40	.	.	.	ID=VAR_040402;Dbxref=dbSNP:rs56079734	
O60566	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_008853;Dbxref=dbSNP:rs1801376	
O60566	UniProtKB	Natural variant	378	378	.	.	.	ID=VAR_054549;Dbxref=dbSNP:rs17851677	
O60566	UniProtKB	Natural variant	390	390	.	.	.	ID=VAR_028922;Dbxref=dbSNP:rs1017842	
O60566	UniProtKB	Natural variant	550	550	.	.	.	ID=VAR_028923;Dbxref=dbSNP:rs28989187;Note=In MVA1%3B heterozygous compound with nonsense mutation.	
O60566	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_008854;Dbxref=dbSNP:rs1801528;Note=In colorectal cancer.	
O60566	UniProtKB	Natural variant	814	814	.	.	.	ID=VAR_028924;Dbxref=dbSNP:rs28989182;Note=In MVA1%3B heterozygous compound with nonsense mutation.	
O60566	UniProtKB	Natural variant	844	844	.	.	.	ID=VAR_028925;Dbxref=dbSNP:rs28989181;Note=In MVA1%3B associated with H-921%3B heterozygous compound with nonsense mutation.	
O60566	UniProtKB	Natural variant	909	909	.	.	.	ID=VAR_028926;Dbxref=dbSNP:rs28989184;Note=In MVA1%3B heterozygous compound with nonsense mutation.	
O60566	UniProtKB	Natural variant	921	921	.	.	.	ID=VAR_028927;Dbxref=dbSNP:rs28989183;Note=In MVA1%3B associated with F-844%3B heterozygous compound with nonsense mutation.	
O60566	UniProtKB	Natural variant	1012	1012	.	.	.	ID=VAR_028928;Dbxref=dbSNP:rs28989185;Note=In MVA1%3B heterozygous compound with nonsense mutation.	
O60566	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Loss of interaction with CASC5.	
O60566	UniProtKB	Mutagenesis	175	175	.	.	.	Note=Loss of interaction with CASC5.	
O60566	UniProtKB	Mutagenesis	579	579	.	.	.	Note=Abolishes the cleavage by caspase-3.	
O60566	UniProtKB	Mutagenesis	610	610	.	.	.	Note=Abolishes the cleavage by caspase-3.	
O60566	UniProtKB	Mutagenesis	620	620	.	.	.	Note=Induces chromosome congression defects and mitotic delay.	
O60566	UniProtKB	Mutagenesis	795	795	.	.	.	Note=Does not abolish the capacity to inhibit APC/CDC20.	
O60566	UniProtKB	Mutagenesis	795	795	.	.	.	Note=Inhibits kinase activity.	
O60566	UniProtKB	Sequence conflict	248	249	.	.	.	.	
O60566	UniProtKB	Sequence conflict	283	283	.	.	.	.	
O60566	UniProtKB	Sequence conflict	788	788	.	.	.	.	
O60566	UniProtKB	Sequence conflict	1018	1018	.	.	.	.	
O60566	UniProtKB	Turn	26	28	.	.	.	.	
O60566	UniProtKB	Helix	60	65	.	.	.	.	
O60566	UniProtKB	Helix	75	88	.	.	.	.	
O60566	UniProtKB	Helix	94	96	.	.	.	.	
O60566	UniProtKB	Helix	98	108	.	.	.	.	
O60566	UniProtKB	Turn	109	111	.	.	.	.	
O60566	UniProtKB	Helix	113	115	.	.	.	.	
O60566	UniProtKB	Helix	119	131	.	.	.	.	
O60566	UniProtKB	Helix	135	144	.	.	.	.	
O60566	UniProtKB	Helix	152	164	.	.	.	.	
O60566	UniProtKB	Helix	168	180	.	.	.	.	
O60566	UniProtKB	Helix	186	218	.	.	.	.	
##sequence-region Q9Z1S0 1 1052
Q9Z1S0	UniProtKB	Chain	1	1052	.	.	.	ID=PRO_0000085674;Note=Mitotic checkpoint serine/threonine-protein kinase BUB1 beta	
Q9Z1S0	UniProtKB	Domain	56	219	.	.	.	Note=BUB1 N-terminal	
Q9Z1S0	UniProtKB	Domain	756	1040	.	.	.	Note=Protein kinase	
Q9Z1S0	UniProtKB	Nucleotide binding	762	770	.	.	.	Note=ATP;status=By similarity	
Q9Z1S0	UniProtKB	Region	146	179	.	.	.	Note=Necessary for interaction with CASC5;status=By similarity	
Q9Z1S0	UniProtKB	Motif	105	112	.	.	.	Note=Nuclear localization signal;status=Potential	
Q9Z1S0	UniProtKB	Motif	217	225	.	.	.	Note=D-box	
Q9Z1S0	UniProtKB	Compositional bias	205	208	.	.	.	Note=Poly-Glu	
Q9Z1S0	UniProtKB	Compositional bias	675	680	.	.	.	Note=Poly-Ser	
Q9Z1S0	UniProtKB	Active site	871	871	.	.	.	Note=Proton acceptor;status=By similarity	
Q9Z1S0	UniProtKB	Binding site	784	784	.	.	.	Note=ATP;status=By similarity	
Q9Z1S0	UniProtKB	Site	572	573	.	.	.	Note=Cleavage%3B by caspase-3;status=By similarity	
Q9Z1S0	UniProtKB	Site	603	604	.	.	.	Note=Cleavage%3B by caspase-3;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	243	243	.	.	.	Note=N6-acetyllysine%3B by PCAF;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	428	428	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	535	535	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	659	659	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	665	665	.	.	.	Note=Phosphoserine%3B by PLK1;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	781	781	.	.	.	Note=Phosphothreonine%3B by PLK1;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	998	998	.	.	.	Note=Phosphothreonine%3B by PLK1;status=By similarity	
Q9Z1S0	UniProtKB	Modified residue	1033	1033	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z1S0	UniProtKB	Sequence conflict	275	275	.	.	.	.	
Q9Z1S0	UniProtKB	Sequence conflict	278	278	.	.	.	.	
Q9Z1S0	UniProtKB	Sequence conflict	664	664	.	.	.	.	
Q9Z1S0	UniProtKB	Sequence conflict	705	705	.	.	.	.	
##sequence-region Q9BY67 1 442
Q9BY67	UniProtKB	Signal peptide	1	44	.	.	.	status=Potential	
Q9BY67	UniProtKB	Chain	45	442	.	.	.	ID=PRO_0000291968;Note=Cell adhesion molecule 1	
Q9BY67	UniProtKB	Topological domain	45	374	.	.	.	Note=Extracellular;status=Potential	
Q9BY67	UniProtKB	Transmembrane	375	395	.	.	.	Note=Helical%3B;status=Potential	
Q9BY67	UniProtKB	Topological domain	396	442	.	.	.	Note=Cytoplasmic;status=Potential	
Q9BY67	UniProtKB	Domain	45	139	.	.	.	Note=Ig-like V-type	
Q9BY67	UniProtKB	Domain	144	238	.	.	.	Note=Ig-like C2-type 1	
Q9BY67	UniProtKB	Domain	243	329	.	.	.	Note=Ig-like C2-type 2	
Q9BY67	UniProtKB	Modified residue	434	434	.	.	.	Note=Phosphoserine;status=By similarity	
Q9BY67	UniProtKB	Glycosylation	67	67	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9BY67	UniProtKB	Glycosylation	101	101	.	.	.	Note=N-linked (GlcNAc...)	
Q9BY67	UniProtKB	Glycosylation	113	113	.	.	.	Note=N-linked (GlcNAc...)	
Q9BY67	UniProtKB	Glycosylation	165	165	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9BY67	UniProtKB	Glycosylation	301	301	.	.	.	Note=N-linked (GlcNAc...)%3B atypical	
Q9BY67	UniProtKB	Glycosylation	302	302	.	.	.	Note=N-linked (GlcNAc...)%3B atypical	
Q9BY67	UniProtKB	Glycosylation	304	304	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9BY67	UniProtKB	Glycosylation	308	308	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9BY67	UniProtKB	Disulfide bond	64	124	.	.	.	status=By similarity	
Q9BY67	UniProtKB	Disulfide bond	166	220	.	.	.	status=By similarity	
Q9BY67	UniProtKB	Disulfide bond	267	313	.	.	.	status=By similarity	
Q9BY67	UniProtKB	Alternative sequence	332	333	.	.	.	ID=VSP_052461;Note=In isoform 2.	
Q9BY67	UniProtKB	Alternative sequence	333	360	.	.	.	ID=VSP_047405;Note=In isoform 5.	
Q9BY67	UniProtKB	Alternative sequence	334	442	.	.	.	ID=VSP_052462;Note=In isoform 2.	
Q9BY67	UniProtKB	Alternative sequence	359	359	.	.	.	ID=VSP_047406;Note=In isoform 3.	
Q9BY67	UniProtKB	Alternative sequence	359	359	.	.	.	ID=VSP_047407;Note=In isoform 4.	
Q9BY67	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_061309;Dbxref=dbSNP:rs45525440	
Q9BY67	UniProtKB	Mutagenesis	406	406	.	.	.	Note=Nearly abolishes EPB41L3 binding.	
Q9BY67	UniProtKB	Mutagenesis	408	408	.	.	.	Note=Strongly reduced affinity for EPB41L3.	
Q9BY67	UniProtKB	Sequence conflict	13	13	.	.	.	.	
Q9BY67	UniProtKB	Sequence conflict	153	153	.	.	.	.	
Q9BY67	UniProtKB	Sequence conflict	333	359	.	.	.	.	
Q9BY67	UniProtKB	Beta strand	405	407	.	.	.	.	
##sequence-region Q8R5M8 1 456
Q8R5M8	UniProtKB	Signal peptide	1	47	.	.	.	status=Potential	
Q8R5M8	UniProtKB	Chain	48	456	.	.	.	ID=PRO_0000291969;Note=Cell adhesion molecule 1	
Q8R5M8	UniProtKB	Topological domain	48	388	.	.	.	Note=Extracellular;status=Potential	
Q8R5M8	UniProtKB	Transmembrane	389	409	.	.	.	Note=Helical%3B;status=Potential	
Q8R5M8	UniProtKB	Topological domain	410	456	.	.	.	Note=Cytoplasmic;status=Potential	
Q8R5M8	UniProtKB	Domain	48	142	.	.	.	Note=Ig-like V-type	
Q8R5M8	UniProtKB	Domain	147	241	.	.	.	Note=Ig-like C2-type 1	
Q8R5M8	UniProtKB	Domain	246	332	.	.	.	Note=Ig-like C2-type 2	
Q8R5M8	UniProtKB	Modified residue	448	448	.	.	.	Note=Phosphoserine	
Q8R5M8	UniProtKB	Glycosylation	70	70	.	.	.	Note=N-linked (GlcNAc...)	
Q8R5M8	UniProtKB	Glycosylation	104	104	.	.	.	Note=N-linked (GlcNAc...)	
Q8R5M8	UniProtKB	Glycosylation	116	116	.	.	.	Note=N-linked (GlcNAc...)	
Q8R5M8	UniProtKB	Glycosylation	168	168	.	.	.	Note=N-linked (GlcNAc...)	
Q8R5M8	UniProtKB	Glycosylation	304	304	.	.	.	Note=N-linked (GlcNAc...)%3B atypical	
Q8R5M8	UniProtKB	Glycosylation	307	307	.	.	.	Note=N-linked (GlcNAc...)	
Q8R5M8	UniProtKB	Glycosylation	311	311	.	.	.	Note=N-linked (GlcNAc...)	
Q8R5M8	UniProtKB	Disulfide bond	67	127	.	.	.	status=By similarity	
Q8R5M8	UniProtKB	Disulfide bond	169	223	.	.	.	status=By similarity	
Q8R5M8	UniProtKB	Disulfide bond	270	316	.	.	.	status=By similarity	
Q8R5M8	UniProtKB	Alternative sequence	1	150	.	.	.	ID=VSP_052463;Note=In isoform 6 and isoform 7.	
Q8R5M8	UniProtKB	Alternative sequence	335	336	.	.	.	ID=VSP_052464;Note=In isoform 5.	
Q8R5M8	UniProtKB	Alternative sequence	336	374	.	.	.	ID=VSP_052465;Note=In isoform 4.	
Q8R5M8	UniProtKB	Alternative sequence	336	363	.	.	.	ID=VSP_052466;Note=In isoform 3.	
Q8R5M8	UniProtKB	Alternative sequence	336	352	.	.	.	ID=VSP_052467;Note=In isoform 7.	
Q8R5M8	UniProtKB	Alternative sequence	337	456	.	.	.	ID=VSP_052468;Note=In isoform 5.	
Q8R5M8	UniProtKB	Alternative sequence	355	365	.	.	.	ID=VSP_052469;Note=In isoform 6.	
Q8R5M8	UniProtKB	Alternative sequence	364	374	.	.	.	ID=VSP_052470;Note=In isoform 2.	
Q8R5M8	UniProtKB	Sequence conflict	8	8	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	8	8	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	266	266	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	266	266	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	315	315	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	315	315	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	330	330	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	330	330	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	356	356	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	356	356	.	.	.	.	
Q8R5M8	UniProtKB	Sequence conflict	429	429	.	.	.	.	
##sequence-region Q8NFZ8 1 388
Q8NFZ8	UniProtKB	Signal peptide	1	20	.	.	.	status=Potential	
Q8NFZ8	UniProtKB	Chain	21	388	.	.	.	ID=PRO_0000291980;Note=Cell adhesion molecule 4	
Q8NFZ8	UniProtKB	Topological domain	21	324	.	.	.	Note=Extracellular;status=Potential	
Q8NFZ8	UniProtKB	Transmembrane	325	345	.	.	.	Note=Helical%3B;status=Potential	
Q8NFZ8	UniProtKB	Topological domain	346	388	.	.	.	Note=Cytoplasmic;status=Potential	
Q8NFZ8	UniProtKB	Domain	21	119	.	.	.	Note=Ig-like V-type	
Q8NFZ8	UniProtKB	Domain	124	219	.	.	.	Note=Ig-like C2-type 1	
Q8NFZ8	UniProtKB	Domain	224	307	.	.	.	Note=Ig-like C2-type 2	
Q8NFZ8	UniProtKB	Glycosylation	31	31	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8NFZ8	UniProtKB	Glycosylation	67	67	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8NFZ8	UniProtKB	Glycosylation	286	286	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8NFZ8	UniProtKB	Disulfide bond	44	104	.	.	.	status=By similarity	
Q8NFZ8	UniProtKB	Disulfide bond	145	199	.	.	.	status=By similarity	
Q8NFZ8	UniProtKB	Disulfide bond	245	291	.	.	.	status=By similarity	
Q8NFZ8	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_032906;Dbxref=dbSNP:rs34246023	
##sequence-region Q8R464 1 388
Q8R464	UniProtKB	Signal peptide	1	20	.	.	.	status=Potential	
Q8R464	UniProtKB	Chain	21	388	.	.	.	ID=PRO_0000291981;Note=Cell adhesion molecule 4	
Q8R464	UniProtKB	Topological domain	25	324	.	.	.	Note=Extracellular;status=Potential	
Q8R464	UniProtKB	Transmembrane	325	345	.	.	.	Note=Helical%3B;status=Potential	
Q8R464	UniProtKB	Topological domain	346	388	.	.	.	Note=Cytoplasmic;status=Potential	
Q8R464	UniProtKB	Domain	21	119	.	.	.	Note=Ig-like V-type	
Q8R464	UniProtKB	Domain	124	219	.	.	.	Note=Ig-like C2-type 1	
Q8R464	UniProtKB	Domain	224	307	.	.	.	Note=Ig-like C2-type 2	
Q8R464	UniProtKB	Glycosylation	31	31	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8R464	UniProtKB	Glycosylation	67	67	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8R464	UniProtKB	Glycosylation	286	286	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8R464	UniProtKB	Disulfide bond	44	104	.	.	.	status=By similarity	
Q8R464	UniProtKB	Disulfide bond	145	199	.	.	.	status=By similarity	
Q8R464	UniProtKB	Disulfide bond	245	291	.	.	.	status=By similarity	
##sequence-region Q1WIM1 1 388
Q1WIM1	UniProtKB	Signal peptide	1	20	.	.	.	status=Potential	
Q1WIM1	UniProtKB	Chain	21	388	.	.	.	ID=PRO_0000291982;Note=Cell adhesion molecule 4	
Q1WIM1	UniProtKB	Topological domain	25	324	.	.	.	Note=Extracellular;status=Potential	
Q1WIM1	UniProtKB	Transmembrane	325	345	.	.	.	Note=Helical%3B;status=Potential	
Q1WIM1	UniProtKB	Topological domain	346	388	.	.	.	Note=Cytoplasmic;status=Potential	
Q1WIM1	UniProtKB	Domain	21	119	.	.	.	Note=Ig-like V-type	
Q1WIM1	UniProtKB	Domain	124	219	.	.	.	Note=Ig-like C2-type 1	
Q1WIM1	UniProtKB	Domain	224	307	.	.	.	Note=Ig-like C2-type 2	
Q1WIM1	UniProtKB	Glycosylation	31	31	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q1WIM1	UniProtKB	Glycosylation	67	67	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q1WIM1	UniProtKB	Glycosylation	286	286	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q1WIM1	UniProtKB	Disulfide bond	44	104	.	.	.	status=By similarity	
Q1WIM1	UniProtKB	Disulfide bond	145	199	.	.	.	status=By similarity	
Q1WIM1	UniProtKB	Disulfide bond	245	291	.	.	.	status=By similarity	
##sequence-region P42771 1 156
P42771	UniProtKB	Chain	1	156	.	.	.	ID=PRO_0000144177;Note=Cyclin-dependent kinase inhibitor 2A%2C isoforms 1/2/3	
P42771	UniProtKB	Repeat	11	40	.	.	.	Note=ANK 1	
P42771	UniProtKB	Repeat	44	72	.	.	.	Note=ANK 2	
P42771	UniProtKB	Repeat	77	106	.	.	.	Note=ANK 3	
P42771	UniProtKB	Repeat	110	139	.	.	.	Note=ANK 4	
P42771	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
P42771	UniProtKB	Modified residue	7	7	.	.	.	Note=Phosphoserine	
P42771	UniProtKB	Modified residue	8	8	.	.	.	Note=Phosphoserine	
P42771	UniProtKB	Modified residue	140	140	.	.	.	Note=Phosphoserine	
P42771	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphoserine	
P42771	UniProtKB	Alternative sequence	1	51	.	.	.	ID=VSP_015864;Note=In isoform 2.	
P42771	UniProtKB	Alternative sequence	52	116	.	.	.	ID=VSP_015865;Note=In isoform 3.	
P42771	UniProtKB	Alternative sequence	117	156	.	.	.	ID=VSP_015866;Note=In isoform 3.	
P42771	UniProtKB	Alternative sequence	153	156	.	.	.	ID=VSP_043577;Note=In isoform 5.	
P42771	UniProtKB	Natural variant	14	14	.	.	.	ID=VAR_001408;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_001409;Note=In a biliary tract tumor and a familial melanoma.	
P42771	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_058549;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_001410;Note=In a lung tumor and melanoma.	
P42771	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_001411;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_001412;Note=In a pancreas tumor and a melanoma%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	24	24	.	.	.	ID=VAR_001413;Note=In CMM2.	
P42771	UniProtKB	Natural variant	24	24	.	.	.	ID=VAR_001414;Note=In CMM2.	
P42771	UniProtKB	Natural variant	24	24	.	.	.	ID=VAR_058550;Note=Found in a patient with multiple primary melanoma%3B partial loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	26	26	.	.	.	ID=VAR_001415;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_001416;Note=In CMM2.	
P42771	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_001417;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_001418;Note=In CMM2%3B also found in a biliary tract tumor and a patient with uveal melanoma%3B partial loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_001419;Note=In CMM2.	
P42771	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_058551;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	48	48	.	.	.	ID=VAR_001420;Note=In CMM2 and a head and neck tumor%3B somatic mutation.	
P42771	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_001421;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_001422	
P42771	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_001423;Note=In CMM2.	
P42771	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_001424;Note=In CMM2.	
P42771	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_001425;Note=Possible polymorphism.	
P42771	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_001426;Note=In pancreas carcinoma%3B somatic mutation%3B partial loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_053027;Dbxref=dbSNP:rs36204273	
P42771	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_001427;Note=In CMM2.	
P42771	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_001428	
P42771	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_053028;Dbxref=dbSNP:rs36204594;Note=In melanoma%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	61	62	.	.	.	ID=VAR_001429	
P42771	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_001430;Note=In CMM2.	
P42771	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_001431;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	67	71	.	.	.	ID=VAR_058552;Note=In melanoma%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_058553;Note=In CMM2%3B partial loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_001432;Note=In CMM2%3B requires 2 nucleotide substitutions.	
P42771	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_001433;Note=In an esophagus tumor.	
P42771	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_001434	
P42771	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_058554;Note=Found in some patients with melanoma%3B partial loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_001435;Note=In a bladder tumor.	
P42771	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_001436;Note=In a lung tumor.	
P42771	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_001437;Note=In CMM2.	
P42771	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_001438	
P42771	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_001439;Note=In an esophagus tumor.	
P42771	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_001440;Note=In a bladder tumor.	
P42771	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_001441;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_058555;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_058556;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_001442;Note=In a head and neck tumor.	
P42771	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_058557;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_001443;Dbxref=dbSNP:rs11552823;Note=In some patients with melanoma%3B impairs the function.	
P42771	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_058558;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_001445;Note=In a lung tumor.	
P42771	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_053029;Dbxref=dbSNP:rs34968276	
P42771	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_001444;Note=In a pancreas and a head and neck tumor.	
P42771	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_001446;Note=In a bladder tumor.	
P42771	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_001447;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_001448;Note=In an esophagus%2C a head and neck and a lung tumor.	
P42771	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_001449;Dbxref=dbSNP:rs11552822;Note=In CMM2%3B also found in a lung and a prostate tumor.	
P42771	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_001450	
P42771	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_001451;Note=In CMM2%3B impairs the function.	
P42771	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_012317;Note=In CMM2%3B partial loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_001452;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_001453;Note=In CMM2%3B somatic mutation.	
P42771	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_001454;Note=In CMM2.	
P42771	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_001455;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	94	94	.	.	.	ID=VAR_023604;Note=In CMM2.	
P42771	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_001456;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_001457;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_001458;Note=In CMM2.	
P42771	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_001459;Note=In CMM2.	
P42771	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_001460;Note=In CMM2%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_001461;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_053030;Dbxref=dbSNP:rs34886500	
P42771	UniProtKB	Natural variant	100	100	.	.	.	ID=VAR_001462;Note=In CMM2%3B requires 2 nucleotide substitutions.	
P42771	UniProtKB	Natural variant	100	100	.	.	.	ID=VAR_001463	
P42771	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_001464;Note=In CMM2 and FAMMMPC%3B impairs the function.	
P42771	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_015818;Note=In LFS%3B somatic mutation.	
P42771	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_053031;Dbxref=dbSNP:rs35741010	
P42771	UniProtKB	Natural variant	104	105	.	.	.	ID=VAR_001465	
P42771	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_001466;Note=In CMM2.	
P42771	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_001467	
P42771	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_001469;Note=In a bladder tumor.	
P42771	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_001468;Note=In a head and neck tumor.	
P42771	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_035068;Note=In CMM2.	
P42771	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_001470;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_058559;Note=Found in some patients with melanoma%3B loss of CDK4 binding.	
P42771	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_001471;Note=In CMM2%3B somatic mutation.	
P42771	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_001472;Note=In CMM2.	
P42771	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_001473;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_001474;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_001475;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_035069;Note=In CMM2.	
P42771	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_001476;Note=In a biliary tract tumor.	
P42771	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_001477;Dbxref=dbSNP:rs6413463;Note=In leukemia.	
P42771	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_053032;Dbxref=dbSNP:rs34170727	
P42771	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_001478;Note=In an esophagus tumor.	
P42771	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_001479;Note=In CMM2%3B impairs the function.	
P42771	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_001480;Dbxref=dbSNP:rs6413464;Note=In squamous cell carcinoma.	
P42771	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_001481;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_001482;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_001483;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_001484;Note=In squamous cell carcinoma.	
P42771	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_001486;Dbxref=dbSNP:rs3731249	
P42771	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_001487;Note=In non-small cell lung carcinoma.	
P42771	UniProtKB	Beta strand	4	6	.	.	.	.	
P42771	UniProtKB	Helix	15	22	.	.	.	.	
P42771	UniProtKB	Helix	25	32	.	.	.	.	
P42771	UniProtKB	Turn	33	35	.	.	.	.	
P42771	UniProtKB	Beta strand	43	45	.	.	.	.	
P42771	UniProtKB	Turn	48	50	.	.	.	.	
P42771	UniProtKB	Helix	57	64	.	.	.	.	
P42771	UniProtKB	Turn	65	67	.	.	.	.	
P42771	UniProtKB	Turn	75	77	.	.	.	.	
P42771	UniProtKB	Helix	81	88	.	.	.	.	
P42771	UniProtKB	Helix	91	100	.	.	.	.	
P42771	UniProtKB	Beta strand	109	111	.	.	.	.	
P42771	UniProtKB	Helix	114	121	.	.	.	.	
P42771	UniProtKB	Helix	124	130	.	.	.	.	
P42771	UniProtKB	Turn	133	135	.	.	.	.	
P42771	UniProtKB	Turn	141	143	.	.	.	.	
P42771	UniProtKB	Beta strand	145	147	.	.	.	.	
P42771	UniProtKB	Beta strand	150	153	.	.	.	.	
##sequence-region O77617 1 171
O77617	UniProtKB	Chain	1	171	.	.	.	ID=PRO_0000004804;Note=Cyclin-dependent kinase inhibitor 2A	
O77617	UniProtKB	Repeat	45	74	.	.	.	Note=ANK 1	
O77617	UniProtKB	Repeat	78	106	.	.	.	Note=ANK 2	
O77617	UniProtKB	Repeat	111	140	.	.	.	Note=ANK 3	
O77617	UniProtKB	Alternative sequence	1	34	.	.	.	ID=VSP_018701;Note=In isoform 3.	
O77617	UniProtKB	Natural variant	151	151	.	.	.	Note=In some primary melanomas and melanoma cell lines.	
##sequence-region P51480 1 168
P51480	UniProtKB	Chain	1	168	.	.	.	ID=PRO_0000144178;Note=Cyclin-dependent kinase inhibitor 2A%2C isoforms 1/2	
P51480	UniProtKB	Repeat	3	32	.	.	.	Note=ANK 1	
P51480	UniProtKB	Repeat	36	64	.	.	.	Note=ANK 2	
P51480	UniProtKB	Repeat	69	98	.	.	.	Note=ANK 3	
P51480	UniProtKB	Repeat	102	131	.	.	.	Note=ANK 4	
P51480	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphoserine;status=By similarity	
P51480	UniProtKB	Modified residue	164	164	.	.	.	Note=Phosphoserine;status=By similarity	
P51480	UniProtKB	Alternative sequence	1	43	.	.	.	ID=VSP_015867;Note=In isoform 2.	
P51480	UniProtKB	Natural variant	12	12	.	.	.	Note=In some liver tumors.	
P51480	UniProtKB	Natural variant	18	18	.	.	.	Note=In strain: 020%2C BALB/c%2C BALB/cJ%2C C3H/21BG%2C C3H/HeJ%2C CBA/J%2C MA/M4J and PL/J.	
P51480	UniProtKB	Natural variant	27	27	.	.	.	Note=In some liver tumors.	
P51480	UniProtKB	Natural variant	51	51	.	.	.	Note=In strain: BALB/c and BALB/cJ.	
P51480	UniProtKB	Natural variant	73	73	.	.	.	Note=In some liver tumors.	
P51480	UniProtKB	Natural variant	74	74	.	.	.	Note=In plasmacytoma cell lines.	
P51480	UniProtKB	Natural variant	75	75	.	.	.	Note=In plasmacytoma cell lines.	
P51480	UniProtKB	Natural variant	90	90	.	.	.	Note=In strain: BALB/cJ%2C C57BL/6J and MOLF/Ei.	
P51480	UniProtKB	Natural variant	90	90	.	.	.	Note=In plasmacytoma cell lines.	
P51480	UniProtKB	Natural variant	127	127	.	.	.	Note=In strain: BALB/cJ%2C C57BL/6J and MOLF/Ei.	
P51480	UniProtKB	Mutagenesis	64	64	.	.	.	Note=No effect on activity.	
P51480	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Loss of activity.	
P51480	UniProtKB	Mutagenesis	84	85	.	.	.	Note=Loss of activity.	
P51480	UniProtKB	Sequence conflict	11	11	.	.	.	.	
P51480	UniProtKB	Turn	13	15	.	.	.	.	
P51480	UniProtKB	Helix	17	25	.	.	.	.	
P51480	UniProtKB	Helix	40	43	.	.	.	.	
P51480	UniProtKB	Helix	49	58	.	.	.	.	
P51480	UniProtKB	Helix	72	80	.	.	.	.	
P51480	UniProtKB	Helix	83	91	.	.	.	.	
P51480	UniProtKB	Helix	106	113	.	.	.	.	
P51480	UniProtKB	Helix	116	123	.	.	.	.	
P51480	UniProtKB	Turn	124	126	.	.	.	.	
P51480	UniProtKB	Helix	139	145	.	.	.	.	
P51480	UniProtKB	Helix	149	157	.	.	.	.	
##sequence-region Q9R0Z3 1 159
Q9R0Z3	UniProtKB	Chain	1	159	.	.	.	ID=PRO_0000144179;Note=Cyclin-dependent kinase inhibitor 2A%2C isoform 1	
Q9R0Z3	UniProtKB	Repeat	3	35	.	.	.	Note=ANK 1	
Q9R0Z3	UniProtKB	Repeat	36	64	.	.	.	Note=ANK 2	
Q9R0Z3	UniProtKB	Repeat	69	98	.	.	.	Note=ANK 3	
Q9R0Z3	UniProtKB	Repeat	102	134	.	.	.	Note=ANK 4	
Q9R0Z3	UniProtKB	Modified residue	143	143	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q8N726 1 132
Q8N726	UniProtKB	Chain	1	132	.	.	.	ID=PRO_0000144180;Note=Cyclin-dependent kinase inhibitor 2A%2C isoform 4	
Q8N726	UniProtKB	Alternative sequence	1	47	.	.	.	ID=VSP_044962;Note=In isoform 6.	
Q8N726	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_029287;Dbxref=dbSNP:rs3731190	
Q8N726	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_053033;Dbxref=dbSNP:rs4987127	
Q8N726	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_053034;Dbxref=dbSNP:rs34886500	
Q8N726	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_053035;Dbxref=dbSNP:rs35741010	
Q8N726	UniProtKB	Sequence conflict	28	30	.	.	.	.	
Q8N726	UniProtKB	Sequence conflict	28	30	.	.	.	.	
Q8N726	UniProtKB	Sequence conflict	28	30	.	.	.	.	
Q8N726	UniProtKB	Sequence conflict	94	94	.	.	.	.	
##sequence-region O77618 1 155
O77618	UniProtKB	Chain	1	155	.	.	.	ID=PRO_0000144181;Note=Cyclin-dependent kinase inhibitor 2A%2C isoform 2	
O77618	UniProtKB	Natural variant	126	126	.	.	.	Note=In some primary melanomas and melanoma cell lines.	
##sequence-region Q64364 1 169
Q64364	UniProtKB	Chain	1	169	.	.	.	ID=PRO_0000144182;Note=Cyclin-dependent kinase inhibitor 2A%2C isoform 3	
Q64364	UniProtKB	Compositional bias	3	168	.	.	.	Note=Arg-rich	
Q64364	UniProtKB	Alternative sequence	1	44	.	.	.	ID=VSP_044963;Note=In isoform 4.	
Q64364	UniProtKB	Mutagenesis	85	85	.	.	.	Note=No effect on activity.	
Q64364	UniProtKB	Mutagenesis	93	93	.	.	.	Note=No effect on activity.	
Q64364	UniProtKB	Mutagenesis	97	97	.	.	.	Note=No effect on activity.	
Q64364	UniProtKB	Mutagenesis	105	106	.	.	.	Note=No effect on activity.	
Q64364	UniProtKB	Mutagenesis	120	120	.	.	.	Note=No effect on activity.	
Q64364	UniProtKB	Helix	4	14	.	.	.	.	
Q64364	UniProtKB	Helix	20	29	.	.	.	.	
##sequence-region Q8QZZ9 1 160
Q8QZZ9	UniProtKB	Chain	1	160	.	.	.	ID=PRO_0000144183;Note=Cyclin-dependent kinase inhibitor 2A%2C isoform 2	
##sequence-region Q5ZLM0 1 531
Q5ZLM0	UniProtKB	Chain	1	531	.	.	.	ID=PRO_0000191806;Note=Parafibromin	
Q5ZLM0	UniProtKB	Motif	125	139	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q5ZLM0	UniProtKB	Compositional bias	361	364	.	.	.	Note=Poly-Ile	
##sequence-region Q6P1J9 1 531
Q6P1J9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q6P1J9	UniProtKB	Chain	2	531	.	.	.	ID=PRO_0000191803;Note=Parafibromin	
Q6P1J9	UniProtKB	Region	200	531	.	.	.	Note=Interaction with POLR2A and PAF1	
Q6P1J9	UniProtKB	Region	200	250	.	.	.	Note=Interaction with CTNNB1	
Q6P1J9	UniProtKB	Motif	125	139	.	.	.	Note=Nuclear localization signal	
Q6P1J9	UniProtKB	Compositional bias	361	364	.	.	.	Note=Poly-Ile	
Q6P1J9	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
Q6P1J9	UniProtKB	Modified residue	212	212	.	.	.	Note=Phosphoserine	
Q6P1J9	UniProtKB	Natural variant	2	2	.	.	.	ID=VAR_064927;Note=Found in parathyroid adenoma samples%3B somatic mutation%3B parathyroid adenoma samples are from a patient with isolated hyperparathyroidism who also carries germline mutation P-91.	
Q6P1J9	UniProtKB	Natural variant	5	10	.	.	.	ID=VAR_064928;Note=Found in a parathyroid carcinoma sample%3B somatic mutation%3B parathyroid carcinoma sample is from a patient with hyperparathyroidism-jaw tumor syndrome who also carries a germline mutation causing a splicing defect.	
Q6P1J9	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_064929;Note=Found in a clear cell renal carcinoma sample%3B somatic mutation%3B unlike wild-type protein the mutant is defective in suppressing CCND1 expression in vivo.	
Q6P1J9	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_064930;Note=Found in a parathyroid carcinoma sample%3B somatic mutation.	
Q6P1J9	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_064931;Note=Found in a kindred with familial hyperparathyroidism.	
Q6P1J9	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_024082;Note=In FIHP%3B does not affect interaction with the Pfa1 complex.	
Q6P1J9	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_064932;Note=Found in a patient with isolated hyperparathyroidism and parathyroid adenomas.	
Q6P1J9	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_064933;Note=Found in a parathyroid adenoma sample%3B somatic mutation%3B parathyroid adenoma sample is from a patient with familial hyperparathyroidism who also carries a germline frameshift mutation.	
Q6P1J9	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_064934;Note=Found in a parathyroid adenoma sample.	
Q6P1J9	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_064935;Note=Found in a Wilms tumor sample%3B somatic mutation.	
Q6P1J9	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_064936;Note=In HPT-JT.	
Q6P1J9	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_031825;Dbxref=dbSNP:rs35590728	
Q6P1J9	UniProtKB	Sequence conflict	123	123	.	.	.	.	
Q6P1J9	UniProtKB	Sequence conflict	184	187	.	.	.	.	
Q6P1J9	UniProtKB	Sequence conflict	372	372	.	.	.	.	
##sequence-region Q8JZM7 1 531
Q8JZM7	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q8JZM7	UniProtKB	Chain	2	531	.	.	.	ID=PRO_0000191804;Note=Parafibromin	
Q8JZM7	UniProtKB	Region	200	531	.	.	.	Note=Interaction with POLR2A and PAF1;status=By similarity	
Q8JZM7	UniProtKB	Region	200	250	.	.	.	Note=Interaction with CTNNB1;status=By similarity	
Q8JZM7	UniProtKB	Motif	125	139	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q8JZM7	UniProtKB	Compositional bias	361	364	.	.	.	Note=Poly-Ile	
Q8JZM7	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q8JZM7	UniProtKB	Modified residue	212	212	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q4V8C8 1 531
Q4V8C8	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q4V8C8	UniProtKB	Chain	2	531	.	.	.	ID=PRO_0000191805;Note=Parafibromin	
Q4V8C8	UniProtKB	Region	200	531	.	.	.	Note=Interaction with POLR2A and PAF1;status=By similarity	
Q4V8C8	UniProtKB	Region	200	250	.	.	.	Note=Interaction with CTNNB1;status=By similarity	
Q4V8C8	UniProtKB	Motif	125	139	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q4V8C8	UniProtKB	Compositional bias	361	364	.	.	.	Note=Poly-Ile	
Q4V8C8	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q4V8C8	UniProtKB	Modified residue	212	212	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region O14519 1 115
O14519	UniProtKB	Chain	1	115	.	.	.	ID=PRO_0000089452;Note=Cyclin-dependent kinase 2-associated protein 1	
O14519	UniProtKB	Region	1	60	.	.	.	Note=intrinsically disordered	
O14519	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by IKKE	
O14519	UniProtKB	Disulfide bond	105	105	.	.	.	Note=Interchain;status=Potential	
O14519	UniProtKB	Alternative sequence	1	28	.	.	.	ID=VSP_046436;Note=In isoform 2.	
O14519	UniProtKB	Mutagenesis	105	105	.	.	.	Note=Does not alter homodimerization.	
O14519	UniProtKB	Helix	62	73	.	.	.	.	
O14519	UniProtKB	Turn	74	76	.	.	.	.	
O14519	UniProtKB	Helix	77	81	.	.	.	.	
O14519	UniProtKB	Helix	85	109	.	.	.	.	
O14519	UniProtKB	Turn	110	114	.	.	.	.	
##sequence-region P49119 1 114
P49119	UniProtKB	Chain	1	114	.	.	.	ID=PRO_0000089453;Note=Cyclin-dependent kinase 2-associated protein 1	
P49119	UniProtKB	Region	1	60	.	.	.	Note=intrinsically disordered;status=By similarity	
P49119	UniProtKB	Modified residue	45	45	.	.	.	Note=Phosphoserine%3B by IKKE;status=By similarity	
P49119	UniProtKB	Disulfide bond	104	104	.	.	.	Note=Interchain;status=Potential	
##sequence-region O35207 1 114
O35207	UniProtKB	Chain	1	114	.	.	.	ID=PRO_0000089454;Note=Cyclin-dependent kinase 2-associated protein 1	
O35207	UniProtKB	Region	1	60	.	.	.	Note=intrinsically disordered;status=By similarity	
O35207	UniProtKB	Modified residue	45	45	.	.	.	Note=Phosphoserine%3B by IKKE;status=By similarity	
O35207	UniProtKB	Disulfide bond	104	104	.	.	.	Note=Interchain;status=Potential	
##sequence-region P49918 1 316
P49918	UniProtKB	Chain	1	316	.	.	.	ID=PRO_0000190087;Note=Cyclin-dependent kinase inhibitor 1C	
P49918	UniProtKB	Repeat	156	159	.	.	.	Note=1	
P49918	UniProtKB	Repeat	160	163	.	.	.	Note=2	
P49918	UniProtKB	Repeat	180	183	.	.	.	Note=3	
P49918	UniProtKB	Repeat	184	187	.	.	.	Note=4	
P49918	UniProtKB	Repeat	188	191	.	.	.	Note=5	
P49918	UniProtKB	Repeat	198	201	.	.	.	Note=6	
P49918	UniProtKB	Repeat	202	205	.	.	.	Note=7	
P49918	UniProtKB	Repeat	206	209	.	.	.	Note=8	
P49918	UniProtKB	Repeat	210	213	.	.	.	Note=9	
P49918	UniProtKB	Region	156	213	.	.	.	Note=9 X 4 AA repeats of P-A-P-A	
P49918	UniProtKB	Motif	278	281	.	.	.	Note=Nuclear localization signal;status=Potential	
P49918	UniProtKB	Modified residue	268	268	.	.	.	Note=Phosphoserine	
P49918	UniProtKB	Alternative sequence	1	11	.	.	.	ID=VSP_000867;Note=In isoform Short.	
P49918	UniProtKB	Natural variant	171	174	.	.	.	ID=VAR_001404;Note=In several cancers.	
P49918	UniProtKB	Natural variant	181	184	.	.	.	ID=VAR_001405;Note=In hepatocellular carcinomas.	
P49918	UniProtKB	Natural variant	200	203	.	.	.	ID=VAR_001406;Note=In a bladder cancer.	
P49918	UniProtKB	Natural variant	206	209	.	.	.	ID=VAR_001407;Note=In a breast cancer.	
P49918	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_068848;Note=In IMAGE.	
P49918	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_068849;Note=In IMAGE%3B PCNA binding is disrupted.	
P49918	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_068850;Note=In IMAGE.	
P49918	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_068851;Note=In IMAGE%3B PCNA binding is disrupted.	
P49918	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_068852;Note=In IMAGE.	
##sequence-region Q2KJD8 1 131
Q2KJD8	UniProtKB	Chain	1	131	.	.	.	ID=PRO_0000310856;Note=Cyclin-dependent kinase 4 inhibitor B	
Q2KJD8	UniProtKB	Repeat	6	35	.	.	.	Note=ANK 1	
Q2KJD8	UniProtKB	Repeat	39	67	.	.	.	Note=ANK 2	
Q2KJD8	UniProtKB	Repeat	72	101	.	.	.	Note=ANK 3	
Q2KJD8	UniProtKB	Repeat	105	131	.	.	.	Note=ANK 4	
##sequence-region P42772 1 138
P42772	UniProtKB	Chain	1	138	.	.	.	ID=PRO_0000144184;Note=Cyclin-dependent kinase 4 inhibitor B	
P42772	UniProtKB	Repeat	13	39	.	.	.	Note=ANK 1%3B truncated	
P42772	UniProtKB	Repeat	46	74	.	.	.	Note=ANK 2	
P42772	UniProtKB	Repeat	79	108	.	.	.	Note=ANK 3	
P42772	UniProtKB	Repeat	112	138	.	.	.	Note=ANK 4	
P42772	UniProtKB	Alternative sequence	54	138	.	.	.	ID=VSP_043898;Note=In isoform 2.	
P42772	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_001488;Note=In lung adenocarcinoma.	
P42772	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_001489;Note=In lung adenocarcinoma.	
P42772	UniProtKB	Sequence conflict	20	22	.	.	.	.	
P42772	UniProtKB	Sequence conflict	32	34	.	.	.	.	
##sequence-region P55271 1 130
P55271	UniProtKB	Chain	1	130	.	.	.	ID=PRO_0000144185;Note=Cyclin-dependent kinase 4 inhibitor B	
P55271	UniProtKB	Repeat	5	34	.	.	.	Note=ANK 1	
P55271	UniProtKB	Repeat	38	66	.	.	.	Note=ANK 2	
P55271	UniProtKB	Repeat	71	100	.	.	.	Note=ANK 3	
P55271	UniProtKB	Repeat	104	130	.	.	.	Note=ANK 4	
P55271	UniProtKB	Modified residue	12	12	.	.	.	Note=Phosphothreonine	
P55271	UniProtKB	Helix	9	15	.	.	.	.	
P55271	UniProtKB	Helix	19	27	.	.	.	.	
P55271	UniProtKB	Turn	41	45	.	.	.	.	
P55271	UniProtKB	Helix	51	60	.	.	.	.	
P55271	UniProtKB	Turn	69	72	.	.	.	.	
P55271	UniProtKB	Helix	75	82	.	.	.	.	
P55271	UniProtKB	Helix	85	93	.	.	.	.	
P55271	UniProtKB	Beta strand	102	106	.	.	.	.	
P55271	UniProtKB	Helix	108	115	.	.	.	.	
P55271	UniProtKB	Helix	118	128	.	.	.	.	
##sequence-region P55272 1 130
P55272	UniProtKB	Chain	1	130	.	.	.	ID=PRO_0000004808;Note=Cyclin-dependent kinase 4 inhibitor B	
P55272	UniProtKB	Repeat	5	34	.	.	.	Note=ANK 1	
P55272	UniProtKB	Repeat	38	66	.	.	.	Note=ANK 2	
P55272	UniProtKB	Repeat	71	100	.	.	.	Note=ANK 3	
P55272	UniProtKB	Repeat	104	130	.	.	.	Note=ANK 4	
P55272	UniProtKB	Modified residue	12	12	.	.	.	Note=Phosphothreonine;status=By similarity	
P55272	UniProtKB	Alternative sequence	1	45	.	.	.	ID=VSP_018702;Note=In isoform Short.	
##sequence-region Q29RV0 1 166
Q29RV0	UniProtKB	Chain	1	166	.	.	.	ID=PRO_0000310855;Note=Cyclin-dependent kinase 4 inhibitor D	
Q29RV0	UniProtKB	Repeat	41	69	.	.	.	Note=ANK 1	
Q29RV0	UniProtKB	Repeat	73	102	.	.	.	Note=ANK 2	
Q29RV0	UniProtKB	Repeat	106	135	.	.	.	Note=ANK 3	
Q29RV0	UniProtKB	Repeat	138	166	.	.	.	Note=ANK 4	
Q29RV0	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
##sequence-region P55273 1 166
P55273	UniProtKB	Chain	1	166	.	.	.	ID=PRO_0000144188;Note=Cyclin-dependent kinase 4 inhibitor D	
P55273	UniProtKB	Repeat	41	69	.	.	.	Note=ANK 1	
P55273	UniProtKB	Repeat	73	102	.	.	.	Note=ANK 2	
P55273	UniProtKB	Repeat	106	135	.	.	.	Note=ANK 3	
P55273	UniProtKB	Repeat	138	166	.	.	.	Note=ANK 4	
P55273	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
P55273	UniProtKB	Sequence conflict	159	159	.	.	.	.	
P55273	UniProtKB	Helix	8	18	.	.	.	.	
P55273	UniProtKB	Helix	21	29	.	.	.	.	
P55273	UniProtKB	Helix	45	48	.	.	.	.	
P55273	UniProtKB	Helix	54	62	.	.	.	.	
P55273	UniProtKB	Helix	77	83	.	.	.	.	
P55273	UniProtKB	Helix	87	95	.	.	.	.	
P55273	UniProtKB	Helix	110	117	.	.	.	.	
P55273	UniProtKB	Helix	120	127	.	.	.	.	
P55273	UniProtKB	Helix	142	148	.	.	.	.	
P55273	UniProtKB	Helix	152	159	.	.	.	.	
##sequence-region Q60773 1 166
Q60773	UniProtKB	Chain	1	166	.	.	.	ID=PRO_0000144189;Note=Cyclin-dependent kinase 4 inhibitor D	
Q60773	UniProtKB	Repeat	41	69	.	.	.	Note=ANK 1	
Q60773	UniProtKB	Repeat	73	102	.	.	.	Note=ANK 2	
Q60773	UniProtKB	Repeat	106	135	.	.	.	Note=ANK 3	
Q60773	UniProtKB	Repeat	138	165	.	.	.	Note=ANK 4	
Q60773	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q60773	UniProtKB	Sequence conflict	16	16	.	.	.	.	
Q60773	UniProtKB	Sequence conflict	17	17	.	.	.	.	
Q60773	UniProtKB	Helix	7	17	.	.	.	.	
Q60773	UniProtKB	Helix	21	29	.	.	.	.	
Q60773	UniProtKB	Helix	45	48	.	.	.	.	
Q60773	UniProtKB	Helix	54	62	.	.	.	.	
Q60773	UniProtKB	Turn	72	74	.	.	.	.	
Q60773	UniProtKB	Helix	77	84	.	.	.	.	
Q60773	UniProtKB	Helix	87	95	.	.	.	.	
Q60773	UniProtKB	Helix	110	117	.	.	.	.	
Q60773	UniProtKB	Helix	120	126	.	.	.	.	
Q60773	UniProtKB	Helix	127	129	.	.	.	.	
Q60773	UniProtKB	Helix	142	148	.	.	.	.	
Q60773	UniProtKB	Helix	152	160	.	.	.	.	
##sequence-region Q3URR0 1 86
Q3URR0	UniProtKB	Chain	1	86	.	.	.	ID=PRO_0000311184;Note=Centromere protein W	
##sequence-region A1L1L1 1 86
A1L1L1	UniProtKB	Chain	1	86	.	.	.	ID=PRO_0000311185;Note=Centromere protein W	
##sequence-region A8WW61 1 658
A8WW61	UniProtKB	Chain	1	658	.	.	.	ID=PRO_0000374067;Note=Transcription factor cep-1	
A8WW61	UniProtKB	DNA binding	238	428	.	.	.	.	
A8WW61	UniProtKB	Region	535	564	.	.	.	Note=Required for tertiary structure stability of the protein;status=By similarity	
A8WW61	UniProtKB	Metal binding	319	319	.	.	.	Note=Zinc;status=By similarity	
A8WW61	UniProtKB	Metal binding	322	322	.	.	.	Note=Zinc;status=By similarity	
A8WW61	UniProtKB	Metal binding	375	375	.	.	.	Note=Zinc;status=By similarity	
A8WW61	UniProtKB	Metal binding	379	379	.	.	.	Note=Zinc;status=By similarity	
##sequence-region Q20646 1 644
Q20646	UniProtKB	Chain	1	644	.	.	.	ID=PRO_0000371248;Note=Transcription factor cep-1	
Q20646	UniProtKB	DNA binding	223	418	.	.	.	.	
Q20646	UniProtKB	Region	528	555	.	.	.	Note=Required for tertiary structure stability of the protein	
Q20646	UniProtKB	Metal binding	307	307	.	.	.	Note=Zinc	
Q20646	UniProtKB	Metal binding	310	310	.	.	.	Note=Zinc	
Q20646	UniProtKB	Metal binding	361	361	.	.	.	Note=Zinc	
Q20646	UniProtKB	Metal binding	365	365	.	.	.	Note=Zinc	
Q20646	UniProtKB	Alternative sequence	1	447	.	.	.	ID=VSP_053085;Note=In isoform b.	
Q20646	UniProtKB	Mutagenesis	544	544	.	.	.	Note=Disrupts homodimer formation.	
Q20646	UniProtKB	Mutagenesis	551	551	.	.	.	Note=Disrupts homodimer formation.	
Q20646	UniProtKB	Mutagenesis	552	552	.	.	.	Note=Disrupts homodimer formation.	
Q20646	UniProtKB	Beta strand	225	230	.	.	.	.	
Q20646	UniProtKB	Helix	232	235	.	.	.	.	
Q20646	UniProtKB	Beta strand	239	245	.	.	.	.	
Q20646	UniProtKB	Beta strand	251	255	.	.	.	.	
Q20646	UniProtKB	Beta strand	261	268	.	.	.	.	
Q20646	UniProtKB	Turn	271	275	.	.	.	.	
Q20646	UniProtKB	Beta strand	279	287	.	.	.	.	
Q20646	UniProtKB	Beta strand	289	291	.	.	.	.	
Q20646	UniProtKB	Helix	293	296	.	.	.	.	
Q20646	UniProtKB	Helix	308	312	.	.	.	.	
Q20646	UniProtKB	Beta strand	316	318	.	.	.	.	
Q20646	UniProtKB	Beta strand	322	327	.	.	.	.	
Q20646	UniProtKB	Beta strand	329	335	.	.	.	.	
Q20646	UniProtKB	Beta strand	339	345	.	.	.	.	
Q20646	UniProtKB	Beta strand	352	361	.	.	.	.	
Q20646	UniProtKB	Helix	363	365	.	.	.	.	
Q20646	UniProtKB	Helix	368	371	.	.	.	.	
Q20646	UniProtKB	Beta strand	373	382	.	.	.	.	
Q20646	UniProtKB	Beta strand	388	399	.	.	.	.	
Q20646	UniProtKB	Helix	403	416	.	.	.	.	
Q20646	UniProtKB	Beta strand	532	538	.	.	.	.	
Q20646	UniProtKB	Helix	539	554	.	.	.	.	
Q20646	UniProtKB	Beta strand	559	561	.	.	.	.	
Q20646	UniProtKB	Helix	563	566	.	.	.	.	
Q20646	UniProtKB	Turn	571	573	.	.	.	.	
Q20646	UniProtKB	Helix	576	581	.	.	.	.	
Q20646	UniProtKB	Turn	585	587	.	.	.	.	
Q20646	UniProtKB	Helix	588	594	.	.	.	.	
Q20646	UniProtKB	Helix	601	608	.	.	.	.	
Q20646	UniProtKB	Helix	612	616	.	.	.	.	
Q20646	UniProtKB	Helix	620	622	.	.	.	.	
Q20646	UniProtKB	Helix	623	641	.	.	.	.	
##sequence-region O96017 1 543
O96017	UniProtKB	Chain	1	543	.	.	.	ID=PRO_0000085858;Note=Serine/threonine-protein kinase Chk2	
O96017	UniProtKB	Domain	113	175	.	.	.	Note=FHA	
O96017	UniProtKB	Domain	220	486	.	.	.	Note=Protein kinase	
O96017	UniProtKB	Nucleotide binding	227	234	.	.	.	Note=ATP	
O96017	UniProtKB	Nucleotide binding	302	308	.	.	.	Note=ATP	
O96017	UniProtKB	Nucleotide binding	351	352	.	.	.	Note=ATP	
O96017	UniProtKB	Region	368	394	.	.	.	Note=T-loop/activation segment	
O96017	UniProtKB	Active site	347	347	.	.	.	Note=Proton acceptor	
O96017	UniProtKB	Binding site	249	249	.	.	.	Note=ATP	
O96017	UniProtKB	Binding site	368	368	.	.	.	Note=ATP	
O96017	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphoserine%3B by PLK3	
O96017	UniProtKB	Modified residue	68	68	.	.	.	Note=Phosphothreonine%3B by ATM and MLTK	
O96017	UniProtKB	Modified residue	73	73	.	.	.	Note=Phosphoserine%3B by PLK3	
O96017	UniProtKB	Modified residue	379	379	.	.	.	Note=Phosphoserine%3B by autocatalysis	
O96017	UniProtKB	Modified residue	383	383	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
O96017	UniProtKB	Modified residue	387	387	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
O96017	UniProtKB	Modified residue	456	456	.	.	.	Note=Phosphoserine	
O96017	UniProtKB	Alternative sequence	1	221	.	.	.	ID=VSP_045148;Note=In isoform 13.	
O96017	UniProtKB	Alternative sequence	75	392	.	.	.	ID=VSP_014556;Note=In isoform 11.	
O96017	UniProtKB	Alternative sequence	107	487	.	.	.	ID=VSP_014559;Note=In isoform 3.	
O96017	UniProtKB	Alternative sequence	107	197	.	.	.	ID=VSP_014558;Note=In isoform 4.	
O96017	UniProtKB	Alternative sequence	107	107	.	.	.	ID=VSP_014557;Note=In isoform 9.	
O96017	UniProtKB	Alternative sequence	131	147	.	.	.	ID=VSP_014560;Note=In isoform 10.	
O96017	UniProtKB	Alternative sequence	148	543	.	.	.	ID=VSP_014561;Note=In isoform 10.	
O96017	UniProtKB	Alternative sequence	150	165	.	.	.	ID=VSP_014562;Note=In isoform 6.	
O96017	UniProtKB	Alternative sequence	166	543	.	.	.	ID=VSP_014563;Note=In isoform 6.	
O96017	UniProtKB	Alternative sequence	198	224	.	.	.	ID=VSP_014564;Note=In isoform 2.	
O96017	UniProtKB	Alternative sequence	199	203	.	.	.	ID=VSP_014565;Note=In isoform 5.	
O96017	UniProtKB	Alternative sequence	204	543	.	.	.	ID=VSP_014566;Note=In isoform 5.	
O96017	UniProtKB	Alternative sequence	228	234	.	.	.	ID=VSP_014567;Note=In isoform 2.	
O96017	UniProtKB	Alternative sequence	235	543	.	.	.	ID=VSP_014568;Note=In isoform 2.	
O96017	UniProtKB	Alternative sequence	283	289	.	.	.	ID=VSP_014569;Note=In isoform 8.	
O96017	UniProtKB	Alternative sequence	290	543	.	.	.	ID=VSP_014570;Note=In isoform 8.	
O96017	UniProtKB	Alternative sequence	337	365	.	.	.	ID=VSP_014571;Note=In isoform 12.	
O96017	UniProtKB	Alternative sequence	337	339	.	.	.	ID=VSP_014572;Note=In isoform 7.	
O96017	UniProtKB	Alternative sequence	340	543	.	.	.	ID=VSP_014573;Note=In isoform 7.	
O96017	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_019101;Note=In an osteogenic sarcoma sample%3B somatic mutation%3B might influence susceptibility to breast cancer%3B does not cause protein abrogation in familial colorectal cancer.	
O96017	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_026630;Note=In multiple cancers.	
O96017	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_019107;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_019102;Dbxref=dbSNP:rs17883862;Note=In an osteogenic sarcoma sample%3B neutral allele among Ashkenazi Jewish women.	
O96017	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_022461;Dbxref=dbSNP:rs28909982	
O96017	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_022462;Note=Might influence susceptibility to breast cancer%3B does not cause protein abrogation in familial colorectal cancer.	
O96017	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_019108;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_008554;Note=In colon cancer and LFS2%3B does not cause protein abrogation in familial colorectal cancer%3B loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation.	
O96017	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_008555;Dbxref=dbSNP:rs17879961;Note=Might influence susceptibility to different types of cancer%3B does not cause protein abrogation in familial colorectal cancer%3B loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation.	
O96017	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_019109;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_019103;Dbxref=dbSNP:rs77130927;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_019110;Dbxref=dbSNP:rs137853009;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_019104;Dbxref=dbSNP:rs137853010;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_019105;Dbxref=dbSNP:rs121908701;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_019106;Note=In prostate cancer%3B germline mutation.	
O96017	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_019111;Note=In prostate cancer%3B germline mutation.	
O96017	UniProtKB	Natural variant	318	318	.	.	.	ID=VAR_019112;Dbxref=dbSNP:rs143611747;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_019113;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	327	327	.	.	.	ID=VAR_019114;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_029154;Dbxref=dbSNP:rs28909980	
O96017	UniProtKB	Natural variant	371	371	.	.	.	ID=VAR_066012;Note=Confers a moderate risk of breast cancer%3B partially reduces kinase activity.	
O96017	UniProtKB	Natural variant	406	406	.	.	.	ID=VAR_024572;Dbxref=dbSNP:rs299671	
O96017	UniProtKB	Natural variant	428	428	.	.	.	ID=VAR_022463;Dbxref=dbSNP:rs137853011;Note=May increase breast cancer risk.	
O96017	UniProtKB	Natural variant	436	436	.	.	.	ID=VAR_021117;Dbxref=dbSNP:rs17882922	
O96017	UniProtKB	Natural variant	446	446	.	.	.	ID=VAR_021118;Dbxref=dbSNP:rs17880867	
O96017	UniProtKB	Natural variant	447	447	.	.	.	ID=VAR_021119;Dbxref=dbSNP:rs17881473	
O96017	UniProtKB	Natural variant	448	448	.	.	.	ID=VAR_021120;Dbxref=dbSNP:rs17886163	
O96017	UniProtKB	Natural variant	476	476	.	.	.	ID=VAR_019115;Note=In prostate cancer%3B somatic mutation.	
O96017	UniProtKB	Natural variant	500	500	.	.	.	ID=VAR_029155;Dbxref=dbSNP:rs28909981	
O96017	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_021121;Dbxref=dbSNP:rs17883172	
O96017	UniProtKB	Natural variant	512	512	.	.	.	ID=VAR_021122;Dbxref=dbSNP:rs17882942	
O96017	UniProtKB	Mutagenesis	68	68	.	.	.	Note=Loss of activation and phosphorylation.	
O96017	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Impaired activation%2C phosphorylation by ATM and G2/M transition checkpoint.	
O96017	UniProtKB	Mutagenesis	347	347	.	.	.	Note=Loss of kinase activity and of the ability to phosphorylate CDC25A.	
O96017	UniProtKB	Mutagenesis	368	368	.	.	.	Note=Loss of autophosphorylation activity.	
O96017	UniProtKB	Mutagenesis	379	379	.	.	.	Note=Abrogates autophosphorylation at Ser-379 and prevents ubiquitination.	
O96017	UniProtKB	Mutagenesis	383	383	.	.	.	Note=Loss of phosphorylation in response to ionizing radiation.	
O96017	UniProtKB	Mutagenesis	387	387	.	.	.	Note=Loss of phosphorylation in response to ionizing radiation.	
O96017	UniProtKB	Mutagenesis	456	456	.	.	.	Note=Increased ubiquitination and degradation by the proteasome.	
O96017	UniProtKB	Beta strand	94	98	.	.	.	.	
O96017	UniProtKB	Beta strand	100	103	.	.	.	.	
O96017	UniProtKB	Beta strand	106	108	.	.	.	.	
O96017	UniProtKB	Beta strand	110	118	.	.	.	.	
O96017	UniProtKB	Beta strand	122	124	.	.	.	.	
O96017	UniProtKB	Helix	128	132	.	.	.	.	
O96017	UniProtKB	Helix	135	138	.	.	.	.	
O96017	UniProtKB	Beta strand	144	150	.	.	.	.	
O96017	UniProtKB	Beta strand	154	162	.	.	.	.	
O96017	UniProtKB	Beta strand	168	170	.	.	.	.	
O96017	UniProtKB	Beta strand	180	182	.	.	.	.	
O96017	UniProtKB	Beta strand	187	193	.	.	.	.	
O96017	UniProtKB	Beta strand	197	203	.	.	.	.	
O96017	UniProtKB	Helix	209	211	.	.	.	.	
O96017	UniProtKB	Helix	214	219	.	.	.	.	
O96017	UniProtKB	Beta strand	220	228	.	.	.	.	
O96017	UniProtKB	Beta strand	230	239	.	.	.	.	
O96017	UniProtKB	Turn	240	243	.	.	.	.	
O96017	UniProtKB	Beta strand	244	251	.	.	.	.	
O96017	UniProtKB	Helix	253	256	.	.	.	.	
O96017	UniProtKB	Helix	270	279	.	.	.	.	
O96017	UniProtKB	Beta strand	288	302	.	.	.	.	
O96017	UniProtKB	Beta strand	307	309	.	.	.	.	
O96017	UniProtKB	Helix	310	313	.	.	.	.	
O96017	UniProtKB	Helix	314	316	.	.	.	.	
O96017	UniProtKB	Helix	321	340	.	.	.	.	
O96017	UniProtKB	Helix	350	352	.	.	.	.	
O96017	UniProtKB	Beta strand	353	361	.	.	.	.	
O96017	UniProtKB	Beta strand	364	366	.	.	.	.	
O96017	UniProtKB	Helix	369	371	.	.	.	.	
O96017	UniProtKB	Helix	379	385	.	.	.	.	
O96017	UniProtKB	Helix	388	390	.	.	.	.	
O96017	UniProtKB	Helix	393	398	.	.	.	.	
O96017	UniProtKB	Turn	399	403	.	.	.	.	
O96017	UniProtKB	Helix	407	422	.	.	.	.	
O96017	UniProtKB	Beta strand	429	431	.	.	.	.	
O96017	UniProtKB	Helix	436	442	.	.	.	.	
O96017	UniProtKB	Helix	449	452	.	.	.	.	
O96017	UniProtKB	Helix	457	466	.	.	.	.	
O96017	UniProtKB	Turn	471	473	.	.	.	.	
O96017	UniProtKB	Helix	477	481	.	.	.	.	
O96017	UniProtKB	Helix	484	486	.	.	.	.	
O96017	UniProtKB	Helix	489	502	.	.	.	.	
O96017	UniProtKB	Turn	504	506	.	.	.	.	
##sequence-region Q96M02 1 699
Q96M02	UniProtKB	Chain	1	699	.	.	.	ID=PRO_0000279492;Note=Centrosomal protein C10orf90	
Q96M02	UniProtKB	Region	116	224	.	.	.	Note=Required for interaction with HDAC1;status=By similarity	
Q96M02	UniProtKB	Region	571	699	.	.	.	Note=ALMS motif;status=By similarity	
Q96M02	UniProtKB	Compositional bias	663	666	.	.	.	Note=Poly-Lys	
Q96M02	UniProtKB	Alternative sequence	415	511	.	.	.	ID=VSP_023458;Note=In isoform 2.	
Q96M02	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_050855;Dbxref=dbSNP:rs11558415	
Q96M02	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_030908;Dbxref=dbSNP:rs11245008	
Q96M02	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_030909;Dbxref=dbSNP:rs11245007	
Q96M02	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_050856;Dbxref=dbSNP:rs12412320	
Q96M02	UniProtKB	Sequence conflict	654	654	.	.	.	.	
##sequence-region D2J0Y4 1 644
D2J0Y4	UniProtKB	Chain	1	644	.	.	.	ID=PRO_0000413487;Note=Centrosomal protein C10orf90 homolog	
D2J0Y4	UniProtKB	Region	67	175	.	.	.	Note=Required for interaction with HDAC1	
D2J0Y4	UniProtKB	Region	516	644	.	.	.	Note=ALMS motif	
D2J0Y4	UniProtKB	Coiled coil	598	629	.	.	.	status=Potential	
D2J0Y4	UniProtKB	Compositional bias	608	611	.	.	.	Note=Poly-Lys	
##sequence-region O60519 1 120
O60519	UniProtKB	Chain	1	120	.	.	.	ID=PRO_0000318192;Note=cAMP-responsive element-binding protein-like 2	
O60519	UniProtKB	Domain	23	86	.	.	.	Note=bZIP	
O60519	UniProtKB	Region	29	60	.	.	.	Note=Basic motif;status=By similarity	
O60519	UniProtKB	Region	62	69	.	.	.	Note=Leucine-zipper;status=By similarity	
##sequence-region P23508 1 829
P23508	UniProtKB	Chain	1	829	.	.	.	ID=PRO_0000079333;Note=Colorectal mutant cancer protein	
P23508	UniProtKB	Motif	826	829	.	.	.	Note=PDZ-binding	
P23508	UniProtKB	Modified residue	828	828	.	.	.	Note=Phosphoserine	
P23508	UniProtKB	Alternative sequence	1	19	.	.	.	ID=VSP_037660;Note=In isoform 2.	
P23508	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_050905;Dbxref=dbSNP:rs6594681	
P23508	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_005141;Note=In a colorectal cancer sample.	
P23508	UniProtKB	Natural variant	486	486	.	.	.	ID=VAR_005142;Dbxref=dbSNP:rs35269015;Note=In a colorectal cancer sample.	
P23508	UniProtKB	Natural variant	490	490	.	.	.	ID=VAR_005143;Note=In a colorectal cancer sample.	
P23508	UniProtKB	Natural variant	506	506	.	.	.	ID=VAR_005144;Note=In colorectal cancer samples%3B somatic mutation.	
P23508	UniProtKB	Natural variant	698	698	.	.	.	ID=VAR_005145;Note=In colorectal cancer samples%3B somatic mutation.	
P23508	UniProtKB	Natural variant	751	751	.	.	.	ID=VAR_033753;Dbxref=dbSNP:rs17313892	
P23508	UniProtKB	Mutagenesis	828	828	.	.	.	Note=Reduced binding to SCRIB.	
P23508	UniProtKB	Mutagenesis	828	828	.	.	.	Note=Higher membrane localization%2C reduced formation of lamellipodia%2C accumulation of MYH10 at the cell cortex.	
P23508	UniProtKB	Sequence conflict	353	353	.	.	.	.	
##sequence-region A2APF3 1 636
A2APF3	UniProtKB	Chain	1	636	.	.	.	ID=PRO_0000373924;Note=Transcriptional repressor CTCFL	
A2APF3	UniProtKB	Zinc finger	257	279	.	.	.	Note=C2H2-type 1	
A2APF3	UniProtKB	Zinc finger	285	307	.	.	.	Note=C2H2-type 2	
A2APF3	UniProtKB	Zinc finger	313	336	.	.	.	Note=C2H2-type 3	
A2APF3	UniProtKB	Zinc finger	342	364	.	.	.	Note=C2H2-type 4	
A2APF3	UniProtKB	Zinc finger	370	392	.	.	.	Note=C2H2-type 5	
A2APF3	UniProtKB	Zinc finger	398	421	.	.	.	Note=C2H2-type 6	
A2APF3	UniProtKB	Zinc finger	428	451	.	.	.	Note=C2H2-type 7	
A2APF3	UniProtKB	Zinc finger	458	480	.	.	.	Note=C2H2-type 8	
A2APF3	UniProtKB	Zinc finger	486	508	.	.	.	Note=C2H2-type 9	
A2APF3	UniProtKB	Zinc finger	514	537	.	.	.	Note=C2H2-type 10	
A2APF3	UniProtKB	Zinc finger	546	572	.	.	.	Note=C2H2-type 11	
A2APF3	UniProtKB	Alternative sequence	598	598	.	.	.	ID=VSP_037281;Note=In isoform 2.	
A2APF3	UniProtKB	Sequence conflict	629	629	.	.	.	.	
A2APF3	UniProtKB	Sequence conflict	629	629	.	.	.	.	
##sequence-region P49711 1 727
P49711	UniProtKB	Chain	1	727	.	.	.	ID=PRO_0000047228;Note=Transcriptional repressor CTCF	
P49711	UniProtKB	Zinc finger	266	288	.	.	.	Note=C2H2-type 1	
P49711	UniProtKB	Zinc finger	294	316	.	.	.	Note=C2H2-type 2	
P49711	UniProtKB	Zinc finger	322	345	.	.	.	Note=C2H2-type 3	
P49711	UniProtKB	Zinc finger	351	373	.	.	.	Note=C2H2-type 4	
P49711	UniProtKB	Zinc finger	379	401	.	.	.	Note=C2H2-type 5	
P49711	UniProtKB	Zinc finger	407	430	.	.	.	Note=C2H2-type 6	
P49711	UniProtKB	Zinc finger	437	460	.	.	.	Note=C2H2-type 7	
P49711	UniProtKB	Zinc finger	467	489	.	.	.	Note=C2H2-type 8	
P49711	UniProtKB	Zinc finger	495	517	.	.	.	Note=C2H2-type 9	
P49711	UniProtKB	Zinc finger	523	546	.	.	.	Note=C2H2-type 10	
P49711	UniProtKB	Zinc finger	555	577	.	.	.	Note=C2H2-type 11%3B atypical	
P49711	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
P49711	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphothreonine	
P49711	UniProtKB	Modified residue	317	317	.	.	.	Note=Phosphothreonine	
P49711	UniProtKB	Modified residue	374	374	.	.	.	Note=Phosphothreonine	
P49711	UniProtKB	Modified residue	402	402	.	.	.	Note=Phosphoserine	
P49711	UniProtKB	Modified residue	609	609	.	.	.	Note=Phosphoserine	
P49711	UniProtKB	Modified residue	610	610	.	.	.	Note=Phosphoserine	
P49711	UniProtKB	Modified residue	612	612	.	.	.	Note=Phosphoserine	
P49711	UniProtKB	Cross-link	74	74	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P49711	UniProtKB	Cross-link	689	689	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P49711	UniProtKB	Alternative sequence	1	328	.	.	.	ID=VSP_045350;Note=In isoform 2.	
P49711	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_013141;Note=In a Wilms' tumor.	
P49711	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_013142;Note=In a breast tumor.	
P49711	UniProtKB	Natural variant	345	345	.	.	.	ID=VAR_013143;Note=In a prostate tumor.	
P49711	UniProtKB	Natural variant	448	448	.	.	.	ID=VAR_013144;Note=In a Wilms' tumor.	
P49711	UniProtKB	Beta strand	406	408	.	.	.	.	
P49711	UniProtKB	Turn	410	412	.	.	.	.	
P49711	UniProtKB	Beta strand	415	417	.	.	.	.	
P49711	UniProtKB	Helix	419	429	.	.	.	.	
P49711	UniProtKB	Beta strand	430	433	.	.	.	.	
P49711	UniProtKB	Beta strand	435	438	.	.	.	.	
P49711	UniProtKB	Beta strand	440	443	.	.	.	.	
P49711	UniProtKB	Beta strand	445	448	.	.	.	.	
P49711	UniProtKB	Helix	449	458	.	.	.	.	
P49711	UniProtKB	Turn	509	511	.	.	.	.	
P49711	UniProtKB	Beta strand	526	529	.	.	.	.	
P49711	UniProtKB	Beta strand	531	534	.	.	.	.	
P49711	UniProtKB	Helix	535	544	.	.	.	.	
P49711	UniProtKB	Beta strand	558	560	.	.	.	.	
P49711	UniProtKB	Beta strand	563	565	.	.	.	.	
P49711	UniProtKB	Helix	567	576	.	.	.	.	
##sequence-region Q61164 1 736
Q61164	UniProtKB	Chain	1	736	.	.	.	ID=PRO_0000047229;Note=Transcriptional repressor CTCF	
Q61164	UniProtKB	Zinc finger	266	288	.	.	.	Note=C2H2-type 1	
Q61164	UniProtKB	Zinc finger	294	316	.	.	.	Note=C2H2-type 2	
Q61164	UniProtKB	Zinc finger	322	345	.	.	.	Note=C2H2-type 3	
Q61164	UniProtKB	Zinc finger	351	373	.	.	.	Note=C2H2-type 4	
Q61164	UniProtKB	Zinc finger	379	401	.	.	.	Note=C2H2-type 5	
Q61164	UniProtKB	Zinc finger	407	430	.	.	.	Note=C2H2-type 6	
Q61164	UniProtKB	Zinc finger	437	460	.	.	.	Note=C2H2-type 7	
Q61164	UniProtKB	Zinc finger	467	489	.	.	.	Note=C2H2-type 8	
Q61164	UniProtKB	Zinc finger	495	517	.	.	.	Note=C2H2-type 9	
Q61164	UniProtKB	Zinc finger	523	546	.	.	.	Note=C2H2-type 10	
Q61164	UniProtKB	Zinc finger	555	577	.	.	.	Note=C2H2-type 11%3B atypical	
Q61164	UniProtKB	Compositional bias	635	676	.	.	.	Note=Pro-rich	
Q61164	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q61164	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphothreonine;status=By similarity	
Q61164	UniProtKB	Modified residue	317	317	.	.	.	Note=Phosphothreonine;status=By similarity	
Q61164	UniProtKB	Modified residue	374	374	.	.	.	Note=Phosphothreonine;status=By similarity	
Q61164	UniProtKB	Modified residue	402	402	.	.	.	Note=Phosphoserine;status=By similarity	
Q61164	UniProtKB	Modified residue	609	609	.	.	.	Note=Phosphoserine;status=By similarity	
Q61164	UniProtKB	Modified residue	610	610	.	.	.	Note=Phosphoserine;status=By similarity	
Q61164	UniProtKB	Modified residue	612	612	.	.	.	Note=Phosphoserine;status=By similarity	
Q61164	UniProtKB	Cross-link	74	74	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
Q61164	UniProtKB	Cross-link	698	698	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
Q61164	UniProtKB	Mutagenesis	74	74	.	.	.	Note=No sumoylation.	
Q61164	UniProtKB	Mutagenesis	698	698	.	.	.	Note=No sumoylation.	
Q61164	UniProtKB	Sequence conflict	38	38	.	.	.	.	
Q61164	UniProtKB	Sequence conflict	257	257	.	.	.	.	
##sequence-region Q9R1D1 1 737
Q9R1D1	UniProtKB	Chain	1	737	.	.	.	ID=PRO_0000047230;Note=Transcriptional repressor CTCF	
Q9R1D1	UniProtKB	Zinc finger	266	288	.	.	.	Note=C2H2-type 1	
Q9R1D1	UniProtKB	Zinc finger	294	316	.	.	.	Note=C2H2-type 2	
Q9R1D1	UniProtKB	Zinc finger	322	345	.	.	.	Note=C2H2-type 3	
Q9R1D1	UniProtKB	Zinc finger	351	373	.	.	.	Note=C2H2-type 4	
Q9R1D1	UniProtKB	Zinc finger	379	401	.	.	.	Note=C2H2-type 5	
Q9R1D1	UniProtKB	Zinc finger	407	430	.	.	.	Note=C2H2-type 6	
Q9R1D1	UniProtKB	Zinc finger	437	460	.	.	.	Note=C2H2-type 7	
Q9R1D1	UniProtKB	Zinc finger	467	489	.	.	.	Note=C2H2-type 8	
Q9R1D1	UniProtKB	Zinc finger	495	517	.	.	.	Note=C2H2-type 9	
Q9R1D1	UniProtKB	Zinc finger	523	546	.	.	.	Note=C2H2-type 10	
Q9R1D1	UniProtKB	Zinc finger	555	577	.	.	.	Note=C2H2-type 11%3B atypical	
Q9R1D1	UniProtKB	Compositional bias	634	677	.	.	.	Note=Pro-rich	
Q9R1D1	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q9R1D1	UniProtKB	Modified residue	289	289	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9R1D1	UniProtKB	Modified residue	317	317	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9R1D1	UniProtKB	Modified residue	374	374	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9R1D1	UniProtKB	Modified residue	402	402	.	.	.	Note=Phosphoserine;status=By similarity	
Q9R1D1	UniProtKB	Modified residue	609	609	.	.	.	Note=Phosphoserine;status=By similarity	
Q9R1D1	UniProtKB	Modified residue	610	610	.	.	.	Note=Phosphoserine;status=By similarity	
Q9R1D1	UniProtKB	Modified residue	612	612	.	.	.	Note=Phosphoserine;status=By similarity	
Q9R1D1	UniProtKB	Cross-link	74	74	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q9R1D1	UniProtKB	Cross-link	699	699	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q9NQC7 1 956
Q9NQC7	UniProtKB	Chain	1	956	.	.	.	ID=PRO_0000080698;Note=Ubiquitin carboxyl-terminal hydrolase CYLD	
Q9NQC7	UniProtKB	Domain	153	198	.	.	.	Note=CAP-Gly 1	
Q9NQC7	UniProtKB	Domain	253	286	.	.	.	Note=CAP-Gly 2	
Q9NQC7	UniProtKB	Domain	492	535	.	.	.	Note=CAP-Gly 3	
Q9NQC7	UniProtKB	Region	106	593	.	.	.	Note=Interaction with TRIP	
Q9NQC7	UniProtKB	Region	394	469	.	.	.	Note=Interaction with TRAF2	
Q9NQC7	UniProtKB	Region	470	554	.	.	.	Note=Interaction with IKBKG/NEMO	
Q9NQC7	UniProtKB	Active site	601	601	.	.	.	Note=Nucleophile	
Q9NQC7	UniProtKB	Active site	871	871	.	.	.	Note=Proton acceptor;status=Probable	
Q9NQC7	UniProtKB	Metal binding	788	788	.	.	.	Note=Zinc 1	
Q9NQC7	UniProtKB	Metal binding	791	791	.	.	.	Note=Zinc 1	
Q9NQC7	UniProtKB	Metal binding	799	799	.	.	.	Note=Zinc 2	
Q9NQC7	UniProtKB	Metal binding	802	802	.	.	.	Note=Zinc 2	
Q9NQC7	UniProtKB	Metal binding	817	817	.	.	.	Note=Zinc 1	
Q9NQC7	UniProtKB	Metal binding	820	820	.	.	.	Note=Zinc 1	
Q9NQC7	UniProtKB	Metal binding	825	825	.	.	.	Note=Zinc 2	
Q9NQC7	UniProtKB	Metal binding	833	833	.	.	.	Note=Zinc 2	
Q9NQC7	UniProtKB	Modified residue	418	418	.	.	.	Note=Phosphoserine	
Q9NQC7	UniProtKB	Alternative sequence	305	307	.	.	.	ID=VSP_011277;Note=In isoform 2.	
Q9NQC7	UniProtKB	Natural variant	747	747	.	.	.	ID=VAR_045967;Note=In MFT1 and BRSS.	
Q9NQC7	UniProtKB	Mutagenesis	418	418	.	.	.	Note=Reduced phosphorylation%3B when associated with A-422%3B A-432 and A-436. Loss of phosphorylation%3B when associated with A-422%3B A-432%3B A-436%3B A-439%3B A-441 and A-444.	
Q9NQC7	UniProtKB	Mutagenesis	418	418	.	.	.	Note=Abolishes deubiquitination of TRAF2%3B when associated with E-422%3B E-432%3B E-436%3B E-439%3B E-441 and E-444.	
Q9NQC7	UniProtKB	Mutagenesis	422	422	.	.	.	Note=Reduced phosphorylation%3B when associated with A-418%3B A-432 and A-436. Loss of phosphorylation%3B when associated with A-418%3B A-432%3B A-436%3B A-439%3B A-441 and A-444.	
Q9NQC7	UniProtKB	Mutagenesis	422	422	.	.	.	Note=Abolishes deubiquitination of TRAF2%3B when associated with E-418%3B E-432%3B E-436%3B E-439%3B E-441 and E-444.	
Q9NQC7	UniProtKB	Mutagenesis	432	432	.	.	.	Note=Slightly reduced phosphorylation%3B when associated with A-436. Reduced phosphorylation%3B when associated with A-418%3B A-422 and A-436. Loss of phosphorylation%3B when associated with A-418%3B A-422%3B A-436%3B A-439%3B A-441 and A-444.	
Q9NQC7	UniProtKB	Mutagenesis	432	432	.	.	.	Note=Abolishes deubiquitination of TRAF2%3B when associated with E-418%3B E-422%3B E-436%3B E-439%3B E-441 and E-444.	
Q9NQC7	UniProtKB	Mutagenesis	436	436	.	.	.	Note=Slightly reduced phosphorylation%3B when associated with A-432. Reduced phosphorylation%3B when associated with A-418%3B A-422 and A-432. Loss of phosphorylation%3B when associated with A-418%3B A-422%3B A-432%3B A-439%3B A-441 and A-444.	
Q9NQC7	UniProtKB	Mutagenesis	436	436	.	.	.	Note=Abolishes deubiquitination of TRAF2%3B when associated with E-418%3B E-422%3B E-432%3B E-439%3B E-441 and E-444.	
Q9NQC7	UniProtKB	Mutagenesis	439	439	.	.	.	Note=Loss of phosphorylation%3B when associated with A-418%3B A-422%3B A-432%3B A-436%3B A-441 and A-444.	
Q9NQC7	UniProtKB	Mutagenesis	439	439	.	.	.	Note=Abolishes deubiquitination of TRAF2%3B when associated with E-418%3B E-422%3B E-432%3B E-436%3B E-441 and E-444.	
Q9NQC7	UniProtKB	Mutagenesis	441	441	.	.	.	Note=Loss of phosphorylation%3B when associated with A-418%3B A-422%3B A-432%3B A-436%3B A-439 and A-444.	
Q9NQC7	UniProtKB	Mutagenesis	441	441	.	.	.	Note=Abolishes deubiquitination of TRAF2%3B when associated with E-418%3B E-422%3B E-432%3B E-436%3B E-439 and E-444.	
Q9NQC7	UniProtKB	Mutagenesis	444	444	.	.	.	Note=Loss of phosphorylation%3B when associated with A-418%3B A-422%3B A-432%3B A-436%3B A-439 and A-441.	
Q9NQC7	UniProtKB	Mutagenesis	444	444	.	.	.	Note=Abolishes deubiquitination of TRAF2%3B when associated with E-418%3B E-422%3B E-432%3B E-436%3B E-439 and E-441.	
Q9NQC7	UniProtKB	Mutagenesis	457	457	.	.	.	Note=Abolishes binding to TRAF2.	
Q9NQC7	UniProtKB	Mutagenesis	601	601	.	.	.	Note=Loss of deubiquitinating activity.	
Q9NQC7	UniProtKB	Mutagenesis	871	871	.	.	.	Note=Loss of deubiquitinating activity.	
Q9NQC7	UniProtKB	Beta strand	130	134	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	136	139	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	141	149	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	154	157	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	163	167	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	169	171	.	.	.	.	
Q9NQC7	UniProtKB	Turn	191	193	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	194	197	.	.	.	.	
Q9NQC7	UniProtKB	Helix	199	201	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	202	204	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	235	240	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	243	253	.	.	.	.	
Q9NQC7	UniProtKB	Turn	259	261	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	264	272	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	278	280	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	283	285	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	293	298	.	.	.	.	
Q9NQC7	UniProtKB	Helix	299	301	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	302	304	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	455	457	.	.	.	.	
Q9NQC7	UniProtKB	Turn	463	465	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	466	468	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	474	478	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	480	482	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	486	492	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	495	497	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	501	508	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	514	518	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	531	535	.	.	.	.	
Q9NQC7	UniProtKB	Helix	536	538	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	539	541	.	.	.	.	
Q9NQC7	UniProtKB	Helix	584	586	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	588	591	.	.	.	.	
Q9NQC7	UniProtKB	Helix	601	611	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	612	614	.	.	.	.	
Q9NQC7	UniProtKB	Helix	615	617	.	.	.	.	
Q9NQC7	UniProtKB	Helix	618	622	.	.	.	.	
Q9NQC7	UniProtKB	Helix	633	642	.	.	.	.	
Q9NQC7	UniProtKB	Helix	645	650	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	652	654	.	.	.	.	
Q9NQC7	UniProtKB	Helix	656	669	.	.	.	.	
Q9NQC7	UniProtKB	Helix	682	690	.	.	.	.	
Q9NQC7	UniProtKB	Turn	691	694	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	699	704	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	710	713	.	.	.	.	
Q9NQC7	UniProtKB	Helix	730	741	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	743	747	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	750	755	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	760	764	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	773	775	.	.	.	.	
Q9NQC7	UniProtKB	Helix	778	780	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	781	784	.	.	.	.	
Q9NQC7	UniProtKB	Turn	789	791	.	.	.	.	
Q9NQC7	UniProtKB	Helix	800	802	.	.	.	.	
Q9NQC7	UniProtKB	Turn	806	811	.	.	.	.	
Q9NQC7	UniProtKB	Helix	818	824	.	.	.	.	
Q9NQC7	UniProtKB	Helix	828	830	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	859	868	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	871	877	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	879	881	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	885	889	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	905	908	.	.	.	.	
Q9NQC7	UniProtKB	Helix	911	914	.	.	.	.	
Q9NQC7	UniProtKB	Helix	920	925	.	.	.	.	
Q9NQC7	UniProtKB	Helix	928	930	.	.	.	.	
Q9NQC7	UniProtKB	Helix	935	940	.	.	.	.	
Q9NQC7	UniProtKB	Beta strand	944	948	.	.	.	.	
Q9NQC7	UniProtKB	Helix	950	952	.	.	.	.	
##sequence-region Q5VWQ8 1 1189
Q5VWQ8	UniProtKB	Chain	1	1189	.	.	.	ID=PRO_0000252407;Note=Disabled homolog 2-interacting protein	
Q5VWQ8	UniProtKB	Domain	101	202	.	.	.	Note=PH	
Q5VWQ8	UniProtKB	Domain	200	295	.	.	.	Note=C2	
Q5VWQ8	UniProtKB	Domain	371	563	.	.	.	Note=Ras-GAP	
Q5VWQ8	UniProtKB	Region	646	943	.	.	.	Note=Necessary for interaction with AKT1	
Q5VWQ8	UniProtKB	Coiled coil	1026	1159	.	.	.	status=Potential	
Q5VWQ8	UniProtKB	Compositional bias	8	52	.	.	.	Note=Arg-rich	
Q5VWQ8	UniProtKB	Compositional bias	112	117	.	.	.	Note=Poly-Ala	
Q5VWQ8	UniProtKB	Compositional bias	867	870	.	.	.	Note=Poly-Ala	
Q5VWQ8	UniProtKB	Compositional bias	903	948	.	.	.	Note=Pro-rich	
Q5VWQ8	UniProtKB	Site	172	173	.	.	.	Note=Breakpoint for translocation to form KMT2A/MLL1-DAB2IP	
Q5VWQ8	UniProtKB	Modified residue	728	728	.	.	.	Note=Phosphoserine%3B by MAP3K5 and RIPK1	
Q5VWQ8	UniProtKB	Modified residue	978	978	.	.	.	Note=Phosphoserine	
Q5VWQ8	UniProtKB	Alternative sequence	1	193	.	.	.	ID=VSP_020952;Note=In isoform 3.	
Q5VWQ8	UniProtKB	Alternative sequence	1	124	.	.	.	ID=VSP_020953;Note=In isoform 2 and isoform 4.	
Q5VWQ8	UniProtKB	Alternative sequence	2	41	.	.	.	ID=VSP_047361;Note=In isoform 5.	
Q5VWQ8	UniProtKB	Alternative sequence	1158	1189	.	.	.	ID=VSP_020954;Note=In isoform 3%2C isoform 4 and isoform 5.	
Q5VWQ8	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_056858;Dbxref=dbSNP:rs7027492	
Q5VWQ8	UniProtKB	Mutagenesis	228	230	.	.	.	Note=Reduces interaction with KDR/VEGFR2. Does not inhibit interaction with MAP3K5.	
Q5VWQ8	UniProtKB	Mutagenesis	281	284	.	.	.	Note=Significantly reduces interaction with MAP3K5. Does not reduce interaction with KDR/VEGFR2.	
Q5VWQ8	UniProtKB	Mutagenesis	413	413	.	.	.	Note=Does not inhibit interaction with MAP3K5. Does not reduce GSK3B-induced beta-catenin transcription activity%2C TNF-alpha-induced apoptosis%2C ARF6-mediated TLR4-TIRAP-MyD88 signaling inhibition%2C Ras and NF-kappa-B activities and tumor development. Does not suppress tumor development%3B when associated with A-728.	
Q5VWQ8	UniProtKB	Mutagenesis	728	728	.	.	.	Note=Inhibits phosphorylation and TNF-alpha-induced MAP3K5 dephosphorylation. Reduces interaction with 14-3-3 proteins%2C AKT1%2C a regulatory p85 subunit%2C MAP3K5%2C RIPK1%2C TRAF2 and TNF-alpha-induced MAP3K5-JNK signaling and apoptosis. Reduces RAS activity. Does not reduce GSK3B-induced beta catenin-mediated transcription activity. Does not reduce NF-kappa-B activity%2C cell invasion%2C epithelial-to-mesenchymal transition (EMT) and tumor development. Does not suppress tumor development%3B when associated with R-413.	
Q5VWQ8	UniProtKB	Mutagenesis	920	929	.	.	.	Note=Reduces interaction with a regulatory p85 subunit of the PI3K complex. Inhibits MAP3K5 active form increase%2C AKT1 active form decrease%2C PI3K-p85 complex activity inhibition and TNF-induced apoptosis.	
Q5VWQ8	UniProtKB	Mutagenesis	935	935	.	.	.	Note=Does not reduce interaction with 14-3-3 proteins.	
Q5VWQ8	UniProtKB	Sequence conflict	482	482	.	.	.	.	
Q5VWQ8	UniProtKB	Sequence conflict	921	921	.	.	.	.	
Q5VWQ8	UniProtKB	Sequence conflict	1091	1092	.	.	.	.	
##sequence-region Q3UHC7 1 1189
Q3UHC7	UniProtKB	Chain	1	1189	.	.	.	ID=PRO_0000252408;Note=Disabled homolog 2-interacting protein	
Q3UHC7	UniProtKB	Domain	101	202	.	.	.	Note=PH	
Q3UHC7	UniProtKB	Domain	200	295	.	.	.	Note=C2	
Q3UHC7	UniProtKB	Domain	371	563	.	.	.	Note=Ras-GAP	
Q3UHC7	UniProtKB	Region	646	943	.	.	.	Note=Necessary for interaction with AKT1;status=By similarity	
Q3UHC7	UniProtKB	Coiled coil	1025	1159	.	.	.	status=Potential	
Q3UHC7	UniProtKB	Compositional bias	8	52	.	.	.	Note=Arg-rich	
Q3UHC7	UniProtKB	Compositional bias	112	117	.	.	.	Note=Poly-Ala	
Q3UHC7	UniProtKB	Compositional bias	867	870	.	.	.	Note=Poly-Ala	
Q3UHC7	UniProtKB	Compositional bias	903	948	.	.	.	Note=Pro-rich	
Q3UHC7	UniProtKB	Modified residue	728	728	.	.	.	Note=Phosphoserine%3B by MAP3K5 and RIPK1;status=By similarity	
Q3UHC7	UniProtKB	Modified residue	978	978	.	.	.	Note=Phosphoserine;status=By similarity	
Q3UHC7	UniProtKB	Alternative sequence	1	124	.	.	.	ID=VSP_020956;Note=In isoform 2.	
Q3UHC7	UniProtKB	Alternative sequence	1	42	.	.	.	ID=VSP_046519;Note=In isoform 4.	
Q3UHC7	UniProtKB	Alternative sequence	990	1040	.	.	.	ID=VSP_020957;Note=In isoform 3.	
Q3UHC7	UniProtKB	Alternative sequence	1157	1189	.	.	.	ID=VSP_046520;Note=In isoform 4.	
Q3UHC7	UniProtKB	Sequence conflict	282	282	.	.	.	.	
Q3UHC7	UniProtKB	Sequence conflict	517	517	.	.	.	.	
Q3UHC7	UniProtKB	Sequence conflict	880	880	.	.	.	.	
Q3UHC7	UniProtKB	Sequence conflict	1058	1058	.	.	.	.	
Q3UHC7	UniProtKB	Sequence conflict	1108	1108	.	.	.	.	
##sequence-region Q6P730 1 996
Q6P730	UniProtKB	Chain	1	996	.	.	.	ID=PRO_0000252409;Note=Disabled homolog 2-interacting protein	
Q6P730	UniProtKB	Domain	7	102	.	.	.	Note=C2	
Q6P730	UniProtKB	Domain	178	370	.	.	.	Note=Ras-GAP	
Q6P730	UniProtKB	Region	453	750	.	.	.	Note=Necessary for interaction with AKT1;status=By similarity	
Q6P730	UniProtKB	Coiled coil	832	966	.	.	.	status=Potential	
Q6P730	UniProtKB	Compositional bias	674	677	.	.	.	Note=Poly-Ala	
Q6P730	UniProtKB	Compositional bias	710	755	.	.	.	Note=Pro-rich	
Q6P730	UniProtKB	Modified residue	535	535	.	.	.	Note=Phosphoserine%3B by MAP3K5 and RIPK1;status=By similarity	
Q6P730	UniProtKB	Modified residue	785	785	.	.	.	Note=Phosphoserine;status=By similarity	
Q6P730	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Loss of GAP activity.	
Q6P730	UniProtKB	Sequence conflict	228	228	.	.	.	.	
Q6P730	UniProtKB	Sequence conflict	238	238	.	.	.	.	
Q6P730	UniProtKB	Sequence conflict	246	246	.	.	.	.	
Q6P730	UniProtKB	Sequence conflict	487	487	.	.	.	.	
##sequence-region P98082 1 770
P98082	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
P98082	UniProtKB	Chain	2	770	.	.	.	ID=PRO_0000079770;Note=Disabled homolog 2	
P98082	UniProtKB	Domain	45	196	.	.	.	Note=PID	
P98082	UniProtKB	Region	230	447	.	.	.	Note=Required for localization to clathrin-coated pits;status=By similarity	
P98082	UniProtKB	Region	604	732	.	.	.	Note=Sufficient for interaction with GRB2;status=By similarity	
P98082	UniProtKB	Region	619	627	.	.	.	Note=Required for interaction with CSK;status=By similarity	
P98082	UniProtKB	Region	649	770	.	.	.	Note=Required for interaction with MYO6;status=By similarity	
P98082	UniProtKB	Region	663	671	.	.	.	Note=Required for interaction with GRB2 and CSK;status=By similarity	
P98082	UniProtKB	Region	709	725	.	.	.	Note=Sufficient for interaction with SH3KBP1 SH3 domain;status=By similarity	
P98082	UniProtKB	Motif	293	295	.	.	.	Note=DPF 1	
P98082	UniProtKB	Motif	298	300	.	.	.	Note=DPF 2	
P98082	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine	
P98082	UniProtKB	Modified residue	326	326	.	.	.	Note=Phosphoserine%3B in mitosis;status=By similarity	
P98082	UniProtKB	Modified residue	328	328	.	.	.	Note=Phosphoserine%3B in mitosis;status=By similarity	
P98082	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphoserine	
P98082	UniProtKB	Modified residue	729	729	.	.	.	Note=Phosphoserine;status=By similarity	
P98082	UniProtKB	Alternative sequence	209	229	.	.	.	ID=VSP_038401;Note=In isoform 3.	
P98082	UniProtKB	Alternative sequence	230	447	.	.	.	ID=VSP_004181;Note=In isoform 2.	
P98082	UniProtKB	Natural variant	586	586	.	.	.	ID=VAR_031705;Dbxref=dbSNP:rs700241	
P98082	UniProtKB	Natural variant	634	634	.	.	.	ID=VAR_050942;Dbxref=dbSNP:rs3733801	
P98082	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Impairs TGF-beta receptor signaling%2C no effect on interaction with SMAD2.	
P98082	UniProtKB	Mutagenesis	684	686	.	.	.	Note=Greatly reduced binding to MYO6.	
P98082	UniProtKB	Mutagenesis	720	720	.	.	.	Note=Abolishes interaction with SH3KBP1.	
P98082	UniProtKB	Sequence conflict	44	47	.	.	.	.	
P98082	UniProtKB	Sequence conflict	82	82	.	.	.	.	
P98082	UniProtKB	Sequence conflict	82	82	.	.	.	.	
P98082	UniProtKB	Sequence conflict	82	82	.	.	.	.	
P98082	UniProtKB	Sequence conflict	82	82	.	.	.	.	
P98082	UniProtKB	Sequence conflict	82	82	.	.	.	.	
P98082	UniProtKB	Sequence conflict	148	148	.	.	.	.	
P98082	UniProtKB	Sequence conflict	197	197	.	.	.	.	
P98082	UniProtKB	Sequence conflict	230	232	.	.	.	.	
P98082	UniProtKB	Sequence conflict	230	232	.	.	.	.	
P98082	UniProtKB	Sequence conflict	275	275	.	.	.	.	
P98082	UniProtKB	Sequence conflict	302	304	.	.	.	.	
P98082	UniProtKB	Sequence conflict	498	498	.	.	.	.	
P98082	UniProtKB	Beta strand	29	31	.	.	.	.	
P98082	UniProtKB	Helix	39	43	.	.	.	.	
P98082	UniProtKB	Turn	44	46	.	.	.	.	
P98082	UniProtKB	Helix	47	55	.	.	.	.	
##sequence-region P43146 1 1447
P43146	UniProtKB	Signal peptide	1	25	.	.	.	status=Potential	
P43146	UniProtKB	Chain	26	1447	.	.	.	ID=PRO_0000014744;Note=Netrin receptor DCC	
P43146	UniProtKB	Topological domain	26	1097	.	.	.	Note=Extracellular;status=Potential	
P43146	UniProtKB	Transmembrane	1098	1122	.	.	.	Note=Helical%3B;status=Potential	
P43146	UniProtKB	Topological domain	1123	1447	.	.	.	Note=Cytoplasmic;status=Potential	
P43146	UniProtKB	Domain	26	135	.	.	.	Note=Ig-like C2-type 1	
P43146	UniProtKB	Domain	139	229	.	.	.	Note=Ig-like C2-type 2	
P43146	UniProtKB	Domain	234	326	.	.	.	Note=Ig-like C2-type 3	
P43146	UniProtKB	Domain	331	416	.	.	.	Note=Ig-like C2-type 4	
P43146	UniProtKB	Domain	429	520	.	.	.	Note=Fibronectin type-III 1	
P43146	UniProtKB	Domain	528	616	.	.	.	Note=Fibronectin type-III 2	
P43146	UniProtKB	Domain	622	714	.	.	.	Note=Fibronectin type-III 3	
P43146	UniProtKB	Domain	726	814	.	.	.	Note=Fibronectin type-III 4	
P43146	UniProtKB	Domain	843	939	.	.	.	Note=Fibronectin type-III 5	
P43146	UniProtKB	Domain	944	1041	.	.	.	Note=Fibronectin type-III 6	
P43146	UniProtKB	Region	1432	1439	.	.	.	Note=Interaction with MYO10	
P43146	UniProtKB	Modified residue	1178	1178	.	.	.	Note=Phosphoserine%3B by MAPK1;status=By similarity	
P43146	UniProtKB	Modified residue	1187	1187	.	.	.	Note=Phosphothreonine%3B by MAPK1;status=By similarity	
P43146	UniProtKB	Modified residue	1267	1267	.	.	.	Note=Phosphoserine%3B by MAPK1;status=By similarity	
P43146	UniProtKB	Glycosylation	94	94	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P43146	UniProtKB	Glycosylation	299	299	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P43146	UniProtKB	Glycosylation	318	318	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P43146	UniProtKB	Glycosylation	478	478	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P43146	UniProtKB	Glycosylation	628	628	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P43146	UniProtKB	Glycosylation	702	702	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P43146	UniProtKB	Disulfide bond	61	117	.	.	.	status=By similarity	
P43146	UniProtKB	Disulfide bond	161	212	.	.	.	status=By similarity	
P43146	UniProtKB	Disulfide bond	261	310	.	.	.	status=By similarity	
P43146	UniProtKB	Disulfide bond	352	400	.	.	.	status=By similarity	
P43146	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_060257;Dbxref=dbSNP:rs9951523	
P43146	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_003909;Note=In a esophageal carcinoma.	
P43146	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_003910;Dbxref=dbSNP:rs2229080	
P43146	UniProtKB	Natural variant	679	679	.	.	.	ID=VAR_060258;Dbxref=dbSNP:rs2271042	
P43146	UniProtKB	Natural variant	759	759	.	.	.	ID=VAR_056043;Dbxref=dbSNP:rs2278339	
P43146	UniProtKB	Natural variant	1017	1017	.	.	.	ID=VAR_024495;Dbxref=dbSNP:rs984274	
P43146	UniProtKB	Natural variant	1039	1039	.	.	.	ID=VAR_035511;Note=In a colorectal cancer sample%3B somatic mutation.	
P43146	UniProtKB	Natural variant	1191	1191	.	.	.	ID=VAR_060259;Dbxref=dbSNP:rs2270950	
P43146	UniProtKB	Natural variant	1375	1375	.	.	.	ID=VAR_003911;Note=In a colorectal carcinoma.	
P43146	UniProtKB	Mutagenesis	1432	1432	.	.	.	Note=Abolishes interaction with MYO10.	
P43146	UniProtKB	Mutagenesis	1435	1436	.	.	.	Note=Abolishes interaction with MYO10.	
P43146	UniProtKB	Mutagenesis	1439	1439	.	.	.	Note=Abolishes interaction with MYO10.	
P43146	UniProtKB	Sequence conflict	951	951	.	.	.	.	
P43146	UniProtKB	Beta strand	425	428	.	.	.	.	
P43146	UniProtKB	Beta strand	436	440	.	.	.	.	
P43146	UniProtKB	Beta strand	445	448	.	.	.	.	
P43146	UniProtKB	Beta strand	459	470	.	.	.	.	
P43146	UniProtKB	Beta strand	475	478	.	.	.	.	
P43146	UniProtKB	Beta strand	486	489	.	.	.	.	
P43146	UniProtKB	Beta strand	494	500	.	.	.	.	
P43146	UniProtKB	Beta strand	503	508	.	.	.	.	
P43146	UniProtKB	Beta strand	517	520	.	.	.	.	
P43146	UniProtKB	Beta strand	532	537	.	.	.	.	
P43146	UniProtKB	Beta strand	543	549	.	.	.	.	
P43146	UniProtKB	Beta strand	560	567	.	.	.	.	
P43146	UniProtKB	Turn	568	570	.	.	.	.	
P43146	UniProtKB	Beta strand	573	578	.	.	.	.	
P43146	UniProtKB	Beta strand	583	587	.	.	.	.	
P43146	UniProtKB	Beta strand	593	601	.	.	.	.	
P43146	UniProtKB	Beta strand	606	609	.	.	.	.	
P43146	UniProtKB	Beta strand	613	616	.	.	.	.	
P43146	UniProtKB	Beta strand	631	635	.	.	.	.	
P43146	UniProtKB	Beta strand	638	642	.	.	.	.	
P43146	UniProtKB	Turn	648	650	.	.	.	.	
P43146	UniProtKB	Beta strand	657	668	.	.	.	.	
P43146	UniProtKB	Beta strand	671	674	.	.	.	.	
P43146	UniProtKB	Beta strand	679	684	.	.	.	.	
P43146	UniProtKB	Beta strand	691	694	.	.	.	.	
P43146	UniProtKB	Beta strand	696	699	.	.	.	.	
P43146	UniProtKB	Beta strand	711	714	.	.	.	.	
P43146	UniProtKB	Beta strand	716	719	.	.	.	.	
P43146	UniProtKB	Beta strand	732	736	.	.	.	.	
P43146	UniProtKB	Beta strand	741	745	.	.	.	.	
P43146	UniProtKB	Beta strand	757	766	.	.	.	.	
P43146	UniProtKB	Beta strand	769	775	.	.	.	.	
P43146	UniProtKB	Beta strand	780	783	.	.	.	.	
P43146	UniProtKB	Beta strand	788	800	.	.	.	.	
P43146	UniProtKB	Beta strand	808	810	.	.	.	.	
P43146	UniProtKB	Beta strand	848	856	.	.	.	.	
P43146	UniProtKB	Beta strand	859	865	.	.	.	.	
P43146	UniProtKB	Beta strand	867	869	.	.	.	.	
P43146	UniProtKB	Beta strand	881	887	.	.	.	.	
P43146	UniProtKB	Beta strand	898	909	.	.	.	.	
P43146	UniProtKB	Beta strand	915	922	.	.	.	.	
P43146	UniProtKB	Beta strand	925	927	.	.	.	.	
P43146	UniProtKB	Beta strand	935	938	.	.	.	.	
P43146	UniProtKB	Beta strand	949	955	.	.	.	.	
P43146	UniProtKB	Beta strand	963	968	.	.	.	.	
P43146	UniProtKB	Beta strand	978	986	.	.	.	.	
P43146	UniProtKB	Beta strand	988	990	.	.	.	.	
P43146	UniProtKB	Turn	992	994	.	.	.	.	
P43146	UniProtKB	Beta strand	995	1001	.	.	.	.	
P43146	UniProtKB	Beta strand	1006	1009	.	.	.	.	
P43146	UniProtKB	Beta strand	1017	1025	.	.	.	.	
P43146	UniProtKB	Beta strand	1037	1040	.	.	.	.	
P43146	UniProtKB	Helix	1415	1421	.	.	.	.	
P43146	UniProtKB	Helix	1425	1443	.	.	.	.	
##sequence-region P70211 1 1447
P70211	UniProtKB	Signal peptide	1	25	.	.	.	status=Potential	
P70211	UniProtKB	Chain	26	1447	.	.	.	ID=PRO_0000014745;Note=Netrin receptor DCC	
P70211	UniProtKB	Topological domain	26	1097	.	.	.	Note=Extracellular;status=Potential	
P70211	UniProtKB	Transmembrane	1098	1122	.	.	.	Note=Helical%3B;status=Potential	
P70211	UniProtKB	Topological domain	1123	1447	.	.	.	Note=Cytoplasmic;status=Potential	
P70211	UniProtKB	Domain	36	135	.	.	.	Note=Ig-like C2-type 1	
P70211	UniProtKB	Domain	139	229	.	.	.	Note=Ig-like C2-type 2	
P70211	UniProtKB	Domain	234	326	.	.	.	Note=Ig-like C2-type 3	
P70211	UniProtKB	Domain	331	416	.	.	.	Note=Ig-like C2-type 4	
P70211	UniProtKB	Domain	429	520	.	.	.	Note=Fibronectin type-III 1	
P70211	UniProtKB	Domain	528	616	.	.	.	Note=Fibronectin type-III 2	
P70211	UniProtKB	Domain	622	714	.	.	.	Note=Fibronectin type-III 3	
P70211	UniProtKB	Domain	726	814	.	.	.	Note=Fibronectin type-III 4	
P70211	UniProtKB	Domain	843	939	.	.	.	Note=Fibronectin type-III 5	
P70211	UniProtKB	Domain	944	1041	.	.	.	Note=Fibronectin type-III 6	
P70211	UniProtKB	Modified residue	1178	1178	.	.	.	Note=Phosphoserine%3B by MAPK1;status=By similarity	
P70211	UniProtKB	Modified residue	1187	1187	.	.	.	Note=Phosphothreonine%3B by MAPK1;status=By similarity	
P70211	UniProtKB	Modified residue	1267	1267	.	.	.	Note=Phosphoserine%3B by MAPK1;status=By similarity	
P70211	UniProtKB	Glycosylation	60	60	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P70211	UniProtKB	Glycosylation	94	94	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P70211	UniProtKB	Glycosylation	299	299	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P70211	UniProtKB	Glycosylation	318	318	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P70211	UniProtKB	Glycosylation	478	478	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P70211	UniProtKB	Glycosylation	628	628	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P70211	UniProtKB	Glycosylation	702	702	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P70211	UniProtKB	Disulfide bond	61	117	.	.	.	status=By similarity	
P70211	UniProtKB	Disulfide bond	161	212	.	.	.	status=By similarity	
P70211	UniProtKB	Disulfide bond	261	310	.	.	.	status=By similarity	
P70211	UniProtKB	Disulfide bond	352	400	.	.	.	status=By similarity	
P70211	UniProtKB	Alternative sequence	1	84	.	.	.	ID=VSP_018807;Note=In isoform B.	
P70211	UniProtKB	Alternative sequence	819	838	.	.	.	ID=VSP_002501;Note=In isoform C.	
P70211	UniProtKB	Sequence conflict	1138	1138	.	.	.	.	
P70211	UniProtKB	Helix	1416	1421	.	.	.	.	
P70211	UniProtKB	Helix	1425	1443	.	.	.	.	
##sequence-region Q63155 1 1445
Q63155	UniProtKB	Signal peptide	1	25	.	.	.	status=Potential	
Q63155	UniProtKB	Chain	26	1445	.	.	.	ID=PRO_0000416246;Note=Netrin receptor DCC	
Q63155	UniProtKB	Transmembrane	1100	1120	.	.	.	Note=Helical%3B;status=Potential	
Q63155	UniProtKB	Domain	26	135	.	.	.	Note=Ig-like C2-type 1	
Q63155	UniProtKB	Domain	139	229	.	.	.	Note=Ig-like C2-type 2	
Q63155	UniProtKB	Domain	234	326	.	.	.	Note=Ig-like C2-type 3	
Q63155	UniProtKB	Domain	331	416	.	.	.	Note=Ig-like C2-type 4	
Q63155	UniProtKB	Domain	429	520	.	.	.	Note=Fibronectin type-III 1	
Q63155	UniProtKB	Domain	528	616	.	.	.	Note=Fibronectin type-III 2	
Q63155	UniProtKB	Domain	622	714	.	.	.	Note=Fibronectin type-III 3	
Q63155	UniProtKB	Domain	726	814	.	.	.	Note=Fibronectin type-III 4	
Q63155	UniProtKB	Domain	843	939	.	.	.	Note=Fibronectin type-III 5	
Q63155	UniProtKB	Domain	944	1041	.	.	.	Note=Fibronectin type-III 6	
Q63155	UniProtKB	Compositional bias	1252	1373	.	.	.	Note=Pro-rich	
Q63155	UniProtKB	Modified residue	1178	1178	.	.	.	Note=Phosphoserine%3B by MAPK1	
Q63155	UniProtKB	Modified residue	1187	1187	.	.	.	Note=Phosphothreonine%3B by MAPK1	
Q63155	UniProtKB	Modified residue	1267	1267	.	.	.	Note=Phosphoserine%3B by MAPK1	
Q63155	UniProtKB	Glycosylation	60	60	.	.	.	Note=N-linked (GlcNAc...)	
Q63155	UniProtKB	Glycosylation	94	94	.	.	.	Note=N-linked (GlcNAc...)	
Q63155	UniProtKB	Glycosylation	299	299	.	.	.	Note=N-linked (GlcNAc...)	
Q63155	UniProtKB	Glycosylation	318	318	.	.	.	Note=N-linked (GlcNAc...)	
Q63155	UniProtKB	Glycosylation	478	478	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q63155	UniProtKB	Glycosylation	628	628	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q63155	UniProtKB	Glycosylation	702	702	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q63155	UniProtKB	Disulfide bond	61	117	.	.	.	.	
Q63155	UniProtKB	Disulfide bond	161	212	.	.	.	.	
Q63155	UniProtKB	Disulfide bond	261	310	.	.	.	.	
Q63155	UniProtKB	Disulfide bond	352	400	.	.	.	.	
Q63155	UniProtKB	Mutagenesis	1178	1178	.	.	.	Note=Abolishes phosphorylation by MAPK1%3B when associated with A-1187 and A-1267.	
Q63155	UniProtKB	Mutagenesis	1187	1187	.	.	.	Note=Abolishes phosphorylation by MAPK1%3B when associated with A-1178 and A-1267.	
Q63155	UniProtKB	Mutagenesis	1267	1267	.	.	.	Note=Abolishes phosphorylation by MAPK1%3B when associated with A-1178 and A-1187.	
Q63155	UniProtKB	Beta strand	39	44	.	.	.	.	
Q63155	UniProtKB	Beta strand	49	51	.	.	.	.	
Q63155	UniProtKB	Beta strand	57	59	.	.	.	.	
Q63155	UniProtKB	Beta strand	62	64	.	.	.	.	
Q63155	UniProtKB	Beta strand	71	76	.	.	.	.	
Q63155	UniProtKB	Beta strand	89	91	.	.	.	.	
Q63155	UniProtKB	Beta strand	97	99	.	.	.	.	
Q63155	UniProtKB	Beta strand	113	120	.	.	.	.	
Q63155	UniProtKB	Helix	122	124	.	.	.	.	
Q63155	UniProtKB	Beta strand	126	128	.	.	.	.	
Q63155	UniProtKB	Beta strand	132	136	.	.	.	.	
Q63155	UniProtKB	Beta strand	149	152	.	.	.	.	
Q63155	UniProtKB	Beta strand	157	159	.	.	.	.	
Q63155	UniProtKB	Beta strand	170	179	.	.	.	.	
Q63155	UniProtKB	Beta strand	188	191	.	.	.	.	
Q63155	UniProtKB	Beta strand	197	199	.	.	.	.	
Q63155	UniProtKB	Helix	204	206	.	.	.	.	
Q63155	UniProtKB	Beta strand	208	215	.	.	.	.	
Q63155	UniProtKB	Beta strand	226	231	.	.	.	.	
Q63155	UniProtKB	Beta strand	238	244	.	.	.	.	
Q63155	UniProtKB	Beta strand	249	252	.	.	.	.	
Q63155	UniProtKB	Beta strand	257	259	.	.	.	.	
Q63155	UniProtKB	Beta strand	262	267	.	.	.	.	
Q63155	UniProtKB	Beta strand	270	275	.	.	.	.	
Q63155	UniProtKB	Beta strand	283	290	.	.	.	.	
Q63155	UniProtKB	Turn	291	293	.	.	.	.	
Q63155	UniProtKB	Beta strand	294	297	.	.	.	.	
Q63155	UniProtKB	Helix	302	304	.	.	.	.	
Q63155	UniProtKB	Beta strand	306	314	.	.	.	.	
Q63155	UniProtKB	Beta strand	317	335	.	.	.	.	
Q63155	UniProtKB	Beta strand	348	350	.	.	.	.	
Q63155	UniProtKB	Beta strand	353	358	.	.	.	.	
Q63155	UniProtKB	Beta strand	361	366	.	.	.	.	
Q63155	UniProtKB	Beta strand	374	380	.	.	.	.	
Q63155	UniProtKB	Turn	381	383	.	.	.	.	
Q63155	UniProtKB	Beta strand	384	389	.	.	.	.	
Q63155	UniProtKB	Helix	392	394	.	.	.	.	
Q63155	UniProtKB	Beta strand	396	404	.	.	.	.	
Q63155	UniProtKB	Beta strand	407	416	.	.	.	.	
##sequence-region Q9P2X7 1 70
Q9P2X7	UniProtKB	Chain	1	70	.	.	.	ID=PRO_0000240631;Note=Deleted in esophageal cancer 1	
Q9P2X7	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_050948;Dbxref=dbSNP:rs2269700	
##sequence-region Q08DM1 1 406
Q08DM1	UniProtKB	Chain	1	406	.	.	.	ID=PRO_0000284659;Note=Dematin	
Q08DM1	UniProtKB	Domain	338	406	.	.	.	Note=HP	
Q08DM1	UniProtKB	Region	225	309	.	.	.	Note=Interaction with RASGRF2;status=By similarity	
Q08DM1	UniProtKB	Compositional bias	217	223	.	.	.	Note=Poly-Glu	
Q08DM1	UniProtKB	Modified residue	96	96	.	.	.	Note=Phosphoserine;status=By similarity	
Q08DM1	UniProtKB	Modified residue	105	105	.	.	.	Note=Phosphoserine;status=By similarity	
Q08DM1	UniProtKB	Modified residue	157	157	.	.	.	Note=Phosphoserine;status=By similarity	
Q08DM1	UniProtKB	Modified residue	227	227	.	.	.	Note=Phosphoserine;status=By similarity	
Q08DM1	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphoserine;status=By similarity	
Q08DM1	UniProtKB	Modified residue	373	373	.	.	.	Note=Phosphoserine;status=By similarity	
Q08DM1	UniProtKB	Modified residue	404	404	.	.	.	Note=Phosphoserine%3B by PKA;status=By similarity	
##sequence-region Q08495 1 405
Q08495	UniProtKB	Chain	1	405	.	.	.	ID=PRO_0000218755;Note=Dematin	
Q08495	UniProtKB	Domain	337	405	.	.	.	Note=HP	
Q08495	UniProtKB	Region	224	308	.	.	.	Note=Interaction with RASGRF2	
Q08495	UniProtKB	Compositional bias	216	222	.	.	.	Note=Poly-Glu	
Q08495	UniProtKB	Modified residue	96	96	.	.	.	Note=Phosphoserine	
Q08495	UniProtKB	Modified residue	105	105	.	.	.	Note=Phosphoserine	
Q08495	UniProtKB	Modified residue	156	156	.	.	.	Note=Phosphoserine	
Q08495	UniProtKB	Modified residue	226	226	.	.	.	Note=Phosphoserine	
Q08495	UniProtKB	Modified residue	333	333	.	.	.	Note=Phosphoserine	
Q08495	UniProtKB	Modified residue	372	372	.	.	.	Note=Phosphoserine	
Q08495	UniProtKB	Modified residue	403	403	.	.	.	Note=Phosphoserine%3B by PKA	
Q08495	UniProtKB	Alternative sequence	7	31	.	.	.	ID=VSP_044803;Note=In isoform 3.	
Q08495	UniProtKB	Alternative sequence	320	341	.	.	.	ID=VSP_004189;Note=In isoform 2 and isoform 3.	
Q08495	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Reduces interaction with plasmodium berghei 14-3-3 protein. Inhibits phosphorylation and interaction with plasmodium berghei 14-3-3 protein%3B when associated with A-333 and A-403.	
Q08495	UniProtKB	Mutagenesis	333	333	.	.	.	Note=Reduces interaction with plasmodium berghei 14-3-3 protein. Inhibits phosphorylation and interaction with plasmodium berghei 14-3-3 protein%3B when associated with A-124 and A-403.	
Q08495	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Inhibits phosphorylation and interaction with plasmodium berghei 14-3-3 protein%3B when associated with A-124 and A-333.	
Q08495	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Reduces F-actin bundling but not F-actin binding activity.	
Q08495	UniProtKB	Sequence conflict	81	81	.	.	.	.	
Q08495	UniProtKB	Sequence conflict	81	81	.	.	.	.	
Q08495	UniProtKB	Sequence conflict	155	155	.	.	.	.	
Q08495	UniProtKB	Sequence conflict	292	292	.	.	.	.	
Q08495	UniProtKB	Sequence conflict	292	292	.	.	.	.	
Q08495	UniProtKB	Sequence conflict	347	347	.	.	.	.	
Q08495	UniProtKB	Sequence conflict	380	380	.	.	.	.	
Q08495	UniProtKB	Sequence conflict	403	403	.	.	.	.	
Q08495	UniProtKB	Turn	346	348	.	.	.	.	
Q08495	UniProtKB	Helix	364	366	.	.	.	.	
Q08495	UniProtKB	Helix	368	370	.	.	.	.	
Q08495	UniProtKB	Helix	373	379	.	.	.	.	
Q08495	UniProtKB	Beta strand	380	382	.	.	.	.	
Q08495	UniProtKB	Helix	384	389	.	.	.	.	
Q08495	UniProtKB	Helix	392	402	.	.	.	.	
##sequence-region Q9WV69 1 405
Q9WV69	UniProtKB	Chain	1	405	.	.	.	ID=PRO_0000218756;Note=Dematin	
Q9WV69	UniProtKB	Domain	337	405	.	.	.	Note=HP	
Q9WV69	UniProtKB	Region	224	308	.	.	.	Note=Interaction with RASGRF2;status=By similarity	
Q9WV69	UniProtKB	Compositional bias	216	222	.	.	.	Note=Poly-Glu	
Q9WV69	UniProtKB	Modified residue	96	96	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV69	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphothreonine	
Q9WV69	UniProtKB	Modified residue	156	156	.	.	.	Note=Phosphoserine	
Q9WV69	UniProtKB	Modified residue	226	226	.	.	.	Note=Phosphoserine	
Q9WV69	UniProtKB	Modified residue	333	333	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV69	UniProtKB	Modified residue	372	372	.	.	.	Note=Phosphoserine	
Q9WV69	UniProtKB	Modified residue	403	403	.	.	.	Note=Phosphoserine%3B by PKA;status=By similarity	
Q9WV69	UniProtKB	Alternative sequence	7	31	.	.	.	ID=VSP_047491;Note=In isoform 3 and isoform 4.	
Q9WV69	UniProtKB	Alternative sequence	320	341	.	.	.	ID=VSP_047492;Note=In isoform 2 and isoform 4.	
##sequence-region Q5R4B6 1 405
Q5R4B6	UniProtKB	Chain	1	405	.	.	.	ID=PRO_0000218757;Note=Dematin	
Q5R4B6	UniProtKB	Domain	337	405	.	.	.	Note=HP	
Q5R4B6	UniProtKB	Region	224	308	.	.	.	Note=Interaction with RASGRF2;status=By similarity	
Q5R4B6	UniProtKB	Compositional bias	216	222	.	.	.	Note=Poly-Glu	
Q5R4B6	UniProtKB	Modified residue	96	96	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4B6	UniProtKB	Modified residue	105	105	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4B6	UniProtKB	Modified residue	156	156	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4B6	UniProtKB	Modified residue	226	226	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4B6	UniProtKB	Modified residue	333	333	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4B6	UniProtKB	Modified residue	372	372	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4B6	UniProtKB	Modified residue	403	403	.	.	.	Note=Phosphoserine%3B by PKA;status=By similarity	
##sequence-region O60443 1 496
O60443	UniProtKB	Chain	1	496	.	.	.	ID=PRO_0000148178;Note=Non-syndromic hearing impairment protein 5	
O60443	UniProtKB	Alternative sequence	1	395	.	.	.	ID=VSP_004190;Note=In isoform 2.	
O60443	UniProtKB	Alternative sequence	1	164	.	.	.	ID=VSP_044276;Note=In isoform 3.	
O60443	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_030824;Dbxref=dbSNP:rs754554	
O60443	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_053102;Dbxref=dbSNP:rs876306	
O60443	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_030825;Dbxref=dbSNP:rs12540919	
##sequence-region P31039 1 665
P31039	UniProtKB	Transit peptide	1	44	.	.	.	Note=Mitochondrion	
P31039	UniProtKB	Chain	45	665	.	.	.	ID=PRO_0000010334;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
P31039	UniProtKB	Nucleotide binding	69	74	.	.	.	Note=FAD;status=By similarity	
P31039	UniProtKB	Nucleotide binding	92	107	.	.	.	Note=FAD;status=By similarity	
P31039	UniProtKB	Nucleotide binding	457	458	.	.	.	Note=FAD;status=By similarity	
P31039	UniProtKB	Active site	341	341	.	.	.	Note=Proton acceptor;status=By similarity	
P31039	UniProtKB	Binding site	276	276	.	.	.	Note=FAD;status=By similarity	
P31039	UniProtKB	Binding site	297	297	.	.	.	Note=Substrate;status=By similarity	
P31039	UniProtKB	Binding site	309	309	.	.	.	Note=Substrate;status=By similarity	
P31039	UniProtKB	Binding site	408	408	.	.	.	Note=Substrate;status=By similarity	
P31039	UniProtKB	Binding site	441	441	.	.	.	Note=FAD;status=By similarity	
P31039	UniProtKB	Binding site	452	452	.	.	.	Note=Substrate;status=By similarity	
P31039	UniProtKB	Modified residue	100	100	.	.	.	Note=Tele-8alpha-FAD histidine;status=By similarity	
P31039	UniProtKB	Modified residue	168	168	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	180	180	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	183	183	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	216	216	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
P31039	UniProtKB	Modified residue	336	336	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	499	499	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	518	518	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	539	539	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	609	609	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Modified residue	637	637	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31039	UniProtKB	Sequence conflict	242	253	.	.	.	.	
##sequence-region P31040 1 664
P31040	UniProtKB	Transit peptide	1	43	.	.	.	Note=Mitochondrion;status=By similarity	
P31040	UniProtKB	Chain	44	664	.	.	.	ID=PRO_0000010335;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
P31040	UniProtKB	Nucleotide binding	68	73	.	.	.	Note=FAD;status=By similarity	
P31040	UniProtKB	Nucleotide binding	91	106	.	.	.	Note=FAD;status=By similarity	
P31040	UniProtKB	Nucleotide binding	456	457	.	.	.	Note=FAD;status=By similarity	
P31040	UniProtKB	Active site	340	340	.	.	.	Note=Proton acceptor;status=By similarity	
P31040	UniProtKB	Binding site	275	275	.	.	.	Note=FAD;status=By similarity	
P31040	UniProtKB	Binding site	296	296	.	.	.	Note=Substrate;status=By similarity	
P31040	UniProtKB	Binding site	308	308	.	.	.	Note=Substrate;status=By similarity	
P31040	UniProtKB	Binding site	407	407	.	.	.	Note=Substrate;status=By similarity	
P31040	UniProtKB	Binding site	440	440	.	.	.	Note=FAD;status=By similarity	
P31040	UniProtKB	Binding site	451	451	.	.	.	Note=Substrate;status=By similarity	
P31040	UniProtKB	Modified residue	99	99	.	.	.	Note=Tele-8alpha-FAD histidine;status=By similarity	
P31040	UniProtKB	Modified residue	167	167	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Modified residue	179	179	.	.	.	Note=N6-acetyllysine	
P31040	UniProtKB	Modified residue	182	182	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Modified residue	215	215	.	.	.	Note=Phosphotyrosine%3B by SRC	
P31040	UniProtKB	Modified residue	335	335	.	.	.	Note=N6-acetyllysine	
P31040	UniProtKB	Modified residue	498	498	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Modified residue	517	517	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Modified residue	538	538	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Modified residue	541	541	.	.	.	Note=N6-acetyllysine	
P31040	UniProtKB	Modified residue	547	547	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Modified residue	608	608	.	.	.	Note=N6-acetyllysine	
P31040	UniProtKB	Modified residue	636	636	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Modified residue	647	647	.	.	.	Note=N6-acetyllysine;status=By similarity	
P31040	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_049214;Dbxref=dbSNP:rs1061518	
P31040	UniProtKB	Natural variant	38	38	.	.	.	ID=VAR_049215;Dbxref=dbSNP:rs34635677	
P31040	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_049216;Dbxref=dbSNP:rs1041946	
P31040	UniProtKB	Natural variant	333	333	.	.	.	ID=VAR_059307;Dbxref=dbSNP:rs1062468	
P31040	UniProtKB	Natural variant	524	524	.	.	.	ID=VAR_016878;Note=In LS.	
P31040	UniProtKB	Natural variant	554	554	.	.	.	ID=VAR_002449;Note=In LS.	
P31040	UniProtKB	Natural variant	555	555	.	.	.	ID=VAR_016879;Note=In MT-C2D and CMD1GG.	
P31040	UniProtKB	Natural variant	589	589	.	.	.	ID=VAR_065975;Note=In PGL5%3B loss of activity.	
P31040	UniProtKB	Natural variant	657	657	.	.	.	ID=VAR_049217;Dbxref=dbSNP:rs6962	
P31040	UniProtKB	Sequence conflict	356	356	.	.	.	.	
P31040	UniProtKB	Sequence conflict	398	398	.	.	.	.	
P31040	UniProtKB	Sequence conflict	591	591	.	.	.	.	
P31040	UniProtKB	Sequence conflict	596	596	.	.	.	.	
P31040	UniProtKB	Sequence conflict	600	600	.	.	.	.	
P31040	UniProtKB	Sequence conflict	629	629	.	.	.	.	
P31040	UniProtKB	Sequence conflict	640	640	.	.	.	.	
##sequence-region Q8HXW3 1 664
Q8HXW3	UniProtKB	Transit peptide	1	43	.	.	.	Note=Mitochondrion;status=By similarity	
Q8HXW3	UniProtKB	Chain	44	664	.	.	.	ID=PRO_0000010336;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
Q8HXW3	UniProtKB	Nucleotide binding	68	73	.	.	.	Note=FAD;status=By similarity	
Q8HXW3	UniProtKB	Nucleotide binding	91	106	.	.	.	Note=FAD;status=By similarity	
Q8HXW3	UniProtKB	Nucleotide binding	456	457	.	.	.	Note=FAD;status=By similarity	
Q8HXW3	UniProtKB	Active site	340	340	.	.	.	Note=Proton acceptor;status=By similarity	
Q8HXW3	UniProtKB	Binding site	275	275	.	.	.	Note=FAD;status=By similarity	
Q8HXW3	UniProtKB	Binding site	296	296	.	.	.	Note=Substrate;status=By similarity	
Q8HXW3	UniProtKB	Binding site	308	308	.	.	.	Note=Substrate;status=By similarity	
Q8HXW3	UniProtKB	Binding site	407	407	.	.	.	Note=Substrate;status=By similarity	
Q8HXW3	UniProtKB	Binding site	440	440	.	.	.	Note=FAD;status=By similarity	
Q8HXW3	UniProtKB	Binding site	451	451	.	.	.	Note=Substrate;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	99	99	.	.	.	Note=Tele-8alpha-FAD histidine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	167	167	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	179	179	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	182	182	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	215	215	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	335	335	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	498	498	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	517	517	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	538	538	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	541	541	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	547	547	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	608	608	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	636	636	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8HXW3	UniProtKB	Modified residue	647	647	.	.	.	Note=N6-acetyllysine;status=By similarity	
##sequence-region Q0QF17 1 551
Q0QF17	UniProtKB	Chain	1	551	.	.	.	ID=PRO_0000394746;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
Q0QF17	UniProtKB	Nucleotide binding	10	15	.	.	.	Note=FAD;status=By similarity	
Q0QF17	UniProtKB	Nucleotide binding	33	48	.	.	.	Note=FAD;status=By similarity	
Q0QF17	UniProtKB	Nucleotide binding	398	399	.	.	.	Note=FAD;status=By similarity	
Q0QF17	UniProtKB	Active site	282	282	.	.	.	Note=Proton acceptor;status=By similarity	
Q0QF17	UniProtKB	Binding site	217	217	.	.	.	Note=FAD;status=By similarity	
Q0QF17	UniProtKB	Binding site	238	238	.	.	.	Note=Substrate;status=By similarity	
Q0QF17	UniProtKB	Binding site	250	250	.	.	.	Note=Substrate;status=By similarity	
Q0QF17	UniProtKB	Binding site	349	349	.	.	.	Note=Substrate;status=By similarity	
Q0QF17	UniProtKB	Binding site	382	382	.	.	.	Note=FAD;status=By similarity	
Q0QF17	UniProtKB	Binding site	393	393	.	.	.	Note=Substrate;status=By similarity	
Q0QF17	UniProtKB	Modified residue	41	41	.	.	.	Note=Tele-8alpha-FAD histidine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	109	109	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	121	121	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	124	124	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	157	157	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q0QF17	UniProtKB	Modified residue	277	277	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	365	365	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	440	440	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	459	459	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	480	480	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Modified residue	489	489	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF17	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q0QF17	UniProtKB	Non-terminal residue	551	551	.	.	.	.	
##sequence-region Q8K2B3 1 664
Q8K2B3	UniProtKB	Transit peptide	1	43	.	.	.	Note=Mitochondrion;status=By similarity	
Q8K2B3	UniProtKB	Chain	44	664	.	.	.	ID=PRO_0000010337;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
Q8K2B3	UniProtKB	Nucleotide binding	68	73	.	.	.	Note=FAD;status=By similarity	
Q8K2B3	UniProtKB	Nucleotide binding	91	106	.	.	.	Note=FAD;status=By similarity	
Q8K2B3	UniProtKB	Nucleotide binding	456	457	.	.	.	Note=FAD;status=By similarity	
Q8K2B3	UniProtKB	Active site	340	340	.	.	.	Note=Proton acceptor;status=By similarity	
Q8K2B3	UniProtKB	Binding site	275	275	.	.	.	Note=FAD;status=By similarity	
Q8K2B3	UniProtKB	Binding site	296	296	.	.	.	Note=Substrate;status=By similarity	
Q8K2B3	UniProtKB	Binding site	308	308	.	.	.	Note=Substrate;status=By similarity	
Q8K2B3	UniProtKB	Binding site	407	407	.	.	.	Note=Substrate;status=By similarity	
Q8K2B3	UniProtKB	Binding site	440	440	.	.	.	Note=FAD;status=By similarity	
Q8K2B3	UniProtKB	Binding site	451	451	.	.	.	Note=Substrate;status=By similarity	
Q8K2B3	UniProtKB	Modified residue	99	99	.	.	.	Note=Tele-8alpha-FAD histidine;status=By similarity	
Q8K2B3	UniProtKB	Modified residue	167	167	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	179	179	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	182	182	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	215	215	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q8K2B3	UniProtKB	Modified residue	335	335	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	423	423	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	498	498	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	517	517	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	538	538	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	547	547	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	608	608	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	636	636	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Modified residue	647	647	.	.	.	Note=N6-acetyllysine	
Q8K2B3	UniProtKB	Sequence conflict	69	69	.	.	.	.	
Q8K2B3	UniProtKB	Sequence conflict	246	246	.	.	.	.	
Q8K2B3	UniProtKB	Sequence conflict	428	428	.	.	.	.	
Q8K2B3	UniProtKB	Sequence conflict	501	501	.	.	.	.	
Q8K2B3	UniProtKB	Sequence conflict	517	517	.	.	.	.	
Q8K2B3	UniProtKB	Sequence conflict	571	571	.	.	.	.	
##sequence-region Q0QF01 1 664
Q0QF01	UniProtKB	Transit peptide	1	42	.	.	.	Note=Mitochondrion	
Q0QF01	UniProtKB	Chain	43	664	.	.	.	ID=PRO_0000391718;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
Q0QF01	UniProtKB	Nucleotide binding	68	73	.	.	.	Note=FAD	
Q0QF01	UniProtKB	Nucleotide binding	91	106	.	.	.	Note=FAD	
Q0QF01	UniProtKB	Nucleotide binding	456	457	.	.	.	Note=FAD	
Q0QF01	UniProtKB	Binding site	275	275	.	.	.	Note=FAD	
Q0QF01	UniProtKB	Binding site	296	296	.	.	.	Note=Substrate	
Q0QF01	UniProtKB	Binding site	308	308	.	.	.	Note=Substrate	
Q0QF01	UniProtKB	Binding site	407	407	.	.	.	Note=Substrate	
Q0QF01	UniProtKB	Binding site	440	440	.	.	.	Note=FAD	
Q0QF01	UniProtKB	Binding site	451	451	.	.	.	Note=Substrate	
Q0QF01	UniProtKB	Modified residue	99	99	.	.	.	Note=Tele-8alpha-FAD histidine	
Q0QF01	UniProtKB	Modified residue	167	167	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	179	179	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	182	182	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	215	215	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q0QF01	UniProtKB	Modified residue	335	335	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	498	498	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	517	517	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	538	538	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	608	608	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	636	636	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Modified residue	647	647	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q0QF01	UniProtKB	Sequence conflict	165	171	.	.	.	.	
Q0QF01	UniProtKB	Sequence conflict	222	222	.	.	.	.	
Q0QF01	UniProtKB	Sequence conflict	235	235	.	.	.	.	
Q0QF01	UniProtKB	Sequence conflict	358	358	.	.	.	.	
Q0QF01	UniProtKB	Sequence conflict	453	453	.	.	.	.	
Q0QF01	UniProtKB	Sequence conflict	509	509	.	.	.	.	
Q0QF01	UniProtKB	Sequence conflict	566	566	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	57	61	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	63	67	.	.	.	.	
Q0QF01	UniProtKB	Helix	71	82	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	87	93	.	.	.	.	
Q0QF01	UniProtKB	Helix	95	97	.	.	.	.	
Q0QF01	UniProtKB	Helix	99	102	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	113	115	.	.	.	.	
Q0QF01	UniProtKB	Helix	119	129	.	.	.	.	
Q0QF01	UniProtKB	Turn	130	132	.	.	.	.	
Q0QF01	UniProtKB	Helix	136	156	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	166	168	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	170	178	.	.	.	.	
Q0QF01	UniProtKB	Turn	179	182	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	185	190	.	.	.	.	
Q0QF01	UniProtKB	Helix	196	208	.	.	.	.	
Q0QF01	UniProtKB	Turn	209	212	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	214	217	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	219	227	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	230	238	.	.	.	.	
Q0QF01	UniProtKB	Turn	239	241	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	244	248	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	250	254	.	.	.	.	
Q0QF01	UniProtKB	Helix	260	262	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	263	268	.	.	.	.	
Q0QF01	UniProtKB	Helix	275	282	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	287	289	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	293	297	.	.	.	.	
Q0QF01	UniProtKB	Turn	301	303	.	.	.	.	
Q0QF01	UniProtKB	Helix	310	314	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	317	319	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	323	325	.	.	.	.	
Q0QF01	UniProtKB	Turn	327	329	.	.	.	.	
Q0QF01	UniProtKB	Turn	332	336	.	.	.	.	
Q0QF01	UniProtKB	Helix	340	353	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	357	361	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	365	367	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	369	371	.	.	.	.	
Q0QF01	UniProtKB	Helix	375	378	.	.	.	.	
Q0QF01	UniProtKB	Helix	381	391	.	.	.	.	
Q0QF01	UniProtKB	Turn	395	397	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	398	402	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	405	409	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	412	415	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	419	425	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	428	437	.	.	.	.	
Q0QF01	UniProtKB	Helix	439	441	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	442	444	.	.	.	.	
Q0QF01	UniProtKB	Helix	456	474	.	.	.	.	
Q0QF01	UniProtKB	Turn	486	489	.	.	.	.	
Q0QF01	UniProtKB	Helix	490	500	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	505	507	.	.	.	.	
Q0QF01	UniProtKB	Helix	508	522	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	523	527	.	.	.	.	
Q0QF01	UniProtKB	Helix	529	545	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	548	550	.	.	.	.	
Q0QF01	UniProtKB	Helix	560	584	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	587	589	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	594	596	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	610	613	.	.	.	.	
Q0QF01	UniProtKB	Helix	618	620	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	624	628	.	.	.	.	
Q0QF01	UniProtKB	Turn	632	634	.	.	.	.	
Q0QF01	UniProtKB	Beta strand	639	643	.	.	.	.	
Q0QF01	UniProtKB	Turn	651	653	.	.	.	.	
##sequence-region Q5R616 1 664
Q5R616	UniProtKB	Transit peptide	1	43	.	.	.	Note=Mitochondrion;status=By similarity	
Q5R616	UniProtKB	Chain	44	664	.	.	.	ID=PRO_0000272304;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
Q5R616	UniProtKB	Nucleotide binding	68	73	.	.	.	Note=FAD;status=By similarity	
Q5R616	UniProtKB	Nucleotide binding	91	106	.	.	.	Note=FAD;status=By similarity	
Q5R616	UniProtKB	Nucleotide binding	456	457	.	.	.	Note=FAD;status=By similarity	
Q5R616	UniProtKB	Active site	340	340	.	.	.	Note=Proton acceptor;status=By similarity	
Q5R616	UniProtKB	Binding site	275	275	.	.	.	Note=FAD;status=By similarity	
Q5R616	UniProtKB	Binding site	296	296	.	.	.	Note=Substrate;status=By similarity	
Q5R616	UniProtKB	Binding site	308	308	.	.	.	Note=Substrate;status=By similarity	
Q5R616	UniProtKB	Binding site	407	407	.	.	.	Note=Substrate;status=By similarity	
Q5R616	UniProtKB	Binding site	440	440	.	.	.	Note=FAD;status=By similarity	
Q5R616	UniProtKB	Binding site	451	451	.	.	.	Note=Substrate;status=By similarity	
Q5R616	UniProtKB	Modified residue	99	99	.	.	.	Note=Tele-8alpha-FAD histidine;status=By similarity	
Q5R616	UniProtKB	Modified residue	167	167	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	179	179	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	182	182	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	215	215	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q5R616	UniProtKB	Modified residue	335	335	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	498	498	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	517	517	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	538	538	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	541	541	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	547	547	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	608	608	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	636	636	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q5R616	UniProtKB	Modified residue	647	647	.	.	.	Note=N6-acetyllysine;status=By similarity	
##sequence-region Q920L2 1 656
Q920L2	UniProtKB	Transit peptide	1	35	.	.	.	Note=Mitochondrion;status=By similarity	
Q920L2	UniProtKB	Chain	36	656	.	.	.	ID=PRO_0000010338;Note=Succinate dehydrogenase [ubiquinone] flavoprotein subunit%2C mitochondrial	
Q920L2	UniProtKB	Nucleotide binding	60	65	.	.	.	Note=FAD;status=By similarity	
Q920L2	UniProtKB	Nucleotide binding	83	98	.	.	.	Note=FAD;status=By similarity	
Q920L2	UniProtKB	Nucleotide binding	448	449	.	.	.	Note=FAD;status=By similarity	
Q920L2	UniProtKB	Active site	332	332	.	.	.	Note=Proton acceptor;status=By similarity	
Q920L2	UniProtKB	Binding site	267	267	.	.	.	Note=FAD;status=By similarity	
Q920L2	UniProtKB	Binding site	288	288	.	.	.	Note=Substrate;status=By similarity	
Q920L2	UniProtKB	Binding site	300	300	.	.	.	Note=Substrate;status=By similarity	
Q920L2	UniProtKB	Binding site	399	399	.	.	.	Note=Substrate;status=By similarity	
Q920L2	UniProtKB	Binding site	432	432	.	.	.	Note=FAD;status=By similarity	
Q920L2	UniProtKB	Binding site	443	443	.	.	.	Note=Substrate;status=By similarity	
Q920L2	UniProtKB	Modified residue	91	91	.	.	.	Note=Tele-8alpha-FAD histidine;status=By similarity	
Q920L2	UniProtKB	Modified residue	171	171	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	174	174	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	207	207	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q920L2	UniProtKB	Modified residue	327	327	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	415	415	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	490	490	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	509	509	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	530	530	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	600	600	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	628	628	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q920L2	UniProtKB	Modified residue	639	639	.	.	.	Note=N6-acetyllysine;status=By similarity	
##sequence-region Q8IYB7 1 885
Q8IYB7	UniProtKB	Chain	1	885	.	.	.	ID=PRO_0000314817;Note=DIS3-like exonuclease 2	
Q8IYB7	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine	
Q8IYB7	UniProtKB	Modified residue	252	252	.	.	.	Note=N6-acetyllysine	
Q8IYB7	UniProtKB	Modified residue	875	875	.	.	.	Note=Phosphoserine;status=By similarity	
Q8IYB7	UniProtKB	Alternative sequence	201	356	.	.	.	ID=VSP_030371;Note=In isoform 5.	
Q8IYB7	UniProtKB	Alternative sequence	236	249	.	.	.	ID=VSP_030372;Note=In isoform 4.	
Q8IYB7	UniProtKB	Alternative sequence	250	885	.	.	.	ID=VSP_030373;Note=In isoform 4.	
Q8IYB7	UniProtKB	Alternative sequence	357	885	.	.	.	ID=VSP_030374;Note=In isoform 5.	
Q8IYB7	UniProtKB	Alternative sequence	528	603	.	.	.	ID=VSP_030375;Note=In isoform 3.	
Q8IYB7	UniProtKB	Alternative sequence	581	619	.	.	.	ID=VSP_030376;Note=In isoform 2.	
Q8IYB7	UniProtKB	Alternative sequence	604	885	.	.	.	ID=VSP_030377;Note=In isoform 3.	
Q8IYB7	UniProtKB	Alternative sequence	620	885	.	.	.	ID=VSP_030378;Note=In isoform 2.	
Q8IYB7	UniProtKB	Natural variant	12	12	.	.	.	ID=VAR_038059;Dbxref=dbSNP:rs723044	
Q8IYB7	UniProtKB	Natural variant	483	483	.	.	.	ID=VAR_067577;Dbxref=dbSNP:rs186865544;Note=Probable disease-associated mutation found in a patient with Wilms tumor%3B does not suppress anchorage-independent cell growth.	
Q8IYB7	UniProtKB	Natural variant	489	489	.	.	.	ID=VAR_067578;Note=In PRLMNS.	
Q8IYB7	UniProtKB	Natural variant	576	576	.	.	.	ID=VAR_067579;Note=Probable disease-associated mutation found in a patient with Wilms tumor%3B does not suppress anchorage-independent cell growth.	
Q8IYB7	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Loss of exoribonuclease activity.	
Q8IYB7	UniProtKB	Sequence conflict	16	16	.	.	.	.	
Q8IYB7	UniProtKB	Sequence conflict	16	16	.	.	.	.	
Q8IYB7	UniProtKB	Sequence conflict	96	96	.	.	.	.	
##sequence-region Q8CI75 1 870
Q8CI75	UniProtKB	Chain	1	870	.	.	.	ID=PRO_0000314818;Note=DIS3-like exonuclease 2	
Q8CI75	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine;status=By similarity	
Q8CI75	UniProtKB	Modified residue	250	250	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8CI75	UniProtKB	Modified residue	864	864	.	.	.	Note=Phosphoserine	
Q8CI75	UniProtKB	Alternative sequence	122	122	.	.	.	ID=VSP_030379;Note=In isoform 2.	
Q8CI75	UniProtKB	Mutagenesis	389	389	.	.	.	Note=Loss of exoribonuclease activity.	
##sequence-region Q0V9R3 1 834
Q0V9R3	UniProtKB	Chain	1	834	.	.	.	ID=PRO_0000314819;Note=DIS3-like exonuclease 2	
Q0V9R3	UniProtKB	Sequence conflict	606	606	.	.	.	.	
##sequence-region Q9Y238 1 1755
Q9Y238	UniProtKB	Chain	1	1755	.	.	.	ID=PRO_0000079929;Note=Deleted in lung and esophageal cancer protein 1	
Q9Y238	UniProtKB	Alternative sequence	704	704	.	.	.	ID=VSP_051847;Note=In isoform 2.	
Q9Y238	UniProtKB	Alternative sequence	856	885	.	.	.	ID=VSP_051848;Note=In isoform 2.	
Q9Y238	UniProtKB	Alternative sequence	886	1755	.	.	.	ID=VSP_051849;Note=In isoform 2.	
Q9Y238	UniProtKB	Alternative sequence	1675	1755	.	.	.	ID=VSP_051850;Note=In isoform 3.	
Q9Y238	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_056860;Dbxref=dbSNP:rs7625806	
Q9Y238	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_056861;Dbxref=dbSNP:rs34012183	
Q9Y238	UniProtKB	Natural variant	351	351	.	.	.	ID=VAR_035908;Note=In a breast cancer sample%3B somatic mutation.	
Q9Y238	UniProtKB	Natural variant	1022	1022	.	.	.	ID=VAR_056862;Dbxref=dbSNP:rs36012922	
Q9Y238	UniProtKB	Natural variant	1150	1150	.	.	.	ID=VAR_056863;Dbxref=dbSNP:rs9840172	
Q9Y238	UniProtKB	Natural variant	1227	1227	.	.	.	ID=VAR_056864;Dbxref=dbSNP:rs9810085	
Q9Y238	UniProtKB	Sequence conflict	704	704	.	.	.	.	
Q9Y238	UniProtKB	Sequence conflict	1442	1442	.	.	.	.	
Q9Y238	UniProtKB	Sequence conflict	1442	1442	.	.	.	.	
##sequence-region Q8BLA1 1 635
Q8BLA1	UniProtKB	Chain	1	635	.	.	.	ID=PRO_0000079930;Note=Deleted in lung and esophageal cancer protein 1 homolog	
##sequence-region Q68FQ8 1 465
Q68FQ8	UniProtKB	Chain	1	465	.	.	.	ID=PRO_0000079931;Note=Deleted in lung and esophageal cancer protein 1 homolog	
##sequence-region Q9UGM3 1 2413
Q9UGM3	UniProtKB	Signal peptide	1	19	.	.	.	status=Potential	
Q9UGM3	UniProtKB	Chain	20	2413	.	.	.	ID=PRO_0000045387;Note=Deleted in malignant brain tumors 1 protein	
Q9UGM3	UniProtKB	Domain	102	202	.	.	.	Note=SRCR 1	
Q9UGM3	UniProtKB	Domain	234	334	.	.	.	Note=SRCR 2	
Q9UGM3	UniProtKB	Domain	363	463	.	.	.	Note=SRCR 3	
Q9UGM3	UniProtKB	Domain	494	594	.	.	.	Note=SRCR 4	
Q9UGM3	UniProtKB	Domain	602	702	.	.	.	Note=SRCR 5	
Q9UGM3	UniProtKB	Domain	733	833	.	.	.	Note=SRCR 6	
Q9UGM3	UniProtKB	Domain	862	962	.	.	.	Note=SRCR 7	
Q9UGM3	UniProtKB	Domain	993	1093	.	.	.	Note=SRCR 8	
Q9UGM3	UniProtKB	Domain	1122	1222	.	.	.	Note=SRCR 9	
Q9UGM3	UniProtKB	Domain	1251	1351	.	.	.	Note=SRCR 10	
Q9UGM3	UniProtKB	Domain	1380	1480	.	.	.	Note=SRCR 11	
Q9UGM3	UniProtKB	Domain	1509	1609	.	.	.	Note=SRCR 12	
Q9UGM3	UniProtKB	Domain	1640	1740	.	.	.	Note=SRCR 13	
Q9UGM3	UniProtKB	Domain	1766	1877	.	.	.	Note=CUB 1	
Q9UGM3	UniProtKB	Domain	1883	1986	.	.	.	Note=SRCR 14	
Q9UGM3	UniProtKB	Domain	2008	2117	.	.	.	Note=CUB 2	
Q9UGM3	UniProtKB	Domain	2126	2381	.	.	.	Note=ZP	
Q9UGM3	UniProtKB	Compositional bias	1755	1759	.	.	.	Note=Poly-Thr	
Q9UGM3	UniProtKB	Glycosylation	566	566	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	737	737	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	1712	1712	.	.	.	Note=N-linked (GlcNAc...)	
Q9UGM3	UniProtKB	Glycosylation	1745	1745	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	1818	1818	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	1832	1832	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	1842	1842	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	1889	1889	.	.	.	Note=N-linked (GlcNAc...)	
Q9UGM3	UniProtKB	Glycosylation	1998	1998	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	2120	2120	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	2188	2188	.	.	.	Note=N-linked (GlcNAc...)	
Q9UGM3	UniProtKB	Glycosylation	2233	2233	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	2240	2240	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Glycosylation	2256	2256	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9UGM3	UniProtKB	Disulfide bond	127	191	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	140	201	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	171	181	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	259	323	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	272	333	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	303	313	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	388	452	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	401	462	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	432	442	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	519	583	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	532	593	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	563	573	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	627	691	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	640	701	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	671	681	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	758	822	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	771	832	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	802	812	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	887	951	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	900	961	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	931	941	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1018	1082	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1031	1092	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1062	1072	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1147	1211	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1160	1221	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1191	1201	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1276	1340	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1289	1350	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1320	1330	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1405	1469	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1418	1479	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1449	1459	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1534	1598	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1547	1608	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1578	1588	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1665	1729	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1678	1739	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1709	1719	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1766	1792	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1819	1841	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1911	1975	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1924	1985	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	1955	1965	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	2008	2034	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	2059	2081	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Disulfide bond	2302	2360	.	.	.	status=By similarity	
Q9UGM3	UniProtKB	Alternative sequence	337	835	.	.	.	ID=VSP_016846;Note=In isoform 2.	
Q9UGM3	UniProtKB	Alternative sequence	464	473	.	.	.	ID=VSP_016847;Note=In isoform 3 and isoform 7.	
Q9UGM3	UniProtKB	Alternative sequence	472	478	.	.	.	ID=VSP_034653;Note=In isoform 8.	
Q9UGM3	UniProtKB	Alternative sequence	479	971	.	.	.	ID=VSP_034654;Note=In isoform 8.	
Q9UGM3	UniProtKB	Alternative sequence	523	1408	.	.	.	ID=VSP_016848;Note=In isoform 4.	
Q9UGM3	UniProtKB	Alternative sequence	1099	1356	.	.	.	ID=VSP_034655;Note=In isoform 8.	
Q9UGM3	UniProtKB	Alternative sequence	1169	1169	.	.	.	ID=VSP_034656;Note=In isoform 6 and isoform 7.	
Q9UGM3	UniProtKB	Alternative sequence	1170	1298	.	.	.	ID=VSP_016849;Note=In isoform 2.	
Q9UGM3	UniProtKB	Alternative sequence	1741	1761	.	.	.	ID=VSP_016850;Note=In isoform 5.	
Q9UGM3	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_024788;Dbxref=dbSNP:rs11523871	
Q9UGM3	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_024789;Dbxref=dbSNP:rs75209396	
Q9UGM3	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_024790;Dbxref=dbSNP:rs3013236	
Q9UGM3	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_024791	
Q9UGM3	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_024792;Dbxref=dbSNP:rs185045706	
Q9UGM3	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_057981;Note=In a glioma cell line.	
Q9UGM3	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_044417;Dbxref=dbSNP:rs1969620	
Q9UGM3	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_024793	
Q9UGM3	UniProtKB	Natural variant	357	357	.	.	.	ID=VAR_024794	
Q9UGM3	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_024795	
Q9UGM3	UniProtKB	Natural variant	420	420	.	.	.	ID=VAR_024796;Note=In a glioma sample%3B glioblastoma multiforme%3B somatic mutation.	
Q9UGM3	UniProtKB	Natural variant	546	546	.	.	.	ID=VAR_057982;Note=In a glioma cell line.	
Q9UGM3	UniProtKB	Natural variant	607	607	.	.	.	ID=VAR_024797;Note=In a glioma sample%3B pilocytic astrocytoma.	
Q9UGM3	UniProtKB	Natural variant	649	649	.	.	.	ID=VAR_024798;Dbxref=dbSNP:rs189478437	
Q9UGM3	UniProtKB	Natural variant	656	656	.	.	.	ID=VAR_024799	
Q9UGM3	UniProtKB	Natural variant	670	670	.	.	.	ID=VAR_052994;Dbxref=dbSNP:rs2277237	
Q9UGM3	UniProtKB	Natural variant	719	719	.	.	.	ID=VAR_052995;Dbxref=dbSNP:rs2277238	
Q9UGM3	UniProtKB	Natural variant	780	780	.	.	.	ID=VAR_024800	
Q9UGM3	UniProtKB	Natural variant	856	856	.	.	.	ID=VAR_024801;Dbxref=dbSNP:rs2277240	
Q9UGM3	UniProtKB	Natural variant	1084	1084	.	.	.	ID=VAR_024802;Dbxref=dbSNP:rs2277244	
Q9UGM3	UniProtKB	Natural variant	1095	1095	.	.	.	ID=VAR_057983	
Q9UGM3	UniProtKB	Natural variant	1102	1102	.	.	.	ID=VAR_057984	
Q9UGM3	UniProtKB	Natural variant	1169	1169	.	.	.	ID=VAR_024803;Dbxref=dbSNP:rs3758437	
Q9UGM3	UniProtKB	Natural variant	1176	1176	.	.	.	ID=VAR_024804	
Q9UGM3	UniProtKB	Natural variant	1434	1434	.	.	.	ID=VAR_057985	
Q9UGM3	UniProtKB	Natural variant	1545	1545	.	.	.	ID=VAR_024805;Dbxref=dbSNP:rs189221852	
Q9UGM3	UniProtKB	Natural variant	1732	1732	.	.	.	ID=VAR_024806;Note=Requires 2 nucleotide substitutions.	
Q9UGM3	UniProtKB	Natural variant	1860	1860	.	.	.	ID=VAR_044418;Dbxref=dbSNP:rs7099177	
Q9UGM3	UniProtKB	Natural variant	1961	1961	.	.	.	ID=VAR_024807	
Q9UGM3	UniProtKB	Natural variant	2255	2255	.	.	.	ID=VAR_057986;Dbxref=dbSNP:rs183135544	
Q9UGM3	UniProtKB	Sequence conflict	10	10	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	31	31	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	42	42	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	42	42	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	74	74	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	125	125	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	468	468	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	594	594	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	603	603	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	711	711	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	902	902	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1034	1034	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1034	1034	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1060	1060	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1069	1069	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1069	1069	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1159	1159	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1204	1204	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1271	1271	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1295	1295	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1336	1336	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1411	1411	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1432	1432	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1443	1443	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1448	1448	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1482	1482	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1583	1583	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1705	1705	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1845	1845	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	1909	1909	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	2004	2005	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	2004	2005	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	2196	2196	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	2380	2380	.	.	.	.	
Q9UGM3	UniProtKB	Sequence conflict	2405	2405	.	.	.	.	
##sequence-region C0LZJ1 1 357
C0LZJ1	UniProtKB	Chain	1	357	.	.	.	ID=PRO_0000416898;Note=Doublesex and mab-3 related transcription factor 1	
C0LZJ1	UniProtKB	DNA binding	58	105	.	.	.	Note=DM	
C0LZJ1	UniProtKB	Compositional bias	306	331	.	.	.	Note=Pro/Ser-rich	
C0LZJ1	UniProtKB	Sequence conflict	307	307	.	.	.	.	
C0LZJ1	UniProtKB	Sequence conflict	307	307	.	.	.	.	
##sequence-region Q9QZ59 1 374
Q9QZ59	UniProtKB	Chain	1	374	.	.	.	ID=PRO_0000207043;Note=Doublesex- and mab-3-related transcription factor 1	
Q9QZ59	UniProtKB	DNA binding	70	116	.	.	.	Note=DM	
Q9QZ59	UniProtKB	Compositional bias	323	346	.	.	.	Note=Pro/Ser-rich	
Q9QZ59	UniProtKB	Alternative sequence	1	180	.	.	.	ID=VSP_042963;Note=In isoform 3.	
Q9QZ59	UniProtKB	Alternative sequence	178	374	.	.	.	ID=VSP_042964;Note=In isoform 4.	
Q9QZ59	UniProtKB	Alternative sequence	213	374	.	.	.	ID=VSP_042965;Note=In isoform 2.	
Q9QZ59	UniProtKB	Sequence conflict	25	25	.	.	.	.	
Q9QZ59	UniProtKB	Sequence conflict	306	306	.	.	.	.	
Q9QZ59	UniProtKB	Sequence conflict	365	365	.	.	.	.	
##sequence-region Q9TT01 1 373
Q9TT01	UniProtKB	Chain	1	373	.	.	.	ID=PRO_0000207044;Note=Doublesex- and mab-3-related transcription factor 1	
Q9TT01	UniProtKB	DNA binding	67	113	.	.	.	Note=DM	
Q9TT01	UniProtKB	Compositional bias	40	46	.	.	.	Note=Poly-Gly	
Q9TT01	UniProtKB	Compositional bias	163	168	.	.	.	Note=Poly-Pro	
Q9TT01	UniProtKB	Compositional bias	324	343	.	.	.	Note=Pro/Ser-rich	
##sequence-region Q6DG03 1 645
Q6DG03	UniProtKB	Chain	1	645	.	.	.	ID=PRO_0000323732;Note=Cyclin-D-binding Myb-like transcription factor 1	
Q6DG03	UniProtKB	Domain	219	257	.	.	.	Note=Myb-like 1	
Q6DG03	UniProtKB	Domain	262	327	.	.	.	Note=HTH myb-type	
Q6DG03	UniProtKB	Domain	333	382	.	.	.	Note=Myb-like 2	
Q6DG03	UniProtKB	DNA binding	300	323	.	.	.	Note=H-T-H motif;status=By similarity	
Q6DG03	UniProtKB	Alternative sequence	395	395	.	.	.	ID=VSP_034966;Note=In isoform 2.	
Q6DG03	UniProtKB	Alternative sequence	396	446	.	.	.	ID=VSP_034967;Note=In isoform 2.	
Q6DG03	UniProtKB	Alternative sequence	528	531	.	.	.	ID=VSP_034968;Note=In isoform 2.	
##sequence-region Q9Y222 1 760
Q9Y222	UniProtKB	Chain	1	760	.	.	.	ID=PRO_0000323729;Note=Cyclin-D-binding Myb-like transcription factor 1	
Q9Y222	UniProtKB	Domain	225	263	.	.	.	Note=Myb-like 1	
Q9Y222	UniProtKB	Domain	268	333	.	.	.	Note=HTH myb-type	
Q9Y222	UniProtKB	Domain	339	388	.	.	.	Note=Myb-like 2	
Q9Y222	UniProtKB	DNA binding	306	329	.	.	.	Note=H-T-H motif;status=By similarity	
Q9Y222	UniProtKB	Region	1	237	.	.	.	Note=Interaction with CCND2;status=By similarity	
Q9Y222	UniProtKB	Region	87	458	.	.	.	Note=Required for DNA-binding;status=By similarity	
Q9Y222	UniProtKB	Region	87	170	.	.	.	Note=Required for transcriptional activation;status=By similarity	
Q9Y222	UniProtKB	Region	176	760	.	.	.	Note=Interaction with CCND1%2C CCND2 and CCND3;status=By similarity	
Q9Y222	UniProtKB	Region	459	760	.	.	.	Note=Required for transcriptional activation;status=By similarity	
Q9Y222	UniProtKB	Alternative sequence	1	88	.	.	.	ID=VSP_041063;Note=In isoform 5.	
Q9Y222	UniProtKB	Alternative sequence	37	78	.	.	.	ID=VSP_032089;Note=In isoform 4.	
Q9Y222	UniProtKB	Alternative sequence	238	285	.	.	.	ID=VSP_032090;Note=In isoform 3 and isoform 4.	
Q9Y222	UniProtKB	Alternative sequence	238	273	.	.	.	ID=VSP_032091;Note=In isoform 2.	
Q9Y222	UniProtKB	Alternative sequence	274	760	.	.	.	ID=VSP_032092;Note=In isoform 2.	
Q9Y222	UniProtKB	Alternative sequence	286	760	.	.	.	ID=VSP_032093;Note=In isoform 3 and isoform 4.	
Q9Y222	UniProtKB	Natural variant	479	479	.	.	.	ID=VAR_039577;Dbxref=dbSNP:rs1558049	
Q9Y222	UniProtKB	Sequence conflict	345	345	.	.	.	.	
Q9Y222	UniProtKB	Sequence conflict	616	616	.	.	.	.	
Q9Y222	UniProtKB	Helix	229	242	.	.	.	.	
Q9Y222	UniProtKB	Helix	246	253	.	.	.	.	
Q9Y222	UniProtKB	Helix	257	266	.	.	.	.	
##sequence-region Q8CE22 1 761
Q8CE22	UniProtKB	Chain	1	761	.	.	.	ID=PRO_0000323730;Note=Cyclin-D-binding Myb-like transcription factor 1	
Q8CE22	UniProtKB	Domain	225	263	.	.	.	Note=Myb-like 1	
Q8CE22	UniProtKB	Domain	268	333	.	.	.	Note=HTH myb-type	
Q8CE22	UniProtKB	Domain	339	388	.	.	.	Note=Myb-like 2	
Q8CE22	UniProtKB	DNA binding	306	329	.	.	.	Note=H-T-H motif;status=By similarity	
Q8CE22	UniProtKB	Region	1	237	.	.	.	Note=Interaction with CCND2	
Q8CE22	UniProtKB	Region	87	458	.	.	.	Note=Required for DNA-binding	
Q8CE22	UniProtKB	Region	87	170	.	.	.	Note=Required for transcriptional activation	
Q8CE22	UniProtKB	Region	176	761	.	.	.	Note=Interaction with CCND1%2C CCND2 and CCND3	
Q8CE22	UniProtKB	Region	459	761	.	.	.	Note=Required for transcriptional activation	
Q8CE22	UniProtKB	Alternative sequence	37	78	.	.	.	ID=VSP_032094;Note=In isoform 4.	
Q8CE22	UniProtKB	Alternative sequence	238	273	.	.	.	ID=VSP_032095;Note=In isoform 5.	
Q8CE22	UniProtKB	Alternative sequence	274	761	.	.	.	ID=VSP_032096;Note=In isoform 5.	
Q8CE22	UniProtKB	Alternative sequence	401	471	.	.	.	ID=VSP_032097;Note=In isoform 2 and isoform 3.	
Q8CE22	UniProtKB	Alternative sequence	402	451	.	.	.	ID=VSP_032098;Note=In isoform 4.	
Q8CE22	UniProtKB	Alternative sequence	452	761	.	.	.	ID=VSP_032099;Note=In isoform 4.	
Q8CE22	UniProtKB	Alternative sequence	500	524	.	.	.	ID=VSP_032100;Note=In isoform 3.	
Q8CE22	UniProtKB	Alternative sequence	525	761	.	.	.	ID=VSP_032101;Note=In isoform 3.	
Q8CE22	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Abrogates DNA-binding.	
Q8CE22	UniProtKB	Sequence conflict	44	44	.	.	.	.	
Q8CE22	UniProtKB	Sequence conflict	73	73	.	.	.	.	
Q8CE22	UniProtKB	Sequence conflict	80	80	.	.	.	.	
Q8CE22	UniProtKB	Sequence conflict	180	180	.	.	.	.	
Q8CE22	UniProtKB	Sequence conflict	480	480	.	.	.	.	
Q8CE22	UniProtKB	Sequence conflict	502	502	.	.	.	.	
Q8CE22	UniProtKB	Sequence conflict	532	532	.	.	.	.	
##sequence-region Q66HG1 1 760
Q66HG1	UniProtKB	Chain	1	760	.	.	.	ID=PRO_0000323731;Note=Cyclin-D-binding Myb-like transcription factor 1	
Q66HG1	UniProtKB	Domain	225	263	.	.	.	Note=Myb-like 1	
Q66HG1	UniProtKB	Domain	268	333	.	.	.	Note=HTH myb-type	
Q66HG1	UniProtKB	Domain	339	388	.	.	.	Note=Myb-like 2	
Q66HG1	UniProtKB	DNA binding	306	329	.	.	.	Note=H-T-H motif;status=By similarity	
Q66HG1	UniProtKB	Region	1	237	.	.	.	Note=Interaction with CCND2;status=By similarity	
Q66HG1	UniProtKB	Region	87	458	.	.	.	Note=Required for DNA-binding;status=By similarity	
Q66HG1	UniProtKB	Region	87	170	.	.	.	Note=Required for transcriptional activation;status=By similarity	
Q66HG1	UniProtKB	Region	176	690	.	.	.	Note=Interaction with CCND1%2C CCND2 and CCND3;status=By similarity	
Q66HG1	UniProtKB	Region	459	760	.	.	.	Note=Required for transcriptional activation;status=By similarity	
Q66HG1	UniProtKB	Alternative sequence	401	471	.	.	.	ID=VSP_032102;Note=In isoform 2.	
##sequence-region Q9BZG8 1 443
Q9BZG8	UniProtKB	Chain	1	443	.	.	.	ID=PRO_0000307882;Note=Diphthamide biosynthesis protein 1	
Q9BZG8	UniProtKB	Alternative sequence	1	140	.	.	.	ID=VSP_028851;Note=In isoform 3.	
Q9BZG8	UniProtKB	Alternative sequence	1	80	.	.	.	ID=VSP_028852;Note=In isoform 2.	
Q9BZG8	UniProtKB	Natural variant	7	7	.	.	.	ID=VAR_036702;Note=In breast and ovarian cancer.	
Q9BZG8	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_036703;Note=In breast and ovarian cancer.	
Q9BZG8	UniProtKB	Natural variant	51	51	.	.	.	ID=VAR_059255;Dbxref=dbSNP:rs8070453	
Q9BZG8	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_055706;Dbxref=dbSNP:rs1131600	
Q9BZG8	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_036704;Dbxref=dbSNP:rs35394823;Note=In breast and ovarian cancer%3B requires 2 nucleotide substitutions.	
Q9BZG8	UniProtKB	Natural variant	389	389	.	.	.	ID=VAR_036705;Note=In breast and ovarian cancer.	
Q9BZG8	UniProtKB	Sequence conflict	8	8	.	.	.	.	
Q9BZG8	UniProtKB	Sequence conflict	162	162	.	.	.	.	
Q9BZG8	UniProtKB	Sequence conflict	358	358	.	.	.	.	
Q9BZG8	UniProtKB	Sequence conflict	358	358	.	.	.	.	
##sequence-region Q5NCQ5 1 438
Q5NCQ5	UniProtKB	Chain	1	438	.	.	.	ID=PRO_0000307883;Note=Diphthamide biosynthesis protein 1	
Q5NCQ5	UniProtKB	Sequence conflict	98	98	.	.	.	.	
Q5NCQ5	UniProtKB	Sequence conflict	208	208	.	.	.	.	
Q5NCQ5	UniProtKB	Sequence conflict	321	321	.	.	.	.	
##sequence-region Q9Y2J2 1 1087
Q9Y2J2	UniProtKB	Chain	1	1087	.	.	.	ID=PRO_0000219399;Note=Band 4.1-like protein 3	
Q9Y2J2	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate	
Q9Y2J2	UniProtKB	Chain	2	1087	.	.	.	ID=PRO_0000423194;Note=Band 4.1-like protein 3%2C N-terminally processed	
Q9Y2J2	UniProtKB	Domain	110	391	.	.	.	Note=FERM	
Q9Y2J2	UniProtKB	Region	394	513	.	.	.	Note=Hydrophilic	
Q9Y2J2	UniProtKB	Region	514	860	.	.	.	Note=Spectrin--actin-binding;status=Potential	
Q9Y2J2	UniProtKB	Region	861	1083	.	.	.	Note=C-terminal (CTD)	
Q9Y2J2	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
Q9Y2J2	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine%3B in Band 4.1-like protein 3%2C N-terminally processed	
Q9Y2J2	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphoserine	
Q9Y2J2	UniProtKB	Modified residue	460	460	.	.	.	Note=Phosphoserine	
Q9Y2J2	UniProtKB	Modified residue	469	469	.	.	.	Note=Phosphothreonine	
Q9Y2J2	UniProtKB	Modified residue	962	962	.	.	.	Note=Phosphoserine	
Q9Y2J2	UniProtKB	Modified residue	1081	1081	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9Y2J2	UniProtKB	Alternative sequence	446	446	.	.	.	ID=VSP_000482;Note=In isoform B and isoform C.	
Q9Y2J2	UniProtKB	Alternative sequence	503	689	.	.	.	ID=VSP_000483;Note=In isoform B and isoform C.	
Q9Y2J2	UniProtKB	Alternative sequence	708	719	.	.	.	ID=VSP_000484;Note=In isoform B and isoform C.	
Q9Y2J2	UniProtKB	Alternative sequence	784	824	.	.	.	ID=VSP_000485;Note=In isoform B and isoform C.	
Q9Y2J2	UniProtKB	Alternative sequence	835	1087	.	.	.	ID=VSP_000486;Note=In isoform C.	
Q9Y2J2	UniProtKB	Natural variant	555	555	.	.	.	ID=VAR_048353;Dbxref=dbSNP:rs9966357	
Q9Y2J2	UniProtKB	Natural variant	575	575	.	.	.	ID=VAR_048354;Dbxref=dbSNP:rs8082898	
Q9Y2J2	UniProtKB	Natural variant	859	859	.	.	.	ID=VAR_048355;Dbxref=dbSNP:rs8096452	
Q9Y2J2	UniProtKB	Sequence conflict	32	32	.	.	.	.	
Q9Y2J2	UniProtKB	Sequence conflict	498	498	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	109	115	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	121	127	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	132	142	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	148	150	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	151	156	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	162	164	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	171	174	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	180	188	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	193	195	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	199	214	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	222	237	.	.	.	.	
Q9Y2J2	UniProtKB	Turn	242	244	.	.	.	.	
Q9Y2J2	UniProtKB	Turn	247	252	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	256	258	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	261	273	.	.	.	.	
Q9Y2J2	UniProtKB	Turn	274	276	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	279	290	.	.	.	.	
Q9Y2J2	UniProtKB	Turn	294	297	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	299	304	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	310	315	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	317	324	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	327	333	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	334	336	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	339	343	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	346	351	.	.	.	.	
Q9Y2J2	UniProtKB	Turn	354	357	.	.	.	.	
Q9Y2J2	UniProtKB	Beta strand	361	366	.	.	.	.	
Q9Y2J2	UniProtKB	Helix	370	388	.	.	.	.	
##sequence-region Q9WV92 1 929
Q9WV92	UniProtKB	Chain	1	929	.	.	.	ID=PRO_0000219400;Note=Band 4.1-like protein 3	
Q9WV92	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate;status=By similarity	
Q9WV92	UniProtKB	Chain	2	929	.	.	.	ID=PRO_0000423195;Note=Band 4.1-like protein 3%2C N-terminally processed	
Q9WV92	UniProtKB	Domain	118	399	.	.	.	Note=FERM	
Q9WV92	UniProtKB	Region	402	528	.	.	.	Note=Hydrophilic	
Q9WV92	UniProtKB	Region	559	602	.	.	.	Note=Spectrin--actin-binding	
Q9WV92	UniProtKB	Region	777	929	.	.	.	Note=C-terminal (CTD)	
Q9WV92	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q9WV92	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine%3B in Band 4.1-like protein 3%2C N-terminally processed;status=By similarity	
Q9WV92	UniProtKB	Modified residue	96	96	.	.	.	Note=Phosphoserine	
Q9WV92	UniProtKB	Modified residue	486	486	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV92	UniProtKB	Modified residue	495	495	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WV92	UniProtKB	Modified residue	804	804	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV92	UniProtKB	Modified residue	923	923	.	.	.	Note=Phosphothreonine	
Q9WV92	UniProtKB	Alternative sequence	455	472	.	.	.	ID=VSP_000487;Note=In isoform 7 and isoform 8.	
Q9WV92	UniProtKB	Alternative sequence	528	528	.	.	.	ID=VSP_023063;Note=In isoform 8.	
Q9WV92	UniProtKB	Alternative sequence	547	558	.	.	.	ID=VSP_000490;Note=In isoform 2%2C isoform 3%2C isoform 5%2C isoform 6 and isoform 7.	
Q9WV92	UniProtKB	Alternative sequence	559	559	.	.	.	ID=VSP_000489;Note=In isoform 2 and isoform 5.	
Q9WV92	UniProtKB	Alternative sequence	623	663	.	.	.	ID=VSP_000488;Note=In isoform 7.	
Q9WV92	UniProtKB	Alternative sequence	894	929	.	.	.	ID=VSP_000491;Note=In isoform 4%2C isoform 5%2C isoform 6%2C isoform 7 and isoform 8.	
Q9WV92	UniProtKB	Sequence conflict	6	10	.	.	.	.	
Q9WV92	UniProtKB	Sequence conflict	28	28	.	.	.	.	
Q9WV92	UniProtKB	Sequence conflict	288	288	.	.	.	.	
Q9WV92	UniProtKB	Sequence conflict	306	306	.	.	.	.	
##sequence-region Q3ZC64 1 205
Q3ZC64	UniProtKB	Signal peptide	1	18	.	.	.	status=By similarity	
Q3ZC64	UniProtKB	Chain	19	182	.	.	.	ID=PRO_0000282935;Note=Ephrin-A1	
Q3ZC64	UniProtKB	Propeptide	183	205	.	.	.	ID=PRO_0000282936;Note=Removed in mature form;status=Potential	
Q3ZC64	UniProtKB	Domain	19	151	.	.	.	Note=Ephrin RBD	
Q3ZC64	UniProtKB	Lipidation	182	182	.	.	.	Note=GPI-anchor amidated serine;status=Potential	
Q3ZC64	UniProtKB	Glycosylation	26	26	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q3ZC64	UniProtKB	Disulfide bond	51	92	.	.	.	status=By similarity	
Q3ZC64	UniProtKB	Disulfide bond	80	140	.	.	.	status=By similarity	
##sequence-region P20827 1 205
P20827	UniProtKB	Signal peptide	1	18	.	.	.	.	
P20827	UniProtKB	Chain	19	182	.	.	.	ID=PRO_0000008353;Note=Ephrin-A1	
P20827	UniProtKB	Propeptide	183	205	.	.	.	ID=PRO_0000008354;Note=Removed in mature form;status=Potential	
P20827	UniProtKB	Domain	19	151	.	.	.	Note=Ephrin RBD	
P20827	UniProtKB	Lipidation	182	182	.	.	.	Note=GPI-anchor amidated serine;status=Potential	
P20827	UniProtKB	Glycosylation	26	26	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P20827	UniProtKB	Disulfide bond	51	92	.	.	.	.	
P20827	UniProtKB	Disulfide bond	80	140	.	.	.	.	
P20827	UniProtKB	Alternative sequence	131	152	.	.	.	ID=VSP_017543;Note=In isoform 2.	
P20827	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_014791;Dbxref=dbSNP:rs4745	
P20827	UniProtKB	Sequence conflict	180	180	.	.	.	.	
P20827	UniProtKB	Beta strand	20	24	.	.	.	.	
P20827	UniProtKB	Helix	30	32	.	.	.	.	
P20827	UniProtKB	Beta strand	38	41	.	.	.	.	
P20827	UniProtKB	Beta strand	46	50	.	.	.	.	
P20827	UniProtKB	Helix	61	63	.	.	.	.	
P20827	UniProtKB	Beta strand	67	72	.	.	.	.	
P20827	UniProtKB	Helix	74	79	.	.	.	.	
P20827	UniProtKB	Helix	85	87	.	.	.	.	
P20827	UniProtKB	Beta strand	88	92	.	.	.	.	
P20827	UniProtKB	Beta strand	98	100	.	.	.	.	
P20827	UniProtKB	Beta strand	103	107	.	.	.	.	
P20827	UniProtKB	Beta strand	125	134	.	.	.	.	
P20827	UniProtKB	Beta strand	142	147	.	.	.	.	
##sequence-region P52793 1 205
P52793	UniProtKB	Signal peptide	1	17	.	.	.	status=Potential	
P52793	UniProtKB	Chain	18	182	.	.	.	ID=PRO_0000008355;Note=Ephrin-A1	
P52793	UniProtKB	Propeptide	183	205	.	.	.	ID=PRO_0000008356;Note=Removed in mature form;status=Potential	
P52793	UniProtKB	Domain	18	161	.	.	.	Note=Ephrin RBD	
P52793	UniProtKB	Lipidation	182	182	.	.	.	Note=GPI-anchor amidated serine;status=Potential	
P52793	UniProtKB	Glycosylation	26	26	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P52793	UniProtKB	Disulfide bond	51	92	.	.	.	status=By similarity	
P52793	UniProtKB	Disulfide bond	80	140	.	.	.	status=By similarity	
P52793	UniProtKB	Sequence conflict	74	74	.	.	.	.	
P52793	UniProtKB	Sequence conflict	79	79	.	.	.	.	
P52793	UniProtKB	Sequence conflict	81	81	.	.	.	.	
P52793	UniProtKB	Sequence conflict	91	91	.	.	.	.	
P52793	UniProtKB	Sequence conflict	94	94	.	.	.	.	
P52793	UniProtKB	Sequence conflict	112	112	.	.	.	.	
P52793	UniProtKB	Sequence conflict	115	115	.	.	.	.	
P52793	UniProtKB	Sequence conflict	138	138	.	.	.	.	
P52793	UniProtKB	Sequence conflict	154	154	.	.	.	.	
P52793	UniProtKB	Sequence conflict	156	156	.	.	.	.	
P52793	UniProtKB	Sequence conflict	159	159	.	.	.	.	
P52793	UniProtKB	Sequence conflict	181	181	.	.	.	.	
P52793	UniProtKB	Sequence conflict	204	204	.	.	.	.	
##sequence-region Q06AS9 1 205
Q06AS9	UniProtKB	Signal peptide	1	18	.	.	.	status=By similarity	
Q06AS9	UniProtKB	Chain	19	182	.	.	.	ID=PRO_0000288608;Note=Ephrin-A1	
Q06AS9	UniProtKB	Propeptide	183	205	.	.	.	ID=PRO_0000288609;Note=Removed in mature form;status=Potential	
Q06AS9	UniProtKB	Domain	19	151	.	.	.	Note=Ephrin RBD	
Q06AS9	UniProtKB	Lipidation	182	182	.	.	.	Note=GPI-anchor amidated serine;status=Potential	
Q06AS9	UniProtKB	Glycosylation	26	26	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q06AS9	UniProtKB	Disulfide bond	51	92	.	.	.	status=By similarity	
Q06AS9	UniProtKB	Disulfide bond	80	140	.	.	.	status=By similarity	
##sequence-region P97553 1 205
P97553	UniProtKB	Signal peptide	1	17	.	.	.	status=Potential	
P97553	UniProtKB	Chain	18	182	.	.	.	ID=PRO_0000008357;Note=Ephrin-A1	
P97553	UniProtKB	Propeptide	183	205	.	.	.	ID=PRO_0000008358;Note=Removed in mature form;status=Potential	
P97553	UniProtKB	Domain	18	151	.	.	.	Note=Ephrin RBD	
P97553	UniProtKB	Lipidation	182	182	.	.	.	Note=GPI-anchor amidated serine;status=Potential	
P97553	UniProtKB	Glycosylation	26	26	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P97553	UniProtKB	Disulfide bond	51	92	.	.	.	status=By similarity	
P97553	UniProtKB	Disulfide bond	80	140	.	.	.	status=By similarity	
P97553	UniProtKB	Sequence conflict	18	18	.	.	.	.	
P97553	UniProtKB	Sequence conflict	68	68	.	.	.	.	
P97553	UniProtKB	Sequence conflict	90	90	.	.	.	.	
P97553	UniProtKB	Sequence conflict	159	159	.	.	.	.	
##sequence-region P00533 1 1210
P00533	UniProtKB	Signal peptide	1	24	.	.	.	.	
P00533	UniProtKB	Chain	25	1210	.	.	.	ID=PRO_0000016665;Note=Epidermal growth factor receptor	
P00533	UniProtKB	Topological domain	25	645	.	.	.	Note=Extracellular;status=Potential	
P00533	UniProtKB	Transmembrane	646	668	.	.	.	Note=Helical%3B;status=Potential	
P00533	UniProtKB	Topological domain	669	1210	.	.	.	Note=Cytoplasmic;status=Potential	
P00533	UniProtKB	Repeat	75	300	.	.	.	Note=Approximate	
P00533	UniProtKB	Repeat	390	600	.	.	.	Note=Approximate	
P00533	UniProtKB	Domain	712	979	.	.	.	Note=Protein kinase	
P00533	UniProtKB	Nucleotide binding	718	726	.	.	.	Note=ATP	
P00533	UniProtKB	Nucleotide binding	790	791	.	.	.	Note=ATP	
P00533	UniProtKB	Region	688	704	.	.	.	Note=Important for dimerization%2C phosphorylation and activation	
P00533	UniProtKB	Compositional bias	1025	1071	.	.	.	Note=Ser-rich	
P00533	UniProtKB	Active site	837	837	.	.	.	Note=Proton acceptor;status=By similarity	
P00533	UniProtKB	Binding site	745	745	.	.	.	Note=ATP	
P00533	UniProtKB	Binding site	855	855	.	.	.	Note=ATP	
P00533	UniProtKB	Site	1016	1016	.	.	.	Note=Important for interaction with PIK3C2B	
P00533	UniProtKB	Modified residue	229	229	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	678	678	.	.	.	Note=Phosphothreonine%3B by PKC and PKD/PRKD1	
P00533	UniProtKB	Modified residue	693	693	.	.	.	Note=Phosphothreonine%3B by PKD/PRKD1	
P00533	UniProtKB	Modified residue	695	695	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	991	991	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	995	995	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	998	998	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P00533	UniProtKB	Modified residue	1016	1016	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P00533	UniProtKB	Modified residue	1026	1026	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1039	1039	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1041	1041	.	.	.	Note=Phosphothreonine	
P00533	UniProtKB	Modified residue	1042	1042	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1064	1064	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1070	1070	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1071	1071	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1081	1081	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1092	1092	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P00533	UniProtKB	Modified residue	1110	1110	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P00533	UniProtKB	Modified residue	1166	1166	.	.	.	Note=Phosphoserine	
P00533	UniProtKB	Modified residue	1172	1172	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P00533	UniProtKB	Modified residue	1197	1197	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P00533	UniProtKB	Modified residue	1199	1199	.	.	.	Note=Omega-N-methylated arginine	
P00533	UniProtKB	Glycosylation	56	56	.	.	.	ID=CAR_000227;Note=N-linked (GlcNAc...) (complex)%3B partial%3B atypical	
P00533	UniProtKB	Glycosylation	73	73	.	.	.	Note=N-linked (GlcNAc...)%3B atypical	
P00533	UniProtKB	Glycosylation	128	128	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	175	175	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	196	196	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	352	352	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	361	361	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	413	413	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	444	444	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	528	528	.	.	.	Note=N-linked (GlcNAc...)	
P00533	UniProtKB	Glycosylation	568	568	.	.	.	Note=N-linked (GlcNAc...)%3B partial	
P00533	UniProtKB	Glycosylation	603	603	.	.	.	Note=N-linked (GlcNAc...)%3B partial	
P00533	UniProtKB	Disulfide bond	31	58	.	.	.	.	
P00533	UniProtKB	Disulfide bond	157	187	.	.	.	.	
P00533	UniProtKB	Disulfide bond	190	199	.	.	.	.	
P00533	UniProtKB	Disulfide bond	194	207	.	.	.	.	
P00533	UniProtKB	Disulfide bond	215	223	.	.	.	.	
P00533	UniProtKB	Disulfide bond	219	231	.	.	.	.	
P00533	UniProtKB	Disulfide bond	232	240	.	.	.	.	
P00533	UniProtKB	Disulfide bond	236	248	.	.	.	.	
P00533	UniProtKB	Disulfide bond	251	260	.	.	.	.	
P00533	UniProtKB	Disulfide bond	264	291	.	.	.	.	
P00533	UniProtKB	Disulfide bond	295	307	.	.	.	.	
P00533	UniProtKB	Disulfide bond	311	326	.	.	.	.	
P00533	UniProtKB	Disulfide bond	329	333	.	.	.	.	
P00533	UniProtKB	Disulfide bond	337	362	.	.	.	.	
P00533	UniProtKB	Disulfide bond	470	499	.	.	.	.	
P00533	UniProtKB	Disulfide bond	506	515	.	.	.	.	
P00533	UniProtKB	Disulfide bond	510	523	.	.	.	.	
P00533	UniProtKB	Disulfide bond	526	535	.	.	.	.	
P00533	UniProtKB	Disulfide bond	539	555	.	.	.	.	
P00533	UniProtKB	Disulfide bond	558	571	.	.	.	.	
P00533	UniProtKB	Disulfide bond	562	579	.	.	.	.	
P00533	UniProtKB	Disulfide bond	582	591	.	.	.	.	
P00533	UniProtKB	Disulfide bond	595	617	.	.	.	.	
P00533	UniProtKB	Disulfide bond	620	628	.	.	.	.	
P00533	UniProtKB	Disulfide bond	624	636	.	.	.	.	
P00533	UniProtKB	Cross-link	716	716	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P00533	UniProtKB	Cross-link	737	737	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P00533	UniProtKB	Cross-link	754	754	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P00533	UniProtKB	Cross-link	867	867	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P00533	UniProtKB	Cross-link	929	929	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P00533	UniProtKB	Cross-link	970	970	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P00533	UniProtKB	Alternative sequence	404	405	.	.	.	ID=VSP_002887;Note=In isoform 2.	
P00533	UniProtKB	Alternative sequence	406	1210	.	.	.	ID=VSP_002888;Note=In isoform 2.	
P00533	UniProtKB	Alternative sequence	628	705	.	.	.	ID=VSP_002889;Note=In isoform 3.	
P00533	UniProtKB	Alternative sequence	628	628	.	.	.	ID=VSP_002891;Note=In isoform 4.	
P00533	UniProtKB	Alternative sequence	629	1210	.	.	.	ID=VSP_002892;Note=In isoform 4.	
P00533	UniProtKB	Alternative sequence	706	1210	.	.	.	ID=VSP_002890;Note=In isoform 3.	
P00533	UniProtKB	Natural variant	30	297	.	.	.	ID=VAR_066493;Note=Variant EGFR vIII%3B found in a lung cancer sample%3B somatic mutation%3B induces lung cancer when exogenously expressed.	
P00533	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_019293;Dbxref=dbSNP:rs17289589	
P00533	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_019294;Dbxref=dbSNP:rs17336639	
P00533	UniProtKB	Natural variant	521	521	.	.	.	ID=VAR_019295;Dbxref=dbSNP:rs2227983	
P00533	UniProtKB	Natural variant	674	674	.	.	.	ID=VAR_019296;Dbxref=dbSNP:rs17337079;Note=Slightly increased autophosphorylation.	
P00533	UniProtKB	Natural variant	709	709	.	.	.	ID=VAR_026084;Note=Found in a lung cancer sample%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	709	709	.	.	.	ID=VAR_069498;Note=Found in a lung cancer sample%3B constitutively activated kinase with higher levels of basal autophosphorylation%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	709	709	.	.	.	ID=VAR_026085;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	719	719	.	.	.	ID=VAR_026086;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	719	719	.	.	.	ID=VAR_026087;Dbxref=dbSNP:rs28929495;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	719	719	.	.	.	ID=VAR_026088;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	719	719	.	.	.	ID=VAR_019297;Note=Found in a lung cancer sample%3B somatic mutation%3B strongly increased kinase activity%3B constitutively activated kinase with higher levels of basal autophosphorylation%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	724	724	.	.	.	ID=VAR_026089;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	734	734	.	.	.	ID=VAR_026090;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	746	752	.	.	.	ID=VAR_069499;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	746	751	.	.	.	ID=VAR_069500;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	746	750	.	.	.	ID=VAR_026092;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	746	746	.	.	.	ID=VAR_026091;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	747	751	.	.	.	ID=VAR_069501;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	747	749	.	.	.	ID=VAR_026094;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	747	747	.	.	.	ID=VAR_026093;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	748	748	.	.	.	ID=VAR_026095;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	752	759	.	.	.	ID=VAR_026096;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	768	768	.	.	.	ID=VAR_069502;Dbxref=dbSNP:rs121913465;Note=Found in a lung cancer sample%3B constitutively activated kinase with higher levels of basal autophosphorylation%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	769	769	.	.	.	ID=VAR_069503;Dbxref=dbSNP:rs147149347;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	787	787	.	.	.	ID=VAR_026097;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	790	790	.	.	.	ID=VAR_026098;Note=Found in a lung cancer sample%3B increased kinase activity.	
P00533	UniProtKB	Natural variant	833	833	.	.	.	ID=VAR_026099;Note=Found in a lung cancer sample%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	834	834	.	.	.	ID=VAR_026100;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	835	835	.	.	.	ID=VAR_069504;Note=Found in a lung cancer sample%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	838	838	.	.	.	ID=VAR_069505;Note=Found in a lung cancer sample%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	858	858	.	.	.	ID=VAR_026101;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	858	858	.	.	.	ID=VAR_019298;Dbxref=dbSNP:rs121434568;Note=Found in a lung cancer sample%3B somatic mutation%3B constitutively activated enzyme with strongly increased kinase activity%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	861	861	.	.	.	ID=VAR_026102;Dbxref=dbSNP:rs121913444;Note=Found in a lung cancer sample%3B constitutively activated kinase with higher levels of basal autophosphorylation%3B more sensitive to gefitinib than wild-type.	
P00533	UniProtKB	Natural variant	873	873	.	.	.	ID=VAR_026103;Note=Found in a lung cancer sample.	
P00533	UniProtKB	Natural variant	962	962	.	.	.	ID=VAR_019299;Dbxref=dbSNP:rs17337451	
P00533	UniProtKB	Natural variant	988	988	.	.	.	ID=VAR_019300;Dbxref=dbSNP:rs17290699	
P00533	UniProtKB	Natural variant	1034	1034	.	.	.	ID=VAR_042095;Dbxref=dbSNP:rs34352568	
P00533	UniProtKB	Natural variant	1210	1210	.	.	.	ID=VAR_042096;Dbxref=dbSNP:rs35918369	
P00533	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Strongly reduced autophosphorylation and activation of downstream kinases%3B when associated with A-309.	
P00533	UniProtKB	Mutagenesis	287	287	.	.	.	Note=Strongly reduced autophosphorylation and activation of downstream kinases%3B when associated with A-309.	
P00533	UniProtKB	Mutagenesis	309	309	.	.	.	Note=Strongly reduced autophosphorylation and activation of downstream kinases%3B when associated with A-275. Strongly reduced autophosphorylation and activation of downstream kinases%3B when associated with A-287.	
P00533	UniProtKB	Mutagenesis	429	429	.	.	.	Note=Abolishes autophosphorylation and activation of downstream kinases.	
P00533	UniProtKB	Mutagenesis	587	590	.	.	.	Note=Decreases intramolecular interactions and facilitates EGF binding.	
P00533	UniProtKB	Mutagenesis	609	609	.	.	.	Note=Decreases intramolecular interactions and facilitates EGF binding.	
P00533	UniProtKB	Mutagenesis	688	688	.	.	.	Note=Strongly reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	689	689	.	.	.	Note=Reduced autophosphorylation.	
P00533	UniProtKB	Mutagenesis	689	689	.	.	.	Note=Constitutively activated kinase.	
P00533	UniProtKB	Mutagenesis	690	690	.	.	.	Note=Reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	692	692	.	.	.	Note=Strongly reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	693	693	.	.	.	Note=Increased phosphorylation.	
P00533	UniProtKB	Mutagenesis	693	693	.	.	.	Note=Strongly reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	694	694	.	.	.	Note=Strongly reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	699	699	.	.	.	Note=Reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	700	700	.	.	.	Note=Abolishes phosphorylation.	
P00533	UniProtKB	Mutagenesis	704	704	.	.	.	Note=Abolishes phosphorylation.	
P00533	UniProtKB	Mutagenesis	705	705	.	.	.	Note=Abolishes phosphorylation.	
P00533	UniProtKB	Mutagenesis	706	706	.	.	.	Note=Abolishes phosphorylation.	
P00533	UniProtKB	Mutagenesis	745	745	.	.	.	Note=Abolishes kinase activity.	
P00533	UniProtKB	Mutagenesis	974	974	.	.	.	Note=Strongly reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	977	977	.	.	.	Note=Reduced phosphorylation.	
P00533	UniProtKB	Mutagenesis	1005	1006	.	.	.	Note=Constitutively activated kinase.	
P00533	UniProtKB	Mutagenesis	1016	1016	.	.	.	Note=50%25 decrease in interaction with PIK3C2B. 65%25 decrease in interaction with PIK3C2B%3B when associated with F-1197. Abolishes interaction with PIK3C2B%3B when associated with F-1197 and F-1092.	
P00533	UniProtKB	Mutagenesis	1092	1092	.	.	.	Note=No change in interaction with PIK3C2B. Abolishes interaction with PIK3C2B%3B when associated with F-1197 and F-1016.	
P00533	UniProtKB	Mutagenesis	1110	1110	.	.	.	Note=No change in interaction with PIK3C2B.	
P00533	UniProtKB	Mutagenesis	1172	1172	.	.	.	Note=No change in interaction with PIK3C2B.	
P00533	UniProtKB	Mutagenesis	1197	1197	.	.	.	Note=No change in interaction with PIK3C2B. 65%25 decrease in interaction with PIK3C2B%3B when associated with F-1016. Abolishes interaction with PIK3C2B%3B when associated with F-1092 and F-1016.	
P00533	UniProtKB	Sequence conflict	540	540	.	.	.	.	
P00533	UniProtKB	Beta strand	40	43	.	.	.	.	
P00533	UniProtKB	Helix	44	55	.	.	.	.	
P00533	UniProtKB	Beta strand	59	68	.	.	.	.	
P00533	UniProtKB	Helix	77	81	.	.	.	.	
P00533	UniProtKB	Beta strand	84	87	.	.	.	.	
P00533	UniProtKB	Beta strand	89	93	.	.	.	.	
P00533	UniProtKB	Helix	101	103	.	.	.	.	
P00533	UniProtKB	Turn	114	116	.	.	.	.	
P00533	UniProtKB	Beta strand	117	122	.	.	.	.	
P00533	UniProtKB	Beta strand	125	129	.	.	.	.	
P00533	UniProtKB	Beta strand	145	152	.	.	.	.	
P00533	UniProtKB	Helix	159	161	.	.	.	.	
P00533	UniProtKB	Helix	164	166	.	.	.	.	
P00533	UniProtKB	Helix	170	173	.	.	.	.	
P00533	UniProtKB	Helix	195	197	.	.	.	.	
P00533	UniProtKB	Beta strand	199	203	.	.	.	.	
P00533	UniProtKB	Helix	204	206	.	.	.	.	
P00533	UniProtKB	Beta strand	211	214	.	.	.	.	
P00533	UniProtKB	Beta strand	223	227	.	.	.	.	
P00533	UniProtKB	Helix	228	230	.	.	.	.	
P00533	UniProtKB	Beta strand	236	245	.	.	.	.	
P00533	UniProtKB	Beta strand	248	256	.	.	.	.	
P00533	UniProtKB	Beta strand	259	263	.	.	.	.	
P00533	UniProtKB	Beta strand	267	270	.	.	.	.	
P00533	UniProtKB	Turn	272	274	.	.	.	.	
P00533	UniProtKB	Beta strand	275	279	.	.	.	.	
P00533	UniProtKB	Beta strand	285	287	.	.	.	.	
P00533	UniProtKB	Beta strand	290	294	.	.	.	.	
P00533	UniProtKB	Turn	296	298	.	.	.	.	
P00533	UniProtKB	Beta strand	299	301	.	.	.	.	
P00533	UniProtKB	Beta strand	305	310	.	.	.	.	
P00533	UniProtKB	Beta strand	313	315	.	.	.	.	
P00533	UniProtKB	Beta strand	318	320	.	.	.	.	
P00533	UniProtKB	Beta strand	323	325	.	.	.	.	
P00533	UniProtKB	Beta strand	330	332	.	.	.	.	
P00533	UniProtKB	Beta strand	336	338	.	.	.	.	
P00533	UniProtKB	Turn	340	342	.	.	.	.	
P00533	UniProtKB	Helix	343	345	.	.	.	.	
P00533	UniProtKB	Beta strand	349	351	.	.	.	.	
P00533	UniProtKB	Turn	353	355	.	.	.	.	
P00533	UniProtKB	Helix	356	359	.	.	.	.	
P00533	UniProtKB	Beta strand	363	367	.	.	.	.	
P00533	UniProtKB	Beta strand	369	371	.	.	.	.	
P00533	UniProtKB	Helix	373	377	.	.	.	.	
P00533	UniProtKB	Turn	380	383	.	.	.	.	
P00533	UniProtKB	Helix	389	397	.	.	.	.	
P00533	UniProtKB	Beta strand	400	403	.	.	.	.	
P00533	UniProtKB	Beta strand	405	407	.	.	.	.	
P00533	UniProtKB	Helix	418	420	.	.	.	.	
P00533	UniProtKB	Turn	433	435	.	.	.	.	
P00533	UniProtKB	Beta strand	436	442	.	.	.	.	
P00533	UniProtKB	Beta strand	458	464	.	.	.	.	
P00533	UniProtKB	Helix	472	474	.	.	.	.	
P00533	UniProtKB	Helix	477	480	.	.	.	.	
P00533	UniProtKB	Beta strand	481	483	.	.	.	.	
P00533	UniProtKB	Beta strand	488	494	.	.	.	.	
P00533	UniProtKB	Helix	496	501	.	.	.	.	
P00533	UniProtKB	Turn	507	509	.	.	.	.	
P00533	UniProtKB	Beta strand	515	519	.	.	.	.	
P00533	UniProtKB	Helix	520	522	.	.	.	.	
P00533	UniProtKB	Beta strand	523	526	.	.	.	.	
P00533	UniProtKB	Beta strand	535	537	.	.	.	.	
P00533	UniProtKB	Beta strand	541	546	.	.	.	.	
P00533	UniProtKB	Beta strand	548	551	.	.	.	.	
P00533	UniProtKB	Beta strand	554	557	.	.	.	.	
P00533	UniProtKB	Beta strand	566	568	.	.	.	.	
P00533	UniProtKB	Beta strand	570	575	.	.	.	.	
P00533	UniProtKB	Beta strand	578	587	.	.	.	.	
P00533	UniProtKB	Beta strand	590	594	.	.	.	.	
P00533	UniProtKB	Beta strand	597	599	.	.	.	.	
P00533	UniProtKB	Helix	602	604	.	.	.	.	
P00533	UniProtKB	Beta strand	607	611	.	.	.	.	
P00533	UniProtKB	Beta strand	615	619	.	.	.	.	
P00533	UniProtKB	Beta strand	629	632	.	.	.	.	
P00533	UniProtKB	Helix	633	635	.	.	.	.	
P00533	UniProtKB	Beta strand	643	646	.	.	.	.	
P00533	UniProtKB	Helix	648	669	.	.	.	.	
P00533	UniProtKB	Beta strand	671	673	.	.	.	.	
P00533	UniProtKB	Helix	679	684	.	.	.	.	
P00533	UniProtKB	Helix	685	687	.	.	.	.	
P00533	UniProtKB	Beta strand	688	692	.	.	.	.	
P00533	UniProtKB	Beta strand	694	697	.	.	.	.	
P00533	UniProtKB	Beta strand	703	706	.	.	.	.	
P00533	UniProtKB	Helix	709	711	.	.	.	.	
P00533	UniProtKB	Beta strand	712	721	.	.	.	.	
P00533	UniProtKB	Beta strand	724	731	.	.	.	.	
P00533	UniProtKB	Turn	734	736	.	.	.	.	
P00533	UniProtKB	Beta strand	740	746	.	.	.	.	
P00533	UniProtKB	Beta strand	748	750	.	.	.	.	
P00533	UniProtKB	Turn	753	755	.	.	.	.	
P00533	UniProtKB	Helix	756	768	.	.	.	.	
P00533	UniProtKB	Beta strand	772	774	.	.	.	.	
P00533	UniProtKB	Beta strand	777	791	.	.	.	.	
P00533	UniProtKB	Beta strand	794	797	.	.	.	.	
P00533	UniProtKB	Helix	798	804	.	.	.	.	
P00533	UniProtKB	Helix	806	808	.	.	.	.	
P00533	UniProtKB	Helix	811	830	.	.	.	.	
P00533	UniProtKB	Helix	840	842	.	.	.	.	
P00533	UniProtKB	Beta strand	843	847	.	.	.	.	
P00533	UniProtKB	Beta strand	850	853	.	.	.	.	
P00533	UniProtKB	Helix	858	862	.	.	.	.	
P00533	UniProtKB	Turn	863	865	.	.	.	.	
P00533	UniProtKB	Helix	867	871	.	.	.	.	
P00533	UniProtKB	Beta strand	873	877	.	.	.	.	
P00533	UniProtKB	Helix	878	880	.	.	.	.	
P00533	UniProtKB	Helix	883	888	.	.	.	.	
P00533	UniProtKB	Helix	893	908	.	.	.	.	
P00533	UniProtKB	Turn	909	911	.	.	.	.	
P00533	UniProtKB	Turn	914	917	.	.	.	.	
P00533	UniProtKB	Helix	920	922	.	.	.	.	
P00533	UniProtKB	Helix	923	928	.	.	.	.	
P00533	UniProtKB	Beta strand	937	939	.	.	.	.	
P00533	UniProtKB	Helix	941	950	.	.	.	.	
P00533	UniProtKB	Helix	955	957	.	.	.	.	
P00533	UniProtKB	Helix	961	972	.	.	.	.	
P00533	UniProtKB	Helix	975	978	.	.	.	.	
P00533	UniProtKB	Helix	984	986	.	.	.	.	
P00533	UniProtKB	Turn	992	994	.	.	.	.	
P00533	UniProtKB	Helix	996	1002	.	.	.	.	
P00533	UniProtKB	Beta strand	1004	1010	.	.	.	.	
P00533	UniProtKB	Helix	1013	1016	.	.	.	.	
P00533	UniProtKB	Beta strand	1068	1070	.	.	.	.	
##sequence-region P29323 1 1055
P29323	UniProtKB	Signal peptide	1	18	.	.	.	status=Potential	
P29323	UniProtKB	Chain	19	1055	.	.	.	ID=PRO_0000016827;Note=Ephrin type-B receptor 2	
P29323	UniProtKB	Topological domain	19	543	.	.	.	Note=Extracellular;status=Potential	
P29323	UniProtKB	Transmembrane	544	564	.	.	.	Note=Helical%3B;status=Potential	
P29323	UniProtKB	Topological domain	565	1055	.	.	.	Note=Cytoplasmic;status=Potential	
P29323	UniProtKB	Domain	20	202	.	.	.	Note=Eph LBD	
P29323	UniProtKB	Domain	325	426	.	.	.	Note=Fibronectin type-III 1	
P29323	UniProtKB	Domain	432	527	.	.	.	Note=Fibronectin type-III 2	
P29323	UniProtKB	Domain	621	884	.	.	.	Note=Protein kinase	
P29323	UniProtKB	Domain	913	977	.	.	.	Note=SAM	
P29323	UniProtKB	Nucleotide binding	627	635	.	.	.	Note=ATP;status=By similarity	
P29323	UniProtKB	Motif	984	986	.	.	.	Note=PDZ-binding (in isoform 2);status=Potential	
P29323	UniProtKB	Compositional bias	184	324	.	.	.	Note=Cys-rich	
P29323	UniProtKB	Active site	746	746	.	.	.	Note=Proton acceptor;status=By similarity	
P29323	UniProtKB	Binding site	653	653	.	.	.	Note=ATP;status=By similarity	
P29323	UniProtKB	Glycosylation	265	265	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P29323	UniProtKB	Glycosylation	336	336	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P29323	UniProtKB	Glycosylation	428	428	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P29323	UniProtKB	Glycosylation	482	482	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P29323	UniProtKB	Disulfide bond	62	184	.	.	.	.	
P29323	UniProtKB	Disulfide bond	97	107	.	.	.	.	
P29323	UniProtKB	Alternative sequence	568	568	.	.	.	ID=VSP_015713;Note=In isoform 3.	
P29323	UniProtKB	Alternative sequence	986	986	.	.	.	ID=VSP_003016;Note=In isoform 2 and isoform 3.	
P29323	UniProtKB	Alternative sequence	987	1055	.	.	.	ID=VSP_003017;Note=In isoform 2 and isoform 3.	
P29323	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_032853;Note=In prostate cancer.	
P29323	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_032854;Dbxref=dbSNP:rs35882952;Note=In prostate cancer.	
P29323	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_042172	
P29323	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_042173;Dbxref=dbSNP:rs56180036	
P29323	UniProtKB	Natural variant	650	650	.	.	.	ID=VAR_032855;Dbxref=dbSNP:rs142173175;Note=In prostate cancer.	
P29323	UniProtKB	Natural variant	678	678	.	.	.	ID=VAR_042174;Dbxref=dbSNP:rs28936395	
P29323	UniProtKB	Natural variant	679	679	.	.	.	ID=VAR_032856;Note=In prostate cancer.	
P29323	UniProtKB	Natural variant	844	844	.	.	.	ID=VAR_042175;Dbxref=dbSNP:rs55826626	
P29323	UniProtKB	Natural variant	883	883	.	.	.	ID=VAR_032857;Note=In prostate cancer.	
P29323	UniProtKB	Natural variant	909	909	.	.	.	ID=VAR_032858;Note=In prostate cancer.	
P29323	UniProtKB	Sequence conflict	1	20	.	.	.	.	
P29323	UniProtKB	Sequence conflict	154	154	.	.	.	.	
P29323	UniProtKB	Sequence conflict	476	476	.	.	.	.	
P29323	UniProtKB	Sequence conflict	495	496	.	.	.	.	
P29323	UniProtKB	Sequence conflict	532	532	.	.	.	.	
P29323	UniProtKB	Sequence conflict	589	589	.	.	.	.	
P29323	UniProtKB	Sequence conflict	671	671	.	.	.	.	
P29323	UniProtKB	Sequence conflict	788	788	.	.	.	.	
P29323	UniProtKB	Sequence conflict	853	853	.	.	.	.	
P29323	UniProtKB	Sequence conflict	853	853	.	.	.	.	
P29323	UniProtKB	Sequence conflict	853	853	.	.	.	.	
P29323	UniProtKB	Sequence conflict	923	923	.	.	.	.	
P29323	UniProtKB	Sequence conflict	923	923	.	.	.	.	
P29323	UniProtKB	Sequence conflict	923	923	.	.	.	.	
P29323	UniProtKB	Sequence conflict	958	958	.	.	.	.	
P29323	UniProtKB	Beta strand	21	25	.	.	.	.	
P29323	UniProtKB	Helix	26	28	.	.	.	.	
P29323	UniProtKB	Beta strand	36	39	.	.	.	.	
P29323	UniProtKB	Beta strand	44	49	.	.	.	.	
P29323	UniProtKB	Beta strand	55	61	.	.	.	.	
P29323	UniProtKB	Beta strand	66	68	.	.	.	.	
P29323	UniProtKB	Beta strand	71	74	.	.	.	.	
P29323	UniProtKB	Beta strand	84	94	.	.	.	.	
P29323	UniProtKB	Helix	97	99	.	.	.	.	
P29323	UniProtKB	Beta strand	111	120	.	.	.	.	
P29323	UniProtKB	Beta strand	130	132	.	.	.	.	
P29323	UniProtKB	Beta strand	135	141	.	.	.	.	
P29323	UniProtKB	Beta strand	148	152	.	.	.	.	
P29323	UniProtKB	Beta strand	155	166	.	.	.	.	
P29323	UniProtKB	Beta strand	171	183	.	.	.	.	
P29323	UniProtKB	Beta strand	185	194	.	.	.	.	
P29323	UniProtKB	Helix	918	924	.	.	.	.	
P29323	UniProtKB	Helix	928	930	.	.	.	.	
P29323	UniProtKB	Helix	931	936	.	.	.	.	
P29323	UniProtKB	Helix	942	945	.	.	.	.	
P29323	UniProtKB	Helix	950	955	.	.	.	.	
P29323	UniProtKB	Helix	961	982	.	.	.	.	
##sequence-region Q15303 1 1308
Q15303	UniProtKB	Signal peptide	1	25	.	.	.	status=Potential	
Q15303	UniProtKB	Chain	26	1308	.	.	.	ID=PRO_0000016674;Note=Receptor tyrosine-protein kinase erbB-4	
Q15303	UniProtKB	Chain	676	1308	.	.	.	ID=PRO_0000396797;Note=ERBB4 intracellular domain;status=By similarity	
Q15303	UniProtKB	Topological domain	26	651	.	.	.	Note=Extracellular;status=Potential	
Q15303	UniProtKB	Transmembrane	652	675	.	.	.	status=Potential	
Q15303	UniProtKB	Topological domain	676	1308	.	.	.	Note=Cytoplasmic;status=Potential	
Q15303	UniProtKB	Domain	718	985	.	.	.	Note=Protein kinase	
Q15303	UniProtKB	Nucleotide binding	724	732	.	.	.	Note=ATP;status=By similarity	
Q15303	UniProtKB	Nucleotide binding	797	799	.	.	.	Note=ATP;status=By similarity	
Q15303	UniProtKB	Nucleotide binding	843	848	.	.	.	Note=ATP;status=By similarity	
Q15303	UniProtKB	Motif	676	684	.	.	.	Note=Nuclear localization signal	
Q15303	UniProtKB	Motif	1032	1035	.	.	.	Note=PPxY motif 1	
Q15303	UniProtKB	Motif	1053	1056	.	.	.	Note=PPxY motif 2	
Q15303	UniProtKB	Motif	1298	1301	.	.	.	Note=PPxY motif 3	
Q15303	UniProtKB	Motif	1306	1308	.	.	.	Note=PDZ-binding	
Q15303	UniProtKB	Compositional bias	186	334	.	.	.	Note=Cys-rich	
Q15303	UniProtKB	Compositional bias	496	633	.	.	.	Note=Cys-rich	
Q15303	UniProtKB	Active site	843	843	.	.	.	Note=Proton acceptor;status=By similarity	
Q15303	UniProtKB	Binding site	751	751	.	.	.	Note=ATP;status=By similarity	
Q15303	UniProtKB	Modified residue	875	875	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1035	1035	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1056	1056	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1150	1150	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1162	1162	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1188	1188	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1202	1202	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1242	1242	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1258	1258	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Modified residue	1284	1284	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q15303	UniProtKB	Glycosylation	138	138	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	174	174	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	181	181	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q15303	UniProtKB	Glycosylation	253	253	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	358	358	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	410	410	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	473	473	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	495	495	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	548	548	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q15303	UniProtKB	Glycosylation	576	576	.	.	.	Note=N-linked (GlcNAc...)	
Q15303	UniProtKB	Glycosylation	620	620	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q15303	UniProtKB	Disulfide bond	29	56	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	156	186	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	189	197	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	193	205	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	213	221	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	217	229	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	230	238	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	234	246	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	249	258	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	262	289	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	293	304	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	308	323	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	326	330	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	503	512	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	507	520	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	523	532	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	536	552	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	555	569	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	559	577	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	580	589	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	593	614	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	617	625	.	.	.	.	
Q15303	UniProtKB	Disulfide bond	621	633	.	.	.	.	
Q15303	UniProtKB	Alternative sequence	626	648	.	.	.	ID=VSP_002895;Note=In isoform JM-B CYT-1 and isoform JM-B CYT-2.	
Q15303	UniProtKB	Alternative sequence	1046	1061	.	.	.	ID=VSP_022148;Note=In isoform JM-A CYT-2 and isoform JM-B CYT-2.	
Q15303	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_042113;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q15303	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_042114;Note=In a lung squamous cell carcinoma sample%3B somatic mutation.	
Q15303	UniProtKB	Mutagenesis	646	646	.	.	.	Note=Constitutively activated kinase.	
Q15303	UniProtKB	Mutagenesis	675	675	.	.	.	Note=Abolishes proteolytic processing and nuclear localization.	
Q15303	UniProtKB	Mutagenesis	681	684	.	.	.	Note=Abolishes nuclear localization of the ERBB4 intracellular domain.	
Q15303	UniProtKB	Mutagenesis	710	710	.	.	.	Note=Strongly reduced autophosphorylation.	
Q15303	UniProtKB	Mutagenesis	721	721	.	.	.	Note=No effect on kinase activity.	
Q15303	UniProtKB	Mutagenesis	751	751	.	.	.	Note=Abolishes kinase activity. Abolishes phosphorylation%2C proteolytic processing and nuclear localization.	
Q15303	UniProtKB	Mutagenesis	766	766	.	.	.	Note=Strongly reduced autophosphorylation.	
Q15303	UniProtKB	Mutagenesis	773	773	.	.	.	Note=No effect on kinase activity.	
Q15303	UniProtKB	Mutagenesis	782	782	.	.	.	Note=No effect on kinase activity.	
Q15303	UniProtKB	Mutagenesis	810	810	.	.	.	Note=No effect on kinase activity.	
Q15303	UniProtKB	Mutagenesis	843	843	.	.	.	Note=Loss of kinase activity.	
Q15303	UniProtKB	Mutagenesis	854	854	.	.	.	Note=No effect on kinase activity.	
Q15303	UniProtKB	Mutagenesis	861	861	.	.	.	Note=Loss of kinase activity.	
Q15303	UniProtKB	Mutagenesis	864	864	.	.	.	Note=Strongly reduced autophosphorylation.	
Q15303	UniProtKB	Mutagenesis	872	872	.	.	.	Note=No effect on kinase activity.	
Q15303	UniProtKB	Mutagenesis	926	926	.	.	.	Note=No effect on kinase activity.	
Q15303	UniProtKB	Mutagenesis	947	947	.	.	.	Note=Constitutively autophosphorylated.	
Q15303	UniProtKB	Mutagenesis	992	992	.	.	.	Note=Abolishes APC/C-mediated degradation%3B when associated with A-995 and A-1000.	
Q15303	UniProtKB	Mutagenesis	995	995	.	.	.	Note=Abolishes APC/C-mediated degradation%3B when associated with A-992 and A-1000.	
Q15303	UniProtKB	Mutagenesis	1000	1000	.	.	.	Note=Abolishes APC/C-mediated degradation%3B when associated with A-992 and A-995.	
Q15303	UniProtKB	Mutagenesis	1035	1035	.	.	.	Note=No effect on interaction with WWOX. Abolishes interaction with WWOX%3B when associated with A-1301.	
Q15303	UniProtKB	Mutagenesis	1056	1056	.	.	.	Note=Abolishes interaction with NEDD4 and impairs ubiquitination. Promotes nuclear translocation of ERBB4 intracellular domain E4ICD1.	
Q15303	UniProtKB	Mutagenesis	1056	1056	.	.	.	Note=Abolishes interaction with WWP1%3B when associated with F-1301.	
Q15303	UniProtKB	Mutagenesis	1301	1301	.	.	.	Note=Abolishes interaction with NEDD4 and impairs ubiquitination.	
Q15303	UniProtKB	Mutagenesis	1301	1301	.	.	.	Note=No effect on interaction with WWOX. Abolishes interaction with WWOX%3B when associated with A-1035. Loss of interaction with YAP1 and stimulation of transcription.	
Q15303	UniProtKB	Mutagenesis	1301	1301	.	.	.	Note=Abolishes interaction with WWP1%3B when associated with F-1056.	
Q15303	UniProtKB	Beta strand	28	30	.	.	.	.	
Q15303	UniProtKB	Beta strand	38	41	.	.	.	.	
Q15303	UniProtKB	Helix	42	53	.	.	.	.	
Q15303	UniProtKB	Beta strand	57	61	.	.	.	.	
Q15303	UniProtKB	Beta strand	63	67	.	.	.	.	
Q15303	UniProtKB	Helix	75	79	.	.	.	.	
Q15303	UniProtKB	Beta strand	82	85	.	.	.	.	
Q15303	UniProtKB	Beta strand	87	91	.	.	.	.	
Q15303	UniProtKB	Beta strand	95	98	.	.	.	.	
Q15303	UniProtKB	Turn	112	114	.	.	.	.	
Q15303	UniProtKB	Beta strand	115	120	.	.	.	.	
Q15303	UniProtKB	Beta strand	125	128	.	.	.	.	
Q15303	UniProtKB	Beta strand	133	135	.	.	.	.	
Q15303	UniProtKB	Beta strand	144	150	.	.	.	.	
Q15303	UniProtKB	Helix	158	160	.	.	.	.	
Q15303	UniProtKB	Helix	163	165	.	.	.	.	
Q15303	UniProtKB	Helix	173	175	.	.	.	.	
Q15303	UniProtKB	Beta strand	176	178	.	.	.	.	
Q15303	UniProtKB	Turn	191	193	.	.	.	.	
Q15303	UniProtKB	Beta strand	197	201	.	.	.	.	
Q15303	UniProtKB	Helix	202	204	.	.	.	.	
Q15303	UniProtKB	Beta strand	221	225	.	.	.	.	
Q15303	UniProtKB	Helix	226	228	.	.	.	.	
Q15303	UniProtKB	Beta strand	234	242	.	.	.	.	
Q15303	UniProtKB	Beta strand	245	254	.	.	.	.	
Q15303	UniProtKB	Beta strand	257	261	.	.	.	.	
Q15303	UniProtKB	Beta strand	265	269	.	.	.	.	
Q15303	UniProtKB	Turn	270	273	.	.	.	.	
Q15303	UniProtKB	Beta strand	274	277	.	.	.	.	
Q15303	UniProtKB	Beta strand	283	285	.	.	.	.	
Q15303	UniProtKB	Beta strand	288	292	.	.	.	.	
Q15303	UniProtKB	Beta strand	298	300	.	.	.	.	
Q15303	UniProtKB	Beta strand	303	307	.	.	.	.	
Q15303	UniProtKB	Beta strand	312	317	.	.	.	.	
Q15303	UniProtKB	Beta strand	320	325	.	.	.	.	
Q15303	UniProtKB	Beta strand	327	329	.	.	.	.	
Q15303	UniProtKB	Beta strand	333	335	.	.	.	.	
Q15303	UniProtKB	Helix	340	342	.	.	.	.	
Q15303	UniProtKB	Turn	350	352	.	.	.	.	
Q15303	UniProtKB	Helix	353	356	.	.	.	.	
Q15303	UniProtKB	Beta strand	360	364	.	.	.	.	
Q15303	UniProtKB	Beta strand	366	368	.	.	.	.	
Q15303	UniProtKB	Helix	370	374	.	.	.	.	
Q15303	UniProtKB	Helix	377	379	.	.	.	.	
Q15303	UniProtKB	Helix	386	394	.	.	.	.	
Q15303	UniProtKB	Beta strand	397	400	.	.	.	.	
Q15303	UniProtKB	Beta strand	402	405	.	.	.	.	
Q15303	UniProtKB	Helix	415	417	.	.	.	.	
Q15303	UniProtKB	Beta strand	432	438	.	.	.	.	
Q15303	UniProtKB	Beta strand	455	461	.	.	.	.	
Q15303	UniProtKB	Helix	469	471	.	.	.	.	
Q15303	UniProtKB	Helix	474	476	.	.	.	.	
Q15303	UniProtKB	Beta strand	479	482	.	.	.	.	
Q15303	UniProtKB	Beta strand	485	487	.	.	.	.	
Q15303	UniProtKB	Beta strand	489	491	.	.	.	.	
Q15303	UniProtKB	Helix	493	497	.	.	.	.	
Q15303	UniProtKB	Turn	498	500	.	.	.	.	
Q15303	UniProtKB	Beta strand	512	516	.	.	.	.	
Q15303	UniProtKB	Beta strand	519	528	.	.	.	.	
Q15303	UniProtKB	Beta strand	531	534	.	.	.	.	
Q15303	UniProtKB	Beta strand	537	543	.	.	.	.	
Q15303	UniProtKB	Beta strand	545	548	.	.	.	.	
Q15303	UniProtKB	Beta strand	551	554	.	.	.	.	
Q15303	UniProtKB	Beta strand	568	573	.	.	.	.	
Q15303	UniProtKB	Beta strand	576	585	.	.	.	.	
Q15303	UniProtKB	Beta strand	588	592	.	.	.	.	
Q15303	UniProtKB	Beta strand	595	608	.	.	.	.	
Q15303	UniProtKB	Beta strand	612	616	.	.	.	.	
Q15303	UniProtKB	Beta strand	625	629	.	.	.	.	
Q15303	UniProtKB	Helix	651	676	.	.	.	.	
Q15303	UniProtKB	Helix	715	717	.	.	.	.	
Q15303	UniProtKB	Beta strand	718	729	.	.	.	.	
Q15303	UniProtKB	Beta strand	731	737	.	.	.	.	
Q15303	UniProtKB	Beta strand	740	743	.	.	.	.	
Q15303	UniProtKB	Beta strand	746	752	.	.	.	.	
Q15303	UniProtKB	Helix	762	773	.	.	.	.	
Q15303	UniProtKB	Beta strand	778	780	.	.	.	.	
Q15303	UniProtKB	Beta strand	783	787	.	.	.	.	
Q15303	UniProtKB	Beta strand	789	791	.	.	.	.	
Q15303	UniProtKB	Beta strand	793	797	.	.	.	.	
Q15303	UniProtKB	Helix	804	810	.	.	.	.	
Q15303	UniProtKB	Helix	812	814	.	.	.	.	
Q15303	UniProtKB	Helix	817	836	.	.	.	.	
Q15303	UniProtKB	Helix	846	848	.	.	.	.	
Q15303	UniProtKB	Beta strand	849	853	.	.	.	.	
Q15303	UniProtKB	Beta strand	856	859	.	.	.	.	
Q15303	UniProtKB	Helix	864	869	.	.	.	.	
Q15303	UniProtKB	Helix	884	886	.	.	.	.	
Q15303	UniProtKB	Helix	889	893	.	.	.	.	
Q15303	UniProtKB	Helix	899	914	.	.	.	.	
Q15303	UniProtKB	Turn	920	923	.	.	.	.	
Q15303	UniProtKB	Turn	926	928	.	.	.	.	
Q15303	UniProtKB	Helix	929	934	.	.	.	.	
Q15303	UniProtKB	Helix	947	955	.	.	.	.	
Q15303	UniProtKB	Helix	961	963	.	.	.	.	
Q15303	UniProtKB	Helix	967	977	.	.	.	.	
Q15303	UniProtKB	Helix	981	983	.	.	.	.	
##sequence-region Q61527 1 1308
Q61527	UniProtKB	Signal peptide	1	25	.	.	.	status=Potential	
Q61527	UniProtKB	Chain	26	1308	.	.	.	ID=PRO_0000270146;Note=Receptor tyrosine-protein kinase erbB-4	
Q61527	UniProtKB	Chain	676	1308	.	.	.	ID=PRO_0000396798;Note=ERBB4 intracellular domain	
Q61527	UniProtKB	Topological domain	26	652	.	.	.	Note=Extracellular;status=Potential	
Q61527	UniProtKB	Transmembrane	653	673	.	.	.	status=Potential	
Q61527	UniProtKB	Topological domain	674	1308	.	.	.	Note=Cytoplasmic;status=Potential	
Q61527	UniProtKB	Domain	718	985	.	.	.	Note=Protein kinase	
Q61527	UniProtKB	Nucleotide binding	724	732	.	.	.	Note=ATP;status=By similarity	
Q61527	UniProtKB	Nucleotide binding	797	799	.	.	.	Note=ATP;status=By similarity	
Q61527	UniProtKB	Nucleotide binding	843	848	.	.	.	Note=ATP;status=By similarity	
Q61527	UniProtKB	Motif	676	684	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q61527	UniProtKB	Motif	1032	1035	.	.	.	Note=PPxy motif 1;status=By similarity	
Q61527	UniProtKB	Motif	1282	1285	.	.	.	Note=PPxY motif 2;status=By similarity	
Q61527	UniProtKB	Motif	1290	1292	.	.	.	Note=PDZ-binding;status=By similarity	
Q61527	UniProtKB	Compositional bias	186	262	.	.	.	Note=Cys-rich	
Q61527	UniProtKB	Compositional bias	496	593	.	.	.	Note=Cys-rich	
Q61527	UniProtKB	Compositional bias	1281	1284	.	.	.	Note=Poly-Pro	
Q61527	UniProtKB	Active site	843	843	.	.	.	Note=Proton acceptor;status=By similarity	
Q61527	UniProtKB	Binding site	751	751	.	.	.	Note=ATP;status=By similarity	
Q61527	UniProtKB	Modified residue	875	875	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1035	1035	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1056	1056	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1150	1150	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1162	1162	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1188	1188	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1202	1202	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1242	1242	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1258	1258	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Modified residue	1284	1284	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q61527	UniProtKB	Glycosylation	138	138	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	174	174	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	181	181	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	253	253	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	410	410	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	473	473	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	495	495	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	548	548	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	576	576	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Glycosylation	620	620	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q61527	UniProtKB	Disulfide bond	29	56	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	156	186	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	189	197	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	193	205	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	213	221	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	217	229	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	230	238	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	234	246	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	249	258	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	262	289	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	293	304	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	308	323	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	326	330	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	503	512	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	507	520	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	523	532	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	536	552	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	555	569	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	559	577	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	580	589	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	593	614	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	617	625	.	.	.	status=By similarity	
Q61527	UniProtKB	Disulfide bond	621	633	.	.	.	status=By similarity	
Q61527	UniProtKB	Alternative sequence	626	648	.	.	.	ID=VSP_002896;Note=In isoform JM-B CYT-2.	
Q61527	UniProtKB	Alternative sequence	1046	1061	.	.	.	ID=VSP_042131;Note=In isoform JM-A CYT-2.	
Q61527	UniProtKB	Sequence conflict	1019	1019	.	.	.	.	
##sequence-region Q62956 1 1308
Q62956	UniProtKB	Signal peptide	1	25	.	.	.	status=Potential	
Q62956	UniProtKB	Chain	26	1308	.	.	.	ID=PRO_0000016675;Note=Receptor tyrosine-protein kinase erbB-4	
Q62956	UniProtKB	Chain	676	1308	.	.	.	ID=PRO_0000396799;Note=ERBB4 intracellular domain;status=By similarity	
Q62956	UniProtKB	Topological domain	26	651	.	.	.	Note=Extracellular;status=Potential	
Q62956	UniProtKB	Transmembrane	652	675	.	.	.	status=Potential	
Q62956	UniProtKB	Topological domain	676	1308	.	.	.	Note=Cytoplasmic;status=Potential	
Q62956	UniProtKB	Domain	718	985	.	.	.	Note=Protein kinase	
Q62956	UniProtKB	Nucleotide binding	724	732	.	.	.	Note=ATP;status=By similarity	
Q62956	UniProtKB	Nucleotide binding	797	799	.	.	.	Note=ATP;status=By similarity	
Q62956	UniProtKB	Nucleotide binding	843	848	.	.	.	Note=ATP;status=By similarity	
Q62956	UniProtKB	Motif	676	684	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q62956	UniProtKB	Motif	1032	1035	.	.	.	Note=PPxy motif 1	
Q62956	UniProtKB	Motif	1298	1301	.	.	.	Note=PPxY motif 2	
Q62956	UniProtKB	Motif	1306	1308	.	.	.	Note=PDZ-binding	
Q62956	UniProtKB	Compositional bias	186	334	.	.	.	Note=Cys-rich	
Q62956	UniProtKB	Compositional bias	496	633	.	.	.	Note=Cys-rich	
Q62956	UniProtKB	Active site	843	843	.	.	.	Note=Proton acceptor;status=By similarity	
Q62956	UniProtKB	Binding site	751	751	.	.	.	Note=ATP;status=By similarity	
Q62956	UniProtKB	Modified residue	875	875	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1035	1035	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1056	1056	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1150	1150	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1162	1162	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1188	1188	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1202	1202	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1242	1242	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1258	1258	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Modified residue	1284	1284	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
Q62956	UniProtKB	Glycosylation	138	138	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	174	174	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	253	253	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	358	358	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	410	410	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	473	473	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	495	495	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	548	548	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	576	576	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Glycosylation	620	620	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q62956	UniProtKB	Disulfide bond	29	56	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	156	186	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	189	197	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	193	205	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	213	221	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	217	229	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	230	238	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	234	246	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	249	258	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	262	289	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	293	304	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	308	323	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	326	330	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	503	512	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	507	520	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	523	532	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	536	552	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	555	569	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	559	577	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	580	589	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	593	614	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	617	625	.	.	.	status=By similarity	
Q62956	UniProtKB	Disulfide bond	621	633	.	.	.	status=By similarity	
Q62956	UniProtKB	Alternative sequence	1046	1062	.	.	.	ID=VSP_022150;Note=In isoform JM-A CYT2.	
Q62956	UniProtKB	Sequence conflict	406	406	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	406	406	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	596	596	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	596	596	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	951	951	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	951	951	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	1062	1062	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	1062	1062	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	1080	1082	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	1082	1082	.	.	.	.	
Q62956	UniProtKB	Sequence conflict	1082	1082	.	.	.	.	
##sequence-region Q9UJM3 1 462
Q9UJM3	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q9UJM3	UniProtKB	Chain	2	462	.	.	.	ID=PRO_0000096487;Note=ERBB receptor feedback inhibitor 1	
Q9UJM3	UniProtKB	Region	334	363	.	.	.	Note=Interaction with EGFR and ERBB2 and regulation of EGFR activation	
Q9UJM3	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine	
Q9UJM3	UniProtKB	Modified residue	131	131	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9UJM3	UniProtKB	Modified residue	251	251	.	.	.	Note=Phosphoserine	
Q9UJM3	UniProtKB	Modified residue	273	273	.	.	.	Note=Phosphoserine;status=By similarity	
Q9UJM3	UniProtKB	Modified residue	302	302	.	.	.	Note=Phosphoserine;status=By similarity	
Q9UJM3	UniProtKB	Modified residue	461	461	.	.	.	Note=Phosphoserine	
Q9UJM3	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_063039;Dbxref=dbSNP:rs34781518	
Q9UJM3	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_050975;Dbxref=dbSNP:rs34974993	
Q9UJM3	UniProtKB	Mutagenesis	346	346	.	.	.	Note=Abolishes inhibition of EGFR activity.	
Q9UJM3	UniProtKB	Mutagenesis	352	352	.	.	.	Note=Abolishes inhibition of EGFR activity.	
Q9UJM3	UniProtKB	Mutagenesis	358	358	.	.	.	Note=Abolishes inhibition of EGFR activity.	
Q9UJM3	UniProtKB	Sequence conflict	7	7	.	.	.	.	
Q9UJM3	UniProtKB	Sequence conflict	36	36	.	.	.	.	
Q9UJM3	UniProtKB	Helix	342	344	.	.	.	.	
Q9UJM3	UniProtKB	Turn	356	358	.	.	.	.	
##sequence-region Q99JZ7 1 461
Q99JZ7	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q99JZ7	UniProtKB	Chain	2	461	.	.	.	ID=PRO_0000096488;Note=ERBB receptor feedback inhibitor 1	
Q99JZ7	UniProtKB	Region	333	362	.	.	.	Note=Interaction with EGFR and ERBB2 and regulation of EGFR activation;status=By similarity	
Q99JZ7	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;status=By similarity	
Q99JZ7	UniProtKB	Modified residue	130	130	.	.	.	Note=Phosphothreonine	
Q99JZ7	UniProtKB	Modified residue	251	251	.	.	.	Note=Phosphoserine	
Q99JZ7	UniProtKB	Modified residue	272	272	.	.	.	Note=Phosphoserine	
Q99JZ7	UniProtKB	Modified residue	301	301	.	.	.	Note=Phosphoserine	
Q99JZ7	UniProtKB	Modified residue	460	460	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region P05432 1 459
P05432	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
P05432	UniProtKB	Chain	2	459	.	.	.	ID=PRO_0000096489;Note=ERBB receptor feedback inhibitor 1	
P05432	UniProtKB	Region	332	361	.	.	.	Note=Interaction with EGFR and ERBB2 and regulation of EGFR activation;status=By similarity	
P05432	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;status=By similarity	
P05432	UniProtKB	Modified residue	130	130	.	.	.	Note=Phosphothreonine;status=By similarity	
P05432	UniProtKB	Modified residue	250	250	.	.	.	Note=Phosphoserine;status=By similarity	
P05432	UniProtKB	Modified residue	271	271	.	.	.	Note=Phosphoserine;status=By similarity	
P05432	UniProtKB	Modified residue	300	300	.	.	.	Note=Phosphoserine;status=By similarity	
P05432	UniProtKB	Modified residue	458	458	.	.	.	Note=Phosphoserine;status=By similarity	
P05432	UniProtKB	Alternative sequence	67	142	.	.	.	ID=VSP_011893;Note=In isoform 2.	
P05432	UniProtKB	Sequence conflict	18	18	.	.	.	.	
P05432	UniProtKB	Sequence conflict	192	192	.	.	.	.	
P05432	UniProtKB	Sequence conflict	302	302	.	.	.	.	
P05432	UniProtKB	Sequence conflict	311	311	.	.	.	.	
P05432	UniProtKB	Sequence conflict	396	396	.	.	.	.	
P05432	UniProtKB	Sequence conflict	410	410	.	.	.	.	
##sequence-region Q16394 1 746
Q16394	UniProtKB	Chain	1	746	.	.	.	ID=PRO_0000149648;Note=Exostosin-1	
Q16394	UniProtKB	Topological domain	1	7	.	.	.	Note=Cytoplasmic;status=Potential	
Q16394	UniProtKB	Transmembrane	8	28	.	.	.	Note=Helical%3B Signal-anchor for type II membrane protein%3B;status=Potential	
Q16394	UniProtKB	Topological domain	29	746	.	.	.	Note=Lumenal;status=Potential	
Q16394	UniProtKB	Glycosylation	89	89	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q16394	UniProtKB	Glycosylation	330	330	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q16394	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_012815;Note=In EXT1%3B no loss of activity.	
Q16394	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_012816;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Natural variant	215	222	.	.	.	ID=VAR_012818;Note=In isolated osteochondroma%3B somatic mutation.	
Q16394	UniProtKB	Natural variant	215	221	.	.	.	ID=VAR_012817;Note=In EXT1.	
Q16394	UniProtKB	Natural variant	235	239	.	.	.	ID=VAR_012819;Note=In multiple osteochondromas.	
Q16394	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_002370;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_002371;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_012820;Note=In chondrosarcoma%3B no loss of activity.	
Q16394	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_002372;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_002373;Note=In EXT1%3B loss of activity%3B still able to form an oligomeric complex.	
Q16394	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_002374;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_002375;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_002376;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Natural variant	486	486	.	.	.	ID=VAR_012821;Dbxref=dbSNP:rs188859975;Note=In EXT1%3B no loss of activity.	
Q16394	UniProtKB	Natural variant	496	496	.	.	.	ID=VAR_012822;Note=In EXT1%3B no loss of activity.	
Q16394	UniProtKB	Natural variant	627	627	.	.	.	ID=VAR_002377;Note=In EXT1%3B loss of activity.	
Q16394	UniProtKB	Mutagenesis	27	27	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	27	27	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Abolishes heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	164	164	.	.	.	Note=Abolishes heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	316	316	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	316	316	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	486	486	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	486	486	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	496	496	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Mutagenesis	496	496	.	.	.	Note=No effect on heparan-sulfate biosynthesis.	
Q16394	UniProtKB	Sequence conflict	60	61	.	.	.	.	
Q16394	UniProtKB	Sequence conflict	60	61	.	.	.	.	
##sequence-region Q93063 1 718
Q93063	UniProtKB	Chain	1	718	.	.	.	ID=PRO_0000149651;Note=Exostosin-2	
Q93063	UniProtKB	Topological domain	1	25	.	.	.	Note=Cytoplasmic;status=Potential	
Q93063	UniProtKB	Transmembrane	26	46	.	.	.	Note=Helical%3B Signal-anchor for type II membrane protein%3B;status=Potential	
Q93063	UniProtKB	Topological domain	47	718	.	.	.	Note=Lumenal;status=Potential	
Q93063	UniProtKB	Glycosylation	288	288	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q93063	UniProtKB	Glycosylation	637	637	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q93063	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_046053;Note=In isoform 3.	
Q93063	UniProtKB	Alternative sequence	392	411	.	.	.	ID=VSP_001798;Note=In isoform 2.	
Q93063	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_033921;Dbxref=dbSNP:rs4755779	
Q93063	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_012823;Note=In EXT2.	
Q93063	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_012824;Note=In EXT2.	
Q93063	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_012825;Note=In EXT2.	
Q93063	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_012826;Note=In EXT2.	
Q93063	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_012827;Note=In EXT2.	
Q93063	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_002378;Note=In EXT2%3B can still form an oligomeric complex.	
Q93063	UniProtKB	Natural variant	380	380	.	.	.	ID=VAR_012828;Note=In EXT2.	
Q93063	UniProtKB	Natural variant	576	576	.	.	.	ID=VAR_012829;Note=In osteochondroma.	
Q93063	UniProtKB	Sequence conflict	322	322	.	.	.	.	
Q93063	UniProtKB	Sequence conflict	568	568	.	.	.	.	
##sequence-region Q9NZB2 1 1118
Q9NZB2	UniProtKB	Chain	1	1118	.	.	.	ID=PRO_0000221627;Note=Constitutive coactivator of PPAR-gamma-like protein 1	
Q9NZB2	UniProtKB	Region	339	405	.	.	.	Note=Interaction with YES1%2C SRC and FYN	
Q9NZB2	UniProtKB	Region	829	1118	.	.	.	Note=RNA binding	
Q9NZB2	UniProtKB	Modified residue	1023	1023	.	.	.	Note=Phosphoserine	
Q9NZB2	UniProtKB	Modified residue	1044	1044	.	.	.	Note=Phosphoserine	
Q9NZB2	UniProtKB	Modified residue	1045	1045	.	.	.	Note=Phosphoserine	
Q9NZB2	UniProtKB	Modified residue	1048	1048	.	.	.	Note=Phosphoserine	
Q9NZB2	UniProtKB	Alternative sequence	473	473	.	.	.	ID=VSP_036324;Note=In isoform F.	
Q9NZB2	UniProtKB	Alternative sequence	579	628	.	.	.	ID=VSP_004147;Note=In isoform B.	
Q9NZB2	UniProtKB	Alternative sequence	629	1118	.	.	.	ID=VSP_004148;Note=In isoform B.	
Q9NZB2	UniProtKB	Alternative sequence	637	651	.	.	.	ID=VSP_017278;Note=In isoform E.	
Q9NZB2	UniProtKB	Alternative sequence	652	1118	.	.	.	ID=VSP_017279;Note=In isoform E.	
Q9NZB2	UniProtKB	Alternative sequence	890	935	.	.	.	ID=VSP_017280;Note=In isoform D.	
Q9NZB2	UniProtKB	Natural variant	327	327	.	.	.	ID=VAR_054400;Dbxref=dbSNP:rs11541747	
Q9NZB2	UniProtKB	Sequence conflict	517	520	.	.	.	.	
Q9NZB2	UniProtKB	Sequence conflict	556	556	.	.	.	.	
##sequence-region P14238 1 820
P14238	UniProtKB	Chain	1	820	.	.	.	ID=PRO_0000088085;Note=Tyrosine-protein kinase Fes/Fps	
P14238	UniProtKB	Domain	1	94	.	.	.	Note=FCH	
P14238	UniProtKB	Domain	458	547	.	.	.	Note=SH2	
P14238	UniProtKB	Domain	559	820	.	.	.	Note=Protein kinase	
P14238	UniProtKB	Nucleotide binding	565	573	.	.	.	Note=ATP;status=By similarity	
P14238	UniProtKB	Region	1	298	.	.	.	Note=Important for interaction with membranes containing phosphoinositides;status=By similarity	
P14238	UniProtKB	Coiled coil	123	163	.	.	.	status=Potential	
P14238	UniProtKB	Coiled coil	318	389	.	.	.	status=Potential	
P14238	UniProtKB	Active site	681	681	.	.	.	Note=Proton acceptor;status=By similarity	
P14238	UniProtKB	Binding site	588	588	.	.	.	Note=ATP;status=By similarity	
P14238	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine;status=By similarity	
P14238	UniProtKB	Modified residue	259	259	.	.	.	Note=Phosphotyrosine;status=By similarity	
P14238	UniProtKB	Modified residue	419	419	.	.	.	Note=Phosphothreonine;status=By similarity	
P14238	UniProtKB	Modified residue	711	711	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
P14238	UniProtKB	Modified residue	714	714	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region P07332 1 822
P07332	UniProtKB	Chain	1	822	.	.	.	ID=PRO_0000088088;Note=Tyrosine-protein kinase Fes/Fps	
P07332	UniProtKB	Domain	1	69	.	.	.	Note=FCH	
P07332	UniProtKB	Domain	460	549	.	.	.	Note=SH2	
P07332	UniProtKB	Domain	561	822	.	.	.	Note=Protein kinase	
P07332	UniProtKB	Nucleotide binding	567	575	.	.	.	Note=ATP;status=By similarity	
P07332	UniProtKB	Region	1	300	.	.	.	Note=Important for interaction with membranes containing phosphoinositides	
P07332	UniProtKB	Coiled coil	125	169	.	.	.	status=Potential	
P07332	UniProtKB	Coiled coil	324	368	.	.	.	status=Potential	
P07332	UniProtKB	Active site	683	683	.	.	.	Note=Proton acceptor;status=By similarity	
P07332	UniProtKB	Binding site	590	590	.	.	.	Note=ATP;status=By similarity	
P07332	UniProtKB	Modified residue	64	64	.	.	.	Note=Phosphoserine	
P07332	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphoserine	
P07332	UniProtKB	Modified residue	261	261	.	.	.	Note=Phosphotyrosine	
P07332	UniProtKB	Modified residue	421	421	.	.	.	Note=Phosphothreonine	
P07332	UniProtKB	Modified residue	713	713	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P07332	UniProtKB	Modified residue	716	716	.	.	.	Note=Phosphoserine	
P07332	UniProtKB	Alternative sequence	72	129	.	.	.	ID=VSP_041748;Note=In isoform 2 and isoform 3.	
P07332	UniProtKB	Alternative sequence	441	510	.	.	.	ID=VSP_041749;Note=In isoform 2 and isoform 4.	
P07332	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_041697;Dbxref=dbSNP:rs56041861	
P07332	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_041698;Dbxref=dbSNP:rs34573430	
P07332	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_041699;Dbxref=dbSNP:rs56296062	
P07332	UniProtKB	Mutagenesis	113	114	.	.	.	Note=Reduced binding to membranes containing phosphoinositides.	
P07332	UniProtKB	Mutagenesis	113	114	.	.	.	Note=Reduced binding to membranes containing phosphoinositides.	
P07332	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Constitutively activated kinase that can act as oncogene. Promotes myeloid cell survival and proliferation.	
P07332	UniProtKB	Mutagenesis	334	334	.	.	.	Note=Abolishes autophosphorylation.	
P07332	UniProtKB	Mutagenesis	463	463	.	.	.	Note=Abolishes kinase activity.	
P07332	UniProtKB	Mutagenesis	483	483	.	.	.	Note=Abolishes pTyr binding. Abolishes association with microtubules. Abolishes autophosphorylation. Reduced kinase activity.	
P07332	UniProtKB	Mutagenesis	590	590	.	.	.	Note=Abolishes kinase activity.	
P07332	UniProtKB	Mutagenesis	704	704	.	.	.	Note=Reduced autophosphorylation and strongly reduced kinase activity.	
P07332	UniProtKB	Mutagenesis	706	706	.	.	.	Note=Negligible effect on autophosphorylation and kinase activity.	
P07332	UniProtKB	Mutagenesis	713	713	.	.	.	Note=Reduces kinase activity by over 90%25.	
P07332	UniProtKB	Mutagenesis	743	743	.	.	.	Note=Strongly reduced autophosphorylation and kinase activity.	
P07332	UniProtKB	Mutagenesis	759	759	.	.	.	Note=Reduced autophosphorylation and strongly reduced kinase activity.	
P07332	UniProtKB	Sequence conflict	719	719	.	.	.	.	
P07332	UniProtKB	Sequence conflict	719	719	.	.	.	.	
P07332	UniProtKB	Sequence conflict	719	719	.	.	.	.	
P07332	UniProtKB	Sequence conflict	719	719	.	.	.	.	
P07332	UniProtKB	Helix	3	6	.	.	.	.	
P07332	UniProtKB	Helix	10	51	.	.	.	.	
P07332	UniProtKB	Helix	68	96	.	.	.	.	
P07332	UniProtKB	Helix	98	131	.	.	.	.	
P07332	UniProtKB	Helix	133	154	.	.	.	.	
P07332	UniProtKB	Helix	167	202	.	.	.	.	
P07332	UniProtKB	Helix	204	234	.	.	.	.	
P07332	UniProtKB	Beta strand	236	238	.	.	.	.	
P07332	UniProtKB	Helix	239	254	.	.	.	.	
P07332	UniProtKB	Helix	257	259	.	.	.	.	
P07332	UniProtKB	Helix	262	268	.	.	.	.	
P07332	UniProtKB	Turn	300	302	.	.	.	.	
P07332	UniProtKB	Helix	303	344	.	.	.	.	
P07332	UniProtKB	Helix	350	353	.	.	.	.	
P07332	UniProtKB	Helix	354	389	.	.	.	.	
P07332	UniProtKB	Turn	390	393	.	.	.	.	
P07332	UniProtKB	Helix	450	452	.	.	.	.	
P07332	UniProtKB	Helix	455	457	.	.	.	.	
P07332	UniProtKB	Beta strand	461	464	.	.	.	.	
P07332	UniProtKB	Helix	467	473	.	.	.	.	
P07332	UniProtKB	Beta strand	479	484	.	.	.	.	
P07332	UniProtKB	Turn	486	489	.	.	.	.	
P07332	UniProtKB	Beta strand	491	494	.	.	.	.	
P07332	UniProtKB	Beta strand	503	506	.	.	.	.	
P07332	UniProtKB	Beta strand	507	509	.	.	.	.	
P07332	UniProtKB	Beta strand	512	517	.	.	.	.	
P07332	UniProtKB	Beta strand	520	522	.	.	.	.	
P07332	UniProtKB	Helix	523	533	.	.	.	.	
P07332	UniProtKB	Turn	539	541	.	.	.	.	
P07332	UniProtKB	Helix	558	560	.	.	.	.	
P07332	UniProtKB	Beta strand	561	570	.	.	.	.	
P07332	UniProtKB	Beta strand	573	580	.	.	.	.	
P07332	UniProtKB	Turn	581	583	.	.	.	.	
P07332	UniProtKB	Beta strand	586	591	.	.	.	.	
P07332	UniProtKB	Helix	598	601	.	.	.	.	
P07332	UniProtKB	Helix	602	605	.	.	.	.	
P07332	UniProtKB	Helix	606	611	.	.	.	.	
P07332	UniProtKB	Beta strand	622	626	.	.	.	.	
P07332	UniProtKB	Beta strand	628	631	.	.	.	.	
P07332	UniProtKB	Beta strand	633	637	.	.	.	.	
P07332	UniProtKB	Helix	644	651	.	.	.	.	
P07332	UniProtKB	Helix	652	654	.	.	.	.	
P07332	UniProtKB	Helix	657	676	.	.	.	.	
P07332	UniProtKB	Helix	686	688	.	.	.	.	
P07332	UniProtKB	Beta strand	689	691	.	.	.	.	
P07332	UniProtKB	Beta strand	697	699	.	.	.	.	
P07332	UniProtKB	Helix	702	704	.	.	.	.	
P07332	UniProtKB	Beta strand	711	714	.	.	.	.	
P07332	UniProtKB	Beta strand	720	723	.	.	.	.	
P07332	UniProtKB	Helix	724	726	.	.	.	.	
P07332	UniProtKB	Helix	729	734	.	.	.	.	
P07332	UniProtKB	Beta strand	736	738	.	.	.	.	
P07332	UniProtKB	Helix	739	754	.	.	.	.	
P07332	UniProtKB	Turn	755	757	.	.	.	.	
P07332	UniProtKB	Helix	766	774	.	.	.	.	
P07332	UniProtKB	Helix	787	796	.	.	.	.	
P07332	UniProtKB	Helix	801	803	.	.	.	.	
P07332	UniProtKB	Helix	807	820	.	.	.	.	
##sequence-region P16879 1 822
P16879	UniProtKB	Chain	1	822	.	.	.	ID=PRO_0000088089;Note=Tyrosine-protein kinase Fes/Fps	
P16879	UniProtKB	Domain	1	96	.	.	.	Note=FCH	
P16879	UniProtKB	Domain	460	549	.	.	.	Note=SH2	
P16879	UniProtKB	Domain	561	818	.	.	.	Note=Protein kinase	
P16879	UniProtKB	Nucleotide binding	567	575	.	.	.	Note=ATP;status=By similarity	
P16879	UniProtKB	Region	1	300	.	.	.	Note=Important for interaction with membranes containing phosphoinositides;status=By similarity	
P16879	UniProtKB	Coiled coil	133	165	.	.	.	status=Potential	
P16879	UniProtKB	Coiled coil	320	369	.	.	.	status=Potential	
P16879	UniProtKB	Active site	683	683	.	.	.	Note=Proton acceptor;status=By similarity	
P16879	UniProtKB	Binding site	590	590	.	.	.	Note=ATP;status=By similarity	
P16879	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphoserine;status=By similarity	
P16879	UniProtKB	Modified residue	261	261	.	.	.	Note=Phosphotyrosine;status=By similarity	
P16879	UniProtKB	Modified residue	421	421	.	.	.	Note=Phosphothreonine;status=By similarity	
P16879	UniProtKB	Modified residue	713	713	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
P16879	UniProtKB	Modified residue	716	716	.	.	.	Note=Phosphoserine;status=By similarity	
P16879	UniProtKB	Sequence conflict	110	111	.	.	.	.	
P16879	UniProtKB	Sequence conflict	413	414	.	.	.	.	
P16879	UniProtKB	Sequence conflict	413	414	.	.	.	.	
P16879	UniProtKB	Sequence conflict	467	467	.	.	.	.	
P16879	UniProtKB	Sequence conflict	477	477	.	.	.	.	
P16879	UniProtKB	Sequence conflict	477	477	.	.	.	.	
P16879	UniProtKB	Sequence conflict	500	500	.	.	.	.	
P16879	UniProtKB	Sequence conflict	500	500	.	.	.	.	
P16879	UniProtKB	Sequence conflict	509	509	.	.	.	.	
P16879	UniProtKB	Sequence conflict	509	509	.	.	.	.	
P16879	UniProtKB	Sequence conflict	664	664	.	.	.	.	
P16879	UniProtKB	Sequence conflict	716	717	.	.	.	.	
P16879	UniProtKB	Sequence conflict	716	717	.	.	.	.	
P16879	UniProtKB	Sequence conflict	749	749	.	.	.	.	
##sequence-region P49789 1 147
P49789	UniProtKB	Chain	1	147	.	.	.	ID=PRO_0000109789;Note=Bis(5'-adenosyl)-triphosphatase	
P49789	UniProtKB	Domain	2	109	.	.	.	Note=HIT	
P49789	UniProtKB	Nucleotide binding	89	92	.	.	.	Note=Substrate	
P49789	UniProtKB	Motif	94	98	.	.	.	Note=Histidine triad motif	
P49789	UniProtKB	Active site	96	96	.	.	.	Note=Tele-AMP-histidine intermediate	
P49789	UniProtKB	Binding site	8	8	.	.	.	Note=Substrate	
P49789	UniProtKB	Binding site	27	27	.	.	.	Note=Substrate	
P49789	UniProtKB	Binding site	83	83	.	.	.	Note=Substrate	
P49789	UniProtKB	Binding site	98	98	.	.	.	Note=Substrate	
P49789	UniProtKB	Site	114	114	.	.	.	Note=Important for induction of apoptosis	
P49789	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphotyrosine%3B by SRC	
P49789	UniProtKB	Modified residue	145	145	.	.	.	Note=Phosphotyrosine	
P49789	UniProtKB	Mutagenesis	10	10	.	.	.	Note=Strongly reduces affinity for substrates and impairs apoptosis%3B when associated with W-25.	
P49789	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Reduces affinity for substrates and impairs apoptosis. Strongly reduces affinity for substrates and impairs apoptosis%3B when associated with W-10.	
P49789	UniProtKB	Mutagenesis	35	35	.	.	.	Note=50%25 decrease in catalytic activity. No loss in substrate binding.	
P49789	UniProtKB	Mutagenesis	94	94	.	.	.	Note=75%25 decrease in catalytic activity. No loss in substrate binding.	
P49789	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Loss of catalytic activity.	
P49789	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Total loss of catalytic activity. Rescuable with free imidazole.	
P49789	UniProtKB	Mutagenesis	96	96	.	.	.	Note=Total loss of catalytic activity. No loss in substrate binding.	
P49789	UniProtKB	Mutagenesis	98	98	.	.	.	Note=98%25 decrease in catalytic activity.	
P49789	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Impairs induction of apoptosis. Strongly reduced affinity for substrates.	
P49789	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Impairs induction of apoptosis. Reduces affinity for substrates.	
P49789	UniProtKB	Mutagenesis	114	114	.	.	.	Note=Loss of phosphorylation by SRC. Impairs induction of apoptosis.	
P49789	UniProtKB	Mutagenesis	145	145	.	.	.	Note=No effect on phosphorylation by SRC.	
P49789	UniProtKB	Beta strand	3	5	.	.	.	.	
P49789	UniProtKB	Beta strand	8	10	.	.	.	.	
P49789	UniProtKB	Helix	12	14	.	.	.	.	
P49789	UniProtKB	Beta strand	15	18	.	.	.	.	
P49789	UniProtKB	Beta strand	20	26	.	.	.	.	
P49789	UniProtKB	Beta strand	36	42	.	.	.	.	
P49789	UniProtKB	Helix	47	49	.	.	.	.	
P49789	UniProtKB	Helix	52	72	.	.	.	.	
P49789	UniProtKB	Beta strand	76	82	.	.	.	.	
P49789	UniProtKB	Helix	86	88	.	.	.	.	
P49789	UniProtKB	Beta strand	92	94	.	.	.	.	
P49789	UniProtKB	Beta strand	97	102	.	.	.	.	
P49789	UniProtKB	Helix	132	144	.	.	.	.	
##sequence-region Q3B7L5 1 579
Q3B7L5	UniProtKB	Chain	1	579	.	.	.	ID=PRO_0000223939;Note=Folliculin	
Q3B7L5	UniProtKB	Coiled coil	285	309	.	.	.	status=Potential	
Q3B7L5	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphoserine;status=By similarity	
Q3B7L5	UniProtKB	Modified residue	73	73	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q8NFG4 1 579
Q8NFG4	UniProtKB	Chain	1	579	.	.	.	ID=PRO_0000223940;Note=Folliculin	
Q8NFG4	UniProtKB	Coiled coil	287	310	.	.	.	status=Potential	
Q8NFG4	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphoserine	
Q8NFG4	UniProtKB	Modified residue	73	73	.	.	.	Note=Phosphoserine;status=By similarity	
Q8NFG4	UniProtKB	Alternative sequence	134	197	.	.	.	ID=VSP_017312;Note=In isoform 3.	
Q8NFG4	UniProtKB	Alternative sequence	198	579	.	.	.	ID=VSP_017313;Note=In isoform 3.	
Q8NFG4	UniProtKB	Alternative sequence	291	342	.	.	.	ID=VSP_017314;Note=In isoform 2.	
Q8NFG4	UniProtKB	Alternative sequence	343	579	.	.	.	ID=VSP_017315;Note=In isoform 2.	
Q8NFG4	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_025356;Note=In a sporadic colorectal carcinoma%3B somatic mutation.	
Q8NFG4	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_066023;Note=In BHD.	
Q8NFG4	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_066024;Note=In PSP.	
Q8NFG4	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_066025;Note=In PSP%3B impaired protein stability.	
Q8NFG4	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_025357;Note=In a renal cell carcinoma cell line.	
Q8NFG4	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_066026;Dbxref=dbSNP:rs78683075;Note=In RCC%3B impaired protein stability.	
Q8NFG4	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_025358;Note=In a primary colorectal cancer.	
Q8NFG4	UniProtKB	Natural variant	362	362	.	.	.	ID=VAR_066027;Note=Found in a colorectal cell line%3B impaired protein stability.	
Q8NFG4	UniProtKB	Natural variant	392	392	.	.	.	ID=VAR_025359;Note=In a primary colorectal cancer%3B somatic mutation.	
Q8NFG4	UniProtKB	Natural variant	429	429	.	.	.	ID=VAR_066028;Note=In PSP.	
Q8NFG4	UniProtKB	Natural variant	444	444	.	.	.	ID=VAR_025360;Note=In a primary clear-cell renal cell carcinoma%3B somatic mutation.	
Q8NFG4	UniProtKB	Natural variant	445	445	.	.	.	ID=VAR_025361;Dbxref=dbSNP:rs41419545;Note=In a sporadic colorectal carcinoma%3B somatic mutation.	
Q8NFG4	UniProtKB	Natural variant	508	508	.	.	.	ID=VAR_066029;Note=In BHD%3B does not impair protein stability%2C growth suppression activity or intracellular localization of folliculin.	
Q8NFG4	UniProtKB	Helix	349	356	.	.	.	.	
Q8NFG4	UniProtKB	Helix	358	370	.	.	.	.	
Q8NFG4	UniProtKB	Beta strand	373	377	.	.	.	.	
Q8NFG4	UniProtKB	Helix	381	391	.	.	.	.	
Q8NFG4	UniProtKB	Helix	392	394	.	.	.	.	
Q8NFG4	UniProtKB	Helix	397	399	.	.	.	.	
Q8NFG4	UniProtKB	Beta strand	402	408	.	.	.	.	
Q8NFG4	UniProtKB	Turn	412	414	.	.	.	.	
Q8NFG4	UniProtKB	Beta strand	416	420	.	.	.	.	
Q8NFG4	UniProtKB	Helix	428	431	.	.	.	.	
Q8NFG4	UniProtKB	Beta strand	436	443	.	.	.	.	
Q8NFG4	UniProtKB	Beta strand	463	469	.	.	.	.	
Q8NFG4	UniProtKB	Helix	481	491	.	.	.	.	
Q8NFG4	UniProtKB	Helix	497	521	.	.	.	.	
Q8NFG4	UniProtKB	Helix	530	538	.	.	.	.	
Q8NFG4	UniProtKB	Helix	544	553	.	.	.	.	
Q8NFG4	UniProtKB	Helix	554	556	.	.	.	.	
##sequence-region Q8QZS3 1 579
Q8QZS3	UniProtKB	Chain	1	579	.	.	.	ID=PRO_0000223941;Note=Folliculin	
Q8QZS3	UniProtKB	Coiled coil	287	310	.	.	.	status=Potential	
Q8QZS3	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphoserine	
Q8QZS3	UniProtKB	Modified residue	73	73	.	.	.	Note=Phosphoserine	
Q8QZS3	UniProtKB	Sequence conflict	29	29	.	.	.	.	
Q8QZS3	UniProtKB	Sequence conflict	240	240	.	.	.	.	
Q8QZS3	UniProtKB	Sequence conflict	328	328	.	.	.	.	
Q8QZS3	UniProtKB	Sequence conflict	377	377	.	.	.	.	
##sequence-region Q76JQ2 1 579
Q76JQ2	UniProtKB	Chain	1	579	.	.	.	ID=PRO_0000223942;Note=Folliculin	
Q76JQ2	UniProtKB	Coiled coil	287	310	.	.	.	status=Potential	
Q76JQ2	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphoserine;status=By similarity	
Q76JQ2	UniProtKB	Modified residue	73	73	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region P42685 1 505
P42685	UniProtKB	Chain	1	505	.	.	.	ID=PRO_0000088097;Note=Tyrosine-protein kinase FRK	
P42685	UniProtKB	Domain	42	110	.	.	.	Note=SH3	
P42685	UniProtKB	Domain	116	208	.	.	.	Note=SH2	
P42685	UniProtKB	Domain	234	491	.	.	.	Note=Protein kinase	
P42685	UniProtKB	Nucleotide binding	240	248	.	.	.	Note=ATP;status=By similarity	
P42685	UniProtKB	Active site	354	354	.	.	.	Note=Proton acceptor;status=By similarity	
P42685	UniProtKB	Binding site	262	262	.	.	.	Note=ATP;status=By similarity	
P42685	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine	
P42685	UniProtKB	Modified residue	387	387	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
P42685	UniProtKB	Natural variant	100	100	.	.	.	ID=VAR_041702;Dbxref=dbSNP:rs34704018	
P42685	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_006283;Dbxref=dbSNP:rs3756772	
P42685	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_041703;Dbxref=dbSNP:rs34064900	
P42685	UniProtKB	Mutagenesis	262	262	.	.	.	Note=Loss of ability to phosphorylate PTEN.	
P42685	UniProtKB	Sequence conflict	115	115	.	.	.	.	
##sequence-region Q922K9 1 512
Q922K9	UniProtKB	Chain	1	512	.	.	.	ID=PRO_0000260826;Note=Tyrosine-protein kinase FRK	
Q922K9	UniProtKB	Domain	42	117	.	.	.	Note=SH3	
Q922K9	UniProtKB	Domain	123	215	.	.	.	Note=SH2	
Q922K9	UniProtKB	Domain	241	498	.	.	.	Note=Protein kinase	
Q922K9	UniProtKB	Nucleotide binding	247	255	.	.	.	Note=ATP;status=By similarity	
Q922K9	UniProtKB	Active site	361	361	.	.	.	Note=Proton acceptor;status=By similarity	
Q922K9	UniProtKB	Binding site	269	269	.	.	.	Note=ATP;status=By similarity	
Q922K9	UniProtKB	Modified residue	394	394	.	.	.	Note=Phosphotyrosine%3B by autocatalysis	
Q922K9	UniProtKB	Sequence conflict	154	154	.	.	.	.	
Q922K9	UniProtKB	Sequence conflict	237	237	.	.	.	.	
Q922K9	UniProtKB	Sequence conflict	335	335	.	.	.	.	
Q922K9	UniProtKB	Sequence conflict	335	335	.	.	.	.	
Q922K9	UniProtKB	Sequence conflict	509	509	.	.	.	.	
Q922K9	UniProtKB	Sequence conflict	509	509	.	.	.	.	
Q922K9	UniProtKB	Beta strand	47	49	.	.	.	.	
Q922K9	UniProtKB	Beta strand	52	58	.	.	.	.	
Q922K9	UniProtKB	Beta strand	63	67	.	.	.	.	
Q922K9	UniProtKB	Beta strand	76	80	.	.	.	.	
Q922K9	UniProtKB	Beta strand	83	91	.	.	.	.	
Q922K9	UniProtKB	Beta strand	103	108	.	.	.	.	
Q922K9	UniProtKB	Turn	109	111	.	.	.	.	
Q922K9	UniProtKB	Beta strand	112	114	.	.	.	.	
Q922K9	UniProtKB	Helix	116	120	.	.	.	.	
Q922K9	UniProtKB	Beta strand	122	124	.	.	.	.	
Q922K9	UniProtKB	Helix	130	137	.	.	.	.	
Q922K9	UniProtKB	Beta strand	138	141	.	.	.	.	
Q922K9	UniProtKB	Beta strand	147	151	.	.	.	.	
Q922K9	UniProtKB	Beta strand	153	157	.	.	.	.	
Q922K9	UniProtKB	Beta strand	159	167	.	.	.	.	
Q922K9	UniProtKB	Beta strand	169	176	.	.	.	.	
Q922K9	UniProtKB	Beta strand	178	180	.	.	.	.	
Q922K9	UniProtKB	Beta strand	182	185	.	.	.	.	
Q922K9	UniProtKB	Beta strand	188	192	.	.	.	.	
Q922K9	UniProtKB	Helix	193	200	.	.	.	.	
Q922K9	UniProtKB	Beta strand	205	209	.	.	.	.	
Q922K9	UniProtKB	Beta strand	220	222	.	.	.	.	
##sequence-region Q62662 1 506
Q62662	UniProtKB	Chain	1	506	.	.	.	ID=PRO_0000260827;Note=Tyrosine-protein kinase FRK	
Q62662	UniProtKB	Domain	42	111	.	.	.	Note=SH3	
Q62662	UniProtKB	Domain	117	209	.	.	.	Note=SH2	
Q62662	UniProtKB	Domain	235	492	.	.	.	Note=Protein kinase	
Q62662	UniProtKB	Nucleotide binding	241	249	.	.	.	Note=ATP;status=By similarity	
Q62662	UniProtKB	Active site	355	355	.	.	.	Note=Proton acceptor;status=By similarity	
Q62662	UniProtKB	Binding site	263	263	.	.	.	Note=ATP;status=By similarity	
Q62662	UniProtKB	Modified residue	388	388	.	.	.	Note=Phosphotyrosine%3B by autocatalysis;status=By similarity	
##sequence-region P07954 1 510
P07954	UniProtKB	Transit peptide	1	44	.	.	.	Note=Mitochondrion;status=By similarity	
P07954	UniProtKB	Chain	45	510	.	.	.	ID=PRO_0000010319;Note=Fumarate hydratase%2C mitochondrial	
P07954	UniProtKB	Region	176	179	.	.	.	Note=B site;status=By similarity	
P07954	UniProtKB	Region	186	188	.	.	.	Note=Substrate binding;status=By similarity	
P07954	UniProtKB	Binding site	147	147	.	.	.	Note=Substrate;status=By similarity	
P07954	UniProtKB	Modified residue	61	61	.	.	.	Note=N6-acetyllysine;status=By similarity	
P07954	UniProtKB	Modified residue	66	66	.	.	.	Note=N6-acetyllysine	
P07954	UniProtKB	Modified residue	80	80	.	.	.	Note=N6-acetyllysine	
P07954	UniProtKB	Modified residue	94	94	.	.	.	Note=N6-acetyllysine	
P07954	UniProtKB	Modified residue	115	115	.	.	.	Note=N6-acetyllysine;status=By similarity	
P07954	UniProtKB	Modified residue	122	122	.	.	.	Note=N6-acetyllysine;status=By similarity	
P07954	UniProtKB	Modified residue	213	213	.	.	.	Note=N6-acetyllysine;status=By similarity	
P07954	UniProtKB	Modified residue	223	223	.	.	.	Note=N6-acetyllysine;status=By similarity	
P07954	UniProtKB	Modified residue	256	256	.	.	.	Note=N6-acetyllysine	
P07954	UniProtKB	Modified residue	292	292	.	.	.	Note=N6-acetyllysine	
P07954	UniProtKB	Modified residue	502	502	.	.	.	Note=N6-acetyllysine;status=By similarity	
P07954	UniProtKB	Alternative sequence	1	43	.	.	.	ID=VSP_018965;Note=In isoform Cytoplasmic.	
P07954	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_013497;Note=In HLRCC.	
P07954	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_013498;Note=In HLRCC.	
P07954	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_013499;Note=In HLRCC.	
P07954	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_013500;Note=In HLRCC.	
P07954	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_002445;Note=In FHD and HLRCC.	
P07954	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_013501;Dbxref=dbSNP:rs28933069;Note=In HLRCC.	
P07954	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_013502;Note=In HLRCC.	
P07954	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_002446;Note=In FHD.	
P07954	UniProtKB	Natural variant	312	312	.	.	.	ID=VAR_002447;Note=In FHD.	
P07954	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_013503;Note=In HLRCC.	
P07954	UniProtKB	Natural variant	425	425	.	.	.	ID=VAR_002448;Note=In FHD.	
P07954	UniProtKB	Beta strand	50	55	.	.	.	.	
P07954	UniProtKB	Beta strand	58	63	.	.	.	.	
P07954	UniProtKB	Helix	70	78	.	.	.	.	
P07954	UniProtKB	Helix	84	86	.	.	.	.	
P07954	UniProtKB	Helix	90	106	.	.	.	.	
P07954	UniProtKB	Helix	107	110	.	.	.	.	
P07954	UniProtKB	Helix	114	128	.	.	.	.	
P07954	UniProtKB	Helix	133	135	.	.	.	.	
P07954	UniProtKB	Beta strand	139	142	.	.	.	.	
P07954	UniProtKB	Helix	147	164	.	.	.	.	
P07954	UniProtKB	Helix	177	181	.	.	.	.	
P07954	UniProtKB	Turn	182	184	.	.	.	.	
P07954	UniProtKB	Helix	187	205	.	.	.	.	
P07954	UniProtKB	Helix	207	224	.	.	.	.	
P07954	UniProtKB	Turn	225	227	.	.	.	.	
P07954	UniProtKB	Beta strand	229	234	.	.	.	.	
P07954	UniProtKB	Beta strand	237	243	.	.	.	.	
P07954	UniProtKB	Helix	244	264	.	.	.	.	
P07954	UniProtKB	Turn	267	269	.	.	.	.	
P07954	UniProtKB	Beta strand	270	272	.	.	.	.	
P07954	UniProtKB	Turn	277	279	.	.	.	.	
P07954	UniProtKB	Helix	289	301	.	.	.	.	
P07954	UniProtKB	Helix	311	316	.	.	.	.	
P07954	UniProtKB	Helix	319	345	.	.	.	.	
P07954	UniProtKB	Beta strand	349	352	.	.	.	.	
P07954	UniProtKB	Helix	375	399	.	.	.	.	
P07954	UniProtKB	Helix	409	433	.	.	.	.	
P07954	UniProtKB	Helix	435	437	.	.	.	.	
P07954	UniProtKB	Helix	442	451	.	.	.	.	
P07954	UniProtKB	Helix	454	459	.	.	.	.	
P07954	UniProtKB	Helix	460	463	.	.	.	.	
P07954	UniProtKB	Helix	465	478	.	.	.	.	
P07954	UniProtKB	Helix	482	488	.	.	.	.	
P07954	UniProtKB	Helix	494	500	.	.	.	.	
P07954	UniProtKB	Helix	503	505	.	.	.	.	
##sequence-region Q14526 1 733
Q14526	UniProtKB	Chain	1	733	.	.	.	ID=PRO_0000046942;Note=Hypermethylated in cancer 1 protein	
Q14526	UniProtKB	Domain	47	110	.	.	.	Note=BTB	
Q14526	UniProtKB	Zinc finger	439	459	.	.	.	Note=C2H2-type 1	
Q14526	UniProtKB	Zinc finger	509	529	.	.	.	Note=C2H2-type 2	
Q14526	UniProtKB	Zinc finger	537	557	.	.	.	Note=C2H2-type 3	
Q14526	UniProtKB	Zinc finger	565	585	.	.	.	Note=C2H2-type 4	
Q14526	UniProtKB	Zinc finger	593	613	.	.	.	Note=C2H2-type 5	
Q14526	UniProtKB	Region	154	315	.	.	.	Note=Mediates HDAC-dependent transcriptional repression	
Q14526	UniProtKB	Region	241	247	.	.	.	Note=Interaction with CTBP1	
Q14526	UniProtKB	Compositional bias	110	119	.	.	.	Note=Poly-Ala	
Q14526	UniProtKB	Compositional bias	160	167	.	.	.	Note=Poly-Gly	
Q14526	UniProtKB	Compositional bias	195	199	.	.	.	Note=Poly-Pro	
Q14526	UniProtKB	Modified residue	333	333	.	.	.	Note=N6-acetyllysine%3B alternate	
Q14526	UniProtKB	Cross-link	333	333	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate	
Q14526	UniProtKB	Alternative sequence	1	19	.	.	.	ID=VSP_006826;Note=In isoform 2.	
Q14526	UniProtKB	Natural variant	725	725	.	.	.	ID=VAR_063109;Dbxref=dbSNP:rs1063317	
Q14526	UniProtKB	Mutagenesis	244	244	.	.	.	Note=Abolishes interaction with CTBP1 and CTBP2. Impairs transcriptional repression.	
Q14526	UniProtKB	Mutagenesis	333	333	.	.	.	Note=Mimicks acetylation. Impairs interaction with RBBP4 and MTA1 and no effect on interaction with CTBP2. Reduces transcriptional repression.	
Q14526	UniProtKB	Mutagenesis	333	333	.	.	.	Note=Abolishes sumoylation%3B impairs transcriptional repression activity.	
Q14526	UniProtKB	Mutagenesis	335	335	.	.	.	Note=Impairs transcriptional repression activity. Decreases interaction with MTA1.	
Q14526	UniProtKB	Mutagenesis	336	336	.	.	.	Note=Impairs K-333 acetylation%3B no effect on sumoylation. Decreases interaction with MTA1.	
Q14526	UniProtKB	Mutagenesis	540	540	.	.	.	Note=Abolishes repression activity.	
Q14526	UniProtKB	Sequence conflict	190	190	.	.	.	.	
##sequence-region Q9WUM7 1 1168
Q9WUM7	UniProtKB	Chain	1	1168	.	.	.	ID=PRO_0000085996;Note=Homeodomain-interacting protein kinase 2	
Q9WUM7	UniProtKB	Domain	199	527	.	.	.	Note=Protein kinase	
Q9WUM7	UniProtKB	Nucleotide binding	205	213	.	.	.	Note=ATP;status=Probable	
Q9WUM7	UniProtKB	Region	97	230	.	.	.	Note=Transcriptional corepression;status=By similarity	
Q9WUM7	UniProtKB	Region	189	520	.	.	.	Note=Interaction with DAXX;status=By similarity	
Q9WUM7	UniProtKB	Region	539	816	.	.	.	Note=Interaction with SKI and SMAD1;status=By similarity	
Q9WUM7	UniProtKB	Region	724	869	.	.	.	Note=Interaction with POU4F1;status=By similarity	
Q9WUM7	UniProtKB	Region	746	848	.	.	.	Note=Interaction with CTBP1;status=By similarity	
Q9WUM7	UniProtKB	Region	759	869	.	.	.	Note=Interaction with HMGA1;status=By similarity	
Q9WUM7	UniProtKB	Region	774	777	.	.	.	Note=Nuclear localization signal 1 (NLS1);status=By similarity	
Q9WUM7	UniProtKB	Region	804	807	.	.	.	Note=Nuclear localization signal 2 (NLS2);status=By similarity	
Q9WUM7	UniProtKB	Region	812	907	.	.	.	Note=Interaction with TP53 and TP73	
Q9WUM7	UniProtKB	Region	845	952	.	.	.	Note=Localization to nuclear speckles;status=By similarity	
Q9WUM7	UniProtKB	Region	845	952	.	.	.	Note=Required for localization to nuclear speckles;status=By similarity	
Q9WUM7	UniProtKB	Region	845	879	.	.	.	Note=Interaction with UBE2I;status=By similarity	
Q9WUM7	UniProtKB	Region	854	876	.	.	.	Note=Interaction with UBL1	
Q9WUM7	UniProtKB	Region	856	880	.	.	.	Note=SUMO interaction motifs (SIM)%3B required for nuclear localization and kinase activity;status=By similarity	
Q9WUM7	UniProtKB	Region	907	1022	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q9WUM7	UniProtKB	Region	956	1168	.	.	.	Note=Autoinhibitory domain (AID);status=By similarity	
Q9WUM7	UniProtKB	Compositional bias	1061	1064	.	.	.	Note=Poly-Ala	
Q9WUM7	UniProtKB	Active site	324	324	.	.	.	Note=Proton acceptor;status=Probable	
Q9WUM7	UniProtKB	Binding site	228	228	.	.	.	Note=ATP;status=Probable	
Q9WUM7	UniProtKB	Site	895	896	.	.	.	Note=Cleavage%3B by CASP6;status=By similarity	
Q9WUM7	UniProtKB	Site	956	957	.	.	.	Note=Cleavage%3B by CASP6;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	16	16	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	118	118	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	135	135	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	141	141	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	252	252	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	273	273	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	361	361	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	441	441	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	482	482	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	517	517	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	566	566	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	607	607	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	641	641	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	660	660	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	787	787	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	799	799	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	906	906	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	1014	1014	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	1125	1125	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Modified residue	1158	1158	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WUM7	UniProtKB	Cross-link	32	32	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q9WUM7	UniProtKB	Cross-link	1161	1161	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q9WUM7	UniProtKB	Mutagenesis	228	228	.	.	.	Note=Abolishes enzymatic activity. Diffuse nuclear staining.	
##sequence-region Q9QZR5 1 1196
Q9QZR5	UniProtKB	Chain	1	1196	.	.	.	ID=PRO_0000085997;Note=Homeodomain-interacting protein kinase 2	
Q9QZR5	UniProtKB	Domain	199	527	.	.	.	Note=Protein kinase	
Q9QZR5	UniProtKB	Nucleotide binding	205	213	.	.	.	Note=ATP;status=Probable	
Q9QZR5	UniProtKB	Region	97	230	.	.	.	Note=Transcriptional corepression	
Q9QZR5	UniProtKB	Region	189	520	.	.	.	Note=Interaction with DAXX;status=By similarity	
Q9QZR5	UniProtKB	Region	539	844	.	.	.	Note=Interaction with SKI and SMAD1;status=By similarity	
Q9QZR5	UniProtKB	Region	752	897	.	.	.	Note=Interaction with POU4F1	
Q9QZR5	UniProtKB	Region	774	876	.	.	.	Note=Interaction with CTBP1	
Q9QZR5	UniProtKB	Region	787	897	.	.	.	Note=Interaction with HMGA1	
Q9QZR5	UniProtKB	Region	802	805	.	.	.	Note=Nuclear localization signal 1 (NLS1);status=By similarity	
Q9QZR5	UniProtKB	Region	832	835	.	.	.	Note=Nuclear localization signal 2 (NLS2);status=By similarity	
Q9QZR5	UniProtKB	Region	839	934	.	.	.	Note=Interaction with TP53 and TP73	
Q9QZR5	UniProtKB	Region	873	980	.	.	.	Note=Localization to nuclear speckles	
Q9QZR5	UniProtKB	Region	873	980	.	.	.	Note=Required for localization to nuclear speckles;status=By similarity	
Q9QZR5	UniProtKB	Region	873	907	.	.	.	Note=Interaction with UBE2I	
Q9QZR5	UniProtKB	Region	884	908	.	.	.	Note=SUMO interaction motifs (SIM)%3B required for nuclear localization and kinase activity;status=By similarity	
Q9QZR5	UniProtKB	Region	935	1050	.	.	.	Note=Interaction with AXIN1	
Q9QZR5	UniProtKB	Region	984	1196	.	.	.	Note=Autoinhibitory domain (AID);status=By similarity	
Q9QZR5	UniProtKB	Compositional bias	1089	1092	.	.	.	Note=Poly-Ala	
Q9QZR5	UniProtKB	Active site	324	324	.	.	.	Note=Proton acceptor;status=Probable	
Q9QZR5	UniProtKB	Binding site	228	228	.	.	.	Note=ATP;status=Probable	
Q9QZR5	UniProtKB	Site	923	924	.	.	.	Note=Cleavage%3B by CASP6;status=By similarity	
Q9QZR5	UniProtKB	Site	984	985	.	.	.	Note=Cleavage%3B by CASP6;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	16	16	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	118	118	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	135	135	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	141	141	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	252	252	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	273	273	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	361	361	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	441	441	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	482	482	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	517	517	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	566	566	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	634	634	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	668	668	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	687	687	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	815	815	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	827	827	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	934	934	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	993	993	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	1042	1042	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	1153	1153	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Modified residue	1186	1186	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QZR5	UniProtKB	Cross-link	32	32	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q9QZR5	UniProtKB	Cross-link	1189	1189	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
Q9QZR5	UniProtKB	Alternative sequence	1	480	.	.	.	ID=VSP_013136;Note=In isoform 5.	
Q9QZR5	UniProtKB	Alternative sequence	1	7	.	.	.	ID=VSP_013135;Note=In isoform 3 and isoform 4.	
Q9QZR5	UniProtKB	Alternative sequence	369	1196	.	.	.	ID=VSP_013137;Note=In isoform 3.	
Q9QZR5	UniProtKB	Alternative sequence	594	620	.	.	.	ID=VSP_004808;Note=In isoform 2 and isoform 4.	
Q9QZR5	UniProtKB	Alternative sequence	595	605	.	.	.	ID=VSP_013138;Note=In isoform 5.	
Q9QZR5	UniProtKB	Alternative sequence	606	1196	.	.	.	ID=VSP_013139;Note=In isoform 5.	
Q9QZR5	UniProtKB	Mutagenesis	228	228	.	.	.	Note=No enzymatic activity%2C but still interacts with TP53 and NLK. Blocks the ability to induce cell growth arrest. Decreases corepressor activity.	
Q9QZR5	UniProtKB	Mutagenesis	1189	1189	.	.	.	Note=Inhibits localization to nuclear speckles.	
Q9QZR5	UniProtKB	Sequence conflict	460	460	.	.	.	.	
Q9QZR5	UniProtKB	Sequence conflict	479	479	.	.	.	.	
Q9QZR5	UniProtKB	Sequence conflict	705	705	.	.	.	.	
Q9QZR5	UniProtKB	Sequence conflict	705	705	.	.	.	.	
Q9QZR5	UniProtKB	Sequence conflict	719	719	.	.	.	.	
Q9QZR5	UniProtKB	Sequence conflict	1120	1120	.	.	.	.	
Q9QZR5	UniProtKB	Sequence conflict	1132	1132	.	.	.	.	
##sequence-region A1YER2 1 242
A1YER2	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
A1YER2	UniProtKB	Chain	2	242	.	.	.	ID=PRO_0000285510;Note=Oxidoreductase HTATIP2	
A1YER2	UniProtKB	Nucleotide binding	19	52	.	.	.	Note=NADP;status=By similarity	
A1YER2	UniProtKB	Active site	143	143	.	.	.	Note=Proton acceptor;status=By similarity	
A1YER2	UniProtKB	Active site	147	147	.	.	.	status=By similarity	
A1YER2	UniProtKB	Binding site	131	131	.	.	.	Note=Substrate;status=By similarity	
A1YER2	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
##sequence-region Q9BUP3 1 242
Q9BUP3	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q9BUP3	UniProtKB	Chain	2	242	.	.	.	ID=PRO_0000072544;Note=Oxidoreductase HTATIP2	
Q9BUP3	UniProtKB	Nucleotide binding	19	52	.	.	.	Note=NADP	
Q9BUP3	UniProtKB	Active site	143	143	.	.	.	Note=Proton acceptor;status=Probable	
Q9BUP3	UniProtKB	Active site	147	147	.	.	.	status=Probable	
Q9BUP3	UniProtKB	Binding site	131	131	.	.	.	Note=Substrate;status=Probable	
Q9BUP3	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
Q9BUP3	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_038339;Note=In isoform 3.	
Q9BUP3	UniProtKB	Alternative sequence	102	133	.	.	.	ID=VSP_051864;Note=In isoform 2.	
Q9BUP3	UniProtKB	Alternative sequence	134	242	.	.	.	ID=VSP_051865;Note=In isoform 2.	
Q9BUP3	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_023713;Note=In a hepatocellular carcinoma sample.	
Q9BUP3	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_023714;Note=In a hepatocellular carcinoma sample.	
Q9BUP3	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_023715;Note=In a hepatocellular carcinoma sample.	
Q9BUP3	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_023716;Note=In a hepatocellular carcinoma sample%3B reduces protein stability.	
Q9BUP3	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_023717;Note=In a hepatocellular carcinoma sample.	
Q9BUP3	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_023718;Dbxref=dbSNP:rs3824886	
Q9BUP3	UniProtKB	Mutagenesis	28	31	.	.	.	Note=Loss of proapoptotic and metastatis-inhibiting effect.	
Q9BUP3	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Loss of association with nucleus.	
Q9BUP3	UniProtKB	Sequence conflict	87	87	.	.	.	.	
Q9BUP3	UniProtKB	Sequence conflict	170	170	.	.	.	.	
Q9BUP3	UniProtKB	Sequence conflict	182	182	.	.	.	.	
Q9BUP3	UniProtKB	Sequence conflict	187	187	.	.	.	.	
Q9BUP3	UniProtKB	Helix	6	16	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	20	24	.	.	.	.	
Q9BUP3	UniProtKB	Helix	29	41	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	45	53	.	.	.	.	
Q9BUP3	UniProtKB	Helix	60	64	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	66	69	.	.	.	.	
Q9BUP3	UniProtKB	Helix	72	82	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	86	90	.	.	.	.	
Q9BUP3	UniProtKB	Helix	96	108	.	.	.	.	
Q9BUP3	UniProtKB	Helix	110	121	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	126	130	.	.	.	.	
Q9BUP3	UniProtKB	Helix	142	155	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	160	166	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	169	171	.	.	.	.	
Q9BUP3	UniProtKB	Helix	175	177	.	.	.	.	
Q9BUP3	UniProtKB	Helix	179	188	.	.	.	.	
Q9BUP3	UniProtKB	Helix	195	198	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	200	202	.	.	.	.	
Q9BUP3	UniProtKB	Helix	203	214	.	.	.	.	
Q9BUP3	UniProtKB	Beta strand	220	226	.	.	.	.	
Q9BUP3	UniProtKB	Helix	227	233	.	.	.	.	
##sequence-region Q9Z2G9 1 242
Q9Z2G9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q9Z2G9	UniProtKB	Chain	2	242	.	.	.	ID=PRO_0000072545;Note=Oxidoreductase HTATIP2	
Q9Z2G9	UniProtKB	Nucleotide binding	19	52	.	.	.	Note=NADP;status=By similarity	
Q9Z2G9	UniProtKB	Active site	143	143	.	.	.	Note=Proton acceptor;status=By similarity	
Q9Z2G9	UniProtKB	Active site	147	147	.	.	.	status=By similarity	
Q9Z2G9	UniProtKB	Binding site	131	131	.	.	.	Note=Substrate;status=By similarity	
Q9Z2G9	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q9Z2G9	UniProtKB	Alternative sequence	102	105	.	.	.	ID=VSP_051866;Note=In isoform 2.	
Q9Z2G9	UniProtKB	Alternative sequence	106	242	.	.	.	ID=VSP_051867;Note=In isoform 2.	
Q9Z2G9	UniProtKB	Sequence conflict	8	8	.	.	.	.	
Q9Z2G9	UniProtKB	Sequence conflict	10	10	.	.	.	.	
Q9Z2G9	UniProtKB	Sequence conflict	27	27	.	.	.	.	
Q9Z2G9	UniProtKB	Sequence conflict	39	39	.	.	.	.	
Q9Z2G9	UniProtKB	Sequence conflict	77	77	.	.	.	.	
Q9Z2G9	UniProtKB	Sequence conflict	213	213	.	.	.	.	
Q9Z2G9	UniProtKB	Sequence conflict	235	235	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	8	16	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	20	24	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	29	41	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	45	53	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	66	69	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	72	82	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	86	90	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	101	108	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	110	121	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	126	130	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	142	156	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	160	166	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	168	171	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	195	199	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	200	202	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	203	215	.	.	.	.	
Q9Z2G9	UniProtKB	Beta strand	219	226	.	.	.	.	
Q9Z2G9	UniProtKB	Helix	227	233	.	.	.	.	
##sequence-region A1YFX9 1 242
A1YFX9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
A1YFX9	UniProtKB	Chain	2	242	.	.	.	ID=PRO_0000285511;Note=Oxidoreductase HTATIP2	
A1YFX9	UniProtKB	Nucleotide binding	19	52	.	.	.	Note=NADP;status=By similarity	
A1YFX9	UniProtKB	Active site	143	143	.	.	.	Note=Proton acceptor;status=By similarity	
A1YFX9	UniProtKB	Active site	147	147	.	.	.	status=By similarity	
A1YFX9	UniProtKB	Binding site	131	131	.	.	.	Note=Substrate;status=By similarity	
A1YFX9	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
##sequence-region A2T7G9 1 242
A2T7G9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
A2T7G9	UniProtKB	Chain	2	242	.	.	.	ID=PRO_0000285512;Note=Oxidoreductase HTATIP2	
A2T7G9	UniProtKB	Nucleotide binding	19	52	.	.	.	Note=NADP;status=By similarity	
A2T7G9	UniProtKB	Active site	143	143	.	.	.	Note=Proton acceptor;status=By similarity	
A2T7G9	UniProtKB	Active site	147	147	.	.	.	status=By similarity	
A2T7G9	UniProtKB	Binding site	131	131	.	.	.	Note=Substrate;status=By similarity	
A2T7G9	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
##sequence-region Q6K0P9 1 492
Q6K0P9	UniProtKB	Chain	1	492	.	.	.	ID=PRO_0000334524;Note=Pyrin and HIN domain-containing protein 1	
Q6K0P9	UniProtKB	Domain	1	88	.	.	.	Note=DAPIN	
Q6K0P9	UniProtKB	Domain	199	399	.	.	.	Note=HIN-200	
Q6K0P9	UniProtKB	Alternative sequence	89	97	.	.	.	ID=VSP_033657;Note=In isoform 2%2C isoform 4 and isoform 6.	
Q6K0P9	UniProtKB	Alternative sequence	194	245	.	.	.	ID=VSP_033658;Note=In isoform 5 and isoform 6.	
Q6K0P9	UniProtKB	Alternative sequence	246	492	.	.	.	ID=VSP_033659;Note=In isoform 5 and isoform 6.	
Q6K0P9	UniProtKB	Alternative sequence	454	492	.	.	.	ID=VSP_033660;Note=In isoform 3 and isoform 4.	
##sequence-region Q9UK53 1 422
Q9UK53	UniProtKB	Chain	1	422	.	.	.	ID=PRO_0000212661;Note=Inhibitor of growth protein 1	
Q9UK53	UniProtKB	Zinc finger	353	402	.	.	.	Note=PHD-type	
Q9UK53	UniProtKB	Region	405	422	.	.	.	Note=PBR;status=By similarity	
Q9UK53	UniProtKB	Binding site	355	355	.	.	.	Note=Histone H3K4me3	
Q9UK53	UniProtKB	Binding site	366	366	.	.	.	Note=Histone H3K4me3	
Q9UK53	UniProtKB	Binding site	370	370	.	.	.	Note=Histone H3K4me3	
Q9UK53	UniProtKB	Binding site	378	378	.	.	.	Note=Histone H3K4me3	
Q9UK53	UniProtKB	Alternative sequence	1	212	.	.	.	ID=VSP_009129;Note=In isoform 3.	
Q9UK53	UniProtKB	Alternative sequence	1	189	.	.	.	ID=VSP_009126;Note=In isoform 2.	
Q9UK53	UniProtKB	Alternative sequence	1	189	.	.	.	ID=VSP_009127;Note=In isoform 4.	
Q9UK53	UniProtKB	Alternative sequence	1	189	.	.	.	ID=VSP_009128;Note=In isoform 5.	
Q9UK53	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_047097;Dbxref=dbSNP:rs7338333	
Q9UK53	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_017420;Note=In HNSCC.	
Q9UK53	UniProtKB	Natural variant	358	358	.	.	.	ID=VAR_017421;Note=In HNSCC.	
Q9UK53	UniProtKB	Natural variant	359	359	.	.	.	ID=VAR_017422;Note=In HNSCC.	
Q9UK53	UniProtKB	Mutagenesis	378	378	.	.	.	Note=Unable to stimulate DNA repair after UV irradiation or promote DNA-damage-induced apoptosis.	
Q9UK53	UniProtKB	Sequence conflict	266	266	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	266	266	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	266	266	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	266	266	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	272	272	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	272	272	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	272	272	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	272	272	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	278	278	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	278	278	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	278	278	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	278	278	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	280	280	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	280	280	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	280	280	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	280	280	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	282	282	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	282	282	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	282	282	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	282	282	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	285	285	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	285	285	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	285	285	.	.	.	.	
Q9UK53	UniProtKB	Sequence conflict	285	285	.	.	.	.	
Q9UK53	UniProtKB	Turn	356	359	.	.	.	.	
Q9UK53	UniProtKB	Beta strand	364	368	.	.	.	.	
Q9UK53	UniProtKB	Beta strand	378	380	.	.	.	.	
Q9UK53	UniProtKB	Helix	382	384	.	.	.	.	
Q9UK53	UniProtKB	Helix	397	400	.	.	.	.	
##sequence-region Q9QXV3 1 279
Q9QXV3	UniProtKB	Chain	1	279	.	.	.	ID=PRO_0000212662;Note=Inhibitor of growth protein 1	
Q9QXV3	UniProtKB	Zinc finger	210	259	.	.	.	Note=PHD-type	
Q9QXV3	UniProtKB	Region	262	279	.	.	.	Note=PBR;status=By similarity	
Q9QXV3	UniProtKB	Binding site	212	212	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9QXV3	UniProtKB	Binding site	223	223	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9QXV3	UniProtKB	Binding site	227	227	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9QXV3	UniProtKB	Binding site	235	235	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9QXV3	UniProtKB	Alternative sequence	1	94	.	.	.	ID=VSP_050378;Note=In isoform 2.	
Q9QXV3	UniProtKB	Sequence conflict	203	203	.	.	.	.	
##sequence-region Q3T095 1 248
Q3T095	UniProtKB	Chain	1	248	.	.	.	ID=PRO_0000212667;Note=Inhibitor of growth protein 4	
Q3T095	UniProtKB	Zinc finger	195	244	.	.	.	Note=PHD-type	
Q3T095	UniProtKB	Coiled coil	25	118	.	.	.	status=Potential	
Q3T095	UniProtKB	Motif	127	147	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q3T095	UniProtKB	Binding site	197	197	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q3T095	UniProtKB	Binding site	208	208	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q3T095	UniProtKB	Binding site	212	212	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q3T095	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q3T095	UniProtKB	Modified residue	127	127	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q3T095	UniProtKB	Modified residue	129	129	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q3T095	UniProtKB	Modified residue	132	132	.	.	.	Note=Citrulline;status=By similarity	
Q3T095	UniProtKB	Modified residue	145	145	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q3T095	UniProtKB	Modified residue	147	147	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q3T095	UniProtKB	Modified residue	155	155	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q3T095	UniProtKB	Modified residue	165	165	.	.	.	Note=Citrulline;status=By similarity	
##sequence-region Q5ZKY4 1 249
Q5ZKY4	UniProtKB	Chain	1	249	.	.	.	ID=PRO_0000212670;Note=Inhibitor of growth protein 4	
Q5ZKY4	UniProtKB	Zinc finger	196	245	.	.	.	Note=PHD-type	
Q5ZKY4	UniProtKB	Coiled coil	25	118	.	.	.	status=Potential	
Q5ZKY4	UniProtKB	Binding site	198	198	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q5ZKY4	UniProtKB	Binding site	209	209	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q5ZKY4	UniProtKB	Binding site	213	213	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q5ZKY4	UniProtKB	Binding site	221	221	.	.	.	Note=Histone H3K4me3;status=By similarity	
##sequence-region Q9UNL4 1 249
Q9UNL4	UniProtKB	Chain	1	249	.	.	.	ID=PRO_0000212668;Note=Inhibitor of growth protein 4	
Q9UNL4	UniProtKB	Zinc finger	196	245	.	.	.	Note=PHD-type	
Q9UNL4	UniProtKB	Coiled coil	25	118	.	.	.	.	
Q9UNL4	UniProtKB	Motif	127	148	.	.	.	Note=Bipartite nuclear localization signal	
Q9UNL4	UniProtKB	Binding site	198	198	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9UNL4	UniProtKB	Binding site	209	209	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9UNL4	UniProtKB	Binding site	213	213	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9UNL4	UniProtKB	Binding site	221	221	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q9UNL4	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine	
Q9UNL4	UniProtKB	Modified residue	127	127	.	.	.	Note=N6-acetyllysine	
Q9UNL4	UniProtKB	Modified residue	129	129	.	.	.	Note=N6-acetyllysine	
Q9UNL4	UniProtKB	Modified residue	133	133	.	.	.	Note=Citrulline	
Q9UNL4	UniProtKB	Modified residue	146	146	.	.	.	Note=N6-acetyllysine	
Q9UNL4	UniProtKB	Modified residue	148	148	.	.	.	Note=N6-acetyllysine	
Q9UNL4	UniProtKB	Modified residue	156	156	.	.	.	Note=N6-acetyllysine	
Q9UNL4	UniProtKB	Modified residue	166	166	.	.	.	Note=Citrulline	
Q9UNL4	UniProtKB	Alternative sequence	13	37	.	.	.	ID=VSP_041288;Note=In isoform 3.	
Q9UNL4	UniProtKB	Alternative sequence	128	131	.	.	.	ID=VSP_041289;Note=In isoform 5.	
Q9UNL4	UniProtKB	Alternative sequence	128	130	.	.	.	ID=VSP_041290;Note=In isoform 7.	
Q9UNL4	UniProtKB	Alternative sequence	129	132	.	.	.	ID=VSP_041291;Note=In isoform 4.	
Q9UNL4	UniProtKB	Alternative sequence	131	131	.	.	.	ID=VSP_012518;Note=In isoform 2.	
Q9UNL4	UniProtKB	Alternative sequence	131	131	.	.	.	ID=VSP_041292;Note=In isoform 6.	
Q9UNL4	UniProtKB	Alternative sequence	132	132	.	.	.	ID=VSP_012519;Note=In isoform 2.	
Q9UNL4	UniProtKB	Alternative sequence	168	249	.	.	.	ID=VSP_041293;Note=In isoform 8.	
Q9UNL4	UniProtKB	Helix	5	12	.	.	.	.	
Q9UNL4	UniProtKB	Helix	14	16	.	.	.	.	
Q9UNL4	UniProtKB	Helix	17	50	.	.	.	.	
Q9UNL4	UniProtKB	Helix	58	103	.	.	.	.	
Q9UNL4	UniProtKB	Turn	199	202	.	.	.	.	
Q9UNL4	UniProtKB	Beta strand	207	211	.	.	.	.	
Q9UNL4	UniProtKB	Beta strand	221	223	.	.	.	.	
Q9UNL4	UniProtKB	Helix	225	227	.	.	.	.	
Q9UNL4	UniProtKB	Helix	240	243	.	.	.	.	
Q9UNL4	UniProtKB	Helix	244	246	.	.	.	.	
##sequence-region Q8C0D7 1 249
Q8C0D7	UniProtKB	Chain	1	249	.	.	.	ID=PRO_0000212669;Note=Inhibitor of growth protein 4	
Q8C0D7	UniProtKB	Zinc finger	196	245	.	.	.	Note=PHD-type	
Q8C0D7	UniProtKB	Coiled coil	25	118	.	.	.	status=Potential	
Q8C0D7	UniProtKB	Motif	127	148	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q8C0D7	UniProtKB	Binding site	198	198	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q8C0D7	UniProtKB	Binding site	209	209	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q8C0D7	UniProtKB	Binding site	213	213	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q8C0D7	UniProtKB	Binding site	221	221	.	.	.	Note=Histone H3K4me3;status=By similarity	
Q8C0D7	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8C0D7	UniProtKB	Modified residue	127	127	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8C0D7	UniProtKB	Modified residue	129	129	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8C0D7	UniProtKB	Modified residue	133	133	.	.	.	Note=Citrulline	
Q8C0D7	UniProtKB	Modified residue	146	146	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8C0D7	UniProtKB	Modified residue	148	148	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8C0D7	UniProtKB	Modified residue	156	156	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8C0D7	UniProtKB	Modified residue	166	166	.	.	.	Note=Citrulline	
Q8C0D7	UniProtKB	Alternative sequence	127	130	.	.	.	ID=VSP_012520;Note=In isoform 5.	
Q8C0D7	UniProtKB	Alternative sequence	131	131	.	.	.	ID=VSP_012521;Note=In isoform 2%2C isoform 3 and isoform 4.	
Q8C0D7	UniProtKB	Alternative sequence	132	132	.	.	.	ID=VSP_012522;Note=In isoform 2%2C isoform 3 and isoform 4.	
Q8C0D7	UniProtKB	Alternative sequence	168	249	.	.	.	ID=VSP_012523;Note=In isoform 4.	
Q8C0D7	UniProtKB	Alternative sequence	170	172	.	.	.	ID=VSP_012524;Note=In isoform 5.	
Q8C0D7	UniProtKB	Alternative sequence	173	249	.	.	.	ID=VSP_012525;Note=In isoform 5.	
Q8C0D7	UniProtKB	Alternative sequence	217	228	.	.	.	ID=VSP_012526;Note=In isoform 3.	
Q8C0D7	UniProtKB	Alternative sequence	229	249	.	.	.	ID=VSP_012527;Note=In isoform 3.	
Q8C0D7	UniProtKB	Sequence conflict	105	105	.	.	.	.	
Q8C0D7	UniProtKB	Sequence conflict	179	179	.	.	.	.	
Q8C0D7	UniProtKB	Beta strand	207	210	.	.	.	.	
Q8C0D7	UniProtKB	Turn	224	228	.	.	.	.	
Q8C0D7	UniProtKB	Turn	240	242	.	.	.	.	
##sequence-region Q3SZP0 1 322
Q3SZP0	UniProtKB	Chain	1	322	.	.	.	ID=PRO_0000223674;Note=Interferon regulatory factor 1	
Q3SZP0	UniProtKB	DNA binding	5	113	.	.	.	Note=IRF tryptophan pentad repeat	
Q3SZP0	UniProtKB	Modified residue	78	78	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q3SZP0	UniProtKB	Cross-link	276	276	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q3SZP0	UniProtKB	Cross-link	296	296	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q3SZP0	UniProtKB	Sequence conflict	302	302	.	.	.	.	
##sequence-region P10914 1 325
P10914	UniProtKB	Chain	1	325	.	.	.	ID=PRO_0000154545;Note=Interferon regulatory factor 1	
P10914	UniProtKB	DNA binding	5	113	.	.	.	Note=IRF tryptophan pentad repeat	
P10914	UniProtKB	Modified residue	78	78	.	.	.	Note=N6-acetyllysine	
P10914	UniProtKB	Cross-link	275	275	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P10914	UniProtKB	Cross-link	299	299	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P10914	UniProtKB	Natural variant	8	8	.	.	.	ID=VAR_065134;Note=In GASC%3B somatic mutation%3B produces a protein with markedly reduced transcriptional activity but unaltered DNA-binding activity.	
P10914	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_065135;Note=In GASC%3B the mutation abolishes DNA binding and transactivating activities.	
P10914	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss of acetylation. Partial loss of DNA-binding and transcriptional activity.	
P10914	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Some loss of sumoylation. Partial inhibition of acetylation and activity. Abolishes sumoylation%2C diminished ubiquitination%2C higher resistance to degradation%2C and increased apoptotic activity%3B when associated with R-299.	
P10914	UniProtKB	Mutagenesis	299	299	.	.	.	Note=Large loss of sumoylation. Abolishes sumoylation%2C diminished ubiquitination%2C higher resistance to degradation%2C and increased apoptotic activity%3B when associated with R-275.	
P10914	UniProtKB	Sequence conflict	5	5	.	.	.	.	
P10914	UniProtKB	Sequence conflict	5	5	.	.	.	.	
P10914	UniProtKB	Sequence conflict	34	35	.	.	.	.	
P10914	UniProtKB	Sequence conflict	34	35	.	.	.	.	
P10914	UniProtKB	Sequence conflict	220	220	.	.	.	.	
P10914	UniProtKB	Sequence conflict	220	220	.	.	.	.	
##sequence-region A0FIN4 1 322
A0FIN4	UniProtKB	Chain	1	322	.	.	.	ID=PRO_0000273191;Note=Interferon regulatory factor 1	
A0FIN4	UniProtKB	DNA binding	5	113	.	.	.	Note=IRF tryptophan pentad repeat	
A0FIN4	UniProtKB	Modified residue	78	78	.	.	.	Note=N6-acetyllysine;status=By similarity	
A0FIN4	UniProtKB	Cross-link	276	276	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
A0FIN4	UniProtKB	Cross-link	296	296	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q14678 1 1352
Q14678	UniProtKB	Chain	1	1352	.	.	.	ID=PRO_0000066911;Note=KN motif and ankyrin repeat domain-containing protein 1	
Q14678	UniProtKB	Repeat	1161	1191	.	.	.	Note=ANK 1	
Q14678	UniProtKB	Repeat	1195	1228	.	.	.	Note=ANK 2	
Q14678	UniProtKB	Repeat	1233	1262	.	.	.	Note=ANK 3	
Q14678	UniProtKB	Repeat	1266	1298	.	.	.	Note=ANK 4	
Q14678	UniProtKB	Repeat	1300	1329	.	.	.	Note=ANK 5	
Q14678	UniProtKB	Region	43	52	.	.	.	Note=Nuclear export signal 1 (NES 1)	
Q14678	UniProtKB	Region	65	68	.	.	.	Note=Nuclear localization signal 1 (NLS 1)	
Q14678	UniProtKB	Region	125	134	.	.	.	Note=Nuclear export signal 2 (NES 2)	
Q14678	UniProtKB	Region	291	467	.	.	.	Note=Interaction with KIF21A	
Q14678	UniProtKB	Region	613	622	.	.	.	Note=Nuclear export signal 3 (NES 3)	
Q14678	UniProtKB	Region	979	992	.	.	.	Note=Nuclear localization signal 2 (NLS 2)	
Q14678	UniProtKB	Region	1156	1308	.	.	.	Note=Interaction with KIF21A	
Q14678	UniProtKB	Coiled coil	258	316	.	.	.	status=Potential	
Q14678	UniProtKB	Coiled coil	361	395	.	.	.	status=Potential	
Q14678	UniProtKB	Coiled coil	446	500	.	.	.	status=Potential	
Q14678	UniProtKB	Modified residue	325	325	.	.	.	Note=Phosphoserine%3B by PKB	
Q14678	UniProtKB	Alternative sequence	1	158	.	.	.	ID=VSP_043958;Note=In isoform 2.	
Q14678	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_026212;Dbxref=dbSNP:rs17857145	
Q14678	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_048298;Dbxref=dbSNP:rs28374506	
Q14678	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_048299;Dbxref=dbSNP:rs17857159	
Q14678	UniProtKB	Natural variant	432	432	.	.	.	ID=VAR_026213;Dbxref=dbSNP:rs4465020	
Q14678	UniProtKB	Natural variant	464	464	.	.	.	ID=VAR_016697;Dbxref=dbSNP:rs912174	
Q14678	UniProtKB	Natural variant	664	664	.	.	.	ID=VAR_048300;Dbxref=dbSNP:rs3824421	
Q14678	UniProtKB	Natural variant	667	667	.	.	.	ID=VAR_048301;Dbxref=dbSNP:rs3824420	
Q14678	UniProtKB	Natural variant	901	901	.	.	.	ID=VAR_048302;Dbxref=dbSNP:rs12352313	
Q14678	UniProtKB	Natural variant	1055	1055	.	.	.	ID=VAR_048303;Dbxref=dbSNP:rs34832656	
Q14678	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Nuclear localization%3B when associated A-52%3B A-125%3B A-129%3B A-134%3B A-613%3B A-616%3B A-620 and A-622.	
Q14678	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-125%3B A-129%3B A-134%3B A-613%3B A-616%3B A-620 and A-622.	
Q14678	UniProtKB	Mutagenesis	65	68	.	.	.	Note=Enhanced cytoplasmic localization%3B when associated with 979-A--A-981 and 991-A-A-992.	
Q14678	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-52%3B A-129%3B A-134%3B A-613%3B A-616%3B A-620 and A-622.	
Q14678	UniProtKB	Mutagenesis	129	129	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-52%3B A-125%3B A-134%3B A-613%3B A-616%3B A-620 and A-622.	
Q14678	UniProtKB	Mutagenesis	134	134	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-52%3B A-125%3B A-129%3B A-613%3B A-616%3B A-620 and A-622.	
Q14678	UniProtKB	Mutagenesis	325	325	.	.	.	Note=Abolishes phosphorylation by PKB. Abolishes interaction with YWHAB%3B YWHAG%3B YWHAE%3B YWHAH%3B YWHAQ%3B YWHAZ and SFN.	
Q14678	UniProtKB	Mutagenesis	613	613	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-52%3B A-125%3B A-129%3B A-134%3B A-616%3B A-620 and A-622.	
Q14678	UniProtKB	Mutagenesis	616	616	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-52%3B A-125%3B A-129%3B A-134%3B A-613%3B A-620 and A-622.	
Q14678	UniProtKB	Mutagenesis	620	620	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-52%3B A-125%3B A-129%3B A-134%3B A-613%3B A-616 and A-622.	
Q14678	UniProtKB	Mutagenesis	622	622	.	.	.	Note=Nuclear localization%3B when associated A-43%3B A-52%3B A-125%3B A-129%3B A-134%3B A-613%3B A-616 and A-620.	
Q14678	UniProtKB	Mutagenesis	979	981	.	.	.	Note=Enhanced cytoplasmic localization%3B when associated with 65-A--A-68 and 991-A-A-992.	
Q14678	UniProtKB	Mutagenesis	991	992	.	.	.	Note=Enhanced cytoplasmic localization%3B when associated with 65-A--68 and 979-A--A-981.	
##sequence-region Q58DF7 1 232
Q58DF7	UniProtKB	Chain	1	232	.	.	.	ID=PRO_0000248590;Note=BTB/POZ domain-containing protein KCTD11	
Q58DF7	UniProtKB	Domain	1	49	.	.	.	Note=BTB	
##sequence-region Q693B1 1 232
Q693B1	UniProtKB	Chain	1	232	.	.	.	ID=PRO_0000248591;Note=BTB/POZ domain-containing protein KCTD11	
Q693B1	UniProtKB	Domain	1	49	.	.	.	Note=BTB	
Q693B1	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_044086;Note=In isoform 2.	
Q693B1	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_027354;Dbxref=dbSNP:rs8080182	
##sequence-region Q8K485 1 232
Q8K485	UniProtKB	Chain	1	232	.	.	.	ID=PRO_0000248592;Note=BTB/POZ domain-containing protein KCTD11	
Q8K485	UniProtKB	Domain	1	49	.	.	.	Note=BTB	
##sequence-region O43240 1 276
O43240	UniProtKB	Signal peptide	1	30	.	.	.	status=Potential	
O43240	UniProtKB	Chain	31	276	.	.	.	ID=PRO_0000027953;Note=Kallikrein-10	
O43240	UniProtKB	Domain	47	274	.	.	.	Note=Peptidase S1	
O43240	UniProtKB	Active site	86	86	.	.	.	Note=Charge relay system;status=By similarity	
O43240	UniProtKB	Active site	137	137	.	.	.	Note=Charge relay system;status=By similarity	
O43240	UniProtKB	Active site	229	229	.	.	.	Note=Charge relay system;status=By similarity	
O43240	UniProtKB	Glycosylation	39	39	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O43240	UniProtKB	Disulfide bond	52	162	.	.	.	status=By similarity	
O43240	UniProtKB	Disulfide bond	71	87	.	.	.	status=By similarity	
O43240	UniProtKB	Disulfide bond	169	235	.	.	.	status=By similarity	
O43240	UniProtKB	Disulfide bond	201	215	.	.	.	status=By similarity	
O43240	UniProtKB	Disulfide bond	225	250	.	.	.	status=By similarity	
O43240	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_027979;Dbxref=dbSNP:rs3745535	
O43240	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_027980;Dbxref=dbSNP:rs2075690	
##sequence-region Q5PU49 1 674
Q5PU49	UniProtKB	Chain	1	674	.	.	.	ID=PRO_0000055693;Note=Protein kinase C delta type	
Q5PU49	UniProtKB	Chain	1	328	.	.	.	ID=PRO_0000421665;Note=Protein kinase C delta type regulatory subunit;status=By similarity	
Q5PU49	UniProtKB	Chain	329	674	.	.	.	ID=PRO_0000421666;Note=Protein kinase C delta type catalytic subunit;status=By similarity	
Q5PU49	UniProtKB	Domain	1	90	.	.	.	Note=C2	
Q5PU49	UniProtKB	Domain	347	601	.	.	.	Note=Protein kinase	
Q5PU49	UniProtKB	Domain	602	673	.	.	.	Note=AGC-kinase C-terminal	
Q5PU49	UniProtKB	Zinc finger	158	208	.	.	.	Note=Phorbol-ester/DAG-type 1	
Q5PU49	UniProtKB	Zinc finger	230	280	.	.	.	Note=Phorbol-ester/DAG-type 2	
Q5PU49	UniProtKB	Nucleotide binding	353	361	.	.	.	Note=ATP;status=By similarity	
Q5PU49	UniProtKB	Active site	471	471	.	.	.	Note=Proton acceptor;status=By similarity	
Q5PU49	UniProtKB	Binding site	376	376	.	.	.	Note=ATP;status=By similarity	
Q5PU49	UniProtKB	Site	48	48	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
Q5PU49	UniProtKB	Site	62	62	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
Q5PU49	UniProtKB	Site	67	67	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
Q5PU49	UniProtKB	Site	123	123	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
Q5PU49	UniProtKB	Site	328	329	.	.	.	Note=Cleavage%3B by caspase-3;status=By similarity	
Q5PU49	UniProtKB	Modified residue	43	43	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5PU49	UniProtKB	Modified residue	64	64	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q5PU49	UniProtKB	Modified residue	130	130	.	.	.	Note=Phosphoserine;status=By similarity	
Q5PU49	UniProtKB	Modified residue	155	155	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q5PU49	UniProtKB	Modified residue	218	218	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5PU49	UniProtKB	Modified residue	299	299	.	.	.	Note=Phosphoserine%3B by autocatalysis;status=By similarity	
Q5PU49	UniProtKB	Modified residue	302	302	.	.	.	Note=Phosphoserine%3B by autocatalysis;status=By similarity	
Q5PU49	UniProtKB	Modified residue	310	310	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q5PU49	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q5PU49	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphothreonine%3B by autocatalysis;status=By similarity	
Q5PU49	UniProtKB	Modified residue	565	565	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q5PU49	UniProtKB	Modified residue	643	643	.	.	.	Note=Phosphoserine;status=Probable	
Q5PU49	UniProtKB	Modified residue	652	652	.	.	.	Note=Phosphoserine;status=By similarity	
Q5PU49	UniProtKB	Modified residue	662	662	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q05655 1 676
Q05655	UniProtKB	Chain	1	676	.	.	.	ID=PRO_0000055694;Note=Protein kinase C delta type	
Q05655	UniProtKB	Chain	1	329	.	.	.	ID=PRO_0000421667;Note=Protein kinase C delta type regulatory subunit;status=By similarity	
Q05655	UniProtKB	Chain	330	676	.	.	.	ID=PRO_0000421668;Note=Protein kinase C delta type catalytic subunit;status=By similarity	
Q05655	UniProtKB	Domain	1	90	.	.	.	Note=C2	
Q05655	UniProtKB	Domain	349	603	.	.	.	Note=Protein kinase	
Q05655	UniProtKB	Domain	604	675	.	.	.	Note=AGC-kinase C-terminal	
Q05655	UniProtKB	Zinc finger	158	208	.	.	.	Note=Phorbol-ester/DAG-type 1	
Q05655	UniProtKB	Zinc finger	230	280	.	.	.	Note=Phorbol-ester/DAG-type 2	
Q05655	UniProtKB	Nucleotide binding	355	363	.	.	.	Note=ATP;status=By similarity	
Q05655	UniProtKB	Active site	473	473	.	.	.	Note=Proton acceptor;status=By similarity	
Q05655	UniProtKB	Binding site	378	378	.	.	.	Note=ATP;status=By similarity	
Q05655	UniProtKB	Site	48	48	.	.	.	Note=Interaction with phosphotyrosine-containing peptide	
Q05655	UniProtKB	Site	62	62	.	.	.	Note=Interaction with phosphotyrosine-containing peptide	
Q05655	UniProtKB	Site	67	67	.	.	.	Note=Interaction with phosphotyrosine-containing peptide	
Q05655	UniProtKB	Site	123	123	.	.	.	Note=Interaction with phosphotyrosine-containing peptide	
Q05655	UniProtKB	Site	329	330	.	.	.	Note=Cleavage%3B by caspase-3;status=By similarity	
Q05655	UniProtKB	Modified residue	43	43	.	.	.	Note=Phosphothreonine;status=By similarity	
Q05655	UniProtKB	Modified residue	64	64	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q05655	UniProtKB	Modified residue	130	130	.	.	.	Note=Phosphoserine	
Q05655	UniProtKB	Modified residue	155	155	.	.	.	Note=Phosphotyrosine	
Q05655	UniProtKB	Modified residue	218	218	.	.	.	Note=Phosphothreonine	
Q05655	UniProtKB	Modified residue	299	299	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q05655	UniProtKB	Modified residue	302	302	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q05655	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphoserine%3B by autocatalysis	
Q05655	UniProtKB	Modified residue	307	307	.	.	.	Note=Phosphoserine	
Q05655	UniProtKB	Modified residue	313	313	.	.	.	Note=Phosphotyrosine	
Q05655	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphotyrosine%3B by SRC;status=Probable	
Q05655	UniProtKB	Modified residue	374	374	.	.	.	Note=Phosphotyrosine	
Q05655	UniProtKB	Modified residue	503	503	.	.	.	Note=Phosphoserine	
Q05655	UniProtKB	Modified residue	507	507	.	.	.	Note=Phosphothreonine%3B by autocatalysis;status=Probable	
Q05655	UniProtKB	Modified residue	567	567	.	.	.	Note=Phosphotyrosine	
Q05655	UniProtKB	Modified residue	645	645	.	.	.	Note=Phosphoserine	
Q05655	UniProtKB	Modified residue	654	654	.	.	.	Note=Phosphoserine	
Q05655	UniProtKB	Modified residue	658	658	.	.	.	Note=Phosphoserine	
Q05655	UniProtKB	Modified residue	664	664	.	.	.	Note=Phosphoserine	
Q05655	UniProtKB	Alternative sequence	328	328	.	.	.	ID=VSP_043899;Note=In isoform 2.	
Q05655	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_035347;Dbxref=dbSNP:rs33911937	
Q05655	UniProtKB	Natural variant	375	375	.	.	.	ID=VAR_006175;Dbxref=dbSNP:rs1056998	
Q05655	UniProtKB	Natural variant	410	410	.	.	.	ID=VAR_035348;Dbxref=dbSNP:rs34502209	
Q05655	UniProtKB	Natural variant	483	483	.	.	.	ID=VAR_046009;Dbxref=dbSNP:rs35891605	
Q05655	UniProtKB	Natural variant	494	494	.	.	.	ID=VAR_020610	
Q05655	UniProtKB	Natural variant	593	593	.	.	.	ID=VAR_006176	
Q05655	UniProtKB	Mutagenesis	299	299	.	.	.	Note=Loss of phosphorylation.	
Q05655	UniProtKB	Mutagenesis	507	507	.	.	.	Note=No effect on kinase activity.	
Q05655	UniProtKB	Sequence conflict	524	524	.	.	.	.	
Q05655	UniProtKB	Sequence conflict	533	533	.	.	.	.	
Q05655	UniProtKB	Beta strand	2	13	.	.	.	.	
Q05655	UniProtKB	Beta strand	20	23	.	.	.	.	
Q05655	UniProtKB	Beta strand	27	38	.	.	.	.	
Q05655	UniProtKB	Beta strand	41	45	.	.	.	.	
Q05655	UniProtKB	Beta strand	58	62	.	.	.	.	
Q05655	UniProtKB	Beta strand	68	76	.	.	.	.	
Q05655	UniProtKB	Beta strand	79	87	.	.	.	.	
Q05655	UniProtKB	Helix	88	96	.	.	.	.	
Q05655	UniProtKB	Turn	97	100	.	.	.	.	
Q05655	UniProtKB	Beta strand	101	107	.	.	.	.	
Q05655	UniProtKB	Beta strand	109	111	.	.	.	.	
Q05655	UniProtKB	Beta strand	113	123	.	.	.	.	
Q05655	UniProtKB	Helix	156	158	.	.	.	.	
Q05655	UniProtKB	Beta strand	161	164	.	.	.	.	
Q05655	UniProtKB	Beta strand	173	175	.	.	.	.	
Q05655	UniProtKB	Beta strand	181	183	.	.	.	.	
Q05655	UniProtKB	Beta strand	186	189	.	.	.	.	
Q05655	UniProtKB	Turn	190	192	.	.	.	.	
Q05655	UniProtKB	Helix	200	202	.	.	.	.	
##sequence-region P28867 1 674
P28867	UniProtKB	Chain	1	674	.	.	.	ID=PRO_0000055695;Note=Protein kinase C delta type	
P28867	UniProtKB	Chain	1	327	.	.	.	ID=PRO_0000421669;Note=Protein kinase C delta type regulatory subunit;status=By similarity	
P28867	UniProtKB	Chain	328	674	.	.	.	ID=PRO_0000421670;Note=Protein kinase C delta type catalytic subunit;status=By similarity	
P28867	UniProtKB	Domain	1	90	.	.	.	Note=C2	
P28867	UniProtKB	Domain	347	601	.	.	.	Note=Protein kinase	
P28867	UniProtKB	Domain	602	673	.	.	.	Note=AGC-kinase C-terminal	
P28867	UniProtKB	Zinc finger	158	208	.	.	.	Note=Phorbol-ester/DAG-type 1	
P28867	UniProtKB	Zinc finger	230	280	.	.	.	Note=Phorbol-ester/DAG-type 2	
P28867	UniProtKB	Nucleotide binding	353	361	.	.	.	Note=ATP;status=By similarity	
P28867	UniProtKB	Active site	471	471	.	.	.	Note=Proton acceptor;status=By similarity	
P28867	UniProtKB	Binding site	376	376	.	.	.	Note=ATP;status=By similarity	
P28867	UniProtKB	Site	48	48	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P28867	UniProtKB	Site	62	62	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P28867	UniProtKB	Site	67	67	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P28867	UniProtKB	Site	123	123	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P28867	UniProtKB	Site	327	328	.	.	.	Note=Cleavage%3B by caspase-3;status=By similarity	
P28867	UniProtKB	Modified residue	43	43	.	.	.	Note=Phosphothreonine	
P28867	UniProtKB	Modified residue	64	64	.	.	.	Note=Phosphotyrosine;status=By similarity	
P28867	UniProtKB	Modified residue	130	130	.	.	.	Note=Phosphoserine;status=By similarity	
P28867	UniProtKB	Modified residue	155	155	.	.	.	Note=Phosphotyrosine;status=By similarity	
P28867	UniProtKB	Modified residue	218	218	.	.	.	Note=Phosphothreonine;status=By similarity	
P28867	UniProtKB	Modified residue	299	299	.	.	.	Note=Phosphoserine%3B by autocatalysis;status=By similarity	
P28867	UniProtKB	Modified residue	311	311	.	.	.	Note=Phosphotyrosine%3B alternate	
P28867	UniProtKB	Modified residue	311	311	.	.	.	Note=Phosphotyrosine%3B by SRC%3B alternate;status=Probable	
P28867	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
P28867	UniProtKB	Modified residue	372	372	.	.	.	Note=Phosphotyrosine;status=By similarity	
P28867	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
P28867	UniProtKB	Modified residue	565	565	.	.	.	Note=Phosphotyrosine;status=By similarity	
P28867	UniProtKB	Modified residue	643	643	.	.	.	Note=Phosphoserine;status=Probable	
P28867	UniProtKB	Modified residue	652	652	.	.	.	Note=Phosphoserine;status=By similarity	
P28867	UniProtKB	Modified residue	662	662	.	.	.	Note=Phosphoserine	
P28867	UniProtKB	Alternative sequence	326	326	.	.	.	ID=VSP_004741;Note=In isoform 2.	
P28867	UniProtKB	Sequence conflict	214	214	.	.	.	.	
P28867	UniProtKB	Sequence conflict	226	226	.	.	.	.	
P28867	UniProtKB	Sequence conflict	319	319	.	.	.	.	
P28867	UniProtKB	Sequence conflict	330	330	.	.	.	.	
P28867	UniProtKB	Sequence conflict	337	337	.	.	.	.	
P28867	UniProtKB	Sequence conflict	501	501	.	.	.	.	
P28867	UniProtKB	Sequence conflict	503	503	.	.	.	.	
P28867	UniProtKB	Sequence conflict	513	513	.	.	.	.	
P28867	UniProtKB	Sequence conflict	518	520	.	.	.	.	
P28867	UniProtKB	Sequence conflict	538	538	.	.	.	.	
P28867	UniProtKB	Beta strand	233	236	.	.	.	.	
P28867	UniProtKB	Turn	245	247	.	.	.	.	
P28867	UniProtKB	Beta strand	253	256	.	.	.	.	
P28867	UniProtKB	Beta strand	258	261	.	.	.	.	
P28867	UniProtKB	Turn	262	264	.	.	.	.	
P28867	UniProtKB	Helix	270	273	.	.	.	.	
P28867	UniProtKB	Beta strand	278	280	.	.	.	.	
##sequence-region P09215 1 673
P09215	UniProtKB	Chain	1	673	.	.	.	ID=PRO_0000055696;Note=Protein kinase C delta type	
P09215	UniProtKB	Chain	1	327	.	.	.	ID=PRO_0000421671;Note=Protein kinase C delta type regulatory subunit	
P09215	UniProtKB	Chain	328	673	.	.	.	ID=PRO_0000421672;Note=Protein kinase C delta type catalytic subunit	
P09215	UniProtKB	Domain	1	90	.	.	.	Note=C2	
P09215	UniProtKB	Domain	347	601	.	.	.	Note=Protein kinase	
P09215	UniProtKB	Domain	602	673	.	.	.	Note=AGC-kinase C-terminal	
P09215	UniProtKB	Zinc finger	158	208	.	.	.	Note=Phorbol-ester/DAG-type 1	
P09215	UniProtKB	Zinc finger	230	280	.	.	.	Note=Phorbol-ester/DAG-type 2	
P09215	UniProtKB	Nucleotide binding	353	361	.	.	.	Note=ATP;status=By similarity	
P09215	UniProtKB	Active site	471	471	.	.	.	Note=Proton acceptor;status=By similarity	
P09215	UniProtKB	Binding site	376	376	.	.	.	Note=ATP;status=By similarity	
P09215	UniProtKB	Site	48	48	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P09215	UniProtKB	Site	62	62	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P09215	UniProtKB	Site	67	67	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P09215	UniProtKB	Site	123	123	.	.	.	Note=Interaction with phosphotyrosine-containing peptide;status=By similarity	
P09215	UniProtKB	Site	327	328	.	.	.	Note=Cleavage%3B by caspase-3;status=Probable	
P09215	UniProtKB	Modified residue	43	43	.	.	.	Note=Phosphothreonine;status=By similarity	
P09215	UniProtKB	Modified residue	64	64	.	.	.	Note=Phosphotyrosine	
P09215	UniProtKB	Modified residue	130	130	.	.	.	Note=Phosphoserine;status=By similarity	
P09215	UniProtKB	Modified residue	155	155	.	.	.	Note=Phosphotyrosine	
P09215	UniProtKB	Modified residue	218	218	.	.	.	Note=Phosphothreonine;status=By similarity	
P09215	UniProtKB	Modified residue	299	299	.	.	.	Note=Phosphoserine%3B by autocatalysis;status=By similarity	
P09215	UniProtKB	Modified residue	311	311	.	.	.	Note=Phosphotyrosine%3B by SRC	
P09215	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphotyrosine%3B by SRC	
P09215	UniProtKB	Modified residue	372	372	.	.	.	Note=Phosphotyrosine;status=By similarity	
P09215	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
P09215	UniProtKB	Modified residue	565	565	.	.	.	Note=Phosphotyrosine;status=By similarity	
P09215	UniProtKB	Modified residue	643	643	.	.	.	Note=Phosphoserine;status=Probable	
P09215	UniProtKB	Modified residue	652	652	.	.	.	Note=Phosphoserine;status=By similarity	
P09215	UniProtKB	Modified residue	662	662	.	.	.	Note=Phosphoserine	
P09215	UniProtKB	Alternative sequence	327	673	.	.	.	ID=VSP_004742;Note=In isoform 2.	
P09215	UniProtKB	Mutagenesis	505	505	.	.	.	Note=Decrease in the phosphorylation level.	
P09215	UniProtKB	Sequence conflict	147	147	.	.	.	.	
P09215	UniProtKB	Sequence conflict	249	249	.	.	.	.	
P09215	UniProtKB	Sequence conflict	249	249	.	.	.	.	
P09215	UniProtKB	Beta strand	3	13	.	.	.	.	
P09215	UniProtKB	Beta strand	27	35	.	.	.	.	
P09215	UniProtKB	Helix	38	40	.	.	.	.	
P09215	UniProtKB	Beta strand	43	46	.	.	.	.	
P09215	UniProtKB	Beta strand	58	62	.	.	.	.	
P09215	UniProtKB	Beta strand	68	76	.	.	.	.	
P09215	UniProtKB	Beta strand	79	87	.	.	.	.	
P09215	UniProtKB	Helix	88	96	.	.	.	.	
P09215	UniProtKB	Turn	97	100	.	.	.	.	
P09215	UniProtKB	Beta strand	101	107	.	.	.	.	
P09215	UniProtKB	Beta strand	109	111	.	.	.	.	
P09215	UniProtKB	Beta strand	113	122	.	.	.	.	
##sequence-region P41743 1 596
P41743	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
P41743	UniProtKB	Chain	2	596	.	.	.	ID=PRO_0000055710;Note=Protein kinase C iota type	
P41743	UniProtKB	Domain	25	108	.	.	.	Note=OPR	
P41743	UniProtKB	Domain	254	522	.	.	.	Note=Protein kinase	
P41743	UniProtKB	Domain	523	594	.	.	.	Note=AGC-kinase C-terminal	
P41743	UniProtKB	Zinc finger	140	190	.	.	.	Note=Phorbol-ester/DAG-type	
P41743	UniProtKB	Nucleotide binding	260	268	.	.	.	Note=ATP;status=By similarity	
P41743	UniProtKB	Region	2	253	.	.	.	Note=Regulatory domain	
P41743	UniProtKB	Region	2	28	.	.	.	Note=Required for interaction with RAB2	
P41743	UniProtKB	Region	72	91	.	.	.	Note=Interaction with PARD6A	
P41743	UniProtKB	Motif	125	134	.	.	.	Note=Pseudosubstrate;status=By similarity	
P41743	UniProtKB	Active site	378	378	.	.	.	Note=Proton acceptor;status=By similarity	
P41743	UniProtKB	Binding site	283	283	.	.	.	Note=ATP;status=By similarity	
P41743	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylproline	
P41743	UniProtKB	Modified residue	3	3	.	.	.	Note=Phosphothreonine	
P41743	UniProtKB	Modified residue	7	7	.	.	.	Note=Phosphoserine	
P41743	UniProtKB	Modified residue	8	8	.	.	.	Note=Phosphoserine	
P41743	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphothreonine	
P41743	UniProtKB	Modified residue	265	265	.	.	.	Note=Phosphotyrosine%3B by SRC	
P41743	UniProtKB	Modified residue	280	280	.	.	.	Note=Phosphotyrosine%3B by SRC	
P41743	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphotyrosine%3B by SRC	
P41743	UniProtKB	Modified residue	412	412	.	.	.	Note=Phosphothreonine%3B by PDPK1;status=Probable	
P41743	UniProtKB	Modified residue	564	564	.	.	.	Note=Phosphothreonine	
P41743	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_042322;Note=In a metastatic melanoma sample%3B somatic mutation.	
P41743	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_042323	
P41743	UniProtKB	Mutagenesis	29	29	.	.	.	Note=No effect on interaction with SQSTM1.	
P41743	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Loss of interaction with ECT2%2C PARD6A and with SQSTM1.	
P41743	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A%3B when associated with A-91.	
P41743	UniProtKB	Mutagenesis	91	91	.	.	.	Note=Slight decrease of interaction with PARD6A. Loss of interaction with PARD6A%3B when associated with A-85.	
P41743	UniProtKB	Mutagenesis	265	265	.	.	.	Note=No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. Little effect on TRAF6-mediated activation of NF-kappa-B. Decreased binding to KPNB1/importin-beta.	
P41743	UniProtKB	Mutagenesis	274	274	.	.	.	Note=No effect on activity.	
P41743	UniProtKB	Mutagenesis	274	274	.	.	.	Note=Abolishes activity.	
P41743	UniProtKB	Mutagenesis	280	280	.	.	.	Note=No effect on the SRC-mediated phosphorylation state. No effect on SRC-induced enzyme activity. No effect on TRAF6-mediated activation of NF-kappa-B.	
P41743	UniProtKB	Mutagenesis	334	334	.	.	.	Note=No effect on the SRC-mediated phosphorylation state. Significant reduction of SRC-induced enzyme activity. Greatly reduced TRAF6-mediated activation of NF-kappa-B. Reduces NGF-dependent cell survival.	
P41743	UniProtKB	Sequence conflict	485	485	.	.	.	.	
P41743	UniProtKB	Sequence conflict	508	508	.	.	.	.	
P41743	UniProtKB	Sequence conflict	560	560	.	.	.	.	
P41743	UniProtKB	Beta strand	26	32	.	.	.	.	
P41743	UniProtKB	Beta strand	35	41	.	.	.	.	
P41743	UniProtKB	Helix	47	57	.	.	.	.	
P41743	UniProtKB	Beta strand	67	71	.	.	.	.	
P41743	UniProtKB	Beta strand	73	75	.	.	.	.	
P41743	UniProtKB	Beta strand	77	79	.	.	.	.	
P41743	UniProtKB	Helix	83	95	.	.	.	.	
P41743	UniProtKB	Beta strand	101	106	.	.	.	.	
P41743	UniProtKB	Helix	251	253	.	.	.	.	
P41743	UniProtKB	Beta strand	254	262	.	.	.	.	
P41743	UniProtKB	Beta strand	264	273	.	.	.	.	
P41743	UniProtKB	Turn	274	277	.	.	.	.	
P41743	UniProtKB	Beta strand	278	286	.	.	.	.	
P41743	UniProtKB	Helix	287	289	.	.	.	.	
P41743	UniProtKB	Helix	293	308	.	.	.	.	
P41743	UniProtKB	Turn	309	311	.	.	.	.	
P41743	UniProtKB	Beta strand	318	323	.	.	.	.	
P41743	UniProtKB	Beta strand	325	332	.	.	.	.	
P41743	UniProtKB	Helix	340	347	.	.	.	.	
P41743	UniProtKB	Helix	352	371	.	.	.	.	
P41743	UniProtKB	Helix	381	383	.	.	.	.	
P41743	UniProtKB	Beta strand	384	386	.	.	.	.	
P41743	UniProtKB	Beta strand	388	390	.	.	.	.	
P41743	UniProtKB	Beta strand	392	394	.	.	.	.	
P41743	UniProtKB	Helix	397	399	.	.	.	.	
P41743	UniProtKB	Helix	417	419	.	.	.	.	
P41743	UniProtKB	Helix	422	425	.	.	.	.	
P41743	UniProtKB	Helix	433	448	.	.	.	.	
P41743	UniProtKB	Turn	452	457	.	.	.	.	
P41743	UniProtKB	Helix	467	476	.	.	.	.	
P41743	UniProtKB	Helix	487	496	.	.	.	.	
P41743	UniProtKB	Turn	501	503	.	.	.	.	
P41743	UniProtKB	Turn	505	507	.	.	.	.	
P41743	UniProtKB	Turn	509	511	.	.	.	.	
P41743	UniProtKB	Helix	512	517	.	.	.	.	
P41743	UniProtKB	Helix	520	522	.	.	.	.	
P41743	UniProtKB	Helix	527	531	.	.	.	.	
P41743	UniProtKB	Turn	545	547	.	.	.	.	
P41743	UniProtKB	Helix	549	551	.	.	.	.	
P41743	UniProtKB	Helix	554	557	.	.	.	.	
P41743	UniProtKB	Helix	568	571	.	.	.	.	
P41743	UniProtKB	Helix	576	579	.	.	.	.	
##sequence-region Q62074 1 595
Q62074	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q62074	UniProtKB	Chain	2	595	.	.	.	ID=PRO_0000055711;Note=Protein kinase C iota type	
Q62074	UniProtKB	Domain	25	108	.	.	.	Note=OPR	
Q62074	UniProtKB	Domain	253	521	.	.	.	Note=Protein kinase	
Q62074	UniProtKB	Domain	522	595	.	.	.	Note=AGC-kinase C-terminal	
Q62074	UniProtKB	Zinc finger	140	190	.	.	.	Note=Phorbol-ester/DAG-type	
Q62074	UniProtKB	Nucleotide binding	259	267	.	.	.	Note=ATP;status=By similarity	
Q62074	UniProtKB	Region	2	252	.	.	.	Note=Regulatory domain;status=By similarity	
Q62074	UniProtKB	Region	2	28	.	.	.	Note=Required for interaction with RAB2;status=By similarity	
Q62074	UniProtKB	Region	72	91	.	.	.	Note=Interaction with PARD6A;status=By similarity	
Q62074	UniProtKB	Motif	125	134	.	.	.	Note=Pseudosubstrate	
Q62074	UniProtKB	Active site	377	377	.	.	.	Note=Proton acceptor;status=By similarity	
Q62074	UniProtKB	Binding site	282	282	.	.	.	Note=ATP;status=By similarity	
Q62074	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylproline;status=By similarity	
Q62074	UniProtKB	Modified residue	3	3	.	.	.	Note=Phosphothreonine;status=By similarity	
Q62074	UniProtKB	Modified residue	7	7	.	.	.	Note=Phosphoserine;status=By similarity	
Q62074	UniProtKB	Modified residue	8	8	.	.	.	Note=Phosphoserine;status=By similarity	
Q62074	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphothreonine;status=By similarity	
Q62074	UniProtKB	Modified residue	264	264	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q62074	UniProtKB	Modified residue	279	279	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q62074	UniProtKB	Modified residue	333	333	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q62074	UniProtKB	Modified residue	411	411	.	.	.	Note=Phosphothreonine%3B alternate	
Q62074	UniProtKB	Modified residue	411	411	.	.	.	Note=Phosphothreonine%3B by PDPK1%3B alternate;status=By similarity	
Q62074	UniProtKB	Modified residue	563	563	.	.	.	Note=Phosphothreonine	
Q62074	UniProtKB	Mutagenesis	27	27	.	.	.	Note=No effect on interaction with SQSTM1.	
Q62074	UniProtKB	Mutagenesis	28	28	.	.	.	Note=No effect on interaction with SQSTM1%3B when associated with A-29.	
Q62074	UniProtKB	Mutagenesis	29	29	.	.	.	Note=No effect on interaction with SQSTM1%3B when associated with A-118.	
Q62074	UniProtKB	Mutagenesis	70	70	.	.	.	Note=Loss of interaction with SQSTM1.	
Q62074	UniProtKB	Mutagenesis	72	72	.	.	.	Note=Loss of interaction with SQSTM1.	
Q62074	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Loss of interaction with SQSTM1.	
Q62074	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Loss of interaction with SQSTM1.	
Q62074	UniProtKB	Mutagenesis	83	83	.	.	.	Note=No effect on interaction with SQSTM1.	
Q62074	UniProtKB	Mutagenesis	85	85	.	.	.	Note=Loss of interaction with SQSTM1.	
Q62074	UniProtKB	Helix	250	252	.	.	.	.	
Q62074	UniProtKB	Beta strand	253	261	.	.	.	.	
Q62074	UniProtKB	Beta strand	263	272	.	.	.	.	
Q62074	UniProtKB	Turn	273	275	.	.	.	.	
Q62074	UniProtKB	Beta strand	278	285	.	.	.	.	
Q62074	UniProtKB	Helix	286	288	.	.	.	.	
Q62074	UniProtKB	Helix	297	308	.	.	.	.	
Q62074	UniProtKB	Beta strand	317	322	.	.	.	.	
Q62074	UniProtKB	Beta strand	324	332	.	.	.	.	
Q62074	UniProtKB	Helix	339	346	.	.	.	.	
Q62074	UniProtKB	Helix	351	370	.	.	.	.	
Q62074	UniProtKB	Helix	380	382	.	.	.	.	
Q62074	UniProtKB	Beta strand	383	385	.	.	.	.	
Q62074	UniProtKB	Beta strand	391	393	.	.	.	.	
Q62074	UniProtKB	Helix	416	418	.	.	.	.	
Q62074	UniProtKB	Helix	421	424	.	.	.	.	
Q62074	UniProtKB	Helix	432	447	.	.	.	.	
Q62074	UniProtKB	Turn	453	456	.	.	.	.	
Q62074	UniProtKB	Helix	466	475	.	.	.	.	
Q62074	UniProtKB	Helix	486	495	.	.	.	.	
Q62074	UniProtKB	Turn	500	502	.	.	.	.	
Q62074	UniProtKB	Turn	508	510	.	.	.	.	
Q62074	UniProtKB	Helix	511	517	.	.	.	.	
Q62074	UniProtKB	Turn	519	523	.	.	.	.	
Q62074	UniProtKB	Helix	526	530	.	.	.	.	
Q62074	UniProtKB	Helix	548	550	.	.	.	.	
Q62074	UniProtKB	Helix	553	556	.	.	.	.	
Q62074	UniProtKB	Helix	567	570	.	.	.	.	
Q62074	UniProtKB	Helix	575	578	.	.	.	.	
##sequence-region Q5R4K9 1 596
Q5R4K9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q5R4K9	UniProtKB	Chain	2	596	.	.	.	ID=PRO_0000055712;Note=Protein kinase C iota type	
Q5R4K9	UniProtKB	Domain	25	108	.	.	.	Note=OPR	
Q5R4K9	UniProtKB	Domain	254	522	.	.	.	Note=Protein kinase	
Q5R4K9	UniProtKB	Domain	523	594	.	.	.	Note=AGC-kinase C-terminal	
Q5R4K9	UniProtKB	Zinc finger	140	190	.	.	.	Note=Phorbol-ester/DAG-type	
Q5R4K9	UniProtKB	Nucleotide binding	260	268	.	.	.	Note=ATP;status=By similarity	
Q5R4K9	UniProtKB	Region	2	253	.	.	.	Note=Regulatory domain;status=By similarity	
Q5R4K9	UniProtKB	Region	2	28	.	.	.	Note=Required for interaction with RAB2;status=By similarity	
Q5R4K9	UniProtKB	Region	72	91	.	.	.	Note=Interaction with PARD6A;status=By similarity	
Q5R4K9	UniProtKB	Motif	125	134	.	.	.	Note=Pseudosubstrate;status=By similarity	
Q5R4K9	UniProtKB	Active site	378	378	.	.	.	Note=Proton acceptor;status=By similarity	
Q5R4K9	UniProtKB	Binding site	283	283	.	.	.	Note=ATP;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylproline;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	3	3	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	7	7	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	8	8	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	265	265	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	280	280	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	412	412	.	.	.	Note=Phosphothreonine%3B by PDPK1;status=By similarity	
Q5R4K9	UniProtKB	Modified residue	564	564	.	.	.	Note=Phosphothreonine;status=Probable	
##sequence-region F1M7Y5 1 596
F1M7Y5	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
F1M7Y5	UniProtKB	Chain	2	596	.	.	.	ID=PRO_0000414090;Note=Protein kinase C iota type	
F1M7Y5	UniProtKB	Domain	26	107	.	.	.	Note=OPR	
F1M7Y5	UniProtKB	Domain	254	522	.	.	.	Note=Protein kinase	
F1M7Y5	UniProtKB	Domain	523	594	.	.	.	Note=AGC-kinase C-terminal	
F1M7Y5	UniProtKB	Zinc finger	140	190	.	.	.	Note=Phorbol-ester/DAG-type	
F1M7Y5	UniProtKB	Nucleotide binding	260	268	.	.	.	Note=ATP;status=By similarity	
F1M7Y5	UniProtKB	Region	2	253	.	.	.	Note=Regulatory domain;status=By similarity	
F1M7Y5	UniProtKB	Region	2	28	.	.	.	Note=Required for interaction with RAB2;status=By similarity	
F1M7Y5	UniProtKB	Region	72	91	.	.	.	Note=Interaction with PARD6A;status=By similarity	
F1M7Y5	UniProtKB	Motif	125	134	.	.	.	Note=Pseudosubstrate;status=By similarity	
F1M7Y5	UniProtKB	Active site	378	378	.	.	.	Note=Proton acceptor;status=By similarity	
F1M7Y5	UniProtKB	Binding site	283	283	.	.	.	Note=ATP;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylproline;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	3	3	.	.	.	Note=Phosphothreonine;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	7	7	.	.	.	Note=Phosphoserine;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	8	8	.	.	.	Note=Phosphoserine;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphothreonine;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	265	265	.	.	.	Note=Phosphotyrosine%3B by SRC	
F1M7Y5	UniProtKB	Modified residue	280	280	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphotyrosine%3B by SRC;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	412	412	.	.	.	Note=Phosphothreonine%3B by PDPK1;status=By similarity	
F1M7Y5	UniProtKB	Modified residue	564	564	.	.	.	Note=Phosphothreonine;status=By similarity	
F1M7Y5	UniProtKB	Mutagenesis	265	265	.	.	.	Note=Loss of phosphorylation and nuclear import.	
F1M7Y5	UniProtKB	Sequence conflict	171	171	.	.	.	.	
##sequence-region Q15349 1 733
Q15349	UniProtKB	Chain	1	733	.	.	.	ID=PRO_0000086201;Note=Ribosomal protein S6 kinase alpha-2	
Q15349	UniProtKB	Domain	59	318	.	.	.	Note=Protein kinase 1	
Q15349	UniProtKB	Domain	319	388	.	.	.	Note=AGC-kinase C-terminal	
Q15349	UniProtKB	Domain	415	672	.	.	.	Note=Protein kinase 2	
Q15349	UniProtKB	Nucleotide binding	65	73	.	.	.	Note=ATP;status=By similarity	
Q15349	UniProtKB	Nucleotide binding	421	429	.	.	.	Note=ATP;status=By similarity	
Q15349	UniProtKB	Active site	184	184	.	.	.	Note=Proton acceptor;status=By similarity	
Q15349	UniProtKB	Active site	532	532	.	.	.	Note=Proton acceptor;status=By similarity	
Q15349	UniProtKB	Binding site	91	91	.	.	.	Note=ATP;status=By similarity	
Q15349	UniProtKB	Binding site	444	444	.	.	.	Note=ATP;status=By similarity	
Q15349	UniProtKB	Modified residue	218	218	.	.	.	Note=Phosphoserine%3B by PDPK1	
Q15349	UniProtKB	Modified residue	377	377	.	.	.	Note=Phosphoserine	
Q15349	UniProtKB	Cross-link	630	630	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
Q15349	UniProtKB	Alternative sequence	1	32	.	.	.	ID=VSP_017732;Note=In isoform 2.	
Q15349	UniProtKB	Alternative sequence	1	32	.	.	.	ID=VSP_041836;Note=In isoform 3.	
Q15349	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_040627;Note=In a metastatic melanoma sample%3B somatic mutation.	
Q15349	UniProtKB	Natural variant	732	732	.	.	.	ID=VAR_040628;Note=In a colorectal adenocarcinoma sample%3B somatic mutation.	
Q15349	UniProtKB	Sequence conflict	256	256	.	.	.	.	
Q15349	UniProtKB	Sequence conflict	269	269	.	.	.	.	
Q15349	UniProtKB	Sequence conflict	339	339	.	.	.	.	
Q15349	UniProtKB	Sequence conflict	339	339	.	.	.	.	
Q15349	UniProtKB	Sequence conflict	447	447	.	.	.	.	
##sequence-region Q9WUT3 1 733
Q9WUT3	UniProtKB	Chain	1	733	.	.	.	ID=PRO_0000086202;Note=Ribosomal protein S6 kinase alpha-2	
Q9WUT3	UniProtKB	Domain	59	318	.	.	.	Note=Protein kinase 1	
Q9WUT3	UniProtKB	Domain	319	388	.	.	.	Note=AGC-kinase C-terminal	
Q9WUT3	UniProtKB	Domain	415	672	.	.	.	Note=Protein kinase 2	
Q9WUT3	UniProtKB	Nucleotide binding	65	73	.	.	.	Note=ATP;status=By similarity	
Q9WUT3	UniProtKB	Nucleotide binding	421	429	.	.	.	Note=ATP;status=By similarity	
Q9WUT3	UniProtKB	Active site	184	184	.	.	.	Note=Proton acceptor;status=By similarity	
Q9WUT3	UniProtKB	Active site	532	532	.	.	.	Note=Proton acceptor;status=By similarity	
Q9WUT3	UniProtKB	Binding site	91	91	.	.	.	Note=ATP;status=By similarity	
Q9WUT3	UniProtKB	Binding site	444	444	.	.	.	Note=ATP;status=By similarity	
Q9WUT3	UniProtKB	Modified residue	218	218	.	.	.	Note=Phosphoserine%3B by PDPK1;status=By similarity	
Q9WUT3	UniProtKB	Modified residue	377	377	.	.	.	Note=Phosphoserine%3B alternate	
Q9WUT3	UniProtKB	Modified residue	377	377	.	.	.	Note=Phosphoserine%3B by autocatalysis%3B alternate;status=By similarity	
Q9WUT3	UniProtKB	Cross-link	630	630	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q9WUT3	UniProtKB	Sequence conflict	72	72	.	.	.	.	
##sequence-region P08111 1 1161
P08111	UniProtKB	Chain	1	1161	.	.	.	ID=PRO_0000084345;Note=Lethal(2) giant larvae protein	
P08111	UniProtKB	Repeat	39	72	.	.	.	Note=WD 1	
P08111	UniProtKB	Repeat	82	128	.	.	.	Note=WD 2	
P08111	UniProtKB	Repeat	131	167	.	.	.	Note=WD 3	
P08111	UniProtKB	Repeat	189	223	.	.	.	Note=WD 4	
P08111	UniProtKB	Repeat	231	263	.	.	.	Note=WD 5	
P08111	UniProtKB	Repeat	278	320	.	.	.	Note=WD 6	
P08111	UniProtKB	Repeat	328	358	.	.	.	Note=WD 7	
P08111	UniProtKB	Repeat	380	464	.	.	.	Note=WD 8	
P08111	UniProtKB	Repeat	513	594	.	.	.	Note=WD 9	
P08111	UniProtKB	Repeat	603	664	.	.	.	Note=WD 10	
P08111	UniProtKB	Repeat	708	778	.	.	.	Note=WD 11	
P08111	UniProtKB	Repeat	787	832	.	.	.	Note=WD 12	
P08111	UniProtKB	Repeat	837	927	.	.	.	Note=WD 13	
P08111	UniProtKB	Repeat	941	964	.	.	.	Note=WD 14	
P08111	UniProtKB	Modified residue	473	473	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	484	484	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	679	679	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	808	808	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	869	869	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	876	876	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	887	887	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	889	889	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	893	893	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Modified residue	1013	1013	.	.	.	Note=Phosphoserine	
P08111	UniProtKB	Alternative sequence	1	49	.	.	.	ID=VSP_021793;Note=In isoform D.	
P08111	UniProtKB	Alternative sequence	17	28	.	.	.	ID=VSP_021794;Note=In isoform B.	
P08111	UniProtKB	Alternative sequence	708	708	.	.	.	ID=VSP_004299;Note=In isoform p78.	
P08111	UniProtKB	Alternative sequence	709	1161	.	.	.	ID=VSP_004300;Note=In isoform p78.	
P08111	UniProtKB	Sequence conflict	2	2	.	.	.	.	
P08111	UniProtKB	Sequence conflict	2	2	.	.	.	.	
P08111	UniProtKB	Sequence conflict	37	38	.	.	.	.	
P08111	UniProtKB	Sequence conflict	58	58	.	.	.	.	
P08111	UniProtKB	Sequence conflict	185	185	.	.	.	.	
P08111	UniProtKB	Sequence conflict	227	227	.	.	.	.	
P08111	UniProtKB	Sequence conflict	243	245	.	.	.	.	
P08111	UniProtKB	Sequence conflict	304	304	.	.	.	.	
P08111	UniProtKB	Sequence conflict	331	331	.	.	.	.	
P08111	UniProtKB	Sequence conflict	338	338	.	.	.	.	
P08111	UniProtKB	Sequence conflict	366	366	.	.	.	.	
P08111	UniProtKB	Sequence conflict	388	388	.	.	.	.	
P08111	UniProtKB	Sequence conflict	512	515	.	.	.	.	
P08111	UniProtKB	Sequence conflict	667	675	.	.	.	.	
P08111	UniProtKB	Sequence conflict	727	727	.	.	.	.	
P08111	UniProtKB	Sequence conflict	857	857	.	.	.	.	
P08111	UniProtKB	Sequence conflict	959	959	.	.	.	.	
P08111	UniProtKB	Sequence conflict	1095	1095	.	.	.	.	
##sequence-region Q08470 1 1166
Q08470	UniProtKB	Chain	1	1166	.	.	.	ID=PRO_0000084346;Note=Protein lethal(2) giant larvae	
Q08470	UniProtKB	Repeat	39	72	.	.	.	Note=WD 1	
Q08470	UniProtKB	Repeat	82	128	.	.	.	Note=WD 2	
Q08470	UniProtKB	Repeat	131	167	.	.	.	Note=WD 3	
Q08470	UniProtKB	Repeat	189	223	.	.	.	Note=WD 4	
Q08470	UniProtKB	Repeat	231	263	.	.	.	Note=WD 5	
Q08470	UniProtKB	Repeat	278	320	.	.	.	Note=WD 6	
Q08470	UniProtKB	Repeat	328	358	.	.	.	Note=WD 7	
Q08470	UniProtKB	Repeat	380	464	.	.	.	Note=WD 8	
Q08470	UniProtKB	Repeat	513	595	.	.	.	Note=WD 9	
Q08470	UniProtKB	Repeat	604	665	.	.	.	Note=WD 10	
Q08470	UniProtKB	Repeat	709	779	.	.	.	Note=WD 11	
Q08470	UniProtKB	Repeat	788	833	.	.	.	Note=WD 12	
Q08470	UniProtKB	Repeat	838	928	.	.	.	Note=WD 13	
Q08470	UniProtKB	Repeat	942	965	.	.	.	Note=WD 14	
Q08470	UniProtKB	Compositional bias	1072	1159	.	.	.	Note=Thr-rich	
Q08470	UniProtKB	Sequence conflict	47	52	.	.	.	.	
Q08470	UniProtKB	Sequence conflict	318	318	.	.	.	.	
Q08470	UniProtKB	Sequence conflict	429	431	.	.	.	.	
Q08470	UniProtKB	Sequence conflict	446	446	.	.	.	.	
Q08470	UniProtKB	Sequence conflict	855	855	.	.	.	.	
Q08470	UniProtKB	Sequence conflict	969	969	.	.	.	.	
Q08470	UniProtKB	Sequence conflict	1003	1003	.	.	.	.	
Q08470	UniProtKB	Sequence conflict	1150	1152	.	.	.	.	
##sequence-region O95835 1 1130
O95835	UniProtKB	Chain	1	1130	.	.	.	ID=PRO_0000086232;Note=Serine/threonine-protein kinase LATS1	
O95835	UniProtKB	Domain	100	141	.	.	.	Note=UBA	
O95835	UniProtKB	Domain	705	1010	.	.	.	Note=Protein kinase	
O95835	UniProtKB	Domain	1011	1090	.	.	.	Note=AGC-kinase C-terminal	
O95835	UniProtKB	Nucleotide binding	711	719	.	.	.	Note=ATP;status=By similarity	
O95835	UniProtKB	Region	526	655	.	.	.	Note=Interaction with YAP1	
O95835	UniProtKB	Motif	373	376	.	.	.	Note=PPxY motif 1	
O95835	UniProtKB	Motif	556	559	.	.	.	Note=PPxY motif 2	
O95835	UniProtKB	Active site	828	828	.	.	.	Note=Proton acceptor;status=By similarity	
O95835	UniProtKB	Binding site	734	734	.	.	.	Note=ATP	
O95835	UniProtKB	Modified residue	246	246	.	.	.	Note=Phosphothreonine	
O95835	UniProtKB	Modified residue	278	278	.	.	.	Note=Phosphoserine	
O95835	UniProtKB	Modified residue	464	464	.	.	.	Note=Phosphoserine%3B by NUAK1 and NUAK2	
O95835	UniProtKB	Modified residue	613	613	.	.	.	Note=Phosphoserine;status=By similarity	
O95835	UniProtKB	Modified residue	674	674	.	.	.	Note=Phosphoserine	
O95835	UniProtKB	Modified residue	909	909	.	.	.	Note=Phosphoserine%3B by STK3/MST2	
O95835	UniProtKB	Modified residue	1079	1079	.	.	.	Note=Phosphothreonine%3B by STK3/MST2	
O95835	UniProtKB	Alternative sequence	672	690	.	.	.	ID=VSP_051604;Note=In isoform 2.	
O95835	UniProtKB	Alternative sequence	691	1130	.	.	.	ID=VSP_051605;Note=In isoform 2.	
O95835	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_040660;Dbxref=dbSNP:rs55945045	
O95835	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_040661;Dbxref=dbSNP:rs34793526	
O95835	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_040662;Dbxref=dbSNP:rs56149740	
O95835	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_040663;Dbxref=dbSNP:rs56348064	
O95835	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_040664;Dbxref=dbSNP:rs55874734	
O95835	UniProtKB	Natural variant	641	641	.	.	.	ID=VAR_040665;Dbxref=dbSNP:rs35163691	
O95835	UniProtKB	Natural variant	669	669	.	.	.	ID=VAR_040666;Note=In a lung adenocarcinoma sample%3B somatic mutation.	
O95835	UniProtKB	Natural variant	806	806	.	.	.	ID=VAR_040667;Note=In a lung large cell carcinoma sample%3B somatic mutation.	
O95835	UniProtKB	Natural variant	1000	1000	.	.	.	ID=VAR_040668;Dbxref=dbSNP:rs56412005	
O95835	UniProtKB	Mutagenesis	464	464	.	.	.	Note=Abolishes phosphorylation by NUAK1 and NUAK2.	
O95835	UniProtKB	Mutagenesis	559	559	.	.	.	Note=Loss of interaction with YAP1.	
O95835	UniProtKB	Mutagenesis	734	734	.	.	.	Note=Loss of kinase activity%2C autophosphorylation%2C increased ploidy%2C prolonged duration of mitosis and lack of p53 expression.	
##sequence-region Q8BYR2 1 1129
Q8BYR2	UniProtKB	Chain	1	1129	.	.	.	ID=PRO_0000086233;Note=Serine/threonine-protein kinase LATS1	
Q8BYR2	UniProtKB	Domain	100	141	.	.	.	Note=UBA	
Q8BYR2	UniProtKB	Domain	704	1009	.	.	.	Note=Protein kinase	
Q8BYR2	UniProtKB	Domain	1010	1089	.	.	.	Note=AGC-kinase C-terminal	
Q8BYR2	UniProtKB	Nucleotide binding	710	718	.	.	.	Note=ATP;status=By similarity	
Q8BYR2	UniProtKB	Region	525	654	.	.	.	Note=Interaction with YAP1;status=By similarity	
Q8BYR2	UniProtKB	Motif	372	375	.	.	.	Note=PPxY motif 1	
Q8BYR2	UniProtKB	Motif	555	558	.	.	.	Note=PPxY motif 2	
Q8BYR2	UniProtKB	Active site	827	827	.	.	.	Note=Proton acceptor;status=By similarity	
Q8BYR2	UniProtKB	Binding site	733	733	.	.	.	Note=ATP;status=By similarity	
Q8BYR2	UniProtKB	Modified residue	246	246	.	.	.	Note=Phosphothreonine	
Q8BYR2	UniProtKB	Modified residue	278	278	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BYR2	UniProtKB	Modified residue	463	463	.	.	.	Note=Phosphoserine%3B alternate	
Q8BYR2	UniProtKB	Modified residue	463	463	.	.	.	Note=Phosphoserine%3B by NUAK1 and NUAK2%3B alternate;status=Probable	
Q8BYR2	UniProtKB	Modified residue	612	612	.	.	.	Note=Phosphoserine	
Q8BYR2	UniProtKB	Modified residue	673	673	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BYR2	UniProtKB	Modified residue	908	908	.	.	.	Note=Phosphoserine%3B by STK3/MST2;status=By similarity	
Q8BYR2	UniProtKB	Modified residue	1078	1078	.	.	.	Note=Phosphothreonine%3B by STK3/MST2;status=By similarity	
Q8BYR2	UniProtKB	Sequence conflict	940	940	.	.	.	.	
Q8BYR2	UniProtKB	Sequence conflict	963	963	.	.	.	.	
Q8BYR2	UniProtKB	Sequence conflict	1061	1061	.	.	.	.	
##sequence-region Q9NRM7 1 1088
Q9NRM7	UniProtKB	Chain	1	1088	.	.	.	ID=PRO_0000086234;Note=Serine/threonine-protein kinase LATS2	
Q9NRM7	UniProtKB	Domain	98	139	.	.	.	Note=UBA	
Q9NRM7	UniProtKB	Domain	668	973	.	.	.	Note=Protein kinase	
Q9NRM7	UniProtKB	Domain	974	1052	.	.	.	Note=AGC-kinase C-terminal	
Q9NRM7	UniProtKB	Nucleotide binding	674	782	.	.	.	Note=ATP;status=By similarity	
Q9NRM7	UniProtKB	Motif	515	518	.	.	.	Note=PPxY motif	
Q9NRM7	UniProtKB	Active site	791	791	.	.	.	Note=Proton acceptor;status=By similarity	
Q9NRM7	UniProtKB	Binding site	697	697	.	.	.	Note=ATP	
Q9NRM7	UniProtKB	Modified residue	83	83	.	.	.	Note=Phosphoserine%3B by AURKA	
Q9NRM7	UniProtKB	Modified residue	279	279	.	.	.	Note=Phosphothreonine	
Q9NRM7	UniProtKB	Modified residue	1041	1041	.	.	.	Note=Phosphothreonine	
Q9NRM7	UniProtKB	Natural variant	40	40	.	.	.	ID=VAR_040669;Note=In a lung adenocarcinoma sample%3B somatic mutation.	
Q9NRM7	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_040670;Dbxref=dbSNP:rs55842804	
Q9NRM7	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_019789;Dbxref=dbSNP:rs558614	
Q9NRM7	UniProtKB	Natural variant	363	363	.	.	.	ID=VAR_047077;Dbxref=dbSNP:rs2770928	
Q9NRM7	UniProtKB	Natural variant	799	799	.	.	.	ID=VAR_040671;Dbxref=dbSNP:rs35368391	
Q9NRM7	UniProtKB	Natural variant	1014	1014	.	.	.	ID=VAR_040672;Dbxref=dbSNP:rs45523141	
Q9NRM7	UniProtKB	Natural variant	1025	1025	.	.	.	ID=VAR_040673;Dbxref=dbSNP:rs56116059	
Q9NRM7	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Fails to localize at the centromere during interphase.	
Q9NRM7	UniProtKB	Mutagenesis	83	83	.	.	.	Note=Fails to localize at the centromere during interphase.	
Q9NRM7	UniProtKB	Mutagenesis	697	697	.	.	.	Note=Loss of kinase activity%2C autophosphorylation and tumor suppressor activity.	
Q9NRM7	UniProtKB	Mutagenesis	872	872	.	.	.	Note=Loss of tumor suppressor activity.	
Q9NRM7	UniProtKB	Sequence conflict	59	61	.	.	.	.	
Q9NRM7	UniProtKB	Sequence conflict	436	436	.	.	.	.	
Q9NRM7	UniProtKB	Sequence conflict	711	711	.	.	.	.	
Q9NRM7	UniProtKB	Sequence conflict	868	868	.	.	.	.	
##sequence-region Q7TSJ6 1 1042
Q7TSJ6	UniProtKB	Chain	1	1042	.	.	.	ID=PRO_0000086235;Note=Serine/threonine-protein kinase LATS2	
Q7TSJ6	UniProtKB	Domain	97	138	.	.	.	Note=UBA	
Q7TSJ6	UniProtKB	Domain	626	931	.	.	.	Note=Protein kinase	
Q7TSJ6	UniProtKB	Domain	932	1010	.	.	.	Note=AGC-kinase C-terminal	
Q7TSJ6	UniProtKB	Nucleotide binding	632	640	.	.	.	Note=ATP;status=By similarity	
Q7TSJ6	UniProtKB	Motif	472	475	.	.	.	Note=PPxY motif	
Q7TSJ6	UniProtKB	Active site	749	749	.	.	.	Note=Proton acceptor;status=By similarity	
Q7TSJ6	UniProtKB	Binding site	655	655	.	.	.	Note=ATP;status=By similarity	
Q7TSJ6	UniProtKB	Modified residue	82	82	.	.	.	Note=Phosphoserine%3B by AURKA;status=By similarity	
Q7TSJ6	UniProtKB	Modified residue	267	267	.	.	.	Note=Phosphothreonine;status=By similarity	
Q7TSJ6	UniProtKB	Modified residue	999	999	.	.	.	Note=Phosphothreonine;status=By similarity	
Q7TSJ6	UniProtKB	Sequence conflict	184	184	.	.	.	.	
Q7TSJ6	UniProtKB	Sequence conflict	279	279	.	.	.	.	
Q7TSJ6	UniProtKB	Sequence conflict	549	549	.	.	.	.	
Q7TSJ6	UniProtKB	Sequence conflict	589	589	.	.	.	.	
Q7TSJ6	UniProtKB	Helix	100	110	.	.	.	.	
Q7TSJ6	UniProtKB	Helix	113	123	.	.	.	.	
Q7TSJ6	UniProtKB	Helix	128	138	.	.	.	.	
##sequence-region O43261 1 78
O43261	UniProtKB	Chain	1	78	.	.	.	ID=PRO_0000084409;Note=Leukemia-associated protein 1	
##sequence-region Q9HBX8 1 967
Q9HBX8	UniProtKB	Signal peptide	1	24	.	.	.	status=Potential	
Q9HBX8	UniProtKB	Chain	25	967	.	.	.	ID=PRO_0000069699;Note=Leucine-rich repeat-containing G-protein coupled receptor 6	
Q9HBX8	UniProtKB	Topological domain	25	567	.	.	.	Note=Extracellular;status=Potential	
Q9HBX8	UniProtKB	Transmembrane	568	588	.	.	.	Note=Helical%3B Name%3D1%3B;status=Potential	
Q9HBX8	UniProtKB	Topological domain	589	598	.	.	.	Note=Cytoplasmic;status=Potential	
Q9HBX8	UniProtKB	Transmembrane	599	619	.	.	.	Note=Helical%3B Name%3D2%3B;status=Potential	
Q9HBX8	UniProtKB	Topological domain	620	644	.	.	.	Note=Extracellular;status=Potential	
Q9HBX8	UniProtKB	Transmembrane	645	665	.	.	.	Note=Helical%3B Name%3D3%3B;status=Potential	
Q9HBX8	UniProtKB	Topological domain	666	687	.	.	.	Note=Cytoplasmic;status=Potential	
Q9HBX8	UniProtKB	Transmembrane	688	708	.	.	.	Note=Helical%3B Name%3D4%3B;status=Potential	
Q9HBX8	UniProtKB	Topological domain	709	727	.	.	.	Note=Extracellular;status=Potential	
Q9HBX8	UniProtKB	Transmembrane	728	748	.	.	.	Note=Helical%3B Name%3D5%3B;status=Potential	
Q9HBX8	UniProtKB	Topological domain	749	774	.	.	.	Note=Cytoplasmic;status=Potential	
Q9HBX8	UniProtKB	Transmembrane	775	795	.	.	.	Note=Helical%3B Name%3D6%3B;status=Potential	
Q9HBX8	UniProtKB	Topological domain	796	809	.	.	.	Note=Extracellular;status=Potential	
Q9HBX8	UniProtKB	Transmembrane	810	830	.	.	.	Note=Helical%3B Name%3D7%3B;status=Potential	
Q9HBX8	UniProtKB	Topological domain	831	967	.	.	.	Note=Cytoplasmic;status=Potential	
Q9HBX8	UniProtKB	Domain	26	66	.	.	.	Note=LRRNT	
Q9HBX8	UniProtKB	Repeat	91	112	.	.	.	Note=LRR 1	
Q9HBX8	UniProtKB	Repeat	115	136	.	.	.	Note=LRR 2	
Q9HBX8	UniProtKB	Repeat	139	160	.	.	.	Note=LRR 3	
Q9HBX8	UniProtKB	Repeat	163	186	.	.	.	Note=LRR 4	
Q9HBX8	UniProtKB	Repeat	187	208	.	.	.	Note=LRR 5	
Q9HBX8	UniProtKB	Repeat	211	232	.	.	.	Note=LRR 6	
Q9HBX8	UniProtKB	Repeat	235	256	.	.	.	Note=LRR 7	
Q9HBX8	UniProtKB	Repeat	258	279	.	.	.	Note=LRR 8	
Q9HBX8	UniProtKB	Repeat	282	303	.	.	.	Note=LRR 9	
Q9HBX8	UniProtKB	Repeat	306	328	.	.	.	Note=LRR 10	
Q9HBX8	UniProtKB	Repeat	329	350	.	.	.	Note=LRR 11	
Q9HBX8	UniProtKB	Repeat	353	374	.	.	.	Note=LRR 12	
Q9HBX8	UniProtKB	Repeat	375	396	.	.	.	Note=LRR 13	
Q9HBX8	UniProtKB	Repeat	399	420	.	.	.	Note=LRR 14	
Q9HBX8	UniProtKB	Repeat	423	443	.	.	.	Note=LRR 15	
Q9HBX8	UniProtKB	Compositional bias	952	955	.	.	.	Note=Poly-Gly	
Q9HBX8	UniProtKB	Glycosylation	77	77	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9HBX8	UniProtKB	Glycosylation	208	208	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9HBX8	UniProtKB	Disulfide bond	642	717	.	.	.	status=By similarity	
Q9HBX8	UniProtKB	Alternative sequence	1	71	.	.	.	ID=VSP_028006;Note=In isoform 1.	
Q9HBX8	UniProtKB	Alternative sequence	1	71	.	.	.	ID=VSP_013596;Note=In isoform 2.	
Q9HBX8	UniProtKB	Alternative sequence	144	239	.	.	.	ID=VSP_028007;Note=In isoform 1.	
Q9HBX8	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_049413;Dbxref=dbSNP:rs7553800	
Q9HBX8	UniProtKB	Natural variant	516	516	.	.	.	ID=VAR_033479;Dbxref=dbSNP:rs6668765	
Q9HBX8	UniProtKB	Natural variant	592	592	.	.	.	ID=VAR_059324;Dbxref=dbSNP:rs788795	
Q9HBX8	UniProtKB	Natural variant	725	725	.	.	.	ID=VAR_035762;Note=In a colorectal cancer sample%3B somatic mutation%3B no effect Wnt signlaing upon RSPO1-binding.	
Q9HBX8	UniProtKB	Natural variant	928	928	.	.	.	ID=VAR_035763;Note=In a colorectal cancer sample%3B somatic mutation%3B no effect Wnt signlaing upon RSPO1-binding.	
Q9HBX8	UniProtKB	Sequence conflict	545	549	.	.	.	.	
Q9HBX8	UniProtKB	Sequence conflict	767	767	.	.	.	.	
Q9HBX8	UniProtKB	Sequence conflict	963	967	.	.	.	.	
##sequence-region G5E5X0 1 674
G5E5X0	UniProtKB	Chain	1	674	.	.	.	ID=PRO_0000416960;Note=LIM domain-containing protein 1	
G5E5X0	UniProtKB	Domain	468	529	.	.	.	Note=LIM zinc-binding 1	
G5E5X0	UniProtKB	Domain	533	593	.	.	.	Note=LIM zinc-binding 2	
G5E5X0	UniProtKB	Domain	594	662	.	.	.	Note=LIM zinc-binding 3	
G5E5X0	UniProtKB	Region	54	136	.	.	.	Note=Mediates nuclear export;status=By similarity	
G5E5X0	UniProtKB	Region	188	259	.	.	.	Note=Interaction with EGLN1/PHD2;status=By similarity	
G5E5X0	UniProtKB	Region	402	440	.	.	.	Note=Interaction with RB1;status=By similarity	
G5E5X0	UniProtKB	Region	470	674	.	.	.	Note=Necessary for nuclear localization;status=By similarity	
G5E5X0	UniProtKB	Compositional bias	58	64	.	.	.	Note=Poly-Gln	
G5E5X0	UniProtKB	Modified residue	271	271	.	.	.	Note=Phosphoserine;status=By similarity	
G5E5X0	UniProtKB	Modified residue	276	276	.	.	.	Note=Phosphoserine;status=By similarity	
G5E5X0	UniProtKB	Modified residue	422	422	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q9UGP4 1 676
Q9UGP4	UniProtKB	Chain	1	676	.	.	.	ID=PRO_0000075801;Note=LIM domain-containing protein 1	
Q9UGP4	UniProtKB	Domain	470	531	.	.	.	Note=LIM zinc-binding 1	
Q9UGP4	UniProtKB	Domain	535	595	.	.	.	Note=LIM zinc-binding 2	
Q9UGP4	UniProtKB	Domain	595	664	.	.	.	Note=LIM zinc-binding 3	
Q9UGP4	UniProtKB	Region	54	134	.	.	.	Note=Mediates nuclear export	
Q9UGP4	UniProtKB	Region	186	260	.	.	.	Note=Interaction with EGLN1/PHD2	
Q9UGP4	UniProtKB	Region	404	442	.	.	.	Note=Interaction with RB1	
Q9UGP4	UniProtKB	Region	472	676	.	.	.	Note=Necessary for nuclear localization	
Q9UGP4	UniProtKB	Modified residue	272	272	.	.	.	Note=Phosphoserine	
Q9UGP4	UniProtKB	Modified residue	277	277	.	.	.	Note=Phosphoserine	
Q9UGP4	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphoserine	
Q9UGP4	UniProtKB	Modified residue	421	421	.	.	.	Note=Phosphoserine	
Q9UGP4	UniProtKB	Modified residue	424	424	.	.	.	Note=Phosphoserine	
Q9UGP4	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_050147;Dbxref=dbSNP:rs2578662	
Q9UGP4	UniProtKB	Natural variant	415	415	.	.	.	ID=VAR_021993;Dbxref=dbSNP:rs3733113	
##sequence-region Q9QXD8 1 668
Q9QXD8	UniProtKB	Chain	1	668	.	.	.	ID=PRO_0000075802;Note=LIM domain-containing protein 1	
Q9QXD8	UniProtKB	Domain	462	523	.	.	.	Note=LIM zinc-binding 1	
Q9QXD8	UniProtKB	Domain	527	587	.	.	.	Note=LIM zinc-binding 2	
Q9QXD8	UniProtKB	Domain	587	656	.	.	.	Note=LIM zinc-binding 3	
Q9QXD8	UniProtKB	Region	54	128	.	.	.	Note=Mediates nuclear export;status=By similarity	
Q9QXD8	UniProtKB	Region	181	256	.	.	.	Note=Interaction with EGLN1/PHD2;status=By similarity	
Q9QXD8	UniProtKB	Region	396	434	.	.	.	Note=Interaction with RB1;status=By similarity	
Q9QXD8	UniProtKB	Region	464	668	.	.	.	Note=Necessary for nuclear localization;status=By similarity	
Q9QXD8	UniProtKB	Modified residue	273	273	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QXD8	UniProtKB	Modified residue	296	296	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QXD8	UniProtKB	Modified residue	413	413	.	.	.	Note=Phosphoserine;status=By similarity	
Q9QXD8	UniProtKB	Sequence conflict	17	17	.	.	.	.	
Q9QXD8	UniProtKB	Sequence conflict	331	331	.	.	.	.	
Q9QXD8	UniProtKB	Sequence conflict	487	487	.	.	.	.	
##sequence-region B5DEH0 1 663
B5DEH0	UniProtKB	Chain	1	663	.	.	.	ID=PRO_0000416961;Note=LIM domain-containing protein 1	
B5DEH0	UniProtKB	Domain	457	518	.	.	.	Note=LIM zinc-binding 1	
B5DEH0	UniProtKB	Domain	522	582	.	.	.	Note=LIM zinc-binding 2	
B5DEH0	UniProtKB	Domain	583	651	.	.	.	Note=LIM zinc-binding 3	
B5DEH0	UniProtKB	Region	54	128	.	.	.	Note=Mediates nuclear export;status=By similarity	
B5DEH0	UniProtKB	Region	180	251	.	.	.	Note=Interaction with EGLN1/PHD2;status=By similarity	
B5DEH0	UniProtKB	Region	391	429	.	.	.	Note=Interaction with RB1;status=By similarity	
B5DEH0	UniProtKB	Region	459	663	.	.	.	Note=Necessary for nuclear localization;status=By similarity	
B5DEH0	UniProtKB	Compositional bias	58	64	.	.	.	Note=Poly-Gln	
B5DEH0	UniProtKB	Modified residue	268	268	.	.	.	Note=Phosphoserine;status=By similarity	
B5DEH0	UniProtKB	Modified residue	291	291	.	.	.	Note=Phosphoserine;status=By similarity	
B5DEH0	UniProtKB	Modified residue	408	408	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q5TKA1 1 542
Q5TKA1	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q5TKA1	UniProtKB	Chain	2	542	.	.	.	ID=PRO_0000249546;Note=Protein lin-9 homolog	
Q5TKA1	UniProtKB	Region	2	296	.	.	.	Note=Sufficient for interaction with RB1	
Q5TKA1	UniProtKB	Coiled coil	354	413	.	.	.	status=Potential	
Q5TKA1	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
Q5TKA1	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine	
Q5TKA1	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphothreonine	
Q5TKA1	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine	
Q5TKA1	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine	
Q5TKA1	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_020509;Note=In isoform 2.	
Q5TKA1	UniProtKB	Alternative sequence	54	88	.	.	.	ID=VSP_020510;Note=In isoform 3.	
Q5TKA1	UniProtKB	Sequence conflict	436	436	.	.	.	.	
Q5TKA1	UniProtKB	Sequence conflict	508	508	.	.	.	.	
##sequence-region Q4R8N2 1 542
Q4R8N2	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q4R8N2	UniProtKB	Chain	2	542	.	.	.	ID=PRO_0000249547;Note=Protein lin-9 homolog	
Q4R8N2	UniProtKB	Region	2	296	.	.	.	Note=Sufficient for interaction with RB1;status=By similarity	
Q4R8N2	UniProtKB	Coiled coil	355	413	.	.	.	status=Potential	
Q4R8N2	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q4R8N2	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R8N2	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphothreonine;status=By similarity	
Q4R8N2	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R8N2	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q8C735 1 542
Q8C735	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q8C735	UniProtKB	Chain	2	542	.	.	.	ID=PRO_0000249548;Note=Protein lin-9 homolog	
Q8C735	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q8C735	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine;status=By similarity	
Q8C735	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphothreonine;status=By similarity	
Q8C735	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine;status=By similarity	
Q8C735	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;status=By similarity	
Q8C735	UniProtKB	Alternative sequence	176	205	.	.	.	ID=VSP_020511;Note=In isoform 3.	
Q8C735	UniProtKB	Alternative sequence	206	542	.	.	.	ID=VSP_020512;Note=In isoform 3.	
Q8C735	UniProtKB	Alternative sequence	416	542	.	.	.	ID=VSP_020513;Note=In isoform 2.	
Q8C735	UniProtKB	Sequence conflict	152	152	.	.	.	.	
##sequence-region Q9Y250 1 596
Q9Y250	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q9Y250	UniProtKB	Chain	2	596	.	.	.	ID=PRO_0000182971;Note=Leucine zipper putative tumor suppressor 1	
Q9Y250	UniProtKB	Coiled coil	256	374	.	.	.	status=Potential	
Q9Y250	UniProtKB	Lipidation	2	2	.	.	.	Note=N-myristoyl glycine;status=By similarity	
Q9Y250	UniProtKB	Alternative sequence	55	76	.	.	.	ID=VSP_009940;Note=In isoform 7.	
Q9Y250	UniProtKB	Alternative sequence	77	596	.	.	.	ID=VSP_009941;Note=In isoform 7.	
Q9Y250	UniProtKB	Alternative sequence	186	571	.	.	.	ID=VSP_009942;Note=In isoform 6.	
Q9Y250	UniProtKB	Alternative sequence	454	545	.	.	.	ID=VSP_009943;Note=In isoform 5.	
Q9Y250	UniProtKB	Alternative sequence	468	526	.	.	.	ID=VSP_009944;Note=In isoform 4.	
Q9Y250	UniProtKB	Alternative sequence	471	503	.	.	.	ID=VSP_009945;Note=In isoform 3.	
Q9Y250	UniProtKB	Alternative sequence	505	527	.	.	.	ID=VSP_009946;Note=In isoform 2.	
Q9Y250	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_018274;Dbxref=dbSNP:rs28937897;Note=Found in an esophageal cancer sample%3B esophageal squamous cell carcinoma%3B somatic mutation.	
Q9Y250	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_053490;Dbxref=dbSNP:rs34620053	
Q9Y250	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_018275;Note=Found in an esophageal cancer sample%3B esophageal squamous cell carcinoma%3B somatic mutation.	
Q9Y250	UniProtKB	Natural variant	475	475	.	.	.	ID=VAR_018276;Dbxref=dbSNP:rs723874	
##sequence-region P60853 1 599
P60853	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
P60853	UniProtKB	Chain	2	599	.	.	.	ID=PRO_0000182972;Note=Leucine zipper putative tumor suppressor 1	
P60853	UniProtKB	Coiled coil	256	572	.	.	.	status=Potential	
P60853	UniProtKB	Lipidation	2	2	.	.	.	Note=N-myristoyl glycine;status=By similarity	
P60853	UniProtKB	Sequence conflict	90	90	.	.	.	.	
##sequence-region Q8CFC9 1 601
Q8CFC9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q8CFC9	UniProtKB	Chain	2	601	.	.	.	ID=PRO_0000182973;Note=Leucine zipper putative tumor suppressor 1	
Q8CFC9	UniProtKB	Coiled coil	255	573	.	.	.	status=Potential	
Q8CFC9	UniProtKB	Lipidation	2	2	.	.	.	Note=N-myristoyl glycine	
##sequence-region Q8NHW3 1 353
Q8NHW3	UniProtKB	Chain	1	353	.	.	.	ID=PRO_0000320274;Note=Transcription factor MafA	
Q8NHW3	UniProtKB	Domain	254	317	.	.	.	Note=bZIP	
Q8NHW3	UniProtKB	Region	254	279	.	.	.	Note=Basic motif	
Q8NHW3	UniProtKB	Region	260	274	.	.	.	Note=Interaction with DNA	
Q8NHW3	UniProtKB	Region	282	303	.	.	.	Note=Leucine-zipper	
Q8NHW3	UniProtKB	Compositional bias	74	86	.	.	.	Note=Poly-Gly	
Q8NHW3	UniProtKB	Compositional bias	147	220	.	.	.	Note=His-rich	
Q8NHW3	UniProtKB	Modified residue	14	14	.	.	.	Note=Phosphoserine%3B by MAPK1	
Q8NHW3	UniProtKB	Modified residue	49	49	.	.	.	Note=Phosphoserine%3B by GSK3	
Q8NHW3	UniProtKB	Modified residue	53	53	.	.	.	Note=Phosphothreonine%3B by GSK3	
Q8NHW3	UniProtKB	Modified residue	57	57	.	.	.	Note=Phosphothreonine%3B by GSK3	
Q8NHW3	UniProtKB	Modified residue	61	61	.	.	.	Note=Phosphoserine%3B by GSK3	
Q8NHW3	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine%3B by MAPK1	
Q8NHW3	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Abolishes transactivation activity%3B when associated with A-65.	
Q8NHW3	UniProtKB	Mutagenesis	49	49	.	.	.	Note=Diminishes transcriptional activity and transforming activity and abolishes ubiquitination%3B when associated with A-53%3B A-57 and A-61.	
Q8NHW3	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Diminishes transcriptional activity and transforming activity and abolishes ubiquitination%3B when associated with A-49%3B A-57 and A-61.	
Q8NHW3	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Diminishes transcriptional activity and transforming activity and abolishes ubiquitination%3B when associated with A-49%3B A-53 and A-61.	
Q8NHW3	UniProtKB	Mutagenesis	61	61	.	.	.	Note=Diminishes transcriptional activity and transforming activity and abolishes ubiquitination%3B when associated with A-49%3B A-53 and A-57.	
Q8NHW3	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Greatly reduces phosphorylation and reduces transcriptional activity%3B when associated with A-14.	
Q8NHW3	UniProtKB	Sequence conflict	199	199	.	.	.	.	
Q8NHW3	UniProtKB	Sequence conflict	199	199	.	.	.	.	
Q8NHW3	UniProtKB	Helix	229	234	.	.	.	.	
Q8NHW3	UniProtKB	Helix	237	243	.	.	.	.	
Q8NHW3	UniProtKB	Turn	244	246	.	.	.	.	
Q8NHW3	UniProtKB	Helix	249	316	.	.	.	.	
##sequence-region Q8CF90 1 359
Q8CF90	UniProtKB	Chain	1	359	.	.	.	ID=PRO_0000320275;Note=Transcription factor MafA	
Q8CF90	UniProtKB	Domain	260	323	.	.	.	Note=bZIP	
Q8CF90	UniProtKB	Region	260	285	.	.	.	Note=Basic motif	
Q8CF90	UniProtKB	Region	266	280	.	.	.	Note=Interaction with DNA;status=By similarity	
Q8CF90	UniProtKB	Region	288	309	.	.	.	Note=Leucine-zipper	
Q8CF90	UniProtKB	Compositional bias	74	83	.	.	.	Note=Poly-Gly	
Q8CF90	UniProtKB	Compositional bias	145	226	.	.	.	Note=His-rich	
Q8CF90	UniProtKB	Modified residue	14	14	.	.	.	Note=Phosphoserine%3B by MAPK1;status=By similarity	
Q8CF90	UniProtKB	Modified residue	49	49	.	.	.	Note=Phosphoserine%3B by GSK3;status=By similarity	
Q8CF90	UniProtKB	Modified residue	53	53	.	.	.	Note=Phosphothreonine%3B by GSK3;status=By similarity	
Q8CF90	UniProtKB	Modified residue	57	57	.	.	.	Note=Phosphothreonine%3B by GSK3;status=By similarity	
Q8CF90	UniProtKB	Modified residue	61	61	.	.	.	Note=Phosphoserine%3B by GSK3;status=By similarity	
Q8CF90	UniProtKB	Modified residue	65	65	.	.	.	Note=Phosphoserine%3B by MAPK1;status=By similarity	
Q8CF90	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Reduces phosphorylation.	
Q8CF90	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Reduces phosphorylation.	
##sequence-region Q9Y5Q3 1 323
Q9Y5Q3	UniProtKB	Chain	1	323	.	.	.	ID=PRO_0000076494;Note=Transcription factor MafB	
Q9Y5Q3	UniProtKB	Domain	238	301	.	.	.	Note=bZIP	
Q9Y5Q3	UniProtKB	Region	238	263	.	.	.	Note=Basic motif;status=By similarity	
Q9Y5Q3	UniProtKB	Region	266	287	.	.	.	Note=Leucine-zipper;status=By similarity	
Q9Y5Q3	UniProtKB	Compositional bias	131	143	.	.	.	Note=Poly-His	
Q9Y5Q3	UniProtKB	Compositional bias	158	167	.	.	.	Note=Poly-His	
Q9Y5Q3	UniProtKB	Cross-link	32	32	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q9Y5Q3	UniProtKB	Cross-link	297	297	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q9Y5Q3	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_067979;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_067980;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_067981;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_067982;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_067983;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_067984;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_067985;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_067986;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_067987;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_067988;Note=In MCTO.	
Q9Y5Q3	UniProtKB	Sequence conflict	52	52	.	.	.	.	
Q9Y5Q3	UniProtKB	Sequence conflict	241	241	.	.	.	.	
##sequence-region Q2PFS4 1 323
Q2PFS4	UniProtKB	Chain	1	323	.	.	.	ID=PRO_0000366122;Note=Transcription factor MafB	
Q2PFS4	UniProtKB	Domain	238	301	.	.	.	Note=bZIP	
Q2PFS4	UniProtKB	Region	238	263	.	.	.	Note=Basic motif;status=By similarity	
Q2PFS4	UniProtKB	Region	266	287	.	.	.	Note=Leucine-zipper;status=By similarity	
Q2PFS4	UniProtKB	Compositional bias	131	167	.	.	.	Note=His-rich	
Q2PFS4	UniProtKB	Cross-link	32	32	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q2PFS4	UniProtKB	Cross-link	297	297	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region P54841 1 323
P54841	UniProtKB	Chain	1	323	.	.	.	ID=PRO_0000076495;Note=Transcription factor MafB	
P54841	UniProtKB	Domain	238	301	.	.	.	Note=bZIP	
P54841	UniProtKB	Region	238	263	.	.	.	Note=Basic motif;status=By similarity	
P54841	UniProtKB	Region	266	287	.	.	.	Note=Leucine-zipper;status=By similarity	
P54841	UniProtKB	Compositional bias	131	143	.	.	.	Note=Poly-His	
P54841	UniProtKB	Compositional bias	158	167	.	.	.	Note=Poly-His	
P54841	UniProtKB	Cross-link	32	32	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P54841	UniProtKB	Cross-link	297	297	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P54841	UniProtKB	Mutagenesis	32	32	.	.	.	Note=Loss of SUMO modification%2C increases transactivation activity%2C increases macrophage differentiation and inhibits myeloid progenitor growth%3B when associated with R-297.	
P54841	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Reduces ability to activate insulin and glucagon gene expression.	
P54841	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Loss of transcriptional activity.	
P54841	UniProtKB	Mutagenesis	297	297	.	.	.	Note=Loss of SUMO modification%2C increases transactivation activity%2C increases macrophage differentiation and inhibits myeloid progenitor growth%3B when associated with R-32.	
P54841	UniProtKB	Sequence conflict	275	275	.	.	.	.	
P54841	UniProtKB	Helix	215	218	.	.	.	.	
P54841	UniProtKB	Helix	221	225	.	.	.	.	
P54841	UniProtKB	Turn	228	230	.	.	.	.	
P54841	UniProtKB	Helix	233	299	.	.	.	.	
##sequence-region P54842 1 323
P54842	UniProtKB	Chain	1	323	.	.	.	ID=PRO_0000076496;Note=Transcription factor MafB	
P54842	UniProtKB	Domain	238	301	.	.	.	Note=bZIP	
P54842	UniProtKB	Region	238	263	.	.	.	Note=Basic motif;status=By similarity	
P54842	UniProtKB	Region	266	287	.	.	.	Note=Leucine-zipper;status=By similarity	
P54842	UniProtKB	Compositional bias	131	143	.	.	.	Note=Poly-His	
P54842	UniProtKB	Compositional bias	158	167	.	.	.	Note=Poly-His	
P54842	UniProtKB	Cross-link	32	32	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P54842	UniProtKB	Cross-link	297	297	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region A7Z017 1 377
A7Z017	UniProtKB	Chain	1	377	.	.	.	ID=PRO_0000364081;Note=Transcription factor Maf	
A7Z017	UniProtKB	Domain	292	355	.	.	.	Note=bZIP	
A7Z017	UniProtKB	Region	126	377	.	.	.	Note=Represses ARE-mediated transcription;status=By similarity	
A7Z017	UniProtKB	Region	292	317	.	.	.	Note=Basic motif;status=By similarity	
A7Z017	UniProtKB	Region	320	341	.	.	.	Note=Leucine-zipper;status=By similarity	
A7Z017	UniProtKB	Compositional bias	126	258	.	.	.	Note=Gly-rich	
A7Z017	UniProtKB	Compositional bias	132	256	.	.	.	Note=Ala-rich	
A7Z017	UniProtKB	Compositional bias	180	196	.	.	.	Note=His-rich	
##sequence-region O75444 1 373
O75444	UniProtKB	Chain	1	373	.	.	.	ID=PRO_0000076491;Note=Transcription factor Maf	
O75444	UniProtKB	Domain	288	351	.	.	.	Note=bZIP	
O75444	UniProtKB	Region	126	373	.	.	.	Note=Represses ARE-mediated transcription	
O75444	UniProtKB	Region	288	313	.	.	.	Note=Basic motif;status=By similarity	
O75444	UniProtKB	Region	316	337	.	.	.	Note=Leucine-zipper;status=By similarity	
O75444	UniProtKB	Compositional bias	126	254	.	.	.	Note=Gly-rich	
O75444	UniProtKB	Compositional bias	132	252	.	.	.	Note=Ala-rich	
O75444	UniProtKB	Compositional bias	180	194	.	.	.	Note=His-rich	
O75444	UniProtKB	Alternative sequence	373	373	.	.	.	ID=VSP_000583;Note=In isoform 1.	
O75444	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_029369;Note=In CTRCT21.	
O75444	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_029370;Note=In CTRCT21.	
##sequence-region P54843 1 370
P54843	UniProtKB	Chain	1	370	.	.	.	ID=PRO_0000076492;Note=Transcription factor Maf	
P54843	UniProtKB	Domain	285	348	.	.	.	Note=bZIP	
P54843	UniProtKB	Region	126	370	.	.	.	Note=Represses ARE-mediated transcription;status=By similarity	
P54843	UniProtKB	Region	285	310	.	.	.	Note=Basic motif;status=By similarity	
P54843	UniProtKB	Region	313	334	.	.	.	Note=Leucine-zipper;status=By similarity	
P54843	UniProtKB	Compositional bias	126	251	.	.	.	Note=Gly-rich	
P54843	UniProtKB	Compositional bias	132	224	.	.	.	Note=Ala-rich	
P54843	UniProtKB	Compositional bias	180	194	.	.	.	Note=His-rich	
P54843	UniProtKB	Alternative sequence	370	370	.	.	.	ID=VSP_036408;Note=In isoform 2.	
P54843	UniProtKB	Alternative sequence	370	370	.	.	.	ID=VSP_036409;Note=In isoform 3.	
P54843	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Inhibition on transcriptional activation on CD13 proximal promoter in endothelial cells.	
P54843	UniProtKB	Mutagenesis	70	70	.	.	.	Note=No effect on transcriptional activation on CD13 proximal promoter. Increases liver specific transactivation on the IL-4 promoter.	
P54843	UniProtKB	Mutagenesis	334	334	.	.	.	Note=Abolishes interaction with USF2.	
P54843	UniProtKB	Sequence conflict	202	202	.	.	.	.	
P54843	UniProtKB	Sequence conflict	208	211	.	.	.	.	
P54843	UniProtKB	Sequence conflict	223	224	.	.	.	.	
P54843	UniProtKB	Sequence conflict	231	231	.	.	.	.	
P54843	UniProtKB	Sequence conflict	248	248	.	.	.	.	
##sequence-region P54844 1 369
P54844	UniProtKB	Chain	1	369	.	.	.	ID=PRO_0000076493;Note=Transcription factor Maf	
P54844	UniProtKB	Domain	284	347	.	.	.	Note=bZIP	
P54844	UniProtKB	Region	126	369	.	.	.	Note=Represses ARE-mediated transcription;status=By similarity	
P54844	UniProtKB	Region	284	309	.	.	.	Note=Basic motif;status=By similarity	
P54844	UniProtKB	Region	312	333	.	.	.	Note=Leucine-zipper;status=By similarity	
P54844	UniProtKB	Compositional bias	126	250	.	.	.	Note=Gly-rich	
P54844	UniProtKB	Compositional bias	132	248	.	.	.	Note=Ala-rich	
P54844	UniProtKB	Compositional bias	180	194	.	.	.	Note=His-rich	
##sequence-region Q8IW41 1 473
Q8IW41	UniProtKB	Chain	1	473	.	.	.	ID=PRO_0000086296;Note=MAP kinase-activated protein kinase 5	
Q8IW41	UniProtKB	Domain	22	304	.	.	.	Note=Protein kinase	
Q8IW41	UniProtKB	Nucleotide binding	28	36	.	.	.	Note=ATP;status=By similarity	
Q8IW41	UniProtKB	Coiled coil	409	440	.	.	.	status=Potential	
Q8IW41	UniProtKB	Active site	148	148	.	.	.	Note=Proton acceptor;status=By similarity	
Q8IW41	UniProtKB	Binding site	51	51	.	.	.	Note=ATP;status=By similarity	
Q8IW41	UniProtKB	Modified residue	115	115	.	.	.	Note=Phosphoserine%3B by PKA;status=By similarity	
Q8IW41	UniProtKB	Modified residue	182	182	.	.	.	Note=Phosphothreonine%3B by MAPK11%2C MAPK14%2C MAPK4%2C MAPK6 and PKA	
Q8IW41	UniProtKB	Modified residue	212	212	.	.	.	Note=Phosphoserine	
Q8IW41	UniProtKB	Alternative sequence	407	408	.	.	.	ID=VSP_011597;Note=In isoform 2.	
Q8IW41	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_040758;Dbxref=dbSNP:rs34132040	
Q8IW41	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_040759;Dbxref=dbSNP:rs34843470	
Q8IW41	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Kinase defective mutant%2C abolishes activity.	
Q8IW41	UniProtKB	Mutagenesis	182	182	.	.	.	Note=No p38-beta/MAPK11-induced activation.	
Q8IW41	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Mimicks phosphorylation state and induces constitutive protein kinase activity.	
Q8IW41	UniProtKB	Mutagenesis	212	212	.	.	.	Note=Mimicks phosphorylation state and displays a slightly higher protein kinase activity.	
Q8IW41	UniProtKB	Mutagenesis	337	337	.	.	.	Note=Induces constitutive protein kinase activity.	
Q8IW41	UniProtKB	Sequence conflict	273	273	.	.	.	.	
Q8IW41	UniProtKB	Sequence conflict	291	291	.	.	.	.	
##sequence-region O54992 1 473
O54992	UniProtKB	Chain	1	473	.	.	.	ID=PRO_0000086297;Note=MAP kinase-activated protein kinase 5	
O54992	UniProtKB	Domain	22	304	.	.	.	Note=Protein kinase	
O54992	UniProtKB	Nucleotide binding	28	36	.	.	.	Note=ATP;status=By similarity	
O54992	UniProtKB	Coiled coil	409	440	.	.	.	status=Potential	
O54992	UniProtKB	Active site	148	148	.	.	.	Note=Proton acceptor;status=By similarity	
O54992	UniProtKB	Binding site	51	51	.	.	.	Note=ATP;status=Probable	
O54992	UniProtKB	Modified residue	115	115	.	.	.	Note=Phosphoserine%3B by PKA	
O54992	UniProtKB	Modified residue	182	182	.	.	.	Note=Phosphothreonine%3B by MAPK11%2C MAPK14%2C MAPK4%2C MAPK6 and PKA	
O54992	UniProtKB	Modified residue	212	212	.	.	.	Note=Phosphoserine;status=By similarity	
O54992	UniProtKB	Alternative sequence	13	161	.	.	.	ID=VSP_011599;Note=In isoform 3 and isoform 4.	
O54992	UniProtKB	Alternative sequence	344	408	.	.	.	ID=VSP_011600;Note=In isoform 2.	
O54992	UniProtKB	Alternative sequence	407	408	.	.	.	ID=VSP_011598;Note=In isoform 4 and isoform 5.	
O54992	UniProtKB	Mutagenesis	51	51	.	.	.	Note=No p38-alpha/MAPK14-%2C p38-beta/MAPK11-%2C ERK3/MAPK6-%2C ERK4/MAPK4-induced activation.	
O54992	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Kinase defective mutant%2C abolishes activity.	
O54992	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Impairs shuttling to the cytoplasm.	
O54992	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Mimicks phosphorylation state%2C lesding to localization to the cytoplasm.	
O54992	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Impairs protein kinase activity and shuttling to the cytoplasm.	
O54992	UniProtKB	Mutagenesis	337	337	.	.	.	Note=Constitutive active mutant. In a knockin model%2C mouse display increased amounts of head dips and open arm time on the maze%2C compared to littermate controls. In addition%2C they also explore further into the open arm on the elevated plus maze and are less active in the closed arm compared to littermate controls. Male knockin mice display no differences in anxiety%2C but their locomotor activity increases compared to non-transgenic littermates.	
##sequence-region Q2KIE4 1 181
Q2KIE4	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000344785;Note=Malignant T-cell-amplified sequence 1	
Q2KIE4	UniProtKB	Domain	92	171	.	.	.	Note=PUA	
Q2KIE4	UniProtKB	Modified residue	81	81	.	.	.	Note=Phosphothreonine;status=By similarity	
Q2KIE4	UniProtKB	Modified residue	118	118	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q9ULC4 1 181
Q9ULC4	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000344786;Note=Malignant T-cell-amplified sequence 1	
Q9ULC4	UniProtKB	Domain	92	171	.	.	.	Note=PUA	
Q9ULC4	UniProtKB	Modified residue	81	81	.	.	.	Note=Phosphothreonine%3B by MAPK1 and MAPK3	
Q9ULC4	UniProtKB	Modified residue	118	118	.	.	.	Note=Phosphoserine%3B by CDK1	
Q9ULC4	UniProtKB	Alternative sequence	1	22	.	.	.	ID=VSP_034856;Note=In isoform 2.	
Q9ULC4	UniProtKB	Alternative sequence	1	4	.	.	.	ID=VSP_041352;Note=In isoform 3.	
Q9ULC4	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_045632;Dbxref=dbSNP:rs2233110	
Q9ULC4	UniProtKB	Mutagenesis	81	81	.	.	.	Note=No phosphorylation by MAPK1%3B decreased stability of MCTS1 protein%3B Significant cell growth reduction.	
Q9ULC4	UniProtKB	Mutagenesis	118	118	.	.	.	Note=No phosphorylation by CDK1%3B No cell growth alteration.	
Q9ULC4	UniProtKB	Sequence conflict	25	25	.	.	.	.	
Q9ULC4	UniProtKB	Helix	7	10	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	11	16	.	.	.	.	
Q9ULC4	UniProtKB	Helix	19	32	.	.	.	.	
Q9ULC4	UniProtKB	Helix	34	39	.	.	.	.	
Q9ULC4	UniProtKB	Helix	40	43	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	50	55	.	.	.	.	
Q9ULC4	UniProtKB	Helix	56	58	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	59	64	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	67	73	.	.	.	.	
Q9ULC4	UniProtKB	Helix	82	87	.	.	.	.	
Q9ULC4	UniProtKB	Helix	89	91	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	94	97	.	.	.	.	
Q9ULC4	UniProtKB	Helix	99	101	.	.	.	.	
Q9ULC4	UniProtKB	Helix	102	105	.	.	.	.	
Q9ULC4	UniProtKB	Turn	106	108	.	.	.	.	
Q9ULC4	UniProtKB	Helix	114	117	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	131	136	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	143	150	.	.	.	.	
Q9ULC4	UniProtKB	Helix	152	158	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	161	169	.	.	.	.	
Q9ULC4	UniProtKB	Helix	173	177	.	.	.	.	
Q9ULC4	UniProtKB	Beta strand	179	181	.	.	.	.	
##sequence-region Q9DB27 1 181
Q9DB27	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000344787;Note=Malignant T-cell-amplified sequence 1	
Q9DB27	UniProtKB	Domain	92	171	.	.	.	Note=PUA	
Q9DB27	UniProtKB	Modified residue	81	81	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9DB27	UniProtKB	Modified residue	118	118	.	.	.	Note=Phosphoserine;status=By similarity	
Q9DB27	UniProtKB	Alternative sequence	1	4	.	.	.	ID=VSP_034857;Note=In isoform 2.	
##sequence-region Q4G009 1 182
Q4G009	UniProtKB	Chain	1	182	.	.	.	ID=PRO_0000344789;Note=Malignant T-cell-amplified sequence 1	
Q4G009	UniProtKB	Domain	93	172	.	.	.	Note=PUA	
Q4G009	UniProtKB	Modified residue	82	82	.	.	.	Note=Phosphothreonine;status=By similarity	
Q4G009	UniProtKB	Modified residue	119	119	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region P35240 1 595
P35240	UniProtKB	Chain	1	595	.	.	.	ID=PRO_0000219412;Note=Merlin	
P35240	UniProtKB	Domain	22	311	.	.	.	Note=FERM	
P35240	UniProtKB	Compositional bias	327	465	.	.	.	Note=Glu-rich	
P35240	UniProtKB	Modified residue	518	518	.	.	.	Note=Phosphoserine%3B by PAK	
P35240	UniProtKB	Alternative sequence	39	121	.	.	.	ID=VSP_007041;Note=In isoform 4 and isoform 10.	
P35240	UniProtKB	Alternative sequence	39	80	.	.	.	ID=VSP_007040;Note=In isoform 6.	
P35240	UniProtKB	Alternative sequence	81	121	.	.	.	ID=VSP_007042;Note=In isoform 5.	
P35240	UniProtKB	Alternative sequence	150	579	.	.	.	ID=VSP_007044;Note=In isoform 9.	
P35240	UniProtKB	Alternative sequence	150	225	.	.	.	ID=VSP_007043;Note=In isoform 10.	
P35240	UniProtKB	Alternative sequence	259	259	.	.	.	ID=VSP_007045;Note=In isoform 7.	
P35240	UniProtKB	Alternative sequence	260	595	.	.	.	ID=VSP_007046;Note=In isoform 7.	
P35240	UniProtKB	Alternative sequence	334	379	.	.	.	ID=VSP_007047;Note=In isoform 10.	
P35240	UniProtKB	Alternative sequence	335	363	.	.	.	ID=VSP_007048;Note=In isoform 8.	
P35240	UniProtKB	Alternative sequence	380	595	.	.	.	ID=VSP_007049;Note=In isoform 10.	
P35240	UniProtKB	Alternative sequence	580	595	.	.	.	ID=VSP_000492;Note=In isoform 2.	
P35240	UniProtKB	Alternative sequence	580	590	.	.	.	ID=VSP_007050;Note=In isoform 3%2C isoform 4%2C isoform 5%2C isoform 6 and isoform 8.	
P35240	UniProtKB	Alternative sequence	591	595	.	.	.	ID=VSP_007051;Note=In isoform 3%2C isoform 4%2C isoform 5%2C isoform 6 and isoform 8.	
P35240	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_000809;Note=In vestibular schwannoma%3B loss of ability to interact with the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.	
P35240	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_000810;Note=In NF2%3B loss of ability to interact with the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.	
P35240	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_043011;Note=In NF2.	
P35240	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_000811;Note=In vestibular schwannoma.	
P35240	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_000812;Note=In NF2 and in sporadic meningioma.	
P35240	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_000813;Note=In NF2.	
P35240	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_000814;Note=In sporadic meningioma.	
P35240	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_000815;Note=In sporadic meningioma.	
P35240	UniProtKB	Natural variant	122	129	.	.	.	ID=VAR_000816;Note=In sporadic meningioma.	
P35240	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_065227;Note=In NF2.	
P35240	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_043012;Note=In NF2%3B loss of ability to interact with the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.	
P35240	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_043013;Note=In NF2.	
P35240	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_000817;Note=In vestibular schwannoma.	
P35240	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_000818;Note=In NF2.	
P35240	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_009123;Note=In NF2 and in retinal hamartoma%3B severe.	
P35240	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_000819;Note=In breast ductal carcinoma.	
P35240	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_000820;Note=In sporadic meningioma.	
P35240	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_048358;Dbxref=dbSNP:rs2229064	
P35240	UniProtKB	Natural variant	351	351	.	.	.	ID=VAR_029041	
P35240	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_000821;Note=In NF2.	
P35240	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_000822;Note=In NF2.	
P35240	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_000823;Note=In melanoma.	
P35240	UniProtKB	Natural variant	413	413	.	.	.	ID=VAR_043014;Note=In NF2.	
P35240	UniProtKB	Natural variant	418	418	.	.	.	ID=VAR_000824;Note=In vestibular schwannoma.	
P35240	UniProtKB	Natural variant	463	463	.	.	.	ID=VAR_035848;Note=In a breast cancer sample%3B somatic mutation.	
P35240	UniProtKB	Natural variant	533	533	.	.	.	ID=VAR_043015;Note=In NF2.	
P35240	UniProtKB	Natural variant	535	535	.	.	.	ID=VAR_000825;Note=In NF2%3B late onset.	
P35240	UniProtKB	Natural variant	538	538	.	.	.	ID=VAR_000826;Note=In NF2%3B mild.	
P35240	UniProtKB	Natural variant	539	539	.	.	.	ID=VAR_043016;Note=In NF2.	
P35240	UniProtKB	Natural variant	579	579	.	.	.	ID=VAR_043017;Note=In NF2.	
P35240	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Abolishes binding to AGAP2 and interaction with the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.	
P35240	UniProtKB	Mutagenesis	518	518	.	.	.	Note=Loss of phosphorylation. Significant accumulation in the nucleus and no effect on binding to VPRBP.	
P35240	UniProtKB	Mutagenesis	518	518	.	.	.	Note=No effect on phosphorylation. Defective nuclear accumulation. Significant decrease in binding to VPRBP and in ability to inhibit cell proliferation.	
P35240	UniProtKB	Sequence conflict	77	77	.	.	.	.	
P35240	UniProtKB	Sequence conflict	581	581	.	.	.	.	
P35240	UniProtKB	Sequence conflict	581	581	.	.	.	.	
P35240	UniProtKB	Beta strand	21	27	.	.	.	.	
P35240	UniProtKB	Beta strand	32	38	.	.	.	.	
P35240	UniProtKB	Helix	43	54	.	.	.	.	
P35240	UniProtKB	Helix	59	61	.	.	.	.	
P35240	UniProtKB	Beta strand	62	68	.	.	.	.	
P35240	UniProtKB	Beta strand	71	74	.	.	.	.	
P35240	UniProtKB	Beta strand	77	80	.	.	.	.	
P35240	UniProtKB	Helix	81	83	.	.	.	.	
P35240	UniProtKB	Beta strand	89	100	.	.	.	.	
P35240	UniProtKB	Helix	105	108	.	.	.	.	
P35240	UniProtKB	Helix	112	127	.	.	.	.	
P35240	UniProtKB	Helix	135	150	.	.	.	.	
P35240	UniProtKB	Turn	155	157	.	.	.	.	
P35240	UniProtKB	Turn	160	165	.	.	.	.	
P35240	UniProtKB	Helix	171	174	.	.	.	.	
P35240	UniProtKB	Helix	181	193	.	.	.	.	
P35240	UniProtKB	Turn	194	197	.	.	.	.	
P35240	UniProtKB	Helix	200	211	.	.	.	.	
P35240	UniProtKB	Turn	215	218	.	.	.	.	
P35240	UniProtKB	Beta strand	220	226	.	.	.	.	
P35240	UniProtKB	Beta strand	231	236	.	.	.	.	
P35240	UniProtKB	Beta strand	238	244	.	.	.	.	
P35240	UniProtKB	Beta strand	249	251	.	.	.	.	
P35240	UniProtKB	Beta strand	253	257	.	.	.	.	
P35240	UniProtKB	Helix	258	260	.	.	.	.	
P35240	UniProtKB	Beta strand	261	267	.	.	.	.	
P35240	UniProtKB	Beta strand	270	277	.	.	.	.	
P35240	UniProtKB	Beta strand	283	286	.	.	.	.	
P35240	UniProtKB	Helix	290	310	.	.	.	.	
##sequence-region P46662 1 596
P46662	UniProtKB	Chain	1	596	.	.	.	ID=PRO_0000219413;Note=Merlin	
P46662	UniProtKB	Domain	22	311	.	.	.	Note=FERM	
P46662	UniProtKB	Compositional bias	327	465	.	.	.	Note=Glu-rich	
P46662	UniProtKB	Modified residue	518	518	.	.	.	Note=Phosphoserine%3B by PAK;status=By similarity	
P46662	UniProtKB	Alternative sequence	581	596	.	.	.	ID=VSP_000493;Note=In isoform 2.	
P46662	UniProtKB	Sequence conflict	475	475	.	.	.	.	
P46662	UniProtKB	Sequence conflict	554	554	.	.	.	.	
P46662	UniProtKB	Sequence conflict	554	554	.	.	.	.	
P46662	UniProtKB	Sequence conflict	570	570	.	.	.	.	
P46662	UniProtKB	Beta strand	21	27	.	.	.	.	
P46662	UniProtKB	Beta strand	32	38	.	.	.	.	
P46662	UniProtKB	Helix	43	54	.	.	.	.	
P46662	UniProtKB	Helix	59	61	.	.	.	.	
P46662	UniProtKB	Beta strand	62	67	.	.	.	.	
P46662	UniProtKB	Beta strand	69	74	.	.	.	.	
P46662	UniProtKB	Beta strand	77	80	.	.	.	.	
P46662	UniProtKB	Turn	81	83	.	.	.	.	
P46662	UniProtKB	Beta strand	89	98	.	.	.	.	
P46662	UniProtKB	Helix	105	108	.	.	.	.	
P46662	UniProtKB	Helix	112	127	.	.	.	.	
P46662	UniProtKB	Helix	135	150	.	.	.	.	
P46662	UniProtKB	Turn	155	157	.	.	.	.	
P46662	UniProtKB	Turn	160	163	.	.	.	.	
P46662	UniProtKB	Beta strand	164	166	.	.	.	.	
P46662	UniProtKB	Helix	171	174	.	.	.	.	
P46662	UniProtKB	Helix	181	194	.	.	.	.	
P46662	UniProtKB	Turn	195	197	.	.	.	.	
P46662	UniProtKB	Helix	200	212	.	.	.	.	
P46662	UniProtKB	Turn	215	218	.	.	.	.	
P46662	UniProtKB	Beta strand	220	222	.	.	.	.	
P46662	UniProtKB	Beta strand	233	236	.	.	.	.	
P46662	UniProtKB	Beta strand	238	245	.	.	.	.	
P46662	UniProtKB	Beta strand	248	251	.	.	.	.	
P46662	UniProtKB	Beta strand	253	257	.	.	.	.	
P46662	UniProtKB	Turn	258	260	.	.	.	.	
P46662	UniProtKB	Beta strand	261	267	.	.	.	.	
P46662	UniProtKB	Beta strand	270	277	.	.	.	.	
P46662	UniProtKB	Turn	278	280	.	.	.	.	
P46662	UniProtKB	Helix	292	311	.	.	.	.	
P46662	UniProtKB	Helix	316	337	.	.	.	.	
##sequence-region P59750 1 595
P59750	UniProtKB	Chain	1	595	.	.	.	ID=PRO_0000219414;Note=Merlin	
P59750	UniProtKB	Domain	22	311	.	.	.	Note=FERM	
P59750	UniProtKB	Compositional bias	327	465	.	.	.	Note=Glu-rich	
P59750	UniProtKB	Modified residue	518	518	.	.	.	Note=Phosphoserine%3B by PAK;status=By similarity	
##sequence-region Q63648 1 586
Q63648	UniProtKB	Chain	1	586	.	.	.	ID=PRO_0000219415;Note=Merlin	
Q63648	UniProtKB	Domain	18	307	.	.	.	Note=FERM	
Q63648	UniProtKB	Compositional bias	323	461	.	.	.	Note=Glu-rich	
Q63648	UniProtKB	Modified residue	514	514	.	.	.	Note=Phosphoserine%3B by PAK;status=By similarity	
Q63648	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region Q9Y4C4 1 1052
Q9Y4C4	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q9Y4C4	UniProtKB	Chain	2	1052	.	.	.	ID=PRO_0000308609;Note=Malignant fibrous histiocytoma-amplified sequence 1	
Q9Y4C4	UniProtKB	Repeat	64	85	.	.	.	Note=LRR 1	
Q9Y4C4	UniProtKB	Repeat	88	109	.	.	.	Note=LRR 2	
Q9Y4C4	UniProtKB	Repeat	112	133	.	.	.	Note=LRR 3	
Q9Y4C4	UniProtKB	Repeat	136	157	.	.	.	Note=LRR 4	
Q9Y4C4	UniProtKB	Repeat	159	180	.	.	.	Note=LRR 5	
Q9Y4C4	UniProtKB	Repeat	182	203	.	.	.	Note=LRR 6	
Q9Y4C4	UniProtKB	Repeat	205	226	.	.	.	Note=LRR 7	
Q9Y4C4	UniProtKB	Repeat	228	249	.	.	.	Note=LRR 8	
Q9Y4C4	UniProtKB	Repeat	251	272	.	.	.	Note=LRR 9	
Q9Y4C4	UniProtKB	Repeat	274	296	.	.	.	Note=LRR 10	
Q9Y4C4	UniProtKB	Repeat	297	318	.	.	.	Note=LRR 11	
Q9Y4C4	UniProtKB	Repeat	320	341	.	.	.	Note=LRR 12	
Q9Y4C4	UniProtKB	Repeat	343	364	.	.	.	Note=LRR 13	
Q9Y4C4	UniProtKB	Domain	403	649	.	.	.	Note=Roc	
Q9Y4C4	UniProtKB	Site	1000	1001	.	.	.	Note=Breakpoint for translocation to form chimeric MASL1	
Q9Y4C4	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
Q9Y4C4	UniProtKB	Modified residue	601	601	.	.	.	Note=N6-acetyllysine	
Q9Y4C4	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_036846;Dbxref=dbSNP:rs34984230	
Q9Y4C4	UniProtKB	Natural variant	892	892	.	.	.	ID=VAR_036847;Dbxref=dbSNP:rs429433	
Q9Y4C4	UniProtKB	Sequence conflict	529	529	.	.	.	.	
##sequence-region P40692 1 756
P40692	UniProtKB	Chain	1	756	.	.	.	ID=PRO_0000178000;Note=DNA mismatch repair protein Mlh1	
P40692	UniProtKB	Region	410	650	.	.	.	Note=Interaction with EXO1	
P40692	UniProtKB	Modified residue	477	477	.	.	.	Note=Phosphoserine	
P40692	UniProtKB	Alternative sequence	1	241	.	.	.	ID=VSP_045201;Note=In isoform 2.	
P40692	UniProtKB	Alternative sequence	1	101	.	.	.	ID=VSP_047023;Note=In isoform 3.	
P40692	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_022663;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_043383;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_043384;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_038023;Dbxref=dbSNP:rs41295280	
P40692	UniProtKB	Natural variant	25	25	.	.	.	ID=VAR_043385;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_004433;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_043386;Note=In HNPCC2%3B unknown pathological significance%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_014876;Dbxref=dbSNP:rs2020872	
P40692	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_043387;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_043388;Note=In MMRCS%3B requires 2 nucleotide substitutions.	
P40692	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_004434;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_004435;Note=Found in an endometrial cancer sample%3B somatic mutation.	
P40692	UniProtKB	Natural variant	38	38	.	.	.	ID=VAR_043389;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	41	41	.	.	.	ID=VAR_043390;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	41	41	.	.	.	ID=VAR_054522;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_004436;Note=In HNPCC2%3B the equivalent substitution in yeast causes loss of function in a mismatch repair assay%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	45	47	.	.	.	ID=VAR_043391;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_012902;Note=In CRC%3B sporadic%3B somatic mutation.	
P40692	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_004437;Note=In HNPCC2%3B reduced repair efficiency in a yeast mismatch repair assay.	
P40692	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_043392;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_004438;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_038024;Note=In CRC.	
P40692	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_004439;Note=In HNPCC2%3B the equivalent substitution in yeast causes loss of function in a mismatch repair assay%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_012903;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_004440;Note=In HNPCC2%3B the equivalent substitution in yeast causes loss of function in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_004441;Note=In HNPCC2%3B reduced repair efficiency in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_043393;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_004442;Note=In HNPCC2 and CRC%3B sporadic%3B normal interaction with PMS2%3B loss of function in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_012904;Note=In CRC%3B sporadic%3B early onset.	
P40692	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_012905;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_012906;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_004443;Dbxref=dbSNP:rs41295282;Note=Common polymorphism%3B normal interaction with PMS2%3B no functional alteration detected by an in vitro mismatch repair assay.	
P40692	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_054523;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_022664;Note=In HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_054524;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_043394;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_043395;Note=In gastric cancer%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_004444;Note=In HNPCC2%3B normal interaction with PMS2%3B loss of function in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_043396;Note=In gastric cancer%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_012907;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_054525;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_004445;Note=In HNPCC2%3B fails to interact with PMS2 and EXO1%3B loss of function in a mismatch repair assay%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_004446;Note=In HNPCC2%3B equivalent substitution in yeast causes loss of function in mismatch repair assay.	
P40692	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_054526;Dbxref=dbSNP:rs200076893;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_012908;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_022665;Dbxref=dbSNP:rs28930073;Note=In CRC%3B sporadic%3B susceptibility to%3B ATPase function attenuated but not eliminated.	
P40692	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_043397;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_012909;Note=In HNPCC2%3B incomplete.	
P40692	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_022666;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_004447;Note=In HNPCC2%3B defective in a mismatch repair assay%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_043398;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_004448;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_012910;Dbxref=dbSNP:rs2308317;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_054527;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_054528;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_004449;Dbxref=dbSNP:rs4986984;Note=In HNPCC2%3B unknown pathological significance%3B proficient in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_020469	
P40692	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_004450;Dbxref=dbSNP:rs1799977;Note=Common polymorphism%3B found in 37%25 of alleles.	
P40692	UniProtKB	Natural variant	226	295	.	.	.	ID=VAR_004452;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_004451;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_043399;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_012911;Note=In HNPCC2%3B defective in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_012912;Note=In CRC%3B sporadic%3B somatic mutation%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_043400;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_054529;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_043401;Note=In CRC.	
P40692	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_012913;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_043402;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_054530;Note=Associated with HNPCC2%3B results in partial exon 10 skipping on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_012914;Note=Rare polymorphism%3B associated with HNPCC2%3B slightly lower mismatch repair efficiency%3B results in partial exon 10 skipping on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_012915;Note=In CRC.	
P40692	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_043403;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_043404;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_012916;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_043405;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_038025	
P40692	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_054531;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_043406;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	325	327	.	.	.	ID=VAR_043407;Note=In colorectal cancer.	
P40692	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_012917;Note=In CRC%3B sporadic%3B somatic mutation%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_004453;Dbxref=dbSNP:rs63751049;Note=In HNPCC2%3B proficient in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	329	329	.	.	.	ID=VAR_012918;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_043408;Note=In HNPCC2%3B results in weak exon 11 skipping on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_043409;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_022667;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_004454;Note=Can be associated with HNPCC in some populations.	
P40692	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_043410;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_043411;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	406	406	.	.	.	ID=VAR_012919;Dbxref=dbSNP:rs41294980	
P40692	UniProtKB	Natural variant	441	441	.	.	.	ID=VAR_012920;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	443	443	.	.	.	ID=VAR_043412;Dbxref=dbSNP:rs34213726	
P40692	UniProtKB	Natural variant	472	472	.	.	.	ID=VAR_043413;Note=In CRC%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	474	474	.	.	.	ID=VAR_043414;Note=In HNPCC2%3B has no effect on ex vivo splicing assay%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	474	474	.	.	.	ID=VAR_054532;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	485	485	.	.	.	ID=VAR_043415;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	485	485	.	.	.	ID=VAR_043416;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	492	492	.	.	.	ID=VAR_004455;Note=In HNPCC2 and CRC%3B sporadic.	
P40692	UniProtKB	Natural variant	506	506	.	.	.	ID=VAR_004456;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	539	539	.	.	.	ID=VAR_054533;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	542	542	.	.	.	ID=VAR_004457;Note=In HNPCC2%3B type II%3B equivalent substitution in yeast causes loss of function in a mismatch repair assay.	
P40692	UniProtKB	Natural variant	542	542	.	.	.	ID=VAR_043417;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	549	549	.	.	.	ID=VAR_012921;Note=In HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	550	550	.	.	.	ID=VAR_043418;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	551	551	.	.	.	ID=VAR_012922;Note=In HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	559	559	.	.	.	ID=VAR_022668;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	565	565	.	.	.	ID=VAR_012923;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	574	574	.	.	.	ID=VAR_004458;Note=In HNPCC2%3B type I%3B abrogates interaction with EXO1.	
P40692	UniProtKB	Natural variant	578	578	.	.	.	ID=VAR_004459;Note=In HNPCC2 and CRC.	
P40692	UniProtKB	Natural variant	582	582	.	.	.	ID=VAR_004460;Dbxref=dbSNP:rs63751713;Note=In HNPCC2%3B type II.	
P40692	UniProtKB	Natural variant	585	585	.	.	.	ID=VAR_054534;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	586	586	.	.	.	ID=VAR_015689;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	588	588	.	.	.	ID=VAR_012924;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	589	589	.	.	.	ID=VAR_043419;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_043420;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	601	601	.	.	.	ID=VAR_043421;Note=In CRC%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	603	603	.	.	.	ID=VAR_012925;Dbxref=dbSNP:rs35831931;Note=In HNPCC2%3B unknown pathological significance%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	607	607	.	.	.	ID=VAR_012926;Dbxref=dbSNP:rs41295284;Note=In LCIS and HNPCC2%3B unknown pathological significance%3B has no effect on ex vivo splicing assay%3B could determine an increased risk of colon cancer.	
P40692	UniProtKB	Natural variant	612	612	.	.	.	ID=VAR_043422;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	616	616	.	.	.	ID=VAR_004461;Note=In HNPCC2 and MMRCS%3B abrogates interaction with EXO1%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_004462;Dbxref=dbSNP:rs35502531;Note=Common polymorphism%3B requires 2 nucleotide substitutions.	
P40692	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_043424;Dbxref=dbSNP:rs63750449;Note=In colorectal cancer.	
P40692	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_004463;Note=In HNPCC2%3B type II.	
P40692	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_043423;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	619	619	.	.	.	ID=VAR_054535;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	622	622	.	.	.	ID=VAR_012927;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	623	623	.	.	.	ID=VAR_043425;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	626	627	.	.	.	ID=VAR_004464;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	631	631	.	.	.	ID=VAR_043426;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	635	635	.	.	.	ID=VAR_043427;Note=In gastric cancer%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	636	636	.	.	.	ID=VAR_043428;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	640	640	.	.	.	ID=VAR_054536;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	640	640	.	.	.	ID=VAR_043429;Note=In HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	646	646	.	.	.	ID=VAR_043430;Dbxref=dbSNP:rs35045067;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	648	648	.	.	.	ID=VAR_012928;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	648	648	.	.	.	ID=VAR_022669;Note=In HNPCC2%3B protein unstable but still functional in mismatch repair.	
P40692	UniProtKB	Natural variant	654	654	.	.	.	ID=VAR_043431;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	655	655	.	.	.	ID=VAR_043432;Dbxref=dbSNP:rs55907433;Note=Found in an endometrial cancer sample%3B also associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	656	656	.	.	.	ID=VAR_054537;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	657	657	.	.	.	ID=VAR_043433;Note=In HNPCC2%3B uncertain pathogenicity.	
P40692	UniProtKB	Natural variant	659	659	.	.	.	ID=VAR_012929;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	659	659	.	.	.	ID=VAR_004465;Note=In HNPCC2%3B interacts only very weakly with PMS2%3B equivalent substitution in yeast causes almost complete loss of function in a mismatch repair assay%3B abrogates interaction with EXO1.	
P40692	UniProtKB	Natural variant	659	659	.	.	.	ID=VAR_043434	
P40692	UniProtKB	Natural variant	662	662	.	.	.	ID=VAR_012930;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	666	666	.	.	.	ID=VAR_054538;Note=Associated with HNPCC2%3B has no effect on ex vivo splicing assay.	
P40692	UniProtKB	Natural variant	681	681	.	.	.	ID=VAR_004466;Note=In HNPCC2%3B unknown pathological significance%3B equivalent substitution in yeast does not affect mismatch repair%3B abrogates interaction with EXO1.	
P40692	UniProtKB	Natural variant	687	687	.	.	.	ID=VAR_012931;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	689	689	.	.	.	ID=VAR_012932;Note=In HNPCC%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	716	716	.	.	.	ID=VAR_012933;Dbxref=dbSNP:rs35831931	
P40692	UniProtKB	Natural variant	718	718	.	.	.	ID=VAR_004467;Dbxref=dbSNP:rs2020873;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	719	719	.	.	.	ID=VAR_043435;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	724	724	.	.	.	ID=VAR_043436;Note=In HNPCC2.	
P40692	UniProtKB	Natural variant	729	729	.	.	.	ID=VAR_004468;Dbxref=dbSNP:rs1800149	
P40692	UniProtKB	Natural variant	749	749	.	.	.	ID=VAR_043437;Note=In colorectal cancer.	
P40692	UniProtKB	Natural variant	751	751	.	.	.	ID=VAR_012934;Note=In HNPCC2%3B unknown pathological significance.	
P40692	UniProtKB	Natural variant	755	755	.	.	.	ID=VAR_012935;Note=In HNPCC%3B incomplete.	
P40692	UniProtKB	Sequence conflict	352	352	.	.	.	.	
P40692	UniProtKB	Sequence conflict	708	711	.	.	.	.	
P40692	UniProtKB	Helix	13	24	.	.	.	.	
P40692	UniProtKB	Helix	28	41	.	.	.	.	
P40692	UniProtKB	Beta strand	45	52	.	.	.	.	
P40692	UniProtKB	Turn	53	56	.	.	.	.	
P40692	UniProtKB	Beta strand	57	63	.	.	.	.	
P40692	UniProtKB	Helix	70	74	.	.	.	.	
P40692	UniProtKB	Turn	75	77	.	.	.	.	
P40692	UniProtKB	Helix	103	109	.	.	.	.	
P40692	UniProtKB	Beta strand	110	118	.	.	.	.	
P40692	UniProtKB	Beta strand	123	131	.	.	.	.	
P40692	UniProtKB	Beta strand	134	137	.	.	.	.	
P40692	UniProtKB	Beta strand	140	142	.	.	.	.	
P40692	UniProtKB	Beta strand	146	154	.	.	.	.	
P40692	UniProtKB	Turn	155	158	.	.	.	.	
P40692	UniProtKB	Helix	160	164	.	.	.	.	
P40692	UniProtKB	Helix	169	186	.	.	.	.	
P40692	UniProtKB	Beta strand	191	196	.	.	.	.	
P40692	UniProtKB	Beta strand	203	205	.	.	.	.	
P40692	UniProtKB	Helix	212	220	.	.	.	.	
P40692	UniProtKB	Helix	222	225	.	.	.	.	
P40692	UniProtKB	Beta strand	228	235	.	.	.	.	
P40692	UniProtKB	Helix	236	238	.	.	.	.	
P40692	UniProtKB	Beta strand	240	247	.	.	.	.	
P40692	UniProtKB	Beta strand	253	255	.	.	.	.	
P40692	UniProtKB	Beta strand	257	262	.	.	.	.	
P40692	UniProtKB	Helix	272	281	.	.	.	.	
P40692	UniProtKB	Beta strand	291	297	.	.	.	.	
P40692	UniProtKB	Helix	324	334	.	.	.	.	
P40692	UniProtKB	Helix	504	516	.	.	.	.	
P40692	UniProtKB	Helix	519	526	.	.	.	.	
P40692	UniProtKB	Beta strand	529	543	.	.	.	.	
P40692	UniProtKB	Beta strand	546	551	.	.	.	.	
P40692	UniProtKB	Helix	552	566	.	.	.	.	
P40692	UniProtKB	Beta strand	572	581	.	.	.	.	
P40692	UniProtKB	Helix	582	590	.	.	.	.	
P40692	UniProtKB	Helix	593	595	.	.	.	.	
P40692	UniProtKB	Helix	604	626	.	.	.	.	
P40692	UniProtKB	Beta strand	634	641	.	.	.	.	
P40692	UniProtKB	Helix	650	652	.	.	.	.	
P40692	UniProtKB	Helix	653	662	.	.	.	.	
P40692	UniProtKB	Helix	669	684	.	.	.	.	
P40692	UniProtKB	Helix	688	690	.	.	.	.	
P40692	UniProtKB	Helix	712	718	.	.	.	.	
P40692	UniProtKB	Helix	720	724	.	.	.	.	
P40692	UniProtKB	Helix	732	735	.	.	.	.	
P40692	UniProtKB	Beta strand	737	745	.	.	.	.	
##sequence-region Q10571 1 1320
Q10571	UniProtKB	Chain	1	1320	.	.	.	ID=PRO_0000096521;Note=Probable tumor suppressor protein MN1	
Q10571	UniProtKB	Compositional bias	294	308	.	.	.	Note=Poly-Gln	
Q10571	UniProtKB	Compositional bias	523	550	.	.	.	Note=Poly-Gln	
Q10571	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
Q10571	UniProtKB	Natural variant	382	382	.	.	.	ID=VAR_047533;Dbxref=dbSNP:rs45589338	
##sequence-region P43246 1 934
P43246	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
P43246	UniProtKB	Chain	2	934	.	.	.	ID=PRO_0000115183;Note=DNA mismatch repair protein Msh2	
P43246	UniProtKB	Nucleotide binding	669	676	.	.	.	Note=ATP;status=Potential	
P43246	UniProtKB	Region	601	671	.	.	.	Note=Interaction with EXO1	
P43246	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
P43246	UniProtKB	Modified residue	555	555	.	.	.	Note=N6-acetyllysine	
P43246	UniProtKB	Alternative sequence	1	66	.	.	.	ID=VSP_045536;Note=In isoform 2.	
P43246	UniProtKB	Natural variant	2	2	.	.	.	ID=VAR_054511;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	8	8	.	.	.	ID=VAR_013171;Dbxref=dbSNP:rs17217716;Note=Could be associated with increased colorectal cancer susceptibility.	
P43246	UniProtKB	Natural variant	13	13	.	.	.	ID=VAR_043736;Note=In colorectal cancer.	
P43246	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_043737;Note=In gastric cancer%3B uncertain pathogenicity%3B cryptic acceptor splice site suppressed on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_043738;Note=In HNPCC1%3B shows slightly reduced mismatch binding or release efficiency.	
P43246	UniProtKB	Natural variant	40	40	.	.	.	ID=VAR_043739;Note=In CRC.	
P43246	UniProtKB	Natural variant	43	43	.	.	.	ID=VAR_019233;Dbxref=dbSNP:rs17217723	
P43246	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_043740;Note=In HNPCC1%3B repair proficient.	
P43246	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_043741;Note=In HNPCC1%3B repair proficient.	
P43246	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_004470;Dbxref=dbSNP:rs33946261;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_043742;Note=In HNPCC1%3B uncertain pathogenicity%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_043743;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_004471	
P43246	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_043744;Note=In HNPCC1%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_043745;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_038026;Dbxref=dbSNP:rs41295286	
P43246	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_043746;Note=In HNPCC1%3B somatic mutation.	
P43246	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_019234;Dbxref=dbSNP:rs17217772;Note=In HNPCC1%3B shows significantly decreased repair efficiency when associated with variant Pro-328%3B presumed to enhance cancer risk considerably when associated with Pro-328%3B this concomitant defect with another variant could explain its recurrent occurrence in CRC patients.	
P43246	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_004472;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_004473;Dbxref=dbSNP:rs63750124;Note=In HNPCC1%3B mismatch repair proficient.	
P43246	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_012936;Note=In HNPCC1%3B affects protein stability%3B associated with an absence of the protein in tumors.	
P43246	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_054512;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_043747;Note=In HNPCC1%3B shows a decreased expression level of the MutS alpha complex and is associated with an abnormal subcellular localization pattern%3B affects protein stability%3B associated with an absence of the protein in tumors.	
P43246	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_043748;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_022670;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_043749;Note=In HNPCC1%3B affects protein stability%3B associated with an absence of the protein in tumors.	
P43246	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_067284;Note=Associated with HNPCC1%3B unknown pathological significance%3B repair deficient.	
P43246	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_004474;Note=In HNPCC1%3B does not show a decreased expression level of the MutS alpha complex and is not associated with an abnormal subcellular localization pattern%3B shows reduced mismatch binding%3B repair proficient.	
P43246	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_043750;Dbxref=dbSNP:rs63750716;Note=In HNPCC1%3B unknown pathological significance.	
P43246	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_043751;Note=In HNPCC1%3B affects protein stability%3B associated with an absence of the protein in tumors.	
P43246	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_043752;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_067285;Note=Associated with HNPCC1%3B requires 2 nucleotide substitutions%3B unknown pathological significance%3B repair proficient.	
P43246	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_043753;Note=In HNPCC1%3B affects protein stability%3B associated with an absence of the protein in tumors.	
P43246	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_054513;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_012937;Note=In glioma%3B also associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_043754;Note=In CRC%3B uncertain pathogenicity%3B somatic mutation.	
P43246	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_068705;Note=Shows no defects%3B mismatch repair proficient.	
P43246	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_012938;Note=In HNPCC1%3B uncertain pathological significance%3B shows slightly reduced mismatch binding or release efficiency.	
P43246	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_043755;Note=In HNPCC1%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	265	314	.	.	.	ID=VAR_004475;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_043756;Dbxref=dbSNP:rs34136999;Note=Associated with HNPCC1%3B unknown pathological significance%3B shows slightly reduced mismatch binding or release efficiency%3B results in partial exon 5 skipping on ex vivo splicing assay%3B repair proficient.	
P43246	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_043757;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_004476;Note=In HNPCC1%3B repair proficient.	
P43246	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_004477;Dbxref=dbSNP:rs4987188;Note=Common polymorphism%3B may be associated with increased colorectal cancer susceptibility%3B the equivalent substitution in yeast reduces the mismatch repair efficiency in vitro%3B shows significantly decreased repair efficiency when associated with variant Glu-487.	
P43246	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_012939;Note=In HNPCC1%3B unknown pathological significance.	
P43246	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_043758;Note=In HNPCC1%3B unknown pathological significance.	
P43246	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_068706;Note=Shows significantly decreased repair efficiency when associated with variant Ser-127%3B presumed to enhance cancer risk considerably when associated with variant Ser-127.	
P43246	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_054514;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	333	333	.	.	.	ID=VAR_043759;Note=In HNPCC1%3B affects protein stability%3B associated with an absence of the protein in tumors.	
P43246	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_043760;Note=In HNPCC1%3B unknown pathological significance.	
P43246	UniProtKB	Natural variant	336	336	.	.	.	ID=VAR_043761;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_043762;Note=In colorectal cancer.	
P43246	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_043763;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	359	359	.	.	.	ID=VAR_043764;Note=In HNPCC1%3B shows a decreased expression level of the MutS alpha comp lex and is associated with an abnormal subcellular localization pattern.	
P43246	UniProtKB	Natural variant	367	367	.	.	.	ID=VAR_068707;Note=Shows no defects%3B mismatch repair proficient.	
P43246	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_067286;Note=Associated with HNPCC1%3B unknown pathological significance%3B repair proficient.	
P43246	UniProtKB	Natural variant	390	390	.	.	.	ID=VAR_004478;Dbxref=dbSNP:rs17224367;Note=In HNPCC1%3B unknown pathological significance%3B the equivalent substitution in yeast partially affects mismatch repair in vitro%3B repair proficient.	
P43246	UniProtKB	Natural variant	393	393	.	.	.	ID=VAR_043765;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_012940;Dbxref=dbSNP:rs63750006;Note=In CRC%3B uncertain pathogenicity%3B the equivalent substitution in yeast partially affects mismatch repair in vitro.	
P43246	UniProtKB	Natural variant	440	440	.	.	.	ID=VAR_043766;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	470	470	.	.	.	ID=VAR_054515;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	487	487	.	.	.	ID=VAR_068708;Note=Mismatch repair deficient%3B shows significantly decreased repair efficiency when associated with variant Asp-322.	
P43246	UniProtKB	Natural variant	492	492	.	.	.	ID=VAR_043767;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	506	506	.	.	.	ID=VAR_012941;Note=In CRC%3B sporadic%3B early onset%3B the equivalent substitution in yeast partially affects mismatch repair in vitro.	
P43246	UniProtKB	Natural variant	519	519	.	.	.	ID=VAR_067287;Note=Associated with HNPCC1%3B unknown pathological significance%3B repair proficient.	
P43246	UniProtKB	Natural variant	524	524	.	.	.	ID=VAR_004479;Note=In HNPCC1%3B defective in mismatch repair activity.	
P43246	UniProtKB	Natural variant	552	552	.	.	.	ID=VAR_043768;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	554	554	.	.	.	ID=VAR_012942;Note=In HNPCC1%3B uncertain pathological significance.	
P43246	UniProtKB	Natural variant	562	562	.	.	.	ID=VAR_004480;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	564	564	.	.	.	ID=VAR_043769;Dbxref=dbSNP:rs55778204;Note=In HNPCC1%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	583	583	.	.	.	ID=VAR_043770;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_012943;Dbxref=dbSNP:rs41295288;Note=In HNPCC1%3B uncertain pathological significance.	
P43246	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_004481;Note=In HNPCC1%3B has no effect on ex vivo splicing assay%3B repair deficient.	
P43246	UniProtKB	Natural variant	600	600	.	.	.	ID=VAR_043771;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	603	603	.	.	.	ID=VAR_043772;Note=In HNPCC1%3B affects protein stability%3B associated with an absence of the protein in tumors.	
P43246	UniProtKB	Natural variant	610	610	.	.	.	ID=VAR_054516;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	619	619	.	.	.	ID=VAR_043773;Note=In CRC.	
P43246	UniProtKB	Natural variant	622	622	.	.	.	ID=VAR_004482;Dbxref=dbSNP:rs28929483;Note=In HNPCC1%3B the equivalent substitution in yeast causes loss of function in a mismatch repair assay%3B confers multiple biochemical defects.	
P43246	UniProtKB	Natural variant	629	629	.	.	.	ID=VAR_043774;Dbxref=dbSNP:rs61756468;Note=In HNPCC1%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	636	636	.	.	.	ID=VAR_012944;Note=In HNPCC1%3B partial functional loss%3B mainly causes defects in mismatch binding or release efficiency.	
P43246	UniProtKB	Natural variant	638	638	.	.	.	ID=VAR_054517;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	639	639	.	.	.	ID=VAR_043775;Note=In HNPCC1%3B shows reduced mismatch binding%3B repair proficient.	
P43246	UniProtKB	Natural variant	639	639	.	.	.	ID=VAR_004483;Dbxref=dbSNP:rs28929484;Note=In HNPCC1%3B the equivalent substitution in yeast does not affect mismatch repair efficiency in vitro.	
P43246	UniProtKB	Natural variant	641	641	.	.	.	ID=VAR_004484	
P43246	UniProtKB	Natural variant	645	645	.	.	.	ID=VAR_054518;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	647	647	.	.	.	ID=VAR_043776;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	656	656	.	.	.	ID=VAR_043777;Note=In HNPCC1%3B somatic mutation.	
P43246	UniProtKB	Natural variant	660	660	.	.	.	ID=VAR_022671;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	669	669	.	.	.	ID=VAR_067761;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	670	670	.	.	.	ID=VAR_038027;Dbxref=dbSNP:rs41294982	
P43246	UniProtKB	Natural variant	671	671	.	.	.	ID=VAR_043778;Note=In HNPCC1%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	674	674	.	.	.	ID=VAR_067288;Note=In HNPCC1%3B confers resistance to ATP-dependent mismatch release%3B repair deficient.	
P43246	UniProtKB	Natural variant	674	674	.	.	.	ID=VAR_004485;Note=In HNPCC1%3B somatic mutation.	
P43246	UniProtKB	Natural variant	675	675	.	.	.	ID=VAR_067289;Note=Associated with HNPCC1%3B requires 2 nucleotide substitutions%3B unknown pathological significance%3B repair deficient.	
P43246	UniProtKB	Natural variant	679	679	.	.	.	ID=VAR_043779;Note=In HNPCC1%3B somatic mutation.	
P43246	UniProtKB	Natural variant	688	688	.	.	.	ID=VAR_012945;Dbxref=dbSNP:rs63750790;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	692	692	.	.	.	ID=VAR_009250;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	696	696	.	.	.	ID=VAR_054519;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	697	697	.	.	.	ID=VAR_004486;Note=In HNPCC1%3B the equivalent substitution in yeast causes loss of function in a mismatch repair assay%3B mainly causes defects in mismatch binding or release efficiency%3B confers multiple biochemical defects%3B repair deficient.	
P43246	UniProtKB	Natural variant	697	697	.	.	.	ID=VAR_009251;Note=In HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	714	714	.	.	.	ID=VAR_043780;Note=In HNPCC1%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	723	723	.	.	.	ID=VAR_043781;Note=In HNPCC1%3B has no effect on ex vivo splicing assay%3B repair deficient.	
P43246	UniProtKB	Natural variant	729	729	.	.	.	ID=VAR_043782;Note=In HNPCC1%3B somatic mutation.	
P43246	UniProtKB	Natural variant	732	732	.	.	.	ID=VAR_043783;Note=In HNPCC1%3B somatic mutation.	
P43246	UniProtKB	Natural variant	745	746	.	.	.	ID=VAR_043784;Note=In HNPCC1%3B mainly causes defects in mismatch binding or release efficiency.	
P43246	UniProtKB	Natural variant	748	748	.	.	.	ID=VAR_054520;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	749	749	.	.	.	ID=VAR_043785;Note=In HNPCC1%3B mainly causes defects in mismatch binding or release efficiency%3B the mutant protein is well expressed in tumors.	
P43246	UniProtKB	Natural variant	759	759	.	.	.	ID=VAR_067290;Note=Associated with HNPCC1%3B unknown pathological significance%3B repair deficient.	
P43246	UniProtKB	Natural variant	770	770	.	.	.	ID=VAR_004487	
P43246	UniProtKB	Natural variant	779	779	.	.	.	ID=VAR_038028;Dbxref=dbSNP:rs41295292	
P43246	UniProtKB	Natural variant	805	805	.	.	.	ID=VAR_067291;Note=Associated with HNPCC1%3B unknown pathological significance%3B repair proficient.	
P43246	UniProtKB	Natural variant	807	807	.	.	.	ID=VAR_038029;Dbxref=dbSNP:rs41295294	
P43246	UniProtKB	Natural variant	813	813	.	.	.	ID=VAR_043786;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	824	824	.	.	.	ID=VAR_043787;Note=In gastric cancer%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	834	834	.	.	.	ID=VAR_004488;Note=In HNPCC1%3B shows no functional defects in gel shift assay%3B is nevertheless repair deficient.	
P43246	UniProtKB	Natural variant	835	835	.	.	.	ID=VAR_038030;Dbxref=dbSNP:rs41295296	
P43246	UniProtKB	Natural variant	839	839	.	.	.	ID=VAR_054521;Note=Associated with HNPCC1%3B has no effect on ex vivo splicing assay.	
P43246	UniProtKB	Natural variant	839	839	.	.	.	ID=VAR_043788;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	843	843	.	.	.	ID=VAR_067292;Note=Associated with HNPCC1%3B unknown pathological significance%3B repair proficient.	
P43246	UniProtKB	Natural variant	845	845	.	.	.	ID=VAR_013172;Dbxref=dbSNP:rs63750571;Note=In HNPCC1.	
P43246	UniProtKB	Natural variant	853	853	.	.	.	ID=VAR_043789;Note=In HNPCC1%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	860	860	.	.	.	ID=VAR_067293;Note=Associated with HNPCC1%3B unknown pathological significance%3B repair proficient.	
P43246	UniProtKB	Natural variant	868	868	.	.	.	ID=VAR_043790;Note=In gastric cancer%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	870	870	.	.	.	ID=VAR_043791;Note=In gastric cancer%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	873	873	.	.	.	ID=VAR_043792;Note=In gastric cancer%3B uncertain pathogenicity.	
P43246	UniProtKB	Natural variant	886	886	.	.	.	ID=VAR_043793;Note=In HNPCC1%3B repair proficient.	
P43246	UniProtKB	Natural variant	905	905	.	.	.	ID=VAR_004489;Note=In HNPCC1%3B uncertain pathological significance.	
P43246	UniProtKB	Natural variant	909	909	.	.	.	ID=VAR_068709;Note=Found in a colorectal cancer sample%3B mismatch repair proficient.	
P43246	UniProtKB	Natural variant	911	911	.	.	.	ID=VAR_038031;Dbxref=dbSNP:rs41295182	
P43246	UniProtKB	Natural variant	923	923	.	.	.	ID=VAR_043794;Note=In HNPCC1%3B uncertain pathological significance.	
P43246	UniProtKB	Natural variant	931	931	.	.	.	ID=VAR_043795;Note=In HNPCC1.	
P43246	UniProtKB	Mutagenesis	674	674	.	.	.	Note=Mainly causes defects in mismatch binding or release efficiency.	
P43246	UniProtKB	Mutagenesis	675	675	.	.	.	Note=No effect on mismatch binding%2C complete loss of DNA repair function when associated with MSH6 mutant R-1140.	
P43246	UniProtKB	Sequence conflict	784	784	.	.	.	.	
P43246	UniProtKB	Sequence conflict	836	836	.	.	.	.	
P43246	UniProtKB	Helix	14	24	.	.	.	.	
P43246	UniProtKB	Beta strand	33	38	.	.	.	.	
P43246	UniProtKB	Beta strand	40	46	.	.	.	.	
P43246	UniProtKB	Helix	48	56	.	.	.	.	
P43246	UniProtKB	Beta strand	59	61	.	.	.	.	
P43246	UniProtKB	Beta strand	65	71	.	.	.	.	
P43246	UniProtKB	Beta strand	75	81	.	.	.	.	
P43246	UniProtKB	Helix	82	94	.	.	.	.	
P43246	UniProtKB	Beta strand	99	105	.	.	.	.	
P43246	UniProtKB	Beta strand	117	124	.	.	.	.	
P43246	UniProtKB	Helix	129	131	.	.	.	.	
P43246	UniProtKB	Helix	132	135	.	.	.	.	
P43246	UniProtKB	Beta strand	147	152	.	.	.	.	
P43246	UniProtKB	Beta strand	155	158	.	.	.	.	
P43246	UniProtKB	Beta strand	160	167	.	.	.	.	
P43246	UniProtKB	Turn	168	171	.	.	.	.	
P43246	UniProtKB	Beta strand	172	179	.	.	.	.	
P43246	UniProtKB	Helix	185	194	.	.	.	.	
P43246	UniProtKB	Beta strand	197	204	.	.	.	.	
P43246	UniProtKB	Helix	208	220	.	.	.	.	
P43246	UniProtKB	Beta strand	223	227	.	.	.	.	
P43246	UniProtKB	Helix	229	232	.	.	.	.	
P43246	UniProtKB	Helix	237	244	.	.	.	.	
P43246	UniProtKB	Turn	252	254	.	.	.	.	
P43246	UniProtKB	Helix	255	257	.	.	.	.	
P43246	UniProtKB	Helix	259	262	.	.	.	.	
P43246	UniProtKB	Helix	264	277	.	.	.	.	
P43246	UniProtKB	Helix	279	281	.	.	.	.	
P43246	UniProtKB	Helix	283	285	.	.	.	.	
P43246	UniProtKB	Beta strand	289	293	.	.	.	.	
P43246	UniProtKB	Helix	296	298	.	.	.	.	
P43246	UniProtKB	Helix	304	309	.	.	.	.	
P43246	UniProtKB	Helix	326	330	.	.	.	.	
P43246	UniProtKB	Helix	336	347	.	.	.	.	
P43246	UniProtKB	Helix	353	367	.	.	.	.	
P43246	UniProtKB	Helix	370	377	.	.	.	.	
P43246	UniProtKB	Turn	378	380	.	.	.	.	
P43246	UniProtKB	Helix	381	383	.	.	.	.	
P43246	UniProtKB	Helix	387	395	.	.	.	.	
P43246	UniProtKB	Helix	401	411	.	.	.	.	
P43246	UniProtKB	Helix	414	423	.	.	.	.	
P43246	UniProtKB	Beta strand	424	426	.	.	.	.	
P43246	UniProtKB	Beta strand	427	429	.	.	.	.	
P43246	UniProtKB	Helix	432	435	.	.	.	.	
P43246	UniProtKB	Helix	437	455	.	.	.	.	
P43246	UniProtKB	Helix	462	464	.	.	.	.	
P43246	UniProtKB	Turn	472	474	.	.	.	.	
P43246	UniProtKB	Helix	476	502	.	.	.	.	
P43246	UniProtKB	Turn	507	509	.	.	.	.	
P43246	UniProtKB	Beta strand	512	515	.	.	.	.	
P43246	UniProtKB	Turn	517	519	.	.	.	.	
P43246	UniProtKB	Beta strand	521	525	.	.	.	.	
P43246	UniProtKB	Helix	527	530	.	.	.	.	
P43246	UniProtKB	Turn	531	535	.	.	.	.	
P43246	UniProtKB	Beta strand	540	544	.	.	.	.	
P43246	UniProtKB	Beta strand	549	552	.	.	.	.	
P43246	UniProtKB	Helix	556	563	.	.	.	.	
P43246	UniProtKB	Turn	564	567	.	.	.	.	
P43246	UniProtKB	Helix	568	585	.	.	.	.	
P43246	UniProtKB	Helix	586	588	.	.	.	.	
P43246	UniProtKB	Helix	589	613	.	.	.	.	
P43246	UniProtKB	Beta strand	615	617	.	.	.	.	
P43246	UniProtKB	Beta strand	623	625	.	.	.	.	
P43246	UniProtKB	Beta strand	631	637	.	.	.	.	
P43246	UniProtKB	Turn	640	644	.	.	.	.	
P43246	UniProtKB	Beta strand	653	658	.	.	.	.	
P43246	UniProtKB	Turn	659	661	.	.	.	.	
P43246	UniProtKB	Beta strand	664	668	.	.	.	.	
P43246	UniProtKB	Helix	675	691	.	.	.	.	
P43246	UniProtKB	Beta strand	695	703	.	.	.	.	
P43246	UniProtKB	Beta strand	706	711	.	.	.	.	
P43246	UniProtKB	Helix	724	738	.	.	.	.	
P43246	UniProtKB	Beta strand	744	749	.	.	.	.	
P43246	UniProtKB	Helix	756	772	.	.	.	.	
P43246	UniProtKB	Beta strand	777	783	.	.	.	.	
P43246	UniProtKB	Helix	785	792	.	.	.	.	
P43246	UniProtKB	Beta strand	797	807	.	.	.	.	
P43246	UniProtKB	Beta strand	810	820	.	.	.	.	
P43246	UniProtKB	Helix	827	833	.	.	.	.	
P43246	UniProtKB	Helix	838	850	.	.	.	.	
P43246	UniProtKB	Turn	851	855	.	.	.	.	
P43246	UniProtKB	Helix	875	892	.	.	.	.	
P43246	UniProtKB	Helix	896	898	.	.	.	.	
P43246	UniProtKB	Helix	901	917	.	.	.	.	
P43246	UniProtKB	Helix	921	928	.	.	.	.	
##sequence-region O43312 1 755
O43312	UniProtKB	Chain	1	755	.	.	.	ID=PRO_0000096639;Note=Metastasis suppressor protein 1	
O43312	UniProtKB	Domain	1	250	.	.	.	Note=IMD	
O43312	UniProtKB	Domain	727	744	.	.	.	Note=WH2	
O43312	UniProtKB	Coiled coil	108	155	.	.	.	status=Potential	
O43312	UniProtKB	Compositional bias	238	359	.	.	.	Note=Ser-rich	
O43312	UniProtKB	Compositional bias	608	726	.	.	.	Note=Pro-rich	
O43312	UniProtKB	Modified residue	322	322	.	.	.	Note=Phosphoserine;status=By similarity	
O43312	UniProtKB	Alternative sequence	1	200	.	.	.	ID=VSP_007420;Note=In isoform 2.	
O43312	UniProtKB	Alternative sequence	345	426	.	.	.	ID=VSP_007421;Note=In isoform 2.	
O43312	UniProtKB	Alternative sequence	346	409	.	.	.	ID=VSP_016216;Note=In isoform 3.	
O43312	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_054010;Dbxref=dbSNP:rs2303956	
O43312	UniProtKB	Natural variant	725	725	.	.	.	ID=VAR_054011;Dbxref=dbSNP:rs3829037	
O43312	UniProtKB	Sequence conflict	153	153	.	.	.	.	
O43312	UniProtKB	Sequence conflict	586	586	.	.	.	.	
O43312	UniProtKB	Sequence conflict	630	630	.	.	.	.	
O43312	UniProtKB	Helix	729	737	.	.	.	.	
##sequence-region Q9ULD2 1 1270
Q9ULD2	UniProtKB	Chain	1	1270	.	.	.	ID=PRO_0000305197;Note=Microtubule-associated tumor suppressor 1	
Q9ULD2	UniProtKB	Coiled coil	940	1231	.	.	.	status=Potential	
Q9ULD2	UniProtKB	Modified residue	381	381	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ULD2	UniProtKB	Modified residue	1224	1224	.	.	.	Note=Phosphoserine	
Q9ULD2	UniProtKB	Modified residue	1255	1255	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ULD2	UniProtKB	Modified residue	1264	1264	.	.	.	Note=Phosphoserine	
Q9ULD2	UniProtKB	Modified residue	1268	1268	.	.	.	Note=Phosphoserine	
Q9ULD2	UniProtKB	Alternative sequence	1	928	.	.	.	ID=VSP_028270;Note=In isoform 4.	
Q9ULD2	UniProtKB	Alternative sequence	1	855	.	.	.	ID=VSP_044849;Note=In isoform 7.	
Q9ULD2	UniProtKB	Alternative sequence	1	834	.	.	.	ID=VSP_028271;Note=In isoform 3.	
Q9ULD2	UniProtKB	Alternative sequence	1	753	.	.	.	ID=VSP_028272;Note=In isoform 6.	
Q9ULD2	UniProtKB	Alternative sequence	754	817	.	.	.	ID=VSP_028273;Note=In isoform 6.	
Q9ULD2	UniProtKB	Alternative sequence	763	817	.	.	.	ID=VSP_028274;Note=In isoform 2.	
Q9ULD2	UniProtKB	Alternative sequence	763	770	.	.	.	ID=VSP_028275;Note=In isoform 5.	
Q9ULD2	UniProtKB	Alternative sequence	771	1270	.	.	.	ID=VSP_028276;Note=In isoform 5.	
Q9ULD2	UniProtKB	Alternative sequence	835	874	.	.	.	ID=VSP_028277;Note=In isoform 3.	
Q9ULD2	UniProtKB	Alternative sequence	929	946	.	.	.	ID=VSP_028278;Note=In isoform 4.	
Q9ULD2	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_035173;Dbxref=dbSNP:rs61733703;Note=In HCC.	
Q9ULD2	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_035174;Dbxref=dbSNP:rs3739407	
Q9ULD2	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_035175;Dbxref=dbSNP:rs141609607;Note=In HNSCC cell lines.	
Q9ULD2	UniProtKB	Natural variant	425	425	.	.	.	ID=VAR_035176;Dbxref=dbSNP:rs61733694	
Q9ULD2	UniProtKB	Natural variant	453	453	.	.	.	ID=VAR_035177;Dbxref=dbSNP:rs17690844	
Q9ULD2	UniProtKB	Natural variant	563	563	.	.	.	ID=VAR_035178;Note=In HCC.	
Q9ULD2	UniProtKB	Natural variant	575	575	.	.	.	ID=VAR_035179;Dbxref=dbSNP:rs209569	
Q9ULD2	UniProtKB	Natural variant	873	873	.	.	.	ID=VAR_035180;Dbxref=dbSNP:rs187103704;Note=In HCC.	
Q9ULD2	UniProtKB	Natural variant	911	911	.	.	.	ID=VAR_035181;Dbxref=dbSNP:rs61748836	
Q9ULD2	UniProtKB	Natural variant	1063	1063	.	.	.	ID=VAR_035182;Dbxref=dbSNP:rs17853231	
Q9ULD2	UniProtKB	Natural variant	1105	1105	.	.	.	ID=VAR_035183;Dbxref=dbSNP:rs61733705	
Q9ULD2	UniProtKB	Natural variant	1201	1201	.	.	.	ID=VAR_035184;Note=In HCC.	
Q9ULD2	UniProtKB	Sequence conflict	266	266	.	.	.	.	
Q9ULD2	UniProtKB	Sequence conflict	918	918	.	.	.	.	
Q9ULD2	UniProtKB	Sequence conflict	999	999	.	.	.	.	
Q9ULD2	UniProtKB	Sequence conflict	1149	1149	.	.	.	.	
##sequence-region P15941 1 1255
P15941	UniProtKB	Signal peptide	1	23	.	.	.	.	
P15941	UniProtKB	Chain	24	1255	.	.	.	ID=PRO_0000019277;Note=Mucin-1	
P15941	UniProtKB	Chain	24	1097	.	.	.	ID=PRO_0000317446;Note=Mucin-1 subunit alpha	
P15941	UniProtKB	Chain	1098	1255	.	.	.	ID=PRO_0000317447;Note=Mucin-1 subunit beta	
P15941	UniProtKB	Topological domain	24	1158	.	.	.	Note=Extracellular;status=Potential	
P15941	UniProtKB	Transmembrane	1159	1181	.	.	.	Note=Helical%3B;status=Potential	
P15941	UniProtKB	Topological domain	1182	1255	.	.	.	Note=Cytoplasmic;status=Potential	
P15941	UniProtKB	Repeat	61	80	.	.	.	Note=1%3B approximate	
P15941	UniProtKB	Repeat	81	100	.	.	.	Note=2%3B approximate	
P15941	UniProtKB	Repeat	101	120	.	.	.	Note=3	
P15941	UniProtKB	Repeat	121	140	.	.	.	Note=4	
P15941	UniProtKB	Repeat	141	160	.	.	.	Note=5	
P15941	UniProtKB	Repeat	161	180	.	.	.	Note=6	
P15941	UniProtKB	Repeat	181	200	.	.	.	Note=7	
P15941	UniProtKB	Repeat	201	220	.	.	.	Note=8	
P15941	UniProtKB	Repeat	221	240	.	.	.	Note=9	
P15941	UniProtKB	Repeat	241	260	.	.	.	Note=10	
P15941	UniProtKB	Repeat	261	280	.	.	.	Note=11	
P15941	UniProtKB	Repeat	281	300	.	.	.	Note=12	
P15941	UniProtKB	Repeat	301	320	.	.	.	Note=13	
P15941	UniProtKB	Repeat	321	340	.	.	.	Note=14	
P15941	UniProtKB	Repeat	341	360	.	.	.	Note=15	
P15941	UniProtKB	Repeat	361	380	.	.	.	Note=16	
P15941	UniProtKB	Repeat	381	400	.	.	.	Note=17	
P15941	UniProtKB	Repeat	401	420	.	.	.	Note=18	
P15941	UniProtKB	Repeat	421	440	.	.	.	Note=19	
P15941	UniProtKB	Repeat	441	460	.	.	.	Note=20	
P15941	UniProtKB	Repeat	461	480	.	.	.	Note=21	
P15941	UniProtKB	Repeat	481	500	.	.	.	Note=22	
P15941	UniProtKB	Repeat	501	520	.	.	.	Note=23	
P15941	UniProtKB	Repeat	521	540	.	.	.	Note=24	
P15941	UniProtKB	Repeat	541	560	.	.	.	Note=25	
P15941	UniProtKB	Repeat	561	580	.	.	.	Note=26	
P15941	UniProtKB	Repeat	581	600	.	.	.	Note=27	
P15941	UniProtKB	Repeat	601	620	.	.	.	Note=28	
P15941	UniProtKB	Repeat	621	640	.	.	.	Note=29	
P15941	UniProtKB	Repeat	641	660	.	.	.	Note=30	
P15941	UniProtKB	Repeat	661	680	.	.	.	Note=31	
P15941	UniProtKB	Repeat	681	700	.	.	.	Note=32	
P15941	UniProtKB	Repeat	701	720	.	.	.	Note=33	
P15941	UniProtKB	Repeat	721	740	.	.	.	Note=34	
P15941	UniProtKB	Repeat	741	760	.	.	.	Note=35	
P15941	UniProtKB	Repeat	761	780	.	.	.	Note=36	
P15941	UniProtKB	Repeat	781	800	.	.	.	Note=37	
P15941	UniProtKB	Repeat	801	820	.	.	.	Note=38	
P15941	UniProtKB	Repeat	821	840	.	.	.	Note=39	
P15941	UniProtKB	Repeat	841	860	.	.	.	Note=40	
P15941	UniProtKB	Repeat	861	880	.	.	.	Note=41	
P15941	UniProtKB	Repeat	881	900	.	.	.	Note=42	
P15941	UniProtKB	Repeat	901	920	.	.	.	Note=43	
P15941	UniProtKB	Repeat	921	940	.	.	.	Note=44	
P15941	UniProtKB	Repeat	941	960	.	.	.	Note=45	
P15941	UniProtKB	Repeat	961	980	.	.	.	Note=46%3B approximate	
P15941	UniProtKB	Repeat	981	1000	.	.	.	Note=47%3B approximate	
P15941	UniProtKB	Repeat	1001	1020	.	.	.	Note=48%3B approximate	
P15941	UniProtKB	Domain	1034	1151	.	.	.	Note=SEA	
P15941	UniProtKB	Region	126	965	.	.	.	Note=42 X 20 AA approximate tandem repeats of P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-R	
P15941	UniProtKB	Region	1192	1228	.	.	.	Note=Interaction with P53	
P15941	UniProtKB	Region	1223	1230	.	.	.	Note=Required for interaction with GSK3B	
P15941	UniProtKB	Region	1233	1241	.	.	.	Note=Required for interaction with beta- and gamma-catenins	
P15941	UniProtKB	Motif	1203	1206	.	.	.	Note=Interaction with GRB2	
P15941	UniProtKB	Motif	1229	1232	.	.	.	Note=Interaction with SRC and ESR1	
P15941	UniProtKB	Motif	1243	1246	.	.	.	Note=Required for interaction with AP1S2	
P15941	UniProtKB	Site	1097	1098	.	.	.	Note=Cleavage%3B by autolysis	
P15941	UniProtKB	Modified residue	1191	1191	.	.	.	Note=Phosphotyrosine	
P15941	UniProtKB	Modified residue	1203	1203	.	.	.	Note=Phosphotyrosine%3B by PDGFR	
P15941	UniProtKB	Modified residue	1209	1209	.	.	.	Note=Phosphotyrosine	
P15941	UniProtKB	Modified residue	1212	1212	.	.	.	Note=Phosphotyrosine	
P15941	UniProtKB	Modified residue	1218	1218	.	.	.	Note=Phosphotyrosine%3B by PDGFR	
P15941	UniProtKB	Modified residue	1224	1224	.	.	.	Note=Phosphothreonine%3B by PKC/PRKCD	
P15941	UniProtKB	Modified residue	1227	1227	.	.	.	Note=Phosphoserine%3B by GSK3-beta	
P15941	UniProtKB	Modified residue	1229	1229	.	.	.	Note=Phosphotyrosine%3B by CSK%2C EGFR and SRC	
P15941	UniProtKB	Modified residue	1243	1243	.	.	.	Note=Phosphotyrosine	
P15941	UniProtKB	Lipidation	1184	1184	.	.	.	Note=S-palmitoyl cysteine	
P15941	UniProtKB	Lipidation	1186	1186	.	.	.	Note=S-palmitoyl cysteine	
P15941	UniProtKB	Glycosylation	131	131	.	.	.	Note=O-linked (GalNAc...);status=Probable	
P15941	UniProtKB	Glycosylation	139	139	.	.	.	Note=O-linked (GalNAc...);status=Probable	
P15941	UniProtKB	Glycosylation	140	140	.	.	.	Note=O-linked (GalNAc...);status=Potential	
P15941	UniProtKB	Glycosylation	144	144	.	.	.	Note=O-linked (GalNAc...);status=Potential	
P15941	UniProtKB	Glycosylation	957	957	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P15941	UniProtKB	Glycosylation	975	975	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P15941	UniProtKB	Glycosylation	1029	1029	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P15941	UniProtKB	Glycosylation	1055	1055	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P15941	UniProtKB	Glycosylation	1133	1133	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
P15941	UniProtKB	Alternative sequence	19	21	.	.	.	ID=VSP_003281;Note=In isoform 3.	
P15941	UniProtKB	Alternative sequence	19	19	.	.	.	ID=VSP_003280;Note=In isoform 2%2C isoform Y-LSP%2C isoform E2%2C isoform J13%2C isoform S2 and isoform T10.	
P15941	UniProtKB	Alternative sequence	20	31	.	.	.	ID=VSP_003282;Note=In isoform 4.	
P15941	UniProtKB	Alternative sequence	54	1151	.	.	.	ID=VSP_047872;Note=In isoform E2.	
P15941	UniProtKB	Alternative sequence	54	1093	.	.	.	ID=VSP_047873;Note=In isoform T10.	
P15941	UniProtKB	Alternative sequence	54	1053	.	.	.	ID=VSP_003285;Note=In isoform J13%2C isoform Y%2C isoform Y-LSP and isoform S2.	
P15941	UniProtKB	Alternative sequence	54	1035	.	.	.	ID=VSP_003286;Note=In isoform 8%2C isoform 9 and isoform M6.	
P15941	UniProtKB	Alternative sequence	54	96	.	.	.	ID=VSP_047575;Note=In isoform ZD.	
P15941	UniProtKB	Alternative sequence	54	87	.	.	.	ID=VSP_035046;Note=In isoform F.	
P15941	UniProtKB	Alternative sequence	54	70	.	.	.	ID=VSP_003283;Note=In isoform 6.	
P15941	UniProtKB	Alternative sequence	71	1095	.	.	.	ID=VSP_003284;Note=In isoform 6.	
P15941	UniProtKB	Alternative sequence	88	1139	.	.	.	ID=VSP_035047;Note=In isoform F.	
P15941	UniProtKB	Alternative sequence	97	1255	.	.	.	ID=VSP_047576;Note=In isoform ZD.	
P15941	UniProtKB	Alternative sequence	1077	1181	.	.	.	ID=VSP_003287;Note=In isoform 9 and isoform S2.	
P15941	UniProtKB	Alternative sequence	1077	1087	.	.	.	ID=VSP_003288;Note=In isoform 5.	
P15941	UniProtKB	Alternative sequence	1088	1255	.	.	.	ID=VSP_003289;Note=In isoform 5.	
P15941	UniProtKB	Alternative sequence	1141	1180	.	.	.	ID=VSP_046962;Note=In isoform M6.	
P15941	UniProtKB	Alternative sequence	1181	1255	.	.	.	ID=VSP_046963;Note=In isoform M6.	
P15941	UniProtKB	Alternative sequence	1232	1255	.	.	.	ID=VSP_047874;Note=In isoform J13.	
P15941	UniProtKB	Natural variant	1117	1117	.	.	.	ID=VAR_019390;Dbxref=dbSNP:rs1611770	
P15941	UniProtKB	Natural variant	1142	1142	.	.	.	ID=VAR_019391;Dbxref=dbSNP:rs11465207	
P15941	UniProtKB	Mutagenesis	1098	1098	.	.	.	Note=Completely abrogates cleavage.	
P15941	UniProtKB	Mutagenesis	1098	1098	.	.	.	Note=Almost complete cleavage.	
P15941	UniProtKB	Mutagenesis	1116	1116	.	.	.	Note=Greatly reduced formation of isoform 5/isoform Y complex.	
P15941	UniProtKB	Mutagenesis	1116	1116	.	.	.	Note=No effect on formation of isoform 5/isoform Y complex.	
P15941	UniProtKB	Mutagenesis	1184	1184	.	.	.	Note=S-palmitoylation reduced by 50%25. Complete loss of palmitoylation%2C no effect on endocytosis%2C recycling inhibited and AP1S1 binding reduced by 30%25%3B when associated with C-1186. Accumulates in intracellular compartments%3B when associated with C-1186 and N-1203.	
P15941	UniProtKB	Mutagenesis	1186	1186	.	.	.	Note=S-palmitoylation reduced by 50%25. Complete loss of palmitoylation%2C no effect on endocytosis%2C recycling inhibited%2C and AP1S1 binding reduced by 30%25%3B when associated with C-1184. Accumulates in intracellular compartments%3B when associated with C-1184 and N-1203.	
P15941	UniProtKB	Mutagenesis	1187	1189	.	.	.	Note=No nuclear targeting of HRG-stimulated MUC1 C-terminal nor JUP/gamma-catenin. No effect on interaction with JUP/gamma-catenin.	
P15941	UniProtKB	Mutagenesis	1187	1189	.	.	.	Note=No effect on palmitoylation.	
P15941	UniProtKB	Mutagenesis	1191	1191	.	.	.	Note=No effect on EGFR-mediated phosphorylation.	
P15941	UniProtKB	Mutagenesis	1191	1191	.	.	.	Note=No effect on endocytosis.	
P15941	UniProtKB	Mutagenesis	1203	1203	.	.	.	Note=No effect on nuclear colocalization of MUC1CT and CTNNB1. No effect on in vitro PDFGR-induced cell invasiveness.	
P15941	UniProtKB	Mutagenesis	1203	1203	.	.	.	Note=No effect on EGFR-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-induced cell invasiveness.	
P15941	UniProtKB	Mutagenesis	1203	1203	.	.	.	Note=Reduced endocytosis by 30%25. Greatly reduced binding to AP1S2 and GRB2. Binding AP1S1 reduced by 25%25. Reduced endocytosis by 77%25%3B when associated with N-1243. Accumulates in intracellular compartments%3B when associated with C-1184 and C-1186.	
P15941	UniProtKB	Mutagenesis	1209	1209	.	.	.	Note=Some reduction in EGFR-mediated phosphorylation.	
P15941	UniProtKB	Mutagenesis	1218	1218	.	.	.	Note=No effect on EGFR-mediated phosphorylation. No nuclear colocalization of MUC1CT and CTNNB1.	
P15941	UniProtKB	Mutagenesis	1223	1223	.	.	.	Note=No change in PRKCD- nor GSK3B-mediated phosphorylation.	
P15941	UniProtKB	Mutagenesis	1224	1224	.	.	.	Note=Loss of PRKCD-mediated phosphorylation. Decreased PRKCD binding. No increased binding to CTNNB1 in the presence of autophosphorylated PRKCD. Increases formation of E-cadherin/beta-catenin complex.	
P15941	UniProtKB	Mutagenesis	1227	1227	.	.	.	Note=No change in PRKCD-mediated phosphorylation. Loss of GSK3B-mediated phosphorylation. CTNNB1.	
P15941	UniProtKB	Mutagenesis	1229	1229	.	.	.	Note=Greatly reduced EGFR- and Src-mediated phosphorylation. No nuclear localization of MUC1CT. Reduced in vitro PDGFR-mediated phosphorylation. Decreased Src-binding.	
P15941	UniProtKB	Mutagenesis	1229	1229	.	.	.	Note=No effect on endocytosis.	
P15941	UniProtKB	Mutagenesis	1243	1243	.	.	.	Note=Reduces binding to AP1S2 by 33%25. Greatly reduced binding to GRB2. Reduced endocytosis by 50%25. Reduced endocytosis by 77%25%3B when associated with N-1203.	
P15941	UniProtKB	Sequence conflict	2	2	.	.	.	.	
P15941	UniProtKB	Sequence conflict	134	134	.	.	.	.	
P15941	UniProtKB	Sequence conflict	154	154	.	.	.	.	
P15941	UniProtKB	Sequence conflict	1021	1021	.	.	.	.	
P15941	UniProtKB	Sequence conflict	1021	1021	.	.	.	.	
P15941	UniProtKB	Sequence conflict	1021	1021	.	.	.	.	
P15941	UniProtKB	Sequence conflict	1143	1143	.	.	.	.	
P15941	UniProtKB	Sequence conflict	1193	1193	.	.	.	.	
P15941	UniProtKB	Sequence conflict	1231	1231	.	.	.	.	
P15941	UniProtKB	Sequence conflict	1251	1251	.	.	.	.	
P15941	UniProtKB	Beta strand	1042	1052	.	.	.	.	
P15941	UniProtKB	Helix	1056	1059	.	.	.	.	
P15941	UniProtKB	Helix	1064	1080	.	.	.	.	
P15941	UniProtKB	Turn	1082	1085	.	.	.	.	
P15941	UniProtKB	Beta strand	1086	1096	.	.	.	.	
P15941	UniProtKB	Beta strand	1099	1107	.	.	.	.	
P15941	UniProtKB	Turn	1109	1111	.	.	.	.	
P15941	UniProtKB	Helix	1114	1132	.	.	.	.	
P15941	UniProtKB	Beta strand	1136	1142	.	.	.	.	
##sequence-region Q9UIF7 1 546
Q9UIF7	UniProtKB	Chain	1	546	.	.	.	ID=PRO_0000102239;Note=A/G-specific adenine DNA glycosylase	
Q9UIF7	UniProtKB	Domain	364	495	.	.	.	Note=Nudix hydrolase	
Q9UIF7	UniProtKB	Motif	404	426	.	.	.	Note=Nudix box	
Q9UIF7	UniProtKB	Metal binding	287	287	.	.	.	Note=Iron-sulfur (4Fe-4S);status=By similarity	
Q9UIF7	UniProtKB	Metal binding	294	294	.	.	.	Note=Iron-sulfur (4Fe-4S);status=By similarity	
Q9UIF7	UniProtKB	Metal binding	297	297	.	.	.	Note=Iron-sulfur (4Fe-4S);status=By similarity	
Q9UIF7	UniProtKB	Metal binding	303	303	.	.	.	Note=Iron-sulfur (4Fe-4S);status=By similarity	
Q9UIF7	UniProtKB	Alternative sequence	1	14	.	.	.	ID=VSP_010548;Note=In isoform Beta-1%2C isoform Gamma-2 and isoform Gamma-3.	
Q9UIF7	UniProtKB	Alternative sequence	53	63	.	.	.	ID=VSP_010550;Note=In isoform Alpha-3 and isoform Gamma-3.	
Q9UIF7	UniProtKB	Alternative sequence	53	62	.	.	.	ID=VSP_010549;Note=In isoform Alpha-2 and isoform Gamma-2.	
Q9UIF7	UniProtKB	Natural variant	22	22	.	.	.	ID=VAR_018872;Dbxref=dbSNP:rs3219484	
Q9UIF7	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_026045;Note=In FAP2.	
Q9UIF7	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_026046;Note=In FAP2.	
Q9UIF7	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_064938;Note=In FAP2%3B dysfunctional in base excision repair assay.	
Q9UIF7	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_018873;Dbxref=dbSNP:rs34612342;Note=In FAP2%3B dysfunctional in base excision repair assay.	
Q9UIF7	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_064939;Note=In FAP2.	
Q9UIF7	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_026047;Note=In FAP2.	
Q9UIF7	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_064940;Note=In FAP2%3B dysfunctional in base excision repair assay.	
Q9UIF7	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_026048;Dbxref=dbSNP:rs34126013;Note=In FAP2.	
Q9UIF7	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_018874;Dbxref=dbSNP:rs3219489	
Q9UIF7	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_048262;Dbxref=dbSNP:rs35352891	
Q9UIF7	UniProtKB	Natural variant	393	393	.	.	.	ID=VAR_018875;Dbxref=dbSNP:rs36053993;Note=In FAP2%3B shows a glycosylase activity very similar to the wild-type protein.	
Q9UIF7	UniProtKB	Natural variant	402	402	.	.	.	ID=VAR_026049;Note=In GASC%3B sporadic.	
Q9UIF7	UniProtKB	Natural variant	411	411	.	.	.	ID=VAR_026050;Note=In GASC%3B sporadic.	
Q9UIF7	UniProtKB	Natural variant	477	477	.	.	.	ID=VAR_064941;Note=In FAP2%3B dysfunctional in base excision repair assay.	
Q9UIF7	UniProtKB	Natural variant	500	500	.	.	.	ID=VAR_018876;Dbxref=dbSNP:rs3219494	
Q9UIF7	UniProtKB	Natural variant	512	512	.	.	.	ID=VAR_026051;Dbxref=dbSNP:rs140118273	
Q9UIF7	UniProtKB	Natural variant	526	526	.	.	.	ID=VAR_018877;Dbxref=dbSNP:rs3219496	
Q9UIF7	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_018878;Dbxref=dbSNP:rs3219497	
Q9UIF7	UniProtKB	Helix	87	104	.	.	.	.	
Q9UIF7	UniProtKB	Helix	109	116	.	.	.	.	
Q9UIF7	UniProtKB	Helix	120	135	.	.	.	.	
Q9UIF7	UniProtKB	Helix	139	152	.	.	.	.	
Q9UIF7	UniProtKB	Helix	156	160	.	.	.	.	
Q9UIF7	UniProtKB	Helix	164	171	.	.	.	.	
Q9UIF7	UniProtKB	Helix	177	193	.	.	.	.	
Q9UIF7	UniProtKB	Helix	202	208	.	.	.	.	
Q9UIF7	UniProtKB	Helix	214	224	.	.	.	.	
Q9UIF7	UniProtKB	Helix	234	243	.	.	.	.	
Q9UIF7	UniProtKB	Helix	253	266	.	.	.	.	
Q9UIF7	UniProtKB	Helix	272	285	.	.	.	.	
Q9UIF7	UniProtKB	Beta strand	289	291	.	.	.	.	
Q9UIF7	UniProtKB	Helix	300	302	.	.	.	.	
Q9UIF7	UniProtKB	Helix	304	316	.	.	.	.	
Q9UIF7	UniProtKB	Helix	330	332	.	.	.	.	
Q9UIF7	UniProtKB	Beta strand	358	360	.	.	.	.	
Q9UIF7	UniProtKB	Beta strand	366	377	.	.	.	.	
Q9UIF7	UniProtKB	Beta strand	379	388	.	.	.	.	
Q9UIF7	UniProtKB	Beta strand	403	405	.	.	.	.	
Q9UIF7	UniProtKB	Helix	410	424	.	.	.	.	
Q9UIF7	UniProtKB	Beta strand	447	456	.	.	.	.	
Q9UIF7	UniProtKB	Beta strand	470	474	.	.	.	.	
Q9UIF7	UniProtKB	Helix	475	480	.	.	.	.	
Q9UIF7	UniProtKB	Helix	485	495	.	.	.	.	
##sequence-region Q93015 1 286
Q93015	UniProtKB	Chain	1	286	.	.	.	ID=PRO_0000074536;Note=N-acetyltransferase 6	
Q93015	UniProtKB	Domain	60	207	.	.	.	Note=N-acetyltransferase	
Q93015	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_037187;Note=In isoform 2.	
Q93015	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_014224;Note=In non-small cell lung cancer cell lines.	
Q93015	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_014225;Note=In non-small cell lung cancer cell lines.	
##sequence-region Q9R123 1 314
Q9R123	UniProtKB	Chain	1	314	.	.	.	ID=PRO_0000074537;Note=N-acetyltransferase 6	
Q9R123	UniProtKB	Domain	90	243	.	.	.	Note=N-acetyltransferase	
##sequence-region Q90YC9 1 177
Q90YC9	UniProtKB	Signal peptide	1	16	.	.	.	status=Potential	
Q90YC9	UniProtKB	Chain	17	177	.	.	.	ID=PRO_0000364337;Note=Neuroblastoma suppressor of tumorigenicity 1	
Q90YC9	UniProtKB	Domain	34	123	.	.	.	Note=CTCK	
Q90YC9	UniProtKB	Compositional bias	151	171	.	.	.	Note=His-rich	
Q90YC9	UniProtKB	Disulfide bond	34	84	.	.	.	status=By similarity	
Q90YC9	UniProtKB	Disulfide bond	48	98	.	.	.	status=By similarity	
Q90YC9	UniProtKB	Disulfide bond	58	117	.	.	.	status=By similarity	
Q90YC9	UniProtKB	Disulfide bond	62	119	.	.	.	status=By similarity	
Q90YC9	UniProtKB	Disulfide bond	81	122	.	.	.	status=By similarity	
Q90YC9	UniProtKB	Sequence conflict	149	165	.	.	.	.	
##sequence-region Q6NZ13 1 183
Q6NZ13	UniProtKB	Signal peptide	1	19	.	.	.	status=Potential	
Q6NZ13	UniProtKB	Chain	20	183	.	.	.	ID=PRO_0000364338;Note=Neuroblastoma suppressor of tumorigenicity 1	
Q6NZ13	UniProtKB	Domain	38	127	.	.	.	Note=CTCK	
Q6NZ13	UniProtKB	Disulfide bond	38	88	.	.	.	status=By similarity	
Q6NZ13	UniProtKB	Disulfide bond	52	102	.	.	.	status=By similarity	
Q6NZ13	UniProtKB	Disulfide bond	62	121	.	.	.	status=By similarity	
Q6NZ13	UniProtKB	Disulfide bond	66	123	.	.	.	status=By similarity	
Q6NZ13	UniProtKB	Disulfide bond	85	126	.	.	.	status=By similarity	
##sequence-region P41271 1 180
P41271	UniProtKB	Signal peptide	1	15	.	.	.	.	
P41271	UniProtKB	Chain	16	180	.	.	.	ID=PRO_0000006722;Note=Neuroblastoma suppressor of tumorigenicity 1	
P41271	UniProtKB	Domain	34	123	.	.	.	Note=CTCK	
P41271	UniProtKB	Compositional bias	141	171	.	.	.	Note=Pro-rich	
P41271	UniProtKB	Disulfide bond	34	84	.	.	.	status=By similarity	
P41271	UniProtKB	Disulfide bond	48	98	.	.	.	status=By similarity	
P41271	UniProtKB	Disulfide bond	58	117	.	.	.	status=By similarity	
P41271	UniProtKB	Disulfide bond	62	119	.	.	.	status=By similarity	
P41271	UniProtKB	Disulfide bond	81	122	.	.	.	status=Potential	
P41271	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_036438;Note=In isoform 2.	
##sequence-region Q61477 1 178
Q61477	UniProtKB	Signal peptide	1	16	.	.	.	status=Potential	
Q61477	UniProtKB	Chain	17	178	.	.	.	ID=PRO_0000006723;Note=Neuroblastoma suppressor of tumorigenicity 1	
Q61477	UniProtKB	Domain	34	123	.	.	.	Note=CTCK	
Q61477	UniProtKB	Compositional bias	141	169	.	.	.	Note=Pro-rich	
Q61477	UniProtKB	Disulfide bond	34	84	.	.	.	status=By similarity	
Q61477	UniProtKB	Disulfide bond	48	98	.	.	.	status=By similarity	
Q61477	UniProtKB	Disulfide bond	58	117	.	.	.	status=By similarity	
Q61477	UniProtKB	Disulfide bond	62	119	.	.	.	status=By similarity	
Q61477	UniProtKB	Disulfide bond	81	122	.	.	.	status=Potential	
Q61477	UniProtKB	Sequence conflict	100	100	.	.	.	.	
##sequence-region Q06880 1 178
Q06880	UniProtKB	Signal peptide	1	16	.	.	.	status=Potential	
Q06880	UniProtKB	Chain	17	178	.	.	.	ID=PRO_0000006724;Note=Neuroblastoma suppressor of tumorigenicity 1	
Q06880	UniProtKB	Domain	34	123	.	.	.	Note=CTCK	
Q06880	UniProtKB	Compositional bias	141	169	.	.	.	Note=Pro-rich	
Q06880	UniProtKB	Disulfide bond	34	84	.	.	.	status=By similarity	
Q06880	UniProtKB	Disulfide bond	48	98	.	.	.	status=By similarity	
Q06880	UniProtKB	Disulfide bond	58	117	.	.	.	status=By similarity	
Q06880	UniProtKB	Disulfide bond	62	119	.	.	.	status=By similarity	
Q06880	UniProtKB	Disulfide bond	81	122	.	.	.	status=Potential	
Q06880	UniProtKB	Sequence conflict	157	157	.	.	.	.	
##sequence-region O73753 1 175
O73753	UniProtKB	Signal peptide	1	17	.	.	.	status=Potential	
O73753	UniProtKB	Chain	18	175	.	.	.	ID=PRO_0000364339;Note=Neuroblastoma suppressor of tumorigenicity 1	
O73753	UniProtKB	Domain	35	124	.	.	.	Note=CTCK	
O73753	UniProtKB	Disulfide bond	35	85	.	.	.	status=By similarity	
O73753	UniProtKB	Disulfide bond	49	99	.	.	.	status=By similarity	
O73753	UniProtKB	Disulfide bond	59	118	.	.	.	status=By similarity	
O73753	UniProtKB	Disulfide bond	63	120	.	.	.	status=By similarity	
O73753	UniProtKB	Disulfide bond	82	123	.	.	.	status=By similarity	
##sequence-region Q6DF53 1 176
Q6DF53	UniProtKB	Signal peptide	1	17	.	.	.	status=Potential	
Q6DF53	UniProtKB	Chain	18	176	.	.	.	ID=PRO_0000364340;Note=Neuroblastoma suppressor of tumorigenicity 1	
Q6DF53	UniProtKB	Domain	34	123	.	.	.	Note=CTCK	
Q6DF53	UniProtKB	Compositional bias	152	155	.	.	.	Note=Poly-His	
Q6DF53	UniProtKB	Disulfide bond	34	84	.	.	.	status=By similarity	
Q6DF53	UniProtKB	Disulfide bond	48	98	.	.	.	status=By similarity	
Q6DF53	UniProtKB	Disulfide bond	58	117	.	.	.	status=By similarity	
Q6DF53	UniProtKB	Disulfide bond	62	119	.	.	.	status=By similarity	
Q6DF53	UniProtKB	Disulfide bond	81	122	.	.	.	status=By similarity	
##sequence-region Q3ZBA8 1 357
Q3ZBA8	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q3ZBA8	UniProtKB	Chain	2	357	.	.	.	ID=PRO_0000238963;Note=Protein NDRG2	
Q3ZBA8	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	312	312	.	.	.	Note=Phosphoserine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	314	314	.	.	.	Note=Phosphoserine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	316	316	.	.	.	Note=Phosphothreonine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	318	318	.	.	.	Note=Phosphoserine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	320	320	.	.	.	Note=Phosphothreonine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	324	324	.	.	.	Note=Phosphoserine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphothreonine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphoserine;status=By similarity	
Q3ZBA8	UniProtKB	Modified residue	343	343	.	.	.	Note=Phosphothreonine;status=By similarity	
##sequence-region Q9UN36 1 371
Q9UN36	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q9UN36	UniProtKB	Chain	2	371	.	.	.	ID=PRO_0000159575;Note=Protein NDRG2	
Q9UN36	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
Q9UN36	UniProtKB	Modified residue	326	326	.	.	.	Note=Phosphoserine;status=By similarity	
Q9UN36	UniProtKB	Modified residue	328	328	.	.	.	Note=Phosphoserine	
Q9UN36	UniProtKB	Modified residue	330	330	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9UN36	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine	
Q9UN36	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9UN36	UniProtKB	Modified residue	335	335	.	.	.	Note=Phosphoserine;status=By similarity	
Q9UN36	UniProtKB	Modified residue	338	338	.	.	.	Note=Phosphoserine	
Q9UN36	UniProtKB	Modified residue	348	348	.	.	.	Note=Phosphothreonine	
Q9UN36	UniProtKB	Modified residue	350	350	.	.	.	Note=Phosphoserine;status=By similarity	
Q9UN36	UniProtKB	Modified residue	357	357	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9UN36	UniProtKB	Alternative sequence	26	39	.	.	.	ID=VSP_003417;Note=In isoform 2%2C isoform 4 and isoform 5.	
Q9UN36	UniProtKB	Alternative sequence	157	185	.	.	.	ID=VSP_019007;Note=In isoform 4.	
Q9UN36	UniProtKB	Alternative sequence	262	272	.	.	.	ID=VSP_003418;Note=In isoform 3.	
Q9UN36	UniProtKB	Alternative sequence	272	287	.	.	.	ID=VSP_019008;Note=In isoform 5.	
Q9UN36	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_050236;Dbxref=dbSNP:rs36007455	
Q9UN36	UniProtKB	Natural variant	48	48	.	.	.	ID=VAR_026572;Dbxref=dbSNP:rs11552412	
Q9UN36	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Decreased interaction with CTNNB1. Abolishes down-regulation of Wnt signaling.	
Q9UN36	UniProtKB	Sequence conflict	54	54	.	.	.	.	
Q9UN36	UniProtKB	Sequence conflict	123	123	.	.	.	.	
Q9UN36	UniProtKB	Sequence conflict	172	172	.	.	.	.	
Q9UN36	UniProtKB	Sequence conflict	250	250	.	.	.	.	
Q9UN36	UniProtKB	Sequence conflict	282	282	.	.	.	.	
Q9UN36	UniProtKB	Sequence conflict	296	296	.	.	.	.	
Q9UN36	UniProtKB	Sequence conflict	306	306	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	40	45	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	48	57	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	64	68	.	.	.	.	
Q9UN36	UniProtKB	Helix	75	78	.	.	.	.	
Q9UN36	UniProtKB	Helix	80	84	.	.	.	.	
Q9UN36	UniProtKB	Helix	86	92	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	97	101	.	.	.	.	
Q9UN36	UniProtKB	Helix	121	125	.	.	.	.	
Q9UN36	UniProtKB	Helix	128	135	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	140	145	.	.	.	.	
Q9UN36	UniProtKB	Helix	147	158	.	.	.	.	
Q9UN36	UniProtKB	Helix	160	162	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	163	170	.	.	.	.	
Q9UN36	UniProtKB	Helix	178	187	.	.	.	.	
Q9UN36	UniProtKB	Turn	188	190	.	.	.	.	
Q9UN36	UniProtKB	Helix	193	201	.	.	.	.	
Q9UN36	UniProtKB	Helix	204	209	.	.	.	.	
Q9UN36	UniProtKB	Helix	212	222	.	.	.	.	
Q9UN36	UniProtKB	Helix	227	238	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	249	251	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	257	262	.	.	.	.	
Q9UN36	UniProtKB	Helix	268	275	.	.	.	.	
Q9UN36	UniProtKB	Turn	280	282	.	.	.	.	
Q9UN36	UniProtKB	Beta strand	283	288	.	.	.	.	
Q9UN36	UniProtKB	Helix	295	298	.	.	.	.	
Q9UN36	UniProtKB	Helix	300	314	.	.	.	.	
##sequence-region Q4R4K0 1 357
Q4R4K0	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q4R4K0	UniProtKB	Chain	2	357	.	.	.	ID=PRO_0000238964;Note=Protein NDRG2	
Q4R4K0	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	312	312	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	314	314	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	316	316	.	.	.	Note=Phosphothreonine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	318	318	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	320	320	.	.	.	Note=Phosphothreonine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	324	324	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphothreonine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R4K0	UniProtKB	Modified residue	343	343	.	.	.	Note=Phosphothreonine;status=By similarity	
##sequence-region Q9QYG0 1 371
Q9QYG0	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q9QYG0	UniProtKB	Chain	2	371	.	.	.	ID=PRO_0000159576;Note=Protein NDRG2	
Q9QYG0	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q9QYG0	UniProtKB	Modified residue	326	326	.	.	.	Note=Phosphoserine	
Q9QYG0	UniProtKB	Modified residue	328	328	.	.	.	Note=Phosphoserine	
Q9QYG0	UniProtKB	Modified residue	330	330	.	.	.	Note=Phosphothreonine%3B by SGK1	
Q9QYG0	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine%3B by PKC/PRKCQ or SGK1	
Q9QYG0	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphothreonine	
Q9QYG0	UniProtKB	Modified residue	335	335	.	.	.	Note=Phosphoserine	
Q9QYG0	UniProtKB	Modified residue	338	338	.	.	.	Note=Phosphoserine	
Q9QYG0	UniProtKB	Modified residue	348	348	.	.	.	Note=Phosphothreonine%3B by PKB/AKT1 or SGK1	
Q9QYG0	UniProtKB	Modified residue	350	350	.	.	.	Note=Phosphoserine	
Q9QYG0	UniProtKB	Modified residue	357	357	.	.	.	Note=Phosphothreonine	
Q9QYG0	UniProtKB	Alternative sequence	26	39	.	.	.	ID=VSP_019009;Note=In isoform 2.	
Q9QYG0	UniProtKB	Sequence conflict	253	253	.	.	.	.	
Q9QYG0	UniProtKB	Sequence conflict	347	347	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	40	45	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	48	56	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	64	68	.	.	.	.	
Q9QYG0	UniProtKB	Helix	75	83	.	.	.	.	
Q9QYG0	UniProtKB	Helix	86	92	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	97	101	.	.	.	.	
Q9QYG0	UniProtKB	Turn	103	105	.	.	.	.	
Q9QYG0	UniProtKB	Helix	121	126	.	.	.	.	
Q9QYG0	UniProtKB	Helix	128	135	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	140	145	.	.	.	.	
Q9QYG0	UniProtKB	Helix	147	158	.	.	.	.	
Q9QYG0	UniProtKB	Helix	160	162	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	163	170	.	.	.	.	
Q9QYG0	UniProtKB	Helix	178	188	.	.	.	.	
Q9QYG0	UniProtKB	Helix	193	201	.	.	.	.	
Q9QYG0	UniProtKB	Helix	204	208	.	.	.	.	
Q9QYG0	UniProtKB	Helix	212	222	.	.	.	.	
Q9QYG0	UniProtKB	Helix	227	238	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	245	247	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	257	262	.	.	.	.	
Q9QYG0	UniProtKB	Helix	268	277	.	.	.	.	
Q9QYG0	UniProtKB	Helix	280	282	.	.	.	.	
Q9QYG0	UniProtKB	Beta strand	283	288	.	.	.	.	
Q9QYG0	UniProtKB	Helix	295	298	.	.	.	.	
Q9QYG0	UniProtKB	Helix	300	311	.	.	.	.	
##sequence-region A5A6K6 1 357
A5A6K6	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
A5A6K6	UniProtKB	Chain	2	357	.	.	.	ID=PRO_0000297549;Note=Protein NDRG2	
A5A6K6	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	312	312	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	314	314	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	316	316	.	.	.	Note=Phosphothreonine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	318	318	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	320	320	.	.	.	Note=Phosphothreonine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	321	321	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	324	324	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphothreonine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6K6	UniProtKB	Modified residue	343	343	.	.	.	Note=Phosphothreonine;status=By similarity	
##sequence-region Q5RBN6 1 371
Q5RBN6	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q5RBN6	UniProtKB	Chain	2	371	.	.	.	ID=PRO_0000238965;Note=Protein NDRG2	
Q5RBN6	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	326	326	.	.	.	Note=Phosphoserine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	328	328	.	.	.	Note=Phosphoserine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	330	330	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	335	335	.	.	.	Note=Phosphoserine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	338	338	.	.	.	Note=Phosphoserine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	348	348	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	350	350	.	.	.	Note=Phosphoserine;status=By similarity	
Q5RBN6	UniProtKB	Modified residue	357	357	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5RBN6	UniProtKB	Alternative sequence	26	39	.	.	.	ID=VSP_019031;Note=In isoform 2.	
Q5RBN6	UniProtKB	Sequence conflict	188	188	.	.	.	.	
Q5RBN6	UniProtKB	Sequence conflict	359	359	.	.	.	.	
##sequence-region Q8VBU2 1 371
Q8VBU2	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q8VBU2	UniProtKB	Chain	2	371	.	.	.	ID=PRO_0000238966;Note=Protein NDRG2	
Q8VBU2	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	326	326	.	.	.	Note=Phosphoserine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	328	328	.	.	.	Note=Phosphoserine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	330	330	.	.	.	Note=Phosphothreonine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine	
Q8VBU2	UniProtKB	Modified residue	334	334	.	.	.	Note=Phosphothreonine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	335	335	.	.	.	Note=Phosphoserine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	338	338	.	.	.	Note=Phosphoserine	
Q8VBU2	UniProtKB	Modified residue	348	348	.	.	.	Note=Phosphothreonine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	350	350	.	.	.	Note=Phosphoserine;status=By similarity	
Q8VBU2	UniProtKB	Modified residue	357	357	.	.	.	Note=Phosphothreonine;status=By similarity	
Q8VBU2	UniProtKB	Alternative sequence	26	39	.	.	.	ID=VSP_019032;Note=In isoform 2.	
Q8VBU2	UniProtKB	Sequence conflict	121	121	.	.	.	.	
Q8VBU2	UniProtKB	Sequence conflict	121	121	.	.	.	.	
##sequence-region P21359 1 2839
P21359	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
P21359	UniProtKB	Chain	2	2839	.	.	.	ID=PRO_0000010773;Note=Neurofibromin	
P21359	UniProtKB	Chain	2	1305	.	.	.	ID=PRO_0000010774;Note=Neurofibromin truncated	
P21359	UniProtKB	Domain	1235	1451	.	.	.	Note=Ras-GAP	
P21359	UniProtKB	Domain	1580	1738	.	.	.	Note=CRAL-TRIO	
P21359	UniProtKB	Compositional bias	1352	1355	.	.	.	Note=Poly-Ser	
P21359	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;status=By similarity	
P21359	UniProtKB	Modified residue	864	864	.	.	.	Note=Phosphoserine	
P21359	UniProtKB	Modified residue	876	876	.	.	.	Note=Phosphoserine	
P21359	UniProtKB	Modified residue	2188	2188	.	.	.	Note=Phosphoserine	
P21359	UniProtKB	Modified residue	2515	2515	.	.	.	Note=Phosphoserine	
P21359	UniProtKB	Modified residue	2521	2521	.	.	.	Note=Phosphoserine	
P21359	UniProtKB	Modified residue	2543	2543	.	.	.	Note=Phosphoserine	
P21359	UniProtKB	Modified residue	2817	2817	.	.	.	Note=Phosphoserine	
P21359	UniProtKB	Alternative sequence	548	551	.	.	.	ID=VSP_001629;Note=In isoform 3.	
P21359	UniProtKB	Alternative sequence	552	2839	.	.	.	ID=VSP_001630;Note=In isoform 3.	
P21359	UniProtKB	Alternative sequence	574	593	.	.	.	ID=VSP_043467;Note=In isoform 5.	
P21359	UniProtKB	Alternative sequence	594	2839	.	.	.	ID=VSP_043468;Note=In isoform 5.	
P21359	UniProtKB	Alternative sequence	1371	1391	.	.	.	ID=VSP_001628;Note=In isoform 1.	
P21359	UniProtKB	Alternative sequence	1591	1598	.	.	.	ID=VSP_001631;Note=In isoform 4.	
P21359	UniProtKB	Alternative sequence	1599	2839	.	.	.	ID=VSP_001632;Note=In isoform 4.	
P21359	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_032459;Dbxref=dbSNP:rs199474725;Note=In NF1.	
P21359	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_017550;Dbxref=dbSNP:rs199474726;Note=In mismatch repair deficient cancer cells.	
P21359	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_022254	
P21359	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_049135;Dbxref=dbSNP:rs4795581	
P21359	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_021730;Dbxref=dbSNP:rs199474729;Note=In NF1.	
P21359	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_017551;Dbxref=dbSNP:rs199474728;Note=In NF1.	
P21359	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_010989;Dbxref=dbSNP:rs199474731;Note=In NF1.	
P21359	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_032460;Dbxref=dbSNP:rs199474734;Note=In NF1.	
P21359	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_021731;Dbxref=dbSNP:rs199474744;Note=In NF1.	
P21359	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_065888;Dbxref=dbSNP:rs199474752;Note=In NF1.	
P21359	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_017552;Dbxref=dbSNP:rs112306990;Note=Found in mismatch repair deficient cancer cells%3B also found in a cutaneous neurofibroma from a patient with neurofibromatosis%3B somatic mutation.	
P21359	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_032461;Note=In NF1%3B reduced splicing enhancement.	
P21359	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_032462;Dbxref=dbSNP:rs199474753;Note=In NFNS.	
P21359	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_021732;Dbxref=dbSNP:rs199474756;Note=In NF1.	
P21359	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_032463;Dbxref=dbSNP:rs199474735;Note=In NF1.	
P21359	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_067201;Dbxref=dbSNP:rs199474767;Note=In a cutaneous neurofibroma from a patient with neurofibromatosis%3B somatic mutation.	
P21359	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_032464;Dbxref=dbSNP:rs199474736;Note=In NF1.	
P21359	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_010990;Dbxref=dbSNP:rs199474773;Note=In NF1.	
P21359	UniProtKB	Natural variant	357	357	.	.	.	ID=VAR_021733;Dbxref=dbSNP:rs137854563;Note=In NF1.	
P21359	UniProtKB	Natural variant	393	393	.	.	.	ID=VAR_067202;Dbxref=dbSNP:rs199474768;Note=In a cutaneous neurofibroma from a patient with neurofibromatosis%3B somatic mutation.	
P21359	UniProtKB	Natural variant	393	393	.	.	.	ID=VAR_067203;Dbxref=dbSNP:rs199474769;Note=In a cutaneous neurofibroma from a patient with neurofibromatosis%3B somatic mutation.	
P21359	UniProtKB	Natural variant	489	489	.	.	.	ID=VAR_032465;Dbxref=dbSNP:rs137854557;Note=In NF1.	
P21359	UniProtKB	Natural variant	491	491	.	.	.	ID=VAR_021734;Dbxref=dbSNP:rs199474757;Note=In NF1.	
P21359	UniProtKB	Natural variant	508	508	.	.	.	ID=VAR_010991;Dbxref=dbSNP:rs137854558;Note=In NF1.	
P21359	UniProtKB	Natural variant	519	519	.	.	.	ID=VAR_067204;Dbxref=dbSNP:rs199474770;Note=In a cutaneous neurofibroma from a patient with neurofibromatosis%3B somatic mutation.	
P21359	UniProtKB	Natural variant	532	532	.	.	.	ID=VAR_032466;Dbxref=dbSNP:rs199474737;Note=In NF1.	
P21359	UniProtKB	Natural variant	549	549	.	.	.	ID=VAR_021735;Dbxref=dbSNP:rs199474758;Note=In NF1.	
P21359	UniProtKB	Natural variant	574	574	.	.	.	ID=VAR_032467;Note=In NF1.	
P21359	UniProtKB	Natural variant	578	578	.	.	.	ID=VAR_021736;Dbxref=dbSNP:rs199474774;Note=In NF1.	
P21359	UniProtKB	Natural variant	581	581	.	.	.	ID=VAR_021737;Dbxref=dbSNP:rs199474759;Note=In NF1.	
P21359	UniProtKB	Natural variant	583	583	.	.	.	ID=VAR_021738;Dbxref=dbSNP:rs199474760;Note=In NF1.	
P21359	UniProtKB	Natural variant	604	604	.	.	.	ID=VAR_017553;Dbxref=dbSNP:rs142712751;Note=In NF1.	
P21359	UniProtKB	Natural variant	629	629	.	.	.	ID=VAR_002653;Dbxref=dbSNP:rs199474738;Note=In NF1%3B affects splicing by creating a novel splice acceptor site.	
P21359	UniProtKB	Natural variant	665	665	.	.	.	ID=VAR_021739;Dbxref=dbSNP:rs145891889;Note=In NF1%3B unknown pathological significance.	
P21359	UniProtKB	Natural variant	678	678	.	.	.	ID=VAR_022255;Dbxref=dbSNP:rs17881753	
P21359	UniProtKB	Natural variant	695	695	.	.	.	ID=VAR_021740;Dbxref=dbSNP:rs199474761;Note=In NF1.	
P21359	UniProtKB	Natural variant	712	712	.	.	.	ID=VAR_017554;Dbxref=dbSNP:rs199474727;Note=In mismatch repair deficient cancer cells.	
P21359	UniProtKB	Natural variant	763	763	.	.	.	ID=VAR_021741;Dbxref=dbSNP:rs199474762;Note=In NF1.	
P21359	UniProtKB	Natural variant	765	765	.	.	.	ID=VAR_021742;Dbxref=dbSNP:rs199474777	
P21359	UniProtKB	Natural variant	776	776	.	.	.	ID=VAR_067205;Dbxref=dbSNP:rs199474771;Note=In a cutaneous neurofibroma from a patient with neurofibromatosis%3B somatic mutation.	
P21359	UniProtKB	Natural variant	777	777	.	.	.	ID=VAR_021743;Dbxref=dbSNP:rs199474745;Note=In NF1.	
P21359	UniProtKB	Natural variant	780	780	.	.	.	ID=VAR_021744;Dbxref=dbSNP:rs199474746;Note=In NF1.	
P21359	UniProtKB	Natural variant	781	781	.	.	.	ID=VAR_021745;Dbxref=dbSNP:rs199474763;Note=In NF1.	
P21359	UniProtKB	Natural variant	784	784	.	.	.	ID=VAR_021746;Dbxref=dbSNP:rs199474778;Note=In NF1.	
P21359	UniProtKB	Natural variant	784	784	.	.	.	ID=VAR_021747;Dbxref=dbSNP:rs199474730;Note=In NF1.	
P21359	UniProtKB	Natural variant	844	844	.	.	.	ID=VAR_010992;Dbxref=dbSNP:rs199474785;Note=In NF1.	
P21359	UniProtKB	Natural variant	844	844	.	.	.	ID=VAR_032468;Dbxref=dbSNP:rs137854566;Note=In NF1.	
P21359	UniProtKB	Natural variant	844	844	.	.	.	ID=VAR_002654;Dbxref=dbSNP:rs137854566;Note=In NF1%3B sporadic.	
P21359	UniProtKB	Natural variant	847	847	.	.	.	ID=VAR_021748;Dbxref=dbSNP:rs199474747;Note=In NF1.	
P21359	UniProtKB	Natural variant	848	848	.	.	.	ID=VAR_021749;Dbxref=dbSNP:rs199474748;Note=In NF1.	
P21359	UniProtKB	Natural variant	873	873	.	.	.	ID=VAR_032469;Dbxref=dbSNP:rs199474739	
P21359	UniProtKB	Natural variant	898	898	.	.	.	ID=VAR_002655;Dbxref=dbSNP:rs199474786;Note=In NF1%3B sporadic.	
P21359	UniProtKB	Natural variant	920	920	.	.	.	ID=VAR_021750;Dbxref=dbSNP:rs199474775;Note=In NF1%3B patient with cafe-au-lait spots%3B may be a distinct form of NF1.	
P21359	UniProtKB	Natural variant	968	968	.	.	.	ID=VAR_021751;Dbxref=dbSNP:rs199474749;Note=In NF1.	
P21359	UniProtKB	Natural variant	991	991	.	.	.	ID=VAR_002656;Note=In NF1.	
P21359	UniProtKB	Natural variant	1035	1035	.	.	.	ID=VAR_002657;Dbxref=dbSNP:rs137854553;Note=In NF1.	
P21359	UniProtKB	Natural variant	1073	1073	.	.	.	ID=VAR_032470;Dbxref=dbSNP:rs199474740;Note=In NF1.	
P21359	UniProtKB	Natural variant	1147	1147	.	.	.	ID=VAR_021752;Dbxref=dbSNP:rs199474779;Note=In NF1.	
P21359	UniProtKB	Natural variant	1156	1156	.	.	.	ID=VAR_021753;Dbxref=dbSNP:rs199474764;Note=In NF1.	
P21359	UniProtKB	Natural variant	1166	1166	.	.	.	ID=VAR_010993;Dbxref=dbSNP:rs199474787;Note=In NF1.	
P21359	UniProtKB	Natural variant	1187	1187	.	.	.	ID=VAR_035543;Note=In a colorectal cancer sample%3B somatic mutation.	
P21359	UniProtKB	Natural variant	1193	1193	.	.	.	ID=VAR_021754;Dbxref=dbSNP:rs199474780;Note=In NF1.	
P21359	UniProtKB	Natural variant	1196	1196	.	.	.	ID=VAR_032471;Dbxref=dbSNP:rs199474741;Note=In NF1.	
P21359	UniProtKB	Natural variant	1204	1204	.	.	.	ID=VAR_021755;Dbxref=dbSNP:rs199474732;Note=In NF1.	
P21359	UniProtKB	Natural variant	1204	1204	.	.	.	ID=VAR_010994;Dbxref=dbSNP:rs199474732;Note=In NF1.	
P21359	UniProtKB	Natural variant	1243	1243	.	.	.	ID=VAR_032472;Dbxref=dbSNP:rs137854564;Note=In NF1%3B with neurofibromatous neuropathy.	
P21359	UniProtKB	Natural variant	1250	1250	.	.	.	ID=VAR_021756;Dbxref=dbSNP:rs199474765;Note=In NF1.	
P21359	UniProtKB	Natural variant	1276	1276	.	.	.	ID=VAR_032473;Dbxref=dbSNP:rs199474742;Note=In NF1.	
P21359	UniProtKB	Natural variant	1276	1276	.	.	.	ID=VAR_010995;Dbxref=dbSNP:rs137854556;Note=In NF1%3B complete loss of GAP activity.	
P21359	UniProtKB	Natural variant	1276	1276	.	.	.	ID=VAR_017555;Dbxref=dbSNP:rs137854556;Note=In NF1 and mismatch repair deficient cancer cells.	
P21359	UniProtKB	Natural variant	1411	1411	.	.	.	ID=VAR_065236;Dbxref=dbSNP:rs199474789;Note=In NFNS.	
P21359	UniProtKB	Natural variant	1412	1412	.	.	.	ID=VAR_010996;Dbxref=dbSNP:rs137854554;Note=In NF1%3B significant reduction of GAP activity.	
P21359	UniProtKB	Natural variant	1422	1422	.	.	.	ID=VAR_022256;Dbxref=dbSNP:rs17884349	
P21359	UniProtKB	Natural variant	1430	1430	.	.	.	ID=VAR_032474;Note=In NF1.	
P21359	UniProtKB	Natural variant	1440	1440	.	.	.	ID=VAR_010997;Dbxref=dbSNP:rs199474790;Note=In NF1.	
P21359	UniProtKB	Natural variant	1440	1440	.	.	.	ID=VAR_002658;Dbxref=dbSNP:rs199474788;Note=In NF1.	
P21359	UniProtKB	Natural variant	1444	1444	.	.	.	ID=VAR_002659;Dbxref=dbSNP:rs137854550;Note=In NF1 and NFNS%3B significant reduction of intrinsic GAP activity.	
P21359	UniProtKB	Natural variant	1444	1444	.	.	.	ID=VAR_021757;Dbxref=dbSNP:rs199474750;Note=In NF1.	
P21359	UniProtKB	Natural variant	1444	1444	.	.	.	ID=VAR_021758;Dbxref=dbSNP:rs199474781;Note=In NF1.	
P21359	UniProtKB	Natural variant	1446	1446	.	.	.	ID=VAR_008129;Dbxref=dbSNP:rs199474733;Note=In NF1.	
P21359	UniProtKB	Natural variant	1451	1451	.	.	.	ID=VAR_032475;Dbxref=dbSNP:rs199474754;Note=In NFNS.	
P21359	UniProtKB	Natural variant	1453	1453	.	.	.	ID=VAR_032476;Dbxref=dbSNP:rs199474755;Note=In NFNS.	
P21359	UniProtKB	Natural variant	1459	1459	.	.	.	ID=VAR_032477;Note=In NFNS.	
P21359	UniProtKB	Natural variant	1484	1484	.	.	.	ID=VAR_067206;Dbxref=dbSNP:rs199474772;Note=In a cutaneous neurofibroma from a patient with neurofibromatosis%3B somatic mutation.	
P21359	UniProtKB	Natural variant	1489	1489	.	.	.	ID=VAR_010998;Dbxref=dbSNP:rs199474743;Note=In NF1.	
P21359	UniProtKB	Natural variant	1605	1605	.	.	.	ID=VAR_021759;Dbxref=dbSNP:rs199474766;Note=In NF1.	
P21359	UniProtKB	Natural variant	1611	1611	.	.	.	ID=VAR_002660;Note=In NF1.	
P21359	UniProtKB	Natural variant	1733	1733	.	.	.	ID=VAR_002661;Note=In NF1.	
P21359	UniProtKB	Natural variant	1785	1785	.	.	.	ID=VAR_021760;Dbxref=dbSNP:rs199474782;Note=In NF1.	
P21359	UniProtKB	Natural variant	1951	1951	.	.	.	ID=VAR_035544;Note=In a colorectal cancer sample%3B somatic mutation.	
P21359	UniProtKB	Natural variant	1952	1952	.	.	.	ID=VAR_002662;Dbxref=dbSNP:rs199474791;Note=In NF1.	
P21359	UniProtKB	Natural variant	1953	1953	.	.	.	ID=VAR_002663;Dbxref=dbSNP:rs199474792;Note=In NF1.	
P21359	UniProtKB	Natural variant	1953	1953	.	.	.	ID=VAR_021761;Note=In NF1.	
P21359	UniProtKB	Natural variant	2001	2001	.	.	.	ID=VAR_021762;Dbxref=dbSNP:rs199474751;Note=In NF1.	
P21359	UniProtKB	Natural variant	2012	2012	.	.	.	ID=VAR_021763;Dbxref=dbSNP:rs199474783;Note=In NF1.	
P21359	UniProtKB	Natural variant	2088	2088	.	.	.	ID=VAR_017669;Dbxref=dbSNP:rs137854561;Note=In FSNF%3B null mutation%3B 50%25 reduction of protein level%3B no cafe-au-lait macules.	
P21359	UniProtKB	Natural variant	2164	2164	.	.	.	ID=VAR_002664;Dbxref=dbSNP:rs137854551;Note=In NF1.	
P21359	UniProtKB	Natural variant	2192	2192	.	.	.	ID=VAR_002665;Note=In NF1.	
P21359	UniProtKB	Natural variant	2221	2221	.	.	.	ID=VAR_021764;Dbxref=dbSNP:rs199474776;Note=In NF1.	
P21359	UniProtKB	Natural variant	2357	2357	.	.	.	ID=VAR_021765;Dbxref=dbSNP:rs199474784;Note=In NF1.	
P21359	UniProtKB	Natural variant	2387	2388	.	.	.	ID=VAR_002666;Note=In NF1.	
P21359	UniProtKB	Natural variant	2507	2507	.	.	.	ID=VAR_021766;Dbxref=dbSNP:rs149055633;Note=In NF1.	
P21359	UniProtKB	Natural variant	2511	2511	.	.	.	ID=VAR_022257;Dbxref=dbSNP:rs2230850	
P21359	UniProtKB	Natural variant	2631	2631	.	.	.	ID=VAR_002667;Dbxref=dbSNP:rs199474793;Note=In NF1.	
P21359	UniProtKB	Natural variant	2745	2745	.	.	.	ID=VAR_035545;Note=In a breast cancer sample%3B somatic mutation.	
P21359	UniProtKB	Sequence conflict	496	496	.	.	.	.	
P21359	UniProtKB	Sequence conflict	496	496	.	.	.	.	
P21359	UniProtKB	Sequence conflict	1576	1576	.	.	.	.	
P21359	UniProtKB	Sequence conflict	1576	1576	.	.	.	.	
P21359	UniProtKB	Sequence conflict	2792	2792	.	.	.	.	
P21359	UniProtKB	Sequence conflict	2792	2792	.	.	.	.	
P21359	UniProtKB	Helix	1208	1216	.	.	.	.	
P21359	UniProtKB	Helix	1224	1228	.	.	.	.	
P21359	UniProtKB	Helix	1233	1235	.	.	.	.	
P21359	UniProtKB	Helix	1236	1248	.	.	.	.	
P21359	UniProtKB	Turn	1249	1251	.	.	.	.	
P21359	UniProtKB	Helix	1253	1263	.	.	.	.	
P21359	UniProtKB	Beta strand	1266	1270	.	.	.	.	
P21359	UniProtKB	Helix	1282	1293	.	.	.	.	
P21359	UniProtKB	Helix	1296	1299	.	.	.	.	
P21359	UniProtKB	Beta strand	1300	1302	.	.	.	.	
P21359	UniProtKB	Turn	1335	1337	.	.	.	.	
P21359	UniProtKB	Turn	1339	1342	.	.	.	.	
P21359	UniProtKB	Helix	1343	1352	.	.	.	.	
P21359	UniProtKB	Turn	1353	1356	.	.	.	.	
P21359	UniProtKB	Helix	1361	1370	.	.	.	.	
P21359	UniProtKB	Turn	1394	1396	.	.	.	.	
P21359	UniProtKB	Helix	1402	1412	.	.	.	.	
P21359	UniProtKB	Helix	1414	1419	.	.	.	.	
P21359	UniProtKB	Helix	1434	1440	.	.	.	.	
P21359	UniProtKB	Helix	1442	1451	.	.	.	.	
P21359	UniProtKB	Helix	1462	1464	.	.	.	.	
P21359	UniProtKB	Helix	1465	1470	.	.	.	.	
P21359	UniProtKB	Helix	1472	1481	.	.	.	.	
P21359	UniProtKB	Helix	1510	1514	.	.	.	.	
P21359	UniProtKB	Helix	1517	1520	.	.	.	.	
P21359	UniProtKB	Helix	1535	1544	.	.	.	.	
P21359	UniProtKB	Helix	1569	1578	.	.	.	.	
P21359	UniProtKB	Turn	1582	1586	.	.	.	.	
P21359	UniProtKB	Helix	1587	1590	.	.	.	.	
P21359	UniProtKB	Beta strand	1592	1598	.	.	.	.	
P21359	UniProtKB	Beta strand	1604	1609	.	.	.	.	
P21359	UniProtKB	Helix	1610	1612	.	.	.	.	
P21359	UniProtKB	Turn	1615	1617	.	.	.	.	
P21359	UniProtKB	Helix	1620	1631	.	.	.	.	
P21359	UniProtKB	Turn	1632	1636	.	.	.	.	
P21359	UniProtKB	Beta strand	1639	1644	.	.	.	.	
P21359	UniProtKB	Helix	1650	1652	.	.	.	.	
P21359	UniProtKB	Helix	1656	1661	.	.	.	.	
P21359	UniProtKB	Turn	1662	1664	.	.	.	.	
P21359	UniProtKB	Helix	1668	1672	.	.	.	.	
P21359	UniProtKB	Beta strand	1674	1681	.	.	.	.	
P21359	UniProtKB	Helix	1684	1692	.	.	.	.	
P21359	UniProtKB	Helix	1694	1697	.	.	.	.	
P21359	UniProtKB	Turn	1698	1702	.	.	.	.	
P21359	UniProtKB	Beta strand	1706	1711	.	.	.	.	
P21359	UniProtKB	Helix	1714	1717	.	.	.	.	
P21359	UniProtKB	Helix	1721	1723	.	.	.	.	
P21359	UniProtKB	Helix	1728	1732	.	.	.	.	
P21359	UniProtKB	Beta strand	1738	1749	.	.	.	.	
P21359	UniProtKB	Beta strand	1751	1757	.	.	.	.	
P21359	UniProtKB	Beta strand	1759	1767	.	.	.	.	
P21359	UniProtKB	Beta strand	1770	1772	.	.	.	.	
P21359	UniProtKB	Beta strand	1775	1777	.	.	.	.	
P21359	UniProtKB	Beta strand	1780	1784	.	.	.	.	
P21359	UniProtKB	Helix	1785	1787	.	.	.	.	
P21359	UniProtKB	Beta strand	1788	1795	.	.	.	.	
P21359	UniProtKB	Beta strand	1798	1803	.	.	.	.	
P21359	UniProtKB	Beta strand	1810	1813	.	.	.	.	
P21359	UniProtKB	Helix	1817	1833	.	.	.	.	
##sequence-region Q99801 1 234
Q99801	UniProtKB	Chain	1	234	.	.	.	ID=PRO_0000048945;Note=Homeobox protein Nkx-3.1	
Q99801	UniProtKB	DNA binding	124	183	.	.	.	Note=Homeobox	
Q99801	UniProtKB	Alternative sequence	8	56	.	.	.	ID=VSP_002230;Note=In isoform 2.	
Q99801	UniProtKB	Alternative sequence	13	87	.	.	.	ID=VSP_002231;Note=In isoform 3.	
Q99801	UniProtKB	Alternative sequence	15	83	.	.	.	ID=VSP_002232;Note=In isoform 4.	
Q99801	UniProtKB	Alternative sequence	40	83	.	.	.	ID=VSP_002233;Note=In isoform 5.	
Q99801	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_011612;Dbxref=dbSNP:rs2228013	
Q99801	UniProtKB	Sequence conflict	8	8	.	.	.	.	
Q99801	UniProtKB	Sequence conflict	85	85	.	.	.	.	
Q99801	UniProtKB	Sequence conflict	135	135	.	.	.	.	
Q99801	UniProtKB	Sequence conflict	196	196	.	.	.	.	
Q99801	UniProtKB	Sequence conflict	224	224	.	.	.	.	
Q99801	UniProtKB	Sequence conflict	234	234	.	.	.	.	
Q99801	UniProtKB	Helix	133	145	.	.	.	.	
Q99801	UniProtKB	Helix	151	160	.	.	.	.	
Q99801	UniProtKB	Helix	165	178	.	.	.	.	
Q99801	UniProtKB	Beta strand	182	185	.	.	.	.	
##sequence-region P97436 1 237
P97436	UniProtKB	Chain	1	237	.	.	.	ID=PRO_0000048946;Note=Homeobox protein Nkx-3.1	
P97436	UniProtKB	DNA binding	125	184	.	.	.	Note=Homeobox	
##sequence-region Q5E9U9 1 380
Q5E9U9	UniProtKB	Chain	1	380	.	.	.	ID=PRO_0000245018;Note=Nitrogen permease regulator 2-like protein	
Q5E9U9	UniProtKB	Region	1	133	.	.	.	Note=Interaction with PDPK1;status=By similarity	
Q5E9U9	UniProtKB	Sequence conflict	226	226	.	.	.	.	
##sequence-region Q8WTW4 1 380
Q8WTW4	UniProtKB	Chain	1	380	.	.	.	ID=PRO_0000213319;Note=Nitrogen permease regulator 2-like protein	
Q8WTW4	UniProtKB	Region	1	133	.	.	.	Note=Interaction with PDPK1	
Q8WTW4	UniProtKB	Alternative sequence	1	120	.	.	.	ID=VSP_010329;Note=In isoform 2.	
Q8WTW4	UniProtKB	Alternative sequence	312	323	.	.	.	ID=VSP_010330;Note=In isoform 2.	
Q8WTW4	UniProtKB	Alternative sequence	324	380	.	.	.	ID=VSP_010331;Note=In isoform 2.	
Q8WTW4	UniProtKB	Sequence conflict	17	17	.	.	.	.	
##sequence-region Q9WUE4 1 380
Q9WUE4	UniProtKB	Chain	1	380	.	.	.	ID=PRO_0000213320;Note=Nitrogen permease regulator 2-like protein	
Q9WUE4	UniProtKB	Region	1	133	.	.	.	Note=Interaction with PDPK1;status=By similarity	
##sequence-region O46685 1 361
O46685	UniProtKB	Chain	1	361	.	.	.	ID=PRO_0000383597;Note=Ovarian cancer G-protein coupled receptor 1	
O46685	UniProtKB	Topological domain	1	22	.	.	.	Note=Extracellular;status=Potential	
O46685	UniProtKB	Transmembrane	23	43	.	.	.	Note=Helical%3B Name%3D1%3B;status=Potential	
O46685	UniProtKB	Topological domain	44	57	.	.	.	Note=Cytoplasmic;status=Potential	
O46685	UniProtKB	Transmembrane	58	78	.	.	.	Note=Helical%3B Name%3D2%3B;status=Potential	
O46685	UniProtKB	Topological domain	79	96	.	.	.	Note=Extracellular;status=Potential	
O46685	UniProtKB	Transmembrane	97	117	.	.	.	Note=Helical%3B Name%3D3%3B;status=Potential	
O46685	UniProtKB	Topological domain	118	137	.	.	.	Note=Cytoplasmic;status=Potential	
O46685	UniProtKB	Transmembrane	138	158	.	.	.	Note=Helical%3B Name%3D4%3B;status=Potential	
O46685	UniProtKB	Topological domain	159	183	.	.	.	Note=Extracellular;status=Potential	
O46685	UniProtKB	Transmembrane	184	204	.	.	.	Note=Helical%3B Name%3D5%3B;status=Potential	
O46685	UniProtKB	Topological domain	205	229	.	.	.	Note=Cytoplasmic;status=Potential	
O46685	UniProtKB	Transmembrane	230	250	.	.	.	Note=Helical%3B Name%3D6%3B;status=Potential	
O46685	UniProtKB	Topological domain	251	269	.	.	.	Note=Extracellular;status=Potential	
O46685	UniProtKB	Transmembrane	270	290	.	.	.	Note=Helical%3B Name%3D7%3B;status=Potential	
O46685	UniProtKB	Topological domain	291	361	.	.	.	Note=Cytoplasmic;status=Potential	
O46685	UniProtKB	Glycosylation	3	3	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O46685	UniProtKB	Glycosylation	8	8	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O46685	UniProtKB	Disulfide bond	94	172	.	.	.	status=By similarity	
##sequence-region Q15743 1 365
Q15743	UniProtKB	Chain	1	365	.	.	.	ID=PRO_0000070113;Note=Ovarian cancer G-protein coupled receptor 1	
Q15743	UniProtKB	Topological domain	1	21	.	.	.	Note=Extracellular;status=Potential	
Q15743	UniProtKB	Transmembrane	22	46	.	.	.	Note=Helical%3B Name%3D1%3B;status=Potential	
Q15743	UniProtKB	Topological domain	47	58	.	.	.	Note=Cytoplasmic;status=Potential	
Q15743	UniProtKB	Transmembrane	59	80	.	.	.	Note=Helical%3B Name%3D2%3B;status=Potential	
Q15743	UniProtKB	Topological domain	81	95	.	.	.	Note=Extracellular;status=Potential	
Q15743	UniProtKB	Transmembrane	96	117	.	.	.	Note=Helical%3B Name%3D3%3B;status=Potential	
Q15743	UniProtKB	Topological domain	118	136	.	.	.	Note=Cytoplasmic;status=Potential	
Q15743	UniProtKB	Transmembrane	137	158	.	.	.	Note=Helical%3B Name%3D4%3B;status=Potential	
Q15743	UniProtKB	Topological domain	159	183	.	.	.	Note=Extracellular;status=Potential	
Q15743	UniProtKB	Transmembrane	184	205	.	.	.	Note=Helical%3B Name%3D5%3B;status=Potential	
Q15743	UniProtKB	Topological domain	206	228	.	.	.	Note=Cytoplasmic;status=Potential	
Q15743	UniProtKB	Transmembrane	229	249	.	.	.	Note=Helical%3B Name%3D6%3B;status=Potential	
Q15743	UniProtKB	Topological domain	250	263	.	.	.	Note=Extracellular;status=Potential	
Q15743	UniProtKB	Transmembrane	264	284	.	.	.	Note=Helical%3B Name%3D7%3B;status=Potential	
Q15743	UniProtKB	Topological domain	285	365	.	.	.	Note=Cytoplasmic;status=Potential	
Q15743	UniProtKB	Glycosylation	3	3	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q15743	UniProtKB	Glycosylation	8	8	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q15743	UniProtKB	Disulfide bond	94	172	.	.	.	status=By similarity	
Q15743	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_064716;Note=Found in a renal cell carcinoma case%3B somatic mutation.	
Q15743	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_058714;Dbxref=dbSNP:rs2230339	
Q15743	UniProtKB	Mutagenesis	17	17	.	.	.	Note=Failed to stimulate IP formation at pH 6.8%2C activity is restored at more acid pH.	
Q15743	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Failed to stimulate IP formation at pH 6.8%2C activity is restored at more acid pH.	
Q15743	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Failed to stimulate IP formation at pH 6.8%2C activity is restored at more acid pH.	
Q15743	UniProtKB	Mutagenesis	89	89	.	.	.	Note=No effect on pH-sensing activity.	
Q15743	UniProtKB	Mutagenesis	159	159	.	.	.	Note=No effect on pH-sensing activity.	
Q15743	UniProtKB	Mutagenesis	169	169	.	.	.	Note=Failed to stimulate IP formation at pH 6.8%2C activity is restored at more acid pH.	
Q15743	UniProtKB	Mutagenesis	175	175	.	.	.	Note=No effect on pH-sensing activity.	
Q15743	UniProtKB	Mutagenesis	245	245	.	.	.	Note=Severe loss pH-sensing activity.	
Q15743	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Failed to stimulate IP formation at pH 6.8%2C activity is restored at more acid pH.	
Q15743	UniProtKB	Sequence conflict	140	142	.	.	.	.	
##sequence-region Q8BFQ3 1 365
Q8BFQ3	UniProtKB	Chain	1	365	.	.	.	ID=PRO_0000070114;Note=Ovarian cancer G-protein coupled receptor 1	
Q8BFQ3	UniProtKB	Topological domain	1	21	.	.	.	Note=Extracellular;status=Potential	
Q8BFQ3	UniProtKB	Transmembrane	22	46	.	.	.	Note=Helical%3B Name%3D1%3B;status=Potential	
Q8BFQ3	UniProtKB	Topological domain	47	58	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BFQ3	UniProtKB	Transmembrane	59	80	.	.	.	Note=Helical%3B Name%3D2%3B;status=Potential	
Q8BFQ3	UniProtKB	Topological domain	81	95	.	.	.	Note=Extracellular;status=Potential	
Q8BFQ3	UniProtKB	Transmembrane	96	117	.	.	.	Note=Helical%3B Name%3D3%3B;status=Potential	
Q8BFQ3	UniProtKB	Topological domain	118	136	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BFQ3	UniProtKB	Transmembrane	137	158	.	.	.	Note=Helical%3B Name%3D4%3B;status=Potential	
Q8BFQ3	UniProtKB	Topological domain	159	183	.	.	.	Note=Extracellular;status=Potential	
Q8BFQ3	UniProtKB	Transmembrane	184	205	.	.	.	Note=Helical%3B Name%3D5%3B;status=Potential	
Q8BFQ3	UniProtKB	Topological domain	206	228	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BFQ3	UniProtKB	Transmembrane	229	249	.	.	.	Note=Helical%3B Name%3D6%3B;status=Potential	
Q8BFQ3	UniProtKB	Topological domain	250	263	.	.	.	Note=Extracellular;status=Potential	
Q8BFQ3	UniProtKB	Transmembrane	264	284	.	.	.	Note=Helical%3B Name%3D7%3B;status=Potential	
Q8BFQ3	UniProtKB	Topological domain	285	365	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BFQ3	UniProtKB	Glycosylation	3	3	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8BFQ3	UniProtKB	Glycosylation	8	8	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8BFQ3	UniProtKB	Disulfide bond	94	172	.	.	.	status=By similarity	
##sequence-region Q9W678 1 369
Q9W678	UniProtKB	Chain	1	369	.	.	.	ID=PRO_0000185717;Note=Cellular tumor antigen p53	
Q9W678	UniProtKB	DNA binding	66	256	.	.	.	status=By similarity	
Q9W678	UniProtKB	Region	1	28	.	.	.	Note=Transcription activation (acidic)	
Q9W678	UniProtKB	Region	237	244	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9W678	UniProtKB	Region	298	329	.	.	.	Note=Oligomerization	
Q9W678	UniProtKB	Region	342	365	.	.	.	Note=Basic (repression of DNA-binding)	
Q9W678	UniProtKB	Motif	270	289	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q9W678	UniProtKB	Motif	312	323	.	.	.	Note=Nuclear export signal;status=By similarity	
Q9W678	UniProtKB	Metal binding	140	140	.	.	.	Note=Zinc;status=By similarity	
Q9W678	UniProtKB	Metal binding	143	143	.	.	.	Note=Zinc;status=By similarity	
Q9W678	UniProtKB	Metal binding	202	202	.	.	.	Note=Zinc;status=By similarity	
Q9W678	UniProtKB	Metal binding	206	206	.	.	.	Note=Zinc;status=By similarity	
Q9W678	UniProtKB	Site	84	84	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region P67938 1 386
P67938	UniProtKB	Chain	1	386	.	.	.	ID=PRO_0000185693;Note=Cellular tumor antigen p53	
P67938	UniProtKB	DNA binding	94	285	.	.	.	status=By similarity	
P67938	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P67938	UniProtKB	Region	63	102	.	.	.	Note=Interaction with WWOX;status=By similarity	
P67938	UniProtKB	Region	92	363	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P67938	UniProtKB	Region	92	293	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P67938	UniProtKB	Region	105	229	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P67938	UniProtKB	Region	108	285	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P67938	UniProtKB	Region	249	287	.	.	.	Note=Interaction with E4F1;status=By similarity	
P67938	UniProtKB	Region	266	273	.	.	.	Note=Interaction with DNA;status=By similarity	
P67938	UniProtKB	Region	312	353	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P67938	UniProtKB	Region	318	349	.	.	.	Note=Oligomerization	
P67938	UniProtKB	Region	352	356	.	.	.	Note=Interaction with USP7;status=By similarity	
P67938	UniProtKB	Region	361	380	.	.	.	Note=Basic (repression of DNA-binding)	
P67938	UniProtKB	Motif	298	314	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P67938	UniProtKB	Motif	332	343	.	.	.	Note=Nuclear export signal;status=By similarity	
P67938	UniProtKB	Motif	363	365	.	.	.	Note=[KR]-[STA]-K motif	
P67938	UniProtKB	Metal binding	168	168	.	.	.	Note=Zinc;status=By similarity	
P67938	UniProtKB	Metal binding	171	171	.	.	.	Note=Zinc;status=By similarity	
P67938	UniProtKB	Metal binding	231	231	.	.	.	Note=Zinc;status=By similarity	
P67938	UniProtKB	Metal binding	235	235	.	.	.	Note=Zinc;status=By similarity	
P67938	UniProtKB	Site	112	112	.	.	.	Note=Interaction with DNA;status=By similarity	
P67938	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P67938	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P67938	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P67938	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P67938	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P67938	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P67938	UniProtKB	Modified residue	175	175	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P67938	UniProtKB	Modified residue	262	262	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P67938	UniProtKB	Modified residue	277	277	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P67938	UniProtKB	Modified residue	298	298	.	.	.	Note=N6-acetyllysine;status=By similarity	
P67938	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P67938	UniProtKB	Modified residue	363	363	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P67938	UniProtKB	Modified residue	363	363	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P67938	UniProtKB	Modified residue	365	365	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P67938	UniProtKB	Modified residue	366	366	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P67938	UniProtKB	Modified residue	366	366	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P67938	UniProtKB	Modified residue	374	374	.	.	.	Note=N6-acetyllysine;status=By similarity	
P67938	UniProtKB	Modified residue	375	375	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P67938	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P67938	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P67938	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P67938	UniProtKB	Cross-link	284	284	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P67938	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P67938	UniProtKB	Cross-link	379	379	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region P67939 1 386
P67939	UniProtKB	Chain	1	386	.	.	.	ID=PRO_0000185694;Note=Cellular tumor antigen p53	
P67939	UniProtKB	DNA binding	94	285	.	.	.	status=By similarity	
P67939	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P67939	UniProtKB	Region	63	102	.	.	.	Note=Interaction with WWOX;status=By similarity	
P67939	UniProtKB	Region	92	363	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P67939	UniProtKB	Region	92	293	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P67939	UniProtKB	Region	105	229	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P67939	UniProtKB	Region	108	285	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P67939	UniProtKB	Region	249	287	.	.	.	Note=Interaction with E4F1;status=By similarity	
P67939	UniProtKB	Region	266	273	.	.	.	Note=Interaction with DNA;status=By similarity	
P67939	UniProtKB	Region	312	353	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P67939	UniProtKB	Region	318	349	.	.	.	Note=Oligomerization	
P67939	UniProtKB	Region	352	356	.	.	.	Note=Interaction with USP7;status=By similarity	
P67939	UniProtKB	Region	361	380	.	.	.	Note=Basic (repression of DNA-binding)	
P67939	UniProtKB	Motif	298	314	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P67939	UniProtKB	Motif	332	343	.	.	.	Note=Nuclear export signal;status=By similarity	
P67939	UniProtKB	Motif	363	365	.	.	.	Note=[KR]-[STA]-K motif	
P67939	UniProtKB	Metal binding	168	168	.	.	.	Note=Zinc;status=By similarity	
P67939	UniProtKB	Metal binding	171	171	.	.	.	Note=Zinc;status=By similarity	
P67939	UniProtKB	Metal binding	231	231	.	.	.	Note=Zinc;status=By similarity	
P67939	UniProtKB	Metal binding	235	235	.	.	.	Note=Zinc;status=By similarity	
P67939	UniProtKB	Site	112	112	.	.	.	Note=Interaction with DNA;status=By similarity	
P67939	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P67939	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P67939	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P67939	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P67939	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P67939	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P67939	UniProtKB	Modified residue	175	175	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P67939	UniProtKB	Modified residue	262	262	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P67939	UniProtKB	Modified residue	277	277	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P67939	UniProtKB	Modified residue	298	298	.	.	.	Note=N6-acetyllysine;status=By similarity	
P67939	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P67939	UniProtKB	Modified residue	363	363	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P67939	UniProtKB	Modified residue	363	363	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P67939	UniProtKB	Modified residue	365	365	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P67939	UniProtKB	Modified residue	366	366	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P67939	UniProtKB	Modified residue	366	366	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P67939	UniProtKB	Modified residue	374	374	.	.	.	Note=N6-acetyllysine;status=By similarity	
P67939	UniProtKB	Modified residue	375	375	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P67939	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P67939	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P67939	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P67939	UniProtKB	Cross-link	284	284	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P67939	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P67939	UniProtKB	Cross-link	379	379	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P67939	UniProtKB	Sequence conflict	380	380	.	.	.	.	
##sequence-region Q29537 1 381
Q29537	UniProtKB	Chain	1	381	.	.	.	ID=PRO_0000185695;Note=Cellular tumor antigen p53	
Q29537	UniProtKB	DNA binding	89	280	.	.	.	status=By similarity	
Q29537	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
Q29537	UniProtKB	Region	63	97	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q29537	UniProtKB	Region	87	358	.	.	.	Note=Interaction with HIPK1;status=By similarity	
Q29537	UniProtKB	Region	87	288	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q29537	UniProtKB	Region	100	224	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q29537	UniProtKB	Region	103	280	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q29537	UniProtKB	Region	244	282	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q29537	UniProtKB	Region	261	268	.	.	.	Note=Interaction with DNA;status=By similarity	
Q29537	UniProtKB	Region	307	348	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q29537	UniProtKB	Region	313	344	.	.	.	Note=Oligomerization	
Q29537	UniProtKB	Region	347	351	.	.	.	Note=Interaction with USP7;status=By similarity	
Q29537	UniProtKB	Region	356	375	.	.	.	Note=Basic (repression of DNA-binding)	
Q29537	UniProtKB	Motif	293	309	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q29537	UniProtKB	Motif	327	338	.	.	.	Note=Nuclear export signal;status=By similarity	
Q29537	UniProtKB	Motif	358	360	.	.	.	Note=[KR]-[STA]-K motif	
Q29537	UniProtKB	Metal binding	163	163	.	.	.	Note=Zinc;status=By similarity	
Q29537	UniProtKB	Metal binding	166	166	.	.	.	Note=Zinc;status=By similarity	
Q29537	UniProtKB	Metal binding	226	226	.	.	.	Note=Zinc;status=By similarity	
Q29537	UniProtKB	Metal binding	230	230	.	.	.	Note=Zinc;status=By similarity	
Q29537	UniProtKB	Site	107	107	.	.	.	Note=Interaction with DNA;status=By similarity	
Q29537	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
Q29537	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
Q29537	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
Q29537	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
Q29537	UniProtKB	Modified residue	107	107	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q29537	UniProtKB	Modified residue	170	170	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q29537	UniProtKB	Modified residue	257	257	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q29537	UniProtKB	Modified residue	272	272	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
Q29537	UniProtKB	Modified residue	293	293	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q29537	UniProtKB	Modified residue	303	303	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q29537	UniProtKB	Modified residue	358	358	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q29537	UniProtKB	Modified residue	358	358	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
Q29537	UniProtKB	Modified residue	360	360	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
Q29537	UniProtKB	Modified residue	361	361	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
Q29537	UniProtKB	Modified residue	361	361	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
Q29537	UniProtKB	Modified residue	369	369	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q29537	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q29537	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
Q29537	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
Q29537	UniProtKB	Modified residue	380	380	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
Q29537	UniProtKB	Cross-link	279	279	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q29537	UniProtKB	Cross-link	280	280	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q29537	UniProtKB	Cross-link	374	374	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q29537	UniProtKB	Sequence conflict	1	4	.	.	.	.	
Q29537	UniProtKB	Sequence conflict	378	378	.	.	.	.	
##sequence-region Q9WUR6 1 391
Q9WUR6	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000185696;Note=Cellular tumor antigen p53	
Q9WUR6	UniProtKB	DNA binding	100	290	.	.	.	status=By similarity	
Q9WUR6	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
Q9WUR6	UniProtKB	Region	64	108	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q9WUR6	UniProtKB	Region	98	368	.	.	.	Note=Interaction with HIPK1;status=By similarity	
Q9WUR6	UniProtKB	Region	98	298	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q9WUR6	UniProtKB	Region	111	234	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q9WUR6	UniProtKB	Region	114	290	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q9WUR6	UniProtKB	Region	254	292	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q9WUR6	UniProtKB	Region	271	278	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9WUR6	UniProtKB	Region	317	358	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q9WUR6	UniProtKB	Region	323	354	.	.	.	Note=Oligomerization	
Q9WUR6	UniProtKB	Region	357	361	.	.	.	Note=Interaction with USP7;status=By similarity	
Q9WUR6	UniProtKB	Region	366	385	.	.	.	Note=Basic (repression of DNA-binding)	
Q9WUR6	UniProtKB	Motif	303	319	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q9WUR6	UniProtKB	Motif	337	348	.	.	.	Note=Nuclear export signal;status=By similarity	
Q9WUR6	UniProtKB	Motif	368	370	.	.	.	Note=[KR]-[STA]-K motif	
Q9WUR6	UniProtKB	Metal binding	174	174	.	.	.	Note=Zinc;status=By similarity	
Q9WUR6	UniProtKB	Metal binding	177	177	.	.	.	Note=Zinc;status=By similarity	
Q9WUR6	UniProtKB	Metal binding	236	236	.	.	.	Note=Zinc;status=By similarity	
Q9WUR6	UniProtKB	Metal binding	240	240	.	.	.	Note=Zinc;status=By similarity	
Q9WUR6	UniProtKB	Site	118	118	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	118	118	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	181	181	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	267	267	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	282	282	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	303	303	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	313	313	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	368	368	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	368	368	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	371	371	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	371	371	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	379	379	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	380	380	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
Q9WUR6	UniProtKB	Modified residue	390	390	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
Q9WUR6	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q9WUR6	UniProtKB	Cross-link	290	290	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q9WUR6	UniProtKB	Cross-link	384	384	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region P10360 1 367
P10360	UniProtKB	Chain	1	367	.	.	.	ID=PRO_0000185716;Note=Cellular tumor antigen p53	
P10360	UniProtKB	DNA binding	87	278	.	.	.	status=By similarity	
P10360	UniProtKB	Region	1	30	.	.	.	Note=Transcription activation (acidic)	
P10360	UniProtKB	Region	259	266	.	.	.	Note=Interaction with DNA;status=By similarity	
P10360	UniProtKB	Region	308	339	.	.	.	Note=Oligomerization	
P10360	UniProtKB	Region	347	364	.	.	.	Note=Basic (repression of DNA-binding)	
P10360	UniProtKB	Motif	286	302	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P10360	UniProtKB	Motif	322	333	.	.	.	Note=Nuclear export signal;status=By similarity	
P10360	UniProtKB	Metal binding	161	161	.	.	.	Note=Zinc;status=By similarity	
P10360	UniProtKB	Metal binding	164	164	.	.	.	Note=Zinc;status=By similarity	
P10360	UniProtKB	Metal binding	224	224	.	.	.	Note=Zinc;status=By similarity	
P10360	UniProtKB	Metal binding	228	228	.	.	.	Note=Zinc;status=By similarity	
P10360	UniProtKB	Site	105	105	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region P13481 1 393
P13481	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185697;Note=Cellular tumor antigen p53	
P13481	UniProtKB	DNA binding	102	292	.	.	.	status=By similarity	
P13481	UniProtKB	Region	1	83	.	.	.	Note=Interaction with HRMT1L2;status=By similarity	
P13481	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P13481	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX;status=By similarity	
P13481	UniProtKB	Region	100	370	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P13481	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P13481	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P13481	UniProtKB	Region	116	292	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P13481	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1;status=By similarity	
P13481	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA;status=By similarity	
P13481	UniProtKB	Region	300	393	.	.	.	Note=Interaction with CARM1;status=By similarity	
P13481	UniProtKB	Region	319	360	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P13481	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
P13481	UniProtKB	Region	359	363	.	.	.	Note=Interaction with USP7;status=By similarity	
P13481	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
P13481	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P13481	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal;status=By similarity	
P13481	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
P13481	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc;status=By similarity	
P13481	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc;status=By similarity	
P13481	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc;status=By similarity	
P13481	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc;status=By similarity	
P13481	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA;status=By similarity	
P13481	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
P13481	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P13481	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P13481	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P13481	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P13481	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P13481	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
P13481	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1 and GRK5%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P13481	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P13481	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P13481	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P13481	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine;status=By similarity	
P13481	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P13481	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P13481	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine;status=By similarity	
P13481	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P13481	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P13481	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P13481	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P13481	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region O09185 1 393
O09185	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185698;Note=Cellular tumor antigen p53	
O09185	UniProtKB	DNA binding	102	292	.	.	.	status=By similarity	
O09185	UniProtKB	Region	1	45	.	.	.	Note=Transcription activation (acidic)	
O09185	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX;status=By similarity	
O09185	UniProtKB	Region	100	370	.	.	.	Note=Interaction with HIPK1;status=By similarity	
O09185	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
O09185	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
O09185	UniProtKB	Region	116	292	.	.	.	Note=Interaction with AXIN1;status=By similarity	
O09185	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1;status=By similarity	
O09185	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA;status=By similarity	
O09185	UniProtKB	Region	319	360	.	.	.	Note=Interaction with HIPK2;status=By similarity	
O09185	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
O09185	UniProtKB	Region	359	363	.	.	.	Note=Interaction with USP7;status=By similarity	
O09185	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
O09185	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
O09185	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal;status=By similarity	
O09185	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
O09185	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc;status=By similarity	
O09185	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc;status=By similarity	
O09185	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc;status=By similarity	
O09185	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc;status=By similarity	
O09185	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA;status=By similarity	
O09185	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
O09185	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
O09185	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
O09185	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
O09185	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
O09185	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
O09185	UniProtKB	Modified residue	47	47	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
O09185	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
O09185	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
O09185	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
O09185	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
O09185	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine;status=By similarity	
O09185	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
O09185	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
O09185	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
O09185	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
O09185	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
O09185	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
O09185	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine;status=By similarity	
O09185	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
O09185	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
O09185	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
O09185	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
O09185	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
O09185	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
O09185	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
O09185	UniProtKB	Natural variant	133	133	.	.	.	Note=In cell line V79-4.	
O09185	UniProtKB	Natural variant	135	135	.	.	.	Note=In cell line V79-4.	
O09185	UniProtKB	Sequence conflict	103	103	.	.	.	.	
##sequence-region P79734 1 373
P79734	UniProtKB	Chain	1	373	.	.	.	ID=PRO_0000185718;Note=Cellular tumor antigen p53	
P79734	UniProtKB	DNA binding	70	260	.	.	.	status=By similarity	
P79734	UniProtKB	Region	1	31	.	.	.	Note=Transcription activation (acidic)	
P79734	UniProtKB	Region	241	248	.	.	.	Note=Interaction with DNA;status=By similarity	
P79734	UniProtKB	Region	301	332	.	.	.	Note=Oligomerization	
P79734	UniProtKB	Region	345	366	.	.	.	Note=Basic (repression of DNA-binding)	
P79734	UniProtKB	Motif	274	296	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P79734	UniProtKB	Motif	315	326	.	.	.	Note=Nuclear export signal;status=By similarity	
P79734	UniProtKB	Metal binding	144	144	.	.	.	Note=Zinc;status=By similarity	
P79734	UniProtKB	Metal binding	147	147	.	.	.	Note=Zinc;status=By similarity	
P79734	UniProtKB	Metal binding	206	206	.	.	.	Note=Zinc;status=By similarity	
P79734	UniProtKB	Metal binding	210	210	.	.	.	Note=Zinc;status=By similarity	
P79734	UniProtKB	Site	88	88	.	.	.	Note=Interaction with DNA;status=By similarity	
P79734	UniProtKB	Mutagenesis	26	26	.	.	.	Note=No effect on transactivation activity.	
P79734	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Loss of transactivation activity. Temperature-sensitive suppression of irradiation-induced apoptosis. No effect on embryonic development.	
P79734	UniProtKB	Mutagenesis	214	214	.	.	.	Note=Loss of transactivation activity. Suppression of irradiation-induced apoptosis. Defective G1-phase but not G2-phase checkpoint response. Development of malignant peripheral nerve sheath tumors. No effect on embryonic development.	
P79734	UniProtKB	Sequence conflict	276	280	.	.	.	.	
P79734	UniProtKB	Sequence conflict	286	286	.	.	.	.	
##sequence-region Q8SPZ3 1 387
Q8SPZ3	UniProtKB	Chain	1	387	.	.	.	ID=PRO_0000185699;Note=Cellular tumor antigen p53	
Q8SPZ3	UniProtKB	DNA binding	95	286	.	.	.	status=By similarity	
Q8SPZ3	UniProtKB	Region	1	45	.	.	.	Note=Transcription activation (acidic);status=By similarity	
Q8SPZ3	UniProtKB	Region	59	103	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q8SPZ3	UniProtKB	Region	93	364	.	.	.	Note=Interaction with HIPK1;status=By similarity	
Q8SPZ3	UniProtKB	Region	93	294	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q8SPZ3	UniProtKB	Region	106	230	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q8SPZ3	UniProtKB	Region	109	286	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q8SPZ3	UniProtKB	Region	250	288	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q8SPZ3	UniProtKB	Region	267	274	.	.	.	Note=Interaction with DNA;status=By similarity	
Q8SPZ3	UniProtKB	Region	313	354	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q8SPZ3	UniProtKB	Region	319	350	.	.	.	Note=Oligomerization;status=By similarity	
Q8SPZ3	UniProtKB	Region	353	357	.	.	.	Note=Interaction with USP7;status=By similarity	
Q8SPZ3	UniProtKB	Region	362	381	.	.	.	Note=Basic (repression of DNA-binding);status=By similarity	
Q8SPZ3	UniProtKB	Motif	299	315	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q8SPZ3	UniProtKB	Motif	333	344	.	.	.	Note=Nuclear export signal;status=By similarity	
Q8SPZ3	UniProtKB	Motif	364	366	.	.	.	Note=[KR]-[STA]-K motif	
Q8SPZ3	UniProtKB	Metal binding	169	169	.	.	.	Note=Zinc;status=By similarity	
Q8SPZ3	UniProtKB	Metal binding	172	172	.	.	.	Note=Zinc;status=By similarity	
Q8SPZ3	UniProtKB	Metal binding	232	232	.	.	.	Note=Zinc;status=By similarity	
Q8SPZ3	UniProtKB	Metal binding	236	236	.	.	.	Note=Zinc;status=By similarity	
Q8SPZ3	UniProtKB	Site	113	113	.	.	.	Note=Interaction with DNA;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	113	113	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	176	176	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	263	263	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	278	278	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	299	299	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	364	364	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	364	364	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	366	366	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	367	367	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	367	367	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	376	376	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	376	376	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	376	376	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
Q8SPZ3	UniProtKB	Modified residue	386	386	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
Q8SPZ3	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q8SPZ3	UniProtKB	Cross-link	286	286	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q8SPZ3	UniProtKB	Cross-link	380	380	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q29480 1 207
Q29480	UniProtKB	Chain	1	207	.	.	.	ID=PRO_0000185700;Note=Cellular tumor antigen p53	
Q29480	UniProtKB	DNA binding	1	168	.	.	.	status=By similarity	
Q29480	UniProtKB	Region	1	112	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q29480	UniProtKB	Region	132	170	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q29480	UniProtKB	Region	149	156	.	.	.	Note=Interaction with DNA;status=By similarity	
Q29480	UniProtKB	Region	201	207	.	.	.	Note=Oligomerization	
Q29480	UniProtKB	Motif	181	197	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q29480	UniProtKB	Metal binding	51	51	.	.	.	Note=Zinc;status=By similarity	
Q29480	UniProtKB	Metal binding	54	54	.	.	.	Note=Zinc;status=By similarity	
Q29480	UniProtKB	Metal binding	114	114	.	.	.	Note=Zinc;status=By similarity	
Q29480	UniProtKB	Metal binding	118	118	.	.	.	Note=Zinc;status=By similarity	
Q29480	UniProtKB	Modified residue	58	58	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q29480	UniProtKB	Modified residue	145	145	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q29480	UniProtKB	Modified residue	160	160	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
Q29480	UniProtKB	Modified residue	181	181	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q29480	UniProtKB	Modified residue	191	191	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q29480	UniProtKB	Cross-link	167	167	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q29480	UniProtKB	Cross-link	168	168	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q29480	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q29480	UniProtKB	Non-terminal residue	207	207	.	.	.	.	
##sequence-region P41685 1 386
P41685	UniProtKB	Chain	1	386	.	.	.	ID=PRO_0000185701;Note=Cellular tumor antigen p53	
P41685	UniProtKB	DNA binding	94	285	.	.	.	status=By similarity	
P41685	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P41685	UniProtKB	Region	63	102	.	.	.	Note=Interaction with WWOX;status=By similarity	
P41685	UniProtKB	Region	92	363	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P41685	UniProtKB	Region	92	293	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P41685	UniProtKB	Region	105	229	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P41685	UniProtKB	Region	108	285	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P41685	UniProtKB	Region	249	287	.	.	.	Note=Interaction with E4F1;status=By similarity	
P41685	UniProtKB	Region	266	273	.	.	.	Note=Interaction with DNA;status=By similarity	
P41685	UniProtKB	Region	312	353	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P41685	UniProtKB	Region	318	349	.	.	.	Note=Oligomerization	
P41685	UniProtKB	Region	352	356	.	.	.	Note=Interaction with USP7;status=By similarity	
P41685	UniProtKB	Region	361	380	.	.	.	Note=Basic (repression of DNA-binding)	
P41685	UniProtKB	Motif	298	314	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P41685	UniProtKB	Motif	332	343	.	.	.	Note=Nuclear export signal;status=By similarity	
P41685	UniProtKB	Motif	363	365	.	.	.	Note=[KR]-[STA]-K motif	
P41685	UniProtKB	Metal binding	168	168	.	.	.	Note=Zinc;status=By similarity	
P41685	UniProtKB	Metal binding	171	171	.	.	.	Note=Zinc;status=By similarity	
P41685	UniProtKB	Metal binding	231	231	.	.	.	Note=Zinc;status=By similarity	
P41685	UniProtKB	Metal binding	235	235	.	.	.	Note=Zinc;status=By similarity	
P41685	UniProtKB	Site	112	112	.	.	.	Note=Interaction with DNA;status=By similarity	
P41685	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P41685	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P41685	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P41685	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P41685	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P41685	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
P41685	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P41685	UniProtKB	Modified residue	262	262	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P41685	UniProtKB	Modified residue	277	277	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P41685	UniProtKB	Modified residue	298	298	.	.	.	Note=N6-acetyllysine;status=By similarity	
P41685	UniProtKB	Modified residue	363	363	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P41685	UniProtKB	Modified residue	363	363	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P41685	UniProtKB	Modified residue	365	365	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P41685	UniProtKB	Modified residue	366	366	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P41685	UniProtKB	Modified residue	366	366	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P41685	UniProtKB	Modified residue	374	374	.	.	.	Note=N6-acetyllysine;status=By similarity	
P41685	UniProtKB	Modified residue	375	375	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P41685	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P41685	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P41685	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P41685	UniProtKB	Cross-link	284	284	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P41685	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P41685	UniProtKB	Cross-link	379	379	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P41685	UniProtKB	Sequence conflict	285	285	.	.	.	.	
##sequence-region P79892 1 280
P79892	UniProtKB	Chain	1	280	.	.	.	ID=PRO_0000185702;Note=Cellular tumor antigen p53	
P79892	UniProtKB	DNA binding	52	243	.	.	.	status=By similarity	
P79892	UniProtKB	Region	26	60	.	.	.	Note=Interaction with WWOX;status=By similarity	
P79892	UniProtKB	Region	50	251	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P79892	UniProtKB	Region	63	187	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P79892	UniProtKB	Region	207	245	.	.	.	Note=Interaction with E4F1;status=By similarity	
P79892	UniProtKB	Region	224	231	.	.	.	Note=Interaction with DNA;status=By similarity	
P79892	UniProtKB	Region	276	280	.	.	.	Note=Oligomerization	
P79892	UniProtKB	Motif	256	272	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P79892	UniProtKB	Metal binding	126	126	.	.	.	Note=Zinc;status=By similarity	
P79892	UniProtKB	Metal binding	129	129	.	.	.	Note=Zinc;status=By similarity	
P79892	UniProtKB	Metal binding	189	189	.	.	.	Note=Zinc;status=By similarity	
P79892	UniProtKB	Metal binding	193	193	.	.	.	Note=Zinc;status=By similarity	
P79892	UniProtKB	Site	70	70	.	.	.	Note=Interaction with DNA;status=By similarity	
P79892	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
P79892	UniProtKB	Modified residue	70	70	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P79892	UniProtKB	Modified residue	133	133	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P79892	UniProtKB	Modified residue	220	220	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P79892	UniProtKB	Modified residue	235	235	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P79892	UniProtKB	Modified residue	256	256	.	.	.	Note=N6-acetyllysine;status=By similarity	
P79892	UniProtKB	Modified residue	266	266	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P79892	UniProtKB	Cross-link	242	242	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P79892	UniProtKB	Cross-link	243	243	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P79892	UniProtKB	Sequence conflict	79	79	.	.	.	.	
P79892	UniProtKB	Sequence conflict	83	83	.	.	.	.	
P79892	UniProtKB	Sequence conflict	111	111	.	.	.	.	
P79892	UniProtKB	Sequence conflict	138	138	.	.	.	.	
P79892	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
P79892	UniProtKB	Non-terminal residue	280	280	.	.	.	.	
##sequence-region P04637 1 393
P04637	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185703;Note=Cellular tumor antigen p53	
P04637	UniProtKB	DNA binding	102	292	.	.	.	.	
P04637	UniProtKB	Region	1	83	.	.	.	Note=Interaction with HRMT1L2	
P04637	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P04637	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX	
P04637	UniProtKB	Region	100	370	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P04637	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A	
P04637	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42	
P04637	UniProtKB	Region	116	292	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P04637	UniProtKB	Region	241	248	.	.	.	Note=Interacts with the 53BP2 SH3 domain	
P04637	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1	
P04637	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA	
P04637	UniProtKB	Region	300	393	.	.	.	Note=Interaction with CARM1	
P04637	UniProtKB	Region	319	360	.	.	.	Note=Interaction with HIPK2	
P04637	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
P04637	UniProtKB	Region	359	363	.	.	.	Note=Interaction with USP7	
P04637	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
P04637	UniProtKB	Motif	17	25	.	.	.	Note=TADI	
P04637	UniProtKB	Motif	48	56	.	.	.	Note=TADII	
P04637	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal	
P04637	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal	
P04637	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
P04637	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc	
P04637	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc	
P04637	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc	
P04637	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc	
P04637	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA	
P04637	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4	
P04637	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM	
P04637	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2	
P04637	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3	
P04637	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7	
P04637	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5	
P04637	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG	
P04637	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1 and GRK5	
P04637	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A	
P04637	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine%3B by AURKB	
P04637	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine%3B by AURKB	
P04637	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine%3B by AURKB	
P04637	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine	
P04637	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2	
P04637	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate	
P04637	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate	
P04637	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7	
P04637	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate	
P04637	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate	
P04637	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine	
P04637	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate	
P04637	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate	
P04637	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate	
P04637	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1	
P04637	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P04637	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P04637	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P04637	UniProtKB	Alternative sequence	1	132	.	.	.	ID=VSP_040833;Note=In isoform 7%2C isoform 8 and isoform 9.	
P04637	UniProtKB	Alternative sequence	1	39	.	.	.	ID=VSP_040832;Note=In isoform 4%2C isoform 5 and isoform 6.	
P04637	UniProtKB	Alternative sequence	332	346	.	.	.	ID=VSP_040560;Note=In isoform 3%2C isoform 6 and isoform 9.	
P04637	UniProtKB	Alternative sequence	332	341	.	.	.	ID=VSP_006535;Note=In isoform 2%2C isoform 5 and isoform 8.	
P04637	UniProtKB	Alternative sequence	342	393	.	.	.	ID=VSP_006536;Note=In isoform 2%2C isoform 5 and isoform 8.	
P04637	UniProtKB	Alternative sequence	347	393	.	.	.	ID=VSP_040561;Note=In isoform 3%2C isoform 6 and isoform 9.	
P04637	UniProtKB	Natural variant	5	5	.	.	.	ID=VAR_044543;Note=In a sporadic cancer%3B somatic mutation%3B abolishes strongly phosphorylation.	
P04637	UniProtKB	Natural variant	6	6	.	.	.	ID=VAR_044544;Note=In a sporadic cancer%3B somatic mutation%3B reduces interaction with ZNF385A.	
P04637	UniProtKB	Natural variant	7	7	.	.	.	ID=VAR_005851;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	8	8	.	.	.	ID=VAR_044545;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_044546;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_044547;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_044548;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_044549;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_044550;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_044551;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	24	24	.	.	.	ID=VAR_044552;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_044553;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	29	30	.	.	.	ID=VAR_047158;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_044554;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_044555;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_044556;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_005852;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_044557;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_044558;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_044559;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_044560;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	39	39	.	.	.	ID=VAR_044561;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_044562;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	43	43	.	.	.	ID=VAR_005853;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_044563;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_044564;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_044565;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	45	45	.	.	.	ID=VAR_044566;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_044567;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_044568;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_044569;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_014632;Dbxref=dbSNP:rs1800371	
P04637	UniProtKB	Natural variant	48	48	.	.	.	ID=VAR_044570;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_044571;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_044572;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_044573;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_044574;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_005854;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_044575;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_044576;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_044577;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_044578;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_044579;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_044580;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_044581;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_044582;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_044583;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_045783;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_044584;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_044585;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_005855;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_044586;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_044587;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_044588;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_044589;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_044590;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_044591;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_044592;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_044593;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_044594;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_044595;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_044596;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_044597;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_044598;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044599;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044600;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044601;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_044602;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_044603;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_044604;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045784;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045785;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045786;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_045787;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_005856;Dbxref=dbSNP:rs1042522	
P04637	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_044605;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_044606;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	73	73	.	.	.	ID=VAR_044607;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_044608;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_044609;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_044610;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_044611;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_044612;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_044613;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_044614;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_044615;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_044616;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_005857;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_044617;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_044618;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_044619;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_044620;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_044621;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_044622;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_044623;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_044624;Dbxref=dbSNP:rs201717599;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_044625;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_044626;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_044627;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_044628;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_044629;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_005858;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_044630;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_044631;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_044632;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_044633;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_044634;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_044635;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_044636;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_044637;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_044638;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_044639;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_044640;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_044641;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	94	94	.	.	.	ID=VAR_044642;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	94	94	.	.	.	ID=VAR_005859;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_044643;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	95	95	.	.	.	ID=VAR_044644;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_044645;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_044646;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_044647;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_044648;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_044649;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_044650;Note=In familial cancer not matching LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_044651;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_044652;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_044653;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_044654;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	100	100	.	.	.	ID=VAR_044655;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_044656;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_044657;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_044658;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	104	104	.	.	.	ID=VAR_044659;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	104	104	.	.	.	ID=VAR_044660;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044661;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044662;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044663;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044664;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_044665;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_044666;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_044667;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_044668;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_044669;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_044670;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_044671;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_044672;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_044673;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_044674;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_044675;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_005860;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_044676;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_044677;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_005861;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation.	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_005862;Dbxref=dbSNP:rs11540654;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_044678;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044679;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044680;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044681;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_044682;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_044683;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_044684;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_005863;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_045788;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_044685;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_044686;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_044687;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_033033;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_044688;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_044689;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_044690;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_044691;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_044692;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_044693;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_044694;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_044695;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_044696;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_044697;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_044698;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044699;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044700;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044701;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_044702;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_044703;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_044704;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_044705;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_044706;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044707;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044708;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044709;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044710;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_044711;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044712;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044713;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_005864;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044714;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_044715;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044716;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_005865;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044717;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_045789;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044718;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_005866;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_044719;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044720;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_005867;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044721;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044722;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_044723;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_044724;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_044725;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_044726;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_005868;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_005869;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_044727;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_044728;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_044729;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044730;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044731;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044732;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044733;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_005870;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_044734;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044735;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044736;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044737;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_005872;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_005871;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044738;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_044739;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	133	.	.	.	ID=VAR_047159;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044740;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_045790;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_005873;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044741;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_005874;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044742;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_044743;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_045791;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044744;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044745;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044746;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044747;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_005875;Dbxref=dbSNP:rs28934873;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_044748;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044749;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044750;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_036504;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044751;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_044752;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_005877;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044753;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044754;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_005876;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_045792;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044755;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_044756;Note=In sporadic cancers%3B somatic mutation%3B decreased E6-mediated binding to E6-AP.	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_005878;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_044757;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_005879;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_044758;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_044759;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_044760;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_044761;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_005880;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_044762;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_044763;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_005881;Dbxref=dbSNP:rs28934875;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_044764;Note=In LFS%3B germline mutation.	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_044765;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	138	138	.	.	.	ID=VAR_033034;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044766;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_005882;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044767;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044768;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	139	139	.	.	.	ID=VAR_044769;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044770;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044771;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044772;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044773;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_044774;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_045793;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_005885;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_005884;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_044775;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_044776;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_044777;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	141	141	.	.	.	ID=VAR_005886;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044778;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_045794;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044779;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044780;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044781;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044782;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_044783;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_005887;Note=In sporadic cancers%3B somatic mutation%3B strong DNA binding ability at 32.5 degrees Celsius%3B strong reduction of transcriptional activity at 37.5 degrees Celsius%3B severely represses interaction with ZNF385A.	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044784;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044785;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044786;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_044787;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044788;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044789;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044790;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_005888;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_044791;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_044792;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_005889;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_005890;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_044793;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_044794;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044795;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044796;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044797;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044798;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_044799;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044800;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_005891;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044801;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044802;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_005892;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_044803;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044804;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044805;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044806;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044807;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044808;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_044809;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_044810;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_005893;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_044811;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044812;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044813;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044814;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044815;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044816;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_044817;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_005894;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_044818;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_044819;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_044820;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_005895;Dbxref=dbSNP:rs28934874;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	151	151	.	.	.	ID=VAR_005896;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044821;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_005897;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044822;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044823;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_005898;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_044824;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044825;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_045795;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044826;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044827;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044828;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_044829;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	153	153	.	.	.	ID=VAR_005899;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044830;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044831;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044832;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_045796;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_044833;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_005900;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_005901;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044834;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044835;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044836;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044837;Note=In sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation.	
P04637	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_044838;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044839;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044840;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044841;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044842;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_005902;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_044843;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_044844;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_005903;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_005904;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_044845;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_012977;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_044846;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005905;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_045797;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005906;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005907;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044847;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044848;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044849;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_044850;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_045798;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044851;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_045799;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044852;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044853;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044854;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044855;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_044856;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	160	161	.	.	.	ID=VAR_047160;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	160	161	.	.	.	ID=VAR_047161;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	160	161	.	.	.	ID=VAR_047162;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_005908;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_044857;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_044858;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_044859;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044860;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_045800;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044861;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044862;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_005909;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044863;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_044864;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044865;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044866;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044867;Note=In a breast cancer with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005910;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_044868;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005911;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_033035;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044869;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044870;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_005912;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044871;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_044872;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044873;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044874;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_005913;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_005914;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044875;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_044876;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_044877;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_044878;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_005915;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_044879;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_005916;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044880;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044881;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_005917;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044882;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_044883;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	167	168	.	.	.	ID=VAR_047163;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	167	168	.	.	.	ID=VAR_047164;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044884;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044885;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044886;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_044887;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	169	.	.	.	ID=VAR_047165;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044888;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044889;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044890;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044891;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044892;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_005918;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_045801;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	168	168	.	.	.	ID=VAR_044893;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	169	170	.	.	.	ID=VAR_047166;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_005919;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_044894;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_005920;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	169	169	.	.	.	ID=VAR_044895;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_044896;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_044897;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_005921;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_044898;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_005922;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044899;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044900;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044901;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044902;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044903;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_044904;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_005923;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044905;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044906;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044907;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	172	172	.	.	.	ID=VAR_044908;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_044909;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_005924;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_044910;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_005925;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_005926;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_045802;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044911;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_005927;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044912;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044913;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044914;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_044915;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005928;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005929;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005932;Dbxref=dbSNP:rs28934578;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation%3B reduces interaction with ZNF385A.	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005930;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005931;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_044916;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_044917;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	176	177	.	.	.	ID=VAR_047167;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_005933;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044918;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044919;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044920;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_005934;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_044921;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044922;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_045803;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044923;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_045804;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_005935;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_036505;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044924;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_044925;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	179	.	.	.	ID=VAR_047168;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044926;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_005936;Note=In a Burkitt lymphoma.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044927;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044928;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044929;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044930;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044931;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_044932;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044933;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044934;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044935;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044936;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044937;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044938;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_044939;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044940;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044941;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044942;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044943;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044944;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_044945;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044946;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044947;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044948;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_005937;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044949;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_044950;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_044951;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_005938;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_044952;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_044953;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_044954;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_044955;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_044956;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_047169;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_044957;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_005939;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044958;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044959;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044960;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044961;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044962;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	185	185	.	.	.	ID=VAR_044963;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044964;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044965;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044966;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044967;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_044968;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_005940;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_005941;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_044969;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_045805;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_044970;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_005942;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_044971;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_044972;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_044973;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044974;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044975;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_005943;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044976;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044977;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	189	189	.	.	.	ID=VAR_044978;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044979;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044980;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_005944;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044981;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044982;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_044983;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044984;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044985;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044986;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_044987;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_005945;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	192	193	.	.	.	ID=VAR_047170;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	192	193	.	.	.	ID=VAR_047171;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044988;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044989;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044990;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_044991;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_005946;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_005947;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044992;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044993;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044994;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044995;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_005948;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_044996;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_044997;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_044998;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_044999;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_005949;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_005950;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_045000;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045001;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_047172;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045002;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045003;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_005951;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045004;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_045806;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045005;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045006;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045007;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045008;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_045009;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045010;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045011;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045012;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_045013;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045014;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045015;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_005952;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045016;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_045017;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045018;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045019;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045020;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_045021;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045022;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045023;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045024;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045807;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045025;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_045026;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	201	202	.	.	.	ID=VAR_047173;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_045027;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_045028;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_045029;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045030;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045031;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045032;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045033;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045034;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_045035;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	203	204	.	.	.	ID=VAR_047174;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045036;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045037;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045038;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045039;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	203	203	.	.	.	ID=VAR_045808;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045040;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045041;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045042;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045043;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045044;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_045045;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_005953;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_005954;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_047175;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_045046;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_045047;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_045048;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_045049;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_045050;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	207	208	.	.	.	ID=VAR_047176;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045051;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045052;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045053;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045054;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045055;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	207	207	.	.	.	ID=VAR_045056;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045057;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045058;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045059;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045809;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045060;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045061;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_045062;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045063;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045064;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045065;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_045066;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045067;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045068;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045069;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045070;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045071;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045072;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_045073;Note=In a familial cancer not matching LFS%3B germline mutation.	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045074;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045075;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045076;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045077;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_045078;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045079;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045080;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045081;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045082;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	212	212	.	.	.	ID=VAR_045083;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_045084;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_045085;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_036506;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_005955;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_045086;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045087;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045088;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_047177;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045089;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	214	214	.	.	.	ID=VAR_045090;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045091;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045092;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045093;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045810;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045094;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045095;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_045096;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045097;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045098;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045099;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045100;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_005956;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_045811;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045101;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045102;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045103;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045104;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_045105;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_047178;Dbxref=dbSNP:rs35163653	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045106;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045107;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045108;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045109;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_045110;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045812;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045111;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045112;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045113;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045114;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_045115;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_005957;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_045116;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_045117;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_005958;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_045118;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_005959;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045119;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045120;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045121;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045122;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_045123;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045124;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045125;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045126;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045127;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045128;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	222	222	.	.	.	ID=VAR_045129;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_047179;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045130;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045131;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045132;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045133;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_045134;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045135;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045136;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045137;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_045138;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045139;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045140;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045141;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045142;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045143;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	225	225	.	.	.	ID=VAR_045144;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045145;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_047180;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045844;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045146;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_045147;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045148;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045149;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045150;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_045151;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045152;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_005960;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045153;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045154;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045155;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045845;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045156;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_045157;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045158;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045846;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045159;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045160;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_045161;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045162;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_005961;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045163;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045164;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_045165;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045166;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045167;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045168;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_045169;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045170;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045171;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045172;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045173;Note=In sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation.	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_005962;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_045174;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045175;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045176;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045177;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045178;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_047181;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_045179;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_005963;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045180;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045181;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_005964;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045847;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045182;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045848;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_045183;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_047182;Note=In an adrenocortical carcinoma with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045184;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045185;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045849;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045186;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045187;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_045188;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045189;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045190;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045191;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045192;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045193;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	236	236	.	.	.	ID=VAR_045194;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_005965;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045195;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045196;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045197;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045198;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_045199;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_005966;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045200;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045850;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045201;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045202;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_045203;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	238	238	.	.	.	ID=VAR_005967;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045204;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045205;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045206;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045207;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045208;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045209;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_045210;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045211;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045212;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_005968;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045213;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045214;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045215;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_045216;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_033036;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_045217;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_005969;Dbxref=dbSNP:rs28934573;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_045218;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_047183;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_045219;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_005970;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045220;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045221;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045222;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045223;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_045224;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	244	.	.	.	ID=VAR_047184;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	244	.	.	.	ID=VAR_047185;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045225;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045226;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045227;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045228;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045229;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_045230;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_047186;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045231;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045232;Dbxref=dbSNP:rs28934572;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045233;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045234;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045235;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_045236;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005971;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005972;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005973;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045237;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045851;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045852;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045853;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045854;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_045238;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005974;Dbxref=dbSNP:rs28934575;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_005975;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_045239;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_045240;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_044020;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_005976;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_005977;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_005978;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	248	.	.	.	ID=VAR_047187;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	248	.	.	.	ID=VAR_047188;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045241;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045855;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_005980;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045242;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045243;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_047189;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_045244;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_045245;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005981;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005982;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_045246;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005983;Dbxref=dbSNP:rs11540652;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	248	248	.	.	.	ID=VAR_005984;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	250	.	.	.	ID=VAR_047190;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	250	.	.	.	ID=VAR_047191;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_005985;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045247;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045248;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_033037;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045856;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_005986;Dbxref=dbSNP:rs28934571;Note=In sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045249;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	249	249	.	.	.	ID=VAR_045250;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045251;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045857;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045252;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_047192;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045858;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045253;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045254;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_045255;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045256;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045257;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045258;Note=In LFS%3B germline mutation.	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_005987;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_033038;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045259;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_045260;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045261;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045262;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045263;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_005988;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_045264;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045265;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045266;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045267;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_047193;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_045268;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045859;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045269;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045270;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045271;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_017908;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045272;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_017909;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_045273;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045274;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045275;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045276;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045277;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045278;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_045279;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045280;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045281;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045282;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_045283;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_005989;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_045284;Dbxref=dbSNP:rs28934577;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_045285;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	257	257	.	.	.	ID=VAR_045286;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045287;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_005990;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045288;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_005991;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045860;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045289;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_045290;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_047194;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045291;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045292;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045293;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045294;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045861;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045862;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_045295;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_033039;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045296;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045297;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045298;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045299;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045300;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_045301;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045302;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045303;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045304;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045305;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_045306;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	262	263	.	.	.	ID=VAR_047195;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045307;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_047196;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045863;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045308;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	262	262	.	.	.	ID=VAR_045309;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045310;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045311;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045312;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045313;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	263	263	.	.	.	ID=VAR_045314;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045315;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045316;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045317;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045318;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_045319;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_045320;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_045321;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_045322;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_047197;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045323;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045324;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045325;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_045326;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045327;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045328;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045329;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_045330;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_036507;Dbxref=dbSNP:rs55832599;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045864;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045331;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045332;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045333;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045334;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	268	268	.	.	.	ID=VAR_045335;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045336;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045337;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_047198;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045338;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045339;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_045340;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045341;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045342;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045343;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045344;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045345;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_045346;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045347;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045348;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045349;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_036508;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045865;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045350;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_045866;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_047199;Note=In an osteosarcoma with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045351;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045352;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045353;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_005992;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_045354;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_005993;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_005994;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_005995;Dbxref=dbSNP:rs28934576;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B abolishes sequence-specific DNA binding%3B does not induce SNAI1 degradation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_036509;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045867;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045355;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045356;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045357;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_045868;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045358;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045359;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_005997;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_047200;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045360;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_045361;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045362;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045363;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045364;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_045365;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_005999;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_005998;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045366;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045367;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045368;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045369;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045370;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_045371;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045372;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_006000;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045373;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045374;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_047201;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_045375;Note=In an osteosarcoma with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006001;Dbxref=dbSNP:rs17849781;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_045869;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006002;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006003;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_045376;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006004;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_006005;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_006006;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_045377;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_045378;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_045379;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_045380;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_006008;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_006007;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_045381;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_045382;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	280	280	.	.	.	ID=VAR_006009;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	282	.	.	.	ID=VAR_047203;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006010;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006011;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006012;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006013;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_047202;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_045870;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_006014;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_045383;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045384;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045385;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_006015;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045386;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_045387;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_006016;Dbxref=dbSNP:rs28934574;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation%3B does not induce SNAI1 degradation.	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006017;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006018;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006019;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_045388;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_006020;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	283	283	.	.	.	ID=VAR_045389;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_006021;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_045390;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_045391;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_006022;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_045392;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_045393;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_045394;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_006023;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_006024;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_006025;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006026;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006027;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006028;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006029;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_045871;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_006030;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_045395;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_047204;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045396;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045397;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045398;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_045399;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045400;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045401;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045402;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045403;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_045404;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045405;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045406;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045407;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045408;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_045409;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_045410;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_045411;Dbxref=dbSNP:rs55819519;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_045412;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045413;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045414;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045415;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_047205;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045416;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_045417;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045418;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045872;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_015819;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045419;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045420;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045421;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_045422;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045423;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045424;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045425;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_045426;Note=In a brain tumor with no family history%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045427;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045428;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045429;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_047206;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045430;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_045431;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045432;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045433;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045434;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_045435;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045873;Note=In sporadic cancers%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045436;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_047207;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045437;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_006031;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045438;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045439;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_045440;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045441;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045442;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045443;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045444;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_045445;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045446;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045447;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045448;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045449;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_045450;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045451;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045452;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045453;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_045454;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_045455;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_045456;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_006032;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	300	300	.	.	.	ID=VAR_045457;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_045458;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_006033;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_045459;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_045460;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_047208;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_045461;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_006034;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_045462;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_006035;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045463;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045464;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045465;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_045466;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_045467;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_045468;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_045469;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_047209;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045470;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045471;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045472;Note=In sporadic cancers%3B somatic mutation%3B loss of nuclear localization.	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045473;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_045474;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_045475;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_006036;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_045476;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_045477;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	307	307	.	.	.	ID=VAR_006037;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_045478;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_045479;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_045480;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_006038;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_045481;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_045482;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045483;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045484;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045485;Dbxref=dbSNP:rs56184981;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_045486;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	312	312	.	.	.	ID=VAR_045487;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	312	312	.	.	.	ID=VAR_045488;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045489;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045490;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045491;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	313	313	.	.	.	ID=VAR_045492;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	314	314	.	.	.	ID=VAR_045493;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_045494;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_045495;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_045496;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_045497;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_045498;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045499;Note=In a kidney cancer with no family history%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045500;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_047210;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045501;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_045502;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	318	318	.	.	.	ID=VAR_045503;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_045504;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_045505;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_045506;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_045507;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_045508;Note=In kidney cancer%3B germline mutation.	
P04637	UniProtKB	Natural variant	321	321	.	.	.	ID=VAR_045509;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_045510;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_045511;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045874;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045512;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045513;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_045514;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_047211;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_045515;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_045875;Note=In a sporadic cancer%3B somatic mutation%3B requires 2 nucleotide substitutions.	
P04637	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_045516;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_045517;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_045518;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_006039;Dbxref=dbSNP:rs28934271;Note=In LFS%3B germline mutation.	
P04637	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_045519;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	327	327	.	.	.	ID=VAR_045520;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	327	327	.	.	.	ID=VAR_045521;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_045522;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_045523;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_045524;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	329	329	.	.	.	ID=VAR_045525;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	329	329	.	.	.	ID=VAR_045526;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_045527;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_047212;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_045528;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_045529;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_045530;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_045531;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	332	332	.	.	.	ID=VAR_045532;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_006040;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_045533;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_045534;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_045535;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	335	335	.	.	.	ID=VAR_045536;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_006041;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_035016;Note=In LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_045537;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_045538;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_045539;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	338	338	.	.	.	ID=VAR_045540;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_022316;Dbxref=dbSNP:rs17882252;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	339	339	.	.	.	ID=VAR_045541;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	341	341	.	.	.	ID=VAR_045542;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_045543;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_045544;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_047213;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	343	343	.	.	.	ID=VAR_045545;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_045546;Note=In LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	344	344	.	.	.	ID=VAR_045547;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	346	346	.	.	.	ID=VAR_045548;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_045549;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_045550;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_045551;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_045552;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_045553;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_045554;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	353	353	.	.	.	ID=VAR_045555;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_045556;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_045557;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_047214;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	356	356	.	.	.	ID=VAR_045558;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	356	356	.	.	.	ID=VAR_045559;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	358	358	.	.	.	ID=VAR_045560;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	358	358	.	.	.	ID=VAR_045561;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_045562;Dbxref=dbSNP:rs35993958	
P04637	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_045563;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	363	363	.	.	.	ID=VAR_045564;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_045565;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_045566;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_045567;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	365	365	.	.	.	ID=VAR_047215;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	365	365	.	.	.	ID=VAR_045568;Note=In a familial cancer not matching LFS%3B germline mutation and in a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	366	366	.	.	.	ID=VAR_022317;Dbxref=dbSNP:rs17881470;Note=In a familial cancer not matching LFS%3B germline mutation and in sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	370	370	.	.	.	ID=VAR_045569;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	376	376	.	.	.	ID=VAR_045570;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	376	376	.	.	.	ID=VAR_045571;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_045572;Note=In sporadic cancers%3B somatic mutation.	
P04637	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_045573;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	389	389	.	.	.	ID=VAR_045574;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Natural variant	392	392	.	.	.	ID=VAR_045575;Note=In a sporadic cancer%3B somatic mutation.	
P04637	UniProtKB	Mutagenesis	15	15	.	.	.	Note=Loss of interaction with PPP2R5C%2C PPP2CA AND PPP2R1A.	
P04637	UniProtKB	Mutagenesis	18	18	.	.	.	Note=No effect on interaction with MDM2 and increase in protein levels after DNA damage.	
P04637	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Abolishes phosphorylation site. Abolishes increase in protein levels after DNA damage.	
P04637	UniProtKB	Mutagenesis	20	20	.	.	.	Note=Constitutively increased TP53 protein levels.	
P04637	UniProtKB	Mutagenesis	22	23	.	.	.	Note=Loss of interaction with MDM2%2C leading to constitutively increased TP53 protein levels.	
P04637	UniProtKB	Mutagenesis	37	37	.	.	.	Note=Abolihes phosphorylation by MAPKAPK5.	
P04637	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Abolishes phosphorylation by DYRK2 and HIPK2 and acetylation of K-382 by CREBBP.	
P04637	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Alters interaction with WWOX.	
P04637	UniProtKB	Mutagenesis	55	55	.	.	.	Note=Blocks phosphorylation by TAF1.	
P04637	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Abolishes strongly phosphorylation.	
P04637	UniProtKB	Mutagenesis	183	183	.	.	.	Note=Inhibits slightly its transcriptional activity.	
P04637	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Does not induce SNAI1 degradation.	
P04637	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Abolishes phosphorylation.	
P04637	UniProtKB	Mutagenesis	269	269	.	.	.	Note=Inhibits strongly its transcriptional activity.	
P04637	UniProtKB	Mutagenesis	284	284	.	.	.	Note=Inhibits strongly its transcriptional activity.	
P04637	UniProtKB	Mutagenesis	291	292	.	.	.	Note=Abolishes polyubiquitination by MKRN1.	
P04637	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Loss of nuclear localization%3B when associated with A-320 and A-321.	
P04637	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Loss of nuclear localization%3B when associated with A-319 and A-321.	
P04637	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Loss of nuclear localization%3B when associated with A-319 and A-320.	
P04637	UniProtKB	Mutagenesis	359	359	.	.	.	Note=Abolishes binding to USP7.	
P04637	UniProtKB	Mutagenesis	361	361	.	.	.	Note=Abolishes binding to USP7.	
P04637	UniProtKB	Mutagenesis	362	362	.	.	.	Note=Abolishes binding to USP7.	
P04637	UniProtKB	Mutagenesis	370	370	.	.	.	Note=Induces a decrease in methylation by SMYD2.	
P04637	UniProtKB	Mutagenesis	372	372	.	.	.	Note=Induces a decrease in protein stabilization.	
P04637	UniProtKB	Mutagenesis	373	373	.	.	.	Note=Abolishes dimethylation by EHMT1 and EHMT2.	
P04637	UniProtKB	Mutagenesis	382	382	.	.	.	Note=Abolishes acetylation by CREBBP.	
P04637	UniProtKB	Mutagenesis	382	382	.	.	.	Note=Abolishes monomethylation by SETD8.	
P04637	UniProtKB	Mutagenesis	383	383	.	.	.	Note=Abolishes S-315 phosphorylation by CDK2/cyclin A.	
P04637	UniProtKB	Mutagenesis	385	385	.	.	.	Note=Reduced SUMO1 conjugation.	
P04637	UniProtKB	Mutagenesis	386	386	.	.	.	Note=Abolishes SUMO1 conjugation%2C in vitro and in vivo.	
P04637	UniProtKB	Mutagenesis	387	387	.	.	.	Note=No effect SUMO1 conjugation.	
P04637	UniProtKB	Mutagenesis	388	388	.	.	.	Note=Abolishes SUMO1 conjugation.	
P04637	UniProtKB	Helix	19	23	.	.	.	.	
P04637	UniProtKB	Beta strand	27	29	.	.	.	.	
P04637	UniProtKB	Beta strand	33	35	.	.	.	.	
P04637	UniProtKB	Helix	36	38	.	.	.	.	
P04637	UniProtKB	Helix	41	44	.	.	.	.	
P04637	UniProtKB	Helix	47	55	.	.	.	.	
P04637	UniProtKB	Turn	105	108	.	.	.	.	
P04637	UniProtKB	Beta strand	110	112	.	.	.	.	
P04637	UniProtKB	Beta strand	118	120	.	.	.	.	
P04637	UniProtKB	Turn	121	123	.	.	.	.	
P04637	UniProtKB	Beta strand	124	127	.	.	.	.	
P04637	UniProtKB	Turn	128	131	.	.	.	.	
P04637	UniProtKB	Beta strand	132	135	.	.	.	.	
P04637	UniProtKB	Beta strand	141	146	.	.	.	.	
P04637	UniProtKB	Beta strand	156	165	.	.	.	.	
P04637	UniProtKB	Helix	166	168	.	.	.	.	
P04637	UniProtKB	Helix	177	180	.	.	.	.	
P04637	UniProtKB	Beta strand	181	183	.	.	.	.	
P04637	UniProtKB	Beta strand	187	189	.	.	.	.	
P04637	UniProtKB	Beta strand	194	199	.	.	.	.	
P04637	UniProtKB	Beta strand	204	207	.	.	.	.	
P04637	UniProtKB	Turn	209	211	.	.	.	.	
P04637	UniProtKB	Beta strand	214	219	.	.	.	.	
P04637	UniProtKB	Turn	225	227	.	.	.	.	
P04637	UniProtKB	Beta strand	228	236	.	.	.	.	
P04637	UniProtKB	Helix	240	242	.	.	.	.	
P04637	UniProtKB	Turn	243	248	.	.	.	.	
P04637	UniProtKB	Beta strand	251	258	.	.	.	.	
P04637	UniProtKB	Beta strand	260	262	.	.	.	.	
P04637	UniProtKB	Beta strand	264	274	.	.	.	.	
P04637	UniProtKB	Helix	278	287	.	.	.	.	
P04637	UniProtKB	Helix	288	290	.	.	.	.	
P04637	UniProtKB	Beta strand	300	303	.	.	.	.	
P04637	UniProtKB	Helix	307	319	.	.	.	.	
P04637	UniProtKB	Helix	322	324	.	.	.	.	
P04637	UniProtKB	Beta strand	327	334	.	.	.	.	
P04637	UniProtKB	Helix	335	354	.	.	.	.	
P04637	UniProtKB	Helix	375	380	.	.	.	.	
P04637	UniProtKB	Turn	382	385	.	.	.	.	
##sequence-region O93379 1 376
O93379	UniProtKB	Chain	1	376	.	.	.	ID=PRO_0000185719;Note=Cellular tumor antigen p53	
O93379	UniProtKB	DNA binding	77	268	.	.	.	status=By similarity	
O93379	UniProtKB	Region	1	36	.	.	.	Note=Transcription activation (acidic)	
O93379	UniProtKB	Region	249	256	.	.	.	Note=Interaction with DNA;status=By similarity	
O93379	UniProtKB	Region	303	334	.	.	.	Note=Oligomerization	
O93379	UniProtKB	Region	347	372	.	.	.	Note=Basic (repression of DNA-binding)	
O93379	UniProtKB	Motif	280	297	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
O93379	UniProtKB	Motif	317	328	.	.	.	Note=Nuclear export signal;status=By similarity	
O93379	UniProtKB	Metal binding	151	151	.	.	.	Note=Zinc;status=By similarity	
O93379	UniProtKB	Metal binding	154	154	.	.	.	Note=Zinc;status=By similarity	
O93379	UniProtKB	Metal binding	214	214	.	.	.	Note=Zinc;status=By similarity	
O93379	UniProtKB	Metal binding	218	218	.	.	.	Note=Zinc;status=By similarity	
O93379	UniProtKB	Site	95	95	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region P56423 1 393
P56423	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185704;Note=Cellular tumor antigen p53	
P56423	UniProtKB	DNA binding	102	292	.	.	.	status=By similarity	
P56423	UniProtKB	Region	1	83	.	.	.	Note=Interaction with HRMT1L2;status=By similarity	
P56423	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P56423	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX;status=By similarity	
P56423	UniProtKB	Region	100	370	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P56423	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P56423	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P56423	UniProtKB	Region	116	292	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P56423	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1;status=By similarity	
P56423	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA;status=By similarity	
P56423	UniProtKB	Region	300	393	.	.	.	Note=Interaction with CARM1;status=By similarity	
P56423	UniProtKB	Region	319	360	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P56423	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
P56423	UniProtKB	Region	359	363	.	.	.	Note=Interaction with USP7;status=By similarity	
P56423	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
P56423	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P56423	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal;status=By similarity	
P56423	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
P56423	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc;status=By similarity	
P56423	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc;status=By similarity	
P56423	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc;status=By similarity	
P56423	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc;status=By similarity	
P56423	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA;status=By similarity	
P56423	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
P56423	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P56423	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P56423	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P56423	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P56423	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P56423	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
P56423	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1 and GRK5%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P56423	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P56423	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P56423	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P56423	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine;status=By similarity	
P56423	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P56423	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P56423	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine;status=By similarity	
P56423	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P56423	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P56423	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P56423	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P56423	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P56423	UniProtKB	Sequence conflict	30	30	.	.	.	.	
##sequence-region P61260 1 393
P61260	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185705;Note=Cellular tumor antigen p53	
P61260	UniProtKB	DNA binding	102	292	.	.	.	status=By similarity	
P61260	UniProtKB	Region	1	83	.	.	.	Note=Interaction with HRMT1L2;status=By similarity	
P61260	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P61260	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX;status=By similarity	
P61260	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P61260	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P61260	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1;status=By similarity	
P61260	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA;status=By similarity	
P61260	UniProtKB	Region	300	393	.	.	.	Note=Interaction with CARM1;status=By similarity	
P61260	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
P61260	UniProtKB	Region	359	363	.	.	.	Note=Interaction with USP7;status=By similarity	
P61260	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
P61260	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P61260	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal;status=By similarity	
P61260	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
P61260	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc;status=By similarity	
P61260	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc;status=By similarity	
P61260	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc;status=By similarity	
P61260	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc;status=By similarity	
P61260	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA;status=By similarity	
P61260	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
P61260	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P61260	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P61260	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P61260	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P61260	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P61260	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
P61260	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1 and GRK5%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P61260	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P61260	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P61260	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P61260	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine;status=By similarity	
P61260	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P61260	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P61260	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine;status=By similarity	
P61260	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P61260	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P61260	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P61260	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P61260	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region P56424 1 393
P56424	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185706;Note=Cellular tumor antigen p53	
P56424	UniProtKB	DNA binding	102	292	.	.	.	status=By similarity	
P56424	UniProtKB	Region	1	83	.	.	.	Note=Interaction with HRMT1L2;status=By similarity	
P56424	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P56424	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX;status=By similarity	
P56424	UniProtKB	Region	100	370	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P56424	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P56424	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P56424	UniProtKB	Region	116	292	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P56424	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1;status=By similarity	
P56424	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA;status=By similarity	
P56424	UniProtKB	Region	300	393	.	.	.	Note=Interaction with CARM1;status=By similarity	
P56424	UniProtKB	Region	319	360	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P56424	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
P56424	UniProtKB	Region	359	363	.	.	.	Note=Interaction with USP7;status=By similarity	
P56424	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
P56424	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P56424	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal;status=By similarity	
P56424	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
P56424	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc;status=By similarity	
P56424	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc;status=By similarity	
P56424	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc;status=By similarity	
P56424	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc;status=By similarity	
P56424	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA;status=By similarity	
P56424	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
P56424	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P56424	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P56424	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P56424	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P56424	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P56424	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
P56424	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1 and GRK5%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P56424	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P56424	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P56424	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P56424	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine;status=By similarity	
P56424	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P56424	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P56424	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine;status=By similarity	
P56424	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P56424	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P56424	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P56424	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P56424	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region O36006 1 391
O36006	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000185707;Note=Cellular tumor antigen p53	
O36006	UniProtKB	DNA binding	100	290	.	.	.	status=By similarity	
O36006	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
O36006	UniProtKB	Region	64	108	.	.	.	Note=Interaction with WWOX;status=By similarity	
O36006	UniProtKB	Region	98	368	.	.	.	Note=Interaction with HIPK1;status=By similarity	
O36006	UniProtKB	Region	98	298	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
O36006	UniProtKB	Region	111	234	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
O36006	UniProtKB	Region	114	290	.	.	.	Note=Interaction with AXIN1;status=By similarity	
O36006	UniProtKB	Region	254	292	.	.	.	Note=Interaction with E4F1;status=By similarity	
O36006	UniProtKB	Region	271	278	.	.	.	Note=Interaction with DNA;status=By similarity	
O36006	UniProtKB	Region	317	358	.	.	.	Note=Interaction with HIPK2;status=By similarity	
O36006	UniProtKB	Region	323	354	.	.	.	Note=Oligomerization	
O36006	UniProtKB	Region	357	361	.	.	.	Note=Interaction with USP7;status=By similarity	
O36006	UniProtKB	Region	366	385	.	.	.	Note=Basic (repression of DNA-binding)	
O36006	UniProtKB	Motif	303	319	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
O36006	UniProtKB	Motif	337	348	.	.	.	Note=Nuclear export signal;status=By similarity	
O36006	UniProtKB	Motif	368	370	.	.	.	Note=[KR]-[STA]-K motif	
O36006	UniProtKB	Metal binding	174	174	.	.	.	Note=Zinc;status=By similarity	
O36006	UniProtKB	Metal binding	177	177	.	.	.	Note=Zinc;status=By similarity	
O36006	UniProtKB	Metal binding	236	236	.	.	.	Note=Zinc;status=By similarity	
O36006	UniProtKB	Metal binding	240	240	.	.	.	Note=Zinc;status=By similarity	
O36006	UniProtKB	Site	118	118	.	.	.	Note=Interaction with DNA;status=By similarity	
O36006	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
O36006	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
O36006	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
O36006	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
O36006	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
O36006	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
O36006	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
O36006	UniProtKB	Modified residue	118	118	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
O36006	UniProtKB	Modified residue	181	181	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
O36006	UniProtKB	Modified residue	267	267	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
O36006	UniProtKB	Modified residue	282	282	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
O36006	UniProtKB	Modified residue	303	303	.	.	.	Note=N6-acetyllysine;status=By similarity	
O36006	UniProtKB	Modified residue	313	313	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
O36006	UniProtKB	Modified residue	368	368	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
O36006	UniProtKB	Modified residue	368	368	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
O36006	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
O36006	UniProtKB	Modified residue	371	371	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
O36006	UniProtKB	Modified residue	371	371	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
O36006	UniProtKB	Modified residue	379	379	.	.	.	Note=N6-acetyllysine;status=By similarity	
O36006	UniProtKB	Modified residue	380	380	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
O36006	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
O36006	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
O36006	UniProtKB	Modified residue	390	390	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
O36006	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
O36006	UniProtKB	Cross-link	384	384	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q00366 1 396
Q00366	UniProtKB	Chain	1	396	.	.	.	ID=PRO_0000185708;Note=Cellular tumor antigen p53	
Q00366	UniProtKB	DNA binding	105	295	.	.	.	status=By similarity	
Q00366	UniProtKB	Region	1	45	.	.	.	Note=Transcription activation (acidic)	
Q00366	UniProtKB	Region	66	113	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q00366	UniProtKB	Region	103	373	.	.	.	Note=Interaction with HIPK1;status=By similarity	
Q00366	UniProtKB	Region	103	303	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q00366	UniProtKB	Region	116	239	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q00366	UniProtKB	Region	119	295	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q00366	UniProtKB	Region	259	297	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q00366	UniProtKB	Region	276	283	.	.	.	Note=Interaction with DNA;status=By similarity	
Q00366	UniProtKB	Region	322	363	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q00366	UniProtKB	Region	328	359	.	.	.	Note=Oligomerization	
Q00366	UniProtKB	Region	362	366	.	.	.	Note=Interaction with USP7;status=By similarity	
Q00366	UniProtKB	Region	371	390	.	.	.	Note=Basic (repression of DNA-binding)	
Q00366	UniProtKB	Motif	308	324	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q00366	UniProtKB	Motif	342	353	.	.	.	Note=Nuclear export signal;status=By similarity	
Q00366	UniProtKB	Motif	373	375	.	.	.	Note=[KR]-[STA]-K motif	
Q00366	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc;status=By similarity	
Q00366	UniProtKB	Metal binding	182	182	.	.	.	Note=Zinc;status=By similarity	
Q00366	UniProtKB	Metal binding	241	241	.	.	.	Note=Zinc;status=By similarity	
Q00366	UniProtKB	Metal binding	245	245	.	.	.	Note=Zinc;status=By similarity	
Q00366	UniProtKB	Site	123	123	.	.	.	Note=Interaction with DNA;status=By similarity	
Q00366	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
Q00366	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
Q00366	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
Q00366	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
Q00366	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
Q00366	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
Q00366	UniProtKB	Modified residue	47	47	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
Q00366	UniProtKB	Modified residue	123	123	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q00366	UniProtKB	Modified residue	186	186	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q00366	UniProtKB	Modified residue	272	272	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q00366	UniProtKB	Modified residue	287	287	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
Q00366	UniProtKB	Modified residue	308	308	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q00366	UniProtKB	Modified residue	318	318	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q00366	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q00366	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
Q00366	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
Q00366	UniProtKB	Modified residue	376	376	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
Q00366	UniProtKB	Modified residue	376	376	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
Q00366	UniProtKB	Modified residue	384	384	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q00366	UniProtKB	Modified residue	385	385	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q00366	UniProtKB	Modified residue	385	385	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
Q00366	UniProtKB	Modified residue	385	385	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
Q00366	UniProtKB	Modified residue	395	395	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
Q00366	UniProtKB	Cross-link	294	294	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q00366	UniProtKB	Cross-link	295	295	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q00366	UniProtKB	Cross-link	389	389	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q00366	UniProtKB	Sequence conflict	188	188	.	.	.	.	
##sequence-region P02340 1 387
P02340	UniProtKB	Chain	1	387	.	.	.	ID=PRO_0000185709;Note=Cellular tumor antigen p53	
P02340	UniProtKB	DNA binding	96	286	.	.	.	status=By similarity	
P02340	UniProtKB	Region	1	42	.	.	.	Note=Transcription activation (acidic)	
P02340	UniProtKB	Region	60	104	.	.	.	Note=Interaction with WWOX;status=By similarity	
P02340	UniProtKB	Region	94	364	.	.	.	Note=Interaction with HIPK1	
P02340	UniProtKB	Region	94	294	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P02340	UniProtKB	Region	107	230	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P02340	UniProtKB	Region	110	286	.	.	.	Note=Interaction with AXIN1	
P02340	UniProtKB	Region	253	291	.	.	.	Note=Interaction with E4F1;status=By similarity	
P02340	UniProtKB	Region	267	274	.	.	.	Note=Interaction with DNA	
P02340	UniProtKB	Region	313	354	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P02340	UniProtKB	Region	319	350	.	.	.	Note=Oligomerization	
P02340	UniProtKB	Region	353	357	.	.	.	Note=Interaction with USP7;status=By similarity	
P02340	UniProtKB	Region	362	381	.	.	.	Note=Basic (repression of DNA-binding)	
P02340	UniProtKB	Motif	299	315	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P02340	UniProtKB	Motif	333	344	.	.	.	Note=Nuclear export signal;status=By similarity	
P02340	UniProtKB	Motif	364	366	.	.	.	Note=[KR]-[STA]-K motif	
P02340	UniProtKB	Metal binding	170	170	.	.	.	Note=Zinc	
P02340	UniProtKB	Metal binding	173	173	.	.	.	Note=Zinc	
P02340	UniProtKB	Metal binding	232	232	.	.	.	Note=Zinc	
P02340	UniProtKB	Metal binding	236	236	.	.	.	Note=Zinc	
P02340	UniProtKB	Site	114	114	.	.	.	Note=Interaction with DNA	
P02340	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4	
P02340	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM	
P02340	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P02340	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P02340	UniProtKB	Modified residue	34	34	.	.	.	Note=Phosphoserine%3B by MAPKAPK5	
P02340	UniProtKB	Modified residue	114	114	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P02340	UniProtKB	Modified residue	177	177	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P02340	UniProtKB	Modified residue	263	263	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P02340	UniProtKB	Modified residue	278	278	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P02340	UniProtKB	Modified residue	299	299	.	.	.	Note=N6-acetyllysine;status=By similarity	
P02340	UniProtKB	Modified residue	309	309	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P02340	UniProtKB	Modified residue	364	364	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P02340	UniProtKB	Modified residue	364	364	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P02340	UniProtKB	Modified residue	366	366	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P02340	UniProtKB	Modified residue	367	367	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P02340	UniProtKB	Modified residue	367	367	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P02340	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-acetyllysine;status=By similarity	
P02340	UniProtKB	Modified residue	376	376	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P02340	UniProtKB	Modified residue	376	376	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P02340	UniProtKB	Modified residue	376	376	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P02340	UniProtKB	Modified residue	386	386	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P02340	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P02340	UniProtKB	Cross-link	286	286	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P02340	UniProtKB	Cross-link	380	380	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P02340	UniProtKB	Natural variant	132	132	.	.	.	Note=Can cooperate with an activated Ras to transform fibroblasts.	
P02340	UniProtKB	Natural variant	165	165	.	.	.	Note=In clone P53-M11.	
P02340	UniProtKB	Natural variant	188	188	.	.	.	.	
P02340	UniProtKB	Sequence conflict	45	45	.	.	.	.	
P02340	UniProtKB	Sequence conflict	76	78	.	.	.	.	
P02340	UniProtKB	Helix	99	101	.	.	.	.	
P02340	UniProtKB	Beta strand	104	106	.	.	.	.	
P02340	UniProtKB	Helix	113	116	.	.	.	.	
P02340	UniProtKB	Beta strand	117	121	.	.	.	.	
P02340	UniProtKB	Turn	122	125	.	.	.	.	
P02340	UniProtKB	Beta strand	126	129	.	.	.	.	
P02340	UniProtKB	Beta strand	134	140	.	.	.	.	
P02340	UniProtKB	Beta strand	150	159	.	.	.	.	
P02340	UniProtKB	Turn	160	164	.	.	.	.	
P02340	UniProtKB	Helix	171	175	.	.	.	.	
P02340	UniProtKB	Beta strand	181	183	.	.	.	.	
P02340	UniProtKB	Beta strand	188	193	.	.	.	.	
P02340	UniProtKB	Beta strand	198	201	.	.	.	.	
P02340	UniProtKB	Turn	203	205	.	.	.	.	
P02340	UniProtKB	Beta strand	208	213	.	.	.	.	
P02340	UniProtKB	Beta strand	222	230	.	.	.	.	
P02340	UniProtKB	Helix	235	237	.	.	.	.	
P02340	UniProtKB	Helix	239	242	.	.	.	.	
P02340	UniProtKB	Beta strand	245	252	.	.	.	.	
P02340	UniProtKB	Beta strand	258	268	.	.	.	.	
P02340	UniProtKB	Helix	272	283	.	.	.	.	
P02340	UniProtKB	Turn	285	287	.	.	.	.	
##sequence-region P25035 1 396
P25035	UniProtKB	Chain	1	396	.	.	.	ID=PRO_0000185720;Note=Cellular tumor antigen p53	
P25035	UniProtKB	DNA binding	90	281	.	.	.	status=By similarity	
P25035	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P25035	UniProtKB	Region	262	269	.	.	.	Note=Interaction with DNA;status=By similarity	
P25035	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
P25035	UniProtKB	Region	369	392	.	.	.	Note=Basic (repression of DNA-binding)	
P25035	UniProtKB	Motif	297	317	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P25035	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal;status=By similarity	
P25035	UniProtKB	Metal binding	164	164	.	.	.	Note=Zinc;status=By similarity	
P25035	UniProtKB	Metal binding	167	167	.	.	.	Note=Zinc;status=By similarity	
P25035	UniProtKB	Metal binding	227	227	.	.	.	Note=Zinc;status=By similarity	
P25035	UniProtKB	Metal binding	231	231	.	.	.	Note=Zinc;status=By similarity	
P25035	UniProtKB	Site	108	108	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region P79820 1 352
P79820	UniProtKB	Chain	1	352	.	.	.	ID=PRO_0000185721;Note=Cellular tumor antigen p53	
P79820	UniProtKB	DNA binding	87	273	.	.	.	status=By similarity	
P79820	UniProtKB	Region	1	48	.	.	.	Note=Transcription activation (acidic)	
P79820	UniProtKB	Region	254	261	.	.	.	Note=Interaction with DNA;status=By similarity	
P79820	UniProtKB	Region	302	331	.	.	.	Note=Oligomerization	
P79820	UniProtKB	Region	334	350	.	.	.	Note=Basic (repression of DNA-binding)	
P79820	UniProtKB	Motif	276	291	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P79820	UniProtKB	Motif	316	327	.	.	.	Note=Nuclear export signal;status=By similarity	
P79820	UniProtKB	Metal binding	161	161	.	.	.	Note=Zinc;status=By similarity	
P79820	UniProtKB	Metal binding	164	164	.	.	.	Note=Zinc;status=By similarity	
P79820	UniProtKB	Metal binding	220	220	.	.	.	Note=Zinc;status=By similarity	
P79820	UniProtKB	Metal binding	224	224	.	.	.	Note=Zinc;status=By similarity	
P79820	UniProtKB	Site	105	105	.	.	.	Note=Interaction with DNA;status=By similarity	
P79820	UniProtKB	Modified residue	351	351	.	.	.	Note=Phosphoserine;status=By similarity	
P79820	UniProtKB	Natural variant	91	91	.	.	.	.	
P79820	UniProtKB	Sequence conflict	22	22	.	.	.	.	
##sequence-region Q9TUB2 1 386
Q9TUB2	UniProtKB	Chain	1	386	.	.	.	ID=PRO_0000185710;Note=Cellular tumor antigen p53	
Q9TUB2	UniProtKB	DNA binding	94	285	.	.	.	status=By similarity	
Q9TUB2	UniProtKB	Region	1	45	.	.	.	Note=Transcription activation (acidic)	
Q9TUB2	UniProtKB	Region	63	102	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q9TUB2	UniProtKB	Region	92	363	.	.	.	Note=Interaction with HIPK1;status=By similarity	
Q9TUB2	UniProtKB	Region	92	293	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q9TUB2	UniProtKB	Region	105	229	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q9TUB2	UniProtKB	Region	108	285	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q9TUB2	UniProtKB	Region	249	287	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q9TUB2	UniProtKB	Region	266	273	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9TUB2	UniProtKB	Region	312	353	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q9TUB2	UniProtKB	Region	318	349	.	.	.	Note=Oligomerization	
Q9TUB2	UniProtKB	Region	352	356	.	.	.	Note=Interaction with USP7;status=By similarity	
Q9TUB2	UniProtKB	Region	361	380	.	.	.	Note=Basic (repression of DNA-binding)	
Q9TUB2	UniProtKB	Motif	298	314	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q9TUB2	UniProtKB	Motif	332	343	.	.	.	Note=Nuclear export signal;status=By similarity	
Q9TUB2	UniProtKB	Motif	363	365	.	.	.	Note=[KR]-[STA]-K motif	
Q9TUB2	UniProtKB	Metal binding	168	168	.	.	.	Note=Zinc;status=By similarity	
Q9TUB2	UniProtKB	Metal binding	171	171	.	.	.	Note=Zinc;status=By similarity	
Q9TUB2	UniProtKB	Metal binding	231	231	.	.	.	Note=Zinc;status=By similarity	
Q9TUB2	UniProtKB	Metal binding	235	235	.	.	.	Note=Zinc;status=By similarity	
Q9TUB2	UniProtKB	Site	112	112	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	47	47	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	112	112	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	175	175	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	262	262	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	277	277	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	298	298	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	363	363	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	363	363	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	365	365	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	366	366	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	366	366	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	374	374	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	375	375	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	375	375	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
Q9TUB2	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
Q9TUB2	UniProtKB	Cross-link	284	284	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q9TUB2	UniProtKB	Cross-link	285	285	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q9TUB2	UniProtKB	Cross-link	379	379	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region O12946 1 366
O12946	UniProtKB	Chain	1	366	.	.	.	ID=PRO_0000185722;Note=Cellular tumor antigen p53	
O12946	UniProtKB	DNA binding	80	267	.	.	.	status=By similarity	
O12946	UniProtKB	Region	1	41	.	.	.	Note=Transcription activation (acidic)	
O12946	UniProtKB	Region	248	255	.	.	.	Note=Interaction with DNA;status=By similarity	
O12946	UniProtKB	Region	305	336	.	.	.	Note=Oligomerization	
O12946	UniProtKB	Region	341	362	.	.	.	Note=Basic (repression of DNA-binding)	
O12946	UniProtKB	Motif	275	295	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
O12946	UniProtKB	Motif	319	330	.	.	.	Note=Nuclear export signal;status=By similarity	
O12946	UniProtKB	Metal binding	154	154	.	.	.	Note=Zinc;status=By similarity	
O12946	UniProtKB	Metal binding	157	157	.	.	.	Note=Zinc;status=By similarity	
O12946	UniProtKB	Metal binding	213	213	.	.	.	Note=Zinc;status=By similarity	
O12946	UniProtKB	Metal binding	217	217	.	.	.	Note=Zinc;status=By similarity	
O12946	UniProtKB	Site	98	98	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region Q95330 1 391
Q95330	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000185711;Note=Cellular tumor antigen p53	
Q95330	UniProtKB	DNA binding	99	289	.	.	.	status=By similarity	
Q95330	UniProtKB	Region	1	43	.	.	.	Note=Transcription activation (acidic)	
Q95330	UniProtKB	Region	63	107	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q95330	UniProtKB	Region	97	368	.	.	.	Note=Interaction with HIPK1;status=By similarity	
Q95330	UniProtKB	Region	97	297	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q95330	UniProtKB	Region	110	233	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q95330	UniProtKB	Region	113	289	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q95330	UniProtKB	Region	253	291	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q95330	UniProtKB	Region	270	277	.	.	.	Note=Interaction with DNA;status=By similarity	
Q95330	UniProtKB	Region	317	358	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q95330	UniProtKB	Region	323	354	.	.	.	Note=Oligomerization	
Q95330	UniProtKB	Region	357	361	.	.	.	Note=Interaction with USP7;status=By similarity	
Q95330	UniProtKB	Region	366	385	.	.	.	Note=Basic (repression of DNA-binding)	
Q95330	UniProtKB	Motif	302	319	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q95330	UniProtKB	Motif	337	348	.	.	.	Note=Nuclear export signal;status=By similarity	
Q95330	UniProtKB	Motif	368	370	.	.	.	Note=[KR]-[STA]-K motif	
Q95330	UniProtKB	Metal binding	173	173	.	.	.	Note=Zinc;status=By similarity	
Q95330	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc;status=By similarity	
Q95330	UniProtKB	Metal binding	235	235	.	.	.	Note=Zinc;status=By similarity	
Q95330	UniProtKB	Metal binding	239	239	.	.	.	Note=Zinc;status=By similarity	
Q95330	UniProtKB	Site	117	117	.	.	.	Note=Interaction with DNA;status=By similarity	
Q95330	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
Q95330	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
Q95330	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
Q95330	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
Q95330	UniProtKB	Modified residue	117	117	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q95330	UniProtKB	Modified residue	180	180	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q95330	UniProtKB	Modified residue	266	266	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
Q95330	UniProtKB	Modified residue	281	281	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
Q95330	UniProtKB	Modified residue	302	302	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q95330	UniProtKB	Modified residue	313	313	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q95330	UniProtKB	Modified residue	368	368	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q95330	UniProtKB	Modified residue	368	368	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
Q95330	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
Q95330	UniProtKB	Modified residue	371	371	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
Q95330	UniProtKB	Modified residue	371	371	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
Q95330	UniProtKB	Modified residue	379	379	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q95330	UniProtKB	Modified residue	380	380	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q95330	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
Q95330	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
Q95330	UniProtKB	Modified residue	390	390	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
Q95330	UniProtKB	Cross-link	288	288	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q95330	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q95330	UniProtKB	Cross-link	384	384	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region P10361 1 391
P10361	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000185712;Note=Cellular tumor antigen p53	
P10361	UniProtKB	DNA binding	100	290	.	.	.	status=By similarity	
P10361	UniProtKB	Region	1	47	.	.	.	Note=Transcription activation (acidic)	
P10361	UniProtKB	Region	64	108	.	.	.	Note=Interaction with WWOX;status=By similarity	
P10361	UniProtKB	Region	98	368	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P10361	UniProtKB	Region	98	298	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P10361	UniProtKB	Region	111	234	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P10361	UniProtKB	Region	114	290	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P10361	UniProtKB	Region	254	292	.	.	.	Note=Interaction with E4F1;status=By similarity	
P10361	UniProtKB	Region	271	278	.	.	.	Note=Interaction with DNA;status=By similarity	
P10361	UniProtKB	Region	317	358	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P10361	UniProtKB	Region	323	354	.	.	.	Note=Oligomerization	
P10361	UniProtKB	Region	357	361	.	.	.	Note=Interaction with USP7;status=By similarity	
P10361	UniProtKB	Region	366	385	.	.	.	Note=Basic (repression of DNA-binding)	
P10361	UniProtKB	Motif	303	319	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P10361	UniProtKB	Motif	337	348	.	.	.	Note=Nuclear export signal;status=By similarity	
P10361	UniProtKB	Motif	368	370	.	.	.	Note=[KR]-[STA]-K motif	
P10361	UniProtKB	Metal binding	174	174	.	.	.	Note=Zinc;status=By similarity	
P10361	UniProtKB	Metal binding	177	177	.	.	.	Note=Zinc;status=By similarity	
P10361	UniProtKB	Metal binding	236	236	.	.	.	Note=Zinc;status=By similarity	
P10361	UniProtKB	Metal binding	240	240	.	.	.	Note=Zinc;status=By similarity	
P10361	UniProtKB	Site	118	118	.	.	.	Note=Interaction with DNA;status=By similarity	
P10361	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
P10361	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P10361	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P10361	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P10361	UniProtKB	Modified residue	39	39	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P10361	UniProtKB	Modified residue	118	118	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P10361	UniProtKB	Modified residue	181	181	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P10361	UniProtKB	Modified residue	267	267	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P10361	UniProtKB	Modified residue	282	282	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P10361	UniProtKB	Modified residue	303	303	.	.	.	Note=N6-acetyllysine;status=By similarity	
P10361	UniProtKB	Modified residue	313	313	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P10361	UniProtKB	Modified residue	368	368	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P10361	UniProtKB	Modified residue	368	368	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P10361	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P10361	UniProtKB	Modified residue	371	371	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P10361	UniProtKB	Modified residue	371	371	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P10361	UniProtKB	Modified residue	379	379	.	.	.	Note=N6-acetyllysine;status=By similarity	
P10361	UniProtKB	Modified residue	380	380	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P10361	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P10361	UniProtKB	Modified residue	380	380	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P10361	UniProtKB	Modified residue	390	390	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P10361	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P10361	UniProtKB	Cross-link	290	290	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P10361	UniProtKB	Cross-link	384	384	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P10361	UniProtKB	Natural variant	103	103	.	.	.	.	
P10361	UniProtKB	Natural variant	256	256	.	.	.	.	
P10361	UniProtKB	Sequence conflict	174	174	.	.	.	.	
##sequence-region P51664 1 382
P51664	UniProtKB	Chain	1	382	.	.	.	ID=PRO_0000185713;Note=Cellular tumor antigen p53	
P51664	UniProtKB	DNA binding	90	281	.	.	.	status=By similarity	
P51664	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
P51664	UniProtKB	Region	64	98	.	.	.	Note=Interaction with WWOX;status=By similarity	
P51664	UniProtKB	Region	88	359	.	.	.	Note=Interaction with HIPK1;status=By similarity	
P51664	UniProtKB	Region	88	289	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
P51664	UniProtKB	Region	101	225	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
P51664	UniProtKB	Region	104	281	.	.	.	Note=Interaction with AXIN1;status=By similarity	
P51664	UniProtKB	Region	245	283	.	.	.	Note=Interaction with E4F1;status=By similarity	
P51664	UniProtKB	Region	262	269	.	.	.	Note=Interaction with DNA;status=By similarity	
P51664	UniProtKB	Region	308	349	.	.	.	Note=Interaction with HIPK2;status=By similarity	
P51664	UniProtKB	Region	314	345	.	.	.	Note=Oligomerization	
P51664	UniProtKB	Region	348	352	.	.	.	Note=Interaction with USP7;status=By similarity	
P51664	UniProtKB	Region	357	376	.	.	.	Note=Basic (repression of DNA-binding)	
P51664	UniProtKB	Motif	294	310	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P51664	UniProtKB	Motif	328	339	.	.	.	Note=Nuclear export signal;status=By similarity	
P51664	UniProtKB	Motif	359	361	.	.	.	Note=[KR]-[STA]-K motif	
P51664	UniProtKB	Metal binding	167	167	.	.	.	Note=Zinc;status=By similarity	
P51664	UniProtKB	Metal binding	227	227	.	.	.	Note=Zinc;status=By similarity	
P51664	UniProtKB	Metal binding	231	231	.	.	.	Note=Zinc;status=By similarity	
P51664	UniProtKB	Site	108	108	.	.	.	Note=Interaction with DNA;status=By similarity	
P51664	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
P51664	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
P51664	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
P51664	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
P51664	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
P51664	UniProtKB	Modified residue	108	108	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
P51664	UniProtKB	Modified residue	171	171	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P51664	UniProtKB	Modified residue	258	258	.	.	.	Note=Phosphoserine%3B by AURKB;status=By similarity	
P51664	UniProtKB	Modified residue	273	273	.	.	.	Note=Phosphothreonine%3B by AURKB;status=By similarity	
P51664	UniProtKB	Modified residue	294	294	.	.	.	Note=N6-acetyllysine;status=By similarity	
P51664	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
P51664	UniProtKB	Modified residue	359	359	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P51664	UniProtKB	Modified residue	359	359	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
P51664	UniProtKB	Modified residue	361	361	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
P51664	UniProtKB	Modified residue	362	362	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
P51664	UniProtKB	Modified residue	362	362	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
P51664	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-acetyllysine;status=By similarity	
P51664	UniProtKB	Modified residue	371	371	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
P51664	UniProtKB	Modified residue	371	371	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
P51664	UniProtKB	Modified residue	371	371	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
P51664	UniProtKB	Modified residue	381	381	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
P51664	UniProtKB	Cross-link	280	280	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P51664	UniProtKB	Cross-link	281	281	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P51664	UniProtKB	Cross-link	375	375	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q64662 1 314
Q64662	UniProtKB	Chain	1	314	.	.	.	ID=PRO_0000185714;Note=Cellular tumor antigen p53	
Q64662	UniProtKB	DNA binding	80	270	.	.	.	status=By similarity	
Q64662	UniProtKB	Region	1	24	.	.	.	Note=Transcription activation (acidic)	
Q64662	UniProtKB	Region	44	88	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q64662	UniProtKB	Region	78	278	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q64662	UniProtKB	Region	91	214	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q64662	UniProtKB	Region	234	272	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q64662	UniProtKB	Region	251	258	.	.	.	Note=Interaction with DNA;status=By similarity	
Q64662	UniProtKB	Region	303	314	.	.	.	Note=Oligomerization	
Q64662	UniProtKB	Motif	283	299	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q64662	UniProtKB	Metal binding	154	154	.	.	.	Note=Zinc;status=By similarity	
Q64662	UniProtKB	Metal binding	157	157	.	.	.	Note=Zinc;status=By similarity	
Q64662	UniProtKB	Metal binding	216	216	.	.	.	Note=Zinc;status=By similarity	
Q64662	UniProtKB	Metal binding	220	220	.	.	.	Note=Zinc;status=By similarity	
Q64662	UniProtKB	Site	98	98	.	.	.	Note=Interaction with DNA;status=By similarity	
Q64662	UniProtKB	Modified residue	13	13	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
Q64662	UniProtKB	Modified residue	17	17	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
Q64662	UniProtKB	Modified residue	26	26	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
Q64662	UniProtKB	Modified residue	98	98	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q64662	UniProtKB	Modified residue	161	161	.	.	.	Note=Phosphoserine;status=By similarity	
Q64662	UniProtKB	Modified residue	247	247	.	.	.	Note=Phosphoserine;status=By similarity	
Q64662	UniProtKB	Modified residue	262	262	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64662	UniProtKB	Modified residue	283	283	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q64662	UniProtKB	Modified residue	293	293	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q64662	UniProtKB	Cross-link	269	269	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q64662	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q64662	UniProtKB	Non-terminal residue	314	314	.	.	.	.	
##sequence-region Q9W679 1 367
Q9W679	UniProtKB	Chain	1	367	.	.	.	ID=PRO_0000185723;Note=Cellular tumor antigen p53	
Q9W679	UniProtKB	DNA binding	86	273	.	.	.	status=By similarity	
Q9W679	UniProtKB	Region	1	47	.	.	.	Note=Transcription activation (acidic)	
Q9W679	UniProtKB	Region	254	261	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9W679	UniProtKB	Region	308	337	.	.	.	Note=Oligomerization	
Q9W679	UniProtKB	Region	342	363	.	.	.	Note=Basic (repression of DNA-binding)	
Q9W679	UniProtKB	Motif	282	300	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q9W679	UniProtKB	Motif	322	333	.	.	.	Note=Nuclear export signal;status=By similarity	
Q9W679	UniProtKB	Metal binding	160	160	.	.	.	Note=Zinc;status=By similarity	
Q9W679	UniProtKB	Metal binding	163	163	.	.	.	Note=Zinc;status=By similarity	
Q9W679	UniProtKB	Metal binding	219	219	.	.	.	Note=Zinc;status=By similarity	
Q9W679	UniProtKB	Metal binding	223	223	.	.	.	Note=Zinc;status=By similarity	
Q9W679	UniProtKB	Site	104	104	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region Q9TTA1 1 393
Q9TTA1	UniProtKB	Chain	1	393	.	.	.	ID=PRO_0000185715;Note=Cellular tumor antigen p53	
Q9TTA1	UniProtKB	DNA binding	102	292	.	.	.	status=By similarity	
Q9TTA1	UniProtKB	Region	1	83	.	.	.	Note=Interaction with HRMT1L2;status=By similarity	
Q9TTA1	UniProtKB	Region	1	44	.	.	.	Note=Transcription activation (acidic)	
Q9TTA1	UniProtKB	Region	66	110	.	.	.	Note=Interaction with WWOX;status=By similarity	
Q9TTA1	UniProtKB	Region	100	370	.	.	.	Note=Interaction with HIPK1;status=By similarity	
Q9TTA1	UniProtKB	Region	100	300	.	.	.	Note=Required for interaction with ZNF385A;status=By similarity	
Q9TTA1	UniProtKB	Region	113	236	.	.	.	Note=Required for interaction with FBXO42;status=By similarity	
Q9TTA1	UniProtKB	Region	116	292	.	.	.	Note=Interaction with AXIN1;status=By similarity	
Q9TTA1	UniProtKB	Region	256	294	.	.	.	Note=Interaction with E4F1;status=By similarity	
Q9TTA1	UniProtKB	Region	273	280	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9TTA1	UniProtKB	Region	300	393	.	.	.	Note=Interaction with CARM1;status=By similarity	
Q9TTA1	UniProtKB	Region	319	360	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q9TTA1	UniProtKB	Region	325	356	.	.	.	Note=Oligomerization	
Q9TTA1	UniProtKB	Region	357	383	.	.	.	Note=Interaction with USP7;status=By similarity	
Q9TTA1	UniProtKB	Region	368	387	.	.	.	Note=Basic (repression of DNA-binding)	
Q9TTA1	UniProtKB	Motif	305	321	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q9TTA1	UniProtKB	Motif	339	350	.	.	.	Note=Nuclear export signal;status=By similarity	
Q9TTA1	UniProtKB	Motif	370	372	.	.	.	Note=[KR]-[STA]-K motif	
Q9TTA1	UniProtKB	Metal binding	176	176	.	.	.	Note=Zinc;status=By similarity	
Q9TTA1	UniProtKB	Metal binding	179	179	.	.	.	Note=Zinc;status=By similarity	
Q9TTA1	UniProtKB	Metal binding	238	238	.	.	.	Note=Zinc;status=By similarity	
Q9TTA1	UniProtKB	Metal binding	242	242	.	.	.	Note=Zinc;status=By similarity	
Q9TTA1	UniProtKB	Site	120	120	.	.	.	Note=Interaction with DNA;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	9	9	.	.	.	Note=Phosphoserine%3B by HIPK4;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	15	15	.	.	.	Note=Phosphoserine%3B by CDK5%2C PRPK%2C AMPK%2C NUAK1 and ATM;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	18	18	.	.	.	Note=Phosphothreonine%3B by CK1%2C VRK1 and VRK2;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	20	20	.	.	.	Note=Phosphoserine%3B by CHEK2%2C CK1 and PLK3;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphoserine%3B by CDK5 and CDK7;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	37	37	.	.	.	Note=Phosphoserine%3B by MAPKAPK5;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	46	46	.	.	.	Note=Phosphoserine%3B by CDK5%2C DYRK2%2C HIPK2 and PKC/PRKCG;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1 and GRK5%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	55	55	.	.	.	Note=Phosphothreonine%3B by TAF1%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	120	120	.	.	.	Note=N6-acetyllysine%3B by KAT6A;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	183	183	.	.	.	Note=Phosphoserine;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	269	269	.	.	.	Note=Phosphoserine;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	284	284	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	305	305	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	315	315	.	.	.	Note=Phosphoserine%3B by AURKA%2C CDK1 and CDK2;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	370	370	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	370	370	.	.	.	Note=N6-methyllysine%3B by SMYD2%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	372	372	.	.	.	Note=N6-methyllysine%3B by SETD7;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	373	373	.	.	.	Note=N6%2CN6-dimethyllysine%3B by EHMT1 and EHMT2%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	373	373	.	.	.	Note=N6-acetyllysine%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	382	382	.	.	.	Note=N6%2CN6-dimethyllysine%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-acetyllysine%3B by KAT6A%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine%3B by SETD8%3B alternate;status=By similarity	
Q9TTA1	UniProtKB	Modified residue	392	392	.	.	.	Note=Phosphoserine%3B by CK2%2C CDK2 and NUAK1;status=By similarity	
Q9TTA1	UniProtKB	Cross-link	291	291	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q9TTA1	UniProtKB	Cross-link	292	292	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q9TTA1	UniProtKB	Cross-link	386	386	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region P07193 1 363
P07193	UniProtKB	Chain	1	363	.	.	.	ID=PRO_0000185726;Note=Cellular tumor antigen p53	
P07193	UniProtKB	DNA binding	76	267	.	.	.	status=By similarity	
P07193	UniProtKB	Region	1	29	.	.	.	Note=Transcription activation (acidic)	
P07193	UniProtKB	Region	248	255	.	.	.	Note=Interaction with DNA;status=By similarity	
P07193	UniProtKB	Region	300	331	.	.	.	Note=Oligomerization	
P07193	UniProtKB	Region	344	356	.	.	.	Note=Basic (repression of DNA-binding)	
P07193	UniProtKB	Motif	275	292	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
P07193	UniProtKB	Motif	314	325	.	.	.	Note=Nuclear export signal;status=By similarity	
P07193	UniProtKB	Metal binding	150	150	.	.	.	Note=Zinc;status=By similarity	
P07193	UniProtKB	Metal binding	153	153	.	.	.	Note=Zinc;status=By similarity	
P07193	UniProtKB	Metal binding	213	213	.	.	.	Note=Zinc;status=By similarity	
P07193	UniProtKB	Metal binding	217	217	.	.	.	Note=Zinc;status=By similarity	
P07193	UniProtKB	Site	94	94	.	.	.	Note=Interaction with DNA;status=By similarity	
P07193	UniProtKB	Sequence conflict	52	52	.	.	.	.	
P07193	UniProtKB	Sequence conflict	71	71	.	.	.	.	
P07193	UniProtKB	Sequence conflict	296	296	.	.	.	.	
P07193	UniProtKB	Sequence conflict	296	296	.	.	.	.	
##sequence-region O57538 1 342
O57538	UniProtKB	Chain	1	342	.	.	.	ID=PRO_0000185725;Note=Cellular tumor antigen p53	
O57538	UniProtKB	DNA binding	68	255	.	.	.	status=By similarity	
O57538	UniProtKB	Region	1	35	.	.	.	Note=Transcription activation (acidic)	
O57538	UniProtKB	Region	236	243	.	.	.	Note=Interaction with DNA;status=By similarity	
O57538	UniProtKB	Region	288	317	.	.	.	Note=Oligomerization	
O57538	UniProtKB	Region	319	336	.	.	.	Note=Basic (repression of DNA-binding)	
O57538	UniProtKB	Motif	261	278	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
O57538	UniProtKB	Motif	302	313	.	.	.	Note=Nuclear export signal;status=By similarity	
O57538	UniProtKB	Metal binding	142	142	.	.	.	Note=Zinc;status=By similarity	
O57538	UniProtKB	Metal binding	145	145	.	.	.	Note=Zinc;status=By similarity	
O57538	UniProtKB	Metal binding	201	201	.	.	.	Note=Zinc;status=By similarity	
O57538	UniProtKB	Metal binding	205	205	.	.	.	Note=Zinc;status=By similarity	
O57538	UniProtKB	Site	86	86	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region Q92143 1 342
Q92143	UniProtKB	Chain	1	342	.	.	.	ID=PRO_0000185724;Note=Cellular tumor antigen p53	
Q92143	UniProtKB	DNA binding	68	255	.	.	.	status=By similarity	
Q92143	UniProtKB	Region	1	35	.	.	.	Note=Transcription activation (acidic)	
Q92143	UniProtKB	Region	236	243	.	.	.	Note=Interaction with DNA;status=By similarity	
Q92143	UniProtKB	Region	288	317	.	.	.	Note=Oligomerization	
Q92143	UniProtKB	Region	319	336	.	.	.	Note=Basic (repression of DNA-binding)	
Q92143	UniProtKB	Motif	261	278	.	.	.	Note=Bipartite nuclear localization signal;status=By similarity	
Q92143	UniProtKB	Motif	302	313	.	.	.	Note=Nuclear export signal;status=By similarity	
Q92143	UniProtKB	Metal binding	142	142	.	.	.	Note=Zinc;status=By similarity	
Q92143	UniProtKB	Metal binding	145	145	.	.	.	Note=Zinc;status=By similarity	
Q92143	UniProtKB	Metal binding	201	201	.	.	.	Note=Zinc;status=By similarity	
Q92143	UniProtKB	Metal binding	205	205	.	.	.	Note=Zinc;status=By similarity	
Q92143	UniProtKB	Site	86	86	.	.	.	Note=Interaction with DNA;status=By similarity	
##sequence-region Q9XSK8 1 637
Q9XSK8	UniProtKB	Chain	1	637	.	.	.	ID=PRO_0000185727;Note=Tumor protein p73	
Q9XSK8	UniProtKB	Domain	485	551	.	.	.	Note=SAM	
Q9XSK8	UniProtKB	Region	1	46	.	.	.	Note=Transactivation;status=By similarity	
Q9XSK8	UniProtKB	Region	131	310	.	.	.	Note=DNA-binding;status=Potential	
Q9XSK8	UniProtKB	Region	345	386	.	.	.	Note=Oligomerization;status=Potential	
Q9XSK8	UniProtKB	Region	345	380	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q9XSK8	UniProtKB	Motif	483	487	.	.	.	Note=WW-binding	
Q9XSK8	UniProtKB	Metal binding	194	194	.	.	.	Note=Zinc;status=By similarity	
Q9XSK8	UniProtKB	Metal binding	197	197	.	.	.	Note=Zinc;status=By similarity	
Q9XSK8	UniProtKB	Metal binding	258	258	.	.	.	Note=Zinc;status=By similarity	
Q9XSK8	UniProtKB	Metal binding	262	262	.	.	.	Note=Zinc;status=By similarity	
Q9XSK8	UniProtKB	Modified residue	27	27	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9XSK8	UniProtKB	Modified residue	28	28	.	.	.	Note=Phosphotyrosine%3B by SRC and HCK;status=By similarity	
Q9XSK8	UniProtKB	Modified residue	99	99	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q9XSK8	UniProtKB	Cross-link	628	628	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B in isoform Alpha;status=By similarity	
Q9XSK8	UniProtKB	Alternative sequence	495	637	.	.	.	ID=VSP_006537;Note=In isoform Beta.	
##sequence-region O15350 1 636
O15350	UniProtKB	Chain	1	636	.	.	.	ID=PRO_0000185728;Note=Tumor protein p73	
O15350	UniProtKB	Domain	485	551	.	.	.	Note=SAM	
O15350	UniProtKB	Region	1	46	.	.	.	Note=Transactivation;status=By similarity	
O15350	UniProtKB	Region	131	310	.	.	.	Note=DNA-binding;status=Potential	
O15350	UniProtKB	Region	345	386	.	.	.	Note=Oligomerization;status=Potential	
O15350	UniProtKB	Region	345	380	.	.	.	Note=Interaction with HIPK2	
O15350	UniProtKB	Motif	483	487	.	.	.	Note=WW-binding	
O15350	UniProtKB	Compositional bias	1	55	.	.	.	Note=Asp/Glu-rich (acidic)	
O15350	UniProtKB	Compositional bias	168	171	.	.	.	Note=Poly-Pro	
O15350	UniProtKB	Compositional bias	391	394	.	.	.	Note=Poly-Gln	
O15350	UniProtKB	Compositional bias	483	486	.	.	.	Note=Poly-Pro	
O15350	UniProtKB	Metal binding	194	194	.	.	.	Note=Zinc;status=By similarity	
O15350	UniProtKB	Metal binding	197	197	.	.	.	Note=Zinc;status=By similarity	
O15350	UniProtKB	Metal binding	258	258	.	.	.	Note=Zinc;status=By similarity	
O15350	UniProtKB	Metal binding	262	262	.	.	.	Note=Zinc;status=By similarity	
O15350	UniProtKB	Modified residue	27	27	.	.	.	Note=Phosphothreonine%3B by PLK1	
O15350	UniProtKB	Modified residue	28	28	.	.	.	Note=Phosphotyrosine%3B by SRC and HCK	
O15350	UniProtKB	Modified residue	99	99	.	.	.	Note=Phosphotyrosine%3B by ABL1	
O15350	UniProtKB	Cross-link	627	627	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B in isoform Alpha	
O15350	UniProtKB	Alternative sequence	1	71	.	.	.	ID=VSP_045082;Note=In isoform 10.	
O15350	UniProtKB	Alternative sequence	1	62	.	.	.	ID=VSP_014368;Note=In isoform dN-Alpha%2C isoform dN-Beta and isoform dN-Gamma.	
O15350	UniProtKB	Alternative sequence	400	495	.	.	.	ID=VSP_006546;Note=In isoform Zeta.	
O15350	UniProtKB	Alternative sequence	400	476	.	.	.	ID=VSP_006540;Note=In isoform Gamma and isoform dN-Gamma.	
O15350	UniProtKB	Alternative sequence	400	445	.	.	.	ID=VSP_006544;Note=In isoform Epsilon.	
O15350	UniProtKB	Alternative sequence	400	403	.	.	.	ID=VSP_006542;Note=In isoform Delta.	
O15350	UniProtKB	Alternative sequence	404	636	.	.	.	ID=VSP_006543;Note=In isoform Delta.	
O15350	UniProtKB	Alternative sequence	446	526	.	.	.	ID=VSP_006545;Note=In isoform Epsilon.	
O15350	UniProtKB	Alternative sequence	477	636	.	.	.	ID=VSP_006541;Note=In isoform Gamma and isoform dN-Gamma.	
O15350	UniProtKB	Alternative sequence	495	636	.	.	.	ID=VSP_006539;Note=In isoform Beta and isoform dN-Beta.	
O15350	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Impaired phosphorylation.	
O15350	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Impaired phosphorylation of isoform beta by ABL1.	
O15350	UniProtKB	Mutagenesis	487	487	.	.	.	Note=Loss of interaction with WWOX.	
O15350	UniProtKB	Mutagenesis	627	627	.	.	.	Note=Strongly diminishes sumoylation but does not affect transcriptional activity.	
O15350	UniProtKB	Turn	123	126	.	.	.	.	
O15350	UniProtKB	Beta strand	128	130	.	.	.	.	
O15350	UniProtKB	Beta strand	136	138	.	.	.	.	
O15350	UniProtKB	Beta strand	141	145	.	.	.	.	
O15350	UniProtKB	Turn	146	149	.	.	.	.	
O15350	UniProtKB	Beta strand	150	153	.	.	.	.	
O15350	UniProtKB	Beta strand	157	164	.	.	.	.	
O15350	UniProtKB	Beta strand	174	181	.	.	.	.	
O15350	UniProtKB	Turn	184	188	.	.	.	.	
O15350	UniProtKB	Helix	195	199	.	.	.	.	
O15350	UniProtKB	Turn	202	206	.	.	.	.	
O15350	UniProtKB	Beta strand	214	219	.	.	.	.	
O15350	UniProtKB	Beta strand	224	227	.	.	.	.	
O15350	UniProtKB	Turn	229	231	.	.	.	.	
O15350	UniProtKB	Beta strand	234	239	.	.	.	.	
O15350	UniProtKB	Beta strand	250	256	.	.	.	.	
O15350	UniProtKB	Helix	260	262	.	.	.	.	
O15350	UniProtKB	Turn	263	268	.	.	.	.	
O15350	UniProtKB	Beta strand	271	278	.	.	.	.	
O15350	UniProtKB	Beta strand	280	282	.	.	.	.	
O15350	UniProtKB	Beta strand	284	294	.	.	.	.	
O15350	UniProtKB	Helix	298	311	.	.	.	.	
O15350	UniProtKB	Beta strand	354	360	.	.	.	.	
O15350	UniProtKB	Helix	362	377	.	.	.	.	
O15350	UniProtKB	Helix	378	380	.	.	.	.	
O15350	UniProtKB	Helix	383	395	.	.	.	.	
O15350	UniProtKB	Helix	493	499	.	.	.	.	
O15350	UniProtKB	Turn	503	505	.	.	.	.	
O15350	UniProtKB	Helix	506	510	.	.	.	.	
O15350	UniProtKB	Turn	511	513	.	.	.	.	
O15350	UniProtKB	Helix	517	521	.	.	.	.	
O15350	UniProtKB	Helix	525	530	.	.	.	.	
O15350	UniProtKB	Turn	535	537	.	.	.	.	
O15350	UniProtKB	Helix	538	547	.	.	.	.	
##sequence-region Q9JJP2 1 631
Q9JJP2	UniProtKB	Chain	1	631	.	.	.	ID=PRO_0000370211;Note=Tumor protein p73	
Q9JJP2	UniProtKB	Domain	479	545	.	.	.	Note=SAM	
Q9JJP2	UniProtKB	Region	1	43	.	.	.	Note=Transactivation;status=By similarity	
Q9JJP2	UniProtKB	Region	123	302	.	.	.	Note=DNA-binding;status=By similarity	
Q9JJP2	UniProtKB	Region	337	378	.	.	.	Note=Oligomerization;status=Potential	
Q9JJP2	UniProtKB	Region	337	372	.	.	.	Note=Interaction with HIPK2;status=By similarity	
Q9JJP2	UniProtKB	Motif	477	481	.	.	.	Note=WW-binding	
Q9JJP2	UniProtKB	Compositional bias	5	10	.	.	.	Note=Poly-Ser	
Q9JJP2	UniProtKB	Compositional bias	383	388	.	.	.	Note=Poly-Gln	
Q9JJP2	UniProtKB	Metal binding	186	186	.	.	.	Note=Zinc;status=By similarity	
Q9JJP2	UniProtKB	Metal binding	189	189	.	.	.	Note=Zinc;status=By similarity	
Q9JJP2	UniProtKB	Metal binding	250	250	.	.	.	Note=Zinc;status=By similarity	
Q9JJP2	UniProtKB	Metal binding	254	254	.	.	.	Note=Zinc;status=By similarity	
Q9JJP2	UniProtKB	Modified residue	24	24	.	.	.	Note=Phosphothreonine%3B by PLK1;status=By similarity	
Q9JJP2	UniProtKB	Modified residue	25	25	.	.	.	Note=Phosphotyrosine%3B by SRC and HCK;status=By similarity	
Q9JJP2	UniProtKB	Modified residue	91	91	.	.	.	Note=Phosphotyrosine%3B by ABL1;status=By similarity	
Q9JJP2	UniProtKB	Cross-link	622	622	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q9JJP2	UniProtKB	Alternative sequence	1	54	.	.	.	ID=VSP_053081;Note=In isoform 2%2C isoform 3 and isoform 4.	
Q9JJP2	UniProtKB	Alternative sequence	394	489	.	.	.	ID=VSP_053082;Note=In isoform 4.	
Q9JJP2	UniProtKB	Alternative sequence	489	493	.	.	.	ID=VSP_053083;Note=In isoform 3.	
Q9JJP2	UniProtKB	Alternative sequence	494	631	.	.	.	ID=VSP_053084;Note=In isoform 3.	
Q9JJP2	UniProtKB	Sequence conflict	118	118	.	.	.	.	
Q9JJP2	UniProtKB	Sequence conflict	127	127	.	.	.	.	
Q9JJP2	UniProtKB	Sequence conflict	254	254	.	.	.	.	
Q9JJP2	UniProtKB	Sequence conflict	352	353	.	.	.	.	
Q9JJP2	UniProtKB	Sequence conflict	376	376	.	.	.	.	
##sequence-region Q8N7H5 1 531
Q8N7H5	UniProtKB	Chain	1	531	.	.	.	ID=PRO_0000326400;Note=RNA polymerase II-associated factor 1 homolog	
Q8N7H5	UniProtKB	Coiled coil	352	400	.	.	.	status=Potential	
Q8N7H5	UniProtKB	Compositional bias	358	452	.	.	.	Note=Glu-rich	
Q8N7H5	UniProtKB	Alternative sequence	17	26	.	.	.	ID=VSP_032650;Note=In isoform 2.	
Q8N7H5	UniProtKB	Alternative sequence	190	212	.	.	.	ID=VSP_032651;Note=In isoform 2.	
Q8N7H5	UniProtKB	Alternative sequence	395	508	.	.	.	ID=VSP_032652;Note=In isoform 2.	
Q8N7H5	UniProtKB	Sequence conflict	58	58	.	.	.	.	
Q8N7H5	UniProtKB	Sequence conflict	68	68	.	.	.	.	
Q8N7H5	UniProtKB	Sequence conflict	152	152	.	.	.	.	
Q8N7H5	UniProtKB	Sequence conflict	378	378	.	.	.	.	
##sequence-region Q86YC2 1 1186
Q86YC2	UniProtKB	Chain	1	1186	.	.	.	ID=PRO_0000252391;Note=Partner and localizer of BRCA2	
Q86YC2	UniProtKB	Repeat	854	915	.	.	.	Note=WD 1	
Q86YC2	UniProtKB	Repeat	917	961	.	.	.	Note=WD 2	
Q86YC2	UniProtKB	Repeat	962	1009	.	.	.	Note=WD 3	
Q86YC2	UniProtKB	Repeat	1010	1052	.	.	.	Note=WD 4	
Q86YC2	UniProtKB	Repeat	1058	1109	.	.	.	Note=WD 5	
Q86YC2	UniProtKB	Repeat	1115	1153	.	.	.	Note=WD 6	
Q86YC2	UniProtKB	Repeat	1155	1186	.	.	.	Note=WD 7	
Q86YC2	UniProtKB	Region	1	319	.	.	.	Note=Interaction with BRCA1	
Q86YC2	UniProtKB	Region	1	200	.	.	.	Note=Interaction with RAD51	
Q86YC2	UniProtKB	Region	1	160	.	.	.	Note=Required for its oligomerization and is important for its focal concentration at DNA damage sites	
Q86YC2	UniProtKB	Region	853	1186	.	.	.	Note=Interaction with RAD51 and BRCA2	
Q86YC2	UniProtKB	Coiled coil	9	41	.	.	.	status=Potential	
Q86YC2	UniProtKB	Modified residue	376	376	.	.	.	Note=Phosphoserine	
Q86YC2	UniProtKB	Modified residue	387	387	.	.	.	Note=Phosphoserine	
Q86YC2	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_066361	
Q86YC2	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_066362	
Q86YC2	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_032959;Dbxref=dbSNP:rs3809683	
Q86YC2	UniProtKB	Natural variant	334	334	.	.	.	ID=VAR_066363	
Q86YC2	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_066364;Dbxref=dbSNP:rs45494092	
Q86YC2	UniProtKB	Natural variant	414	414	.	.	.	ID=VAR_066365	
Q86YC2	UniProtKB	Natural variant	425	425	.	.	.	ID=VAR_066366	
Q86YC2	UniProtKB	Natural variant	491	491	.	.	.	ID=VAR_066367	
Q86YC2	UniProtKB	Natural variant	515	515	.	.	.	ID=VAR_066368	
Q86YC2	UniProtKB	Natural variant	559	559	.	.	.	ID=VAR_066369;Dbxref=dbSNP:rs152451	
Q86YC2	UniProtKB	Natural variant	672	672	.	.	.	ID=VAR_066370;Dbxref=dbSNP:rs45532440	
Q86YC2	UniProtKB	Natural variant	712	712	.	.	.	ID=VAR_066371;Dbxref=dbSNP:rs141458731	
Q86YC2	UniProtKB	Natural variant	728	728	.	.	.	ID=VAR_066372	
Q86YC2	UniProtKB	Natural variant	864	864	.	.	.	ID=VAR_054150;Dbxref=dbSNP:rs45568339	
Q86YC2	UniProtKB	Natural variant	917	917	.	.	.	ID=VAR_066373	
Q86YC2	UniProtKB	Natural variant	932	932	.	.	.	ID=VAR_066374;Dbxref=dbSNP:rs45624036	
Q86YC2	UniProtKB	Natural variant	939	939	.	.	.	ID=VAR_066375;Dbxref=dbSNP:rs45478192;Note=May be associated with breast cancer susceptibility.	
Q86YC2	UniProtKB	Natural variant	966	966	.	.	.	ID=VAR_066376	
Q86YC2	UniProtKB	Natural variant	998	998	.	.	.	ID=VAR_066377;Dbxref=dbSNP:rs45551636;Note=May be associated with breast cancer susceptibility.	
Q86YC2	UniProtKB	Natural variant	1025	1025	.	.	.	ID=VAR_066378	
Q86YC2	UniProtKB	Natural variant	1043	1043	.	.	.	ID=VAR_066379;Note=May be associated with breast cancer susceptibility.	
Q86YC2	UniProtKB	Natural variant	1075	1075	.	.	.	ID=VAR_066380	
Q86YC2	UniProtKB	Natural variant	1105	1105	.	.	.	ID=VAR_066381	
Q86YC2	UniProtKB	Natural variant	1114	1114	.	.	.	ID=VAR_066382	
Q86YC2	UniProtKB	Natural variant	1143	1143	.	.	.	ID=VAR_066383;Note=May be associated with breast cancer susceptibility.	
Q86YC2	UniProtKB	Natural variant	1170	1170	.	.	.	ID=VAR_066384	
Q86YC2	UniProtKB	Mutagenesis	14	14	.	.	.	Note=Loss of interaction with BRCA1 but no effect on interaction with BRCA2.	
Q86YC2	UniProtKB	Mutagenesis	21	21	.	.	.	Note=Loss of interaction with BRCA1 but no effect on interaction with BRCA2.	
Q86YC2	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Loss of interaction with BRCA1 but no effect on interaction with BRCA2.	
Q86YC2	UniProtKB	Mutagenesis	35	35	.	.	.	Note=Loss of interaction with BRCA1 but no effect on interaction with BRCA2.	
Q86YC2	UniProtKB	Mutagenesis	42	42	.	.	.	Note=Loss of interaction with BRCA1 but no effect on interaction with BRCA2.	
Q86YC2	UniProtKB	Beta strand	855	861	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	869	877	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	884	913	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	919	922	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	932	936	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	938	947	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	958	972	.	.	.	.	
Q86YC2	UniProtKB	Turn	973	975	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	976	984	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	988	994	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1000	1006	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1013	1020	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1025	1030	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1033	1039	.	.	.	.	
Q86YC2	UniProtKB	Turn	1040	1042	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1045	1050	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1053	1055	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1059	1066	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1069	1075	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1090	1096	.	.	.	.	
Q86YC2	UniProtKB	Turn	1097	1100	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1101	1108	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1118	1124	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1127	1132	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1137	1141	.	.	.	.	
Q86YC2	UniProtKB	Turn	1142	1144	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1146	1151	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1161	1164	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1166	1174	.	.	.	.	
Q86YC2	UniProtKB	Beta strand	1180	1185	.	.	.	.	
##sequence-region Q3U0P1 1 1104
Q3U0P1	UniProtKB	Chain	1	1104	.	.	.	ID=PRO_0000252392;Note=Partner and localizer of BRCA2	
Q3U0P1	UniProtKB	Repeat	772	833	.	.	.	Note=WD 1	
Q3U0P1	UniProtKB	Repeat	835	879	.	.	.	Note=WD 2	
Q3U0P1	UniProtKB	Repeat	880	927	.	.	.	Note=WD 3	
Q3U0P1	UniProtKB	Repeat	928	970	.	.	.	Note=WD 4	
Q3U0P1	UniProtKB	Repeat	976	1027	.	.	.	Note=WD 5	
Q3U0P1	UniProtKB	Repeat	1033	1071	.	.	.	Note=WD 6	
Q3U0P1	UniProtKB	Repeat	1073	1104	.	.	.	Note=WD 7	
Q3U0P1	UniProtKB	Region	1	308	.	.	.	Note=Interaction with BRCA1;status=By similarity	
Q3U0P1	UniProtKB	Region	1	195	.	.	.	Note=Interaction with RAD51;status=By similarity	
Q3U0P1	UniProtKB	Region	1	157	.	.	.	Note=Required for its oligomerization and is important for its focal concentration at DNA damage sites;status=By similarity	
Q3U0P1	UniProtKB	Region	771	1104	.	.	.	Note=Interaction with RAD51 and BRCA2;status=By similarity	
Q3U0P1	UniProtKB	Coiled coil	9	48	.	.	.	status=Potential	
Q3U0P1	UniProtKB	Modified residue	364	364	.	.	.	Note=Phosphoserine;status=By similarity	
Q3U0P1	UniProtKB	Alternative sequence	36	755	.	.	.	ID=VSP_020928;Note=In isoform 3.	
Q3U0P1	UniProtKB	Alternative sequence	170	532	.	.	.	ID=VSP_020929;Note=In isoform 2.	
Q3U0P1	UniProtKB	Alternative sequence	533	544	.	.	.	ID=VSP_020930;Note=In isoform 4.	
Q3U0P1	UniProtKB	Alternative sequence	545	1104	.	.	.	ID=VSP_020931;Note=In isoform 4.	
##sequence-region Q5E946 1 189
Q5E946	UniProtKB	Active site	106	106	.	.	.	status=By similarity	
Q5E946	UniProtKB	Active site	126	126	.	.	.	status=By similarity	
Q5E946	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q5E946	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H);status=By similarity	
Q5E946	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q8UW59 1 189
Q8UW59	UniProtKB	Active site	106	106	.	.	.	status=By similarity	
Q8UW59	UniProtKB	Active site	126	126	.	.	.	status=By similarity	
Q8UW59	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q8UW59	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H);status=By similarity	
Q8UW59	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q95LI9 1 189
Q95LI9	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q95LI9	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H);status=By similarity	
Q95LI9	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q5XJ36 1 189
Q5XJ36	UniProtKB	Active site	106	106	.	.	.	status=By similarity	
Q5XJ36	UniProtKB	Active site	126	126	.	.	.	status=By similarity	
Q5XJ36	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H);status=By similarity	
Q5XJ36	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q99497 1 189
Q99497	UniProtKB	Active site	106	106	.	.	.	status=Probable	
Q99497	UniProtKB	Active site	126	126	.	.	.	status=Probable	
Q99497	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphotyrosine	
Q99497	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H)	
Q99497	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
Q99497	UniProtKB	Natural variant	26	26	.	.	.	ID=VAR_020492;Note=In PARK7%3B does not affect protein stability and degradation%3B does not interfere with homodimerization.	
Q99497	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_020493;Note=In PARK7%3B no apparent effect on protein stability%3B impaired mitochondrial morphology.	
Q99497	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_020494;Dbxref=dbSNP:rs71653619	
Q99497	UniProtKB	Natural variant	104	104	.	.	.	ID=VAR_020495;Note=In PARK7.	
Q99497	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_020496;Dbxref=dbSNP:rs74315352;Note=In PARK7.	
Q99497	UniProtKB	Natural variant	150	150	.	.	.	ID=VAR_020497	
Q99497	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_034801	
Q99497	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_020498;Dbxref=dbSNP:rs28938172;Note=In PARK7%3B reduces protein stability and leads to increased degradation%3B interferes with homodimerization%3B abolishes interaction with PIAS2%3B strongly reduces chaperone activity%3B ubiquitinated by PARK2%2C leading to its recognition by HDAC6 and targeting to aggresome where is degraded.	
Q99497	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_020499	
Q99497	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Reduces protein stability. No effect on oxidation.	
Q99497	UniProtKB	Mutagenesis	46	46	.	.	.	Note=No effect on mitochondrial translocation.	
Q99497	UniProtKB	Mutagenesis	51	51	.	.	.	Note=Disrupts dimer formation and strongly reduces ability to eliminate hydrogen peroxide.	
Q99497	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Strongly reduces chaperone activity and ability to eliminate hydrogen peroxide.	
Q99497	UniProtKB	Mutagenesis	53	53	.	.	.	Note=No effect on mitochondrial translocation.	
Q99497	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Abolishes oxidation%2C association with mitochondria and protease activity. No effect on chaperone activity. Reduced binding to OTUD7B.	
Q99497	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Abolishes oxidation and association with mitochondria. No effect on chaperone activity.	
Q99497	UniProtKB	Mutagenesis	106	106	.	.	.	Note=No effect on mitochondrial translocation. Reduced protease activity.	
Q99497	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Abolishes protease activity.	
Q99497	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Partially compensates for loss of stability%3B when associated with P-166.	
Q99497	UniProtKB	Sequence conflict	119	119	.	.	.	.	
Q99497	UniProtKB	Beta strand	5	10	.	.	.	.	
Q99497	UniProtKB	Helix	16	28	.	.	.	.	
Q99497	UniProtKB	Beta strand	32	37	.	.	.	.	
Q99497	UniProtKB	Turn	38	41	.	.	.	.	
Q99497	UniProtKB	Beta strand	51	53	.	.	.	.	
Q99497	UniProtKB	Beta strand	55	57	.	.	.	.	
Q99497	UniProtKB	Helix	58	62	.	.	.	.	
Q99497	UniProtKB	Beta strand	68	72	.	.	.	.	
Q99497	UniProtKB	Helix	76	84	.	.	.	.	
Q99497	UniProtKB	Helix	86	97	.	.	.	.	
Q99497	UniProtKB	Beta strand	101	105	.	.	.	.	
Q99497	UniProtKB	Turn	106	108	.	.	.	.	
Q99497	UniProtKB	Helix	109	114	.	.	.	.	
Q99497	UniProtKB	Helix	127	129	.	.	.	.	
Q99497	UniProtKB	Helix	130	133	.	.	.	.	
Q99497	UniProtKB	Turn	134	136	.	.	.	.	
Q99497	UniProtKB	Beta strand	139	141	.	.	.	.	
Q99497	UniProtKB	Beta strand	145	149	.	.	.	.	
Q99497	UniProtKB	Beta strand	152	155	.	.	.	.	
Q99497	UniProtKB	Helix	158	160	.	.	.	.	
Q99497	UniProtKB	Helix	161	173	.	.	.	.	
Q99497	UniProtKB	Helix	175	182	.	.	.	.	
Q99497	UniProtKB	Helix	183	185	.	.	.	.	
##sequence-region Q7TQ35 1 189
Q7TQ35	UniProtKB	Active site	106	106	.	.	.	status=By similarity	
Q7TQ35	UniProtKB	Active site	126	126	.	.	.	status=By similarity	
Q7TQ35	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q7TQ35	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H);status=By similarity	
Q7TQ35	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q99LX0 1 189
Q99LX0	UniProtKB	Active site	106	106	.	.	.	status=By similarity	
Q99LX0	UniProtKB	Active site	126	126	.	.	.	status=By similarity	
Q99LX0	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q99LX0	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H);status=By similarity	
Q99LX0	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q99LX0	UniProtKB	Mutagenesis	46	46	.	.	.	Note=Sulfinic acid detected following treatment with hydrogen peroxide.	
Q99LX0	UniProtKB	Mutagenesis	53	53	.	.	.	Note=Sulfinic acid detected following treatment with hydrogen peroxide.	
Q99LX0	UniProtKB	Mutagenesis	106	106	.	.	.	Note=No sulfinic acid detected following treatment with hydrogen peroxide.	
Q99LX0	UniProtKB	Sequence conflict	127	127	.	.	.	.	
##sequence-region O88767 1 189
O88767	UniProtKB	Active site	106	106	.	.	.	status=By similarity	
O88767	UniProtKB	Active site	126	126	.	.	.	status=By similarity	
O88767	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphotyrosine;status=By similarity	
O88767	UniProtKB	Modified residue	106	106	.	.	.	Note=Cysteine sulfinic acid (-SO2H);status=By similarity	
O88767	UniProtKB	Cross-link	130	130	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q86U86 1 1689
Q86U86	UniProtKB	Chain	1	1689	.	.	.	ID=PRO_0000211207;Note=Protein polybromo-1	
Q86U86	UniProtKB	Domain	64	134	.	.	.	Note=Bromo 1	
Q86U86	UniProtKB	Domain	200	270	.	.	.	Note=Bromo 2	
Q86U86	UniProtKB	Domain	400	470	.	.	.	Note=Bromo 3	
Q86U86	UniProtKB	Domain	538	608	.	.	.	Note=Bromo 4	
Q86U86	UniProtKB	Domain	676	746	.	.	.	Note=Bromo 5	
Q86U86	UniProtKB	Domain	792	862	.	.	.	Note=Bromo 6	
Q86U86	UniProtKB	Domain	956	1074	.	.	.	Note=BAH 1	
Q86U86	UniProtKB	Domain	1156	1272	.	.	.	Note=BAH 2	
Q86U86	UniProtKB	DNA binding	1379	1447	.	.	.	Note=HMG box	
Q86U86	UniProtKB	Compositional bias	630	633	.	.	.	Note=Poly-Asp	
Q86U86	UniProtKB	Compositional bias	1468	1599	.	.	.	Note=Pro-rich	
Q86U86	UniProtKB	Modified residue	10	10	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	39	39	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	131	131	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	316	316	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	319	319	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	353	353	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	355	355	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	371	371	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	375	375	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	498	498	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	636	636	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	648	648	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	1289	1289	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q86U86	UniProtKB	Modified residue	1405	1405	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Modified residue	1453	1453	.	.	.	Note=Phosphoserine	
Q86U86	UniProtKB	Alternative sequence	300	332	.	.	.	ID=VSP_015231;Note=In isoform 3.	
Q86U86	UniProtKB	Alternative sequence	513	513	.	.	.	ID=VSP_035499;Note=In isoform 7 and isoform 8.	
Q86U86	UniProtKB	Alternative sequence	857	1689	.	.	.	ID=VSP_015232;Note=In isoform 6.	
Q86U86	UniProtKB	Alternative sequence	989	1013	.	.	.	ID=VSP_015233;Note=In isoform 4 and isoform 9.	
Q86U86	UniProtKB	Alternative sequence	1336	1362	.	.	.	ID=VSP_015234;Note=In isoform 4.	
Q86U86	UniProtKB	Alternative sequence	1430	1484	.	.	.	ID=VSP_015235;Note=In isoform 2%2C isoform 3%2C isoform 4%2C isoform 5%2C isoform 7 and isoform 9.	
Q86U86	UniProtKB	Alternative sequence	1485	1536	.	.	.	ID=VSP_015236;Note=In isoform 5%2C isoform 7 and isoform 8.	
Q86U86	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_064653;Note=Found in a lung cancer cell line.	
Q86U86	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_064654;Note=Found in a brain cancer cell line.	
Q86U86	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_064655;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_064656;Note=Found in a colon cancer cell line.	
Q86U86	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_064657;Note=Found in a bladder cancer cell line.	
Q86U86	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_064658;Note=Found in a malignant melanoma cell line.	
Q86U86	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_064659;Note=Found in a malignant melanoma cell line.	
Q86U86	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_064660;Note=Found in a endometrial cancer cell line.	
Q86U86	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_064661;Note=Found in hematopoietic and lymphoid cancer cell lines.	
Q86U86	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_064662;Note=Found in hematopoietic and lymphoid cancer cell lines.	
Q86U86	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_064663;Dbxref=dbSNP:rs201022657;Note=Found in a breast cancer cell line.	
Q86U86	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_064664;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	233	233	.	.	.	ID=VAR_064665;Note=Found in a renal carcinoma cell line.	
Q86U86	UniProtKB	Natural variant	256	256	.	.	.	ID=VAR_064666;Note=Found in an ovary carcinoma cell line.	
Q86U86	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_064667;Note=Found in a malignant melanoma cell line.	
Q86U86	UniProtKB	Natural variant	523	523	.	.	.	ID=VAR_064668;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	540	540	.	.	.	ID=VAR_064669;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	597	597	.	.	.	ID=VAR_064670;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	621	621	.	.	.	ID=VAR_064671;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	661	661	.	.	.	ID=VAR_064672;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	674	674	.	.	.	ID=VAR_064673;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	678	678	.	.	.	ID=VAR_064674	
Q86U86	UniProtKB	Natural variant	893	893	.	.	.	ID=VAR_064675;Note=Found in hematopoietic%2C lymphoid%2C lung and liver cancer cell lines.	
Q86U86	UniProtKB	Natural variant	895	895	.	.	.	ID=VAR_064676;Note=Found in a lung cancer cell line.	
Q86U86	UniProtKB	Natural variant	922	922	.	.	.	ID=VAR_064677;Note=Found in a breast cancer cell line.	
Q86U86	UniProtKB	Natural variant	925	925	.	.	.	ID=VAR_064678;Note=Found in a colon cancer cell line.	
Q86U86	UniProtKB	Natural variant	1079	1079	.	.	.	ID=VAR_064679;Note=Requires 2 nucleotide substitutions%3B found in a colon cancer cell line.	
Q86U86	UniProtKB	Natural variant	1098	1098	.	.	.	ID=VAR_064680;Note=Found in hematopoietic and lymphoid cancer cell lines.	
Q86U86	UniProtKB	Natural variant	1120	1120	.	.	.	ID=VAR_064681;Note=Found in hematopoietic and lymphoid cancer cell lines.	
Q86U86	UniProtKB	Natural variant	1177	1177	.	.	.	ID=VAR_064682;Note=Found in a kidney cancer cell line.	
Q86U86	UniProtKB	Natural variant	1204	1204	.	.	.	ID=VAR_064683;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	1209	1214	.	.	.	ID=VAR_064684;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	1287	1287	.	.	.	ID=VAR_064685;Note=Found in a breast cancer cell line.	
Q86U86	UniProtKB	Natural variant	1414	1414	.	.	.	ID=VAR_064686;Note=Found in a lung cancer cell line.	
Q86U86	UniProtKB	Natural variant	1503	1503	.	.	.	ID=VAR_064687;Note=Found in a stomach cancer cell line.	
Q86U86	UniProtKB	Natural variant	1560	1560	.	.	.	ID=VAR_064688;Note=Found in an endometrial cancer cell line.	
Q86U86	UniProtKB	Natural variant	1614	1614	.	.	.	ID=VAR_064689;Note=Found in a case of clear cell renal carcinoma%3B somatic mutation.	
Q86U86	UniProtKB	Natural variant	1647	1647	.	.	.	ID=VAR_064690;Note=Found in a breast cancer cell line.	
Q86U86	UniProtKB	Sequence conflict	1	1	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	65	65	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	242	242	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	251	251	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	430	430	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	553	553	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	567	567	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	750	750	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	792	792	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	927	927	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	927	927	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	963	963	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	1144	1144	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	1245	1245	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	1306	1306	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	1349	1349	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	1488	1488	.	.	.	.	
Q86U86	UniProtKB	Sequence conflict	1568	1568	.	.	.	.	
Q86U86	UniProtKB	Helix	46	59	.	.	.	.	
Q86U86	UniProtKB	Helix	68	72	.	.	.	.	
Q86U86	UniProtKB	Helix	78	80	.	.	.	.	
Q86U86	UniProtKB	Helix	82	87	.	.	.	.	
Q86U86	UniProtKB	Helix	94	102	.	.	.	.	
Q86U86	UniProtKB	Helix	109	126	.	.	.	.	
Q86U86	UniProtKB	Helix	132	152	.	.	.	.	
Q86U86	UniProtKB	Beta strand	176	178	.	.	.	.	
Q86U86	UniProtKB	Helix	179	195	.	.	.	.	
Q86U86	UniProtKB	Helix	206	208	.	.	.	.	
Q86U86	UniProtKB	Turn	214	216	.	.	.	.	
Q86U86	UniProtKB	Helix	218	223	.	.	.	.	
Q86U86	UniProtKB	Helix	230	239	.	.	.	.	
Q86U86	UniProtKB	Helix	245	262	.	.	.	.	
Q86U86	UniProtKB	Helix	268	291	.	.	.	.	
Q86U86	UniProtKB	Helix	388	394	.	.	.	.	
Q86U86	UniProtKB	Beta strand	399	401	.	.	.	.	
Q86U86	UniProtKB	Helix	406	408	.	.	.	.	
Q86U86	UniProtKB	Turn	414	416	.	.	.	.	
Q86U86	UniProtKB	Helix	418	423	.	.	.	.	
Q86U86	UniProtKB	Helix	430	438	.	.	.	.	
Q86U86	UniProtKB	Helix	445	462	.	.	.	.	
Q86U86	UniProtKB	Helix	468	490	.	.	.	.	
Q86U86	UniProtKB	Helix	511	532	.	.	.	.	
Q86U86	UniProtKB	Turn	536	538	.	.	.	.	
Q86U86	UniProtKB	Helix	542	546	.	.	.	.	
Q86U86	UniProtKB	Turn	552	554	.	.	.	.	
Q86U86	UniProtKB	Helix	556	561	.	.	.	.	
Q86U86	UniProtKB	Helix	568	576	.	.	.	.	
Q86U86	UniProtKB	Helix	583	600	.	.	.	.	
Q86U86	UniProtKB	Helix	606	625	.	.	.	.	
Q86U86	UniProtKB	Helix	657	671	.	.	.	.	
Q86U86	UniProtKB	Helix	680	684	.	.	.	.	
Q86U86	UniProtKB	Turn	690	692	.	.	.	.	
Q86U86	UniProtKB	Helix	694	699	.	.	.	.	
Q86U86	UniProtKB	Beta strand	700	702	.	.	.	.	
Q86U86	UniProtKB	Helix	706	714	.	.	.	.	
Q86U86	UniProtKB	Helix	721	738	.	.	.	.	
Q86U86	UniProtKB	Helix	744	762	.	.	.	.	
Q86U86	UniProtKB	Turn	763	765	.	.	.	.	
Q86U86	UniProtKB	Helix	777	790	.	.	.	.	
Q86U86	UniProtKB	Helix	800	804	.	.	.	.	
Q86U86	UniProtKB	Helix	822	830	.	.	.	.	
Q86U86	UniProtKB	Helix	837	854	.	.	.	.	
Q86U86	UniProtKB	Helix	860	882	.	.	.	.	
Q86U86	UniProtKB	Helix	889	892	.	.	.	.	
Q86U86	UniProtKB	Helix	895	909	.	.	.	.	
Q86U86	UniProtKB	Helix	910	913	.	.	.	.	
##sequence-region Q8BSQ9 1 1634
Q8BSQ9	UniProtKB	Chain	1	1634	.	.	.	ID=PRO_0000351134;Note=Protein polybromo-1	
Q8BSQ9	UniProtKB	Domain	64	134	.	.	.	Note=Bromo 1	
Q8BSQ9	UniProtKB	Domain	200	270	.	.	.	Note=Bromo 2	
Q8BSQ9	UniProtKB	Domain	400	470	.	.	.	Note=Bromo 3	
Q8BSQ9	UniProtKB	Domain	538	608	.	.	.	Note=Bromo 4	
Q8BSQ9	UniProtKB	Domain	676	746	.	.	.	Note=Bromo 5	
Q8BSQ9	UniProtKB	Domain	792	862	.	.	.	Note=Bromo 6	
Q8BSQ9	UniProtKB	Domain	956	1074	.	.	.	Note=BAH 1	
Q8BSQ9	UniProtKB	Domain	1156	1272	.	.	.	Note=BAH 2	
Q8BSQ9	UniProtKB	DNA binding	1379	1447	.	.	.	Note=HMG box	
Q8BSQ9	UniProtKB	Compositional bias	630	633	.	.	.	Note=Poly-Asp	
Q8BSQ9	UniProtKB	Compositional bias	1468	1599	.	.	.	Note=Pro-rich	
Q8BSQ9	UniProtKB	Modified residue	10	10	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	39	39	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	131	131	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	319	319	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	353	353	.	.	.	Note=Phosphoserine	
Q8BSQ9	UniProtKB	Modified residue	355	355	.	.	.	Note=Phosphoserine	
Q8BSQ9	UniProtKB	Modified residue	371	371	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	375	375	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	498	498	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	636	636	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	648	648	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Modified residue	1289	1289	.	.	.	Note=Phosphotyrosine	
Q8BSQ9	UniProtKB	Modified residue	1405	1405	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BSQ9	UniProtKB	Alternative sequence	300	332	.	.	.	ID=VSP_035471;Note=In isoform 2.	
Q8BSQ9	UniProtKB	Sequence conflict	417	417	.	.	.	.	
Q8BSQ9	UniProtKB	Sequence conflict	695	695	.	.	.	.	
Q8BSQ9	UniProtKB	Helix	659	671	.	.	.	.	
Q8BSQ9	UniProtKB	Beta strand	675	677	.	.	.	.	
Q8BSQ9	UniProtKB	Beta strand	679	681	.	.	.	.	
Q8BSQ9	UniProtKB	Helix	682	684	.	.	.	.	
Q8BSQ9	UniProtKB	Turn	690	692	.	.	.	.	
Q8BSQ9	UniProtKB	Helix	694	699	.	.	.	.	
Q8BSQ9	UniProtKB	Helix	706	714	.	.	.	.	
Q8BSQ9	UniProtKB	Helix	721	738	.	.	.	.	
Q8BSQ9	UniProtKB	Helix	744	759	.	.	.	.	
##sequence-region Q53EL6 1 469
Q53EL6	UniProtKB	Chain	1	469	.	.	.	ID=PRO_0000256519;Note=Programmed cell death protein 4	
Q53EL6	UniProtKB	Domain	163	284	.	.	.	Note=MI 1	
Q53EL6	UniProtKB	Domain	326	449	.	.	.	Note=MI 2	
Q53EL6	UniProtKB	Motif	58	64	.	.	.	Note=Nuclear localization signal;status=Potential	
Q53EL6	UniProtKB	Motif	70	76	.	.	.	Note=Phosphodegron	
Q53EL6	UniProtKB	Motif	241	250	.	.	.	Note=Nuclear localization signal;status=Potential	
Q53EL6	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
Q53EL6	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphoserine%3B by PKB and RPS6KB1	
Q53EL6	UniProtKB	Modified residue	76	76	.	.	.	Note=Phosphoserine	
Q53EL6	UniProtKB	Modified residue	78	78	.	.	.	Note=Phosphoserine	
Q53EL6	UniProtKB	Modified residue	80	80	.	.	.	Note=Phosphoserine	
Q53EL6	UniProtKB	Modified residue	94	94	.	.	.	Note=Phosphoserine	
Q53EL6	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphotyrosine	
Q53EL6	UniProtKB	Modified residue	457	457	.	.	.	Note=Phosphoserine%3B by PKB	
Q53EL6	UniProtKB	Alternative sequence	1	15	.	.	.	ID=VSP_045622;Note=In isoform 2.	
Q53EL6	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_028901;Dbxref=dbSNP:rs7081726	
Q53EL6	UniProtKB	Natural variant	48	48	.	.	.	ID=VAR_028902;Dbxref=dbSNP:rs11548765	
Q53EL6	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_036375;Note=In a breast cancer sample%3B somatic mutation.	
Q53EL6	UniProtKB	Mutagenesis	67	67	.	.	.	Note=Loss of phosphorylation site. Reduces interaction with BTRC. Abolishes phosphorylation by PKB%3B when associated with A-457.	
Q53EL6	UniProtKB	Mutagenesis	71	71	.	.	.	Note=Strongly reduced interaction with BTRC. Strongly reduced ubiquitination.	
Q53EL6	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Strongly reduced interaction with BTRC. Strongly reduced ubiquitination.	
Q53EL6	UniProtKB	Mutagenesis	174	174	.	.	.	Note=Reduced inhibition of EIF4A1 helicase activity.	
Q53EL6	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	249	249	.	.	.	Note=Reduced interaction with EIF4A1.	
Q53EL6	UniProtKB	Mutagenesis	252	252	.	.	.	Note=Strongly reduced interaction with EIF4A1. Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	253	253	.	.	.	Note=Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation. Reduced inhibition of EIF4A1 helicase activity.	
Q53EL6	UniProtKB	Mutagenesis	255	255	.	.	.	Note=Reduced inhibition of EIF4A1 helicase activity. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	333	333	.	.	.	Note=No effect on inhibition of EIF4A1 and on inhibition of translation%3B when associated with A-340.	
Q53EL6	UniProtKB	Mutagenesis	337	337	.	.	.	Note=No effect on inhibition of EIF4A1 and on inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	340	340	.	.	.	Note=No effect on inhibition of EIF4A1 and on inhibition of translation%3B when associated with A-333.	
Q53EL6	UniProtKB	Mutagenesis	358	358	.	.	.	Note=Strongly reduced interaction with EIF4A1.	
Q53EL6	UniProtKB	Mutagenesis	359	359	.	.	.	Note=Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	361	361	.	.	.	Note=Strongly reduced inhibition of EIF4A1. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	418	418	.	.	.	Note=Reduced interaction with EIF4A1. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	420	420	.	.	.	Note=Strongly reduced interaction with EIF4A1. Strongly reduced inhibition of translation.	
Q53EL6	UniProtKB	Mutagenesis	457	457	.	.	.	Note=Loss of phosphorylation site%2C and loss of nuclear accumulation. Abolishes phosphorylation by PKB%3B when associated with A-67.	
Q53EL6	UniProtKB	Sequence conflict	79	79	.	.	.	.	
Q53EL6	UniProtKB	Sequence conflict	102	102	.	.	.	.	
Q53EL6	UniProtKB	Sequence conflict	130	130	.	.	.	.	
Q53EL6	UniProtKB	Sequence conflict	220	220	.	.	.	.	
Q53EL6	UniProtKB	Sequence conflict	222	222	.	.	.	.	
Q53EL6	UniProtKB	Sequence conflict	309	309	.	.	.	.	
Q53EL6	UniProtKB	Sequence conflict	314	314	.	.	.	.	
Q53EL6	UniProtKB	Sequence conflict	440	440	.	.	.	.	
Q53EL6	UniProtKB	Helix	161	178	.	.	.	.	
Q53EL6	UniProtKB	Helix	181	191	.	.	.	.	
Q53EL6	UniProtKB	Helix	195	198	.	.	.	.	
Q53EL6	UniProtKB	Helix	199	209	.	.	.	.	
Q53EL6	UniProtKB	Helix	213	226	.	.	.	.	
Q53EL6	UniProtKB	Turn	227	229	.	.	.	.	
Q53EL6	UniProtKB	Helix	233	253	.	.	.	.	
Q53EL6	UniProtKB	Helix	257	270	.	.	.	.	
Q53EL6	UniProtKB	Helix	278	281	.	.	.	.	
Q53EL6	UniProtKB	Turn	282	284	.	.	.	.	
Q53EL6	UniProtKB	Helix	289	303	.	.	.	.	
Q53EL6	UniProtKB	Beta strand	308	313	.	.	.	.	
Q53EL6	UniProtKB	Helix	324	341	.	.	.	.	
Q53EL6	UniProtKB	Helix	344	354	.	.	.	.	
Q53EL6	UniProtKB	Helix	357	359	.	.	.	.	
Q53EL6	UniProtKB	Helix	360	372	.	.	.	.	
Q53EL6	UniProtKB	Helix	378	393	.	.	.	.	
Q53EL6	UniProtKB	Helix	398	418	.	.	.	.	
Q53EL6	UniProtKB	Helix	422	435	.	.	.	.	
Q53EL6	UniProtKB	Helix	441	445	.	.	.	.	
##sequence-region Q61823 1 469
Q61823	UniProtKB	Chain	1	469	.	.	.	ID=PRO_0000256520;Note=Programmed cell death protein 4	
Q61823	UniProtKB	Domain	163	284	.	.	.	Note=MI 1	
Q61823	UniProtKB	Domain	326	449	.	.	.	Note=MI 2	
Q61823	UniProtKB	Motif	58	64	.	.	.	Note=Nuclear localization signal;status=Potential	
Q61823	UniProtKB	Motif	70	76	.	.	.	Note=Phosphodegron;status=By similarity	
Q61823	UniProtKB	Motif	448	454	.	.	.	Note=Nuclear localization signal;status=Potential	
Q61823	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q61823	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphoserine%3B by PKB and RPS6KB1;status=By similarity	
Q61823	UniProtKB	Modified residue	76	76	.	.	.	Note=Phosphoserine;status=By similarity	
Q61823	UniProtKB	Modified residue	78	78	.	.	.	Note=Phosphoserine;status=By similarity	
Q61823	UniProtKB	Modified residue	94	94	.	.	.	Note=Phosphoserine;status=By similarity	
Q61823	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q61823	UniProtKB	Modified residue	457	457	.	.	.	Note=Phosphoserine%3B by PKB;status=By similarity	
Q61823	UniProtKB	Mutagenesis	414	414	.	.	.	Note=Strongly reduced interaction with EIF4A1.	
Q61823	UniProtKB	Mutagenesis	418	418	.	.	.	Note=Strongly reduced interaction with EIF4A1.	
Q61823	UniProtKB	Mutagenesis	457	457	.	.	.	Note=No effect on interaction with EIF4A1.	
Q61823	UniProtKB	Sequence conflict	232	232	.	.	.	.	
Q61823	UniProtKB	Sequence conflict	232	232	.	.	.	.	
Q61823	UniProtKB	Sequence conflict	369	369	.	.	.	.	
Q61823	UniProtKB	Sequence conflict	369	369	.	.	.	.	
Q61823	UniProtKB	Sequence conflict	414	414	.	.	.	.	
Q61823	UniProtKB	Helix	162	178	.	.	.	.	
Q61823	UniProtKB	Helix	181	189	.	.	.	.	
Q61823	UniProtKB	Turn	190	192	.	.	.	.	
Q61823	UniProtKB	Helix	195	199	.	.	.	.	
Q61823	UniProtKB	Helix	200	208	.	.	.	.	
Q61823	UniProtKB	Helix	213	224	.	.	.	.	
Q61823	UniProtKB	Turn	225	229	.	.	.	.	
Q61823	UniProtKB	Helix	233	245	.	.	.	.	
Q61823	UniProtKB	Helix	247	253	.	.	.	.	
Q61823	UniProtKB	Helix	257	270	.	.	.	.	
Q61823	UniProtKB	Helix	280	282	.	.	.	.	
Q61823	UniProtKB	Helix	289	302	.	.	.	.	
Q61823	UniProtKB	Beta strand	320	322	.	.	.	.	
Q61823	UniProtKB	Helix	326	341	.	.	.	.	
Q61823	UniProtKB	Helix	344	354	.	.	.	.	
Q61823	UniProtKB	Helix	357	359	.	.	.	.	
Q61823	UniProtKB	Helix	360	373	.	.	.	.	
Q61823	UniProtKB	Beta strand	374	377	.	.	.	.	
Q61823	UniProtKB	Helix	378	392	.	.	.	.	
Q61823	UniProtKB	Helix	398	418	.	.	.	.	
Q61823	UniProtKB	Helix	422	435	.	.	.	.	
Q61823	UniProtKB	Helix	441	445	.	.	.	.	
##sequence-region Q5R8S3 1 469
Q5R8S3	UniProtKB	Chain	1	469	.	.	.	ID=PRO_0000256521;Note=Programmed cell death protein 4	
Q5R8S3	UniProtKB	Domain	163	284	.	.	.	Note=MI 1	
Q5R8S3	UniProtKB	Domain	326	449	.	.	.	Note=MI 2	
Q5R8S3	UniProtKB	Motif	58	64	.	.	.	Note=Nuclear localization signal;status=Potential	
Q5R8S3	UniProtKB	Motif	70	76	.	.	.	Note=Phosphodegron;status=By similarity	
Q5R8S3	UniProtKB	Motif	448	454	.	.	.	Note=Nuclear localization signal;status=Potential	
Q5R8S3	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q5R8S3	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphoserine%3B by PKB and RPS6KB1;status=By similarity	
Q5R8S3	UniProtKB	Modified residue	76	76	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R8S3	UniProtKB	Modified residue	78	78	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R8S3	UniProtKB	Modified residue	94	94	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R8S3	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q5R8S3	UniProtKB	Modified residue	457	457	.	.	.	Note=Phosphoserine%3B by PKB;status=By similarity	
##sequence-region Q9JID1 1 469
Q9JID1	UniProtKB	Chain	1	469	.	.	.	ID=PRO_0000256522;Note=Programmed cell death protein 4	
Q9JID1	UniProtKB	Domain	163	284	.	.	.	Note=MI 1	
Q9JID1	UniProtKB	Domain	326	449	.	.	.	Note=MI 2	
Q9JID1	UniProtKB	Motif	58	64	.	.	.	Note=Nuclear localization signal;status=Potential	
Q9JID1	UniProtKB	Motif	70	76	.	.	.	Note=Phosphodegron;status=By similarity	
Q9JID1	UniProtKB	Motif	448	454	.	.	.	Note=Nuclear localization signal;status=Potential	
Q9JID1	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q9JID1	UniProtKB	Modified residue	67	67	.	.	.	Note=Phosphoserine%3B by PKB and RPS6KB1;status=By similarity	
Q9JID1	UniProtKB	Modified residue	76	76	.	.	.	Note=Phosphoserine;status=By similarity	
Q9JID1	UniProtKB	Modified residue	78	78	.	.	.	Note=Phosphoserine;status=By similarity	
Q9JID1	UniProtKB	Modified residue	94	94	.	.	.	Note=Phosphoserine;status=By similarity	
Q9JID1	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q9JID1	UniProtKB	Modified residue	457	457	.	.	.	Note=Phosphoserine%3B by PKB;status=By similarity	
Q9JID1	UniProtKB	Alternative sequence	367	403	.	.	.	ID=VSP_021356;Note=In isoform 2.	
##sequence-region Q3T0C2 1 266
Q3T0C2	UniProtKB	Chain	1	266	.	.	.	ID=PRO_0000240130;Note=15-hydroxyprostaglandin dehydrogenase [NAD(+)]	
Q3T0C2	UniProtKB	Nucleotide binding	12	20	.	.	.	Note=NAD;status=By similarity	
Q3T0C2	UniProtKB	Nucleotide binding	36	37	.	.	.	Note=NAD;status=By similarity	
Q3T0C2	UniProtKB	Nucleotide binding	63	65	.	.	.	Note=NAD;status=By similarity	
Q3T0C2	UniProtKB	Nucleotide binding	151	155	.	.	.	Note=NAD;status=By similarity	
Q3T0C2	UniProtKB	Nucleotide binding	186	188	.	.	.	Note=NAD;status=By similarity	
Q3T0C2	UniProtKB	Active site	151	151	.	.	.	Note=Proton acceptor;status=By similarity	
Q3T0C2	UniProtKB	Binding site	91	91	.	.	.	Note=NAD%3B via carbonyl oxygen;status=By similarity	
Q3T0C2	UniProtKB	Binding site	138	138	.	.	.	Note=Substrate;status=By similarity	
Q3T0C2	UniProtKB	Binding site	148	148	.	.	.	Note=Substrate;status=By similarity	
##sequence-region P70684 1 265
P70684	UniProtKB	Chain	1	265	.	.	.	ID=PRO_0000253625;Note=15-hydroxyprostaglandin dehydrogenase [NAD(+)]	
P70684	UniProtKB	Nucleotide binding	12	20	.	.	.	Note=NAD;status=By similarity	
P70684	UniProtKB	Nucleotide binding	36	37	.	.	.	Note=NAD;status=By similarity	
P70684	UniProtKB	Nucleotide binding	63	65	.	.	.	Note=NAD;status=By similarity	
P70684	UniProtKB	Nucleotide binding	151	155	.	.	.	Note=NAD;status=By similarity	
P70684	UniProtKB	Nucleotide binding	186	188	.	.	.	Note=NAD;status=By similarity	
P70684	UniProtKB	Active site	151	151	.	.	.	Note=Proton acceptor;status=By similarity	
P70684	UniProtKB	Binding site	91	91	.	.	.	Note=NAD%3B via carbonyl oxygen;status=By similarity	
P70684	UniProtKB	Binding site	138	138	.	.	.	Note=Substrate;status=By similarity	
P70684	UniProtKB	Binding site	148	148	.	.	.	Note=Substrate;status=By similarity	
##sequence-region P15428 1 266
P15428	UniProtKB	Chain	1	266	.	.	.	ID=PRO_0000054744;Note=15-hydroxyprostaglandin dehydrogenase [NAD(+)]	
P15428	UniProtKB	Nucleotide binding	12	20	.	.	.	Note=NAD	
P15428	UniProtKB	Nucleotide binding	36	37	.	.	.	Note=NAD	
P15428	UniProtKB	Nucleotide binding	63	65	.	.	.	Note=NAD	
P15428	UniProtKB	Nucleotide binding	151	155	.	.	.	Note=NAD	
P15428	UniProtKB	Nucleotide binding	186	188	.	.	.	Note=NAD	
P15428	UniProtKB	Active site	151	151	.	.	.	Note=Proton acceptor	
P15428	UniProtKB	Binding site	91	91	.	.	.	Note=NAD%3B via carbonyl oxygen	
P15428	UniProtKB	Binding site	138	138	.	.	.	Note=Substrate;status=Probable	
P15428	UniProtKB	Binding site	148	148	.	.	.	Note=Substrate;status=Probable	
P15428	UniProtKB	Alternative sequence	1	121	.	.	.	ID=VSP_045106;Note=In isoform 3.	
P15428	UniProtKB	Alternative sequence	73	140	.	.	.	ID=VSP_045579;Note=In isoform 5.	
P15428	UniProtKB	Alternative sequence	140	143	.	.	.	ID=VSP_045107;Note=In isoform 4.	
P15428	UniProtKB	Alternative sequence	144	266	.	.	.	ID=VSP_045108;Note=In isoform 4.	
P15428	UniProtKB	Alternative sequence	167	266	.	.	.	ID=VSP_043032;Note=In isoform 2.	
P15428	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_046209;Note=In COA%3B inactive.	
P15428	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_060792;Note=In ICNC.	
P15428	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_006972	
P15428	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Loss of activity.	
P15428	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Reduced affinity for NAD and prostaglandin E2.	
P15428	UniProtKB	Mutagenesis	151	151	.	.	.	Note=Loss of activity.	
P15428	UniProtKB	Sequence conflict	50	50	.	.	.	.	
P15428	UniProtKB	Sequence conflict	50	50	.	.	.	.	
P15428	UniProtKB	Sequence conflict	97	97	.	.	.	.	
P15428	UniProtKB	Sequence conflict	219	219	.	.	.	.	
P15428	UniProtKB	Beta strand	7	11	.	.	.	.	
P15428	UniProtKB	Turn	12	14	.	.	.	.	
P15428	UniProtKB	Helix	16	27	.	.	.	.	
P15428	UniProtKB	Beta strand	31	37	.	.	.	.	
P15428	UniProtKB	Helix	39	49	.	.	.	.	
P15428	UniProtKB	Turn	50	52	.	.	.	.	
P15428	UniProtKB	Helix	55	57	.	.	.	.	
P15428	UniProtKB	Beta strand	58	62	.	.	.	.	
P15428	UniProtKB	Helix	68	82	.	.	.	.	
P15428	UniProtKB	Beta strand	87	90	.	.	.	.	
P15428	UniProtKB	Beta strand	97	99	.	.	.	.	
P15428	UniProtKB	Helix	100	107	.	.	.	.	
P15428	UniProtKB	Helix	109	122	.	.	.	.	
P15428	UniProtKB	Helix	124	126	.	.	.	.	
P15428	UniProtKB	Beta strand	131	136	.	.	.	.	
P15428	UniProtKB	Helix	139	141	.	.	.	.	
P15428	UniProtKB	Helix	149	172	.	.	.	.	
P15428	UniProtKB	Beta strand	176	184	.	.	.	.	
P15428	UniProtKB	Beta strand	186	188	.	.	.	.	
P15428	UniProtKB	Helix	189	192	.	.	.	.	
P15428	UniProtKB	Helix	193	195	.	.	.	.	
P15428	UniProtKB	Helix	197	200	.	.	.	.	
P15428	UniProtKB	Helix	201	206	.	.	.	.	
P15428	UniProtKB	Helix	207	217	.	.	.	.	
P15428	UniProtKB	Helix	222	234	.	.	.	.	
P15428	UniProtKB	Beta strand	242	246	.	.	.	.	
P15428	UniProtKB	Turn	247	249	.	.	.	.	
P15428	UniProtKB	Beta strand	250	253	.	.	.	.	
##sequence-region Q8MJY8 1 266
Q8MJY8	UniProtKB	Chain	1	266	.	.	.	ID=PRO_0000054745;Note=15-hydroxyprostaglandin dehydrogenase [NAD(+)]	
Q8MJY8	UniProtKB	Nucleotide binding	12	20	.	.	.	Note=NAD;status=By similarity	
Q8MJY8	UniProtKB	Nucleotide binding	36	37	.	.	.	Note=NAD;status=By similarity	
Q8MJY8	UniProtKB	Nucleotide binding	63	65	.	.	.	Note=NAD;status=By similarity	
Q8MJY8	UniProtKB	Nucleotide binding	151	155	.	.	.	Note=NAD;status=By similarity	
Q8MJY8	UniProtKB	Nucleotide binding	186	188	.	.	.	Note=NAD;status=By similarity	
Q8MJY8	UniProtKB	Active site	151	151	.	.	.	Note=Proton acceptor;status=By similarity	
Q8MJY8	UniProtKB	Binding site	91	91	.	.	.	Note=NAD%3B via carbonyl oxygen;status=By similarity	
Q8MJY8	UniProtKB	Binding site	138	138	.	.	.	Note=Substrate;status=By similarity	
Q8MJY8	UniProtKB	Binding site	148	148	.	.	.	Note=Substrate;status=By similarity	
##sequence-region Q8VCC1 1 269
Q8VCC1	UniProtKB	Chain	1	269	.	.	.	ID=PRO_0000253626;Note=15-hydroxyprostaglandin dehydrogenase [NAD(+)]	
Q8VCC1	UniProtKB	Nucleotide binding	12	20	.	.	.	Note=NAD;status=By similarity	
Q8VCC1	UniProtKB	Nucleotide binding	36	37	.	.	.	Note=NAD;status=By similarity	
Q8VCC1	UniProtKB	Nucleotide binding	63	65	.	.	.	Note=NAD;status=By similarity	
Q8VCC1	UniProtKB	Nucleotide binding	151	155	.	.	.	Note=NAD;status=By similarity	
Q8VCC1	UniProtKB	Nucleotide binding	186	188	.	.	.	Note=NAD;status=By similarity	
Q8VCC1	UniProtKB	Active site	151	151	.	.	.	Note=Proton acceptor;status=By similarity	
Q8VCC1	UniProtKB	Binding site	91	91	.	.	.	Note=NAD%3B via carbonyl oxygen;status=By similarity	
Q8VCC1	UniProtKB	Binding site	138	138	.	.	.	Note=Substrate;status=By similarity	
Q8VCC1	UniProtKB	Binding site	148	148	.	.	.	Note=Substrate;status=By similarity	
Q8VCC1	UniProtKB	Sequence conflict	113	113	.	.	.	.	
Q8VCC1	UniProtKB	Sequence conflict	153	153	.	.	.	.	
Q8VCC1	UniProtKB	Sequence conflict	205	205	.	.	.	.	
Q8VCC1	UniProtKB	Sequence conflict	224	224	.	.	.	.	
Q8VCC1	UniProtKB	Sequence conflict	231	231	.	.	.	.	
Q8VCC1	UniProtKB	Sequence conflict	241	241	.	.	.	.	
Q8VCC1	UniProtKB	Sequence conflict	246	246	.	.	.	.	
Q8VCC1	UniProtKB	Sequence conflict	249	249	.	.	.	.	
##sequence-region O08699 1 266
O08699	UniProtKB	Chain	1	266	.	.	.	ID=PRO_0000253627;Note=15-hydroxyprostaglandin dehydrogenase [NAD(+)]	
O08699	UniProtKB	Nucleotide binding	12	20	.	.	.	Note=NAD;status=By similarity	
O08699	UniProtKB	Nucleotide binding	36	37	.	.	.	Note=NAD;status=By similarity	
O08699	UniProtKB	Nucleotide binding	63	65	.	.	.	Note=NAD;status=By similarity	
O08699	UniProtKB	Nucleotide binding	151	155	.	.	.	Note=NAD;status=By similarity	
O08699	UniProtKB	Nucleotide binding	186	188	.	.	.	Note=NAD;status=By similarity	
O08699	UniProtKB	Active site	151	151	.	.	.	Note=Proton acceptor;status=By similarity	
O08699	UniProtKB	Binding site	91	91	.	.	.	Note=NAD%3B via carbonyl oxygen;status=By similarity	
O08699	UniProtKB	Binding site	138	138	.	.	.	Note=Substrate;status=By similarity	
O08699	UniProtKB	Binding site	148	148	.	.	.	Note=Substrate;status=By similarity	
O08699	UniProtKB	Sequence conflict	146	146	.	.	.	.	
##sequence-region Q8AW35 1 127
Q8AW35	UniProtKB	Chain	1	127	.	.	.	ID=PRO_0000369391;Note=Pleckstrin homology-like domain family A member 3	
Q8AW35	UniProtKB	Domain	5	108	.	.	.	Note=PH	
##sequence-region Q9Y5J5 1 127
Q9Y5J5	UniProtKB	Chain	1	127	.	.	.	ID=PRO_0000053902;Note=Pleckstrin homology-like domain family A member 3	
Q9Y5J5	UniProtKB	Domain	8	127	.	.	.	Note=PH	
Q9Y5J5	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_050515;Dbxref=dbSNP:rs35383942	
Q9Y5J5	UniProtKB	Sequence conflict	8	8	.	.	.	.	
Q9Y5J5	UniProtKB	Sequence conflict	88	88	.	.	.	.	
##sequence-region Q9WV95 1 125
Q9WV95	UniProtKB	Chain	1	125	.	.	.	ID=PRO_0000053903;Note=Pleckstrin homology-like domain family A member 3	
Q9WV95	UniProtKB	Domain	6	125	.	.	.	Note=PH	
Q9WV95	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Impairs the ability to resucue growth in cdc25ts mutant yeasts.	
Q9WV95	UniProtKB	Mutagenesis	28	28	.	.	.	Note=Impairs the ability to resucue growth in cdc25ts mutant yeasts.	
##sequence-region Q5PQT7 1 125
Q5PQT7	UniProtKB	Chain	1	125	.	.	.	ID=PRO_0000053904;Note=Pleckstrin homology-like domain family A member 3	
Q5PQT7	UniProtKB	Domain	6	125	.	.	.	Note=PH	
##sequence-region O60346 1 1717
O60346	UniProtKB	Chain	1	1717	.	.	.	ID=PRO_0000057781;Note=PH domain leucine-rich repeat-containing protein phosphatase 1	
O60346	UniProtKB	Domain	536	636	.	.	.	Note=PH	
O60346	UniProtKB	Repeat	638	659	.	.	.	Note=LRR 1	
O60346	UniProtKB	Repeat	661	682	.	.	.	Note=LRR 2	
O60346	UniProtKB	Repeat	692	712	.	.	.	Note=LRR 3	
O60346	UniProtKB	Repeat	715	736	.	.	.	Note=LRR 4	
O60346	UniProtKB	Repeat	738	760	.	.	.	Note=LRR 5	
O60346	UniProtKB	Repeat	761	783	.	.	.	Note=LRR 6	
O60346	UniProtKB	Repeat	784	804	.	.	.	Note=LRR 7	
O60346	UniProtKB	Repeat	808	831	.	.	.	Note=LRR 8	
O60346	UniProtKB	Repeat	832	853	.	.	.	Note=LRR 9	
O60346	UniProtKB	Repeat	873	894	.	.	.	Note=LRR 10	
O60346	UniProtKB	Repeat	895	916	.	.	.	Note=LRR 11	
O60346	UniProtKB	Repeat	918	939	.	.	.	Note=LRR 12	
O60346	UniProtKB	Repeat	941	962	.	.	.	Note=LRR 13	
O60346	UniProtKB	Repeat	963	984	.	.	.	Note=LRR 14	
O60346	UniProtKB	Repeat	987	1008	.	.	.	Note=LRR 15	
O60346	UniProtKB	Repeat	1013	1033	.	.	.	Note=LRR 16	
O60346	UniProtKB	Repeat	1037	1058	.	.	.	Note=LRR 17	
O60346	UniProtKB	Repeat	1061	1082	.	.	.	Note=LRR 18	
O60346	UniProtKB	Repeat	1084	1105	.	.	.	Note=LRR 19	
O60346	UniProtKB	Repeat	1106	1127	.	.	.	Note=LRR 20	
O60346	UniProtKB	Repeat	1129	1150	.	.	.	Note=LRR 21	
O60346	UniProtKB	Domain	1165	1420	.	.	.	Note=PP2C-like	
O60346	UniProtKB	Motif	1715	1717	.	.	.	Note=PDZ-binding	
O60346	UniProtKB	Compositional bias	4	7	.	.	.	Note=Poly-Ala	
O60346	UniProtKB	Compositional bias	21	45	.	.	.	Note=Poly-Ala	
O60346	UniProtKB	Compositional bias	132	137	.	.	.	Note=Poly-Ala	
O60346	UniProtKB	Compositional bias	138	144	.	.	.	Note=Poly-Ser	
O60346	UniProtKB	Compositional bias	145	148	.	.	.	Note=Poly-Ala	
O60346	UniProtKB	Compositional bias	254	257	.	.	.	Note=Poly-Ala	
O60346	UniProtKB	Compositional bias	463	469	.	.	.	Note=Poly-Pro	
O60346	UniProtKB	Compositional bias	1682	1689	.	.	.	Note=Poly-Gln	
O60346	UniProtKB	Metal binding	1210	1210	.	.	.	Note=Manganese 1;status=By similarity	
O60346	UniProtKB	Metal binding	1210	1210	.	.	.	Note=Manganese 2;status=By similarity	
O60346	UniProtKB	Metal binding	1211	1211	.	.	.	Note=Manganese 1%3B via carbonyl oxygen;status=By similarity	
O60346	UniProtKB	Metal binding	1374	1374	.	.	.	Note=Manganese 2;status=By similarity	
O60346	UniProtKB	Metal binding	1413	1413	.	.	.	Note=Manganese 2;status=By similarity	
O60346	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
O60346	UniProtKB	Natural variant	1118	1118	.	.	.	ID=VAR_056725;Dbxref=dbSNP:rs9950585	
O60346	UniProtKB	Mutagenesis	1715	1717	.	.	.	Note=Loss of function in vivo%2C but does not abolishes intrinsic phosphatase activity.	
O60346	UniProtKB	Sequence conflict	691	691	.	.	.	.	
O60346	UniProtKB	Sequence conflict	1062	1062	.	.	.	.	
O60346	UniProtKB	Sequence conflict	1083	1083	.	.	.	.	
O60346	UniProtKB	Sequence conflict	1227	1227	.	.	.	.	
O60346	UniProtKB	Sequence conflict	1490	1490	.	.	.	.	
O60346	UniProtKB	Sequence conflict	1580	1580	.	.	.	.	
##sequence-region Q9WTR8 1 1696
Q9WTR8	UniProtKB	Chain	1	1696	.	.	.	ID=PRO_0000057783;Note=PH domain leucine-rich repeat protein phosphatase 1	
Q9WTR8	UniProtKB	Domain	499	599	.	.	.	Note=PH	
Q9WTR8	UniProtKB	Repeat	601	622	.	.	.	Note=LRR 1	
Q9WTR8	UniProtKB	Repeat	624	645	.	.	.	Note=LRR 2	
Q9WTR8	UniProtKB	Repeat	655	676	.	.	.	Note=LRR 3	
Q9WTR8	UniProtKB	Repeat	678	699	.	.	.	Note=LRR 4	
Q9WTR8	UniProtKB	Repeat	701	722	.	.	.	Note=LRR 5	
Q9WTR8	UniProtKB	Repeat	724	746	.	.	.	Note=LRR 6	
Q9WTR8	UniProtKB	Repeat	836	857	.	.	.	Note=LRR 7	
Q9WTR8	UniProtKB	Repeat	858	879	.	.	.	Note=LRR 8	
Q9WTR8	UniProtKB	Repeat	881	902	.	.	.	Note=LRR 9	
Q9WTR8	UniProtKB	Repeat	904	925	.	.	.	Note=LRR 10	
Q9WTR8	UniProtKB	Repeat	926	947	.	.	.	Note=LRR 11	
Q9WTR8	UniProtKB	Repeat	950	971	.	.	.	Note=LRR 12	
Q9WTR8	UniProtKB	Repeat	976	996	.	.	.	Note=LRR 13	
Q9WTR8	UniProtKB	Repeat	1000	1021	.	.	.	Note=LRR 14	
Q9WTR8	UniProtKB	Repeat	1024	1045	.	.	.	Note=LRR 15	
Q9WTR8	UniProtKB	Repeat	1047	1068	.	.	.	Note=LRR 16	
Q9WTR8	UniProtKB	Repeat	1069	1090	.	.	.	Note=LRR 17	
Q9WTR8	UniProtKB	Repeat	1092	1113	.	.	.	Note=LRR 18	
Q9WTR8	UniProtKB	Domain	1128	1383	.	.	.	Note=PP2C-like	
Q9WTR8	UniProtKB	Motif	1694	1696	.	.	.	Note=PDZ-binding	
Q9WTR8	UniProtKB	Compositional bias	4	9	.	.	.	Note=Poly-Ala	
Q9WTR8	UniProtKB	Compositional bias	21	28	.	.	.	Note=Poly-Ala	
Q9WTR8	UniProtKB	Compositional bias	116	126	.	.	.	Note=Poly-Ser	
Q9WTR8	UniProtKB	Compositional bias	339	343	.	.	.	Note=Poly-Ser	
Q9WTR8	UniProtKB	Compositional bias	405	410	.	.	.	Note=Poly-Ala	
Q9WTR8	UniProtKB	Compositional bias	1431	1434	.	.	.	Note=Poly-Ser	
Q9WTR8	UniProtKB	Compositional bias	1645	1661	.	.	.	Note=Poly-Gln	
Q9WTR8	UniProtKB	Compositional bias	1662	1669	.	.	.	Note=Poly-Pro	
Q9WTR8	UniProtKB	Metal binding	1173	1173	.	.	.	Note=Manganese 1;status=By similarity	
Q9WTR8	UniProtKB	Metal binding	1173	1173	.	.	.	Note=Manganese 2;status=By similarity	
Q9WTR8	UniProtKB	Metal binding	1174	1174	.	.	.	Note=Manganese 1%3B via carbonyl oxygen;status=By similarity	
Q9WTR8	UniProtKB	Metal binding	1337	1337	.	.	.	Note=Manganese 2;status=By similarity	
Q9WTR8	UniProtKB	Metal binding	1376	1376	.	.	.	Note=Manganese 2;status=By similarity	
Q9WTR8	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
##sequence-region Q6ZVD8 1 1323
Q6ZVD8	UniProtKB	Chain	1	1323	.	.	.	ID=PRO_0000057784;Note=PH domain leucine-rich repeat-containing protein phosphatase 2	
Q6ZVD8	UniProtKB	Domain	150	248	.	.	.	Note=PH	
Q6ZVD8	UniProtKB	Repeat	250	271	.	.	.	Note=LRR 1	
Q6ZVD8	UniProtKB	Repeat	273	296	.	.	.	Note=LRR 2	
Q6ZVD8	UniProtKB	Repeat	300	321	.	.	.	Note=LRR 3	
Q6ZVD8	UniProtKB	Repeat	323	344	.	.	.	Note=LRR 4	
Q6ZVD8	UniProtKB	Repeat	346	368	.	.	.	Note=LRR 5	
Q6ZVD8	UniProtKB	Repeat	369	390	.	.	.	Note=LRR 6	
Q6ZVD8	UniProtKB	Repeat	392	412	.	.	.	Note=LRR 7	
Q6ZVD8	UniProtKB	Repeat	416	439	.	.	.	Note=LRR 8	
Q6ZVD8	UniProtKB	Repeat	440	460	.	.	.	Note=LRR 9	
Q6ZVD8	UniProtKB	Repeat	461	480	.	.	.	Note=LRR 10	
Q6ZVD8	UniProtKB	Repeat	481	502	.	.	.	Note=LRR 11	
Q6ZVD8	UniProtKB	Repeat	503	524	.	.	.	Note=LRR 12	
Q6ZVD8	UniProtKB	Repeat	526	547	.	.	.	Note=LRR 13	
Q6ZVD8	UniProtKB	Repeat	549	570	.	.	.	Note=LRR 14	
Q6ZVD8	UniProtKB	Repeat	571	592	.	.	.	Note=LRR 15	
Q6ZVD8	UniProtKB	Repeat	595	616	.	.	.	Note=LRR 16	
Q6ZVD8	UniProtKB	Repeat	621	644	.	.	.	Note=LRR 17	
Q6ZVD8	UniProtKB	Repeat	645	666	.	.	.	Note=LRR 18	
Q6ZVD8	UniProtKB	Repeat	669	690	.	.	.	Note=LRR 19	
Q6ZVD8	UniProtKB	Repeat	692	713	.	.	.	Note=LRR 20	
Q6ZVD8	UniProtKB	Repeat	714	735	.	.	.	Note=LRR 21	
Q6ZVD8	UniProtKB	Repeat	737	758	.	.	.	Note=LRR 22	
Q6ZVD8	UniProtKB	Domain	775	1031	.	.	.	Note=PP2C-like	
Q6ZVD8	UniProtKB	Compositional bias	40	49	.	.	.	Note=Poly-Thr	
Q6ZVD8	UniProtKB	Compositional bias	50	60	.	.	.	Note=Poly-Ser	
Q6ZVD8	UniProtKB	Compositional bias	1071	1074	.	.	.	Note=Poly-Ser	
Q6ZVD8	UniProtKB	Metal binding	820	820	.	.	.	Note=Manganese 1;status=By similarity	
Q6ZVD8	UniProtKB	Metal binding	820	820	.	.	.	Note=Manganese 2;status=By similarity	
Q6ZVD8	UniProtKB	Metal binding	821	821	.	.	.	Note=Manganese 1%3B via carbonyl oxygen;status=By similarity	
Q6ZVD8	UniProtKB	Metal binding	985	985	.	.	.	Note=Manganese 2;status=By similarity	
Q6ZVD8	UniProtKB	Metal binding	1024	1024	.	.	.	Note=Manganese 2;status=By similarity	
Q6ZVD8	UniProtKB	Alternative sequence	596	662	.	.	.	ID=VSP_017265;Note=In isoform 3.	
Q6ZVD8	UniProtKB	Alternative sequence	940	956	.	.	.	ID=VSP_014056;Note=In isoform 2.	
Q6ZVD8	UniProtKB	Alternative sequence	957	1323	.	.	.	ID=VSP_014057;Note=In isoform 2.	
Q6ZVD8	UniProtKB	Sequence conflict	147	147	.	.	.	.	
Q6ZVD8	UniProtKB	Sequence conflict	542	542	.	.	.	.	
Q6ZVD8	UniProtKB	Sequence conflict	766	766	.	.	.	.	
Q6ZVD8	UniProtKB	Sequence conflict	896	896	.	.	.	.	
Q6ZVD8	UniProtKB	Sequence conflict	978	978	.	.	.	.	
Q6ZVD8	UniProtKB	Sequence conflict	1016	1016	.	.	.	.	
Q6ZVD8	UniProtKB	Sequence conflict	1312	1312	.	.	.	.	
##sequence-region Q8BXA7 1 1320
Q8BXA7	UniProtKB	Chain	1	1320	.	.	.	ID=PRO_0000057785;Note=PH domain leucine-rich repeat-containing protein phosphatase 2	
Q8BXA7	UniProtKB	Domain	147	245	.	.	.	Note=PH	
Q8BXA7	UniProtKB	Repeat	247	268	.	.	.	Note=LRR 1	
Q8BXA7	UniProtKB	Repeat	270	293	.	.	.	Note=LRR 2	
Q8BXA7	UniProtKB	Repeat	297	318	.	.	.	Note=LRR 3	
Q8BXA7	UniProtKB	Repeat	320	341	.	.	.	Note=LRR 4	
Q8BXA7	UniProtKB	Repeat	343	364	.	.	.	Note=LRR 5	
Q8BXA7	UniProtKB	Repeat	366	388	.	.	.	Note=LRR 6	
Q8BXA7	UniProtKB	Repeat	389	409	.	.	.	Note=LRR 7	
Q8BXA7	UniProtKB	Repeat	413	434	.	.	.	Note=LRR 8	
Q8BXA7	UniProtKB	Repeat	437	457	.	.	.	Note=LRR 9	
Q8BXA7	UniProtKB	Repeat	458	477	.	.	.	Note=LRR 10	
Q8BXA7	UniProtKB	Repeat	478	499	.	.	.	Note=LRR 11	
Q8BXA7	UniProtKB	Repeat	500	521	.	.	.	Note=LRR 12	
Q8BXA7	UniProtKB	Repeat	523	544	.	.	.	Note=LRR 13	
Q8BXA7	UniProtKB	Repeat	546	567	.	.	.	Note=LRR 14	
Q8BXA7	UniProtKB	Repeat	568	589	.	.	.	Note=LRR 15	
Q8BXA7	UniProtKB	Repeat	592	613	.	.	.	Note=LRR 16	
Q8BXA7	UniProtKB	Repeat	618	641	.	.	.	Note=LRR 17	
Q8BXA7	UniProtKB	Repeat	642	663	.	.	.	Note=LRR 18	
Q8BXA7	UniProtKB	Repeat	666	687	.	.	.	Note=LRR 19	
Q8BXA7	UniProtKB	Repeat	689	710	.	.	.	Note=LRR 20	
Q8BXA7	UniProtKB	Repeat	711	732	.	.	.	Note=LRR 21	
Q8BXA7	UniProtKB	Repeat	734	755	.	.	.	Note=LRR 22	
Q8BXA7	UniProtKB	Domain	772	1028	.	.	.	Note=PP2C-like	
Q8BXA7	UniProtKB	Compositional bias	40	47	.	.	.	Note=Poly-Thr	
Q8BXA7	UniProtKB	Compositional bias	48	57	.	.	.	Note=Poly-Ser	
Q8BXA7	UniProtKB	Compositional bias	1068	1071	.	.	.	Note=Poly-Ser	
Q8BXA7	UniProtKB	Metal binding	817	817	.	.	.	Note=Manganese 1;status=By similarity	
Q8BXA7	UniProtKB	Metal binding	817	817	.	.	.	Note=Manganese 2;status=By similarity	
Q8BXA7	UniProtKB	Metal binding	818	818	.	.	.	Note=Manganese 1%3B via carbonyl oxygen;status=By similarity	
Q8BXA7	UniProtKB	Metal binding	982	982	.	.	.	Note=Manganese 2;status=By similarity	
Q8BXA7	UniProtKB	Metal binding	1021	1021	.	.	.	Note=Manganese 2;status=By similarity	
Q8BXA7	UniProtKB	Sequence conflict	67	67	.	.	.	.	
##sequence-region Q9H307 1 717
Q9H307	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q9H307	UniProtKB	Chain	2	717	.	.	.	ID=PRO_0000190242;Note=Pinin	
Q9H307	UniProtKB	Region	2	284	.	.	.	Note=Necessary for interaction with RNPS1	
Q9H307	UniProtKB	Region	2	167	.	.	.	Note=Necessary for mediating alternative 5' splicing	
Q9H307	UniProtKB	Region	2	98	.	.	.	Note=Necessary for interactions with KRT8%2C KRT18 and KRT19	
Q9H307	UniProtKB	Region	221	284	.	.	.	Note=Sufficient for PSAP complex assembly	
Q9H307	UniProtKB	Region	606	717	.	.	.	Note=Necessary for interaction with PPIG	
Q9H307	UniProtKB	Coiled coil	2	32	.	.	.	status=Potential	
Q9H307	UniProtKB	Coiled coil	163	234	.	.	.	status=Potential	
Q9H307	UniProtKB	Coiled coil	287	379	.	.	.	status=Potential	
Q9H307	UniProtKB	Coiled coil	446	467	.	.	.	status=Potential	
Q9H307	UniProtKB	Compositional bias	172	471	.	.	.	Note=Glu-rich	
Q9H307	UniProtKB	Compositional bias	469	520	.	.	.	Note=Gln-rich	
Q9H307	UniProtKB	Compositional bias	552	704	.	.	.	Note=Ser-rich	
Q9H307	UniProtKB	Compositional bias	632	717	.	.	.	Note=Arg-rich	
Q9H307	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine	
Q9H307	UniProtKB	Modified residue	58	58	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	66	66	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	96	96	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	100	100	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	114	114	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	115	115	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	124	124	.	.	.	Note=Phosphothreonine	
Q9H307	UniProtKB	Modified residue	238	238	.	.	.	Note=N6-acetyllysine	
Q9H307	UniProtKB	Modified residue	347	347	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	375	375	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	381	381	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	443	443	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	450	450	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	552	552	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	658	658	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	692	692	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Modified residue	695	695	.	.	.	Note=Phosphoserine	
Q9H307	UniProtKB	Alternative sequence	1	133	.	.	.	ID=VSP_015307;Note=In isoform 2.	
Q9H307	UniProtKB	Natural variant	441	441	.	.	.	ID=VAR_050540;Dbxref=dbSNP:rs2180792	
Q9H307	UniProtKB	Natural variant	671	671	.	.	.	ID=VAR_023368;Dbxref=dbSNP:rs13021	
Q9H307	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Abolishes interaction with KRT18.	
Q9H307	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Abolishes interaction with KRT18.	
Q9H307	UniProtKB	Mutagenesis	502	503	.	.	.	Note=Abolishes interaction with CTBP1 and shows moderate relief of CTBP1-mediated repression.	
Q9H307	UniProtKB	Sequence conflict	69	69	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	168	168	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	268	268	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	303	303	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	320	320	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	343	343	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	402	403	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	459	459	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	478	478	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	491	492	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	497	497	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	520	520	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	523	523	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	541	541	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	543	543	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	547	547	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	550	550	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	551	551	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	553	557	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	566	566	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	569	571	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	618	618	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	618	618	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	626	626	.	.	.	.	
Q9H307	UniProtKB	Sequence conflict	664	664	.	.	.	.	
##sequence-region Q96BK5 1 328
Q96BK5	UniProtKB	Chain	1	328	.	.	.	ID=PRO_0000058443;Note=PIN2/TERF1-interacting telomerase inhibitor 1	
Q96BK5	UniProtKB	Domain	26	72	.	.	.	Note=G-patch	
Q96BK5	UniProtKB	Region	254	328	.	.	.	Note=Telomerase inhibitory domain (TID)	
Q96BK5	UniProtKB	Motif	287	297	.	.	.	Note=TBM	
Q96BK5	UniProtKB	Alternative sequence	133	174	.	.	.	ID=VSP_003945;Note=In isoform 2.	
Q96BK5	UniProtKB	Alternative sequence	175	328	.	.	.	ID=VSP_003946;Note=In isoform 2.	
Q96BK5	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_054024;Dbxref=dbSNP:rs35530857	
Q96BK5	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_054025;Dbxref=dbSNP:rs17855458	
Q96BK5	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_054026;Dbxref=dbSNP:rs17711777	
Q96BK5	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_054027;Dbxref=dbSNP:rs1078543	
Q96BK5	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_054028;Dbxref=dbSNP:rs34656824	
Q96BK5	UniProtKB	Mutagenesis	291	291	.	.	.	Note=Abolishes interaction with TERF1.	
Q96BK5	UniProtKB	Mutagenesis	293	293	.	.	.	Note=Does not affect interaction with TERF1.	
Q96BK5	UniProtKB	Sequence conflict	50	50	.	.	.	.	
Q96BK5	UniProtKB	Sequence conflict	185	186	.	.	.	.	
Q96BK5	UniProtKB	Sequence conflict	204	204	.	.	.	.	
Q96BK5	UniProtKB	Sequence conflict	205	205	.	.	.	.	
Q96BK5	UniProtKB	Sequence conflict	259	259	.	.	.	.	
##sequence-region Q9CZX5 1 332
Q9CZX5	UniProtKB	Chain	1	332	.	.	.	ID=PRO_0000058444;Note=PIN2/TERF1-interacting telomerase inhibitor 1	
Q9CZX5	UniProtKB	Domain	26	72	.	.	.	Note=G-patch	
Q9CZX5	UniProtKB	Region	254	328	.	.	.	Note=Telomerase inhibitory domain (TID)	
Q9CZX5	UniProtKB	Motif	291	301	.	.	.	Note=TBM	
Q9CZX5	UniProtKB	Sequence conflict	40	40	.	.	.	.	
Q9CZX5	UniProtKB	Sequence conflict	210	213	.	.	.	.	
##sequence-region A4L691 1 331
A4L691	UniProtKB	Chain	1	331	.	.	.	ID=PRO_0000294933;Note=PIN2/TERF1-interacting telomerase inhibitor 1	
A4L691	UniProtKB	Domain	26	72	.	.	.	Note=G-patch	
A4L691	UniProtKB	Region	254	328	.	.	.	Note=Telomerase inhibitory domain (TID)	
A4L691	UniProtKB	Motif	291	301	.	.	.	Note=TBM	
##sequence-region Q9H7P9 1 1386
Q9H7P9	UniProtKB	Chain	1	1386	.	.	.	ID=PRO_0000306861;Note=Pleckstrin homology domain-containing family G member 2	
Q9H7P9	UniProtKB	Domain	102	283	.	.	.	Note=DH	
Q9H7P9	UniProtKB	Domain	313	411	.	.	.	Note=PH	
Q9H7P9	UniProtKB	Compositional bias	593	600	.	.	.	Note=Poly-Glu	
Q9H7P9	UniProtKB	Compositional bias	1067	1184	.	.	.	Note=Pro-rich	
Q9H7P9	UniProtKB	Compositional bias	1319	1328	.	.	.	Note=Poly-Pro	
Q9H7P9	UniProtKB	Compositional bias	1344	1347	.	.	.	Note=Poly-Gly	
Q9H7P9	UniProtKB	Modified residue	445	445	.	.	.	Note=Phosphothreonine	
Q9H7P9	UniProtKB	Modified residue	450	450	.	.	.	Note=Phosphoserine	
Q9H7P9	UniProtKB	Modified residue	1257	1257	.	.	.	Note=Phosphothreonine	
Q9H7P9	UniProtKB	Alternative sequence	468	496	.	.	.	ID=VSP_028529;Note=In isoform 3.	
Q9H7P9	UniProtKB	Alternative sequence	560	1368	.	.	.	ID=VSP_028530;Note=In isoform 2.	
Q9H7P9	UniProtKB	Natural variant	540	540	.	.	.	ID=VAR_035324;Dbxref=dbSNP:rs35904695	
Q9H7P9	UniProtKB	Natural variant	622	622	.	.	.	ID=VAR_035325;Dbxref=dbSNP:rs16973407	
Q9H7P9	UniProtKB	Natural variant	647	647	.	.	.	ID=VAR_035326;Dbxref=dbSNP:rs10407035	
Q9H7P9	UniProtKB	Natural variant	992	992	.	.	.	ID=VAR_035327;Dbxref=dbSNP:rs31726	
Q9H7P9	UniProtKB	Natural variant	1302	1302	.	.	.	ID=VAR_035328;Dbxref=dbSNP:rs34603507	
Q9H7P9	UniProtKB	Natural variant	1329	1329	.	.	.	ID=VAR_035329;Dbxref=dbSNP:rs31728	
##sequence-region Q6KAU7 1 1340
Q6KAU7	UniProtKB	Chain	1	1340	.	.	.	ID=PRO_0000306862;Note=Pleckstrin homology domain-containing family G member 2	
Q6KAU7	UniProtKB	Domain	98	279	.	.	.	Note=DH	
Q6KAU7	UniProtKB	Domain	309	407	.	.	.	Note=PH	
Q6KAU7	UniProtKB	Compositional bias	589	594	.	.	.	Note=Poly-Glu	
Q6KAU7	UniProtKB	Compositional bias	1303	1306	.	.	.	Note=Poly-Gly	
Q6KAU7	UniProtKB	Modified residue	441	441	.	.	.	Note=Phosphothreonine;status=By similarity	
Q6KAU7	UniProtKB	Modified residue	446	446	.	.	.	Note=Phosphoserine;status=By similarity	
Q6KAU7	UniProtKB	Modified residue	1215	1215	.	.	.	Note=Phosphothreonine;status=By similarity	
Q6KAU7	UniProtKB	Alternative sequence	1	42	.	.	.	ID=VSP_028531;Note=In isoform 2.	
Q6KAU7	UniProtKB	Alternative sequence	478	478	.	.	.	ID=VSP_028532;Note=In isoform 3.	
Q6KAU7	UniProtKB	Sequence conflict	37	37	.	.	.	.	
Q6KAU7	UniProtKB	Sequence conflict	519	519	.	.	.	.	
Q6KAU7	UniProtKB	Sequence conflict	519	519	.	.	.	.	
Q6KAU7	UniProtKB	Sequence conflict	519	519	.	.	.	.	
Q6KAU7	UniProtKB	Sequence conflict	823	825	.	.	.	.	
##sequence-region A4IFK0 1 409
A4IFK0	UniProtKB	Chain	1	409	.	.	.	ID=PRO_0000310422;Note=Pleckstrin homology domain-containing family O member 1	
A4IFK0	UniProtKB	Domain	21	132	.	.	.	Note=PH	
A4IFK0	UniProtKB	Region	133	193	.	.	.	Note=Interaction with capping proteins (CPs);status=By similarity	
A4IFK0	UniProtKB	Region	136	308	.	.	.	Note=Interaction with ATM%2C CKIP%2C IFP35 and NMI;status=By similarity	
A4IFK0	UniProtKB	Region	308	409	.	.	.	Note=Negative regulator of AP-1 activity;status=By similarity	
A4IFK0	UniProtKB	Binding site	155	155	.	.	.	Note=Capping protein;status=By similarity	
A4IFK0	UniProtKB	Binding site	157	157	.	.	.	Note=Capping protein;status=By similarity	
A4IFK0	UniProtKB	Site	310	311	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
A4IFK0	UniProtKB	Site	345	346	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
A4IFK0	UniProtKB	Modified residue	227	227	.	.	.	Note=Phosphoserine;status=By similarity	
A4IFK0	UniProtKB	Modified residue	271	271	.	.	.	Note=Phosphoserine;status=By similarity	
A4IFK0	UniProtKB	Modified residue	342	342	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q53GL0 1 409
Q53GL0	UniProtKB	Chain	1	409	.	.	.	ID=PRO_0000310423;Note=Pleckstrin homology domain-containing family O member 1	
Q53GL0	UniProtKB	Domain	21	132	.	.	.	Note=PH	
Q53GL0	UniProtKB	Region	133	193	.	.	.	Note=Interaction with capping proteins (CPs)	
Q53GL0	UniProtKB	Region	136	308	.	.	.	Note=Interaction with ATM%2C CKIP%2C IFP35 and NMI	
Q53GL0	UniProtKB	Region	308	409	.	.	.	Note=Negative regulator of AP-1 activity	
Q53GL0	UniProtKB	Binding site	155	155	.	.	.	Note=Capping protein	
Q53GL0	UniProtKB	Binding site	157	157	.	.	.	Note=Capping protein	
Q53GL0	UniProtKB	Site	310	311	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
Q53GL0	UniProtKB	Site	345	346	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
Q53GL0	UniProtKB	Modified residue	227	227	.	.	.	Note=Phosphoserine;status=By similarity	
Q53GL0	UniProtKB	Modified residue	271	271	.	.	.	Note=Phosphoserine;status=By similarity	
Q53GL0	UniProtKB	Modified residue	342	342	.	.	.	Note=Phosphoserine;status=By similarity	
Q53GL0	UniProtKB	Alternative sequence	142	175	.	.	.	ID=VSP_029282;Note=In isoform 2.	
Q53GL0	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_037034;Dbxref=dbSNP:rs2306235	
Q53GL0	UniProtKB	Mutagenesis	42	42	.	.	.	Note=No effect on subcellular localization. No effect on subcellular localization%3B when associated with C-44. Disruption of membrane localization%2C loss of phospholipid binding and impaired interaction with CK2%3B when associated with W-123. Disruption of membrane localization%2C loss of phospholipid binding and impaired interaction with CK2%3B when associated with C-44 and W-123.	
Q53GL0	UniProtKB	Mutagenesis	44	44	.	.	.	Note=No effect on subcellular localization. No effect on subcellular localization%3B when associated with C-42. Disruption of membrane localization%2C loss of phospholipid binding and impaired interaction with CK2%3B when associated with W-123. Disruption of membrane localization%2C loss of phospholipid binding and impaired interaction with CK2%3B when associated with C-42 and W-123.	
Q53GL0	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Disruption of membrane localization and impaired interaction with CK2. Loss of phospholipid binding%3B when associated with C-42. Loss of phospholipid binding%3B when associated with C-44. Disruption of membrane localization%2C loss of phospholipid binding and impaired interaction with CK2%3B when associated with C-42 and C-44.	
Q53GL0	UniProtKB	Mutagenesis	133	133	.	.	.	Note=No effect on binding to capping proteins and loss of phospholipid binding%3B when associated with A-135 and A-137.	
Q53GL0	UniProtKB	Mutagenesis	133	133	.	.	.	Note=No effect on binding to capping proteins%3B when associated with E-135.	
Q53GL0	UniProtKB	Mutagenesis	135	135	.	.	.	Note=No effect on binding to capping proteins%3B when associated with A-133 and A-137.	
Q53GL0	UniProtKB	Mutagenesis	135	135	.	.	.	Note=No effect on binding to capping proteins%3B when associated with E-133.	
Q53GL0	UniProtKB	Mutagenesis	137	137	.	.	.	Note=No effect on binding to capping proteins%3B when associated with A-133 and A-135.	
Q53GL0	UniProtKB	Mutagenesis	155	155	.	.	.	Note=No change in cell morphology and actin cytoskeleton. Great loss of binding to capping proteins%3B when associated with A-157. Great loss of binding to capping proteins%3B when associated with A-157 and A-159.	
Q53GL0	UniProtKB	Mutagenesis	155	155	.	.	.	Note=No change in cell morphology and actin cytoskeleton. Great loss of binding to capping proteins and no change in cell morphology and actin cytoskeleton%3B when associated with E-157.	
Q53GL0	UniProtKB	Mutagenesis	157	157	.	.	.	Note=No change in cell morphology and actin cytoskeleton. Great loss of binding to capping proteins%3B when associated with A-155. Great loss of binding to capping proteins%3B when associated with A-155 and A-159.	
Q53GL0	UniProtKB	Mutagenesis	157	157	.	.	.	Note=No change in cell morphology and actin cytoskeleton. Great loss of binding to capping proteins and no change in cell morphology and actin cytoskeleton%3B when associated with E-155.	
Q53GL0	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Great loss of binding to capping proteins%3B when associated with A-155 and A-157.	
Q53GL0	UniProtKB	Sequence conflict	1	10	.	.	.	.	
Q53GL0	UniProtKB	Sequence conflict	285	285	.	.	.	.	
Q53GL0	UniProtKB	Helix	153	155	.	.	.	.	
##sequence-region Q9JIY0 1 408
Q9JIY0	UniProtKB	Chain	1	408	.	.	.	ID=PRO_0000310424;Note=Pleckstrin homology domain-containing family O member 1	
Q9JIY0	UniProtKB	Domain	20	131	.	.	.	Note=PH	
Q9JIY0	UniProtKB	Region	132	192	.	.	.	Note=Interaction with capping proteins (CPs);status=By similarity	
Q9JIY0	UniProtKB	Region	135	307	.	.	.	Note=Interaction with ATM%2C CKIP%2C IFP35 and NMI;status=By similarity	
Q9JIY0	UniProtKB	Region	307	408	.	.	.	Note=Negative regulator of AP-1 activity;status=By similarity	
Q9JIY0	UniProtKB	Binding site	154	154	.	.	.	Note=Capping protein;status=By similarity	
Q9JIY0	UniProtKB	Binding site	156	156	.	.	.	Note=Capping protein;status=By similarity	
Q9JIY0	UniProtKB	Site	309	310	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
Q9JIY0	UniProtKB	Site	344	345	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
Q9JIY0	UniProtKB	Modified residue	226	226	.	.	.	Note=Phosphoserine	
Q9JIY0	UniProtKB	Modified residue	270	270	.	.	.	Note=Phosphoserine	
Q9JIY0	UniProtKB	Modified residue	341	341	.	.	.	Note=Phosphoserine;status=By similarity	
Q9JIY0	UniProtKB	Sequence conflict	116	116	.	.	.	.	
##sequence-region Q5BJM5 1 408
Q5BJM5	UniProtKB	Chain	1	408	.	.	.	ID=PRO_0000310425;Note=Pleckstrin homology domain-containing family O member 1	
Q5BJM5	UniProtKB	Domain	20	131	.	.	.	Note=PH	
Q5BJM5	UniProtKB	Region	132	192	.	.	.	Note=Interaction with capping proteins (CPs);status=By similarity	
Q5BJM5	UniProtKB	Region	135	307	.	.	.	Note=Interaction with ATM%2C CKIP%2C IFP35 and NMI;status=By similarity	
Q5BJM5	UniProtKB	Region	307	408	.	.	.	Note=Negative regulator of AP-1 activity;status=By similarity	
Q5BJM5	UniProtKB	Binding site	154	154	.	.	.	Note=Capping protein;status=By similarity	
Q5BJM5	UniProtKB	Binding site	156	156	.	.	.	Note=Capping protein;status=By similarity	
Q5BJM5	UniProtKB	Site	309	310	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
Q5BJM5	UniProtKB	Site	344	345	.	.	.	Note=Cleavage%3B by caspase-3;status=Potential	
Q5BJM5	UniProtKB	Modified residue	226	226	.	.	.	Note=Phosphoserine;status=By similarity	
Q5BJM5	UniProtKB	Modified residue	270	270	.	.	.	Note=Phosphoserine;status=By similarity	
Q5BJM5	UniProtKB	Modified residue	341	341	.	.	.	Note=Phosphoserine	
##sequence-region Q9NYY3 1 685
Q9NYY3	UniProtKB	Chain	1	685	.	.	.	ID=PRO_0000086561;Note=Serine/threonine-protein kinase PLK2	
Q9NYY3	UniProtKB	Domain	82	334	.	.	.	Note=Protein kinase	
Q9NYY3	UniProtKB	Domain	510	573	.	.	.	Note=POLO box 1	
Q9NYY3	UniProtKB	Domain	606	677	.	.	.	Note=POLO box 2	
Q9NYY3	UniProtKB	Nucleotide binding	88	96	.	.	.	Note=ATP;status=By similarity	
Q9NYY3	UniProtKB	Compositional bias	57	64	.	.	.	Note=Poly-His	
Q9NYY3	UniProtKB	Active site	205	205	.	.	.	Note=Proton acceptor;status=By similarity	
Q9NYY3	UniProtKB	Binding site	111	111	.	.	.	Note=ATP;status=By similarity	
Q9NYY3	UniProtKB	Modified residue	239	239	.	.	.	Note=Phosphothreonine;status=By similarity	
Q9NYY3	UniProtKB	Natural variant	14	14	.	.	.	ID=VAR_041023;Note=In an ovarian Endometrioid carcinoma sample%3B somatic mutation.	
Q9NYY3	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_041024;Note=In a lung adenocarcinoma sample%3B somatic mutation.	
Q9NYY3	UniProtKB	Natural variant	436	436	.	.	.	ID=VAR_041025;Dbxref=dbSNP:rs55768901	
Q9NYY3	UniProtKB	Natural variant	487	487	.	.	.	ID=VAR_041026;Dbxref=dbSNP:rs55645589	
Q9NYY3	UniProtKB	Mutagenesis	210	210	.	.	.	Note=Loss of kinase activity.	
Q9NYY3	UniProtKB	Mutagenesis	503	503	.	.	.	Note=Impairs localization to the centrosome and centriole duplication%3B when associated with A-629 and M-631.	
Q9NYY3	UniProtKB	Mutagenesis	629	629	.	.	.	Note=Impairs localization to the centrosome and centriole duplication%3B when associated with F-503 and M-631.	
Q9NYY3	UniProtKB	Mutagenesis	631	631	.	.	.	Note=Impairs localization to the centrosome and centriole duplication%3B when associated with F-503 and A-631.	
Q9NYY3	UniProtKB	Sequence conflict	28	28	.	.	.	.	
##sequence-region P53351 1 682
P53351	UniProtKB	Chain	1	682	.	.	.	ID=PRO_0000086562;Note=Serine/threonine-protein kinase PLK2	
P53351	UniProtKB	Domain	79	331	.	.	.	Note=Protein kinase	
P53351	UniProtKB	Domain	507	570	.	.	.	Note=POLO box 1	
P53351	UniProtKB	Domain	603	674	.	.	.	Note=POLO box 2	
P53351	UniProtKB	Nucleotide binding	85	93	.	.	.	Note=ATP;status=By similarity	
P53351	UniProtKB	Compositional bias	54	59	.	.	.	Note=Poly-His	
P53351	UniProtKB	Active site	202	202	.	.	.	Note=Proton acceptor;status=By similarity	
P53351	UniProtKB	Binding site	108	108	.	.	.	Note=ATP;status=Probable	
P53351	UniProtKB	Modified residue	236	236	.	.	.	Note=Phosphothreonine	
P53351	UniProtKB	Mutagenesis	108	108	.	.	.	Note=In DN mutant%3B Loss of kinase activity%3B leading to disrupted Ras and Rap protein signaling%2C altered spine morphology and aberrant memory formation in mice.	
P53351	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Does not significantely affect kinase activity.	
P53351	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Mimicks phosphorylation state%2C leading to increased activity.	
##sequence-region Q5R4L1 1 685
Q5R4L1	UniProtKB	Chain	1	685	.	.	.	ID=PRO_0000260301;Note=Serine/threonine-protein kinase PLK2	
Q5R4L1	UniProtKB	Domain	82	334	.	.	.	Note=Protein kinase	
Q5R4L1	UniProtKB	Domain	510	573	.	.	.	Note=POLO box 1	
Q5R4L1	UniProtKB	Domain	606	677	.	.	.	Note=POLO box 2	
Q5R4L1	UniProtKB	Nucleotide binding	88	96	.	.	.	Note=ATP;status=By similarity	
Q5R4L1	UniProtKB	Compositional bias	57	64	.	.	.	Note=Poly-His	
Q5R4L1	UniProtKB	Active site	205	205	.	.	.	Note=Proton acceptor;status=By similarity	
Q5R4L1	UniProtKB	Binding site	111	111	.	.	.	Note=ATP;status=By similarity	
Q5R4L1	UniProtKB	Modified residue	239	239	.	.	.	Note=Phosphothreonine;status=By similarity	
##sequence-region Q9R012 1 682
Q9R012	UniProtKB	Chain	1	682	.	.	.	ID=PRO_0000086563;Note=Serine/threonine-protein kinase PLK2	
Q9R012	UniProtKB	Domain	79	331	.	.	.	Note=Protein kinase	
Q9R012	UniProtKB	Domain	507	570	.	.	.	Note=POLO box 1	
Q9R012	UniProtKB	Domain	603	674	.	.	.	Note=POLO box 2	
Q9R012	UniProtKB	Nucleotide binding	85	93	.	.	.	Note=ATP;status=By similarity	
Q9R012	UniProtKB	Compositional bias	54	59	.	.	.	Note=Poly-His	
Q9R012	UniProtKB	Active site	202	202	.	.	.	Note=Proton acceptor;status=Probable	
Q9R012	UniProtKB	Binding site	108	108	.	.	.	Note=ATP	
Q9R012	UniProtKB	Modified residue	236	236	.	.	.	Note=Phosphothreonine	
Q9R012	UniProtKB	Mutagenesis	108	108	.	.	.	Note=Loss of kinase activity.	
Q9R012	UniProtKB	Mutagenesis	202	202	.	.	.	Note=Loss of kinase activity.	
Q9R012	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Mimicks phosphorylation state%2C leading to increased activity.	
Q9R012	UniProtKB	Mutagenesis	504	504	.	.	.	Note=Abolishes interaction with SIPA1L1.	
Q9R012	UniProtKB	Mutagenesis	504	504	.	.	.	Note=Does not affect interaction with NSF and ability to dissociate NSF from GRIA2.	
##sequence-region P29590 1 882
P29590	UniProtKB	Chain	1	882	.	.	.	ID=PRO_0000056001;Note=Protein PML	
P29590	UniProtKB	Zinc finger	57	92	.	.	.	Note=RING-type	
P29590	UniProtKB	Zinc finger	124	166	.	.	.	Note=B box-type 1%3B atypical	
P29590	UniProtKB	Zinc finger	183	236	.	.	.	Note=B box-type 2	
P29590	UniProtKB	Region	448	555	.	.	.	Note=Interaction with PER2	
P29590	UniProtKB	Region	476	490	.	.	.	Note=Nuclear localization signal	
P29590	UniProtKB	Region	556	562	.	.	.	Note=Sumo interaction motif (SIM)	
P29590	UniProtKB	Coiled coil	228	253	.	.	.	status=Potential	
P29590	UniProtKB	Compositional bias	3	46	.	.	.	Note=Pro-rich	
P29590	UniProtKB	Metal binding	57	57	.	.	.	Note=Zinc 1	
P29590	UniProtKB	Metal binding	60	60	.	.	.	Note=Zinc 1	
P29590	UniProtKB	Metal binding	72	72	.	.	.	Note=Zinc 2	
P29590	UniProtKB	Metal binding	74	74	.	.	.	Note=Zinc 2	
P29590	UniProtKB	Metal binding	77	77	.	.	.	Note=Zinc 1	
P29590	UniProtKB	Metal binding	80	80	.	.	.	Note=Zinc 1	
P29590	UniProtKB	Metal binding	88	88	.	.	.	Note=Zinc 2	
P29590	UniProtKB	Metal binding	91	91	.	.	.	Note=Zinc 2	
P29590	UniProtKB	Site	394	395	.	.	.	Note=Breakpoint for translocation to form PML-RARA oncogene in type A APL	
P29590	UniProtKB	Site	552	553	.	.	.	Note=Breakpoint for translocation to form PML-RARA oncogene in type B APL	
P29590	UniProtKB	Modified residue	8	8	.	.	.	Note=Phosphoserine%3B by HIPK2	
P29590	UniProtKB	Modified residue	28	28	.	.	.	Note=Phosphothreonine%3B by MAPK1	
P29590	UniProtKB	Modified residue	36	36	.	.	.	Note=Phosphoserine%3B by HIPK2 and MAPK1	
P29590	UniProtKB	Modified residue	38	38	.	.	.	Note=Phosphoserine%3B by HIPK2 and MAPK1	
P29590	UniProtKB	Modified residue	40	40	.	.	.	Note=Phosphoserine%3B by MAPK1	
P29590	UniProtKB	Modified residue	42	42	.	.	.	Note=Phosphothreonine	
P29590	UniProtKB	Modified residue	117	117	.	.	.	Note=Phosphoserine%3B by CHEK2	
P29590	UniProtKB	Modified residue	403	403	.	.	.	Note=Phosphoserine%3B by MAPK1 and MAPK7	
P29590	UniProtKB	Modified residue	409	409	.	.	.	Note=Phosphothreonine%3B by MAPK7	
P29590	UniProtKB	Modified residue	487	487	.	.	.	Note=N6-acetyllysine	
P29590	UniProtKB	Modified residue	504	504	.	.	.	Note=Phosphoserine;status=By similarity	
P29590	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphoserine%3B by MAPK1	
P29590	UniProtKB	Modified residue	515	515	.	.	.	Note=N6-acetyllysine;status=Probable	
P29590	UniProtKB	Modified residue	518	518	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK2	
P29590	UniProtKB	Modified residue	527	527	.	.	.	Note=Phosphoserine%3B by MAPK1	
P29590	UniProtKB	Modified residue	530	530	.	.	.	Note=Phosphoserine%3B by MAPK1	
P29590	UniProtKB	Modified residue	535	535	.	.	.	Note=Phosphoserine	
P29590	UniProtKB	Modified residue	565	565	.	.	.	Note=Phosphoserine%3B by CK2	
P29590	UniProtKB	Cross-link	65	65	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P29590	UniProtKB	Cross-link	160	160	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P29590	UniProtKB	Cross-link	380	380	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P29590	UniProtKB	Cross-link	400	400	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P29590	UniProtKB	Cross-link	401	401	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P29590	UniProtKB	Cross-link	476	476	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P29590	UniProtKB	Cross-link	490	490	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P29590	UniProtKB	Cross-link	497	497	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P29590	UniProtKB	Alternative sequence	419	466	.	.	.	ID=VSP_040590;Note=In isoform PML-11%2C isoform PML-12 and isoform PML-13.	
P29590	UniProtKB	Alternative sequence	419	435	.	.	.	ID=VSP_040591;Note=In isoform PML-7.	
P29590	UniProtKB	Alternative sequence	419	423	.	.	.	ID=VSP_040592;Note=In isoform PML-14.	
P29590	UniProtKB	Alternative sequence	424	882	.	.	.	ID=VSP_040593;Note=In isoform PML-14.	
P29590	UniProtKB	Alternative sequence	436	882	.	.	.	ID=VSP_040594;Note=In isoform PML-7.	
P29590	UniProtKB	Alternative sequence	553	560	.	.	.	ID=VSP_005742;Note=In isoform PML-6.	
P29590	UniProtKB	Alternative sequence	561	882	.	.	.	ID=VSP_005743;Note=In isoform PML-6.	
P29590	UniProtKB	Alternative sequence	571	882	.	.	.	ID=VSP_040595;Note=In isoform PML-2 and isoform PML-13.	
P29590	UniProtKB	Alternative sequence	571	882	.	.	.	ID=VSP_005741;Note=In isoform PML-8.	
P29590	UniProtKB	Alternative sequence	571	641	.	.	.	ID=VSP_040596;Note=In isoform PML-3.	
P29590	UniProtKB	Alternative sequence	571	611	.	.	.	ID=VSP_005739;Note=In isoform PML-5.	
P29590	UniProtKB	Alternative sequence	612	882	.	.	.	ID=VSP_005740;Note=In isoform PML-5.	
P29590	UniProtKB	Alternative sequence	621	633	.	.	.	ID=VSP_005744;Note=In isoform PML-4 and isoform PML-12.	
P29590	UniProtKB	Alternative sequence	634	882	.	.	.	ID=VSP_005745;Note=In isoform PML-4 and isoform PML-12.	
P29590	UniProtKB	Alternative sequence	642	882	.	.	.	ID=VSP_040597;Note=In isoform PML-3.	
P29590	UniProtKB	Natural variant	645	645	.	.	.	ID=VAR_052090;Dbxref=dbSNP:rs5742915	
P29590	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Strongly reduced sumoylation%3B when associated with S-60.	
P29590	UniProtKB	Mutagenesis	60	60	.	.	.	Note=Strongly reduced sumoylation%3B when associated with S-57.	
P29590	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Loss of one sumoylation. No effect on nuclear body formation. Loss of 2 sumoylations%3B when associated with R-490 with or without R-133 or R-150. No effect on nuclear body formation%3B when associated with R-490. No sumoylation nor nuclear body formation%3B when associated with R-160 and R-490.	
P29590	UniProtKB	Mutagenesis	68	68	.	.	.	Note=No effect on sumoylation levels.	
P29590	UniProtKB	Mutagenesis	88	88	.	.	.	Note=No nuclear microspeckle location%2C no sumoylation and loss of intrinsic transcriptional repressor activity of PML-RARA oncoprotein%3B when associated with R-89.	
P29590	UniProtKB	Mutagenesis	89	89	.	.	.	Note=No nuclear microspeckle location%2C no sumoylation and loss of intrinsic transcriptional repressor activity of PML-RARA oncoprotein%3B when associated with S-88.	
P29590	UniProtKB	Mutagenesis	133	133	.	.	.	Note=Loss of 2 sumoylations%3B when associated with R-65 and R-490.	
P29590	UniProtKB	Mutagenesis	150	150	.	.	.	Note=Loss of 2 sumoylations%3B when associated with R-65 and R-490.	
P29590	UniProtKB	Mutagenesis	160	160	.	.	.	Note=Loss of 2 sumoylations%3B when associated with or without R-65. No sumoylation nor nuclear body formation%3B when associated with or without R-65 and R-490.	
P29590	UniProtKB	Mutagenesis	487	487	.	.	.	Note=Loss of nuclear localization%3B when associated with A-490.	
P29590	UniProtKB	Mutagenesis	487	487	.	.	.	Note=Loss of nuclear localization. Reduced acetylation. Further decrease in acetylation%3B when associated with R-515.	
P29590	UniProtKB	Mutagenesis	490	490	.	.	.	Note=Loss of nuclear localization%3B when associated with A-487.	
P29590	UniProtKB	Mutagenesis	490	490	.	.	.	Note=Loss of 2 sumoylations%3B when associated with R-65 with or without R-133. No effect on nuclear body formation%3B when associated with R-65. No sumoylation nor nuclear body formation%3B when associated with R-65 and R-160.	
P29590	UniProtKB	Mutagenesis	515	515	.	.	.	Note=Slightly reduced acetylation. Further decrease in acetylation%3B when associated with R-487.	
P29590	UniProtKB	Mutagenesis	556	559	.	.	.	Note=Abolishes SUMO1 binding.	
P29590	UniProtKB	Sequence conflict	224	224	.	.	.	.	
P29590	UniProtKB	Sequence conflict	224	224	.	.	.	.	
P29590	UniProtKB	Sequence conflict	224	224	.	.	.	.	
P29590	UniProtKB	Sequence conflict	419	419	.	.	.	.	
P29590	UniProtKB	Sequence conflict	419	419	.	.	.	.	
P29590	UniProtKB	Sequence conflict	419	419	.	.	.	.	
P29590	UniProtKB	Sequence conflict	419	419	.	.	.	.	
P29590	UniProtKB	Sequence conflict	419	419	.	.	.	.	
P29590	UniProtKB	Sequence conflict	419	419	.	.	.	.	
P29590	UniProtKB	Sequence conflict	419	419	.	.	.	.	
P29590	UniProtKB	Beta strand	58	60	.	.	.	.	
P29590	UniProtKB	Beta strand	82	87	.	.	.	.	
P29590	UniProtKB	Beta strand	93	96	.	.	.	.	
##sequence-region Q60953 1 885
Q60953	UniProtKB	Chain	1	885	.	.	.	ID=PRO_0000056002;Note=Protein PML	
Q60953	UniProtKB	Zinc finger	62	97	.	.	.	Note=RING-type	
Q60953	UniProtKB	Zinc finger	129	171	.	.	.	Note=B box-type 1	
Q60953	UniProtKB	Zinc finger	188	239	.	.	.	Note=B box-type 2	
Q60953	UniProtKB	Region	458	565	.	.	.	Note=Interaction with PER2;status=By similarity	
Q60953	UniProtKB	Region	486	500	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q60953	UniProtKB	Region	566	572	.	.	.	Note=Sumo interaction motif (SIM);status=By similarity	
Q60953	UniProtKB	Coiled coil	295	331	.	.	.	status=Potential	
Q60953	UniProtKB	Compositional bias	12	38	.	.	.	Note=Pro-rich	
Q60953	UniProtKB	Metal binding	62	62	.	.	.	Note=Zinc 1;status=By similarity	
Q60953	UniProtKB	Metal binding	65	65	.	.	.	Note=Zinc 1;status=By similarity	
Q60953	UniProtKB	Metal binding	77	77	.	.	.	Note=Zinc 2;status=By similarity	
Q60953	UniProtKB	Metal binding	79	79	.	.	.	Note=Zinc 2;status=By similarity	
Q60953	UniProtKB	Metal binding	82	82	.	.	.	Note=Zinc 1;status=By similarity	
Q60953	UniProtKB	Metal binding	85	85	.	.	.	Note=Zinc 1;status=By similarity	
Q60953	UniProtKB	Metal binding	93	93	.	.	.	Note=Zinc 2;status=By similarity	
Q60953	UniProtKB	Metal binding	96	96	.	.	.	Note=Zinc 2;status=By similarity	
Q60953	UniProtKB	Modified residue	17	17	.	.	.	Note=Phosphoserine%3B by HIPK2	
Q60953	UniProtKB	Modified residue	45	45	.	.	.	Note=Phosphoserine%3B by HIPK2 and MAPK1;status=By similarity	
Q60953	UniProtKB	Modified residue	47	47	.	.	.	Note=Phosphoserine%3B by HIPK2 and MAPK1;status=By similarity	
Q60953	UniProtKB	Modified residue	404	404	.	.	.	Note=Phosphoserine%3B by MAPK1 and MAPK7;status=By similarity	
Q60953	UniProtKB	Modified residue	497	497	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q60953	UniProtKB	Modified residue	514	514	.	.	.	Note=Phosphoserine	
Q60953	UniProtKB	Modified residue	515	515	.	.	.	Note=Phosphoserine%3B by MAPK1	
Q60953	UniProtKB	Modified residue	528	528	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK2	
Q60953	UniProtKB	Modified residue	540	540	.	.	.	Note=Phosphoserine%3B by MAPK1;status=By similarity	
Q60953	UniProtKB	Modified residue	575	575	.	.	.	Note=Phosphoserine%3B by CK2;status=By similarity	
Q60953	UniProtKB	Cross-link	70	70	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q60953	UniProtKB	Cross-link	165	165	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q60953	UniProtKB	Cross-link	384	384	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q60953	UniProtKB	Cross-link	486	486	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q60953	UniProtKB	Cross-link	500	500	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
Q60953	UniProtKB	Alternative sequence	431	476	.	.	.	ID=VSP_026028;Note=In isoform 2.	
Q60953	UniProtKB	Sequence conflict	210	210	.	.	.	.	
Q60953	UniProtKB	Sequence conflict	414	414	.	.	.	.	
Q60953	UniProtKB	Sequence conflict	424	424	.	.	.	.	
Q60953	UniProtKB	Sequence conflict	429	429	.	.	.	.	
##sequence-region P54277 1 932
P54277	UniProtKB	Chain	1	932	.	.	.	ID=PRO_0000178004;Note=PMS1 protein homolog 1	
P54277	UniProtKB	DNA binding	571	639	.	.	.	Note=HMG box	
P54277	UniProtKB	Alternative sequence	1	176	.	.	.	ID=VSP_047692;Note=In isoform 4.	
P54277	UniProtKB	Alternative sequence	195	233	.	.	.	ID=VSP_043371;Note=In isoform 3 and isoform 4.	
P54277	UniProtKB	Alternative sequence	619	619	.	.	.	ID=VSP_042676;Note=In isoform 2 and isoform 4.	
P54277	UniProtKB	Alternative sequence	620	781	.	.	.	ID=VSP_042677;Note=In isoform 2 and isoform 4.	
P54277	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_019166;Dbxref=dbSNP:rs5742973	
P54277	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_014877;Dbxref=dbSNP:rs2066459	
P54277	UniProtKB	Natural variant	394	394	.	.	.	ID=VAR_012967;Dbxref=dbSNP:rs1145231	
P54277	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_012968;Dbxref=dbSNP:rs1145232	
P54277	UniProtKB	Natural variant	632	632	.	.	.	ID=VAR_014878;Dbxref=dbSNP:rs2066456	
P54277	UniProtKB	Natural variant	720	720	.	.	.	ID=VAR_014879;Dbxref=dbSNP:rs2066455	
P54277	UniProtKB	Natural variant	793	793	.	.	.	ID=VAR_014880;Dbxref=dbSNP:rs1145234	
P54277	UniProtKB	Beta strand	569	571	.	.	.	.	
P54277	UniProtKB	Helix	577	592	.	.	.	.	
P54277	UniProtKB	Helix	598	610	.	.	.	.	
P54277	UniProtKB	Helix	614	625	.	.	.	.	
P54277	UniProtKB	Turn	626	628	.	.	.	.	
P54277	UniProtKB	Helix	629	638	.	.	.	.	
##sequence-region P54278 1 862
P54278	UniProtKB	Chain	1	862	.	.	.	ID=PRO_0000178005;Note=Mismatch repair endonuclease PMS2	
P54278	UniProtKB	Modified residue	597	597	.	.	.	Note=Phosphothreonine	
P54278	UniProtKB	Alternative sequence	180	183	.	.	.	ID=VSP_029384;Note=In isoform 4.	
P54278	UniProtKB	Alternative sequence	184	862	.	.	.	ID=VSP_029385;Note=In isoform 4.	
P54278	UniProtKB	Alternative sequence	269	669	.	.	.	ID=VSP_029386;Note=In isoform 2.	
P54278	UniProtKB	Alternative sequence	560	572	.	.	.	ID=VSP_029387;Note=In isoform 3.	
P54278	UniProtKB	Alternative sequence	573	862	.	.	.	ID=VSP_029388;Note=In isoform 3.	
P54278	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_004469;Dbxref=dbSNP:rs10254120	
P54278	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_066838;Note=In MMRCS.	
P54278	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_016133;Dbxref=dbSNP:rs1805322	
P54278	UniProtKB	Natural variant	470	470	.	.	.	ID=VAR_016134;Dbxref=dbSNP:rs1805321	
P54278	UniProtKB	Natural variant	479	479	.	.	.	ID=VAR_012969	
P54278	UniProtKB	Natural variant	485	485	.	.	.	ID=VAR_012970;Dbxref=dbSNP:rs1805323	
P54278	UniProtKB	Natural variant	511	511	.	.	.	ID=VAR_012971;Dbxref=dbSNP:rs2228007	
P54278	UniProtKB	Natural variant	541	541	.	.	.	ID=VAR_024541;Dbxref=dbSNP:rs2228006	
P54278	UniProtKB	Natural variant	597	597	.	.	.	ID=VAR_012972;Dbxref=dbSNP:rs1805318;Note=May be associated with increased susceptibility to colorectal cancer%3B significantly reduced interaction with MLH1.	
P54278	UniProtKB	Natural variant	622	622	.	.	.	ID=VAR_012973;Dbxref=dbSNP:rs1805324;Note=May be associated with increased susceptibility to colorectal cancer%3B significantly reduced interaction with MLH1.	
P54278	UniProtKB	Natural variant	705	705	.	.	.	ID=VAR_012974;Note=In MMRCS%3B could be a rare polymorphism.	
P54278	UniProtKB	Natural variant	775	775	.	.	.	ID=VAR_016135;Dbxref=dbSNP:rs17420802	
P54278	UniProtKB	Beta strand	30	32	.	.	.	.	
P54278	UniProtKB	Helix	35	48	.	.	.	.	
P54278	UniProtKB	Beta strand	52	59	.	.	.	.	
P54278	UniProtKB	Helix	60	62	.	.	.	.	
P54278	UniProtKB	Beta strand	64	70	.	.	.	.	
P54278	UniProtKB	Helix	77	79	.	.	.	.	
P54278	UniProtKB	Helix	81	84	.	.	.	.	
P54278	UniProtKB	Beta strand	101	109	.	.	.	.	
P54278	UniProtKB	Helix	110	117	.	.	.	.	
P54278	UniProtKB	Beta strand	118	125	.	.	.	.	
P54278	UniProtKB	Beta strand	133	137	.	.	.	.	
P54278	UniProtKB	Beta strand	143	148	.	.	.	.	
P54278	UniProtKB	Beta strand	153	161	.	.	.	.	
P54278	UniProtKB	Turn	162	165	.	.	.	.	
P54278	UniProtKB	Helix	167	175	.	.	.	.	
P54278	UniProtKB	Helix	177	194	.	.	.	.	
P54278	UniProtKB	Beta strand	199	205	.	.	.	.	
P54278	UniProtKB	Beta strand	211	216	.	.	.	.	
P54278	UniProtKB	Helix	223	231	.	.	.	.	
P54278	UniProtKB	Helix	233	237	.	.	.	.	
P54278	UniProtKB	Beta strand	239	241	.	.	.	.	
P54278	UniProtKB	Helix	249	255	.	.	.	.	
P54278	UniProtKB	Turn	259	263	.	.	.	.	
P54278	UniProtKB	Beta strand	268	274	.	.	.	.	
P54278	UniProtKB	Turn	278	280	.	.	.	.	
P54278	UniProtKB	Beta strand	281	285	.	.	.	.	
P54278	UniProtKB	Beta strand	288	292	.	.	.	.	
P54278	UniProtKB	Beta strand	295	297	.	.	.	.	
P54278	UniProtKB	Helix	300	311	.	.	.	.	
P54278	UniProtKB	Beta strand	321	326	.	.	.	.	
P54278	UniProtKB	Helix	329	331	.	.	.	.	
P54278	UniProtKB	Beta strand	332	334	.	.	.	.	
P54278	UniProtKB	Beta strand	343	345	.	.	.	.	
P54278	UniProtKB	Helix	348	363	.	.	.	.	
##sequence-region P54279 1 859
P54279	UniProtKB	Chain	1	859	.	.	.	ID=PRO_0000178006;Note=Mismatch repair endonuclease PMS2	
##sequence-region Q8NEB5 1 264
Q8NEB5	UniProtKB	Chain	1	264	.	.	.	ID=PRO_0000286945;Note=Phosphatidate phosphatase PPAPDC1B	
Q8NEB5	UniProtKB	Transmembrane	55	75	.	.	.	Note=Helical%3B;status=Potential	
Q8NEB5	UniProtKB	Transmembrane	91	111	.	.	.	Note=Helical%3B;status=Potential	
Q8NEB5	UniProtKB	Transmembrane	155	175	.	.	.	Note=Helical%3B;status=Potential	
Q8NEB5	UniProtKB	Transmembrane	180	200	.	.	.	Note=Helical%3B;status=Potential	
Q8NEB5	UniProtKB	Transmembrane	209	228	.	.	.	Note=Helical%3B;status=Potential	
Q8NEB5	UniProtKB	Region	108	116	.	.	.	Note=Phosphatase sequence motif I	
Q8NEB5	UniProtKB	Region	149	152	.	.	.	Note=Phosphatase sequence motif II	
Q8NEB5	UniProtKB	Region	201	211	.	.	.	Note=Phosphatase sequence motif III	
Q8NEB5	UniProtKB	Alternative sequence	1	41	.	.	.	ID=VSP_040055;Note=In isoform 3.	
Q8NEB5	UniProtKB	Alternative sequence	212	216	.	.	.	ID=VSP_025241;Note=In isoform 2.	
Q8NEB5	UniProtKB	Alternative sequence	217	264	.	.	.	ID=VSP_025242;Note=In isoform 2.	
Q8NEB5	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Loss of phosphatase activity%3B when associated with A-152 and with A-208.	
Q8NEB5	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Loss of phosphatase activity%3B when associated with A-115 and with A-208.	
Q8NEB5	UniProtKB	Mutagenesis	208	208	.	.	.	Note=Loss of phosphatase activity%3B when associated with A-115 and with A-152.	
##sequence-region A4FV37 1 260
A4FV37	UniProtKB	Chain	1	260	.	.	.	ID=PRO_0000331411;Note=Protein kinase C delta-binding protein	
A4FV37	UniProtKB	Modified residue	162	162	.	.	.	Note=Phosphoserine;status=By similarity	
A4FV37	UniProtKB	Modified residue	163	163	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q969G5 1 261
Q969G5	UniProtKB	Chain	1	261	.	.	.	ID=PRO_0000331412;Note=Protein kinase C delta-binding protein	
Q969G5	UniProtKB	Modified residue	165	165	.	.	.	Note=Phosphoserine	
Q969G5	UniProtKB	Modified residue	166	166	.	.	.	Note=Phosphoserine	
Q969G5	UniProtKB	Natural variant	8	8	.	.	.	ID=VAR_042851;Dbxref=dbSNP:rs2682123	
Q969G5	UniProtKB	Natural variant	104	104	.	.	.	ID=VAR_042852;Dbxref=dbSNP:rs10839551	
Q969G5	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_042853;Dbxref=dbSNP:rs1051992	
Q969G5	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_042854;Dbxref=dbSNP:rs12294600	
##sequence-region Q91VJ2 1 260
Q91VJ2	UniProtKB	Chain	1	260	.	.	.	ID=PRO_0000331413;Note=Protein kinase C delta-binding protein	
Q91VJ2	UniProtKB	Modified residue	165	165	.	.	.	Note=Phosphoserine	
Q91VJ2	UniProtKB	Modified residue	166	166	.	.	.	Note=Phosphoserine	
Q91VJ2	UniProtKB	Sequence conflict	225	225	.	.	.	.	
##sequence-region Q9Z1H9 1 263
Q9Z1H9	UniProtKB	Chain	1	263	.	.	.	ID=PRO_0000331414;Note=Protein kinase C delta-binding protein	
Q9Z1H9	UniProtKB	Modified residue	165	165	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z1H9	UniProtKB	Modified residue	166	166	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z1H9	UniProtKB	Sequence conflict	5	5	.	.	.	.	
##sequence-region P85299 1 388
P85299	UniProtKB	Chain	1	388	.	.	.	ID=PRO_0000308162;Note=Proline-rich protein 5	
P85299	UniProtKB	Region	10	95	.	.	.	Note=Interaction with RICTOR	
P85299	UniProtKB	Region	188	218	.	.	.	Note=Interaction with RICTOR	
P85299	UniProtKB	Compositional bias	24	27	.	.	.	Note=Poly-Ala	
P85299	UniProtKB	Alternative sequence	1	101	.	.	.	ID=VSP_001646;Note=In isoform 2.	
P85299	UniProtKB	Alternative sequence	1	95	.	.	.	ID=VSP_028884;Note=In isoform 4.	
P85299	UniProtKB	Alternative sequence	1	9	.	.	.	ID=VSP_028885;Note=In isoform 3.	
P85299	UniProtKB	Alternative sequence	1	5	.	.	.	ID=VSP_045883;Note=In isoform 5.	
P85299	UniProtKB	Alternative sequence	102	107	.	.	.	ID=VSP_001648;Note=In isoform 2.	
P85299	UniProtKB	Natural variant	243	243	.	.	.	ID=VAR_062230;Dbxref=dbSNP:rs36082900	
P85299	UniProtKB	Sequence conflict	280	280	.	.	.	.	
##sequence-region Q812A5 1 387
Q812A5	UniProtKB	Chain	1	387	.	.	.	ID=PRO_0000308163;Note=Proline-rich protein 5	
Q812A5	UniProtKB	Region	10	96	.	.	.	Note=Interaction with RICTOR;status=By similarity	
Q812A5	UniProtKB	Region	189	219	.	.	.	Note=Interaction with RICTOR;status=By similarity	
Q812A5	UniProtKB	Alternative sequence	1	9	.	.	.	ID=VSP_052580;Note=In isoform 2.	
Q812A5	UniProtKB	Sequence conflict	49	49	.	.	.	.	
Q812A5	UniProtKB	Sequence conflict	301	303	.	.	.	.	
Q812A5	UniProtKB	Sequence conflict	305	305	.	.	.	.	
Q812A5	UniProtKB	Sequence conflict	340	340	.	.	.	.	
##sequence-region Q5FVG6 1 387
Q5FVG6	UniProtKB	Chain	1	387	.	.	.	ID=PRO_0000308164;Note=Proline-rich protein 5	
Q5FVG6	UniProtKB	Region	10	96	.	.	.	Note=Interaction with RICTOR;status=By similarity	
Q5FVG6	UniProtKB	Region	189	219	.	.	.	Note=Interaction with RICTOR;status=By similarity	
##sequence-region Q13635 1 1447
Q13635	UniProtKB	Chain	1	1447	.	.	.	ID=PRO_0000205964;Note=Protein patched homolog 1	
Q13635	UniProtKB	Topological domain	1	100	.	.	.	Note=Cytoplasmic;status=Potential	
Q13635	UniProtKB	Transmembrane	101	121	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	122	436	.	.	.	Note=Extracellular;status=Potential	
Q13635	UniProtKB	Transmembrane	437	457	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	458	472	.	.	.	Note=Cytoplasmic;status=Potential	
Q13635	UniProtKB	Transmembrane	473	493	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	494	501	.	.	.	Note=Extracellular;status=Potential	
Q13635	UniProtKB	Transmembrane	502	522	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	523	547	.	.	.	Note=Cytoplasmic;status=Potential	
Q13635	UniProtKB	Transmembrane	548	568	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	569	577	.	.	.	Note=Extracellular;status=Potential	
Q13635	UniProtKB	Transmembrane	578	598	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	599	748	.	.	.	Note=Cytoplasmic;status=Potential	
Q13635	UniProtKB	Transmembrane	749	769	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	770	1027	.	.	.	Note=Extracellular;status=Potential	
Q13635	UniProtKB	Transmembrane	1028	1048	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	1049	1055	.	.	.	Note=Cytoplasmic;status=Potential	
Q13635	UniProtKB	Transmembrane	1056	1076	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	1077	1083	.	.	.	Note=Extracellular;status=Potential	
Q13635	UniProtKB	Transmembrane	1084	1104	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	1105	1121	.	.	.	Note=Cytoplasmic;status=Potential	
Q13635	UniProtKB	Transmembrane	1122	1141	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	1142	1154	.	.	.	Note=Extracellular;status=Potential	
Q13635	UniProtKB	Transmembrane	1155	1175	.	.	.	Note=Helical%3B;status=Potential	
Q13635	UniProtKB	Topological domain	1176	1447	.	.	.	Note=Cytoplasmic;status=Potential	
Q13635	UniProtKB	Domain	438	598	.	.	.	Note=SSD	
Q13635	UniProtKB	Compositional bias	14	31	.	.	.	Note=Gly-rich	
Q13635	UniProtKB	Glycosylation	141	141	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q13635	UniProtKB	Glycosylation	312	312	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q13635	UniProtKB	Glycosylation	349	349	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q13635	UniProtKB	Glycosylation	414	414	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q13635	UniProtKB	Glycosylation	875	875	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q13635	UniProtKB	Glycosylation	1000	1000	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q13635	UniProtKB	Alternative sequence	1	66	.	.	.	ID=VSP_041369;Note=In isoform L'.	
Q13635	UniProtKB	Alternative sequence	2	152	.	.	.	ID=VSP_041370;Note=In isoform S.	
Q13635	UniProtKB	Alternative sequence	2	67	.	.	.	ID=VSP_041371;Note=In isoform M.	
Q13635	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_007843;Note=In BCNS%3B sporadic BCC.	
Q13635	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_020845;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	376	376	.	.	.	ID=VAR_007844;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	393	393	.	.	.	ID=VAR_032952;Note=In HPE7.	
Q13635	UniProtKB	Natural variant	443	443	.	.	.	ID=VAR_032953;Note=In HPE7.	
Q13635	UniProtKB	Natural variant	505	506	.	.	.	ID=VAR_020846;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	509	509	.	.	.	ID=VAR_010974;Note=In BCNS%3B could be a rare polymorphism.	
Q13635	UniProtKB	Natural variant	509	509	.	.	.	ID=VAR_010975;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	513	513	.	.	.	ID=VAR_010976;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	728	728	.	.	.	ID=VAR_032954;Dbxref=dbSNP:rs28936404;Note=In HPE7.	
Q13635	UniProtKB	Natural variant	751	751	.	.	.	ID=VAR_032955;Note=In HPE7.	
Q13635	UniProtKB	Natural variant	815	815	.	.	.	ID=VAR_007845;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	816	816	.	.	.	ID=VAR_010977;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	827	827	.	.	.	ID=VAR_032956;Dbxref=dbSNP:rs199476092;Note=In HPE7.	
Q13635	UniProtKB	Natural variant	829	829	.	.	.	ID=VAR_010978;Note=In squamous cell carcinoma.	
Q13635	UniProtKB	Natural variant	908	908	.	.	.	ID=VAR_032957;Note=In HPE7.	
Q13635	UniProtKB	Natural variant	1052	1052	.	.	.	ID=VAR_032958;Dbxref=dbSNP:rs28936405;Note=In HPE7.	
Q13635	UniProtKB	Natural variant	1069	1069	.	.	.	ID=VAR_010979;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	1083	1083	.	.	.	ID=VAR_007846;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	1114	1114	.	.	.	ID=VAR_007847;Note=In BCNS and BCC.	
Q13635	UniProtKB	Natural variant	1132	1132	.	.	.	ID=VAR_010980;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	1132	1132	.	.	.	ID=VAR_010981;Note=In BCNS.	
Q13635	UniProtKB	Natural variant	1195	1195	.	.	.	ID=VAR_020440;Dbxref=dbSNP:rs2236405	
Q13635	UniProtKB	Natural variant	1242	1242	.	.	.	ID=VAR_010982;Note=In squamous cell carcinoma.	
Q13635	UniProtKB	Natural variant	1282	1282	.	.	.	ID=VAR_020847;Dbxref=dbSNP:rs2227968	
Q13635	UniProtKB	Natural variant	1315	1315	.	.	.	ID=VAR_010983;Dbxref=dbSNP:rs357564	
Q13635	UniProtKB	Natural variant	1438	1438	.	.	.	ID=VAR_010984;Note=In BCNS%3B sporadic NBCCS.	
Q13635	UniProtKB	Sequence conflict	1109	1109	.	.	.	.	
Q13635	UniProtKB	Sequence conflict	1144	1144	.	.	.	.	
Q13635	UniProtKB	Sequence conflict	1175	1175	.	.	.	.	
Q13635	UniProtKB	Sequence conflict	1283	1283	.	.	.	.	
Q13635	UniProtKB	Sequence conflict	1309	1309	.	.	.	.	
Q13635	UniProtKB	Sequence conflict	1353	1353	.	.	.	.	
##sequence-region P60483 1 403
P60483	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
P60483	UniProtKB	Chain	2	403	.	.	.	ID=PRO_0000215903;Note=Phosphatidylinositol 3%2C4%2C5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	
P60483	UniProtKB	Domain	14	185	.	.	.	Note=Phosphatase tensin-type	
P60483	UniProtKB	Domain	190	350	.	.	.	Note=C2 tensin-type	
P60483	UniProtKB	Region	401	403	.	.	.	Note=PDZ domain-binding;status=By similarity	
P60483	UniProtKB	Active site	124	124	.	.	.	Note=Phosphocysteine intermediate;status=Potential	
P60483	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine;status=By similarity	
P60483	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphotyrosine%3B by FRK;status=By similarity	
P60483	UniProtKB	Modified residue	366	366	.	.	.	Note=Phosphothreonine%3B by GSK3-beta and PLK3;status=By similarity	
P60483	UniProtKB	Modified residue	370	370	.	.	.	Note=Phosphoserine%3B by CK2 and PLK3;status=By similarity	
P60483	UniProtKB	Modified residue	380	380	.	.	.	Note=Phosphoserine%3B by ROCK1;status=By similarity	
P60483	UniProtKB	Modified residue	382	382	.	.	.	Note=Phosphothreonine%3B by ROCK1;status=By similarity	
P60483	UniProtKB	Modified residue	383	383	.	.	.	Note=Phosphothreonine%3B by ROCK1;status=By similarity	
P60483	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2;status=By similarity	
P60483	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphothreonine;status=By similarity	
P60483	UniProtKB	Cross-link	13	13	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
P60483	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
##sequence-region P60484 1 403
P60484	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
P60484	UniProtKB	Chain	2	403	.	.	.	ID=PRO_0000215904;Note=Phosphatidylinositol 3%2C4%2C5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	
P60484	UniProtKB	Domain	14	185	.	.	.	Note=Phosphatase tensin-type	
P60484	UniProtKB	Domain	190	350	.	.	.	Note=C2 tensin-type	
P60484	UniProtKB	Region	401	403	.	.	.	Note=PDZ domain-binding	
P60484	UniProtKB	Active site	124	124	.	.	.	Note=Phosphocysteine intermediate;status=Potential	
P60484	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine	
P60484	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphotyrosine%3B by FRK	
P60484	UniProtKB	Modified residue	366	366	.	.	.	Note=Phosphothreonine%3B by GSK3-beta and PLK3	
P60484	UniProtKB	Modified residue	370	370	.	.	.	Note=Phosphoserine%3B by CK2 and PLK3	
P60484	UniProtKB	Modified residue	380	380	.	.	.	Note=Phosphoserine%3B by ROCK1 and CK2	
P60484	UniProtKB	Modified residue	382	382	.	.	.	Note=Phosphothreonine%3B by ROCK1 and CK2	
P60484	UniProtKB	Modified residue	383	383	.	.	.	Note=Phosphothreonine%3B by ROCK1 and CK2	
P60484	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2	
P60484	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphothreonine	
P60484	UniProtKB	Cross-link	13	13	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P60484	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
P60484	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_026248;Note=Retains phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains the ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_007457;Note=In glioma.	
P60484	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_026249;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains the ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_018100;Note=In malignant melanoma%3B somatic mutation.	
P60484	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_026250;Note=Reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains phosphatase activity towards PtdIns(3%2C4%2C5)P3.	
P60484	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_026251;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	33	33	.	.	.	ID=VAR_008733;Note=In CWS1.	
P60484	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_008734;Note=In BRRS.	
P60484	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_008036;Note=In CWS1.	
P60484	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_007458;Note=In glioma.	
P60484	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_026252;Note=In endometrial hyperplasia.	
P60484	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_007459;Note=In glioma%3B retains phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains the ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_011587;Note=In CWS1.	
P60484	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_007460;Note=In glioma%3B loss of protein phosphatase activity.	
P60484	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_018101;Note=In VATER.	
P60484	UniProtKB	Natural variant	61	61	.	.	.	ID=VAR_026253;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_007461;Note=In CWS1.	
P60484	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_007462;Note=In CWS1 and BRRS%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains the ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_018102;Note=In CWS1.	
P60484	UniProtKB	Natural variant	71	71	.	.	.	ID=VAR_026254;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_032634;Note=In MCEPHAS.	
P60484	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_026255;Note=In CWS1.	
P60484	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_026256;Note=In BRRS%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_008735;Note=In BRRS.	
P60484	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_026257;Note=In BRRS and glioblastoma%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_007807;Note=In CWS1 and LDD%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_026258;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_011588;Note=In multiple cancers.	
P60484	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_018103;Note=In HNSCC.	
P60484	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_026259;Note=In glioblastoma%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_007463;Note=In CWS1.	
P60484	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_026260;Note=In endometrial cancer%3B loss of protein phosphatase activity.	
P60484	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_007464;Note=In CWS1.	
P60484	UniProtKB	Natural variant	124	124	.	.	.	ID=VAR_018104;Note=In CWS1%3B phosphatase-dead protein with neither lipid nor protein phosphatase activity.	
P60484	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_007465;Note=In CWS1%3B no lipid phosphatase activity but retains protein phosphatase activity%3B retains ability to inhibit focal adhesion formation.	
P60484	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_007466;Note=In glioblastoma%3B severely reduced protein phosphatase activity%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_026261;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3.	
P60484	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_007467;Note=In CWS1 and endometrial hyperplasia%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_007468;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_032635;Note=In one patient with clinical findings suggesting hamartoma tumor syndrome.	
P60484	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_026262;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P3.	
P60484	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_007469;Note=In prostate cancer%3B no effect on protein phosphatase activity%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P3 but retains PtdIns(3%2C4%2C5)P3 phosphatase activity.	
P60484	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_008736;Note=In BRRS.	
P60484	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_007808;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P3.	
P60484	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_008737;Note=In CWS1.	
P60484	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_026263;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_011589;Note=In multiple cancers.	
P60484	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_008739;Note=In CWS1.	
P60484	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_026264;Note=In glioblastoma%3B severely reduced protein phosphatase activity%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_008738;Note=In CWS1.	
P60484	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_026265;Note=In breast cancer%3B severely reduced protein phosphatase activity.	
P60484	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_026266;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_007470;Note=In BRRS%3B severely reduced protein phosphatase activity%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_026267;Note=In endometrial hyperplasia%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_026268;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_026269;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_026270;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_026271;Note=In endometrial hyperplasia.	
P60484	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_018105;Note=In malignant melanoma%3B somatic mutation.	
P60484	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_026272;Note=Reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 but retains PtdIns(3%2C4%2C5)P3 phosphatase activity.	
P60484	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_018106;Note=In a patient with glioma and meningioma%3B not capable of inducing apoptosis%3B induced increased cell proliferation%3B led to high constitutive AKT1 activation which could not be increased further by stimulation with insulin.	
P60484	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_032636;Note=In MCEPHAS.	
P60484	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_008740;Note=In CWS1 and BRRS.	
P60484	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_026273;Note=Loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_032637;Note=In MCEPHAS.	
P60484	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_008741;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_025167;Dbxref=dbSNP:rs35600253	
P60484	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_026274;Note=In glioma%3B reduced tumor suppressor activity%3B fails to inactivate AKT/PKB.	
P60484	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_026275;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	341	341	.	.	.	ID=VAR_026276;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_026277;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4 but PtdIns(3%2C4%2C5)P3 phosphatase activity is similar to wild-type.	
P60484	UniProtKB	Natural variant	343	343	.	.	.	ID=VAR_008742;Note=In CWS1%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	345	345	.	.	.	ID=VAR_026278;Note=In glioblastoma%3B reduced tumor suppressor activity%3B loss of phosphatase activity towards Ins(1%2C3%2C4%2C5)P4%3B reduced ability to inactivate AKT/PKB%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_008743;Note=In CWS1%3B reduced phosphatase activity towards Ins(1%2C3%2C4%2C5)P4.	
P60484	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_026279;Note=In endometrial hyperplasia%3B reduced phosphatase activity towards PtdIns(3%2C4%2C5)P3%3B mildly reduced tumor suppressor activity%3B reduced ability to inactivate AKT/PKB.	
P60484	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_026280;Note=Retains Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3 phosphatase activity%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Natural variant	401	401	.	.	.	ID=VAR_026281;Note=Retains Ins(1%2C3%2C4%2C5)P4 and PtdIns(3%2C4%2C5)P3 phosphatase activity%3B retains ability to bind phospholipid membranes.	
P60484	UniProtKB	Mutagenesis	13	13	.	.	.	Note=Nuclear. Cytoplasmic%3B when associated with E-289. Shows less tumor suppressive ability%3B when associated with E-289.	
P60484	UniProtKB	Mutagenesis	92	92	.	.	.	Note=700-fold reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3. Loss of protein phosphatase activity. Unable to inhibit focal adhesion formation.	
P60484	UniProtKB	Mutagenesis	93	93	.	.	.	Note=75%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3. Modest reduction in phosphatase activity towards PtdIns(3%2C4)P2.	
P60484	UniProtKB	Mutagenesis	124	124	.	.	.	Note=Loss of protein phosphatase activity. Unable to inhibit focal adhesion formation.	
P60484	UniProtKB	Mutagenesis	125	125	.	.	.	Note=Reduced phosphatase activity towards PtdIns(3%2C4%2C5)P3%2C PtdIns(3%2C4)P2 and PtdIns(3)P.	
P60484	UniProtKB	Mutagenesis	128	128	.	.	.	Note=85%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3.	
P60484	UniProtKB	Mutagenesis	128	128	.	.	.	Note=Does not reduce phosphatase activity towards PtdIns(3%2C4%2C5)P3.	
P60484	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Does not affect the ability to inhibit AKT/PKB activation.	
P60484	UniProtKB	Mutagenesis	167	167	.	.	.	Note=60%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3.	
P60484	UniProtKB	Mutagenesis	171	171	.	.	.	Note=75%25 reduction in phosphatase activity towards PtdIns(3%2C4%2C5)P3.	
P60484	UniProtKB	Mutagenesis	263	269	.	.	.	Note=Reduces the growth suppression activity and cells show anchorage-independent growth. Reduces binding to phospholipid membranes in vitro. Phosphatase activity towards PtdIns(3%2C4%2C5)P3 is not affected.	
P60484	UniProtKB	Mutagenesis	289	289	.	.	.	Note=Nuclear. Cytoplasmic%3B when associated with E-13. Shows less tumor suppressive ability%3B when associated with E-13.	
P60484	UniProtKB	Mutagenesis	327	335	.	.	.	Note=Reduces growth suppression activity and promotes anchorage-independent growth. Reduces binding to phospholipid membranes in vitro%3B phosphatase activity towards PtdIns(3%2C4%2C5)P3 is not affected.	
P60484	UniProtKB	Mutagenesis	336	336	.	.	.	Note=Significantly lower phosphatase activity%2C reduced protein stability and decreased growth-inhibitory effect.	
P60484	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Decreased stability.	
P60484	UniProtKB	Mutagenesis	370	370	.	.	.	Note=Decreased stability.	
P60484	UniProtKB	Mutagenesis	401	401	.	.	.	Note=Loss of DLG1-binding. No effect on MAGI2- and MAST2-binding.	
P60484	UniProtKB	Mutagenesis	402	402	.	.	.	Note=No effect on MAGI2-%2C MAST2- and DLG1-binding.	
P60484	UniProtKB	Mutagenesis	402	402	.	.	.	Note=Loss of DLG1-%2C MAGI2-%2C MAGI3- and MAST2-binding. Decrease of protein stability.	
P60484	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Loss of DLG1-%2C MAGI2-%2C MAGI3-%2C MAST1-%2C MAST2- and MAST3-binding.	
P60484	UniProtKB	Turn	19	22	.	.	.	.	
P60484	UniProtKB	Beta strand	23	29	.	.	.	.	
P60484	UniProtKB	Beta strand	32	35	.	.	.	.	
P60484	UniProtKB	Beta strand	39	41	.	.	.	.	
P60484	UniProtKB	Helix	50	60	.	.	.	.	
P60484	UniProtKB	Beta strand	61	63	.	.	.	.	
P60484	UniProtKB	Beta strand	65	73	.	.	.	.	
P60484	UniProtKB	Beta strand	85	90	.	.	.	.	
P60484	UniProtKB	Helix	98	100	.	.	.	.	
P60484	UniProtKB	Helix	101	112	.	.	.	.	
P60484	UniProtKB	Turn	113	115	.	.	.	.	
P60484	UniProtKB	Beta strand	118	123	.	.	.	.	
P60484	UniProtKB	Beta strand	125	128	.	.	.	.	
P60484	UniProtKB	Helix	129	141	.	.	.	.	
P60484	UniProtKB	Helix	148	159	.	.	.	.	
P60484	UniProtKB	Beta strand	161	163	.	.	.	.	
P60484	UniProtKB	Helix	169	184	.	.	.	.	
P60484	UniProtKB	Beta strand	192	202	.	.	.	.	
P60484	UniProtKB	Beta strand	213	219	.	.	.	.	
P60484	UniProtKB	Beta strand	222	226	.	.	.	.	
P60484	UniProtKB	Beta strand	232	235	.	.	.	.	
P60484	UniProtKB	Beta strand	238	259	.	.	.	.	
P60484	UniProtKB	Beta strand	268	276	.	.	.	.	
P60484	UniProtKB	Helix	277	279	.	.	.	.	
P60484	UniProtKB	Beta strand	315	321	.	.	.	.	
P60484	UniProtKB	Helix	322	324	.	.	.	.	
P60484	UniProtKB	Helix	328	330	.	.	.	.	
P60484	UniProtKB	Beta strand	335	337	.	.	.	.	
P60484	UniProtKB	Beta strand	342	349	.	.	.	.	
P60484	UniProtKB	Beta strand	395	403	.	.	.	.	
##sequence-region O08586 1 403
O08586	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
O08586	UniProtKB	Chain	2	403	.	.	.	ID=PRO_0000215905;Note=Phosphatidylinositol 3%2C4%2C5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	
O08586	UniProtKB	Domain	14	185	.	.	.	Note=Phosphatase tensin-type	
O08586	UniProtKB	Domain	190	350	.	.	.	Note=C2 tensin-type	
O08586	UniProtKB	Region	401	403	.	.	.	Note=PDZ domain-binding;status=By similarity	
O08586	UniProtKB	Active site	124	124	.	.	.	Note=Phosphocysteine intermediate;status=Potential	
O08586	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylthreonine;status=By similarity	
O08586	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphotyrosine%3B by FRK;status=By similarity	
O08586	UniProtKB	Modified residue	366	366	.	.	.	Note=Phosphothreonine%3B by GSK3-beta and PLK3	
O08586	UniProtKB	Modified residue	370	370	.	.	.	Note=Phosphoserine%3B by CK2 and PLK3	
O08586	UniProtKB	Modified residue	380	380	.	.	.	Note=Phosphoserine%3B by ROCK1	
O08586	UniProtKB	Modified residue	382	382	.	.	.	Note=Phosphothreonine%3B by ROCK1	
O08586	UniProtKB	Modified residue	383	383	.	.	.	Note=Phosphothreonine%3B by ROCK1	
O08586	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B alternate	
O08586	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by CK2%3B alternate;status=By similarity	
O08586	UniProtKB	Modified residue	401	401	.	.	.	Note=Phosphothreonine;status=By similarity	
O08586	UniProtKB	Cross-link	13	13	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
O08586	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
O08586	UniProtKB	Sequence conflict	50	50	.	.	.	.	
##sequence-region Q9PUT6 1 402
Q9PUT6	UniProtKB	Chain	1	402	.	.	.	ID=PRO_0000227539;Note=Phosphatidylinositol 3%2C4%2C5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	
Q9PUT6	UniProtKB	Domain	14	184	.	.	.	Note=Phosphatase tensin-type	
Q9PUT6	UniProtKB	Domain	189	349	.	.	.	Note=C2 tensin-type	
Q9PUT6	UniProtKB	Motif	400	402	.	.	.	Note=PDZ-binding	
Q9PUT6	UniProtKB	Active site	123	123	.	.	.	Note=Phosphocysteine intermediate;status=Potential	
##sequence-region P62833 1 184
P62833	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000030197;Note=Ras-related protein Rap-1A	
P62833	UniProtKB	Propeptide	182	184	.	.	.	ID=PRO_0000030198;Note=Removed in mature form;status=By similarity	
P62833	UniProtKB	Nucleotide binding	10	17	.	.	.	Note=GTP;status=By similarity	
P62833	UniProtKB	Nucleotide binding	57	61	.	.	.	Note=GTP;status=By similarity	
P62833	UniProtKB	Nucleotide binding	116	119	.	.	.	Note=GTP;status=By similarity	
P62833	UniProtKB	Motif	32	40	.	.	.	Note=Effector region;status=Probable	
P62833	UniProtKB	Modified residue	181	181	.	.	.	Note=Cysteine methyl ester;status=By similarity	
P62833	UniProtKB	Lipidation	181	181	.	.	.	Note=S-geranylgeranyl cysteine;status=By similarity	
##sequence-region P62834 1 184
P62834	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000030199;Note=Ras-related protein Rap-1A	
P62834	UniProtKB	Propeptide	182	184	.	.	.	ID=PRO_0000030200;Note=Removed in mature form	
P62834	UniProtKB	Nucleotide binding	10	17	.	.	.	Note=GTP;status=By similarity	
P62834	UniProtKB	Nucleotide binding	57	61	.	.	.	Note=GTP;status=By similarity	
P62834	UniProtKB	Nucleotide binding	116	119	.	.	.	Note=GTP;status=By similarity	
P62834	UniProtKB	Motif	32	40	.	.	.	Note=Effector region;status=Probable	
P62834	UniProtKB	Modified residue	181	181	.	.	.	Note=Cysteine methyl ester	
P62834	UniProtKB	Lipidation	181	181	.	.	.	Note=S-geranylgeranyl cysteine	
P62834	UniProtKB	Beta strand	3	9	.	.	.	.	
P62834	UniProtKB	Helix	16	25	.	.	.	.	
P62834	UniProtKB	Beta strand	36	48	.	.	.	.	
P62834	UniProtKB	Beta strand	50	58	.	.	.	.	
P62834	UniProtKB	Helix	67	74	.	.	.	.	
P62834	UniProtKB	Beta strand	76	83	.	.	.	.	
P62834	UniProtKB	Helix	87	91	.	.	.	.	
P62834	UniProtKB	Helix	93	104	.	.	.	.	
P62834	UniProtKB	Beta strand	111	116	.	.	.	.	
P62834	UniProtKB	Helix	121	123	.	.	.	.	
P62834	UniProtKB	Helix	128	137	.	.	.	.	
P62834	UniProtKB	Turn	138	140	.	.	.	.	
P62834	UniProtKB	Beta strand	142	145	.	.	.	.	
P62834	UniProtKB	Turn	148	151	.	.	.	.	
P62834	UniProtKB	Helix	154	165	.	.	.	.	
##sequence-region P62835 1 184
P62835	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000030201;Note=Ras-related protein Rap-1A	
P62835	UniProtKB	Propeptide	182	184	.	.	.	ID=PRO_0000030202;Note=Removed in mature form;status=By similarity	
P62835	UniProtKB	Nucleotide binding	10	17	.	.	.	Note=GTP;status=By similarity	
P62835	UniProtKB	Nucleotide binding	57	61	.	.	.	Note=GTP;status=By similarity	
P62835	UniProtKB	Nucleotide binding	116	119	.	.	.	Note=GTP;status=By similarity	
P62835	UniProtKB	Motif	32	40	.	.	.	Note=Effector region;status=Probable	
P62835	UniProtKB	Modified residue	181	181	.	.	.	Note=Cysteine methyl ester;status=By similarity	
P62835	UniProtKB	Lipidation	181	181	.	.	.	Note=S-geranylgeranyl cysteine;status=By similarity	
##sequence-region P62836 1 184
P62836	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000030203;Note=Ras-related protein Rap-1A	
P62836	UniProtKB	Propeptide	182	184	.	.	.	ID=PRO_0000030204;Note=Removed in mature form;status=By similarity	
P62836	UniProtKB	Nucleotide binding	10	17	.	.	.	Note=GTP;status=By similarity	
P62836	UniProtKB	Nucleotide binding	57	61	.	.	.	Note=GTP;status=By similarity	
P62836	UniProtKB	Nucleotide binding	116	119	.	.	.	Note=GTP;status=By similarity	
P62836	UniProtKB	Motif	32	40	.	.	.	Note=Effector region;status=Probable	
P62836	UniProtKB	Modified residue	181	181	.	.	.	Note=Cysteine methyl ester;status=By similarity	
P62836	UniProtKB	Lipidation	181	181	.	.	.	Note=S-geranylgeranyl cysteine;status=By similarity	
##sequence-region Q9NS23 1 344
Q9NS23	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q9NS23	UniProtKB	Chain	2	344	.	.	.	ID=PRO_0000068891;Note=Ras association domain-containing protein 1	
Q9NS23	UniProtKB	Domain	198	292	.	.	.	Note=Ras-associating	
Q9NS23	UniProtKB	Domain	294	341	.	.	.	Note=SARAH	
Q9NS23	UniProtKB	Zinc finger	51	105	.	.	.	Note=Phorbol-ester/DAG-type	
Q9NS23	UniProtKB	Region	2	119	.	.	.	Note=Mediates interaction with E4F1	
Q9NS23	UniProtKB	Region	315	318	.	.	.	Note=MOAP1-binding	
Q9NS23	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine	
Q9NS23	UniProtKB	Modified residue	2	2	.	.	.	Note=Phosphoserine	
Q9NS23	UniProtKB	Alternative sequence	1	155	.	.	.	ID=VSP_050770;Note=In isoform B.	
Q9NS23	UniProtKB	Alternative sequence	1	74	.	.	.	ID=VSP_050773;Note=In isoform C and isoform H.	
Q9NS23	UniProtKB	Alternative sequence	75	123	.	.	.	ID=VSP_050774;Note=In isoform C and isoform H.	
Q9NS23	UniProtKB	Alternative sequence	84	149	.	.	.	ID=VSP_050775;Note=In isoform G.	
Q9NS23	UniProtKB	Alternative sequence	84	88	.	.	.	ID=VSP_050771;Note=In isoform A and isoform E.	
Q9NS23	UniProtKB	Alternative sequence	85	91	.	.	.	ID=VSP_050776;Note=In isoform F.	
Q9NS23	UniProtKB	Alternative sequence	93	344	.	.	.	ID=VSP_050777;Note=In isoform F.	
Q9NS23	UniProtKB	Alternative sequence	123	123	.	.	.	ID=VSP_050772;Note=In isoform E.	
Q9NS23	UniProtKB	Alternative sequence	150	344	.	.	.	ID=VSP_050778;Note=In isoform G and isoform H.	
Q9NS23	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_019542;Dbxref=dbSNP:rs4688725	
Q9NS23	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_019543;Dbxref=dbSNP:rs201618726	
Q9NS23	UniProtKB	Natural variant	133	133	.	.	.	ID=VAR_019544;Dbxref=dbSNP:rs76335415	
Q9NS23	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_019545;Note=Prevents G1 cell cycle arrest%3B reduced protein phosphorylation.	
Q9NS23	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_019546;Dbxref=dbSNP:rs2073498;Note=Prevents G1 cell cycle arrest%3B reduced protein phosphorylation.	
Q9NS23	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_059794;Dbxref=dbSNP:rs12488879	
Q9NS23	UniProtKB	Natural variant	329	329	.	.	.	ID=VAR_019547	
##sequence-region Q99MK9 1 340
Q99MK9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q99MK9	UniProtKB	Chain	2	340	.	.	.	ID=PRO_0000068892;Note=Ras association domain-containing protein 1	
Q99MK9	UniProtKB	Domain	194	288	.	.	.	Note=Ras-associating	
Q99MK9	UniProtKB	Domain	290	337	.	.	.	Note=SARAH	
Q99MK9	UniProtKB	Zinc finger	51	101	.	.	.	Note=Phorbol-ester/DAG-type	
Q99MK9	UniProtKB	Region	2	115	.	.	.	Note=Mediates interaction with E4F1;status=By similarity	
Q99MK9	UniProtKB	Region	311	314	.	.	.	Note=MOAP1-binding;status=By similarity	
Q99MK9	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;status=By similarity	
Q99MK9	UniProtKB	Modified residue	2	2	.	.	.	Note=Phosphoserine;status=By similarity	
Q99MK9	UniProtKB	Alternative sequence	1	70	.	.	.	ID=VSP_050779;Note=In isoform C.	
Q99MK9	UniProtKB	Alternative sequence	71	119	.	.	.	ID=VSP_050780;Note=In isoform C.	
##sequence-region P50749 1 326
P50749	UniProtKB	Chain	1	326	.	.	.	ID=PRO_0000097172;Note=Ras association domain-containing protein 2	
P50749	UniProtKB	Domain	176	264	.	.	.	Note=Ras-associating	
P50749	UniProtKB	Domain	272	319	.	.	.	Note=SARAH	
P50749	UniProtKB	Natural variant	144	144	.	.	.	ID=VAR_035825;Note=In a colorectal cancer sample%3B somatic mutation.	
P50749	UniProtKB	Sequence conflict	166	166	.	.	.	.	
P50749	UniProtKB	Sequence conflict	256	256	.	.	.	.	
##sequence-region Q8BMS9 1 326
Q8BMS9	UniProtKB	Chain	1	326	.	.	.	ID=PRO_0000233038;Note=Ras association domain-containing protein 2	
Q8BMS9	UniProtKB	Domain	176	264	.	.	.	Note=Ras-associating	
Q8BMS9	UniProtKB	Domain	272	319	.	.	.	Note=SARAH	
##sequence-region Q3B7D5 1 326
Q3B7D5	UniProtKB	Chain	1	326	.	.	.	ID=PRO_0000233039;Note=Ras association domain-containing protein 2	
Q3B7D5	UniProtKB	Domain	176	264	.	.	.	Note=Ras-associating	
Q3B7D5	UniProtKB	Domain	272	319	.	.	.	Note=SARAH	
##sequence-region Q9H2L5 1 321
Q9H2L5	UniProtKB	Chain	1	321	.	.	.	ID=PRO_0000240398;Note=Ras association domain-containing protein 4	
Q9H2L5	UniProtKB	Domain	174	262	.	.	.	Note=Ras-associating	
Q9H2L5	UniProtKB	Domain	270	317	.	.	.	Note=SARAH	
Q9H2L5	UniProtKB	Alternative sequence	1	70	.	.	.	ID=VSP_019355;Note=In isoform 3.	
Q9H2L5	UniProtKB	Alternative sequence	29	46	.	.	.	ID=VSP_019356;Note=In isoform 2.	
Q9H2L5	UniProtKB	Alternative sequence	94	94	.	.	.	ID=VSP_019357;Note=In isoform 2.	
Q9H2L5	UniProtKB	Alternative sequence	95	126	.	.	.	ID=VSP_019358;Note=In isoform 4.	
Q9H2L5	UniProtKB	Alternative sequence	127	321	.	.	.	ID=VSP_019359;Note=In isoform 4.	
Q9H2L5	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_034438;Dbxref=dbSNP:rs34692238	
Q9H2L5	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_034439;Dbxref=dbSNP:rs870957	
Q9H2L5	UniProtKB	Sequence conflict	107	107	.	.	.	.	
Q9H2L5	UniProtKB	Sequence conflict	107	107	.	.	.	.	
##sequence-region Q8CB96 1 322
Q8CB96	UniProtKB	Chain	1	322	.	.	.	ID=PRO_0000240399;Note=Ras association domain-containing protein 4	
Q8CB96	UniProtKB	Domain	175	264	.	.	.	Note=Ras-associating	
Q8CB96	UniProtKB	Domain	271	318	.	.	.	Note=SARAH	
Q8CB96	UniProtKB	Alternative sequence	179	276	.	.	.	ID=VSP_019360;Note=In isoform 3.	
Q8CB96	UniProtKB	Alternative sequence	277	322	.	.	.	ID=VSP_019361;Note=In isoform 3.	
Q8CB96	UniProtKB	Alternative sequence	304	322	.	.	.	ID=VSP_019362;Note=In isoform 2.	
Q8CB96	UniProtKB	Sequence conflict	153	153	.	.	.	.	
Q8CB96	UniProtKB	Sequence conflict	291	291	.	.	.	.	
Q8CB96	UniProtKB	Sequence conflict	295	295	.	.	.	.	
##sequence-region Q566C5 1 322
Q566C5	UniProtKB	Chain	1	322	.	.	.	ID=PRO_0000240400;Note=Ras association domain-containing protein 4	
Q566C5	UniProtKB	Domain	175	263	.	.	.	Note=Ras-associating	
Q566C5	UniProtKB	Domain	271	318	.	.	.	Note=SARAH	
##sequence-region Q8WWW0 1 418
Q8WWW0	UniProtKB	Chain	1	418	.	.	.	ID=PRO_0000240401;Note=Ras association domain-containing protein 5	
Q8WWW0	UniProtKB	Domain	274	364	.	.	.	Note=Ras-associating	
Q8WWW0	UniProtKB	Domain	366	413	.	.	.	Note=SARAH	
Q8WWW0	UniProtKB	Zinc finger	122	170	.	.	.	Note=Phorbol-ester/DAG-type	
Q8WWW0	UniProtKB	Modified residue	352	352	.	.	.	Note=Phosphothreonine	
Q8WWW0	UniProtKB	Alternative sequence	1	153	.	.	.	ID=VSP_019363;Note=In isoform 2.	
Q8WWW0	UniProtKB	Alternative sequence	154	193	.	.	.	ID=VSP_019364;Note=In isoform 2.	
Q8WWW0	UniProtKB	Alternative sequence	331	336	.	.	.	ID=VSP_019365;Note=In isoform 3.	
Q8WWW0	UniProtKB	Alternative sequence	337	418	.	.	.	ID=VSP_019366;Note=In isoform 3.	
##sequence-region Q5EBH1 1 413
Q5EBH1	UniProtKB	Chain	1	413	.	.	.	ID=PRO_0000240402;Note=Ras association domain-containing protein 5	
Q5EBH1	UniProtKB	Domain	265	359	.	.	.	Note=Ras-associating	
Q5EBH1	UniProtKB	Domain	361	408	.	.	.	Note=SARAH	
Q5EBH1	UniProtKB	Zinc finger	117	165	.	.	.	Note=Phorbol-ester/DAG-type	
Q5EBH1	UniProtKB	Modified residue	347	347	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5EBH1	UniProtKB	Alternative sequence	1	142	.	.	.	ID=VSP_019368;Note=In isoform 2.	
Q5EBH1	UniProtKB	Alternative sequence	143	188	.	.	.	ID=VSP_019369;Note=In isoform 2.	
Q5EBH1	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	220	220	.	.	.	Note=Strongly reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	221	221	.	.	.	Note=Strongly reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	234	234	.	.	.	Note=Reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	280	280	.	.	.	Note=Reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	283	283	.	.	.	Note=Very strong reduction of the interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	284	284	.	.	.	Note=Reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Mutagenesis	302	302	.	.	.	Note=Reduced specificity for HRAS and diminished discrimination between HRAS and RAP1A.	
Q5EBH1	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Strongly reduced interaction with HRAS.	
Q5EBH1	UniProtKB	Sequence conflict	179	179	.	.	.	.	
Q5EBH1	UniProtKB	Sequence conflict	251	257	.	.	.	.	
Q5EBH1	UniProtKB	Helix	112	114	.	.	.	.	
Q5EBH1	UniProtKB	Turn	133	135	.	.	.	.	
Q5EBH1	UniProtKB	Beta strand	137	139	.	.	.	.	
Q5EBH1	UniProtKB	Turn	147	149	.	.	.	.	
Q5EBH1	UniProtKB	Helix	155	158	.	.	.	.	
Q5EBH1	UniProtKB	Helix	203	215	.	.	.	.	
Q5EBH1	UniProtKB	Helix	219	221	.	.	.	.	
Q5EBH1	UniProtKB	Helix	227	229	.	.	.	.	
Q5EBH1	UniProtKB	Beta strand	231	245	.	.	.	.	
Q5EBH1	UniProtKB	Beta strand	275	288	.	.	.	.	
Q5EBH1	UniProtKB	Helix	293	303	.	.	.	.	
Q5EBH1	UniProtKB	Helix	310	312	.	.	.	.	
Q5EBH1	UniProtKB	Beta strand	313	321	.	.	.	.	
Q5EBH1	UniProtKB	Beta strand	324	329	.	.	.	.	
Q5EBH1	UniProtKB	Helix	336	343	.	.	.	.	
Q5EBH1	UniProtKB	Turn	347	349	.	.	.	.	
Q5EBH1	UniProtKB	Beta strand	351	356	.	.	.	.	
Q5EBH1	UniProtKB	Helix	370	405	.	.	.	.	
##sequence-region O35141 1 413
O35141	UniProtKB	Chain	1	413	.	.	.	ID=PRO_0000240403;Note=Ras association domain-containing protein 5	
O35141	UniProtKB	Domain	265	359	.	.	.	Note=Ras-associating	
O35141	UniProtKB	Domain	361	408	.	.	.	Note=SARAH	
O35141	UniProtKB	Zinc finger	117	165	.	.	.	Note=Phorbol-ester/DAG-type	
O35141	UniProtKB	Modified residue	347	347	.	.	.	Note=Phosphothreonine;status=By similarity	
##sequence-region Q8TDY2 1 1594
Q8TDY2	UniProtKB	Chain	1	1594	.	.	.	ID=PRO_0000097183;Note=RB1-inducible coiled-coil protein 1	
Q8TDY2	UniProtKB	Coiled coil	859	1397	.	.	.	status=Potential	
Q8TDY2	UniProtKB	Coiled coil	1438	1485	.	.	.	status=Potential	
Q8TDY2	UniProtKB	Motif	566	569	.	.	.	Note=Nuclear localization signal;status=Potential	
Q8TDY2	UniProtKB	Compositional bias	663	666	.	.	.	Note=Poly-Thr	
Q8TDY2	UniProtKB	Modified residue	237	237	.	.	.	Note=Phosphoserine	
Q8TDY2	UniProtKB	Modified residue	243	243	.	.	.	Note=Phosphoserine	
Q8TDY2	UniProtKB	Modified residue	257	257	.	.	.	Note=Phosphoserine	
Q8TDY2	UniProtKB	Modified residue	624	624	.	.	.	Note=Phosphoserine	
Q8TDY2	UniProtKB	Modified residue	647	647	.	.	.	Note=Phosphoserine	
Q8TDY2	UniProtKB	Modified residue	653	653	.	.	.	Note=Phosphoserine	
Q8TDY2	UniProtKB	Alternative sequence	1543	1545	.	.	.	ID=VSP_040097;Note=In isoform 2.	
Q8TDY2	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_023776;Dbxref=dbSNP:rs17337252	
Q8TDY2	UniProtKB	Natural variant	708	708	.	.	.	ID=VAR_051309;Dbxref=dbSNP:rs34016926	
Q8TDY2	UniProtKB	Natural variant	1216	1216	.	.	.	ID=VAR_051310;Dbxref=dbSNP:rs35534432	
Q8TDY2	UniProtKB	Natural variant	1314	1314	.	.	.	ID=VAR_051311;Dbxref=dbSNP:rs34701924	
Q8TDY2	UniProtKB	Natural variant	1424	1424	.	.	.	ID=VAR_051312;Dbxref=dbSNP:rs35342973	
Q8TDY2	UniProtKB	Natural variant	1514	1514	.	.	.	ID=VAR_033031;Note=In a breast cancer sample%3B somatic mutation.	
Q8TDY2	UniProtKB	Sequence conflict	1136	1136	.	.	.	.	
##sequence-region Q9ESK9 1 1588
Q9ESK9	UniProtKB	Chain	1	1588	.	.	.	ID=PRO_0000097184;Note=RB1-inducible coiled-coil protein 1	
Q9ESK9	UniProtKB	Coiled coil	858	1393	.	.	.	status=Potential	
Q9ESK9	UniProtKB	Coiled coil	1440	1479	.	.	.	status=Potential	
Q9ESK9	UniProtKB	Motif	565	568	.	.	.	Note=Nuclear localization signal	
Q9ESK9	UniProtKB	Compositional bias	662	665	.	.	.	Note=Poly-Thr	
Q9ESK9	UniProtKB	Modified residue	237	237	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ESK9	UniProtKB	Modified residue	243	243	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ESK9	UniProtKB	Modified residue	257	257	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ESK9	UniProtKB	Modified residue	623	623	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ESK9	UniProtKB	Modified residue	646	646	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ESK9	UniProtKB	Modified residue	652	652	.	.	.	Note=Phosphoserine;status=By similarity	
Q9ESK9	UniProtKB	Sequence conflict	809	809	.	.	.	.	
Q9ESK9	UniProtKB	Sequence conflict	809	809	.	.	.	.	
Q9ESK9	UniProtKB	Sequence conflict	981	981	.	.	.	.	
Q9ESK9	UniProtKB	Sequence conflict	981	981	.	.	.	.	
Q9ESK9	UniProtKB	Sequence conflict	1222	1222	.	.	.	.	
Q9ESK9	UniProtKB	Sequence conflict	1450	1451	.	.	.	.	
Q9ESK9	UniProtKB	Sequence conflict	1537	1539	.	.	.	.	
##sequence-region P28749 1 1068
P28749	UniProtKB	Chain	1	1068	.	.	.	ID=PRO_0000167839;Note=Retinoblastoma-like protein 1	
P28749	UniProtKB	Region	385	949	.	.	.	Note=Pocket%3B binds T and E1A	
P28749	UniProtKB	Region	385	584	.	.	.	Note=Domain A	
P28749	UniProtKB	Region	585	780	.	.	.	Note=Spacer	
P28749	UniProtKB	Region	781	949	.	.	.	Note=Domain B	
P28749	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphothreonine%3B by CDK2	
P28749	UniProtKB	Modified residue	369	369	.	.	.	Note=Phosphothreonine%3B by CDK4	
P28749	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphothreonine%3B by CDK2	
P28749	UniProtKB	Modified residue	640	640	.	.	.	Note=Phosphoserine%3B by CDK2 and CDK4	
P28749	UniProtKB	Modified residue	650	650	.	.	.	Note=Phosphoserine	
P28749	UniProtKB	Modified residue	749	749	.	.	.	Note=Phosphoserine	
P28749	UniProtKB	Modified residue	762	762	.	.	.	Note=Phosphoserine%3B by CDK2	
P28749	UniProtKB	Modified residue	964	964	.	.	.	Note=Phosphoserine%3B by CDK2 and CDK4	
P28749	UniProtKB	Modified residue	975	975	.	.	.	Note=Phosphoserine%3B by CDK2 and CDK4	
P28749	UniProtKB	Modified residue	988	988	.	.	.	Note=Phosphoserine%3B by CDK2	
P28749	UniProtKB	Modified residue	997	997	.	.	.	Note=Phosphothreonine%3B by CDK2	
P28749	UniProtKB	Modified residue	1009	1009	.	.	.	Note=Phosphoserine%3B by CDK2	
P28749	UniProtKB	Modified residue	1041	1041	.	.	.	Note=Phosphoserine;status=By similarity	
P28749	UniProtKB	Alternative sequence	1013	1068	.	.	.	ID=VSP_017496;Note=In isoform 2.	
P28749	UniProtKB	Natural variant	1035	1035	.	.	.	ID=VAR_034443;Dbxref=dbSNP:rs8114297	
P28749	UniProtKB	Mutagenesis	640	640	.	.	.	Note=Strongly reduces phosphorylation by CDK2 and CDK4.	
P28749	UniProtKB	Mutagenesis	643	643	.	.	.	Note=No effect on S-640 phosphorylation%2C but strongly increases S-640 phosphorylation%3B when associated with 657-A--A-660.	
P28749	UniProtKB	Mutagenesis	650	650	.	.	.	Note=No effect on phosphorylation by CDK2.	
P28749	UniProtKB	Mutagenesis	657	660	.	.	.	Note=Reduces S-640 phosphorylation by CDK2 and CDK4.	
P28749	UniProtKB	Sequence conflict	326	326	.	.	.	.	
P28749	UniProtKB	Sequence conflict	928	928	.	.	.	.	
P28749	UniProtKB	Sequence conflict	928	928	.	.	.	.	
##sequence-region Q64701 1 1063
Q64701	UniProtKB	Chain	1	1063	.	.	.	ID=PRO_0000167840;Note=Retinoblastoma-like protein 1	
Q64701	UniProtKB	Region	383	944	.	.	.	Note=Pocket%3B binds T and E1A	
Q64701	UniProtKB	Region	383	584	.	.	.	Note=Domain A	
Q64701	UniProtKB	Region	585	779	.	.	.	Note=Spacer	
Q64701	UniProtKB	Region	780	944	.	.	.	Note=Domain B	
Q64701	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64701	UniProtKB	Modified residue	369	369	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64701	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64701	UniProtKB	Modified residue	640	640	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	650	650	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	748	748	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	761	761	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	959	959	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	970	970	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	983	983	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	992	992	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64701	UniProtKB	Modified residue	1004	1004	.	.	.	Note=Phosphoserine;status=By similarity	
Q64701	UniProtKB	Modified residue	1036	1036	.	.	.	Note=Phosphoserine	
Q64701	UniProtKB	Alternative sequence	592	594	.	.	.	ID=VSP_005537;Note=In isoform Short.	
Q64701	UniProtKB	Alternative sequence	595	1063	.	.	.	ID=VSP_005538;Note=In isoform Short.	
Q64701	UniProtKB	Sequence conflict	26	26	.	.	.	.	
Q64701	UniProtKB	Sequence conflict	430	430	.	.	.	.	
Q64701	UniProtKB	Sequence conflict	863	863	.	.	.	.	
Q64701	UniProtKB	Sequence conflict	989	989	.	.	.	.	
##sequence-region Q08999 1 1139
Q08999	UniProtKB	Chain	1	1139	.	.	.	ID=PRO_0000167841;Note=Retinoblastoma-like protein 2	
Q08999	UniProtKB	Region	417	1024	.	.	.	Note=Pocket%3B binds E1A	
Q08999	UniProtKB	Region	417	616	.	.	.	Note=Domain A	
Q08999	UniProtKB	Region	617	827	.	.	.	Note=Spacer	
Q08999	UniProtKB	Region	828	1024	.	.	.	Note=Domain B	
Q08999	UniProtKB	Compositional bias	9	16	.	.	.	Note=Poly-Pro	
Q08999	UniProtKB	Compositional bias	17	20	.	.	.	Note=Poly-Ala	
Q08999	UniProtKB	Compositional bias	23	26	.	.	.	Note=Poly-Glu	
Q08999	UniProtKB	Compositional bias	998	1001	.	.	.	Note=Poly-Glu	
Q08999	UniProtKB	Modified residue	639	639	.	.	.	Note=Phosphoserine	
Q08999	UniProtKB	Modified residue	642	642	.	.	.	Note=Phosphothreonine;status=By similarity	
Q08999	UniProtKB	Modified residue	662	662	.	.	.	Note=Phosphoserine	
Q08999	UniProtKB	Modified residue	672	672	.	.	.	Note=Phosphoserine	
Q08999	UniProtKB	Modified residue	948	948	.	.	.	Note=Phosphoserine;status=By similarity	
Q08999	UniProtKB	Modified residue	952	952	.	.	.	Note=Phosphoserine	
Q08999	UniProtKB	Modified residue	966	966	.	.	.	Note=Phosphoserine	
Q08999	UniProtKB	Modified residue	971	971	.	.	.	Note=Phosphoserine;status=Probable	
Q08999	UniProtKB	Modified residue	972	972	.	.	.	Note=Phosphoserine;status=Probable	
Q08999	UniProtKB	Modified residue	973	973	.	.	.	Note=Phosphoserine;status=Probable	
Q08999	UniProtKB	Modified residue	974	974	.	.	.	Note=Phosphothreonine;status=Probable	
Q08999	UniProtKB	Modified residue	981	981	.	.	.	Note=Phosphoserine;status=Probable	
Q08999	UniProtKB	Modified residue	982	982	.	.	.	Note=Phosphoserine	
Q08999	UniProtKB	Modified residue	986	986	.	.	.	Note=Phosphothreonine	
Q08999	UniProtKB	Modified residue	1035	1035	.	.	.	Note=Phosphoserine	
Q08999	UniProtKB	Natural variant	99	99	.	.	.	ID=VAR_069377	
Q08999	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_028437;Dbxref=dbSNP:rs17800727	
Q08999	UniProtKB	Sequence conflict	37	37	.	.	.	.	
Q08999	UniProtKB	Sequence conflict	37	37	.	.	.	.	
Q08999	UniProtKB	Sequence conflict	64	64	.	.	.	.	
Q08999	UniProtKB	Sequence conflict	64	64	.	.	.	.	
Q08999	UniProtKB	Sequence conflict	206	206	.	.	.	.	
##sequence-region Q64700 1 1135
Q64700	UniProtKB	Chain	1	1135	.	.	.	ID=PRO_0000167842;Note=Retinoblastoma-like protein 2	
Q64700	UniProtKB	Region	414	1021	.	.	.	Note=Pocket%3B binds E1A	
Q64700	UniProtKB	Region	414	613	.	.	.	Note=Domain A	
Q64700	UniProtKB	Region	614	824	.	.	.	Note=Spacer	
Q64700	UniProtKB	Region	825	1021	.	.	.	Note=Domain B	
Q64700	UniProtKB	Compositional bias	9	13	.	.	.	Note=Poly-Pro	
Q64700	UniProtKB	Compositional bias	14	17	.	.	.	Note=Poly-Ala	
Q64700	UniProtKB	Compositional bias	20	24	.	.	.	Note=Poly-Glu	
Q64700	UniProtKB	Compositional bias	992	995	.	.	.	Note=Poly-Glu	
Q64700	UniProtKB	Modified residue	636	636	.	.	.	Note=Phosphoserine	
Q64700	UniProtKB	Modified residue	639	639	.	.	.	Note=Phosphothreonine	
Q64700	UniProtKB	Modified residue	659	659	.	.	.	Note=Phosphoserine;status=By similarity	
Q64700	UniProtKB	Modified residue	669	669	.	.	.	Note=Phosphoserine;status=By similarity	
Q64700	UniProtKB	Modified residue	942	942	.	.	.	Note=Phosphoserine	
Q64700	UniProtKB	Modified residue	946	946	.	.	.	Note=Phosphoserine;status=By similarity	
Q64700	UniProtKB	Modified residue	960	960	.	.	.	Note=Phosphoserine;status=By similarity	
Q64700	UniProtKB	Modified residue	976	976	.	.	.	Note=Phosphoserine;status=By similarity	
Q64700	UniProtKB	Modified residue	980	980	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64700	UniProtKB	Modified residue	1031	1031	.	.	.	Note=Phosphoserine;status=By similarity	
Q64700	UniProtKB	Sequence conflict	209	251	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	341	341	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	342	342	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	381	381	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	428	428	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	431	431	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	443	443	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	483	492	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	768	768	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	826	826	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	947	948	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	1023	1023	.	.	.	.	
Q64700	UniProtKB	Sequence conflict	1044	1044	.	.	.	.	
##sequence-region O55081 1 1135
O55081	UniProtKB	Chain	1	1135	.	.	.	ID=PRO_0000167843;Note=Retinoblastoma-like protein 2	
O55081	UniProtKB	Region	414	1021	.	.	.	Note=Pocket%3B binds E1A	
O55081	UniProtKB	Region	414	613	.	.	.	Note=Domain A	
O55081	UniProtKB	Region	614	824	.	.	.	Note=Spacer	
O55081	UniProtKB	Region	825	1021	.	.	.	Note=Domain B	
O55081	UniProtKB	Compositional bias	10	13	.	.	.	Note=Poly-Pro	
O55081	UniProtKB	Compositional bias	14	17	.	.	.	Note=Poly-Ala	
O55081	UniProtKB	Compositional bias	20	24	.	.	.	Note=Poly-Glu	
O55081	UniProtKB	Compositional bias	992	995	.	.	.	Note=Poly-Glu	
O55081	UniProtKB	Modified residue	636	636	.	.	.	Note=Phosphoserine;status=By similarity	
O55081	UniProtKB	Modified residue	639	639	.	.	.	Note=Phosphothreonine;status=By similarity	
O55081	UniProtKB	Modified residue	659	659	.	.	.	Note=Phosphoserine;status=By similarity	
O55081	UniProtKB	Modified residue	669	669	.	.	.	Note=Phosphoserine;status=By similarity	
O55081	UniProtKB	Modified residue	942	942	.	.	.	Note=Phosphoserine;status=By similarity	
O55081	UniProtKB	Modified residue	946	946	.	.	.	Note=Phosphoserine;status=By similarity	
O55081	UniProtKB	Modified residue	960	960	.	.	.	Note=Phosphoserine;status=By similarity	
O55081	UniProtKB	Modified residue	976	976	.	.	.	Note=Phosphoserine;status=By similarity	
O55081	UniProtKB	Modified residue	980	980	.	.	.	Note=Phosphothreonine;status=By similarity	
O55081	UniProtKB	Modified residue	1031	1031	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q29RT0 1 396
Q29RT0	UniProtKB	Chain	1	396	.	.	.	ID=PRO_0000240607;Note=RNA-binding motif protein%2C X chromosome	
Q29RT0	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate;status=By similarity	
Q29RT0	UniProtKB	Chain	2	396	.	.	.	ID=PRO_0000367118;Note=RNA-binding motif protein%2C X chromosome%2C N-terminally processed	
Q29RT0	UniProtKB	Domain	8	86	.	.	.	Note=RRM	
Q29RT0	UniProtKB	Region	186	236	.	.	.	Note=Necessary for the association to nascent RNAPII transcripts and nuclear localization;status=By similarity	
Q29RT0	UniProtKB	Region	336	396	.	.	.	Note=Necessary for RNA-binding;status=By similarity	
Q29RT0	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine%3B in Heterogeneous nuclear ribonucleoprotein G%3B alternate;status=By similarity	
Q29RT0	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylvaline%3B in Heterogeneous nuclear ribonucleoprotein G%2C N-terminally processed;status=By similarity	
Q29RT0	UniProtKB	Modified residue	30	30	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q29RT0	UniProtKB	Modified residue	185	185	.	.	.	Note=Omega-N-methylated arginine;status=By similarity	
Q29RT0	UniProtKB	Modified residue	335	335	.	.	.	Note=Phosphoserine;status=By similarity	
Q29RT0	UniProtKB	Modified residue	355	355	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region P38159 1 391
P38159	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000081854;Note=RNA-binding motif protein%2C X chromosome	
P38159	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate	
P38159	UniProtKB	Chain	2	391	.	.	.	ID=PRO_0000304582;Note=RNA-binding motif protein%2C X chromosome%2C N-terminally processed	
P38159	UniProtKB	Domain	8	86	.	.	.	Note=RRM	
P38159	UniProtKB	Region	186	236	.	.	.	Note=Necessary for the association to nascent RNAPII transcripts and nuclear localization	
P38159	UniProtKB	Region	333	391	.	.	.	Note=Necessary for RNA-binding	
P38159	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine%3B in Heterogeneous nuclear ribonucleoprotein G%3B alternate	
P38159	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylvaline%3B in Heterogeneous nuclear ribonucleoprotein G%2C N-terminally processed	
P38159	UniProtKB	Modified residue	30	30	.	.	.	Note=N6-acetyllysine	
P38159	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphoserine	
P38159	UniProtKB	Modified residue	329	329	.	.	.	Note=Phosphoserine	
P38159	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine	
P38159	UniProtKB	Modified residue	352	352	.	.	.	Note=Phosphoserine	
P38159	UniProtKB	Alternative sequence	45	57	.	.	.	ID=VSP_042203;Note=In isoform 2.	
P38159	UniProtKB	Alternative sequence	73	196	.	.	.	ID=VSP_043650;Note=In isoform 3.	
P38159	UniProtKB	Alternative sequence	197	391	.	.	.	ID=VSP_043651;Note=In isoform 3.	
P38159	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Promotes cell proliferation. Inhibits transcriptional up-regulation of the TXNIP promoter.	
P38159	UniProtKB	Sequence conflict	259	259	.	.	.	.	
##sequence-region Q4R7F0 1 391
Q4R7F0	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000413018;Note=RNA-binding motif protein%2C X chromosome	
Q4R7F0	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate;status=By similarity	
Q4R7F0	UniProtKB	Chain	2	391	.	.	.	ID=PRO_0000413019;Note=RNA-binding motif protein%2C X chromosome%2C N-terminally processed	
Q4R7F0	UniProtKB	Domain	8	86	.	.	.	Note=RRM	
Q4R7F0	UniProtKB	Region	186	236	.	.	.	Note=Necessary for the association to nascent RNAPII transcripts and nuclear localization;status=By similarity	
Q4R7F0	UniProtKB	Region	333	391	.	.	.	Note=Necessary for RNA-binding;status=By similarity	
Q4R7F0	UniProtKB	Compositional bias	96	100	.	.	.	Note=Poly-Pro	
Q4R7F0	UniProtKB	Compositional bias	249	337	.	.	.	Note=Ser-rich	
Q4R7F0	UniProtKB	Compositional bias	363	368	.	.	.	Note=Poly-Ser	
Q4R7F0	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine%3B in Heterogeneous nuclear ribonucleoprotein G%3B alternate;status=By similarity	
Q4R7F0	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylvaline%3B in Heterogeneous nuclear ribonucleoprotein G%2C N-terminally processed;status=By similarity	
Q4R7F0	UniProtKB	Modified residue	30	30	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q4R7F0	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R7F0	UniProtKB	Modified residue	329	329	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R7F0	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine;status=By similarity	
Q4R7F0	UniProtKB	Modified residue	352	352	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q9WV02 1 391
Q9WV02	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000414747;Note=RNA-binding motif protein%2C X chromosome	
Q9WV02	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate;status=By similarity	
Q9WV02	UniProtKB	Chain	2	391	.	.	.	ID=PRO_0000414748;Note=RNA-binding motif protein%2C X chromosome%2C N-terminally processed	
Q9WV02	UniProtKB	Domain	8	86	.	.	.	Note=RRM	
Q9WV02	UniProtKB	Compositional bias	104	192	.	.	.	Note=Gly-rich	
Q9WV02	UniProtKB	Compositional bias	249	337	.	.	.	Note=Ser-rich	
Q9WV02	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q9WV02	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylvaline%3B in RNA-binding motif protein%2C X chromosome%2C N-terminally processed;status=By similarity	
Q9WV02	UniProtKB	Modified residue	30	30	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q9WV02	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV02	UniProtKB	Modified residue	185	185	.	.	.	Note=Omega-N-methylated arginine;status=By similarity	
Q9WV02	UniProtKB	Modified residue	329	329	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV02	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV02	UniProtKB	Modified residue	352	352	.	.	.	Note=Phosphoserine;status=By similarity	
Q9WV02	UniProtKB	Alternative sequence	290	391	.	.	.	ID=VSP_042129;Note=In isoform 2.	
##sequence-region A5A6M3 1 391
A5A6M3	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000309746;Note=RNA-binding motif protein%2C X chromosome	
A5A6M3	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate;status=By similarity	
A5A6M3	UniProtKB	Chain	2	391	.	.	.	ID=PRO_0000413016;Note=RNA-binding motif protein%2C X chromosome%2C N-terminally processed	
A5A6M3	UniProtKB	Domain	8	86	.	.	.	Note=RRM	
A5A6M3	UniProtKB	Region	186	236	.	.	.	Note=Necessary for the association to nascent RNAPII transcripts and nuclear localization;status=By similarity	
A5A6M3	UniProtKB	Region	333	391	.	.	.	Note=Necessary for RNA-binding;status=By similarity	
A5A6M3	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine%3B in Heterogeneous nuclear ribonucleoprotein G%3B alternate;status=By similarity	
A5A6M3	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylvaline%3B in Heterogeneous nuclear ribonucleoprotein G%2C N-terminally processed;status=By similarity	
A5A6M3	UniProtKB	Modified residue	30	30	.	.	.	Note=N6-acetyllysine;status=By similarity	
A5A6M3	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6M3	UniProtKB	Modified residue	185	185	.	.	.	Note=Omega-N-methylated arginine;status=By similarity	
A5A6M3	UniProtKB	Modified residue	329	329	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6M3	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine;status=By similarity	
A5A6M3	UniProtKB	Modified residue	352	352	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q4V898 1 390
Q4V898	UniProtKB	Chain	1	390	.	.	.	ID=PRO_0000413089;Note=RNA-binding motif protein%2C X chromosome	
Q4V898	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed%3B alternate;status=By similarity	
Q4V898	UniProtKB	Chain	2	390	.	.	.	ID=PRO_0000413017;Note=RNA-binding motif protein%2C X chromosome%2C N-terminally processed	
Q4V898	UniProtKB	Domain	8	86	.	.	.	Note=RRM	
Q4V898	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine%3B in Heterogeneous nuclear ribonucleoprotein G%3B alternate;status=By similarity	
Q4V898	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylvaline%3B in Heterogeneous nuclear ribonucleoprotein G%2C N-terminally processed;status=By similarity	
Q4V898	UniProtKB	Modified residue	30	30	.	.	.	Note=N6-acetyllysine;status=By similarity	
Q4V898	UniProtKB	Modified residue	88	88	.	.	.	Note=Phosphoserine;status=By similarity	
Q4V898	UniProtKB	Modified residue	185	185	.	.	.	Note=Omega-N-methylated arginine;status=By similarity	
Q4V898	UniProtKB	Modified residue	329	329	.	.	.	Note=Phosphoserine;status=By similarity	
Q4V898	UniProtKB	Modified residue	332	332	.	.	.	Note=Phosphoserine;status=By similarity	
Q4V898	UniProtKB	Modified residue	352	352	.	.	.	Note=Phosphoserine;status=By similarity	
Q4V898	UniProtKB	Sequence conflict	12	12	.	.	.	.	
Q4V898	UniProtKB	Sequence conflict	348	348	.	.	.	.	
##sequence-region Q90600 1 921
Q90600	UniProtKB	Chain	1	921	.	.	.	ID=PRO_0000331619;Note=Retinoblastoma-associated protein	
Q90600	UniProtKB	Motif	863	869	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q90600	UniProtKB	Compositional bias	76	79	.	.	.	Note=Poly-Lys	
Q90600	UniProtKB	Sequence conflict	63	63	.	.	.	.	
Q90600	UniProtKB	Sequence conflict	163	163	.	.	.	.	
Q90600	UniProtKB	Sequence conflict	411	411	.	.	.	.	
Q90600	UniProtKB	Sequence conflict	619	619	.	.	.	.	
Q90600	UniProtKB	Sequence conflict	791	792	.	.	.	.	
##sequence-region P13405 1 921
P13405	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
P13405	UniProtKB	Chain	2	921	.	.	.	ID=PRO_0000167837;Note=Retinoblastoma-associated protein	
P13405	UniProtKB	Region	367	764	.	.	.	Note=Pocket%3B binds T and E1A;status=By similarity	
P13405	UniProtKB	Region	367	573	.	.	.	Note=Domain A;status=By similarity	
P13405	UniProtKB	Region	574	632	.	.	.	Note=Spacer;status=By similarity	
P13405	UniProtKB	Region	633	764	.	.	.	Note=Domain B;status=By similarity	
P13405	UniProtKB	Region	756	921	.	.	.	Note=Interaction with LIMD1;status=By similarity	
P13405	UniProtKB	Region	764	921	.	.	.	Note=Domain%3B mediates interaction with E4F1;status=By similarity	
P13405	UniProtKB	Motif	863	869	.	.	.	Note=Nuclear localization signal;status=By similarity	
P13405	UniProtKB	Compositional bias	9	12	.	.	.	Note=Poly-Ala	
P13405	UniProtKB	Compositional bias	14	22	.	.	.	Note=Poly-Pro	
P13405	UniProtKB	Modified residue	2	2	.	.	.	Note=N%2CN-dimethylproline%3B by NTM1	
P13405	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine;status=By similarity	
P13405	UniProtKB	Modified residue	243	243	.	.	.	Note=Phosphoserine%3B by CDK1;status=By similarity	
P13405	UniProtKB	Modified residue	246	246	.	.	.	Note=Phosphothreonine%3B by CDK1;status=By similarity	
P13405	UniProtKB	Modified residue	350	350	.	.	.	Note=Phosphothreonine;status=By similarity	
P13405	UniProtKB	Modified residue	367	367	.	.	.	Note=Phosphothreonine%3B by CDK1;status=By similarity	
P13405	UniProtKB	Modified residue	561	561	.	.	.	Note=Phosphoserine%3B by CDK2;status=By similarity	
P13405	UniProtKB	Modified residue	605	605	.	.	.	Note=Phosphoserine%3B by CHEK2 and CHEK1;status=By similarity	
P13405	UniProtKB	Modified residue	788	788	.	.	.	Note=Phosphoserine;status=By similarity	
P13405	UniProtKB	Modified residue	800	800	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK3;status=By similarity	
P13405	UniProtKB	Modified residue	803	803	.	.	.	Note=N6-methyllysine%3B by SMYD2;status=By similarity	
P13405	UniProtKB	Modified residue	804	804	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK3;status=By similarity	
P13405	UniProtKB	Modified residue	814	814	.	.	.	Note=Phosphothreonine%3B by CDK6;status=By similarity	
P13405	UniProtKB	Modified residue	816	816	.	.	.	Note=Phosphothreonine;status=By similarity	
P13405	UniProtKB	Modified residue	819	819	.	.	.	Note=Phosphothreonine%3B by CDK4	
P13405	UniProtKB	Modified residue	834	834	.	.	.	Note=Phosphothreonine;status=By similarity	
P13405	UniProtKB	Modified residue	853	853	.	.	.	Note=N6-methyllysine%3B by SMYD2;status=By similarity	
P13405	UniProtKB	Modified residue	866	866	.	.	.	Note=N6-acetyllysine%3B by PCAF;status=By similarity	
P13405	UniProtKB	Modified residue	867	867	.	.	.	Note=N6-acetyllysine%3B by PCAF;status=By similarity	
P13405	UniProtKB	Mutagenesis	746	746	.	.	.	Note=Abolishes the interaction with many chromatin regulators but not that with SUV420H1 and SUV420H2%3B when associated with A-750 and A-754.	
P13405	UniProtKB	Mutagenesis	750	750	.	.	.	Note=Abolishes the interaction with many chromatin regulators but not that with SUV420H1 and SUV420H2%3B when associated with A-746 and A-754.	
P13405	UniProtKB	Mutagenesis	754	754	.	.	.	Note=Abolishes the interaction with many chromatin regulators but not that with SUV420H1 and SUV420H2%3B when associated with A-746 and A-750.	
P13405	UniProtKB	Sequence conflict	867	868	.	.	.	.	
##sequence-region P33568 1 920
P33568	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
P33568	UniProtKB	Chain	2	920	.	.	.	ID=PRO_0000167838;Note=Retinoblastoma-associated protein	
P33568	UniProtKB	Region	366	763	.	.	.	Note=Pocket%3B binds T and E1A;status=By similarity	
P33568	UniProtKB	Region	366	572	.	.	.	Note=Domain A;status=By similarity	
P33568	UniProtKB	Region	573	631	.	.	.	Note=Spacer;status=By similarity	
P33568	UniProtKB	Region	632	763	.	.	.	Note=Domain B;status=By similarity	
P33568	UniProtKB	Region	755	920	.	.	.	Note=Interaction with LIMD1;status=By similarity	
P33568	UniProtKB	Region	763	920	.	.	.	Note=Domain C%3B mediates interaction with E4F1;status=By similarity	
P33568	UniProtKB	Motif	862	868	.	.	.	Note=Nuclear localization signal;status=By similarity	
P33568	UniProtKB	Modified residue	2	2	.	.	.	Note=N%2CN-dimethylproline;status=By similarity	
P33568	UniProtKB	Modified residue	30	30	.	.	.	Note=Phosphoserine;status=By similarity	
P33568	UniProtKB	Modified residue	242	242	.	.	.	Note=Phosphoserine%3B by CDK1;status=By similarity	
P33568	UniProtKB	Modified residue	245	245	.	.	.	Note=Phosphothreonine%3B by CDK1;status=By similarity	
P33568	UniProtKB	Modified residue	349	349	.	.	.	Note=Phosphothreonine;status=By similarity	
P33568	UniProtKB	Modified residue	366	366	.	.	.	Note=Phosphothreonine%3B by CDK1;status=By similarity	
P33568	UniProtKB	Modified residue	560	560	.	.	.	Note=Phosphoserine%3B by CDK2;status=By similarity	
P33568	UniProtKB	Modified residue	604	604	.	.	.	Note=Phosphoserine%3B by CHEK2 and CHEK1;status=By similarity	
P33568	UniProtKB	Modified residue	772	772	.	.	.	Note=Phosphoserine;status=Potential	
P33568	UniProtKB	Modified residue	780	780	.	.	.	Note=Phosphoserine;status=Potential	
P33568	UniProtKB	Modified residue	787	787	.	.	.	Note=Phosphoserine	
P33568	UniProtKB	Modified residue	799	799	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK3;status=By similarity	
P33568	UniProtKB	Modified residue	802	802	.	.	.	Note=N6-methyllysine%3B by SMYD2;status=By similarity	
P33568	UniProtKB	Modified residue	803	803	.	.	.	Note=Phosphoserine%3B by CDK1 and CDK3;status=By similarity	
P33568	UniProtKB	Modified residue	813	813	.	.	.	Note=Phosphothreonine%3B by CDK6;status=By similarity	
P33568	UniProtKB	Modified residue	815	815	.	.	.	Note=Phosphothreonine;status=By similarity	
P33568	UniProtKB	Modified residue	818	818	.	.	.	Note=Phosphothreonine%3B by CDK4;status=By similarity	
P33568	UniProtKB	Modified residue	833	833	.	.	.	Note=Phosphothreonine;status=By similarity	
P33568	UniProtKB	Modified residue	852	852	.	.	.	Note=N6-methyllysine%3B by SMYD2;status=By similarity	
P33568	UniProtKB	Modified residue	865	865	.	.	.	Note=N6-acetyllysine%3B by PCAF;status=By similarity	
P33568	UniProtKB	Modified residue	866	866	.	.	.	Note=N6-acetyllysine%3B by PCAF;status=By similarity	
P33568	UniProtKB	Mutagenesis	772	772	.	.	.	Note=Decreased association with HDAC1%3B when associated with A-780 and A-787.	
P33568	UniProtKB	Mutagenesis	780	780	.	.	.	Note=Decreased association with HDAC1%3B when associated with A-772 and A-787.	
P33568	UniProtKB	Mutagenesis	787	787	.	.	.	Note=Decreased association with HDAC1%3B when associated with A-772 and A-780.	
P33568	UniProtKB	Sequence conflict	668	668	.	.	.	.	
P33568	UniProtKB	Sequence conflict	798	798	.	.	.	.	
P33568	UniProtKB	Sequence conflict	866	867	.	.	.	.	
##sequence-region O95980 1 971
O95980	UniProtKB	Signal peptide	1	22	.	.	.	status=Potential	
O95980	UniProtKB	Chain	23	942	.	.	.	ID=PRO_0000016583;Note=Reversion-inducing cysteine-rich protein with Kazal motifs	
O95980	UniProtKB	Propeptide	943	971	.	.	.	ID=PRO_0000016584;Note=Removed in mature form;status=Potential	
O95980	UniProtKB	Repeat	37	84	.	.	.	Note=Knot 1	
O95980	UniProtKB	Repeat	104	141	.	.	.	Note=Knot 2	
O95980	UniProtKB	Repeat	151	197	.	.	.	Note=Knot 3	
O95980	UniProtKB	Repeat	216	263	.	.	.	Note=Knot 4	
O95980	UniProtKB	Repeat	292	338	.	.	.	Note=Knot 5	
O95980	UniProtKB	Domain	627	673	.	.	.	Note=Kazal-like 1	
O95980	UniProtKB	Domain	698	752	.	.	.	Note=Kazal-like 2	
O95980	UniProtKB	Domain	753	789	.	.	.	Note=Kazal-like 3	
O95980	UniProtKB	Region	37	338	.	.	.	Note=5 X Knot repeats	
O95980	UniProtKB	Lipidation	942	942	.	.	.	Note=GPI-anchor amidated serine;status=Potential	
O95980	UniProtKB	Glycosylation	39	39	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O95980	UniProtKB	Glycosylation	86	86	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O95980	UniProtKB	Glycosylation	200	200	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O95980	UniProtKB	Glycosylation	297	297	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O95980	UniProtKB	Glycosylation	352	352	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
O95980	UniProtKB	Disulfide bond	633	658	.	.	.	status=By similarity	
O95980	UniProtKB	Disulfide bond	635	654	.	.	.	status=By similarity	
O95980	UniProtKB	Disulfide bond	643	677	.	.	.	status=By similarity	
O95980	UniProtKB	Natural variant	275	275	.	.	.	ID=VAR_034021;Dbxref=dbSNP:rs16932912	
##sequence-region Q9Z0J1 1 971
Q9Z0J1	UniProtKB	Signal peptide	1	22	.	.	.	status=Potential	
Q9Z0J1	UniProtKB	Chain	23	942	.	.	.	ID=PRO_0000016585;Note=Reversion-inducing cysteine-rich protein with Kazal motifs	
Q9Z0J1	UniProtKB	Propeptide	943	971	.	.	.	ID=PRO_0000016586;Note=Removed in mature form;status=Potential	
Q9Z0J1	UniProtKB	Repeat	37	84	.	.	.	Note=Knot 1	
Q9Z0J1	UniProtKB	Repeat	104	141	.	.	.	Note=Knot 2	
Q9Z0J1	UniProtKB	Repeat	151	197	.	.	.	Note=Knot 3	
Q9Z0J1	UniProtKB	Repeat	216	263	.	.	.	Note=Knot 4	
Q9Z0J1	UniProtKB	Repeat	292	338	.	.	.	Note=Knot 5	
Q9Z0J1	UniProtKB	Domain	627	673	.	.	.	Note=Kazal-like 1	
Q9Z0J1	UniProtKB	Domain	698	752	.	.	.	Note=Kazal-like 2	
Q9Z0J1	UniProtKB	Domain	704	750	.	.	.	Note=Kazal-like 2%3B degenerate	
Q9Z0J1	UniProtKB	Domain	753	789	.	.	.	Note=Kazal-like 3	
Q9Z0J1	UniProtKB	Region	37	338	.	.	.	Note=5 X Knot repeats	
Q9Z0J1	UniProtKB	Lipidation	942	942	.	.	.	Note=GPI-anchor amidated serine;status=Potential	
Q9Z0J1	UniProtKB	Glycosylation	39	39	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9Z0J1	UniProtKB	Glycosylation	86	86	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9Z0J1	UniProtKB	Glycosylation	200	200	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9Z0J1	UniProtKB	Glycosylation	297	297	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9Z0J1	UniProtKB	Glycosylation	352	352	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q9Z0J1	UniProtKB	Disulfide bond	633	658	.	.	.	status=By similarity	
Q9Z0J1	UniProtKB	Disulfide bond	635	654	.	.	.	status=By similarity	
Q9Z0J1	UniProtKB	Disulfide bond	643	677	.	.	.	status=By similarity	
Q9Z0J1	UniProtKB	Sequence conflict	447	449	.	.	.	.	
Q9Z0J1	UniProtKB	Sequence conflict	539	539	.	.	.	.	
Q9Z0J1	UniProtKB	Sequence conflict	662	663	.	.	.	.	
Q9Z0J1	UniProtKB	Sequence conflict	757	757	.	.	.	.	
Q9Z0J1	UniProtKB	Sequence conflict	804	804	.	.	.	.	
Q9Z0J1	UniProtKB	Sequence conflict	921	921	.	.	.	.	
Q9Z0J1	UniProtKB	Sequence conflict	925	925	.	.	.	.	
Q9Z0J1	UniProtKB	Sequence conflict	960	960	.	.	.	.	
##sequence-region A7E300 1 1112
A7E300	UniProtKB	Chain	1	1112	.	.	.	ID=PRO_0000382027;Note=Rho GTPase-activating protein 7	
A7E300	UniProtKB	Domain	37	104	.	.	.	Note=SAM	
A7E300	UniProtKB	Domain	662	868	.	.	.	Note=Rho-GAP	
A7E300	UniProtKB	Domain	898	1105	.	.	.	Note=START	
A7E300	UniProtKB	Region	296	468	.	.	.	Note=Focal adhesion-targeting (FAT);status=By similarity	
A7E300	UniProtKB	Region	635	657	.	.	.	Note=Polybasic cluster (PBR);status=By similarity	
A7E300	UniProtKB	Compositional bias	319	352	.	.	.	Note=Ser-rich	
A7E300	UniProtKB	Compositional bias	452	458	.	.	.	Note=Poly-Ser	
A7E300	UniProtKB	Modified residue	112	112	.	.	.	Note=Phosphoserine;status=By similarity	
A7E300	UniProtKB	Modified residue	115	115	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region B9VTT2 1 1091
B9VTT2	UniProtKB	Chain	1	1091	.	.	.	ID=PRO_0000382028;Note=Rho GTPase-activating protein 7	
B9VTT2	UniProtKB	Domain	11	78	.	.	.	Note=SAM	
B9VTT2	UniProtKB	Domain	641	847	.	.	.	Note=Rho-GAP	
B9VTT2	UniProtKB	Domain	877	1084	.	.	.	Note=START	
B9VTT2	UniProtKB	Region	273	447	.	.	.	Note=Focal adhesion-targeting (FAT);status=By similarity	
B9VTT2	UniProtKB	Region	614	636	.	.	.	Note=Polybasic cluster (PBR);status=By similarity	
B9VTT2	UniProtKB	Compositional bias	296	329	.	.	.	Note=Ser-rich	
B9VTT2	UniProtKB	Compositional bias	431	437	.	.	.	Note=Poly-Ser	
B9VTT2	UniProtKB	Modified residue	86	86	.	.	.	Note=Phosphoserine;status=By similarity	
B9VTT2	UniProtKB	Modified residue	89	89	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q96QB1 1 1528
Q96QB1	UniProtKB	Chain	1	1528	.	.	.	ID=PRO_0000056707;Note=Rho GTPase-activating protein 7	
Q96QB1	UniProtKB	Domain	448	515	.	.	.	Note=SAM	
Q96QB1	UniProtKB	Domain	1078	1284	.	.	.	Note=Rho-GAP	
Q96QB1	UniProtKB	Domain	1314	1521	.	.	.	Note=START	
Q96QB1	UniProtKB	Region	710	884	.	.	.	Note=Focal adhesion-targeting (FAT)	
Q96QB1	UniProtKB	Region	1051	1073	.	.	.	Note=Polybasic cluster (PBR)	
Q96QB1	UniProtKB	Compositional bias	741	747	.	.	.	Note=Poly-Ser	
Q96QB1	UniProtKB	Compositional bias	868	874	.	.	.	Note=Poly-Ser	
Q96QB1	UniProtKB	Modified residue	523	523	.	.	.	Note=Phosphoserine;status=By similarity	
Q96QB1	UniProtKB	Modified residue	526	526	.	.	.	Note=Phosphoserine;status=By similarity	
Q96QB1	UniProtKB	Alternative sequence	1	437	.	.	.	ID=VSP_037871;Note=In isoform 1 and isoform 4.	
Q96QB1	UniProtKB	Alternative sequence	438	511	.	.	.	ID=VSP_044651;Note=In isoform 4.	
Q96QB1	UniProtKB	Alternative sequence	438	450	.	.	.	ID=VSP_037872;Note=In isoform 1.	
Q96QB1	UniProtKB	Alternative sequence	450	498	.	.	.	ID=VSP_037873;Note=In isoform 3.	
Q96QB1	UniProtKB	Alternative sequence	450	463	.	.	.	ID=VSP_046331;Note=In isoform 5.	
Q96QB1	UniProtKB	Alternative sequence	464	1528	.	.	.	ID=VSP_046332;Note=In isoform 5.	
Q96QB1	UniProtKB	Alternative sequence	499	1528	.	.	.	ID=VSP_037874;Note=In isoform 3.	
Q96QB1	UniProtKB	Natural variant	27	27	.	.	.	ID=VAR_059293;Dbxref=dbSNP:rs34575560	
Q96QB1	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_059294;Dbxref=dbSNP:rs3816748	
Q96QB1	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_059295;Dbxref=dbSNP:rs11203495	
Q96QB1	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_059296;Dbxref=dbSNP:rs11203494	
Q96QB1	UniProtKB	Natural variant	260	260	.	.	.	ID=VAR_059297;Dbxref=dbSNP:rs3816747	
Q96QB1	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_059298;Dbxref=dbSNP:rs34591797	
Q96QB1	UniProtKB	Natural variant	712	712	.	.	.	ID=VAR_014229;Dbxref=dbSNP:rs1044092	
Q96QB1	UniProtKB	Natural variant	791	791	.	.	.	ID=VAR_014230;Dbxref=dbSNP:rs532841	
Q96QB1	UniProtKB	Natural variant	959	959	.	.	.	ID=VAR_014231	
Q96QB1	UniProtKB	Natural variant	998	998	.	.	.	ID=VAR_014232;Dbxref=dbSNP:rs149295187	
Q96QB1	UniProtKB	Natural variant	1025	1025	.	.	.	ID=VAR_014233	
Q96QB1	UniProtKB	Natural variant	1199	1199	.	.	.	ID=VAR_014234;Dbxref=dbSNP:rs1044093	
Q96QB1	UniProtKB	Natural variant	1209	1209	.	.	.	ID=VAR_014235;Dbxref=dbSNP:rs1044094	
Q96QB1	UniProtKB	Mutagenesis	475	475	.	.	.	Note=Abolishes interaction with EF1A1.	
Q96QB1	UniProtKB	Mutagenesis	476	476	.	.	.	Note=Abolishes interaction with EF1A1.	
Q96QB1	UniProtKB	Mutagenesis	879	879	.	.	.	Note=Unable to displace endogenous DLC1 from focal adhesions.	
Q96QB1	UniProtKB	Mutagenesis	1114	1114	.	.	.	Note=No catalytic activity.	
Q96QB1	UniProtKB	Sequence conflict	43	43	.	.	.	.	
Q96QB1	UniProtKB	Sequence conflict	130	130	.	.	.	.	
Q96QB1	UniProtKB	Sequence conflict	571	571	.	.	.	.	
Q96QB1	UniProtKB	Sequence conflict	1114	1114	.	.	.	.	
Q96QB1	UniProtKB	Sequence conflict	1364	1364	.	.	.	.	
Q96QB1	UniProtKB	Beta strand	443	445	.	.	.	.	
Q96QB1	UniProtKB	Helix	446	463	.	.	.	.	
Q96QB1	UniProtKB	Helix	468	473	.	.	.	.	
Q96QB1	UniProtKB	Turn	474	476	.	.	.	.	
Q96QB1	UniProtKB	Helix	481	487	.	.	.	.	
Q96QB1	UniProtKB	Turn	488	490	.	.	.	.	
Q96QB1	UniProtKB	Helix	493	509	.	.	.	.	
Q96QB1	UniProtKB	Turn	510	514	.	.	.	.	
Q96QB1	UniProtKB	Helix	1080	1087	.	.	.	.	
Q96QB1	UniProtKB	Beta strand	1088	1091	.	.	.	.	
Q96QB1	UniProtKB	Helix	1093	1105	.	.	.	.	
Q96QB1	UniProtKB	Turn	1110	1114	.	.	.	.	
Q96QB1	UniProtKB	Helix	1119	1129	.	.	.	.	
Q96QB1	UniProtKB	Beta strand	1131	1134	.	.	.	.	
Q96QB1	UniProtKB	Helix	1143	1156	.	.	.	.	
Q96QB1	UniProtKB	Beta strand	1157	1159	.	.	.	.	
Q96QB1	UniProtKB	Helix	1166	1176	.	.	.	.	
Q96QB1	UniProtKB	Helix	1179	1181	.	.	.	.	
Q96QB1	UniProtKB	Helix	1182	1191	.	.	.	.	
Q96QB1	UniProtKB	Helix	1195	1213	.	.	.	.	
Q96QB1	UniProtKB	Helix	1215	1218	.	.	.	.	
Q96QB1	UniProtKB	Helix	1222	1234	.	.	.	.	
Q96QB1	UniProtKB	Helix	1260	1278	.	.	.	.	
##sequence-region Q9R0Z9 1 1092
Q9R0Z9	UniProtKB	Chain	1	1092	.	.	.	ID=PRO_0000056708;Note=Rho GTPase-activating protein 7	
Q9R0Z9	UniProtKB	Domain	11	78	.	.	.	Note=SAM	
Q9R0Z9	UniProtKB	Domain	642	848	.	.	.	Note=Rho-GAP	
Q9R0Z9	UniProtKB	Domain	878	1085	.	.	.	Note=START	
Q9R0Z9	UniProtKB	Region	275	448	.	.	.	Note=Focal adhesion-targeting (FAT);status=By similarity	
Q9R0Z9	UniProtKB	Region	615	637	.	.	.	Note=Polybasic cluster (PBR);status=By similarity	
Q9R0Z9	UniProtKB	Compositional bias	306	312	.	.	.	Note=Poly-Ser	
Q9R0Z9	UniProtKB	Compositional bias	432	438	.	.	.	Note=Poly-Ser	
Q9R0Z9	UniProtKB	Modified residue	86	86	.	.	.	Note=Phosphoserine	
Q9R0Z9	UniProtKB	Modified residue	89	89	.	.	.	Note=Phosphoserine	
Q9R0Z9	UniProtKB	Alternative sequence	1	13	.	.	.	ID=VSP_026144;Note=In isoform 2.	
Q9R0Z9	UniProtKB	Sequence conflict	42	42	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	42	42	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	120	120	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	120	120	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	192	192	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	421	422	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	715	717	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	730	735	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	917	917	.	.	.	.	
Q9R0Z9	UniProtKB	Sequence conflict	917	917	.	.	.	.	
##sequence-region Q63744 1 1091
Q63744	UniProtKB	Chain	1	1091	.	.	.	ID=PRO_0000056709;Note=Rho GTPase-activating protein 7	
Q63744	UniProtKB	Domain	11	78	.	.	.	Note=SAM	
Q63744	UniProtKB	Domain	641	847	.	.	.	Note=Rho-GAP	
Q63744	UniProtKB	Domain	877	1084	.	.	.	Note=START	
Q63744	UniProtKB	Region	274	447	.	.	.	Note=Focal adhesion-targeting (FAT);status=By similarity	
Q63744	UniProtKB	Region	614	636	.	.	.	Note=Polybasic cluster (PBR);status=By similarity	
Q63744	UniProtKB	Compositional bias	305	311	.	.	.	Note=Poly-Ser	
Q63744	UniProtKB	Compositional bias	431	437	.	.	.	Note=Poly-Ser	
Q63744	UniProtKB	Modified residue	86	86	.	.	.	Note=Phosphoserine;status=By similarity	
Q63744	UniProtKB	Modified residue	89	89	.	.	.	Note=Phosphoserine;status=By similarity	
Q63744	UniProtKB	Mutagenesis	677	677	.	.	.	Note=Loss of activity.	
Q63744	UniProtKB	Mutagenesis	714	714	.	.	.	Note=Loss of activity.	
Q63744	UniProtKB	Mutagenesis	718	718	.	.	.	Note=Loss of activity.	
Q63744	UniProtKB	Mutagenesis	787	787	.	.	.	Note=No loss of activity.	
##sequence-region Q9P2F6 1 1191
Q9P2F6	UniProtKB	Chain	1	1191	.	.	.	ID=PRO_0000283086;Note=Rho GTPase-activating protein 20	
Q9P2F6	UniProtKB	Domain	78	180	.	.	.	Note=PH	
Q9P2F6	UniProtKB	Domain	194	295	.	.	.	Note=Ras-associating	
Q9P2F6	UniProtKB	Domain	365	551	.	.	.	Note=Rho-GAP	
Q9P2F6	UniProtKB	Compositional bias	934	973	.	.	.	Note=Ser-rich	
Q9P2F6	UniProtKB	Alternative sequence	1	36	.	.	.	ID=VSP_024296;Note=In isoform 4.	
Q9P2F6	UniProtKB	Alternative sequence	1	34	.	.	.	ID=VSP_024294;Note=In isoform 2.	
Q9P2F6	UniProtKB	Alternative sequence	1	33	.	.	.	ID=VSP_024295;Note=In isoform 3.	
Q9P2F6	UniProtKB	Natural variant	522	522	.	.	.	ID=VAR_031489;Dbxref=dbSNP:rs7936020	
Q9P2F6	UniProtKB	Natural variant	632	632	.	.	.	ID=VAR_031490;Dbxref=dbSNP:rs17853925	
Q9P2F6	UniProtKB	Helix	367	370	.	.	.	.	
Q9P2F6	UniProtKB	Helix	372	374	.	.	.	.	
Q9P2F6	UniProtKB	Helix	378	390	.	.	.	.	
Q9P2F6	UniProtKB	Helix	391	393	.	.	.	.	
Q9P2F6	UniProtKB	Turn	395	399	.	.	.	.	
Q9P2F6	UniProtKB	Helix	404	415	.	.	.	.	
Q9P2F6	UniProtKB	Helix	427	439	.	.	.	.	
Q9P2F6	UniProtKB	Turn	442	447	.	.	.	.	
Q9P2F6	UniProtKB	Helix	448	450	.	.	.	.	
Q9P2F6	UniProtKB	Helix	451	456	.	.	.	.	
Q9P2F6	UniProtKB	Helix	457	459	.	.	.	.	
Q9P2F6	UniProtKB	Beta strand	460	462	.	.	.	.	
Q9P2F6	UniProtKB	Helix	463	474	.	.	.	.	
Q9P2F6	UniProtKB	Helix	479	496	.	.	.	.	
Q9P2F6	UniProtKB	Helix	499	502	.	.	.	.	
Q9P2F6	UniProtKB	Helix	506	517	.	.	.	.	
Q9P2F6	UniProtKB	Helix	526	550	.	.	.	.	
##sequence-region P83509 1 1500
P83509	UniProtKB	Chain	1	1500	.	.	.	ID=PRO_0000056729;Note=Rho GTPase-activating protein 35	
P83509	UniProtKB	Domain	270	327	.	.	.	Note=FF 1	
P83509	UniProtKB	Domain	368	422	.	.	.	Note=FF 2	
P83509	UniProtKB	Domain	429	483	.	.	.	Note=FF 3	
P83509	UniProtKB	Domain	485	550	.	.	.	Note=FF 4	
P83509	UniProtKB	Domain	1250	1437	.	.	.	Note=Rho-GAP	
P83509	UniProtKB	Compositional bias	1441	1485	.	.	.	Note=Pro-rich	
P83509	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphotyrosine;status=By similarity	
P83509	UniProtKB	Modified residue	589	589	.	.	.	Note=Phosphoserine;status=By similarity	
P83509	UniProtKB	Modified residue	773	773	.	.	.	Note=Phosphoserine;status=By similarity	
P83509	UniProtKB	Modified residue	970	970	.	.	.	Note=Phosphoserine;status=By similarity	
P83509	UniProtKB	Modified residue	975	975	.	.	.	Note=Phosphoserine;status=By similarity	
P83509	UniProtKB	Modified residue	1073	1073	.	.	.	Note=Phosphoserine;status=By similarity	
P83509	UniProtKB	Modified residue	1088	1088	.	.	.	Note=Phosphotyrosine;status=By similarity	
P83509	UniProtKB	Modified residue	1106	1106	.	.	.	Note=Phosphotyrosine%3B by ABL2 and PTK6;status=By similarity	
P83509	UniProtKB	Modified residue	1135	1135	.	.	.	Note=Phosphoserine;status=By similarity	
P83509	UniProtKB	Modified residue	1151	1151	.	.	.	Note=Phosphoserine;status=By similarity	
P83509	UniProtKB	Modified residue	1180	1180	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q9NRY4 1 1499
Q9NRY4	UniProtKB	Chain	1	1499	.	.	.	ID=PRO_0000056730;Note=Rho GTPase-activating protein 35	
Q9NRY4	UniProtKB	Domain	270	327	.	.	.	Note=FF 1	
Q9NRY4	UniProtKB	Domain	368	422	.	.	.	Note=FF 2	
Q9NRY4	UniProtKB	Domain	429	483	.	.	.	Note=FF 3	
Q9NRY4	UniProtKB	Domain	485	550	.	.	.	Note=FF 4	
Q9NRY4	UniProtKB	Domain	1249	1436	.	.	.	Note=Rho-GAP	
Q9NRY4	UniProtKB	Compositional bias	1440	1490	.	.	.	Note=Pro-rich	
Q9NRY4	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphotyrosine	
Q9NRY4	UniProtKB	Modified residue	589	589	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Modified residue	773	773	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Modified residue	970	970	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Modified residue	975	975	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Modified residue	1072	1072	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Modified residue	1087	1087	.	.	.	Note=Phosphotyrosine	
Q9NRY4	UniProtKB	Modified residue	1105	1105	.	.	.	Note=Phosphotyrosine%3B by ABL2 and PTK6	
Q9NRY4	UniProtKB	Modified residue	1134	1134	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Modified residue	1150	1150	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Modified residue	1179	1179	.	.	.	Note=Phosphoserine	
Q9NRY4	UniProtKB	Sequence conflict	251	251	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	309	309	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	362	362	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	414	414	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	414	414	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	474	474	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	474	474	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	978	978	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	1292	1292	.	.	.	.	
Q9NRY4	UniProtKB	Sequence conflict	1452	1453	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	14	21	.	.	.	.	
Q9NRY4	UniProtKB	Turn	25	30	.	.	.	.	
Q9NRY4	UniProtKB	Helix	35	43	.	.	.	.	
Q9NRY4	UniProtKB	Turn	47	49	.	.	.	.	
Q9NRY4	UniProtKB	Helix	60	63	.	.	.	.	
Q9NRY4	UniProtKB	Turn	66	70	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	72	79	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	91	96	.	.	.	.	
Q9NRY4	UniProtKB	Turn	102	104	.	.	.	.	
Q9NRY4	UniProtKB	Helix	110	112	.	.	.	.	
Q9NRY4	UniProtKB	Helix	116	120	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	123	126	.	.	.	.	
Q9NRY4	UniProtKB	Helix	136	138	.	.	.	.	
Q9NRY4	UniProtKB	Helix	142	144	.	.	.	.	
Q9NRY4	UniProtKB	Helix	151	153	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	154	156	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	159	165	.	.	.	.	
Q9NRY4	UniProtKB	Helix	174	190	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	195	200	.	.	.	.	
Q9NRY4	UniProtKB	Helix	202	204	.	.	.	.	
Q9NRY4	UniProtKB	Helix	207	218	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	220	222	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	225	227	.	.	.	.	
Q9NRY4	UniProtKB	Turn	230	233	.	.	.	.	
Q9NRY4	UniProtKB	Helix	236	248	.	.	.	.	
Q9NRY4	UniProtKB	Turn	268	271	.	.	.	.	
Q9NRY4	UniProtKB	Helix	272	284	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	286	288	.	.	.	.	
Q9NRY4	UniProtKB	Helix	292	299	.	.	.	.	
Q9NRY4	UniProtKB	Helix	303	311	.	.	.	.	
Q9NRY4	UniProtKB	Helix	314	330	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1251	1254	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	1257	1259	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1263	1275	.	.	.	.	
Q9NRY4	UniProtKB	Turn	1280	1284	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1289	1301	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1308	1310	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1314	1327	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	1328	1330	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1335	1344	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1350	1362	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1366	1383	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1386	1389	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1393	1405	.	.	.	.	
Q9NRY4	UniProtKB	Beta strand	1409	1412	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1414	1430	.	.	.	.	
Q9NRY4	UniProtKB	Helix	1432	1436	.	.	.	.	
##sequence-region Q91YM2 1 1499
Q91YM2	UniProtKB	Chain	1	1499	.	.	.	ID=PRO_0000056731;Note=Rho GTPase-activating protein 35	
Q91YM2	UniProtKB	Domain	270	327	.	.	.	Note=FF 1	
Q91YM2	UniProtKB	Domain	368	422	.	.	.	Note=FF 2	
Q91YM2	UniProtKB	Domain	429	483	.	.	.	Note=FF 3	
Q91YM2	UniProtKB	Domain	485	550	.	.	.	Note=FF 4	
Q91YM2	UniProtKB	Domain	1249	1436	.	.	.	Note=Rho-GAP	
Q91YM2	UniProtKB	Compositional bias	1440	1487	.	.	.	Note=Pro-rich	
Q91YM2	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	589	589	.	.	.	Note=Phosphoserine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	773	773	.	.	.	Note=Phosphoserine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	970	970	.	.	.	Note=Phosphoserine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	975	975	.	.	.	Note=Phosphoserine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	1072	1072	.	.	.	Note=Phosphoserine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	1087	1087	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	1105	1105	.	.	.	Note=Phosphotyrosine%3B by ABL2 and PTK6	
Q91YM2	UniProtKB	Modified residue	1134	1134	.	.	.	Note=Phosphoserine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	1150	1150	.	.	.	Note=Phosphoserine;status=By similarity	
Q91YM2	UniProtKB	Modified residue	1179	1179	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region P81128 1 1513
P81128	UniProtKB	Chain	1	1513	.	.	.	ID=PRO_0000056732;Note=Rho GTPase-activating protein 35	
P81128	UniProtKB	Domain	270	327	.	.	.	Note=FF 1	
P81128	UniProtKB	Domain	368	422	.	.	.	Note=FF 2	
P81128	UniProtKB	Domain	429	483	.	.	.	Note=FF 3	
P81128	UniProtKB	Domain	485	550	.	.	.	Note=FF 4	
P81128	UniProtKB	Domain	1249	1436	.	.	.	Note=Rho-GAP	
P81128	UniProtKB	Modified residue	308	308	.	.	.	Note=Phosphotyrosine;status=By similarity	
P81128	UniProtKB	Modified residue	589	589	.	.	.	Note=Phosphoserine;status=By similarity	
P81128	UniProtKB	Modified residue	773	773	.	.	.	Note=Phosphoserine;status=By similarity	
P81128	UniProtKB	Modified residue	970	970	.	.	.	Note=Phosphoserine;status=By similarity	
P81128	UniProtKB	Modified residue	975	975	.	.	.	Note=Phosphoserine;status=By similarity	
P81128	UniProtKB	Modified residue	1072	1072	.	.	.	Note=Phosphoserine;status=By similarity	
P81128	UniProtKB	Modified residue	1087	1087	.	.	.	Note=Phosphotyrosine;status=By similarity	
P81128	UniProtKB	Modified residue	1105	1105	.	.	.	Note=Phosphotyrosine%3B by ABL2 and PTK6;status=By similarity	
P81128	UniProtKB	Modified residue	1134	1134	.	.	.	Note=Phosphoserine;status=By similarity	
P81128	UniProtKB	Modified residue	1150	1150	.	.	.	Note=Phosphoserine;status=By similarity	
P81128	UniProtKB	Modified residue	1179	1179	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q3ZBW5 1 196
Q3ZBW5	UniProtKB	Chain	1	193	.	.	.	ID=PRO_0000284908;Note=Rho-related GTP-binding protein RhoB	
Q3ZBW5	UniProtKB	Propeptide	194	196	.	.	.	ID=PRO_0000284909;Note=Removed in mature form;status=By similarity	
Q3ZBW5	UniProtKB	Nucleotide binding	12	19	.	.	.	Note=GTP;status=By similarity	
Q3ZBW5	UniProtKB	Nucleotide binding	59	63	.	.	.	Note=GTP;status=By similarity	
Q3ZBW5	UniProtKB	Nucleotide binding	117	120	.	.	.	Note=GTP;status=By similarity	
Q3ZBW5	UniProtKB	Motif	34	42	.	.	.	Note=Effector region;status=Potential	
Q3ZBW5	UniProtKB	Modified residue	154	154	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q3ZBW5	UniProtKB	Modified residue	193	193	.	.	.	Note=Cysteine methyl ester;status=By similarity	
Q3ZBW5	UniProtKB	Lipidation	189	189	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
Q3ZBW5	UniProtKB	Lipidation	192	192	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
Q3ZBW5	UniProtKB	Lipidation	193	193	.	.	.	Note=S-farnesyl cysteine%3B in plasma membrane form;status=By similarity	
Q3ZBW5	UniProtKB	Lipidation	193	193	.	.	.	Note=S-geranylgeranyl cysteine%3B in endosomal form;status=By similarity	
##sequence-region P62745 1 196
P62745	UniProtKB	Chain	1	193	.	.	.	ID=PRO_0000030417;Note=Rho-related GTP-binding protein RhoB	
P62745	UniProtKB	Propeptide	194	196	.	.	.	ID=PRO_0000030418;Note=Removed in mature form	
P62745	UniProtKB	Nucleotide binding	12	19	.	.	.	Note=GTP;status=By similarity	
P62745	UniProtKB	Nucleotide binding	59	63	.	.	.	Note=GTP;status=By similarity	
P62745	UniProtKB	Nucleotide binding	117	120	.	.	.	Note=GTP;status=By similarity	
P62745	UniProtKB	Motif	34	42	.	.	.	Note=Effector region;status=Potential	
P62745	UniProtKB	Modified residue	41	41	.	.	.	Note=ADP-ribosylasparagine%3B by botulinum toxin;status=By similarity	
P62745	UniProtKB	Modified residue	154	154	.	.	.	Note=Phosphotyrosine;status=By similarity	
P62745	UniProtKB	Modified residue	193	193	.	.	.	Note=Cysteine methyl ester	
P62745	UniProtKB	Lipidation	189	189	.	.	.	Note=S-palmitoyl cysteine	
P62745	UniProtKB	Lipidation	192	192	.	.	.	Note=S-palmitoyl cysteine	
P62745	UniProtKB	Lipidation	193	193	.	.	.	Note=S-farnesyl cysteine%3B in plasma membrane form	
P62745	UniProtKB	Lipidation	193	193	.	.	.	Note=S-geranylgeranyl cysteine%3B in endosomal form	
P62745	UniProtKB	Mutagenesis	14	14	.	.	.	Note=No effect on internalization of EGF receptor but decreases trafficking of receptor to the lysosome with associated accumulation in late endosomes.	
P62745	UniProtKB	Mutagenesis	39	39	.	.	.	Note=Abolishes binding to PKN1 and trafficking of EGF receptor.	
P62745	UniProtKB	Mutagenesis	189	189	.	.	.	Note=No effect on prenylation. Reduced palmitoylation. Abolishes palmitoylation%3B when associated with S-192.	
P62745	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Reduced geranylgeranylation but no effect on farnesylation. Reduced palmitoylation. Abolishes palmitoylation%3B when associated with S-189.	
P62745	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Abolishes methylation%2C palmitoylation and prenylation.	
P62745	UniProtKB	Mutagenesis	194	194	.	.	.	Note=No effect on palmitoylation or prenylation.	
P62745	UniProtKB	Beta strand	3	12	.	.	.	.	
P62745	UniProtKB	Helix	18	27	.	.	.	.	
P62745	UniProtKB	Beta strand	41	48	.	.	.	.	
P62745	UniProtKB	Beta strand	51	59	.	.	.	.	
P62745	UniProtKB	Turn	67	69	.	.	.	.	
P62745	UniProtKB	Helix	70	73	.	.	.	.	
P62745	UniProtKB	Beta strand	79	85	.	.	.	.	
P62745	UniProtKB	Helix	89	97	.	.	.	.	
P62745	UniProtKB	Helix	99	106	.	.	.	.	
P62745	UniProtKB	Beta strand	112	117	.	.	.	.	
P62745	UniProtKB	Helix	119	123	.	.	.	.	
P62745	UniProtKB	Helix	125	133	.	.	.	.	
P62745	UniProtKB	Helix	141	150	.	.	.	.	
P62745	UniProtKB	Beta strand	154	158	.	.	.	.	
P62745	UniProtKB	Turn	161	163	.	.	.	.	
P62745	UniProtKB	Helix	167	179	.	.	.	.	
##sequence-region P62746 1 196
P62746	UniProtKB	Chain	1	193	.	.	.	ID=PRO_0000030419;Note=Rho-related GTP-binding protein RhoB	
P62746	UniProtKB	Propeptide	194	196	.	.	.	ID=PRO_0000030420;Note=Removed in mature form;status=By similarity	
P62746	UniProtKB	Nucleotide binding	12	19	.	.	.	Note=GTP;status=By similarity	
P62746	UniProtKB	Nucleotide binding	59	63	.	.	.	Note=GTP;status=By similarity	
P62746	UniProtKB	Nucleotide binding	117	120	.	.	.	Note=GTP;status=By similarity	
P62746	UniProtKB	Motif	34	42	.	.	.	Note=Effector region;status=Potential	
P62746	UniProtKB	Modified residue	154	154	.	.	.	Note=Phosphotyrosine	
P62746	UniProtKB	Modified residue	193	193	.	.	.	Note=Cysteine methyl ester;status=By similarity	
P62746	UniProtKB	Lipidation	189	189	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
P62746	UniProtKB	Lipidation	192	192	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
P62746	UniProtKB	Lipidation	193	193	.	.	.	Note=S-farnesyl cysteine%3B in plasma membrane form;status=By similarity	
P62746	UniProtKB	Lipidation	193	193	.	.	.	Note=S-geranylgeranyl cysteine%3B in endosomal form;status=By similarity	
##sequence-region P62747 1 196
P62747	UniProtKB	Chain	1	193	.	.	.	ID=PRO_0000030421;Note=Rho-related GTP-binding protein RhoB	
P62747	UniProtKB	Propeptide	194	196	.	.	.	ID=PRO_0000030422;Note=Removed in mature form;status=By similarity	
P62747	UniProtKB	Nucleotide binding	12	19	.	.	.	Note=GTP;status=By similarity	
P62747	UniProtKB	Nucleotide binding	59	63	.	.	.	Note=GTP;status=By similarity	
P62747	UniProtKB	Nucleotide binding	117	120	.	.	.	Note=GTP;status=By similarity	
P62747	UniProtKB	Motif	34	42	.	.	.	Note=Effector region;status=Potential	
P62747	UniProtKB	Modified residue	154	154	.	.	.	Note=Phosphotyrosine;status=By similarity	
P62747	UniProtKB	Modified residue	193	193	.	.	.	Note=Cysteine methyl ester;status=By similarity	
P62747	UniProtKB	Lipidation	189	189	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
P62747	UniProtKB	Lipidation	192	192	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
P62747	UniProtKB	Lipidation	193	193	.	.	.	Note=S-farnesyl cysteine%3B in plasma membrane form;status=By similarity	
P62747	UniProtKB	Lipidation	193	193	.	.	.	Note=S-geranylgeranyl cysteine%3B in endosomal form;status=By similarity	
##sequence-region Q8JHJ1 1 123
Q8JHJ1	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q8JHJ1	UniProtKB	Chain	2	123	.	.	.	ID=PRO_0000130537;Note=60S ribosomal protein L35	
##sequence-region Q92737 1 203
Q92737	UniProtKB	Chain	1	200	.	.	.	ID=PRO_0000082706;Note=Ras-like protein family member 10A	
Q92737	UniProtKB	Propeptide	201	203	.	.	.	ID=PRO_0000281360;Note=Removed in mature form;status=By similarity	
Q92737	UniProtKB	Nucleotide binding	11	18	.	.	.	Note=GTP;status=By similarity	
Q92737	UniProtKB	Nucleotide binding	59	62	.	.	.	Note=GTP;status=By similarity	
Q92737	UniProtKB	Nucleotide binding	129	132	.	.	.	Note=GTP;status=By similarity	
Q92737	UniProtKB	Region	1	203	.	.	.	Note=Small GTPase-like	
Q92737	UniProtKB	Motif	33	42	.	.	.	Note=Effector region;status=Probable	
Q92737	UniProtKB	Modified residue	200	200	.	.	.	Note=Cysteine methyl ester;status=By similarity	
Q92737	UniProtKB	Lipidation	200	200	.	.	.	Note=S-farnesyl cysteine	
Q92737	UniProtKB	Alternative sequence	116	203	.	.	.	ID=VSP_013372;Note=In isoform 2.	
Q92737	UniProtKB	Sequence conflict	25	25	.	.	.	.	
##sequence-region Q8K5A4 1 203
Q8K5A4	UniProtKB	Chain	1	200	.	.	.	ID=PRO_0000082707;Note=Ras-like protein family member 10A	
Q8K5A4	UniProtKB	Propeptide	201	203	.	.	.	ID=PRO_0000281361;Note=Removed in mature form;status=By similarity	
Q8K5A4	UniProtKB	Nucleotide binding	11	18	.	.	.	Note=GTP;status=By similarity	
Q8K5A4	UniProtKB	Nucleotide binding	59	62	.	.	.	Note=GTP;status=By similarity	
Q8K5A4	UniProtKB	Nucleotide binding	129	132	.	.	.	Note=GTP;status=By similarity	
Q8K5A4	UniProtKB	Region	1	203	.	.	.	Note=Small GTPase-like	
Q8K5A4	UniProtKB	Motif	33	42	.	.	.	Note=Effector region	
Q8K5A4	UniProtKB	Modified residue	200	200	.	.	.	Note=Cysteine methyl ester;status=By similarity	
Q8K5A4	UniProtKB	Lipidation	200	200	.	.	.	Note=S-farnesyl cysteine;status=By similarity	
##sequence-region O94885 1 1247
O94885	UniProtKB	Chain	1	1247	.	.	.	ID=PRO_0000097597;Note=SAM and SH3 domain-containing protein 1	
O94885	UniProtKB	Domain	557	614	.	.	.	Note=SH3	
O94885	UniProtKB	Domain	633	697	.	.	.	Note=SAM 1	
O94885	UniProtKB	Domain	1177	1241	.	.	.	Note=SAM 2	
O94885	UniProtKB	Compositional bias	9	33	.	.	.	Note=Pro-rich	
O94885	UniProtKB	Compositional bias	978	1059	.	.	.	Note=Pro-rich	
O94885	UniProtKB	Modified residue	90	90	.	.	.	Note=Phosphoserine	
O94885	UniProtKB	Modified residue	407	407	.	.	.	Note=Phosphoserine;status=By similarity	
O94885	UniProtKB	Modified residue	839	839	.	.	.	Note=Phosphoserine;status=By similarity	
O94885	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_031714;Dbxref=dbSNP:rs35078400	
O94885	UniProtKB	Natural variant	884	884	.	.	.	ID=VAR_031715;Dbxref=dbSNP:rs208696	
O94885	UniProtKB	Sequence conflict	751	751	.	.	.	.	
O94885	UniProtKB	Sequence conflict	1157	1157	.	.	.	.	
O94885	UniProtKB	Beta strand	556	561	.	.	.	.	
O94885	UniProtKB	Beta strand	582	587	.	.	.	.	
O94885	UniProtKB	Beta strand	590	592	.	.	.	.	
O94885	UniProtKB	Beta strand	594	597	.	.	.	.	
O94885	UniProtKB	Beta strand	602	605	.	.	.	.	
O94885	UniProtKB	Beta strand	610	612	.	.	.	.	
##sequence-region P59808 1 1230
P59808	UniProtKB	Chain	1	1230	.	.	.	ID=PRO_0000097598;Note=SAM and SH3 domain-containing protein 1	
P59808	UniProtKB	Domain	550	607	.	.	.	Note=SH3	
P59808	UniProtKB	Domain	626	690	.	.	.	Note=SAM 1	
P59808	UniProtKB	Domain	1160	1224	.	.	.	Note=SAM 2	
P59808	UniProtKB	Compositional bias	972	1042	.	.	.	Note=Pro-rich	
P59808	UniProtKB	Modified residue	83	83	.	.	.	Note=Phosphoserine	
P59808	UniProtKB	Modified residue	400	400	.	.	.	Note=Phosphoserine	
P59808	UniProtKB	Modified residue	831	831	.	.	.	Note=Phosphoserine	
##sequence-region Q8N695 1 610
Q8N695	UniProtKB	Chain	1	610	.	.	.	ID=PRO_0000334499;Note=Sodium-coupled monocarboxylate transporter 1	
Q8N695	UniProtKB	Topological domain	1	9	.	.	.	Note=Extracellular;status=Potential	
Q8N695	UniProtKB	Transmembrane	10	30	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	31	51	.	.	.	Note=Cytoplasmic;status=Potential	
Q8N695	UniProtKB	Transmembrane	52	72	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	73	83	.	.	.	Note=Extracellular;status=Potential	
Q8N695	UniProtKB	Transmembrane	84	104	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	105	132	.	.	.	Note=Cytoplasmic;status=Potential	
Q8N695	UniProtKB	Transmembrane	133	153	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	154	161	.	.	.	Note=Extracellular;status=Potential	
Q8N695	UniProtKB	Transmembrane	162	182	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	183	189	.	.	.	Note=Cytoplasmic;status=Potential	
Q8N695	UniProtKB	Transmembrane	190	210	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	211	239	.	.	.	Note=Extracellular;status=Potential	
Q8N695	UniProtKB	Transmembrane	240	260	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	261	279	.	.	.	Note=Cytoplasmic;status=Potential	
Q8N695	UniProtKB	Transmembrane	280	300	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	301	336	.	.	.	Note=Extracellular;status=Potential	
Q8N695	UniProtKB	Transmembrane	337	359	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	360	389	.	.	.	Note=Cytoplasmic;status=Potential	
Q8N695	UniProtKB	Transmembrane	390	410	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	411	415	.	.	.	Note=Extracellular;status=Potential	
Q8N695	UniProtKB	Transmembrane	416	436	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	437	439	.	.	.	Note=Cytoplasmic;status=Potential	
Q8N695	UniProtKB	Transmembrane	440	460	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	461	518	.	.	.	Note=Extracellular;status=Potential	
Q8N695	UniProtKB	Transmembrane	519	539	.	.	.	Note=Helical%3B;status=Potential	
Q8N695	UniProtKB	Topological domain	540	610	.	.	.	Note=Cytoplasmic;status=Potential	
Q8N695	UniProtKB	Compositional bias	569	572	.	.	.	Note=Poly-Lys	
Q8N695	UniProtKB	Glycosylation	485	485	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8N695	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_057336;Dbxref=dbSNP:rs1709189	
Q8N695	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_057337;Dbxref=dbSNP:rs11834933	
Q8N695	UniProtKB	Sequence conflict	490	490	.	.	.	.	
Q8N695	UniProtKB	Sequence conflict	490	490	.	.	.	.	
Q8N695	UniProtKB	Sequence conflict	490	490	.	.	.	.	
##sequence-region Q8BYF6 1 611
Q8BYF6	UniProtKB	Chain	1	611	.	.	.	ID=PRO_0000334500;Note=Sodium-coupled monocarboxylate transporter 1	
Q8BYF6	UniProtKB	Topological domain	1	9	.	.	.	Note=Extracellular;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	10	30	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	31	51	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	52	72	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	73	86	.	.	.	Note=Extracellular;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	87	107	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	108	132	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	133	153	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	154	161	.	.	.	Note=Extracellular;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	162	182	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	183	184	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	185	205	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	206	239	.	.	.	Note=Extracellular;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	240	260	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	261	279	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	280	300	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	301	336	.	.	.	Note=Extracellular;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	337	359	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	360	389	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	390	410	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	411	415	.	.	.	Note=Extracellular;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	416	436	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	437	439	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	440	460	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	461	518	.	.	.	Note=Extracellular;status=Potential	
Q8BYF6	UniProtKB	Transmembrane	519	539	.	.	.	Note=Helical%3B;status=Potential	
Q8BYF6	UniProtKB	Topological domain	540	611	.	.	.	Note=Cytoplasmic;status=Potential	
Q8BYF6	UniProtKB	Glycosylation	485	485	.	.	.	Note=N-linked (GlcNAc...);status=Potential	
Q8BYF6	UniProtKB	Sequence conflict	587	587	.	.	.	.	
##sequence-region P57059 1 783
P57059	UniProtKB	Chain	1	783	.	.	.	ID=PRO_0000086659;Note=Serine/threonine-protein kinase SIK1	
P57059	UniProtKB	Domain	27	278	.	.	.	Note=Protein kinase	
P57059	UniProtKB	Domain	303	343	.	.	.	Note=UBA	
P57059	UniProtKB	Nucleotide binding	33	41	.	.	.	Note=ATP;status=By similarity	
P57059	UniProtKB	Region	584	610	.	.	.	Note=RK-rich region;status=By similarity	
P57059	UniProtKB	Active site	149	149	.	.	.	Note=Proton acceptor;status=By similarity	
P57059	UniProtKB	Binding site	56	56	.	.	.	Note=ATP;status=Probable	
P57059	UniProtKB	Modified residue	182	182	.	.	.	Note=Phosphothreonine%3B by LKB1 and GSK3-beta	
P57059	UniProtKB	Modified residue	186	186	.	.	.	Note=Phosphoserine%3B by autocatalysis	
P57059	UniProtKB	Modified residue	322	322	.	.	.	Note=Phosphothreonine%3B by CaMK1;status=By similarity	
P57059	UniProtKB	Modified residue	575	575	.	.	.	Note=Phosphoserine%3B by PKA;status=Probable	
P57059	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_041087;Dbxref=dbSNP:rs3746951	
P57059	UniProtKB	Natural variant	142	142	.	.	.	ID=VAR_041088;Dbxref=dbSNP:rs45491503	
P57059	UniProtKB	Natural variant	211	211	.	.	.	ID=VAR_041089;Note=In a glioblastoma multiforme sample%3B somatic mutation.	
P57059	UniProtKB	Natural variant	430	430	.	.	.	ID=VAR_033910;Dbxref=dbSNP:rs34164089	
P57059	UniProtKB	Natural variant	469	469	.	.	.	ID=VAR_041090;Note=In a metastatic melanoma sample%3B somatic mutation.	
P57059	UniProtKB	Natural variant	615	615	.	.	.	ID=VAR_021255;Dbxref=dbSNP:rs430554	
P57059	UniProtKB	Natural variant	696	696	.	.	.	ID=VAR_041091;Dbxref=dbSNP:rs56386767	
P57059	UniProtKB	Natural variant	725	725	.	.	.	ID=VAR_041092;Dbxref=dbSNP:rs35596465	
P57059	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Loss of kinase activity.	
P57059	UniProtKB	Mutagenesis	135	135	.	.	.	Note=Decreased kinase activity without affecting much autophosphorylation status.	
P57059	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Prevents phosphorylation and activation by STK11/LKB1 complex.	
P57059	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Impaired autophosphorylation and kinase activity.	
P57059	UniProtKB	Mutagenesis	186	186	.	.	.	Note=Does not autophosphorylation and kinase activity.	
P57059	UniProtKB	Mutagenesis	209	209	.	.	.	Note=Decreased kinase activity without affecting much autophosphorylation status.	
P57059	UniProtKB	Mutagenesis	248	248	.	.	.	Note=Decreased kinase activity without affecting much autophosphorylation status.	
P57059	UniProtKB	Sequence conflict	166	166	.	.	.	.	
P57059	UniProtKB	Sequence conflict	489	490	.	.	.	.	
##sequence-region Q60670 1 779
Q60670	UniProtKB	Chain	1	779	.	.	.	ID=PRO_0000086660;Note=Serine/threonine-protein kinase SIK1	
Q60670	UniProtKB	Domain	27	278	.	.	.	Note=Protein kinase	
Q60670	UniProtKB	Domain	303	343	.	.	.	Note=UBA	
Q60670	UniProtKB	Nucleotide binding	33	41	.	.	.	Note=ATP;status=By similarity	
Q60670	UniProtKB	Region	586	612	.	.	.	Note=RK-rich region	
Q60670	UniProtKB	Active site	149	149	.	.	.	Note=Proton acceptor;status=By similarity	
Q60670	UniProtKB	Binding site	56	56	.	.	.	Note=ATP	
Q60670	UniProtKB	Modified residue	182	182	.	.	.	Note=Phosphothreonine%3B by LKB1 and GSK3-beta	
Q60670	UniProtKB	Modified residue	186	186	.	.	.	Note=Phosphoserine%3B by autocatalysis;status=By similarity	
Q60670	UniProtKB	Modified residue	322	322	.	.	.	Note=Phosphothreonine%3B by CaMK1;status=By similarity	
Q60670	UniProtKB	Modified residue	577	577	.	.	.	Note=Phosphoserine%3B by PKA	
Q60670	UniProtKB	Mutagenesis	56	56	.	.	.	Note=Loss of kinase activity.	
Q60670	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Loss of kinase activity.	
Q60670	UniProtKB	Mutagenesis	182	182	.	.	.	Note=Low levels of constitutive activity.	
Q60670	UniProtKB	Mutagenesis	268	268	.	.	.	Note=Does not affect phosphorylation by PKA and nuclear export following ACTH treatment.	
Q60670	UniProtKB	Mutagenesis	475	475	.	.	.	Note=Does not affect phosphorylation by PKA and nuclear export following ACTH treatment.	
Q60670	UniProtKB	Mutagenesis	577	577	.	.	.	Note=Abolishes phosphorylation by PKA and impairs nuclear export following ACTH treatment.	
Q60670	UniProtKB	Mutagenesis	577	577	.	.	.	Note=Constitutively active.	
Q60670	UniProtKB	Mutagenesis	593	594	.	.	.	Note=Localizes mainly in cytoplasm and not in nucleus.	
Q60670	UniProtKB	Mutagenesis	597	599	.	.	.	Note=Localizes mainly in cytoplasm and not in nucleus.	
Q60670	UniProtKB	Mutagenesis	606	608	.	.	.	Note=Localizes mainly in cytoplasm and not in nucleus.	
Q60670	UniProtKB	Mutagenesis	607	607	.	.	.	Note=Localizes mainly in cytoplasm and not in nucleus%3B when associated with D-483 and A-610.	
Q60670	UniProtKB	Mutagenesis	610	610	.	.	.	Note=Localizes mainly in cytoplasm and not in nucleus%3B when associated with D-483 and A-607.	
Q60670	UniProtKB	Sequence conflict	183	184	.	.	.	.	
##sequence-region Q9R1U5 1 776
Q9R1U5	UniProtKB	Chain	1	776	.	.	.	ID=PRO_0000086661;Note=Serine/threonine-protein kinase SIK1	
Q9R1U5	UniProtKB	Domain	27	278	.	.	.	Note=Protein kinase	
Q9R1U5	UniProtKB	Domain	303	343	.	.	.	Note=UBA	
Q9R1U5	UniProtKB	Nucleotide binding	33	41	.	.	.	Note=ATP;status=By similarity	
Q9R1U5	UniProtKB	Region	586	612	.	.	.	Note=RK-rich region;status=By similarity	
Q9R1U5	UniProtKB	Active site	149	149	.	.	.	Note=Proton acceptor;status=By similarity	
Q9R1U5	UniProtKB	Binding site	56	56	.	.	.	Note=ATP;status=By similarity	
Q9R1U5	UniProtKB	Modified residue	182	182	.	.	.	Note=Phosphothreonine%3B by LKB1 and GSK3-beta;status=By similarity	
Q9R1U5	UniProtKB	Modified residue	186	186	.	.	.	Note=Phosphoserine%3B by autocatalysis;status=By similarity	
Q9R1U5	UniProtKB	Modified residue	322	322	.	.	.	Note=Phosphothreonine%3B by CaMK1	
Q9R1U5	UniProtKB	Modified residue	577	577	.	.	.	Note=Phosphoserine%3B by PKA;status=By similarity	
Q9R1U5	UniProtKB	Mutagenesis	322	322	.	.	.	Note=Abolishes ability to regulate sodium/potassium-transporting ATPase activity following increases in intracellular sodium.	
Q9R1U5	UniProtKB	Sequence conflict	473	473	.	.	.	.	
##sequence-region Q1JQC6 1 315
Q1JQC6	UniProtKB	Transit peptide	1	29	.	.	.	Note=Mitochondrion;status=By similarity	
Q1JQC6	UniProtKB	Chain	30	315	.	.	.	ID=PRO_0000260458;Note=NAD-dependent protein deacetylase sirtuin-4	
Q1JQC6	UniProtKB	Domain	46	315	.	.	.	Note=Deacetylase sirtuin-type	
Q1JQC6	UniProtKB	Nucleotide binding	63	83	.	.	.	Note=NAD;status=By similarity	
Q1JQC6	UniProtKB	Nucleotide binding	144	147	.	.	.	Note=NAD;status=By similarity	
Q1JQC6	UniProtKB	Nucleotide binding	261	263	.	.	.	Note=NAD;status=By similarity	
Q1JQC6	UniProtKB	Nucleotide binding	287	289	.	.	.	Note=NAD;status=By similarity	
Q1JQC6	UniProtKB	Active site	162	162	.	.	.	Note=Proton acceptor;status=By similarity	
Q1JQC6	UniProtKB	Metal binding	170	170	.	.	.	Note=Zinc;status=By similarity	
Q1JQC6	UniProtKB	Metal binding	173	173	.	.	.	Note=Zinc;status=By similarity	
Q1JQC6	UniProtKB	Metal binding	221	221	.	.	.	Note=Zinc;status=By similarity	
Q1JQC6	UniProtKB	Metal binding	224	224	.	.	.	Note=Zinc;status=By similarity	
Q1JQC6	UniProtKB	Binding site	305	305	.	.	.	Note=NAD%3B via amide nitrogen;status=By similarity	
##sequence-region Q9Y6E7 1 314
Q9Y6E7	UniProtKB	Transit peptide	1	28	.	.	.	Note=Mitochondrion	
Q9Y6E7	UniProtKB	Chain	29	314	.	.	.	ID=PRO_0000110264;Note=NAD-dependent protein deacetylase sirtuin-4	
Q9Y6E7	UniProtKB	Domain	45	314	.	.	.	Note=Deacetylase sirtuin-type	
Q9Y6E7	UniProtKB	Nucleotide binding	62	82	.	.	.	Note=NAD;status=By similarity	
Q9Y6E7	UniProtKB	Nucleotide binding	143	146	.	.	.	Note=NAD;status=By similarity	
Q9Y6E7	UniProtKB	Nucleotide binding	260	262	.	.	.	Note=NAD;status=By similarity	
Q9Y6E7	UniProtKB	Nucleotide binding	286	288	.	.	.	Note=NAD;status=By similarity	
Q9Y6E7	UniProtKB	Active site	161	161	.	.	.	Note=Proton acceptor;status=By similarity	
Q9Y6E7	UniProtKB	Metal binding	169	169	.	.	.	Note=Zinc;status=By similarity	
Q9Y6E7	UniProtKB	Metal binding	172	172	.	.	.	Note=Zinc;status=By similarity	
Q9Y6E7	UniProtKB	Metal binding	220	220	.	.	.	Note=Zinc;status=By similarity	
Q9Y6E7	UniProtKB	Metal binding	223	223	.	.	.	Note=Zinc;status=By similarity	
Q9Y6E7	UniProtKB	Binding site	304	304	.	.	.	Note=NAD%3B via amide nitrogen;status=By similarity	
##sequence-region Q8R216 1 333
Q8R216	UniProtKB	Transit peptide	1	25	.	.	.	Note=Mitochondrion;status=By similarity	
Q8R216	UniProtKB	Chain	26	333	.	.	.	ID=PRO_0000110265;Note=NAD-dependent protein deacetylase sirtuin-4	
Q8R216	UniProtKB	Domain	42	317	.	.	.	Note=Deacetylase sirtuin-type	
Q8R216	UniProtKB	Nucleotide binding	59	79	.	.	.	Note=NAD;status=By similarity	
Q8R216	UniProtKB	Nucleotide binding	140	143	.	.	.	Note=NAD;status=By similarity	
Q8R216	UniProtKB	Nucleotide binding	257	259	.	.	.	Note=NAD;status=By similarity	
Q8R216	UniProtKB	Nucleotide binding	283	285	.	.	.	Note=NAD;status=By similarity	
Q8R216	UniProtKB	Active site	158	158	.	.	.	Note=Proton acceptor;status=By similarity	
Q8R216	UniProtKB	Metal binding	166	166	.	.	.	Note=Zinc;status=By similarity	
Q8R216	UniProtKB	Metal binding	169	169	.	.	.	Note=Zinc;status=By similarity	
Q8R216	UniProtKB	Metal binding	217	217	.	.	.	Note=Zinc;status=By similarity	
Q8R216	UniProtKB	Metal binding	220	220	.	.	.	Note=Zinc;status=By similarity	
Q8R216	UniProtKB	Binding site	301	301	.	.	.	Note=NAD%3B via amide nitrogen;status=By similarity	
Q8R216	UniProtKB	Sequence conflict	67	67	.	.	.	.	
##sequence-region Q5BIN2 1 385
Q5BIN2	UniProtKB	Chain	1	385	.	.	.	ID=PRO_0000205947;Note=SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	
Q5BIN2	UniProtKB	Repeat	186	245	.	.	.	Note=1	
Q5BIN2	UniProtKB	Repeat	259	319	.	.	.	Note=2	
Q5BIN2	UniProtKB	Region	106	183	.	.	.	Note=DNA-binding;status=Potential	
Q5BIN2	UniProtKB	Region	183	243	.	.	.	Note=HIV-1 integrase-binding	
Q5BIN2	UniProtKB	Region	186	319	.	.	.	Note=2 X approximate tandem repeats	
Q5BIN2	UniProtKB	Region	186	245	.	.	.	Note=MYC-binding;status=By similarity	
Q5BIN2	UniProtKB	Region	304	318	.	.	.	Note=Interaction with PPP1R15A;status=By similarity	
Q5BIN2	UniProtKB	Modified residue	129	129	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q12824 1 385
Q12824	UniProtKB	Chain	1	385	.	.	.	ID=PRO_0000205948;Note=SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	
Q12824	UniProtKB	Repeat	186	245	.	.	.	Note=1	
Q12824	UniProtKB	Repeat	259	319	.	.	.	Note=2	
Q12824	UniProtKB	Region	106	183	.	.	.	Note=DNA-binding;status=Potential	
Q12824	UniProtKB	Region	183	243	.	.	.	Note=HIV-1 integrase-binding	
Q12824	UniProtKB	Region	186	319	.	.	.	Note=2 X approximate tandem repeats	
Q12824	UniProtKB	Region	186	245	.	.	.	Note=MYC-binding	
Q12824	UniProtKB	Region	304	318	.	.	.	Note=Interaction with PPP1R15A	
Q12824	UniProtKB	Modified residue	129	129	.	.	.	Note=Phosphoserine	
Q12824	UniProtKB	Alternative sequence	69	77	.	.	.	ID=VSP_004399;Note=In isoform B.	
Q12824	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_068178;Note=In MRD15.	
Q12824	UniProtKB	Natural variant	377	377	.	.	.	ID=VAR_068179;Note=In MRD15.	
Q12824	UniProtKB	Sequence conflict	136	136	.	.	.	.	
Q12824	UniProtKB	Sequence conflict	136	136	.	.	.	.	
Q12824	UniProtKB	Sequence conflict	378	378	.	.	.	.	
Q12824	UniProtKB	Sequence conflict	382	382	.	.	.	.	
Q12824	UniProtKB	Sequence conflict	382	382	.	.	.	.	
##sequence-region Q9Z0H3 1 385
Q9Z0H3	UniProtKB	Chain	1	385	.	.	.	ID=PRO_0000205949;Note=SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1	
Q9Z0H3	UniProtKB	Repeat	186	245	.	.	.	Note=1	
Q9Z0H3	UniProtKB	Repeat	259	319	.	.	.	Note=2	
Q9Z0H3	UniProtKB	Region	106	183	.	.	.	Note=DNA-binding;status=Potential	
Q9Z0H3	UniProtKB	Region	186	319	.	.	.	Note=2 X approximate tandem repeats	
Q9Z0H3	UniProtKB	Region	186	245	.	.	.	Note=MYC-binding;status=By similarity	
Q9Z0H3	UniProtKB	Region	304	318	.	.	.	Note=Interaction with PPP1R15A;status=By similarity	
Q9Z0H3	UniProtKB	Modified residue	129	129	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z0H3	UniProtKB	Alternative sequence	69	77	.	.	.	ID=VSP_004400;Note=In isoform B.	
##sequence-region Q9HBF5 1 79
Q9HBF5	UniProtKB	Chain	1	79	.	.	.	ID=PRO_0000341245;Note=Suppressor of tumorigenicity 20 protein	
Q9HBF5	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_044034;Dbxref=dbSNP:rs7257	
##sequence-region Q9Y3M8 1 1113
Q9Y3M8	UniProtKB	Chain	1	1113	.	.	.	ID=PRO_0000220679;Note=StAR-related lipid transfer protein 13	
Q9Y3M8	UniProtKB	Domain	55	122	.	.	.	Note=SAM	
Q9Y3M8	UniProtKB	Domain	663	868	.	.	.	Note=Rho-GAP	
Q9Y3M8	UniProtKB	Domain	899	1107	.	.	.	Note=START	
Q9Y3M8	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
Q9Y3M8	UniProtKB	Modified residue	133	133	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Y3M8	UniProtKB	Alternative sequence	1	118	.	.	.	ID=VSP_017353;Note=In isoform 3.	
Q9Y3M8	UniProtKB	Alternative sequence	1	56	.	.	.	ID=VSP_017354;Note=In isoform 2 and isoform 5.	
Q9Y3M8	UniProtKB	Alternative sequence	1	56	.	.	.	ID=VSP_017355;Note=In isoform 4.	
Q9Y3M8	UniProtKB	Alternative sequence	695	695	.	.	.	ID=VSP_017356;Note=In isoform 5.	
Q9Y3M8	UniProtKB	Alternative sequence	696	1113	.	.	.	ID=VSP_017357;Note=In isoform 5.	
Q9Y3M8	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_037494;Dbxref=dbSNP:rs9568878	
Q9Y3M8	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_022098;Dbxref=dbSNP:rs3742321	
Q9Y3M8	UniProtKB	Natural variant	383	383	.	.	.	ID=VAR_037495;Dbxref=dbSNP:rs34425674	
Q9Y3M8	UniProtKB	Natural variant	798	798	.	.	.	ID=VAR_037496;Dbxref=dbSNP:rs35144435	
Q9Y3M8	UniProtKB	Mutagenesis	699	699	.	.	.	Note=Loss of RhoGAP activity.	
Q9Y3M8	UniProtKB	Mutagenesis	736	736	.	.	.	Note=Loss of RhoGAP activity.	
Q9Y3M8	UniProtKB	Mutagenesis	740	740	.	.	.	Note=Loss of RhoGAP activity.	
Q9Y3M8	UniProtKB	Sequence conflict	143	143	.	.	.	.	
Q9Y3M8	UniProtKB	Sequence conflict	397	397	.	.	.	.	
Q9Y3M8	UniProtKB	Sequence conflict	1097	1097	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	56	69	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	73	77	.	.	.	.	
Q9Y3M8	UniProtKB	Turn	78	82	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	88	92	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	100	102	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	103	117	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	913	924	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	929	931	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	934	936	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	938	942	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	952	961	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	963	972	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	974	976	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	985	991	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	994	1001	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	1004	1006	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	1010	1020	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	1023	1025	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	1027	1033	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	1043	1046	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	1049	1058	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	1064	1072	.	.	.	.	
Q9Y3M8	UniProtKB	Beta strand	1075	1077	.	.	.	.	
Q9Y3M8	UniProtKB	Turn	1079	1084	.	.	.	.	
Q9Y3M8	UniProtKB	Helix	1085	1099	.	.	.	.	
##sequence-region Q0GGW5 1 440
Q0GGW5	UniProtKB	Chain	1	440	.	.	.	ID=PRO_0000260033;Note=Serine/threonine-protein kinase STK11	
Q0GGW5	UniProtKB	Domain	49	309	.	.	.	Note=Protein kinase	
Q0GGW5	UniProtKB	Nucleotide binding	55	63	.	.	.	Note=ATP;status=By similarity	
Q0GGW5	UniProtKB	Active site	176	176	.	.	.	Note=Proton acceptor;status=By similarity	
Q0GGW5	UniProtKB	Binding site	78	78	.	.	.	Note=ATP;status=By similarity	
Q0GGW5	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphothreonine%3B by autocatalysis;status=By similarity	
Q0GGW5	UniProtKB	Modified residue	365	365	.	.	.	Note=Phosphothreonine%3B by autocatalysis;status=By similarity	
Q0GGW5	UniProtKB	Modified residue	435	435	.	.	.	Note=Phosphoserine%3B by PKA;status=By similarity	
##sequence-region Q15831 1 433
Q15831	UniProtKB	Chain	1	430	.	.	.	ID=PRO_0000086699;Note=Serine/threonine-protein kinase STK11	
Q15831	UniProtKB	Propeptide	431	433	.	.	.	ID=PRO_0000422300;Note=Removed in mature form;status=By similarity	
Q15831	UniProtKB	Domain	49	309	.	.	.	Note=Protein kinase	
Q15831	UniProtKB	Nucleotide binding	55	63	.	.	.	Note=ATP;status=By similarity	
Q15831	UniProtKB	Active site	176	176	.	.	.	Note=Proton acceptor	
Q15831	UniProtKB	Binding site	78	78	.	.	.	Note=ATP;status=Probable	
Q15831	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine;status=By similarity	
Q15831	UniProtKB	Modified residue	189	189	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
Q15831	UniProtKB	Modified residue	325	325	.	.	.	Note=Phosphoserine;status=By similarity	
Q15831	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
Q15831	UniProtKB	Modified residue	363	363	.	.	.	Note=Phosphothreonine%3B by ATM and autocatalysis	
Q15831	UniProtKB	Modified residue	428	428	.	.	.	Note=Phosphoserine%3B by PKA and RPS6KA1	
Q15831	UniProtKB	Modified residue	430	430	.	.	.	Note=Cysteine methyl ester;status=By similarity	
Q15831	UniProtKB	Lipidation	418	418	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
Q15831	UniProtKB	Lipidation	430	430	.	.	.	Note=S-farnesyl cysteine;status=By similarity	
Q15831	UniProtKB	Alternative sequence	371	433	.	.	.	ID=VSP_041746;Note=In isoform 2.	
Q15831	UniProtKB	Natural variant	14	14	.	.	.	ID=VAR_065627;Note=In cervical cancer%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_065628;Note=In PJS.	
Q15831	UniProtKB	Natural variant	49	49	.	.	.	ID=VAR_033138;Note=In melanoma%3B sporadic malignant%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_065629;Note=In cervical carcinoma%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_006202;Note=In PJS.	
Q15831	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_065630;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_041139;Note=In a metastatic melanoma sample%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_065631;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_033139;Note=In melanoma%3B sporadic malignant%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_065632;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_065633;Note=In cervical cancer%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	162	164	.	.	.	ID=VAR_007920;Note=In PJS.	
Q15831	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_033140;Note=In TGCT%3B a tumor with seminoma and teratoma components%3B associated with severely impaired but detectable kinase activity%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_065634;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_065635;Note=In colorectal cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_065636;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_065637;Note=In sporadic cancer%3B somatic mutation%3B Loss of kinase activity.	
Q15831	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_065638;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_065639;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39%3B requires 2 nucleotide substitutions.	
Q15831	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_007921;Note=In PJS.	
Q15831	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_065640;Note=In lung cancer%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_033141;Note=In melanoma%3B sporadic malignant%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_065641;Note=In colorectal cancer%3B somatic mutation%3B impaired kinase activity.	
Q15831	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_065642;Note=In sporadic cancer%3B somatic mutation%3B does not affect kinase activity.	
Q15831	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_065643;Note=In sporadic cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	208	208	.	.	.	ID=VAR_065644;Note=In colorectal cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_065645;Note=In colorectal cancer%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_065646;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_065647;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_065648;Note=In sporadic cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_065649;Note=In cervical cancer%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_065650;Note=In sporadic cancer%3B somatic mutation%3B no effect heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_033142;Note=In PJS%3B late onset suggests reduced penetrance.	
Q15831	UniProtKB	Natural variant	245	245	.	.	.	ID=VAR_065651;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	247	247	.	.	.	ID=VAR_006203;Note=In PJS.	
Q15831	UniProtKB	Natural variant	250	250	.	.	.	ID=VAR_065652;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_065653;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_065654;Note=In sporadic cancer%3B somatic mutation%3B no effect on kinase activity nor in heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_065655;Note=In ovarian carcinoma%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_065656;Note=In sporadic cancer%3B somatic mutation%3B impairs heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_007922;Note=In PJS.	
Q15831	UniProtKB	Natural variant	303	306	.	.	.	ID=VAR_033143;Note=In PJS.	
Q15831	UniProtKB	Natural variant	314	314	.	.	.	ID=VAR_065657;Note=In colorectal cancer%3B no effect heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_033144;Note=In PJS%3B pathogenicity uncertain%3B no effect heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_065658;Note=In gastric carcinoma%3B no effect heterotrimeric complex assembly with STRADA and CAB39.	
Q15831	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_065659;Note=In colorectal cancer%3B somatic mutation.	
Q15831	UniProtKB	Natural variant	367	367	.	.	.	ID=VAR_065660;Note=In colorectal cancer%3B somatic mutation.	
Q15831	UniProtKB	Mutagenesis	74	74	.	.	.	Note=Impaired formation of a heterotrimeric complex with STRADA and CAB39%3B when associated with A-204.	
Q15831	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss of kinase activity%2C leading to reduced autophosphorylation and acting as a dominant-negative mutant.	
Q15831	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Reduced phosphorylation.	
Q15831	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Loss of kinase activity.	
Q15831	UniProtKB	Mutagenesis	204	204	.	.	.	Note=No effect. Impaired formation of a heterotrimeric complex with STRADA and CAB39%3B when associated with A-74.	
Q15831	UniProtKB	Mutagenesis	428	428	.	.	.	Note=No effect on kinase activity.	
Q15831	UniProtKB	Beta strand	54	57	.	.	.	.	
Q15831	UniProtKB	Beta strand	62	68	.	.	.	.	
Q15831	UniProtKB	Turn	69	71	.	.	.	.	
Q15831	UniProtKB	Beta strand	74	80	.	.	.	.	
Q15831	UniProtKB	Helix	82	87	.	.	.	.	
Q15831	UniProtKB	Helix	91	102	.	.	.	.	
Q15831	UniProtKB	Beta strand	113	118	.	.	.	.	
Q15831	UniProtKB	Beta strand	125	130	.	.	.	.	
Q15831	UniProtKB	Beta strand	133	135	.	.	.	.	
Q15831	UniProtKB	Helix	136	142	.	.	.	.	
Q15831	UniProtKB	Helix	150	169	.	.	.	.	
Q15831	UniProtKB	Helix	179	181	.	.	.	.	
Q15831	UniProtKB	Beta strand	182	184	.	.	.	.	
Q15831	UniProtKB	Beta strand	190	192	.	.	.	.	
Q15831	UniProtKB	Helix	217	219	.	.	.	.	
Q15831	UniProtKB	Helix	222	225	.	.	.	.	
Q15831	UniProtKB	Beta strand	231	233	.	.	.	.	
Q15831	UniProtKB	Helix	234	250	.	.	.	.	
Q15831	UniProtKB	Helix	260	269	.	.	.	.	
Q15831	UniProtKB	Beta strand	276	278	.	.	.	.	
Q15831	UniProtKB	Helix	280	289	.	.	.	.	
Q15831	UniProtKB	Turn	294	296	.	.	.	.	
Q15831	UniProtKB	Helix	300	305	.	.	.	.	
Q15831	UniProtKB	Helix	307	310	.	.	.	.	
Q15831	UniProtKB	Helix	339	341	.	.	.	.	
##sequence-region Q9WTK7 1 436
Q9WTK7	UniProtKB	Chain	1	433	.	.	.	ID=PRO_0000260032;Note=Serine/threonine-protein kinase STK11	
Q9WTK7	UniProtKB	Propeptide	434	436	.	.	.	ID=PRO_0000422301;Note=Removed in mature form	
Q9WTK7	UniProtKB	Domain	49	309	.	.	.	Note=Protein kinase	
Q9WTK7	UniProtKB	Nucleotide binding	55	63	.	.	.	Note=ATP;status=By similarity	
Q9WTK7	UniProtKB	Active site	176	176	.	.	.	Note=Proton acceptor;status=By similarity	
Q9WTK7	UniProtKB	Binding site	78	78	.	.	.	Note=ATP;status=Probable	
Q9WTK7	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine	
Q9WTK7	UniProtKB	Modified residue	189	189	.	.	.	Note=Phosphothreonine%3B by autocatalysis;status=By similarity	
Q9WTK7	UniProtKB	Modified residue	325	325	.	.	.	Note=Phosphoserine	
Q9WTK7	UniProtKB	Modified residue	336	336	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
Q9WTK7	UniProtKB	Modified residue	366	366	.	.	.	Note=Phosphothreonine%3B by ATM and autocatalysis	
Q9WTK7	UniProtKB	Modified residue	431	431	.	.	.	Note=Phosphoserine%3B by PKA and RPS6KA1	
Q9WTK7	UniProtKB	Modified residue	433	433	.	.	.	Note=Cysteine methyl ester	
Q9WTK7	UniProtKB	Lipidation	422	422	.	.	.	Note=S-palmitoyl cysteine	
Q9WTK7	UniProtKB	Lipidation	433	433	.	.	.	Note=S-farnesyl cysteine	
Q9WTK7	UniProtKB	Alternative sequence	374	415	.	.	.	ID=VSP_052222;Note=In isoform 2.	
Q9WTK7	UniProtKB	Alternative sequence	416	436	.	.	.	ID=VSP_052223;Note=In isoform 2.	
Q9WTK7	UniProtKB	Mutagenesis	31	31	.	.	.	Note=No change in kinase activity%3B when associated with A-325%3B A-336 and A-366.	
Q9WTK7	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Loss of kinase activity.	
Q9WTK7	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Loss of kinase activity and descreased phosphorylation.	
Q9WTK7	UniProtKB	Mutagenesis	325	325	.	.	.	Note=No change in kinase activity%3B when associated with A-31%3B A-336 and A-366.	
Q9WTK7	UniProtKB	Mutagenesis	336	336	.	.	.	Note=Abolishes ability to suppress cell growth. Decreased phosphorylation%3B when associated with A-366. No change in kinase activity%3B when associated with A-31%3B A-325 and A-366.	
Q9WTK7	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Decreased phosphorylation%3B when associated with A-336. No change in kinase activity%3B when associated with A-31%3B A-325 and A-336.	
Q9WTK7	UniProtKB	Mutagenesis	431	431	.	.	.	Note=Does not prevent S-farnesylation. Defects in neuron polarization.	
Q9WTK7	UniProtKB	Mutagenesis	433	433	.	.	.	Note=Does not affect nuclear localization. Does not prevent phosphorylation at S-431.	
Q9WTK7	UniProtKB	Sequence conflict	95	95	.	.	.	.	
##sequence-region D4AE59 1 438
D4AE59	UniProtKB	Chain	1	435	.	.	.	ID=PRO_0000412651;Note=Serine/threonine-protein kinase STK11	
D4AE59	UniProtKB	Propeptide	436	438	.	.	.	ID=PRO_0000422302;Note=Removed in mature form;status=By similarity	
D4AE59	UniProtKB	Domain	49	311	.	.	.	Note=Protein kinase	
D4AE59	UniProtKB	Nucleotide binding	55	63	.	.	.	Note=ATP;status=By similarity	
D4AE59	UniProtKB	Active site	178	178	.	.	.	Note=Proton acceptor;status=By similarity	
D4AE59	UniProtKB	Binding site	78	78	.	.	.	Note=ATP;status=By similarity	
D4AE59	UniProtKB	Modified residue	31	31	.	.	.	Note=Phosphoserine;status=By similarity	
D4AE59	UniProtKB	Modified residue	191	191	.	.	.	Note=Phosphothreonine%3B by autocatalysis;status=By similarity	
D4AE59	UniProtKB	Modified residue	327	327	.	.	.	Note=Phosphoserine;status=By similarity	
D4AE59	UniProtKB	Modified residue	338	338	.	.	.	Note=Phosphothreonine%3B by autocatalysis;status=By similarity	
D4AE59	UniProtKB	Modified residue	368	368	.	.	.	Note=Phosphothreonine%3B by ATM and autocatalysis;status=By similarity	
D4AE59	UniProtKB	Modified residue	433	433	.	.	.	Note=Phosphoserine%3B by PKA and RPS6KA1;status=By similarity	
D4AE59	UniProtKB	Modified residue	435	435	.	.	.	Note=Cysteine methyl ester;status=By similarity	
D4AE59	UniProtKB	Lipidation	424	424	.	.	.	Note=S-palmitoyl cysteine;status=By similarity	
D4AE59	UniProtKB	Lipidation	435	435	.	.	.	Note=S-farnesyl cysteine;status=By similarity	
##sequence-region Q91604 1 432
Q91604	UniProtKB	Chain	1	432	.	.	.	ID=PRO_0000086700;Note=Serine/threonine-protein kinase stk11	
Q91604	UniProtKB	Domain	52	312	.	.	.	Note=Protein kinase	
Q91604	UniProtKB	Nucleotide binding	58	66	.	.	.	Note=ATP;status=By similarity	
Q91604	UniProtKB	Active site	179	179	.	.	.	Note=Proton acceptor;status=By similarity	
Q91604	UniProtKB	Binding site	81	81	.	.	.	Note=ATP	
Q91604	UniProtKB	Modified residue	192	192	.	.	.	Note=Phosphothreonine%3B by autocatalysis	
Q91604	UniProtKB	Modified residue	427	427	.	.	.	Note=Phosphoserine%3B by PKA;status=Potential	
Q91604	UniProtKB	Mutagenesis	81	81	.	.	.	Note=Loss of activity.	
Q91604	UniProtKB	Mutagenesis	192	192	.	.	.	Note=Loss of autophosphorylation.	
##sequence-region Q9UMX1 1 484
Q9UMX1	UniProtKB	Chain	1	484	.	.	.	ID=PRO_0000072302;Note=Suppressor of fused homolog	
Q9UMX1	UniProtKB	Modified residue	303	303	.	.	.	Note=N6-acetyllysine	
Q9UMX1	UniProtKB	Modified residue	481	481	.	.	.	Note=Phosphoserine	
Q9UMX1	UniProtKB	Alternative sequence	433	484	.	.	.	ID=VSP_013280;Note=In isoform 3.	
Q9UMX1	UniProtKB	Alternative sequence	433	433	.	.	.	ID=VSP_013278;Note=In isoform 2.	
Q9UMX1	UniProtKB	Alternative sequence	434	484	.	.	.	ID=VSP_013279;Note=In isoform 2.	
Q9UMX1	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_021566;Dbxref=dbSNP:rs28942088	
Q9UMX1	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_021567;Dbxref=dbSNP:rs34135067	
Q9UMX1	UniProtKB	Mutagenesis	106	106	.	.	.	Note=No effect on down-regulation of GLI1 activity.	
Q9UMX1	UniProtKB	Mutagenesis	111	111	.	.	.	Note=No effect on down-regulation of GLI1 activity.	
Q9UMX1	UniProtKB	Mutagenesis	128	128	.	.	.	Note=No effect on down-regulation of GLI1 activity.	
Q9UMX1	UniProtKB	Mutagenesis	152	152	.	.	.	Note=No effect on down-regulation of GLI1 activity.	
Q9UMX1	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Abolishes down-regulation of GLI1 activity. Has only slight effect on GLI1 binding.	
Q9UMX1	UniProtKB	Mutagenesis	181	181	.	.	.	Note=No effect on down-regulation of GLI1 activity.	
Q9UMX1	UniProtKB	Mutagenesis	221	221	.	.	.	Note=No effect on down-regulation of GLI1 activity.	
Q9UMX1	UniProtKB	Mutagenesis	262	262	.	.	.	Note=No effect on down-regulation of GLI1 activity.	
Q9UMX1	UniProtKB	Sequence conflict	336	336	.	.	.	.	
Q9UMX1	UniProtKB	Helix	32	44	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	52	55	.	.	.	.	
Q9UMX1	UniProtKB	Helix	60	62	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	69	76	.	.	.	.	
Q9UMX1	UniProtKB	Turn	80	83	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	87	96	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	101	105	.	.	.	.	
Q9UMX1	UniProtKB	Turn	109	111	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	112	125	.	.	.	.	
Q9UMX1	UniProtKB	Helix	136	151	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	169	171	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	176	181	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	188	190	.	.	.	.	
Q9UMX1	UniProtKB	Beta strand	193	203	.	.	.	.	
Q9UMX1	UniProtKB	Helix	205	213	.	.	.	.	
Q9UMX1	UniProtKB	Helix	216	225	.	.	.	.	
Q9UMX1	UniProtKB	Helix	227	229	.	.	.	.	
Q9UMX1	UniProtKB	Turn	231	234	.	.	.	.	
Q9UMX1	UniProtKB	Helix	244	247	.	.	.	.	
Q9UMX1	UniProtKB	Helix	251	260	.	.	.	.	
##sequence-region Q96A56 1 240
Q96A56	UniProtKB	Chain	1	240	.	.	.	ID=PRO_0000072406;Note=Tumor protein p53-inducible nuclear protein 1	
Q96A56	UniProtKB	Motif	25	37	.	.	.	Note=LIR	
Q96A56	UniProtKB	Compositional bias	14	17	.	.	.	Note=Poly-Ser	
Q96A56	UniProtKB	Compositional bias	20	61	.	.	.	Note=Glu-rich	
Q96A56	UniProtKB	Alternative sequence	159	240	.	.	.	ID=VSP_013176;Note=In isoform 2.	
Q96A56	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_051404;Dbxref=dbSNP:rs11991800	
##sequence-region Q9QXE4 1 239
Q9QXE4	UniProtKB	Chain	1	239	.	.	.	ID=PRO_0000072407;Note=Tumor protein p53-inducible nuclear protein 1	
Q9QXE4	UniProtKB	Motif	25	37	.	.	.	Note=LIR	
Q9QXE4	UniProtKB	Compositional bias	46	52	.	.	.	Note=Poly-Glu	
Q9QXE4	UniProtKB	Alternative sequence	158	239	.	.	.	ID=VSP_013177;Note=In isoform 2.	
##sequence-region Q80YE2 1 239
Q80YE2	UniProtKB	Chain	1	239	.	.	.	ID=PRO_0000072408;Note=Tumor protein p53-inducible nuclear protein 1	
Q80YE2	UniProtKB	Motif	25	37	.	.	.	Note=LIR	
Q80YE2	UniProtKB	Compositional bias	46	52	.	.	.	Note=Poly-Glu	
##sequence-region Q3YBR2 1 411
Q3YBR2	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
Q3YBR2	UniProtKB	Chain	2	411	.	.	.	ID=PRO_0000274218;Note=Transforming growth factor beta regulator 1	
Q3YBR2	UniProtKB	Domain	182	241	.	.	.	Note=FYR N-terminal	
Q3YBR2	UniProtKB	Domain	242	321	.	.	.	Note=FYR C-terminal	
Q3YBR2	UniProtKB	Compositional bias	134	161	.	.	.	Note=Lys-rich	
Q3YBR2	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine	
Q3YBR2	UniProtKB	Modified residue	10	10	.	.	.	Note=Phosphoserine	
Q3YBR2	UniProtKB	Alternative sequence	1	224	.	.	.	ID=VSP_022644;Note=In isoform 3.	
Q3YBR2	UniProtKB	Alternative sequence	1	197	.	.	.	ID=VSP_022645;Note=In isoform 2.	
Q3YBR2	UniProtKB	Sequence conflict	406	406	.	.	.	.	
Q3YBR2	UniProtKB	Beta strand	185	187	.	.	.	.	
Q3YBR2	UniProtKB	Beta strand	190	197	.	.	.	.	
Q3YBR2	UniProtKB	Helix	203	205	.	.	.	.	
Q3YBR2	UniProtKB	Beta strand	214	223	.	.	.	.	
Q3YBR2	UniProtKB	Beta strand	230	240	.	.	.	.	
Q3YBR2	UniProtKB	Beta strand	242	251	.	.	.	.	
Q3YBR2	UniProtKB	Helix	255	257	.	.	.	.	
Q3YBR2	UniProtKB	Beta strand	259	263	.	.	.	.	
Q3YBR2	UniProtKB	Helix	264	279	.	.	.	.	
Q3YBR2	UniProtKB	Helix	290	294	.	.	.	.	
Q3YBR2	UniProtKB	Helix	299	305	.	.	.	.	
Q3YBR2	UniProtKB	Helix	311	313	.	.	.	.	
##sequence-region Q3UB74 1 406
Q3UB74	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q3UB74	UniProtKB	Chain	2	406	.	.	.	ID=PRO_0000274219;Note=Transforming growth factor beta regulator 1	
Q3UB74	UniProtKB	Domain	177	236	.	.	.	Note=FYR N-terminal	
Q3UB74	UniProtKB	Domain	237	316	.	.	.	Note=FYR C-terminal	
Q3UB74	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine	
Q3UB74	UniProtKB	Modified residue	13	13	.	.	.	Note=Phosphothreonine	
Q3UB74	UniProtKB	Sequence conflict	32	32	.	.	.	.	
Q3UB74	UniProtKB	Sequence conflict	180	180	.	.	.	.	
Q3UB74	UniProtKB	Sequence conflict	188	188	.	.	.	.	
Q3UB74	UniProtKB	Sequence conflict	207	207	.	.	.	.	
Q3UB74	UniProtKB	Sequence conflict	228	228	.	.	.	.	
Q3UB74	UniProtKB	Sequence conflict	271	271	.	.	.	.	
Q3UB74	UniProtKB	Sequence conflict	304	304	.	.	.	.	
Q3UB74	UniProtKB	Sequence conflict	382	382	.	.	.	.	
##sequence-region Q5PQK8 1 406
Q5PQK8	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;status=By similarity	
Q5PQK8	UniProtKB	Chain	2	406	.	.	.	ID=PRO_0000274220;Note=Transforming growth factor beta regulator 1	
Q5PQK8	UniProtKB	Domain	177	236	.	.	.	Note=FYR N-terminal	
Q5PQK8	UniProtKB	Domain	237	316	.	.	.	Note=FYR C-terminal	
Q5PQK8	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;status=By similarity	
Q5PQK8	UniProtKB	Modified residue	13	13	.	.	.	Note=Phosphothreonine;status=By similarity	
##sequence-region Q9BT92 1 498
Q9BT92	UniProtKB	Chain	1	498	.	.	.	ID=PRO_0000292609;Note=Trichoplein keratin filament-binding protein	
Q9BT92	UniProtKB	Region	73	498	.	.	.	Note=Interaction with keratin proteins	
Q9BT92	UniProtKB	Region	259	425	.	.	.	Note=Trichohyalin/plectin homology domain	
Q9BT92	UniProtKB	Coiled coil	11	39	.	.	.	status=Potential	
Q9BT92	UniProtKB	Coiled coil	66	136	.	.	.	status=Potential	
Q9BT92	UniProtKB	Coiled coil	163	353	.	.	.	status=Potential	
Q9BT92	UniProtKB	Coiled coil	380	479	.	.	.	status=Potential	
Q9BT92	UniProtKB	Compositional bias	70	482	.	.	.	Note=Glu-rich	
Q9BT92	UniProtKB	Natural variant	44	44	.	.	.	ID=VAR_064056;Note=In a gastric carcinoma sample.	
Q9BT92	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_064057;Note=In a pancreatic carcinoma sample.	
Q9BT92	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_053924;Dbxref=dbSNP:rs10774978	
Q9BT92	UniProtKB	Natural variant	417	417	.	.	.	ID=VAR_053925;Dbxref=dbSNP:rs16940680	
Q9BT92	UniProtKB	Sequence conflict	326	326	.	.	.	.	
##sequence-region Q3TVW5 1 497
Q3TVW5	UniProtKB	Chain	1	497	.	.	.	ID=PRO_0000292610;Note=Trichoplein keratin filament-binding protein	
Q3TVW5	UniProtKB	Region	72	457	.	.	.	Note=Interaction with keratin proteins;status=By similarity	
Q3TVW5	UniProtKB	Region	258	424	.	.	.	Note=Trichohyalin/plectin homology domain;status=By similarity	
Q3TVW5	UniProtKB	Coiled coil	67	140	.	.	.	status=Potential	
Q3TVW5	UniProtKB	Coiled coil	166	271	.	.	.	status=Potential	
Q3TVW5	UniProtKB	Coiled coil	327	479	.	.	.	status=Potential	
Q3TVW5	UniProtKB	Compositional bias	69	466	.	.	.	Note=Glu-rich	
Q3TVW5	UniProtKB	Alternative sequence	441	497	.	.	.	ID=VSP_052475;Note=In isoform 2.	
Q3TVW5	UniProtKB	Sequence conflict	109	109	.	.	.	.	
Q3TVW5	UniProtKB	Sequence conflict	229	232	.	.	.	.	
##sequence-region Q5RE49 1 498
Q5RE49	UniProtKB	Chain	1	498	.	.	.	ID=PRO_0000292611;Note=Trichoplein keratin filament-binding protein	
Q5RE49	UniProtKB	Region	73	498	.	.	.	Note=Interaction with keratin proteins;status=By similarity	
Q5RE49	UniProtKB	Region	259	425	.	.	.	Note=Trichohyalin/plectin homology domain;status=By similarity	
Q5RE49	UniProtKB	Coiled coil	11	39	.	.	.	status=Potential	
Q5RE49	UniProtKB	Coiled coil	66	353	.	.	.	status=Potential	
Q5RE49	UniProtKB	Coiled coil	380	479	.	.	.	status=Potential	
Q5RE49	UniProtKB	Compositional bias	70	482	.	.	.	Note=Glu-rich	
##sequence-region Q6N021 1 2002
Q6N021	UniProtKB	Chain	1	2002	.	.	.	ID=PRO_0000324588;Note=Methylcytosine dioxygenase TET2	
Q6N021	UniProtKB	Compositional bias	398	419	.	.	.	Note=Pro-rich	
Q6N021	UniProtKB	Compositional bias	591	969	.	.	.	Note=Gln-rich	
Q6N021	UniProtKB	Compositional bias	1523	1553	.	.	.	Note=Gln-rich	
Q6N021	UniProtKB	Metal binding	1382	1382	.	.	.	Note=Iron%3B catalytic;status=Probable	
Q6N021	UniProtKB	Metal binding	1384	1384	.	.	.	Note=Iron%3B catalytic;status=Probable	
Q6N021	UniProtKB	Metal binding	1881	1881	.	.	.	Note=Iron%3B catalytic;status=By similarity	
Q6N021	UniProtKB	Binding site	1896	1896	.	.	.	Note=2-oxoglutarate;status=By similarity	
Q6N021	UniProtKB	Modified residue	99	99	.	.	.	Note=Phosphoserine	
Q6N021	UniProtKB	Modified residue	1107	1107	.	.	.	Note=Phosphoserine	
Q6N021	UniProtKB	Alternative sequence	1137	1194	.	.	.	ID=VSP_032282;Note=In isoform 3.	
Q6N021	UniProtKB	Alternative sequence	1137	1165	.	.	.	ID=VSP_032283;Note=In isoform 2.	
Q6N021	UniProtKB	Alternative sequence	1166	2002	.	.	.	ID=VSP_032284;Note=In isoform 2.	
Q6N021	UniProtKB	Alternative sequence	1195	2002	.	.	.	ID=VSP_032285;Note=In isoform 3.	
Q6N021	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_039841;Dbxref=dbSNP:rs12498609	
Q6N021	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_058171;Dbxref=dbSNP:rs111948941	
Q6N021	UniProtKB	Natural variant	123	123	.	.	.	ID=VAR_058130	
Q6N021	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_058172;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_058173;Dbxref=dbSNP:rs146031219	
Q6N021	UniProtKB	Natural variant	218	218	.	.	.	ID=VAR_039842;Dbxref=dbSNP:rs6843141	
Q6N021	UniProtKB	Natural variant	308	308	.	.	.	ID=VAR_058131;Note=In chronic myelomonocytic leukemia and acute myeloid leukemia samples.	
Q6N021	UniProtKB	Natural variant	312	312	.	.	.	ID=VAR_058174;Note=In an acute myeloid leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_058132;Dbxref=dbSNP:rs61744960	
Q6N021	UniProtKB	Natural variant	363	363	.	.	.	ID=VAR_039843;Dbxref=dbSNP:rs17253672	
Q6N021	UniProtKB	Natural variant	399	399	.	.	.	ID=VAR_058133;Note=In myelodysplastic/myeloproliferative disorders%3B a patient positive for mutation F-617 in JAK2.	
Q6N021	UniProtKB	Natural variant	429	429	.	.	.	ID=VAR_058134	
Q6N021	UniProtKB	Natural variant	460	460	.	.	.	ID=VAR_058175;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	666	666	.	.	.	ID=VAR_058176;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	817	817	.	.	.	ID=VAR_058135;Note=In myelodysplastic/myeloproliferative disorders.	
Q6N021	UniProtKB	Natural variant	867	867	.	.	.	ID=VAR_058177;Dbxref=dbSNP:rs144386291	
Q6N021	UniProtKB	Natural variant	912	912	.	.	.	ID=VAR_039844;Dbxref=dbSNP:rs4145756	
Q6N021	UniProtKB	Natural variant	924	924	.	.	.	ID=VAR_058136;Dbxref=dbSNP:rs34485921	
Q6N021	UniProtKB	Natural variant	941	941	.	.	.	ID=VAR_058178;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	949	949	.	.	.	ID=VAR_058137	
Q6N021	UniProtKB	Natural variant	1073	1073	.	.	.	ID=VAR_058179	
Q6N021	UniProtKB	Natural variant	1084	1084	.	.	.	ID=VAR_058180;Dbxref=dbSNP:rs75056899	
Q6N021	UniProtKB	Natural variant	1135	1135	.	.	.	ID=VAR_058181;Note=In a myeloproliferative disorder%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1167	1167	.	.	.	ID=VAR_058138;Note=In a myelodysplatic/myeloproliferative disorder and a chronic myelomonocytic leukemia sample.	
Q6N021	UniProtKB	Natural variant	1175	1175	.	.	.	ID=VAR_058139;Note=In a refractory anemia with ringed sideroblasts sample.	
Q6N021	UniProtKB	Natural variant	1204	1204	.	.	.	ID=VAR_058182;Note=In a myeloproliferative disorder%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1214	1214	.	.	.	ID=VAR_058183;Note=In a myelodysplastic syndrome%3B somatic mutation in a chronic myelomonocytic leukemia sample.	
Q6N021	UniProtKB	Natural variant	1237	1239	.	.	.	ID=VAR_058140;Note=In a polycythemia vera sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1242	1242	.	.	.	ID=VAR_058198;Note=Requires 2 nucleotide substitutions.	
Q6N021	UniProtKB	Natural variant	1242	1242	.	.	.	ID=VAR_058184;Note=In myeloproliferative disorders.	
Q6N021	UniProtKB	Natural variant	1245	1245	.	.	.	ID=VAR_058185;Note=In a myeloproliferative disorder%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1261	1261	.	.	.	ID=VAR_058186;Note=In a myeloproliferative disorder%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1261	1261	.	.	.	ID=VAR_058187;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1261	1261	.	.	.	ID=VAR_058141;Note=In a myelodysplastic syndrome.	
Q6N021	UniProtKB	Natural variant	1285	1285	.	.	.	ID=VAR_058142;Note=In a myelodysplastic syndrome%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1287	1287	.	.	.	ID=VAR_058143;Note=In myelodysplastic/myeloproliferative disorders.	
Q6N021	UniProtKB	Natural variant	1291	1291	.	.	.	ID=VAR_058144;Note=In a myelodysplastic syndrome%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1299	1299	.	.	.	ID=VAR_058145;Note=In a refractory anemia sample.	
Q6N021	UniProtKB	Natural variant	1299	1299	.	.	.	ID=VAR_058146;Note=In chronic myelomonocytic leukemia samples.	
Q6N021	UniProtKB	Natural variant	1302	1302	.	.	.	ID=VAR_058147;Note=In primary myelofibrosis and chronic myelomonocytic leukemia samples.	
Q6N021	UniProtKB	Natural variant	1318	1318	.	.	.	ID=VAR_058148;Note=In chronic myelomonocytic leukemia samples.	
Q6N021	UniProtKB	Natural variant	1367	1367	.	.	.	ID=VAR_058149;Note=In a chronic myelomonocytic leukemia sample.	
Q6N021	UniProtKB	Natural variant	1396	1396	.	.	.	ID=VAR_058150;Note=In a myelodysplastic syndrome.	
Q6N021	UniProtKB	Natural variant	1398	1398	.	.	.	ID=VAR_058151;Note=In a myelodysplastic syndrome%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1417	1417	.	.	.	ID=VAR_058188;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1701	1701	.	.	.	ID=VAR_058189;Dbxref=dbSNP:rs62623390	
Q6N021	UniProtKB	Natural variant	1718	1718	.	.	.	ID=VAR_058190;Dbxref=dbSNP:rs142312318;Note=In refractory anemia with ringed sideroblasts%3B somatic mutation in an acute myeloid leukemia sample.	
Q6N021	UniProtKB	Natural variant	1721	1721	.	.	.	ID=VAR_058191;Dbxref=dbSNP:rs34402524	
Q6N021	UniProtKB	Natural variant	1723	1723	.	.	.	ID=VAR_058192;Dbxref=dbSNP:rs146348065	
Q6N021	UniProtKB	Natural variant	1757	1757	.	.	.	ID=VAR_058152;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1762	1762	.	.	.	ID=VAR_058193;Dbxref=dbSNP:rs2454206	
Q6N021	UniProtKB	Natural variant	1778	1778	.	.	.	ID=VAR_058194;Dbxref=dbSNP:rs62621450	
Q6N021	UniProtKB	Natural variant	1811	1811	.	.	.	ID=VAR_058153;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1828	1828	.	.	.	ID=VAR_058154;Note=In a myeloproliferative disorder%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1869	1869	.	.	.	ID=VAR_058155;Note=In an essential thrombocythemia sample.	
Q6N021	UniProtKB	Natural variant	1872	1872	.	.	.	ID=VAR_058156;Note=In a refractory anemia with excess blasts sample.	
Q6N021	UniProtKB	Natural variant	1873	1873	.	.	.	ID=VAR_058157;Note=In myelodysplastic syndromes%2C myeloproliferative disorders and chronic myelomonocytic leukemia%3B somatic mutation in acute myeloid leukemia and chronic myelomonocytic leukemia samples.	
Q6N021	UniProtKB	Natural variant	1875	1875	.	.	.	ID=VAR_058195;Note=In a myelodysplastic syndrome%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1881	1881	.	.	.	ID=VAR_058196;Note=In a myelodysplastic syndrome%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1881	1881	.	.	.	ID=VAR_058158;Note=In a myeloproliferative disorder%3B somatic mutation%3B also in a patient with systemic mastocytosis associated with chronic myelomonocytic leukemia.	
Q6N021	UniProtKB	Natural variant	1896	1896	.	.	.	ID=VAR_058159;Note=In a primary acute myeloid leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1896	1896	.	.	.	ID=VAR_058197;Note=In a myeloproliferative disorder%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1898	1898	.	.	.	ID=VAR_058160;Note=In a secondary acute myeloid leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1900	1900	.	.	.	ID=VAR_058161	
Q6N021	UniProtKB	Natural variant	1911	1916	.	.	.	ID=VAR_058162;Note=In a myelodysplastic syndrome%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1913	1913	.	.	.	ID=VAR_058163;Note=In myelodysplastic syndromes%3B refractory cytopenia with multilineage dysplasia and ringed sideroblasts%3B somatic mutation in a patient.	
Q6N021	UniProtKB	Natural variant	1919	1919	.	.	.	ID=VAR_058164;Note=In a myeloproliferative disorder%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1926	1926	.	.	.	ID=VAR_058165;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1941	1941	.	.	.	ID=VAR_058166;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1962	1962	.	.	.	ID=VAR_058167;Note=In a myelodysplastic syndrome.	
Q6N021	UniProtKB	Natural variant	1966	1966	.	.	.	ID=VAR_058168;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	1974	1974	.	.	.	ID=VAR_058169;Note=In a chronic myelomonocytic leukemia sample%3B somatic mutation.	
Q6N021	UniProtKB	Natural variant	2000	2000	.	.	.	ID=VAR_058170	
Q6N021	UniProtKB	Mutagenesis	1382	1382	.	.	.	Note=Loss of enzyme activity. Still able to enhance histone H2B GlcNAcylation by OGT%3B when associated with A-1384.	
Q6N021	UniProtKB	Mutagenesis	1384	1384	.	.	.	Note=Loss of enzyme activity. Still able to enhance histone H2B GlcNAcylation by OGT%3B when associated with Y-1382.	
Q6N021	UniProtKB	Sequence conflict	599	599	.	.	.	.	
Q6N021	UniProtKB	Sequence conflict	702	702	.	.	.	.	
Q6N021	UniProtKB	Sequence conflict	878	878	.	.	.	.	
##sequence-region O15164 1 1050
O15164	UniProtKB	Chain	1	1050	.	.	.	ID=PRO_0000056390;Note=Transcription intermediary factor 1-alpha	
O15164	UniProtKB	Domain	932	987	.	.	.	Note=Bromo	
O15164	UniProtKB	Zinc finger	56	82	.	.	.	Note=RING-type	
O15164	UniProtKB	Zinc finger	158	211	.	.	.	Note=B box-type 1	
O15164	UniProtKB	Zinc finger	218	259	.	.	.	Note=B box-type 2	
O15164	UniProtKB	Zinc finger	826	873	.	.	.	Note=PHD-type	
O15164	UniProtKB	Region	754	779	.	.	.	Note=Nuclear receptor binding site (NRBS)	
O15164	UniProtKB	Region	834	840	.	.	.	Note=Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)	
O15164	UniProtKB	Region	979	980	.	.	.	Note=Interaction with histone H3 that is acetylated at 'Lys-23' (H3K23ac)	
O15164	UniProtKB	Coiled coil	289	359	.	.	.	status=Potential	
O15164	UniProtKB	Motif	891	907	.	.	.	Note=Nuclear localization signal;status=Potential	
O15164	UniProtKB	Compositional bias	9	15	.	.	.	Note=Poly-Ala	
O15164	UniProtKB	Compositional bias	344	347	.	.	.	Note=Poly-Gln	
O15164	UniProtKB	Site	476	477	.	.	.	Note=Breakpoint for translocation to form TRIM24-RET oncogene	
O15164	UniProtKB	Site	827	827	.	.	.	Note=Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0)	
O15164	UniProtKB	Modified residue	101	101	.	.	.	Note=Phosphothreonine	
O15164	UniProtKB	Modified residue	110	110	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	667	667	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	744	744	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	768	768	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	808	808	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	811	811	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	818	818	.	.	.	Note=Phosphothreonine	
O15164	UniProtKB	Modified residue	1019	1019	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	1025	1025	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	1028	1028	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Modified residue	1042	1042	.	.	.	Note=Phosphoserine	
O15164	UniProtKB	Cross-link	723	723	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
O15164	UniProtKB	Cross-link	741	741	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
O15164	UniProtKB	Alternative sequence	477	510	.	.	.	ID=VSP_005772;Note=In isoform Short.	
O15164	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_042382;Note=In an ovarian serous carcinoma sample%3B somatic mutation.	
O15164	UniProtKB	Natural variant	403	403	.	.	.	ID=VAR_042383;Note=In a lung squamous cell carcinoma sample%3B somatic mutation.	
O15164	UniProtKB	Natural variant	762	762	.	.	.	ID=VAR_042384	
O15164	UniProtKB	Natural variant	796	796	.	.	.	ID=VAR_052148;Dbxref=dbSNP:rs35356723	
O15164	UniProtKB	Natural variant	1009	1009	.	.	.	ID=VAR_042385;Dbxref=dbSNP:rs34585297	
O15164	UniProtKB	Mutagenesis	827	827	.	.	.	Note=Strongly reduced affinity for histone H3 that is not methylated at 'Lys-4' (H3K4me0).	
O15164	UniProtKB	Mutagenesis	840	840	.	.	.	Note=Abolishes interaction with histone H3.	
O15164	UniProtKB	Mutagenesis	979	980	.	.	.	Note=Strongly reduced affinity for histone H3 that is acetylated at 'Lys-23' (H3K23ac).	
O15164	UniProtKB	Sequence conflict	14	20	.	.	.	.	
O15164	UniProtKB	Sequence conflict	24	28	.	.	.	.	
O15164	UniProtKB	Sequence conflict	109	114	.	.	.	.	
O15164	UniProtKB	Sequence conflict	350	350	.	.	.	.	
O15164	UniProtKB	Sequence conflict	600	600	.	.	.	.	
O15164	UniProtKB	Sequence conflict	608	608	.	.	.	.	
O15164	UniProtKB	Sequence conflict	967	967	.	.	.	.	
O15164	UniProtKB	Beta strand	827	829	.	.	.	.	
O15164	UniProtKB	Turn	830	832	.	.	.	.	
O15164	UniProtKB	Beta strand	836	840	.	.	.	.	
O15164	UniProtKB	Beta strand	842	845	.	.	.	.	
O15164	UniProtKB	Turn	850	852	.	.	.	.	
O15164	UniProtKB	Beta strand	853	855	.	.	.	.	
O15164	UniProtKB	Turn	868	870	.	.	.	.	
O15164	UniProtKB	Beta strand	873	875	.	.	.	.	
O15164	UniProtKB	Helix	881	883	.	.	.	.	
O15164	UniProtKB	Turn	889	891	.	.	.	.	
O15164	UniProtKB	Helix	902	917	.	.	.	.	
O15164	UniProtKB	Helix	919	921	.	.	.	.	
O15164	UniProtKB	Helix	922	925	.	.	.	.	
O15164	UniProtKB	Helix	935	938	.	.	.	.	
O15164	UniProtKB	Helix	945	953	.	.	.	.	
O15164	UniProtKB	Beta strand	954	956	.	.	.	.	
O15164	UniProtKB	Helix	962	979	.	.	.	.	
O15164	UniProtKB	Helix	985	1004	.	.	.	.	
O15164	UniProtKB	Beta strand	1005	1007	.	.	.	.	
##sequence-region Q64127 1 1051
Q64127	UniProtKB	Chain	1	1051	.	.	.	ID=PRO_0000056391;Note=Transcription intermediary factor 1-alpha	
Q64127	UniProtKB	Domain	933	988	.	.	.	Note=Bromo	
Q64127	UniProtKB	Zinc finger	52	77	.	.	.	Note=RING-type	
Q64127	UniProtKB	Zinc finger	158	211	.	.	.	Note=B box-type 1	
Q64127	UniProtKB	Zinc finger	218	259	.	.	.	Note=B box-type 2	
Q64127	UniProtKB	Zinc finger	827	874	.	.	.	Note=PHD-type	
Q64127	UniProtKB	Region	755	780	.	.	.	Note=Nuclear receptor binding site (NRBS)	
Q64127	UniProtKB	Region	835	841	.	.	.	Note=Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0);status=By similarity	
Q64127	UniProtKB	Coiled coil	289	359	.	.	.	status=Potential	
Q64127	UniProtKB	Motif	892	908	.	.	.	Note=Nuclear localization signal;status=Potential	
Q64127	UniProtKB	Compositional bias	8	15	.	.	.	Note=Poly-Ala	
Q64127	UniProtKB	Compositional bias	19	22	.	.	.	Note=Poly-Ala	
Q64127	UniProtKB	Compositional bias	344	347	.	.	.	Note=Poly-Gln	
Q64127	UniProtKB	Compositional bias	583	587	.	.	.	Note=Poly-Ser	
Q64127	UniProtKB	Site	332	333	.	.	.	Note=Breakpoint for translocation to form TRIM24-BRAF oncogene	
Q64127	UniProtKB	Site	828	828	.	.	.	Note=Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0);status=By similarity	
Q64127	UniProtKB	Modified residue	97	97	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64127	UniProtKB	Modified residue	110	110	.	.	.	Note=Phosphoserine;status=By similarity	
Q64127	UniProtKB	Modified residue	668	668	.	.	.	Note=Phosphoserine;status=By similarity	
Q64127	UniProtKB	Modified residue	745	745	.	.	.	Note=Phosphoserine;status=By similarity	
Q64127	UniProtKB	Modified residue	769	769	.	.	.	Note=Phosphoserine;status=By similarity	
Q64127	UniProtKB	Modified residue	809	809	.	.	.	Note=Phosphoserine;status=By similarity	
Q64127	UniProtKB	Modified residue	812	812	.	.	.	Note=Phosphoserine;status=By similarity	
Q64127	UniProtKB	Modified residue	819	819	.	.	.	Note=Phosphothreonine;status=By similarity	
Q64127	UniProtKB	Modified residue	1026	1026	.	.	.	Note=Phosphoserine	
Q64127	UniProtKB	Modified residue	1029	1029	.	.	.	Note=Phosphoserine	
Q64127	UniProtKB	Modified residue	1043	1043	.	.	.	Note=Phosphoserine;status=By similarity	
Q64127	UniProtKB	Cross-link	724	724	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=Probable	
Q64127	UniProtKB	Cross-link	742	742	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=Probable	
Q64127	UniProtKB	Alternative sequence	477	510	.	.	.	ID=VSP_005773;Note=In isoform Short.	
Q64127	UniProtKB	Mutagenesis	724	724	.	.	.	Note=Loss of sumoylation%3B when associated with R-742.	
Q64127	UniProtKB	Mutagenesis	742	742	.	.	.	Note=Loss of sumoylation%3B when associated with R-724.	
##sequence-region O75204 1 238
O75204	UniProtKB	Chain	1	238	.	.	.	ID=PRO_0000251718;Note=Transmembrane protein 127	
O75204	UniProtKB	Transmembrane	96	116	.	.	.	Note=Helical%3B;status=Potential	
O75204	UniProtKB	Transmembrane	130	150	.	.	.	Note=Helical%3B;status=Potential	
O75204	UniProtKB	Transmembrane	169	189	.	.	.	Note=Helical%3B;status=Potential	
O75204	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine	
O75204	UniProtKB	Modified residue	17	17	.	.	.	Note=Phosphoserine	
O75204	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_063595;Dbxref=dbSNP:rs121908823;Note=In a pheochromocytoma sample arising from adrenal medulla.	
##sequence-region Q8BGP5 1 238
Q8BGP5	UniProtKB	Chain	1	238	.	.	.	ID=PRO_0000251719;Note=Transmembrane protein 127	
Q8BGP5	UniProtKB	Transmembrane	96	116	.	.	.	Note=Helical%3B;status=Potential	
Q8BGP5	UniProtKB	Transmembrane	130	150	.	.	.	Note=Helical%3B;status=Potential	
Q8BGP5	UniProtKB	Transmembrane	169	189	.	.	.	Note=Helical%3B;status=Potential	
Q8BGP5	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;status=By similarity	
Q8BGP5	UniProtKB	Modified residue	17	17	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q92574 1 1164
Q92574	UniProtKB	Chain	1	1164	.	.	.	ID=PRO_0000065651;Note=Hamartin	
Q92574	UniProtKB	Coiled coil	721	997	.	.	.	status=Potential	
Q92574	UniProtKB	Compositional bias	1034	1037	.	.	.	Note=Poly-Gly	
Q92574	UniProtKB	Compositional bias	1038	1043	.	.	.	Note=Poly-Ser	
Q92574	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphoserine	
Q92574	UniProtKB	Modified residue	511	511	.	.	.	Note=Phosphoserine	
Q92574	UniProtKB	Modified residue	598	598	.	.	.	Note=Phosphoserine	
Q92574	UniProtKB	Alternative sequence	70	120	.	.	.	ID=VSP_042890;Note=In isoform 2.	
Q92574	UniProtKB	Natural variant	51	51	.	.	.	ID=VAR_009397;Note=In TSC1%3B unknown pathological significance.	
Q92574	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_054386;Note=In a bladder tumor%3B somatic mutation%3B reduced stability%3B does not affect interaction with TSC2.	
Q92574	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_054387;Note=In TSC1.	
Q92574	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_054388;Note=In a bladder tumor%3B somatic mutation%3B reduced stability%3B does not affect interaction with TSC2.	
Q92574	UniProtKB	Natural variant	190	190	.	.	.	ID=VAR_009398	
Q92574	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_009399;Note=In TSC1%3B unknown pathological significance.	
Q92574	UniProtKB	Natural variant	198	199	.	.	.	ID=VAR_009400;Note=In TSC1.	
Q92574	UniProtKB	Natural variant	206	206	.	.	.	ID=VAR_054389;Note=In a bladder tumor%3B somatic mutation%3B reduced stability%3B does not affect interaction with TSC2.	
Q92574	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_054390;Note=In a bladder tumor%3B diffuse punctate cytoplasmic distribution in aminoacid-starved conditions%3B does not affect interaction with TSC2.	
Q92574	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_009401;Note=In TSC1%3B unknown pathological significance.	
Q92574	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_009402;Dbxref=dbSNP:rs1073123	
Q92574	UniProtKB	Natural variant	417	417	.	.	.	ID=VAR_009403;Dbxref=dbSNP:rs77464996;Note=In TSC1%3B unknown pathological significance%3B does not affect interaction with TSC2.	
Q92574	UniProtKB	Natural variant	500	500	.	.	.	ID=VAR_054391;Note=In TSC1.	
Q92574	UniProtKB	Natural variant	577	577	.	.	.	ID=VAR_009404	
Q92574	UniProtKB	Natural variant	586	589	.	.	.	ID=VAR_009405;Note=In TSC1.	
Q92574	UniProtKB	Natural variant	587	587	.	.	.	ID=VAR_009406;Dbxref=dbSNP:rs118203576	
Q92574	UniProtKB	Natural variant	654	654	.	.	.	ID=VAR_009407;Dbxref=dbSNP:rs75820036;Note=In TSC1.	
Q92574	UniProtKB	Natural variant	726	726	.	.	.	ID=VAR_009408;Note=In TSC1.	
Q92574	UniProtKB	Natural variant	732	732	.	.	.	ID=VAR_009409;Dbxref=dbSNP:rs118203657;Note=In FCDBC%3B unknown pathological significance.	
Q92574	UniProtKB	Natural variant	809	809	.	.	.	ID=VAR_009410	
Q92574	UniProtKB	Natural variant	829	829	.	.	.	ID=VAR_009411	
Q92574	UniProtKB	Natural variant	899	899	.	.	.	ID=VAR_009412;Note=In TSC1.	
Q92574	UniProtKB	Natural variant	1035	1035	.	.	.	ID=VAR_009413;Dbxref=dbSNP:rs118203742	
Q92574	UniProtKB	Natural variant	1108	1108	.	.	.	ID=VAR_009414	
##sequence-region Q9EP53 1 1161
Q9EP53	UniProtKB	Chain	1	1161	.	.	.	ID=PRO_0000379922;Note=Hamartin	
Q9EP53	UniProtKB	Coiled coil	721	849	.	.	.	status=Potential	
Q9EP53	UniProtKB	Coiled coil	879	917	.	.	.	status=Potential	
Q9EP53	UniProtKB	Coiled coil	967	991	.	.	.	status=Potential	
Q9EP53	UniProtKB	Compositional bias	312	315	.	.	.	Note=Poly-Ser	
Q9EP53	UniProtKB	Compositional bias	692	695	.	.	.	Note=Poly-Leu	
Q9EP53	UniProtKB	Compositional bias	1035	1040	.	.	.	Note=Poly-Ser	
Q9EP53	UniProtKB	Compositional bias	1106	1111	.	.	.	Note=Poly-Ser	
Q9EP53	UniProtKB	Modified residue	502	502	.	.	.	Note=Phosphoserine;status=By similarity	
Q9EP53	UniProtKB	Modified residue	508	508	.	.	.	Note=Phosphoserine;status=By similarity	
Q9EP53	UniProtKB	Modified residue	595	595	.	.	.	Note=Phosphoserine;status=By similarity	
Q9EP53	UniProtKB	Alternative sequence	381	381	.	.	.	ID=VSP_037747;Note=In isoform 2%2C isoform 3 and isoform 4.	
Q9EP53	UniProtKB	Alternative sequence	678	682	.	.	.	ID=VSP_037748;Note=In isoform 3.	
Q9EP53	UniProtKB	Alternative sequence	1056	1067	.	.	.	ID=VSP_037749;Note=In isoform 4.	
##sequence-region Q9Z136 1 1163
Q9Z136	UniProtKB	Chain	1	1163	.	.	.	ID=PRO_0000065652;Note=Hamartin	
Q9Z136	UniProtKB	Coiled coil	721	919	.	.	.	status=Potential	
Q9Z136	UniProtKB	Coiled coil	970	994	.	.	.	status=Potential	
Q9Z136	UniProtKB	Compositional bias	1038	1043	.	.	.	Note=Poly-Ser	
Q9Z136	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z136	UniProtKB	Modified residue	511	511	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z136	UniProtKB	Modified residue	598	598	.	.	.	Note=Phosphoserine;status=By similarity	
Q9Z136	UniProtKB	Mutagenesis	287	287	.	.	.	Note=In chemically induced renal carcinogenesis.	
Q9Z136	UniProtKB	Mutagenesis	674	674	.	.	.	Note=In chemically induced renal carcinogenesis.	
Q9Z136	UniProtKB	Mutagenesis	1027	1027	.	.	.	Note=In chemically induced renal carcinogenesis.	
Q9Z136	UniProtKB	Mutagenesis	1106	1106	.	.	.	Note=In chemically induced renal carcinogenesis.	
##sequence-region P49815 1 1807
P49815	UniProtKB	Chain	1	1807	.	.	.	ID=PRO_0000065654;Note=Tuberin	
P49815	UniProtKB	Domain	1531	1758	.	.	.	Note=Rap-GAP	
P49815	UniProtKB	Region	1	400	.	.	.	Note=Required for interaction with TSC1	
P49815	UniProtKB	Modified residue	927	927	.	.	.	Note=Phosphothreonine	
P49815	UniProtKB	Modified residue	939	939	.	.	.	Note=Phosphoserine%3B by PKB/AKT1	
P49815	UniProtKB	Modified residue	981	981	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1132	1132	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1155	1155	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1330	1330	.	.	.	Note=Phosphothreonine%3B by AMPK	
P49815	UniProtKB	Modified residue	1337	1337	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1338	1338	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1346	1346	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1387	1387	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1411	1411	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1418	1418	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1420	1420	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1448	1448	.	.	.	Note=Phosphoserine%3B by AMPK	
P49815	UniProtKB	Modified residue	1452	1452	.	.	.	Note=Phosphoserine	
P49815	UniProtKB	Modified residue	1462	1462	.	.	.	Note=Phosphothreonine%3B by PKB/AKT1	
P49815	UniProtKB	Modified residue	1798	1798	.	.	.	Note=Phosphoserine%3B by RPS6KA1	
P49815	UniProtKB	Alternative sequence	76	112	.	.	.	ID=VSP_038355;Note=In isoform 6.	
P49815	UniProtKB	Alternative sequence	946	989	.	.	.	ID=VSP_004471;Note=In isoform 3 and isoform 5.	
P49815	UniProtKB	Alternative sequence	946	988	.	.	.	ID=VSP_004470;Note=In isoform 2 and isoform 6.	
P49815	UniProtKB	Alternative sequence	1272	1294	.	.	.	ID=VSP_004472;Note=In isoform 4%2C isoform 5 and isoform 6.	
P49815	UniProtKB	Natural variant	94	94	.	.	.	ID=VAR_008019;Dbxref=dbSNP:rs1051616	
P49815	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_009415;Dbxref=dbSNP:rs45517107;Note=In TSC2%3B unknown pathological significance.	
P49815	UniProtKB	Natural variant	160	160	.	.	.	ID=VAR_009416;Dbxref=dbSNP:rs45517109	
P49815	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_008020;Dbxref=dbSNP:rs45517122;Note=In TSC2.	
P49815	UniProtKB	Natural variant	258	258	.	.	.	ID=VAR_009417;Note=In TSC2.	
P49815	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_009418;Dbxref=dbSNP:rs45502703;Note=In TSC2.	
P49815	UniProtKB	Natural variant	261	261	.	.	.	ID=VAR_009419;Dbxref=dbSNP:rs45517130	
P49815	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_009420;Dbxref=dbSNP:rs45517136	
P49815	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_009421;Dbxref=dbSNP:rs1800748	
P49815	UniProtKB	Natural variant	292	292	.	.	.	ID=VAR_005646;Dbxref=dbSNP:rs45517138;Note=In TSC2.	
P49815	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_009422;Dbxref=dbSNP:rs45487497;Note=In TSC2.	
P49815	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_009423;Note=In TSC2.	
P49815	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_009424	
P49815	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_009425;Dbxref=dbSNP:rs1131825;Note=Could be associated with TSC2.	
P49815	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_008021;Dbxref=dbSNP:rs45517153;Note=In TSC2.	
P49815	UniProtKB	Natural variant	361	361	.	.	.	ID=VAR_009426;Dbxref=dbSNP:rs45517147;Note=In TSC2.	
P49815	UniProtKB	Natural variant	365	365	.	.	.	ID=VAR_009427;Note=In TSC2.	
P49815	UniProtKB	Natural variant	367	367	.	.	.	ID=VAR_009428;Dbxref=dbSNP:rs1800725	
P49815	UniProtKB	Natural variant	378	378	.	.	.	ID=VAR_009429;Dbxref=dbSNP:rs45517154	
P49815	UniProtKB	Natural variant	407	407	.	.	.	ID=VAR_005647;Note=In TSC2.	
P49815	UniProtKB	Natural variant	440	440	.	.	.	ID=VAR_009430;Dbxref=dbSNP:rs45484298	
P49815	UniProtKB	Natural variant	449	449	.	.	.	ID=VAR_005648;Note=In TSC2.	
P49815	UniProtKB	Natural variant	463	463	.	.	.	ID=VAR_009431	
P49815	UniProtKB	Natural variant	486	486	.	.	.	ID=VAR_008022;Note=In TSC2.	
P49815	UniProtKB	Natural variant	490	490	.	.	.	ID=VAR_008023	
P49815	UniProtKB	Natural variant	525	525	.	.	.	ID=VAR_009432;Note=In TSC2.	
P49815	UniProtKB	Natural variant	536	536	.	.	.	ID=VAR_008024	
P49815	UniProtKB	Natural variant	583	583	.	.	.	ID=VAR_009433;Dbxref=dbSNP:rs1800729	
P49815	UniProtKB	Natural variant	593	593	.	.	.	ID=VAR_009434	
P49815	UniProtKB	Natural variant	599	599	.	.	.	ID=VAR_009435;Note=In TSC2%3B impairs repression of EIF4EBP1 phosphorylation.	
P49815	UniProtKB	Natural variant	607	607	.	.	.	ID=VAR_005649	
P49815	UniProtKB	Natural variant	611	611	.	.	.	ID=VAR_005650;Note=In TSC2 and LAM%3B impairs phosphorylation at S-1387%2C S-1418 and S-1420.	
P49815	UniProtKB	Natural variant	611	611	.	.	.	ID=VAR_005651;Note=In TSC2%3B impairs phosphorylation at S-1387%2C S-1418 and S-1420.	
P49815	UniProtKB	Natural variant	614	614	.	.	.	ID=VAR_009436;Note=In TSC2.	
P49815	UniProtKB	Natural variant	615	615	.	.	.	ID=VAR_008025	
P49815	UniProtKB	Natural variant	619	619	.	.	.	ID=VAR_060584;Dbxref=dbSNP:rs1131826	
P49815	UniProtKB	Natural variant	647	647	.	.	.	ID=VAR_009437;Note=In TSC2%3B unknown pathological significance.	
P49815	UniProtKB	Natural variant	694	694	.	.	.	ID=VAR_009438;Note=In TSC2.	
P49815	UniProtKB	Natural variant	696	696	.	.	.	ID=VAR_009439;Note=In TSC2.	
P49815	UniProtKB	Natural variant	717	717	.	.	.	ID=VAR_009440;Note=In TSC2.	
P49815	UniProtKB	Natural variant	769	769	.	.	.	ID=VAR_009441;Note=In TSC2%3B unknown pathological significance.	
P49815	UniProtKB	Natural variant	802	802	.	.	.	ID=VAR_060585;Dbxref=dbSNP:rs1051621	
P49815	UniProtKB	Natural variant	816	816	.	.	.	ID=VAR_008026;Note=In TSC2.	
P49815	UniProtKB	Natural variant	826	826	.	.	.	ID=VAR_005652;Note=In TSC2.	
P49815	UniProtKB	Natural variant	862	862	.	.	.	ID=VAR_018600	
P49815	UniProtKB	Natural variant	895	895	.	.	.	ID=VAR_009442;Note=In TSC2.	
P49815	UniProtKB	Natural variant	905	905	.	.	.	ID=VAR_005653;Note=In TSC2.	
P49815	UniProtKB	Natural variant	905	905	.	.	.	ID=VAR_005654;Note=In TSC2.	
P49815	UniProtKB	Natural variant	963	963	.	.	.	ID=VAR_009443;Note=In TSC2%3B unknown pathological significance.	
P49815	UniProtKB	Natural variant	1027	1027	.	.	.	ID=VAR_022919;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1084	1084	.	.	.	ID=VAR_005655;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1141	1141	.	.	.	ID=VAR_057014;Dbxref=dbSNP:rs34870424	
P49815	UniProtKB	Natural variant	1144	1144	.	.	.	ID=VAR_008027;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1200	1200	.	.	.	ID=VAR_005656;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1227	1227	.	.	.	ID=VAR_005657;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1240	1240	.	.	.	ID=VAR_005658;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1282	1282	.	.	.	ID=VAR_009444	
P49815	UniProtKB	Natural variant	1295	1295	.	.	.	ID=VAR_005659;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1315	1315	.	.	.	ID=VAR_008028;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1329	1329	.	.	.	ID=VAR_008029;Dbxref=dbSNP:rs45517323;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1341	1341	.	.	.	ID=VAR_022920	
P49815	UniProtKB	Natural variant	1429	1429	.	.	.	ID=VAR_018601;Dbxref=dbSNP:rs45474795	
P49815	UniProtKB	Natural variant	1450	1450	.	.	.	ID=VAR_018602	
P49815	UniProtKB	Natural variant	1497	1497	.	.	.	ID=VAR_009445;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1498	1498	.	.	.	ID=VAR_009446;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1509	1509	.	.	.	ID=VAR_005660;Note=In TSC2%3B could be a rare polymorphism.	
P49815	UniProtKB	Natural variant	1549	1549	.	.	.	ID=VAR_005661;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1594	1594	.	.	.	ID=VAR_009447;Note=In TSC2%3B unknown pathological significance.	
P49815	UniProtKB	Natural variant	1614	1614	.	.	.	ID=VAR_005662;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1620	1620	.	.	.	ID=VAR_009448;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1636	1636	.	.	.	ID=VAR_022921	
P49815	UniProtKB	Natural variant	1643	1643	.	.	.	ID=VAR_005663;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1643	1643	.	.	.	ID=VAR_009449;Note=In TSC2%3B Abolishes GAP activity.	
P49815	UniProtKB	Natural variant	1650	1650	.	.	.	ID=VAR_005664;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1651	1651	.	.	.	ID=VAR_009450;Note=In TSC2%3B greatly reduces the ability to enhance the RHEB GTPase activity.	
P49815	UniProtKB	Natural variant	1653	1653	.	.	.	ID=VAR_018603;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1673	1673	.	.	.	ID=VAR_022922	
P49815	UniProtKB	Natural variant	1675	1675	.	.	.	ID=VAR_009451;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1681	1681	.	.	.	ID=VAR_009452;Note=In TSC2%3B Abolishes GAP activity.	
P49815	UniProtKB	Natural variant	1690	1690	.	.	.	ID=VAR_005665;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1704	1704	.	.	.	ID=VAR_009453;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1709	1709	.	.	.	ID=VAR_008030;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1712	1712	.	.	.	ID=VAR_005666;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1743	1743	.	.	.	ID=VAR_009454;Note=In TSC2%3B Abolishes GAP activity.	
P49815	UniProtKB	Natural variant	1743	1743	.	.	.	ID=VAR_008031;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1744	1744	.	.	.	ID=VAR_009455;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1746	1751	.	.	.	ID=VAR_009456;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1750	1750	.	.	.	ID=VAR_005667;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1773	1773	.	.	.	ID=VAR_008032;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1774	1774	.	.	.	ID=VAR_057015;Dbxref=dbSNP:rs9209	
P49815	UniProtKB	Natural variant	1783	1783	.	.	.	ID=VAR_008033;Note=In TSC2.	
P49815	UniProtKB	Natural variant	1787	1787	.	.	.	ID=VAR_009457;Dbxref=dbSNP:rs45517419	
P49815	UniProtKB	Natural variant	1791	1791	.	.	.	ID=VAR_009458	
P49815	UniProtKB	Mutagenesis	939	939	.	.	.	Note=Inhibits insulin-stimulated phosphorylation and activation of S6K1%3B when associated with A-1462.	
P49815	UniProtKB	Mutagenesis	1330	1330	.	.	.	Note=Abolishes AMPK-mediated phosphorylation%3B when associated with A-1448.	
P49815	UniProtKB	Mutagenesis	1448	1448	.	.	.	Note=Abolishes AMPK-mediated phosphorylation%3B when associated with A-1330.	
P49815	UniProtKB	Mutagenesis	1462	1462	.	.	.	Note=Inhibits insulin-stimulated phosphorylation and activation of S6K1%3B when associated with A-939.	
P49815	UniProtKB	Mutagenesis	1637	1639	.	.	.	Note=Abolishes GAP activity.	
P49815	UniProtKB	Mutagenesis	1745	1745	.	.	.	Note=Abolishes GAP activity.	
P49815	UniProtKB	Mutagenesis	1749	1751	.	.	.	Note=No effect.	
P49815	UniProtKB	Sequence conflict	187	187	.	.	.	.	
P49815	UniProtKB	Sequence conflict	210	210	.	.	.	.	
P49815	UniProtKB	Sequence conflict	335	335	.	.	.	.	
P49815	UniProtKB	Sequence conflict	392	392	.	.	.	.	
P49815	UniProtKB	Sequence conflict	422	422	.	.	.	.	
P49815	UniProtKB	Sequence conflict	660	660	.	.	.	.	
P49815	UniProtKB	Sequence conflict	704	704	.	.	.	.	
P49815	UniProtKB	Sequence conflict	706	706	.	.	.	.	
P49815	UniProtKB	Sequence conflict	1015	1015	.	.	.	.	
P49815	UniProtKB	Sequence conflict	1239	1239	.	.	.	.	
P49815	UniProtKB	Sequence conflict	1398	1398	.	.	.	.	
P49815	UniProtKB	Sequence conflict	1672	1672	.	.	.	.	
P49815	UniProtKB	Sequence conflict	1807	1807	.	.	.	.	
##sequence-region Q61037 1 1814
Q61037	UniProtKB	Chain	1	1814	.	.	.	ID=PRO_0000065655;Note=Tuberin	
Q61037	UniProtKB	Domain	1532	1766	.	.	.	Note=Rap-GAP	
Q61037	UniProtKB	Modified residue	927	927	.	.	.	Note=Phosphothreonine;status=By similarity	
Q61037	UniProtKB	Modified residue	939	939	.	.	.	Note=Phosphoserine%3B by PKB/AKT1;status=By similarity	
Q61037	UniProtKB	Modified residue	981	981	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1132	1132	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1155	1155	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1339	1339	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1340	1340	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1348	1348	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1388	1388	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1412	1412	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1419	1419	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1421	1421	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1451	1451	.	.	.	Note=Phosphoserine%3B by AMPK;status=By similarity	
Q61037	UniProtKB	Modified residue	1455	1455	.	.	.	Note=Phosphoserine;status=By similarity	
Q61037	UniProtKB	Modified residue	1465	1465	.	.	.	Note=Phosphothreonine%3B by PKB/AKT1;status=By similarity	
Q61037	UniProtKB	Modified residue	1805	1805	.	.	.	Note=Phosphoserine%3B by RPS6KA1;status=By similarity	
Q61037	UniProtKB	Alternative sequence	79	115	.	.	.	ID=VSP_004473;Note=In isoform A.	
Q61037	UniProtKB	Alternative sequence	534	572	.	.	.	ID=VSP_004474;Note=In isoform B.	
Q61037	UniProtKB	Alternative sequence	947	990	.	.	.	ID=VSP_004476;Note=In isoform C.	
Q61037	UniProtKB	Alternative sequence	947	989	.	.	.	ID=VSP_004475;Note=In isoform F.	
Q61037	UniProtKB	Alternative sequence	1245	1258	.	.	.	ID=VSP_004477;Note=In isoform E and isoform F.	
Q61037	UniProtKB	Alternative sequence	1271	1293	.	.	.	ID=VSP_004478;Note=In isoform D%2C isoform E and isoform F.	
Q61037	UniProtKB	Alternative sequence	1693	1728	.	.	.	ID=VSP_004479;Note=In isoform E and isoform F.	
Q61037	UniProtKB	Alternative sequence	1776	1814	.	.	.	ID=VSP_004480;Note=In isoform F.	
Q61037	UniProtKB	Sequence conflict	161	161	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	161	161	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	269	269	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	269	269	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	462	462	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	462	462	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	476	476	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	476	476	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	549	549	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	549	549	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	707	707	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	861	862	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	861	862	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	1127	1127	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	1127	1127	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	1665	1665	.	.	.	.	
Q61037	UniProtKB	Sequence conflict	1665	1665	.	.	.	.	
##sequence-region P49816 1 1809
P49816	UniProtKB	Chain	1	1809	.	.	.	ID=PRO_0000065656;Note=Tuberin	
P49816	UniProtKB	Domain	1533	1760	.	.	.	Note=Rap-GAP	
P49816	UniProtKB	Modified residue	927	927	.	.	.	Note=Phosphothreonine;status=By similarity	
P49816	UniProtKB	Modified residue	939	939	.	.	.	Note=Phosphoserine%3B by PKB/AKT1;status=By similarity	
P49816	UniProtKB	Modified residue	981	981	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1132	1132	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1155	1155	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1340	1340	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1341	1341	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1349	1349	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1389	1389	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1413	1413	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1420	1420	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1422	1422	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1452	1452	.	.	.	Note=Phosphoserine%3B by AMPK;status=By similarity	
P49816	UniProtKB	Modified residue	1456	1456	.	.	.	Note=Phosphoserine;status=By similarity	
P49816	UniProtKB	Modified residue	1466	1466	.	.	.	Note=Phosphothreonine%3B by PKB/AKT1;status=By similarity	
P49816	UniProtKB	Modified residue	1800	1800	.	.	.	Note=Phosphoserine%3B by RPS6KA1;status=By similarity	
P49816	UniProtKB	Alternative sequence	947	989	.	.	.	ID=VSP_004481;Note=In isoform 2 and isoform 4.	
P49816	UniProtKB	Alternative sequence	1272	1294	.	.	.	ID=VSP_004482;Note=In isoform 3 and isoform 4.	
P49816	UniProtKB	Mutagenesis	314	314	.	.	.	Note=In chemically induced renal carcinoma.	
P49816	UniProtKB	Mutagenesis	713	713	.	.	.	Note=In chemically induced renal carcinoma.	
P49816	UniProtKB	Sequence conflict	932	932	.	.	.	.	
P49816	UniProtKB	Sequence conflict	1514	1514	.	.	.	.	
P49816	UniProtKB	Sequence conflict	1730	1730	.	.	.	.	
##sequence-region O75896 1 110
O75896	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed	
O75896	UniProtKB	Chain	2	110	.	.	.	ID=PRO_0000148170;Note=Tumor suppressor candidate 2	
O75896	UniProtKB	Modified residue	50	50	.	.	.	Note=Phosphoserine	
O75896	UniProtKB	Lipidation	2	2	.	.	.	Note=N-myristoyl glycine	
##sequence-region Q9H3M7 1 391
Q9H3M7	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000250489;Note=Thioredoxin-interacting protein	
Q9H3M7	UniProtKB	Modified residue	361	361	.	.	.	Note=Phosphoserine	
Q9H3M7	UniProtKB	Disulfide bond	63	63	.	.	.	Note=Interchain	
Q9H3M7	UniProtKB	Cross-link	212	212	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)	
Q9H3M7	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_048334;Dbxref=dbSNP:rs6674773	
Q9H3M7	UniProtKB	Sequence conflict	26	26	.	.	.	.	
Q9H3M7	UniProtKB	Sequence conflict	26	26	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	8	16	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	20	22	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	26	34	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	39	41	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	43	58	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	61	76	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	79	81	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	89	91	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	97	104	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	116	130	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	137	142	.	.	.	.	
Q9H3M7	UniProtKB	Beta strand	144	146	.	.	.	.	
##sequence-region Q8BG60 1 397
Q8BG60	UniProtKB	Chain	1	397	.	.	.	ID=PRO_0000250490;Note=Thioredoxin-interacting protein	
Q8BG60	UniProtKB	Modified residue	362	362	.	.	.	Note=Phosphoserine;status=By similarity	
Q8BG60	UniProtKB	Disulfide bond	63	63	.	.	.	Note=Interchain;status=By similarity	
Q8BG60	UniProtKB	Cross-link	213	213	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
Q8BG60	UniProtKB	Alternative sequence	84	84	.	.	.	ID=VSP_020653;Note=In isoform 2.	
Q8BG60	UniProtKB	Sequence conflict	79	79	.	.	.	.	
Q8BG60	UniProtKB	Sequence conflict	165	165	.	.	.	.	
Q8BG60	UniProtKB	Sequence conflict	175	175	.	.	.	.	
Q8BG60	UniProtKB	Sequence conflict	308	308	.	.	.	.	
Q8BG60	UniProtKB	Sequence conflict	308	308	.	.	.	.	
Q8BG60	UniProtKB	Sequence conflict	395	395	.	.	.	.	
Q8BG60	UniProtKB	Sequence conflict	395	395	.	.	.	.	
##sequence-region Q2HY40 1 391
Q2HY40	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000250491;Note=Thioredoxin-interacting protein	
Q2HY40	UniProtKB	Modified residue	361	361	.	.	.	Note=Phosphoserine;status=By similarity	
Q2HY40	UniProtKB	Disulfide bond	63	63	.	.	.	Note=Interchain;status=By similarity	
Q2HY40	UniProtKB	Cross-link	212	212	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
##sequence-region Q5R811 1 391
Q5R811	UniProtKB	Chain	1	391	.	.	.	ID=PRO_0000250492;Note=Thioredoxin-interacting protein	
Q5R811	UniProtKB	Modified residue	361	361	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R811	UniProtKB	Disulfide bond	63	63	.	.	.	Note=Interchain;status=By similarity	
Q5R811	UniProtKB	Cross-link	212	212	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
##sequence-region Q5M7W1 1 394
Q5M7W1	UniProtKB	Chain	1	394	.	.	.	ID=PRO_0000250493;Note=Thioredoxin-interacting protein	
Q5M7W1	UniProtKB	Modified residue	361	361	.	.	.	Note=Phosphoserine;status=By similarity	
Q5M7W1	UniProtKB	Disulfide bond	63	63	.	.	.	Note=Interchain;status=By similarity	
Q5M7W1	UniProtKB	Cross-link	212	212	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);status=By similarity	
##sequence-region A1A4I9 1 792
A1A4I9	UniProtKB	Chain	1	792	.	.	.	ID=PRO_0000328122;Note=E3 UFM1-protein ligase 1	
A1A4I9	UniProtKB	Region	1	212	.	.	.	Note=Required for E3 UFM1-protein ligase activity;status=By similarity	
A1A4I9	UniProtKB	Modified residue	458	458	.	.	.	Note=Phosphoserine;status=By similarity	
A1A4I9	UniProtKB	Modified residue	752	752	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q5ZMG1 1 789
Q5ZMG1	UniProtKB	Chain	1	789	.	.	.	ID=PRO_0000050773;Note=E3 UFM1-protein ligase 1	
##sequence-region Q6PGY6 1 793
Q6PGY6	UniProtKB	Chain	1	793	.	.	.	ID=PRO_0000328124;Note=E3 UFM1-protein ligase 1	
##sequence-region O94874 1 794
O94874	UniProtKB	Chain	1	794	.	.	.	ID=PRO_0000050771;Note=E3 UFM1-protein ligase 1	
O94874	UniProtKB	Region	1	212	.	.	.	Note=Required for E3 UFM1-protein ligase activity	
O94874	UniProtKB	Region	121	250	.	.	.	Note=Involved in CDK5RAP3-binding	
O94874	UniProtKB	Modified residue	458	458	.	.	.	Note=Phosphoserine	
O94874	UniProtKB	Alternative sequence	1	65	.	.	.	ID=VSP_038759;Note=In isoform 2.	
O94874	UniProtKB	Alternative sequence	508	509	.	.	.	ID=VSP_038760;Note=In isoform 3.	
O94874	UniProtKB	Alternative sequence	510	794	.	.	.	ID=VSP_038761;Note=In isoform 3.	
O94874	UniProtKB	Natural variant	137	137	.	.	.	ID=VAR_034037;Dbxref=dbSNP:rs28372909	
##sequence-region Q4R367 1 793
Q4R367	UniProtKB	Chain	1	793	.	.	.	ID=PRO_0000328123;Note=E3 UFM1-protein ligase 1	
Q4R367	UniProtKB	Region	1	212	.	.	.	Note=Required for E3 UFM1-protein ligase activity;status=By similarity	
Q4R367	UniProtKB	Modified residue	458	458	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q8CCJ3 1 793
Q8CCJ3	UniProtKB	Chain	1	793	.	.	.	ID=PRO_0000050772;Note=E3 UFM1-protein ligase 1	
Q8CCJ3	UniProtKB	Region	1	212	.	.	.	Note=Required for E3 UFM1-protein ligase activity;status=By similarity	
Q8CCJ3	UniProtKB	Modified residue	458	458	.	.	.	Note=Phosphoserine;status=By similarity	
Q8CCJ3	UniProtKB	Modified residue	752	752	.	.	.	Note=Phosphoserine	
Q8CCJ3	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine	
Q8CCJ3	UniProtKB	Alternative sequence	1	476	.	.	.	ID=VSP_014249;Note=In isoform 3.	
Q8CCJ3	UniProtKB	Alternative sequence	1	80	.	.	.	ID=VSP_014250;Note=In isoform 2.	
Q8CCJ3	UniProtKB	Alternative sequence	81	84	.	.	.	ID=VSP_014251;Note=In isoform 2.	
Q8CCJ3	UniProtKB	Sequence conflict	122	122	.	.	.	.	
Q8CCJ3	UniProtKB	Sequence conflict	122	122	.	.	.	.	
Q8CCJ3	UniProtKB	Sequence conflict	122	122	.	.	.	.	
Q8CCJ3	UniProtKB	Sequence conflict	389	389	.	.	.	.	
Q8CCJ3	UniProtKB	Sequence conflict	408	408	.	.	.	.	
Q8CCJ3	UniProtKB	Sequence conflict	409	409	.	.	.	.	
##sequence-region B2GV24 1 793
B2GV24	UniProtKB	Chain	1	793	.	.	.	ID=PRO_0000391875;Note=E3 UFM1-protein ligase 1	
B2GV24	UniProtKB	Region	1	212	.	.	.	Note=Required for E3 UFM1-protein ligase activity;status=By similarity	
B2GV24	UniProtKB	Modified residue	458	458	.	.	.	Note=Phosphoserine;status=By similarity	
B2GV24	UniProtKB	Modified residue	752	752	.	.	.	Note=Phosphoserine;status=By similarity	
B2GV24	UniProtKB	Modified residue	753	753	.	.	.	Note=Phosphoserine;status=By similarity	
##sequence-region Q5Q9Z2 1 219
Q5Q9Z2	UniProtKB	Chain	1	219	.	.	.	ID=PRO_0000065808;Note=Von Hippel-Lindau disease tumor suppressor	
Q5Q9Z2	UniProtKB	Region	157	166	.	.	.	Note=Interaction with Elongin BC complex;status=By similarity	
##sequence-region P40337 1 213
P40337	UniProtKB	Chain	1	213	.	.	.	ID=PRO_0000065809;Note=Von Hippel-Lindau disease tumor suppressor	
P40337	UniProtKB	Repeat	14	18	.	.	.	Note=1	
P40337	UniProtKB	Repeat	19	23	.	.	.	Note=2	
P40337	UniProtKB	Repeat	24	28	.	.	.	Note=3	
P40337	UniProtKB	Repeat	29	33	.	.	.	Note=4	
P40337	UniProtKB	Repeat	34	38	.	.	.	Note=5	
P40337	UniProtKB	Repeat	39	43	.	.	.	Note=6	
P40337	UniProtKB	Repeat	44	48	.	.	.	Note=7	
P40337	UniProtKB	Repeat	49	53	.	.	.	Note=8	
P40337	UniProtKB	Region	14	53	.	.	.	Note=8 X 5 AA tandem repeats of G-[PAVG]-E-E-[DAYSLE]	
P40337	UniProtKB	Region	100	155	.	.	.	Note=Involved in binding to CCT complex	
P40337	UniProtKB	Region	157	166	.	.	.	Note=Interaction with Elongin BC complex	
P40337	UniProtKB	Alternative sequence	1	53	.	.	.	ID=VSP_007740;Note=In isoform 3.	
P40337	UniProtKB	Alternative sequence	114	154	.	.	.	ID=VSP_004488;Note=In isoform 2.	
P40337	UniProtKB	Natural variant	25	25	.	.	.	ID=VAR_034562;Dbxref=dbSNP:rs35460768;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	38	38	.	.	.	ID=VAR_005670;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_005671;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_034987;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_034988;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_034989;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_005672;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	65	65	.	.	.	ID=VAR_005673;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	66	73	.	.	.	ID=VAR_005674;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	68	68	.	.	.	ID=VAR_005675;Note=In pheochromocytoma and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	70	70	.	.	.	ID=VAR_005676;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	74	74	.	.	.	ID=VAR_005677;Dbxref=dbSNP:rs5030803;Note=In VHLD%3B type I-II.	
P40337	UniProtKB	Natural variant	75	75	.	.	.	ID=VAR_034990;Note=In VHLD.	
P40337	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_005679;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_005680;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_005681;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_005678;Note=In VHLD%3B type I%3B common mutation.	
P40337	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_005682;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_005683;Dbxref=dbSNP:rs5030804;Note=In VHLD%3B type I%3B common mutation.	
P40337	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_005684;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_005685;Note=In VHLD.	
P40337	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_005686;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_005688;Dbxref=dbSNP:rs5030805;Note=In pheochromocytoma and VHLD%3B type I.	
P40337	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_005687;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	81	81	.	.	.	ID=VAR_005689;Dbxref=dbSNP:rs5030806;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	82	84	.	.	.	ID=VAR_005691;Note=In VHLD.	
P40337	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_005690;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_005692;Dbxref=dbSNP:rs5030827;Note=In VHLD%3B type II and type 2C.	
P40337	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_005693;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_008097;Note=In VHLD.	
P40337	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_005694;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_005695;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	86	86	.	.	.	ID=VAR_005696;Note=In VHLD.	
P40337	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_005697;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_005698;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_005699;Note=In lung cancer.	
P40337	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_005700;Dbxref=dbSNP:rs5030807;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_005701;Note=In cerebellar hemangioblastoma.	
P40337	UniProtKB	Natural variant	92	97	.	.	.	ID=VAR_005702;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_005703;Dbxref=dbSNP:rs5030808;Note=In pheochromocytoma and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_005704;Note=In VHLD.	
P40337	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_005705;Dbxref=dbSNP:rs5030808;Note=In pheochromocytoma and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	96	96	.	.	.	ID=VAR_005706;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_005707;Dbxref=dbSNP:rs5030809;Note=In pheochromocytoma and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_005708;Note=In VHLD%3B type I%3B requires 2 nucleotide substitutions.	
P40337	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_005709;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	104	104	.	.	.	ID=VAR_005710;Note=In cerebellar hemangioblastoma.	
P40337	UniProtKB	Natural variant	105	105	.	.	.	ID=VAR_005711;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_005712;Note=In lung cancer.	
P40337	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_034991;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_005713;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	110	110	.	.	.	ID=VAR_055087;Dbxref=dbSNP:rs17855706	
P40337	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_005714;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_005715;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_005716;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_005717;Note=In VHLD%3B type IIA.	
P40337	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_034992;Note=In VHLD.	
P40337	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_005718;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_005719;Note=In VHLD%3B type I-II.	
P40337	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_005720;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_005723;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_008098;Dbxref=dbSNP:rs5030812;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_005722;Dbxref=dbSNP:rs5030811;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_005724;Note=In VHLD.	
P40337	UniProtKB	Natural variant	117	117	.	.	.	ID=VAR_005725;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_005726;Dbxref=dbSNP:rs5030830;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_005727;Note=In VHLD.	
P40337	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_005728;Note=In pheochromocytoma and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	119	119	.	.	.	ID=VAR_005729;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	121	121	.	.	.	ID=VAR_005730;Dbxref=dbSNP:rs5030832;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	122	122	.	.	.	ID=VAR_034993;Note=In pheochromocytoma%3B requires 2 nucleotide substitutions.	
P40337	UniProtKB	Natural variant	126	126	.	.	.	ID=VAR_034994;Note=In ECYT2.	
P40337	UniProtKB	Natural variant	128	128	.	.	.	ID=VAR_005731;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_005732;Note=In VHLD.	
P40337	UniProtKB	Natural variant	130	130	.	.	.	ID=VAR_005733;Note=In ECYT2 and VHLD%3B type I.	
P40337	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_005734;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_005735;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	135	135	.	.	.	ID=VAR_034995;Note=In hemangioblastoma.	
P40337	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_005737;Dbxref=dbSNP:rs5030833;Note=In pheochromocytoma and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_005736;Note=In VHLD.	
P40337	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_008099;Note=In VHLD.	
P40337	UniProtKB	Natural variant	143	143	.	.	.	ID=VAR_005738;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	145	145	.	.	.	ID=VAR_008100;Note=In VHLD.	
P40337	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_034996;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_005739;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	149	149	.	.	.	ID=VAR_005740;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	154	154	.	.	.	ID=VAR_005741;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_005742;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	155	155	.	.	.	ID=VAR_008101;Note=In VHLD%3B with RCC.	
P40337	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_005743;Note=In pheochromocytoma and VHLD%3B type I.	
P40337	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_005744;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_034997;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_005746;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	157	157	.	.	.	ID=VAR_005747;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005748;Note=In VHLD%3B type I-II%3B abolishes release from chaperonin complex and the interaction with Elongin BC complex.	
P40337	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_005749;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_005750;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_005753;Dbxref=dbSNP:rs5030818;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_005752;Note=In pheochromocytoma and VHLD%3B type I.	
P40337	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_005751;Note=In pheochromocytoma and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005754;Note=In VHLD%3B type I%3B No effect on interaction with HIF1A nor on HIF1A degradation.	
P40337	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005755;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005756;Dbxref=dbSNP:rs5030622;Note=In VHLD%3B type I-II.	
P40337	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_005757;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	163	163	.	.	.	ID=VAR_034998;Dbxref=dbSNP:rs28940297;Note=In RCC%3B with paraneoplastic erythrocytosis%3B inhibits binding to HIF1AN.	
P40337	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_008102;Note=In VHLD.	
P40337	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_005758;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_008103;Note=In VHLD%3B with RCC.	
P40337	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_005759;Note=In VHLD%3B type IIA.	
P40337	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_005760;Note=In VHLD%3B type I-II.	
P40337	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_005761;Dbxref=dbSNP:rs5030821;Note=In pheochromocytoma and VHLD%3B type II%3B common mutation.	
P40337	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_005762;Dbxref=dbSNP:rs5030820;Note=In pheochromocytoma and VHLD%3B type II%3B common mutation.	
P40337	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_005763;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_005764;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_005765;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_005766;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	176	176	.	.	.	ID=VAR_008104;Note=In VHLD.	
P40337	UniProtKB	Natural variant	177	177	.	.	.	ID=VAR_005767;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_005768;Note=In VHLD%3B type I-II%3B common mutation.	
P40337	UniProtKB	Natural variant	178	178	.	.	.	ID=VAR_005769;Dbxref=dbSNP:rs5030822;Note=In VHLD%3B type II.	
P40337	UniProtKB	Natural variant	180	180	.	.	.	ID=VAR_005770;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_005772;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	184	184	.	.	.	ID=VAR_005771;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_005773;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	186	186	.	.	.	ID=VAR_005774;Note=In VHLD.	
P40337	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_005775;Note=In VHLD%3B type I-II.	
P40337	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_005776;Note=In VHLD%3B type I.	
P40337	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_005777;Dbxref=dbSNP:rs5030824;Note=In ECYT2%2C pheochromocytoma and VHLD%3B type IIA.	
P40337	UniProtKB	Natural variant	191	191	.	.	.	ID=VAR_034999;Dbxref=dbSNP:rs28940301;Note=In ECYT2.	
P40337	UniProtKB	Natural variant	192	192	.	.	.	ID=VAR_035000;Dbxref=dbSNP:rs28940300;Note=In ECYT2.	
P40337	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_035001;Note=In pheochromocytoma.	
P40337	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_005778;Note=In ECY2 and VHLD%3B type II.	
P40337	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_005779;Dbxref=dbSNP:rs28940298;Note=In ECYT2 and VHLD%3B type I.	
P40337	UniProtKB	Mutagenesis	98	98	.	.	.	Note=No interaction with HIF1A. No HIF1A degradation.	
P40337	UniProtKB	Beta strand	71	78	.	.	.	.	
P40337	UniProtKB	Beta strand	80	82	.	.	.	.	
P40337	UniProtKB	Beta strand	84	89	.	.	.	.	
P40337	UniProtKB	Beta strand	91	93	.	.	.	.	
P40337	UniProtKB	Beta strand	95	97	.	.	.	.	
P40337	UniProtKB	Beta strand	105	112	.	.	.	.	
P40337	UniProtKB	Beta strand	116	121	.	.	.	.	
P40337	UniProtKB	Turn	122	124	.	.	.	.	
P40337	UniProtKB	Beta strand	127	130	.	.	.	.	
P40337	UniProtKB	Beta strand	142	144	.	.	.	.	
P40337	UniProtKB	Beta strand	147	152	.	.	.	.	
P40337	UniProtKB	Helix	158	169	.	.	.	.	
P40337	UniProtKB	Helix	172	177	.	.	.	.	
P40337	UniProtKB	Beta strand	178	180	.	.	.	.	
P40337	UniProtKB	Helix	183	189	.	.	.	.	
P40337	UniProtKB	Helix	194	206	.	.	.	.	
##sequence-region P40338 1 181
P40338	UniProtKB	Chain	1	181	.	.	.	ID=PRO_0000065810;Note=Von Hippel-Lindau disease tumor suppressor	
P40338	UniProtKB	Region	123	132	.	.	.	Note=Interaction with Elongin BC complex;status=By similarity	
##sequence-region Q64259 1 185
Q64259	UniProtKB	Chain	1	185	.	.	.	ID=PRO_0000065811;Note=Von Hippel-Lindau disease tumor suppressor	
Q64259	UniProtKB	Region	123	132	.	.	.	Note=Interaction with Elongin BC complex;status=By similarity	
##sequence-region O00534 1 786
O00534	UniProtKB	Chain	1	786	.	.	.	ID=PRO_0000084411;Note=von Willebrand factor A domain-containing protein 5A	
O00534	UniProtKB	Domain	1	131	.	.	.	Note=VIT	
O00534	UniProtKB	Domain	281	462	.	.	.	Note=VWFA	
O00534	UniProtKB	Alternative sequence	265	266	.	.	.	ID=VSP_013364;Note=In isoform 4.	
O00534	UniProtKB	Alternative sequence	267	786	.	.	.	ID=VSP_013365;Note=In isoform 4.	
O00534	UniProtKB	Alternative sequence	389	426	.	.	.	ID=VSP_013367;Note=In isoform 2.	
O00534	UniProtKB	Alternative sequence	416	786	.	.	.	ID=VSP_013366;Note=In isoform 3.	
O00534	UniProtKB	Alternative sequence	427	786	.	.	.	ID=VSP_013368;Note=In isoform 2.	
O00534	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_059692;Dbxref=dbSNP:rs35496433	
O00534	UniProtKB	Natural variant	205	205	.	.	.	ID=VAR_059693;Dbxref=dbSNP:rs35215239	
O00534	UniProtKB	Natural variant	499	499	.	.	.	ID=VAR_014193;Dbxref=dbSNP:rs2276054	
O00534	UniProtKB	Natural variant	506	506	.	.	.	ID=VAR_014194;Dbxref=dbSNP:rs2276053	
O00534	UniProtKB	Natural variant	757	757	.	.	.	ID=VAR_014195;Dbxref=dbSNP:rs117689747	
O00534	UniProtKB	Natural variant	759	759	.	.	.	ID=VAR_014196	
##sequence-region Q99KC8 1 793
Q99KC8	UniProtKB	Chain	1	793	.	.	.	ID=PRO_0000084412;Note=von Willebrand factor A domain-containing protein 5A	
Q99KC8	UniProtKB	Domain	1	131	.	.	.	Note=VIT	
Q99KC8	UniProtKB	Domain	281	469	.	.	.	Note=VWFA	
Q99KC8	UniProtKB	Modified residue	622	622	.	.	.	Note=Phosphotyrosine	
Q99KC8	UniProtKB	Sequence conflict	152	152	.	.	.	.	
Q99KC8	UniProtKB	Sequence conflict	172	172	.	.	.	.	
Q99KC8	UniProtKB	Sequence conflict	179	179	.	.	.	.	
Q99KC8	UniProtKB	Sequence conflict	347	347	.	.	.	.	
Q99KC8	UniProtKB	Sequence conflict	733	733	.	.	.	.	
##sequence-region Q75WE7 1 822
Q75WE7	UniProtKB	Chain	1	822	.	.	.	ID=PRO_0000084413;Note=von Willebrand factor A domain-containing protein 5A	
Q75WE7	UniProtKB	Domain	1	131	.	.	.	Note=VIT	
Q75WE7	UniProtKB	Domain	281	469	.	.	.	Note=VWFA	
##sequence-region Q9VA38 1 1105
Q9VA38	UniProtKB	Chain	1	1105	.	.	.	ID=PRO_0000394392;Note=Serine/threonine-protein kinase Warts	
Q9VA38	UniProtKB	Domain	719	1020	.	.	.	Note=Protein kinase	
Q9VA38	UniProtKB	Domain	1021	1091	.	.	.	Note=AGC-kinase C-terminal	
Q9VA38	UniProtKB	Nucleotide binding	725	733	.	.	.	Note=ATP;status=By similarity	
Q9VA38	UniProtKB	Compositional bias	84	87	.	.	.	Note=Poly-Pro	
Q9VA38	UniProtKB	Compositional bias	185	302	.	.	.	Note=Pro-rich	
Q9VA38	UniProtKB	Compositional bias	355	533	.	.	.	Note=Gln-rich	
Q9VA38	UniProtKB	Compositional bias	546	549	.	.	.	Note=Poly-Pro	
Q9VA38	UniProtKB	Compositional bias	553	598	.	.	.	Note=Asn-rich	
Q9VA38	UniProtKB	Active site	843	843	.	.	.	Note=Proton acceptor;status=By similarity	
Q9VA38	UniProtKB	Binding site	749	749	.	.	.	Note=ATP;status=By similarity	
##sequence-region B7ZSG3 1 414
B7ZSG3	UniProtKB	Chain	1	414	.	.	.	ID=PRO_0000391387;Note=Wilms tumor protein homolog A	
B7ZSG3	UniProtKB	Zinc finger	288	312	.	.	.	Note=C2H2-type 1	
B7ZSG3	UniProtKB	Zinc finger	318	342	.	.	.	Note=C2H2-type 2	
B7ZSG3	UniProtKB	Zinc finger	348	370	.	.	.	Note=C2H2-type 3	
B7ZSG3	UniProtKB	Zinc finger	379	403	.	.	.	Note=C2H2-type 4	
B7ZSG3	UniProtKB	Region	332	346	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B7ZSG3	UniProtKB	Region	358	366	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B7ZSG3	UniProtKB	Motif	373	375	.	.	.	Note=KTS motif	
B7ZSG3	UniProtKB	Site	389	389	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B7ZSG3	UniProtKB	Site	395	395	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B7ZSG3	UniProtKB	Cross-link	55	55	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
B7ZSG3	UniProtKB	Cross-link	158	158	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
B7ZSG3	UniProtKB	Alternative sequence	373	375	.	.	.	ID=VSP_038721;Note=In isoform 2.	
B7ZSG3	UniProtKB	Sequence conflict	147	147	.	.	.	.	
##sequence-region P79958 1 407
P79958	UniProtKB	Chain	1	407	.	.	.	ID=PRO_0000391388;Note=Wilms tumor protein homolog B	
P79958	UniProtKB	Zinc finger	284	308	.	.	.	Note=C2H2-type 1	
P79958	UniProtKB	Zinc finger	314	338	.	.	.	Note=C2H2-type 2	
P79958	UniProtKB	Zinc finger	344	366	.	.	.	Note=C2H2-type 3	
P79958	UniProtKB	Zinc finger	372	396	.	.	.	Note=C2H2-type 4	
P79958	UniProtKB	Region	328	342	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P79958	UniProtKB	Region	354	362	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P79958	UniProtKB	Site	382	382	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P79958	UniProtKB	Site	388	388	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P79958	UniProtKB	Cross-link	55	55	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P79958	UniProtKB	Cross-link	158	158	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region P19544 1 449
P19544	UniProtKB	Chain	1	449	.	.	.	ID=PRO_0000047131;Note=Wilms tumor protein	
P19544	UniProtKB	Zinc finger	323	347	.	.	.	Note=C2H2-type 1	
P19544	UniProtKB	Zinc finger	353	377	.	.	.	Note=C2H2-type 2	
P19544	UniProtKB	Zinc finger	383	405	.	.	.	Note=C2H2-type 3	
P19544	UniProtKB	Zinc finger	414	438	.	.	.	Note=C2H2-type 4	
P19544	UniProtKB	Region	367	381	.	.	.	Note=Important for interaction with target DNA	
P19544	UniProtKB	Region	393	401	.	.	.	Note=Important for interaction with target DNA	
P19544	UniProtKB	Motif	408	410	.	.	.	Note=KTS motif	
P19544	UniProtKB	Compositional bias	27	83	.	.	.	Note=Pro-rich	
P19544	UniProtKB	Site	424	424	.	.	.	Note=Important for interaction with target DNA	
P19544	UniProtKB	Site	430	430	.	.	.	Note=Important for interaction with target DNA	
P19544	UniProtKB	Cross-link	73	73	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P19544	UniProtKB	Cross-link	177	177	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)	
P19544	UniProtKB	Alternative sequence	1	144	.	.	.	ID=VSP_037582;Note=In isoform 6 and isoform 9.	
P19544	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_037583;Note=In isoform 7 and isoform 8.	
P19544	UniProtKB	Alternative sequence	145	147	.	.	.	ID=VSP_037584;Note=In isoform 6 and isoform 9.	
P19544	UniProtKB	Alternative sequence	250	266	.	.	.	ID=VSP_006866;Note=In isoform 2%2C isoform 3%2C isoform 8 and isoform 9.	
P19544	UniProtKB	Alternative sequence	408	410	.	.	.	ID=VSP_006867;Note=In isoform 2%2C isoform 4 and isoform 6.	
P19544	UniProtKB	Natural variant	131	131	.	.	.	ID=VAR_043798;Note=In a patient with hypospadias.	
P19544	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_007739;Dbxref=dbSNP:rs2234584;Note=In WT1.	
P19544	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_007740;Note=In WT1.	
P19544	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_007741;Note=In WT1.	
P19544	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_007742;Dbxref=dbSNP:rs121907908;Note=Found in a mesothelioma sample%3B somatic mutation.	
P19544	UniProtKB	Natural variant	281	281	.	.	.	ID=VAR_058021;Note=In RNA edited version.	
P19544	UniProtKB	Natural variant	312	312	.	.	.	ID=VAR_015053;Note=In NPHS4.	
P19544	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_007743;Note=In DDS.	
P19544	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_015054;Note=In DDS.	
P19544	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_043799;Note=In WT1.	
P19544	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_015055;Note=In DDS.	
P19544	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_007744;Note=In DDS.	
P19544	UniProtKB	Natural variant	360	360	.	.	.	ID=VAR_043800;Note=In DDS.	
P19544	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_043801;Note=In NPHS4.	
P19544	UniProtKB	Natural variant	366	366	.	.	.	ID=VAR_007745;Note=In WT1%2C DDS and MEACHS.	
P19544	UniProtKB	Natural variant	366	366	.	.	.	ID=VAR_007746;Note=In DDS and WT1.	
P19544	UniProtKB	Natural variant	366	366	.	.	.	ID=VAR_043802;Note=In DDS.	
P19544	UniProtKB	Natural variant	369	369	.	.	.	ID=VAR_043803;Note=In DDS.	
P19544	UniProtKB	Natural variant	373	373	.	.	.	ID=VAR_007747;Note=In DDS and WT1.	
P19544	UniProtKB	Natural variant	373	373	.	.	.	ID=VAR_015056;Note=In DDS.	
P19544	UniProtKB	Natural variant	377	377	.	.	.	ID=VAR_015057;Note=In DDS.	
P19544	UniProtKB	Natural variant	377	377	.	.	.	ID=VAR_007748;Note=In NPHS4.	
P19544	UniProtKB	Natural variant	379	379	.	.	.	ID=VAR_043804;Note=In NPHS4.	
P19544	UniProtKB	Natural variant	383	383	.	.	.	ID=VAR_007749;Note=In NPHS4.	
P19544	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_015058;Note=In DDS.	
P19544	UniProtKB	Natural variant	388	388	.	.	.	ID=VAR_015059;Note=In DDS.	
P19544	UniProtKB	Natural variant	388	388	.	.	.	ID=VAR_043805;Note=In NPHS4.	
P19544	UniProtKB	Natural variant	388	388	.	.	.	ID=VAR_043806;Note=In DDS.	
P19544	UniProtKB	Natural variant	392	392	.	.	.	ID=VAR_015060;Note=In FS.	
P19544	UniProtKB	Natural variant	394	394	.	.	.	ID=VAR_043807;Note=In WT1.	
P19544	UniProtKB	Natural variant	394	394	.	.	.	ID=VAR_043808;Note=In DDS.	
P19544	UniProtKB	Natural variant	394	394	.	.	.	ID=VAR_015061;Note=In DDS.	
P19544	UniProtKB	Natural variant	394	394	.	.	.	ID=VAR_007750;Note=In DDS%2C WT1 and MEACHS.	
P19544	UniProtKB	Natural variant	396	396	.	.	.	ID=VAR_007752;Note=In DDS.	
P19544	UniProtKB	Natural variant	396	396	.	.	.	ID=VAR_007751;Note=In DDS and NPHS4.	
P19544	UniProtKB	Natural variant	396	396	.	.	.	ID=VAR_043809;Note=In DDS.	
P19544	UniProtKB	Natural variant	397	397	.	.	.	ID=VAR_043810;Note=In NPHS4.	
P19544	UniProtKB	Natural variant	398	398	.	.	.	ID=VAR_015062;Note=In DDS.	
P19544	UniProtKB	Natural variant	401	401	.	.	.	ID=VAR_043811;Note=In DDS.	
P19544	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_043812;Note=In DDS.	
P19544	UniProtKB	Mutagenesis	73	73	.	.	.	Note=Abolishes sumoylation%3B when associated with R-177.	
P19544	UniProtKB	Mutagenesis	177	177	.	.	.	Note=Abolishes sumoylation%3B when associated with R-77.	
P19544	UniProtKB	Mutagenesis	343	343	.	.	.	Note=Reduced RNA binding.	
P19544	UniProtKB	Mutagenesis	366	366	.	.	.	Note=Strongly reduced binding of DNA and RNA.	
P19544	UniProtKB	Mutagenesis	372	372	.	.	.	Note=Strongly reduced binding of DNA and RNA.	
P19544	UniProtKB	Mutagenesis	394	394	.	.	.	Note=Strongly reduced binding of DNA and RNA.	
P19544	UniProtKB	Mutagenesis	434	434	.	.	.	Note=Reduced RNA binding.	
P19544	UniProtKB	Sequence conflict	288	288	.	.	.	.	
P19544	UniProtKB	Sequence conflict	365	365	.	.	.	.	
P19544	UniProtKB	Sequence conflict	365	365	.	.	.	.	
P19544	UniProtKB	Sequence conflict	387	387	.	.	.	.	
P19544	UniProtKB	Beta strand	322	324	.	.	.	.	
P19544	UniProtKB	Turn	328	330	.	.	.	.	
P19544	UniProtKB	Beta strand	333	337	.	.	.	.	
P19544	UniProtKB	Helix	338	344	.	.	.	.	
P19544	UniProtKB	Helix	345	349	.	.	.	.	
P19544	UniProtKB	Beta strand	363	366	.	.	.	.	
P19544	UniProtKB	Helix	367	378	.	.	.	.	
P19544	UniProtKB	Turn	386	388	.	.	.	.	
P19544	UniProtKB	Beta strand	391	393	.	.	.	.	
P19544	UniProtKB	Helix	395	406	.	.	.	.	
P19544	UniProtKB	Beta strand	418	420	.	.	.	.	
P19544	UniProtKB	Beta strand	424	427	.	.	.	.	
P19544	UniProtKB	Helix	428	435	.	.	.	.	
##sequence-region P22561 1 449
P22561	UniProtKB	Chain	1	449	.	.	.	ID=PRO_0000047132;Note=Wilms tumor protein homolog	
P22561	UniProtKB	Zinc finger	323	347	.	.	.	Note=C2H2-type 1	
P22561	UniProtKB	Zinc finger	353	377	.	.	.	Note=C2H2-type 2	
P22561	UniProtKB	Zinc finger	383	405	.	.	.	Note=C2H2-type 3	
P22561	UniProtKB	Zinc finger	414	438	.	.	.	Note=C2H2-type 4	
P22561	UniProtKB	Region	367	381	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P22561	UniProtKB	Region	393	401	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P22561	UniProtKB	Motif	408	410	.	.	.	Note=KTS motif;status=By similarity	
P22561	UniProtKB	Compositional bias	28	83	.	.	.	Note=Pro-rich	
P22561	UniProtKB	Site	424	424	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P22561	UniProtKB	Site	430	430	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P22561	UniProtKB	Cross-link	73	73	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P22561	UniProtKB	Cross-link	177	177	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P22561	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_037585;Note=In isoform 5 and isoform 6.	
P22561	UniProtKB	Alternative sequence	250	266	.	.	.	ID=VSP_006868;Note=In isoform 2%2C isoform 3 and isoform 6.	
P22561	UniProtKB	Alternative sequence	408	410	.	.	.	ID=VSP_006869;Note=In isoform 2 and isoform 4.	
P22561	UniProtKB	Natural variant	281	281	.	.	.	Note=In RNA edited version.	
P22561	UniProtKB	Sequence conflict	33	33	.	.	.	.	
P22561	UniProtKB	Sequence conflict	269	269	.	.	.	.	
P22561	UniProtKB	Sequence conflict	446	447	.	.	.	.	
##sequence-region O62651 1 449
O62651	UniProtKB	Chain	1	449	.	.	.	ID=PRO_0000047133;Note=Wilms tumor protein homolog	
O62651	UniProtKB	Zinc finger	323	347	.	.	.	Note=C2H2-type 1	
O62651	UniProtKB	Zinc finger	353	377	.	.	.	Note=C2H2-type 2	
O62651	UniProtKB	Zinc finger	383	405	.	.	.	Note=C2H2-type 3	
O62651	UniProtKB	Zinc finger	414	438	.	.	.	Note=C2H2-type 4	
O62651	UniProtKB	Region	367	381	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
O62651	UniProtKB	Region	393	401	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
O62651	UniProtKB	Motif	408	410	.	.	.	Note=KTS motif;status=By similarity	
O62651	UniProtKB	Compositional bias	28	83	.	.	.	Note=Pro-rich	
O62651	UniProtKB	Site	424	424	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
O62651	UniProtKB	Site	430	430	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
O62651	UniProtKB	Cross-link	73	73	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
O62651	UniProtKB	Cross-link	177	177	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
O62651	UniProtKB	Alternative sequence	250	266	.	.	.	ID=VSP_006870;Note=In isoform 2 and isoform 3.	
O62651	UniProtKB	Alternative sequence	408	410	.	.	.	ID=VSP_006871;Note=In isoform 2 and isoform 4.	
O62651	UniProtKB	Natural variant	281	281	.	.	.	Note=In RNA edited version.	
##sequence-region P49952 1 448
P49952	UniProtKB	Chain	1	448	.	.	.	ID=PRO_0000047134;Note=Wilms tumor protein homolog	
P49952	UniProtKB	Zinc finger	322	346	.	.	.	Note=C2H2-type 1	
P49952	UniProtKB	Zinc finger	352	376	.	.	.	Note=C2H2-type 2	
P49952	UniProtKB	Zinc finger	382	404	.	.	.	Note=C2H2-type 3	
P49952	UniProtKB	Zinc finger	413	437	.	.	.	Note=C2H2-type 4	
P49952	UniProtKB	Region	366	380	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49952	UniProtKB	Region	392	400	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49952	UniProtKB	Motif	407	409	.	.	.	Note=KTS motif;status=By similarity	
P49952	UniProtKB	Compositional bias	27	82	.	.	.	Note=Pro-rich	
P49952	UniProtKB	Site	423	423	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49952	UniProtKB	Site	429	429	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49952	UniProtKB	Cross-link	72	72	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P49952	UniProtKB	Cross-link	176	176	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
P49952	UniProtKB	Alternative sequence	249	265	.	.	.	ID=VSP_006872;Note=In isoform 2 and isoform 3.	
P49952	UniProtKB	Alternative sequence	407	409	.	.	.	ID=VSP_006873;Note=In isoform 2 and isoform 4.	
P49952	UniProtKB	Natural variant	280	280	.	.	.	Note=In RNA edited version.	
##sequence-region P49953 1 239
P49953	UniProtKB	Chain	1	239	.	.	.	ID=PRO_0000047136;Note=Wilms tumor protein homolog	
P49953	UniProtKB	Zinc finger	113	137	.	.	.	Note=C2H2-type 1	
P49953	UniProtKB	Zinc finger	143	167	.	.	.	Note=C2H2-type 2	
P49953	UniProtKB	Zinc finger	173	195	.	.	.	Note=C2H2-type 3	
P49953	UniProtKB	Zinc finger	204	228	.	.	.	Note=C2H2-type 4	
P49953	UniProtKB	Region	157	171	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49953	UniProtKB	Region	183	191	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49953	UniProtKB	Motif	198	200	.	.	.	Note=KTS motif;status=By similarity	
P49953	UniProtKB	Site	214	214	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49953	UniProtKB	Site	220	220	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
P49953	UniProtKB	Alternative sequence	198	200	.	.	.	ID=VSP_006875;Note=In isoform 2.	
P49953	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region B5DE03 1 413
B5DE03	UniProtKB	Chain	1	413	.	.	.	ID=PRO_0000391389;Note=Wilms tumor protein homolog	
B5DE03	UniProtKB	Zinc finger	290	314	.	.	.	Note=C2H2-type 1	
B5DE03	UniProtKB	Zinc finger	320	344	.	.	.	Note=C2H2-type 2	
B5DE03	UniProtKB	Zinc finger	350	372	.	.	.	Note=C2H2-type 3	
B5DE03	UniProtKB	Zinc finger	378	402	.	.	.	Note=C2H2-type 4	
B5DE03	UniProtKB	Region	334	348	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B5DE03	UniProtKB	Region	360	368	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B5DE03	UniProtKB	Site	388	388	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B5DE03	UniProtKB	Site	394	394	.	.	.	Note=Important for interaction with target DNA;status=By similarity	
B5DE03	UniProtKB	Cross-link	56	56	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
B5DE03	UniProtKB	Cross-link	159	159	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);status=By similarity	
##sequence-region Q9NZC7 1 414
Q9NZC7	UniProtKB	Chain	1	414	.	.	.	ID=PRO_0000054815;Note=WW domain-containing oxidoreductase	
Q9NZC7	UniProtKB	Domain	16	49	.	.	.	Note=WW 1	
Q9NZC7	UniProtKB	Domain	57	90	.	.	.	Note=WW 2	
Q9NZC7	UniProtKB	Nucleotide binding	131	137	.	.	.	Note=NADP;status=By similarity	
Q9NZC7	UniProtKB	Region	125	414	.	.	.	Note=Interaction with MAPT;status=By similarity	
Q9NZC7	UniProtKB	Region	209	273	.	.	.	Note=Mediates targeting to the mitochondria;status=By similarity	
Q9NZC7	UniProtKB	Motif	50	55	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q9NZC7	UniProtKB	Active site	293	293	.	.	.	Note=Proton acceptor;status=By similarity	
Q9NZC7	UniProtKB	Binding site	260	260	.	.	.	Note=Substrate;status=By similarity	
Q9NZC7	UniProtKB	Modified residue	12	12	.	.	.	Note=Phosphothreonine	
Q9NZC7	UniProtKB	Modified residue	14	14	.	.	.	Note=Phosphoserine	
Q9NZC7	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphotyrosine	
Q9NZC7	UniProtKB	Modified residue	287	287	.	.	.	Note=Phosphotyrosine%3B by TNK2	
Q9NZC7	UniProtKB	Alternative sequence	36	36	.	.	.	ID=VSP_016358;Note=In isoform 4.	
Q9NZC7	UniProtKB	Alternative sequence	37	414	.	.	.	ID=VSP_016359;Note=In isoform 4.	
Q9NZC7	UniProtKB	Alternative sequence	137	414	.	.	.	ID=VSP_016360;Note=In isoform 6.	
Q9NZC7	UniProtKB	Alternative sequence	138	213	.	.	.	ID=VSP_016362;Note=In isoform 7.	
Q9NZC7	UniProtKB	Alternative sequence	173	352	.	.	.	ID=VSP_016363;Note=In isoform 5.	
Q9NZC7	UniProtKB	Alternative sequence	173	189	.	.	.	ID=VSP_016364;Note=In isoform 3.	
Q9NZC7	UniProtKB	Alternative sequence	190	414	.	.	.	ID=VSP_016365;Note=In isoform 3.	
Q9NZC7	UniProtKB	Alternative sequence	214	414	.	.	.	ID=VSP_016366;Note=In isoform 7.	
Q9NZC7	UniProtKB	Alternative sequence	353	363	.	.	.	ID=VSP_016367;Note=In isoform 2.	
Q9NZC7	UniProtKB	Alternative sequence	364	414	.	.	.	ID=VSP_016369;Note=In isoform 2.	
Q9NZC7	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_023916;Dbxref=dbSNP:rs144601717	
Q9NZC7	UniProtKB	Natural variant	111	111	.	.	.	ID=VAR_023917;Dbxref=dbSNP:rs114755364;Note=In a Burkitt lymphoma cell line.	
Q9NZC7	UniProtKB	Natural variant	120	120	.	.	.	ID=VAR_023918;Dbxref=dbSNP:rs141361080;Note=In a primary colorectal tumor and a histiocytic lymphoma cell line.	
Q9NZC7	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_023919;Dbxref=dbSNP:rs12918952	
Q9NZC7	UniProtKB	Natural variant	216	216	.	.	.	ID=VAR_052323;Dbxref=dbSNP:rs7201683	
Q9NZC7	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_023920;Dbxref=dbSNP:rs186745328	
Q9NZC7	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_023921;Dbxref=dbSNP:rs3764340	
Q9NZC7	UniProtKB	Natural variant	291	291	.	.	.	ID=VAR_023922;Note=Found in a esophageal cancer sample%3B somatic mutation.	
Q9NZC7	UniProtKB	Natural variant	314	314	.	.	.	ID=VAR_023923;Dbxref=dbSNP:rs73572838;Note=In a cervical carcinoma cell line.	
Q9NZC7	UniProtKB	Mutagenesis	28	28	.	.	.	Note=No effect on interaction with TP53. Abolishes interaction with MAPK8%3B when associated with V-29.	
Q9NZC7	UniProtKB	Mutagenesis	29	29	.	.	.	Note=No effect on interaction with TP53. Abolishes interaction with MAPK8%3B when associated with T-28.	
Q9NZC7	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Loss of phosphorylation.	
Q9NZC7	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Abolishes interaction with TP53%2C TP73%2C MAPK8 and ERBB4. Partial loss of interaction with TFAP2C. Loss of phosphorylation. Loss of the proapoptotic activity.	
Q9NZC7	UniProtKB	Mutagenesis	44	47	.	.	.	Note=Abolishes interaction with LITAF.	
Q9NZC7	UniProtKB	Mutagenesis	61	61	.	.	.	Note=No effect on interaction with TP73.	
Q9NZC7	UniProtKB	Mutagenesis	85	88	.	.	.	Note=No effect on interaction with LITAF.	
Q9NZC7	UniProtKB	Mutagenesis	287	287	.	.	.	Note=Loss of phosphorylation by TNK2.	
Q9NZC7	UniProtKB	Beta strand	63	67	.	.	.	.	
Q9NZC7	UniProtKB	Beta strand	73	80	.	.	.	.	
Q9NZC7	UniProtKB	Beta strand	83	86	.	.	.	.	
##sequence-region Q91WL8 1 414
Q91WL8	UniProtKB	Chain	1	414	.	.	.	ID=PRO_0000054816;Note=WW domain-containing oxidoreductase	
Q91WL8	UniProtKB	Domain	16	49	.	.	.	Note=WW 1	
Q91WL8	UniProtKB	Domain	57	90	.	.	.	Note=WW 2	
Q91WL8	UniProtKB	Nucleotide binding	131	137	.	.	.	Note=NADP;status=By similarity	
Q91WL8	UniProtKB	Region	125	414	.	.	.	Note=Interaction with MAPT	
Q91WL8	UniProtKB	Region	209	273	.	.	.	Note=Mediates targeting to the mitochondria	
Q91WL8	UniProtKB	Motif	50	55	.	.	.	Note=Nuclear localization signal	
Q91WL8	UniProtKB	Active site	293	293	.	.	.	Note=Proton acceptor;status=By similarity	
Q91WL8	UniProtKB	Binding site	260	260	.	.	.	Note=Substrate;status=By similarity	
Q91WL8	UniProtKB	Modified residue	12	12	.	.	.	Note=Phosphothreonine;status=By similarity	
Q91WL8	UniProtKB	Modified residue	14	14	.	.	.	Note=Phosphoserine;status=By similarity	
Q91WL8	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphotyrosine	
Q91WL8	UniProtKB	Modified residue	287	287	.	.	.	Note=Phosphotyrosine%3B by TNK2;status=By similarity	
Q91WL8	UniProtKB	Alternative sequence	137	158	.	.	.	ID=VSP_016370;Note=In isoform 2.	
Q91WL8	UniProtKB	Alternative sequence	159	414	.	.	.	ID=VSP_016371;Note=In isoform 2.	
Q91WL8	UniProtKB	Alternative sequence	353	367	.	.	.	ID=VSP_016372;Note=In isoform 4.	
Q91WL8	UniProtKB	Alternative sequence	353	354	.	.	.	ID=VSP_016373;Note=In isoform 3.	
Q91WL8	UniProtKB	Alternative sequence	355	414	.	.	.	ID=VSP_016374;Note=In isoform 3.	
Q91WL8	UniProtKB	Alternative sequence	368	414	.	.	.	ID=VSP_016375;Note=In isoform 4.	
Q91WL8	UniProtKB	Mutagenesis	51	54	.	.	.	Note=Abolishes the TNF-induced nuclear translocation.	
Q91WL8	UniProtKB	Sequence conflict	135	135	.	.	.	.	
Q91WL8	UniProtKB	Sequence conflict	231	231	.	.	.	.	
Q91WL8	UniProtKB	Sequence conflict	231	231	.	.	.	.	
##sequence-region Q5R9W5 1 414
Q5R9W5	UniProtKB	Chain	1	414	.	.	.	ID=PRO_0000054817;Note=WW domain-containing oxidoreductase	
Q5R9W5	UniProtKB	Domain	16	49	.	.	.	Note=WW 1	
Q5R9W5	UniProtKB	Domain	57	90	.	.	.	Note=WW 2	
Q5R9W5	UniProtKB	Nucleotide binding	131	137	.	.	.	Note=NADP;status=By similarity	
Q5R9W5	UniProtKB	Region	125	414	.	.	.	Note=Interaction with MAPT;status=By similarity	
Q5R9W5	UniProtKB	Region	209	273	.	.	.	Note=Mediates targeting to the mitochondria;status=By similarity	
Q5R9W5	UniProtKB	Motif	50	55	.	.	.	Note=Nuclear localization signal;status=By similarity	
Q5R9W5	UniProtKB	Active site	293	293	.	.	.	Note=Proton acceptor;status=By similarity	
Q5R9W5	UniProtKB	Binding site	260	260	.	.	.	Note=Substrate;status=By similarity	
Q5R9W5	UniProtKB	Modified residue	12	12	.	.	.	Note=Phosphothreonine;status=By similarity	
Q5R9W5	UniProtKB	Modified residue	14	14	.	.	.	Note=Phosphoserine;status=By similarity	
Q5R9W5	UniProtKB	Modified residue	33	33	.	.	.	Note=Phosphotyrosine;status=By similarity	
Q5R9W5	UniProtKB	Modified residue	287	287	.	.	.	Note=Phosphotyrosine%3B by TNK2;status=By similarity	
##sequence-region Q58DH1 1 297
Q58DH1	UniProtKB	Chain	1	297	.	.	.	ID=PRO_0000329027;Note=XIAP-associated factor 1	
Q58DH1	UniProtKB	Zinc finger	22	99	.	.	.	Note=TRAF-type	
Q58DH1	UniProtKB	Alternative sequence	284	297	.	.	.	ID=VSP_032917;Note=In isoform 2.	
Q58DH1	UniProtKB	Sequence conflict	26	26	.	.	.	.	
Q58DH1	UniProtKB	Sequence conflict	72	72	.	.	.	.	
Q58DH1	UniProtKB	Sequence conflict	130	130	.	.	.	.	
##sequence-region Q6GPH4 1 301
Q6GPH4	UniProtKB	Chain	1	301	.	.	.	ID=PRO_0000329028;Note=XIAP-associated factor 1	
Q6GPH4	UniProtKB	Zinc finger	22	99	.	.	.	Note=TRAF-type	
Q6GPH4	UniProtKB	Alternative sequence	1	102	.	.	.	ID=VSP_032918;Note=In isoform 6.	
Q6GPH4	UniProtKB	Alternative sequence	57	75	.	.	.	ID=VSP_032919;Note=In isoform 2 and isoform 4.	
Q6GPH4	UniProtKB	Alternative sequence	57	74	.	.	.	ID=VSP_032920;Note=In isoform 7.	
Q6GPH4	UniProtKB	Alternative sequence	103	140	.	.	.	ID=VSP_032921;Note=In isoform 6.	
Q6GPH4	UniProtKB	Alternative sequence	141	301	.	.	.	ID=VSP_032922;Note=In isoform 5.	
Q6GPH4	UniProtKB	Alternative sequence	142	301	.	.	.	ID=VSP_032923;Note=In isoform 3 and isoform 4.	
Q6GPH4	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_042616;Dbxref=dbSNP:rs34195599	
Q6GPH4	UniProtKB	Natural variant	132	132	.	.	.	ID=VAR_042617;Dbxref=dbSNP:rs2271232	
Q6GPH4	UniProtKB	Natural variant	188	188	.	.	.	ID=VAR_042618;Dbxref=dbSNP:rs34625877	
Q6GPH4	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_042619;Dbxref=dbSNP:rs3736433	
Q6GPH4	UniProtKB	Sequence conflict	132	132	.	.	.	.	
Q6GPH4	UniProtKB	Sequence conflict	138	138	.	.	.	.	
Q6GPH4	UniProtKB	Sequence conflict	196	196	.	.	.	.	
##sequence-region Q5NBU8 1 273
Q5NBU8	UniProtKB	Chain	1	273	.	.	.	ID=PRO_0000329029;Note=XIAP-associated factor 1	
Q5NBU8	UniProtKB	Zinc finger	22	80	.	.	.	Note=TRAF-type	
Q5NBU8	UniProtKB	Alternative sequence	57	151	.	.	.	ID=VSP_039715;Note=In isoform 2.	
##sequence-region Q8IZH2 1 1706
Q8IZH2	UniProtKB	Chain	1	1706	.	.	.	ID=PRO_0000071392;Note=5'-3' exoribonuclease 1	
Q8IZH2	UniProtKB	Modified residue	1348	1348	.	.	.	Note=Phosphoserine;status=By similarity	
Q8IZH2	UniProtKB	Alternative sequence	449	459	.	.	.	ID=VSP_016692;Note=In isoform 3.	
Q8IZH2	UniProtKB	Alternative sequence	460	1706	.	.	.	ID=VSP_016693;Note=In isoform 3.	
Q8IZH2	UniProtKB	Alternative sequence	1354	1354	.	.	.	ID=VSP_016694;Note=In isoform 2.	
Q8IZH2	UniProtKB	Alternative sequence	1540	1552	.	.	.	ID=VSP_016695;Note=In isoform 2.	
Q8IZH2	UniProtKB	Natural variant	674	674	.	.	.	ID=VAR_053000;Dbxref=dbSNP:rs35214510	
Q8IZH2	UniProtKB	Natural variant	1259	1259	.	.	.	ID=VAR_053001;Dbxref=dbSNP:rs35902661	
Q8IZH2	UniProtKB	Sequence conflict	48	48	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	55	55	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	113	113	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	142	142	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	148	148	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	572	572	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	722	722	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	834	834	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	1250	1250	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	1463	1463	.	.	.	.	
Q8IZH2	UniProtKB	Sequence conflict	1686	1686	.	.	.	.	
##sequence-region A1YPR0 1 619
A1YPR0	UniProtKB	Chain	1	619	.	.	.	ID=PRO_0000337869;Note=Zinc finger and BTB domain-containing protein 7C	
A1YPR0	UniProtKB	Domain	34	101	.	.	.	Note=BTB	
A1YPR0	UniProtKB	Zinc finger	364	386	.	.	.	Note=C2H2-type 1	
A1YPR0	UniProtKB	Zinc finger	392	414	.	.	.	Note=C2H2-type 2	
A1YPR0	UniProtKB	Zinc finger	420	442	.	.	.	Note=C2H2-type 3	
A1YPR0	UniProtKB	Zinc finger	448	478	.	.	.	Note=C2H2-type 4%3B degenerate	
A1YPR0	UniProtKB	Compositional bias	125	162	.	.	.	Note=Glu-rich	
A1YPR0	UniProtKB	Compositional bias	132	182	.	.	.	Note=Asp-rich	
A1YPR0	UniProtKB	Compositional bias	298	324	.	.	.	Note=Pro-rich	
##sequence-region Q8VCZ7 1 619
Q8VCZ7	UniProtKB	Chain	1	619	.	.	.	ID=PRO_0000337870;Note=Zinc finger and BTB domain-containing protein 7C	
Q8VCZ7	UniProtKB	Domain	34	101	.	.	.	Note=BTB	
Q8VCZ7	UniProtKB	Zinc finger	364	386	.	.	.	Note=C2H2-type 1	
Q8VCZ7	UniProtKB	Zinc finger	392	414	.	.	.	Note=C2H2-type 2	
Q8VCZ7	UniProtKB	Zinc finger	420	442	.	.	.	Note=C2H2-type 3	
Q8VCZ7	UniProtKB	Zinc finger	448	478	.	.	.	Note=C2H2-type 4%3B degenerate	
Q8VCZ7	UniProtKB	Compositional bias	125	169	.	.	.	Note=Glu-rich	
Q8VCZ7	UniProtKB	Compositional bias	137	209	.	.	.	Note=Asp-rich	
Q8VCZ7	UniProtKB	Compositional bias	299	304	.	.	.	Note=Poly-Pro	
##sequence-region Q8IUH5 1 632
Q8IUH5	UniProtKB	Chain	1	632	.	.	.	ID=PRO_0000212900;Note=Palmitoyltransferase ZDHHC17	
Q8IUH5	UniProtKB	Topological domain	1	304	.	.	.	Note=Cytoplasmic;status=Potential	
Q8IUH5	UniProtKB	Transmembrane	305	325	.	.	.	Note=Helical%3B;status=Potential	
Q8IUH5	UniProtKB	Transmembrane	326	346	.	.	.	Note=Helical%3B;status=Potential	
Q8IUH5	UniProtKB	Topological domain	347	357	.	.	.	Note=Cytoplasmic;status=Potential	
Q8IUH5	UniProtKB	Transmembrane	358	378	.	.	.	Note=Helical%3B;status=Potential	
Q8IUH5	UniProtKB	Topological domain	379	381	.	.	.	Note=Lumenal;status=Potential	
Q8IUH5	UniProtKB	Transmembrane	382	402	.	.	.	Note=Helical%3B;status=Potential	
Q8IUH5	UniProtKB	Topological domain	403	480	.	.	.	Note=Cytoplasmic;status=Potential	
Q8IUH5	UniProtKB	Transmembrane	481	501	.	.	.	Note=Helical%3B;status=Potential	
Q8IUH5	UniProtKB	Topological domain	502	529	.	.	.	Note=Lumenal;status=Potential	
Q8IUH5	UniProtKB	Transmembrane	530	550	.	.	.	Note=Helical%3B;status=Potential	
Q8IUH5	UniProtKB	Topological domain	551	632	.	.	.	Note=Cytoplasmic;status=Potential	
Q8IUH5	UniProtKB	Repeat	89	118	.	.	.	Note=ANK 1	
Q8IUH5	UniProtKB	Repeat	123	155	.	.	.	Note=ANK 2	
Q8IUH5	UniProtKB	Repeat	156	188	.	.	.	Note=ANK 3	
Q8IUH5	UniProtKB	Repeat	189	219	.	.	.	Note=ANK 4	
Q8IUH5	UniProtKB	Repeat	224	253	.	.	.	Note=ANK 5	
Q8IUH5	UniProtKB	Zinc finger	437	487	.	.	.	Note=DHHC-type	
Q8IUH5	UniProtKB	Active site	467	467	.	.	.	Note=S-palmitoyl cysteine intermediate;status=Probable	
Q8IUH5	UniProtKB	Alternative sequence	1	50	.	.	.	ID=VSP_010021;Note=In isoform 2.	
Q8IUH5	UniProtKB	Alternative sequence	51	66	.	.	.	ID=VSP_010022;Note=In isoform 2.	
Q8IUH5	UniProtKB	Alternative sequence	204	632	.	.	.	ID=VSP_010023;Note=In isoform 3.	
Q8IUH5	UniProtKB	Alternative sequence	258	266	.	.	.	ID=VSP_010024;Note=In isoform 2.	
Q8IUH5	UniProtKB	Alternative sequence	267	632	.	.	.	ID=VSP_010025;Note=In isoform 2.	
Q8IUH5	UniProtKB	Natural variant	383	383	.	.	.	ID=VAR_052978;Dbxref=dbSNP:rs33996476	
Q8IUH5	UniProtKB	Mutagenesis	467	467	.	.	.	Note=Abolishes palmitoyltransferase activity.	
Q8IUH5	UniProtKB	Sequence conflict	3	3	.	.	.	.	
Q8IUH5	UniProtKB	Sequence conflict	39	39	.	.	.	.	
Q8IUH5	UniProtKB	Sequence conflict	173	173	.	.	.	.	
Q8IUH5	UniProtKB	Sequence conflict	182	182	.	.	.	.	
Q8IUH5	UniProtKB	Helix	56	58	.	.	.	.	
Q8IUH5	UniProtKB	Helix	61	66	.	.	.	.	
Q8IUH5	UniProtKB	Helix	70	78	.	.	.	.	
Q8IUH5	UniProtKB	Helix	93	99	.	.	.	.	
Q8IUH5	UniProtKB	Helix	103	111	.	.	.	.	
Q8IUH5	UniProtKB	Turn	121	124	.	.	.	.	
Q8IUH5	UniProtKB	Helix	127	134	.	.	.	.	
Q8IUH5	UniProtKB	Helix	137	145	.	.	.	.	
Q8IUH5	UniProtKB	Helix	160	166	.	.	.	.	
Q8IUH5	UniProtKB	Helix	170	178	.	.	.	.	
Q8IUH5	UniProtKB	Helix	193	200	.	.	.	.	
Q8IUH5	UniProtKB	Helix	207	212	.	.	.	.	
Q8IUH5	UniProtKB	Turn	222	224	.	.	.	.	
Q8IUH5	UniProtKB	Helix	228	235	.	.	.	.	
Q8IUH5	UniProtKB	Helix	238	247	.	.	.	.	
Q8IUH5	UniProtKB	Helix	261	267	.	.	.	.	
Q8IUH5	UniProtKB	Helix	271	280	.	.	.	.	
##sequence-region Q80TN5 1 632
Q80TN5	UniProtKB	Chain	1	632	.	.	.	ID=PRO_0000212901;Note=Palmitoyltransferase ZDHHC17	
Q80TN5	UniProtKB	Topological domain	1	304	.	.	.	Note=Cytoplasmic;status=Potential	
Q80TN5	UniProtKB	Transmembrane	305	325	.	.	.	Note=Helical%3B;status=Potential	
Q80TN5	UniProtKB	Transmembrane	326	346	.	.	.	Note=Helical%3B;status=Potential	
Q80TN5	UniProtKB	Topological domain	347	357	.	.	.	Note=Cytoplasmic;status=Potential	
Q80TN5	UniProtKB	Transmembrane	358	378	.	.	.	Note=Helical%3B;status=Potential	
Q80TN5	UniProtKB	Topological domain	379	381	.	.	.	Note=Lumenal;status=Potential	
Q80TN5	UniProtKB	Transmembrane	382	402	.	.	.	Note=Helical%3B;status=Potential	
Q80TN5	UniProtKB	Topological domain	403	480	.	.	.	Note=Cytoplasmic;status=Potential	
Q80TN5	UniProtKB	Transmembrane	481	501	.	.	.	Note=Helical%3B;status=Potential	
Q80TN5	UniProtKB	Topological domain	502	529	.	.	.	Note=Lumenal;status=Potential	
Q80TN5	UniProtKB	Transmembrane	530	550	.	.	.	Note=Helical%3B;status=Potential	
Q80TN5	UniProtKB	Topological domain	551	632	.	.	.	Note=Cytoplasmic;status=Potential	
Q80TN5	UniProtKB	Repeat	89	118	.	.	.	Note=ANK 1	
Q80TN5	UniProtKB	Repeat	123	152	.	.	.	Note=ANK 2	
Q80TN5	UniProtKB	Repeat	156	185	.	.	.	Note=ANK 3	
Q80TN5	UniProtKB	Repeat	189	219	.	.	.	Note=ANK 4	
Q80TN5	UniProtKB	Repeat	224	253	.	.	.	Note=ANK 5	
Q80TN5	UniProtKB	Zinc finger	437	487	.	.	.	Note=DHHC-type	
Q80TN5	UniProtKB	Active site	467	467	.	.	.	Note=S-palmitoyl cysteine intermediate;status=By similarity	
Q80TN5	UniProtKB	Alternative sequence	423	429	.	.	.	ID=VSP_010026;Note=In isoform 2.	
Q80TN5	UniProtKB	Alternative sequence	430	632	.	.	.	ID=VSP_010027;Note=In isoform 2.	
Q80TN5	UniProtKB	Sequence conflict	288	288	.	.	.	.	
##sequence-region K7PPA8 1 393
##sequence-region A4GWB5 1 99
A4GWB5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4GWB5	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region A4GW67 1 82
A4GW67	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4GW67	UniProtKB	Non-terminal residue	82	82	.	.	.	.	
##sequence-region L0EQ05 1 107
L0EQ05	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQ05	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0EPY0 1 107
L0EPY0	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EPY0	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region Q1MSX0 1 382
Q1MSX0	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q1MSX0	UniProtKB	Non-terminal residue	382	382	.	.	.	.	
##sequence-region L0EQS1 1 99
L0EQS1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQS1	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region L0EQ92 1 107
L0EQ92	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQ92	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region Q1MSW9 1 285
Q1MSW9	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q1MSW9	UniProtKB	Non-terminal residue	285	285	.	.	.	.	
##sequence-region L0EPV7 1 107
L0EPV7	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EPV7	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region Q1MSW8 1 343
Q1MSW8	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q1MSW8	UniProtKB	Non-terminal residue	343	343	.	.	.	.	
##sequence-region L0ENG9 1 107
L0ENG9	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ENG9	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0EQU5 1 107
L0EQU5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQU5	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region J3KP33 1 343
##sequence-region A4GW76 1 73
A4GW76	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4GW76	UniProtKB	Non-terminal residue	73	73	.	.	.	.	
##sequence-region A4GW97 1 80
A4GW97	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4GW97	UniProtKB	Non-terminal residue	80	80	.	.	.	.	
##sequence-region B4DNI2 1 383
##sequence-region E7ESS1 1 199
E7ESS1	UniProtKB	Non-terminal residue	199	199	.	.	.	.	
##sequence-region H2EHT1 1 354
##sequence-region A4GW74 1 75
A4GW74	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4GW74	UniProtKB	Non-terminal residue	75	75	.	.	.	.	
##sequence-region E7EMR6 1 165
E7EMR6	UniProtKB	Non-terminal residue	165	165	.	.	.	.	
##sequence-region A4GW75 1 77
A4GW75	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4GW75	UniProtKB	Non-terminal residue	77	77	.	.	.	.	
##sequence-region C9D7D0 1 416
##sequence-region B2ZAH2 1 39
B2ZAH2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
B2ZAH2	UniProtKB	Non-terminal residue	39	39	.	.	.	.	
##sequence-region B7Z8Z1 1 350
##sequence-region E7EQX7 1 285
##sequence-region H6U5S2 1 393
H6U5S2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region H6U5S3 1 393
H6U5S3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region H6U5S4 1 286
H6U5S4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region L0EQP9 1 107
L0EQP9	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQP9	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0EP99 1 99
L0EP99	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EP99	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region L0EPZ1 1 107
L0EPZ1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EPZ1	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0EQ52 1 107
L0EQ52	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQ52	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0ERS6 1 99
L0ERS6	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ERS6	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region Q2XSC7 1 393
##sequence-region Q5U0E4 1 393
Q5U0E4	UniProtKB	Modified residue	382	382	.	.	.	Note=N6-methyllysine	
##sequence-region C9D7C9 1 356
##sequence-region L0ENF7 1 107
L0ENF7	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ENF7	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0ES92 1 99
L0ES92	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ES92	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region Q27HK5 1 112
Q27HK5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q27HK5	UniProtKB	Non-terminal residue	112	112	.	.	.	.	
##sequence-region L0EPW3 1 107
L0EPW3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EPW3	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0EQT1 1 99
L0EQT1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQT1	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region A4GWB4 1 82
A4GWB4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4GWB4	UniProtKB	Non-terminal residue	82	82	.	.	.	.	
##sequence-region B6E4X6 1 393
##sequence-region L0ERL2 1 99
L0ERL2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ERL2	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region E2G6R5 1 99
E2G6R5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
E2G6R5	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region L0EQQ9 1 107
L0EQQ9	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQQ9	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0ERB4 1 107
L0ERB4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ERB4	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region Q53GA5 1 158
Q53GA5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region L0ERI9 1 99
L0ERI9	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ERI9	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region B7Z8X6 1 369
##sequence-region L0EQX9 1 99
L0EQX9	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQX9	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region L0EQP1 1 107
L0EQP1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQP1	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0ERJ3 1 99
L0ERJ3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ERJ3	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region E5RMA8 1 393
##sequence-region B4DMH2 1 368
##sequence-region B4E095 1 197
##sequence-region H6U5S5 1 175
H6U5S5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region L0EQV3 1 99
L0EQV3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQV3	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region L0EQ89 1 99
L0EQ89	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQ89	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region K7PPU4 1 393
##sequence-region L0ENG6 1 107
L0ENG6	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ENG6	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0ERK8 1 99
L0ERK8	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0ERK8	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region Q0ZAK1 1 155
Q0ZAK1	UniProtKB	Non-terminal residue	155	155	.	.	.	.	
##sequence-region L0EQX3 1 107
L0EQX3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQX3	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0EQ03 1 107
L0EQ03	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQ03	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region L0EQJ1 1 99
L0EQJ1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQJ1	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region L0EQY4 1 99
L0EQY4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EQY4	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region Q0ZAK0 1 116
Q0ZAK0	UniProtKB	Non-terminal residue	116	116	.	.	.	.	
##sequence-region E9PFT5 1 155
E9PFT5	UniProtKB	Non-terminal residue	155	155	.	.	.	.	
##sequence-region L0EP82 1 99
L0EP82	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L0EP82	UniProtKB	Non-terminal residue	99	99	.	.	.	.	
##sequence-region F7GNX0 1 395
##sequence-region E3U906 1 393
##sequence-region H2QC53 1 393
##sequence-region Q533U3 1 217
Q533U3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q533U3	UniProtKB	Non-terminal residue	217	217	.	.	.	.	
##sequence-region H9EYN2 1 213
H9EYN2	UniProtKB	Non-terminal residue	213	213	.	.	.	.	
##sequence-region F7H4N6 1 200
F7H4N6	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region H9FFS1 1 159
H9FFS1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
H9FFS1	UniProtKB	Non-terminal residue	159	159	.	.	.	.	
##sequence-region F7GP14 1 385
##sequence-region F7IE51 1 143
F7IE51	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region F7F8L3 1 341
##sequence-region G9KUQ2 1 348
G9KUQ2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
G9KUQ2	UniProtKB	Non-terminal residue	348	348	.	.	.	.	
##sequence-region M3YC88 1 375
##sequence-region G9KUR7 1 379
G9KUR7	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
G9KUR7	UniProtKB	Non-terminal residue	379	379	.	.	.	.	
##sequence-region L9KM90 1 424
##sequence-region Q5I2N4 1 72
Q5I2N4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q5I2N4	UniProtKB	Non-terminal residue	72	72	.	.	.	.	
##sequence-region F1SY23 1 386
##sequence-region Q0Z9Z4 1 386
##sequence-region F7AQJ5 1 71
F7AQJ5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region F7DTE6 1 436
F7DTE6	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region F7AQB0 1 87
F7AQB0	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region C3VC56 1 382
##sequence-region A4ZWB4 1 229
A4ZWB4	UniProtKB	Non-terminal residue	229	229	.	.	.	.	
##sequence-region Q8MJ40 1 82
Q8MJ40	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q8MJ40	UniProtKB	Non-terminal residue	82	82	.	.	.	.	
##sequence-region H0XGB0 1 393
##sequence-region H2NSL2 1 393
##sequence-region L5MJN5 1 403
##sequence-region L5M0C7 1 400
##sequence-region F7FQR2 1 151
##sequence-region Q8HY32 1 258
Q8HY32	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q8HY32	UniProtKB	Non-terminal residue	258	258	.	.	.	.	
##sequence-region G3WS63 1 371
##sequence-region Q9N2C6 1 181
Q9N2C6	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9N2C6	UniProtKB	Non-terminal residue	181	181	.	.	.	.	
##sequence-region A6YLR3 1 142
A6YLR3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A6YLR3	UniProtKB	Non-terminal residue	142	142	.	.	.	.	
##sequence-region Q29484 1 196
Q29484	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q29484	UniProtKB	Non-terminal residue	196	196	.	.	.	.	
##sequence-region F6TL72 1 269
F6TL72	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region E9NME8 1 381
##sequence-region G3T035 1 392
##sequence-region G3UHE5 1 367
##sequence-region G3UAZ0 1 364
##sequence-region G3ULT4 1 367
G3ULT4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region G3UJ00 1 360
##sequence-region G3UHY3 1 288
G3UHY3	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region G3UK14 1 365
##sequence-region G3U6U6 1 367
##sequence-region G3UI57 1 360
##sequence-region G3TS21 1 363
G3TS21	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region G3UDE4 1 362
##sequence-region G3U6D1 1 364
G3U6D1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region I3LA53 1 381
##sequence-region Q9N252 1 387
##sequence-region L8IPI8 1 386
##sequence-region G1RF61 1 393
##sequence-region E7FIY6 1 381
##sequence-region Q29475 1 281
Q29475	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q29475	UniProtKB	Non-terminal residue	281	281	.	.	.	.	
##sequence-region F1PI27 1 383
F1PI27	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region Q29469 1 146
Q29469	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q29469	UniProtKB	Non-terminal residue	146	146	.	.	.	.	
##sequence-region Q9TUX4 1 246
Q9TUX4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9TUX4	UniProtKB	Non-terminal residue	246	246	.	.	.	.	
##sequence-region Q28299 1 77
Q28299	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q28299	UniProtKB	Non-terminal residue	77	77	.	.	.	.	
##sequence-region Q95326 1 285
Q95326	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q95326	UniProtKB	Non-terminal residue	285	285	.	.	.	.	
##sequence-region G1MEP6 1 381
##sequence-region D2HPX0 1 354
D2HPX0	UniProtKB	Non-terminal residue	354	354	.	.	.	.	
##sequence-region G3R2U9 1 393
##sequence-region G7PTI9 1 393
##sequence-region L7N1B2 1 392
L7N1B2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region G1PZ51 1 388
G1PZ51	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region F6MDM8 1 386
##sequence-region G1U940 1 368
G1U940	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region G1SEU0 1 391
##sequence-region L5JZ91 1 378
##sequence-region Q9Z0I2 1 95
Q9Z0I2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9Z0I2	UniProtKB	Non-terminal residue	95	95	.	.	.	.	
##sequence-region Q549C9 1 390
##sequence-region Q8C526 1 314
Q8C526	UniProtKB	Non-terminal residue	314	314	.	.	.	.	
##sequence-region Q569E5 1 393
##sequence-region Q80ZA1 1 381
##sequence-region I7HIK9 1 378
##sequence-region Q9Z0I0 1 95
Q9Z0I0	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9Z0I0	UniProtKB	Non-terminal residue	95	95	.	.	.	.	
##sequence-region Q9Z0I1 1 95
Q9Z0I1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9Z0I1	UniProtKB	Non-terminal residue	95	95	.	.	.	.	
##sequence-region Q9EQL0 1 271
##sequence-region D5I217 1 51
D5I217	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I217	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region D5I218 1 51
D5I218	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I218	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region Q9Z2V1 1 95
Q9Z2V1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9Z2V1	UniProtKB	Non-terminal residue	95	95	.	.	.	.	
##sequence-region A4UD34 1 51
A4UD34	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
A4UD34	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region D5I214 1 51
D5I214	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I214	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region F1M2U8 1 349
F1M2U8	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region M0R497 1 261
##sequence-region Q920Y0 1 390
##sequence-region Q68VB0 1 391
##sequence-region D5I219 1 51
D5I219	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I219	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region Q6LEB6 1 206
Q6LEB6	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q6LEB6	UniProtKB	Non-terminal residue	206	206	.	.	.	.	
##sequence-region I3N5N2 1 391
##sequence-region D5I213 1 51
D5I213	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I213	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region D5I216 1 51
D5I216	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I216	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region L7X447 1 391
##sequence-region P89002 1 378
P89002	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region O35873 1 205
O35873	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
O35873	UniProtKB	Non-terminal residue	205	205	.	.	.	.	
##sequence-region Q64396 1 136
Q64396	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q64396	UniProtKB	Non-terminal residue	136	136	.	.	.	.	
##sequence-region Q60434 1 136
Q60434	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q60434	UniProtKB	Non-terminal residue	136	136	.	.	.	.	
##sequence-region P89004 1 238
P89004	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region D5I212 1 51
D5I212	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I212	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region P89003 1 286
P89003	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region G3GY68 1 148
##sequence-region P90332 1 286
P90332	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region L7X1P3 1 392
##sequence-region G5B5D6 1 391
##sequence-region L7X0Y9 1 392
##sequence-region Q3UGQ1 1 357
Q3UGQ1	UniProtKB	Non-terminal residue	357	357	.	.	.	.	
##sequence-region H3BK76 1 213
H3BK76	UniProtKB	Non-terminal residue	213	213	.	.	.	.	
##sequence-region Q9ER40 1 307
##sequence-region Q925E2 1 207
Q925E2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q925E2	UniProtKB	Non-terminal residue	207	207	.	.	.	.	
##sequence-region G3UYS2 1 367
##sequence-region Q91XH8 1 391
##sequence-region Q64451 1 135
Q64451	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q64451	UniProtKB	Non-terminal residue	135	135	.	.	.	.	
##sequence-region O70366 1 390
##sequence-region D5I215 1 51
D5I215	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
D5I215	UniProtKB	Non-terminal residue	51	51	.	.	.	.	
##sequence-region Q66LL7 1 100
Q66LL7	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q66LL7	UniProtKB	Non-terminal residue	100	100	.	.	.	.	
##sequence-region Q9I885 1 146
Q9I885	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9I885	UniProtKB	Non-terminal residue	146	146	.	.	.	.	
##sequence-region Q9I880 1 146
Q9I880	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9I880	UniProtKB	Non-terminal residue	146	146	.	.	.	.	
##sequence-region Q6DG24 1 434
##sequence-region B3TLB0 1 372
##sequence-region G5E3U7 1 102
G5E3U7	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
G5E3U7	UniProtKB	Non-terminal residue	102	102	.	.	.	.	
##sequence-region A5JSV4 1 365
##sequence-region Q9W680 1 265
Q9W680	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9W680	UniProtKB	Non-terminal residue	265	265	.	.	.	.	
##sequence-region S4RZ38 1 231
##sequence-region H3B1Z4 1 401
##sequence-region G9J1L8 1 387
##sequence-region Q3YAW4 1 62
Q3YAW4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q3YAW4	UniProtKB	Non-terminal residue	62	62	.	.	.	.	
##sequence-region G1DHP9 1 126
G1DHP9	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
G1DHP9	UniProtKB	Non-terminal residue	126	126	.	.	.	.	
##sequence-region C0PUM1 1 383
C0PUM1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region C0H8X1 1 396
##sequence-region F7A9U0 1 366
##sequence-region F7A9M9 1 361
##sequence-region Q6NTF1 1 362
##sequence-region H2LPP5 1 380
H2LPP5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region B2ZZT2 1 83
B2ZZT2	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
B2ZZT2	UniProtKB	Non-terminal residue	83	83	.	.	.	.	
##sequence-region H2LPP7 1 309
##sequence-region H2MLP0 1 367
##sequence-region H2MLN8 1 365
##sequence-region H2MLN7 1 432
##sequence-region Q71TU9 1 351
##sequence-region Q9W681 1 265
Q9W681	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9W681	UniProtKB	Non-terminal residue	265	265	.	.	.	.	
##sequence-region B3GNE1 1 57
B3GNE1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
B3GNE1	UniProtKB	Non-terminal residue	57	57	.	.	.	.	
##sequence-region C6ERD9 1 372
##sequence-region Q6PX73 1 237
Q6PX73	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q6PX73	UniProtKB	Non-terminal residue	237	237	.	.	.	.	
##sequence-region M7CJF0 1 287
##sequence-region I3KRX9 1 372
##sequence-region B6V3M5 1 114
B6V3M5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
B6V3M5	UniProtKB	Non-terminal residue	114	114	.	.	.	.	
##sequence-region D5KTJ0 1 377
##sequence-region Q9W682 1 265
Q9W682	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q9W682	UniProtKB	Non-terminal residue	265	265	.	.	.	.	
##sequence-region B0R0M3 1 369
##sequence-region Q502Q9 1 374
##sequence-region F1QLJ1 1 440
##sequence-region G1K2L5 1 374
##sequence-region Q4SF81 1 271
Q4SF81	UniProtKB	Non-terminal residue	271	271	.	.	.	.	
##sequence-region H3CXQ0 1 364
##sequence-region F1P1U2 1 202
##sequence-region H9GVA1 1 158
H9GVA1	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
##sequence-region A9XR54 1 365
##sequence-region H6UGW8 1 107
H6UGW8	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
H6UGW8	UniProtKB	Non-terminal residue	107	107	.	.	.	.	
##sequence-region R9TM96 1 285
R9TM96	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
R9TM96	UniProtKB	Non-terminal residue	285	285	.	.	.	.	
##sequence-region F8RKR1 1 380
##sequence-region R9XXS5 1 380
##sequence-region L7NCR5 1 392
##sequence-region K7G3P4 1 390
##sequence-region G3PK82 1 367
##sequence-region G3Q6V7 1 353
##sequence-region G3Q6V4 1 366
##sequence-region Q3YAW5 1 95
Q3YAW5	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q3YAW5	UniProtKB	Non-terminal residue	95	95	.	.	.	.	
##sequence-region F5A7P3 1 378
##sequence-region F5A7P4 1 114
F5A7P4	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
F5A7P4	UniProtKB	Non-terminal residue	114	114	.	.	.	.	
##sequence-region Q0GMA7 1 387
##sequence-region Q6PX74 1 225
Q6PX74	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
Q6PX74	UniProtKB	Non-terminal residue	225	225	.	.	.	.	
##sequence-region B5TJK8 1 393
##sequence-region Q7T1D0 1 362
##sequence-region Q5XHJ3 1 362
##sequence-region L7WGZ6 1 70
L7WGZ6	UniProtKB	Non-terminal residue	1	1	.	.	.	.	
L7WGZ6	UniProtKB	Non-terminal residue	70	70	.	.	.	.	
##sequence-region Q98SW0 1 365
##sequence-region H2U133 1 309
##sequence-region H2U134 1 354
##sequence-region H2U135 1 348
